https://crcwarriors.org/ 2026-09-07 daily 1.0 https://crcwarriors.org/ensayos-clinicos 2026-09-07 daily 0.9 https://crcwarriors.org/medicamentos 2026-09-07 weekly 0.9 https://crcwarriors.org/noticias-cientificas 2026-09-07 daily 0.8 https://crcwarriors.org/noticias 2026-09-07 daily 0.8 https://crcwarriors.org/combinaciones 2026-09-01 weekly 0.8 https://crcwarriors.org/eficacia 2026-09-01 weekly 0.8 https://crcwarriors.org/eficacia/kras 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/braf 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/msi 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/biomarker-unselected 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/her2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/msi-h 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/mmr 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/mss 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ras 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/egfr 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/pik3ca 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/nras 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/tp53 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/all 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ras%2Fbraf 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/apc 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/met 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ntrk 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ddr 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/tmb 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/alk 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/atm 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/smad4 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/pten 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ret 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/vegf 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/arid1a 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/mlh1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/pd-l1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/erbb2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ccne1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/fgfr2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/fbxw7 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/rad51 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ros1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/tie2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/blm 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ccnd1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/pole 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/erbb3 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ntrk1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/prex2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/rb1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/brca1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/cdh17 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/mutyh 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ntrk2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/pms2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/brca2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/egfr+pathway 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ntrk3 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ctnnb1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/msh2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/msi-h%2Fdmmr 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/nf1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/palb2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/actl6b 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/cdkn2a 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/idh1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/keap1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/msh6 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/notch1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/pathogenic+variants 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/pik3r1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/rad51d 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/tcf7l2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/wild-type 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/bcl2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/chek2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/erbb4 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/fgfr3 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/idh2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/smarca4 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/tgfbr2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/arid1b 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/cdk4 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/cna 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/igf1r 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/line-1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/myc 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/nthl1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/pi3k+pathway 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/pold1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/sox9 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/vegfa 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/arid2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/cdk6 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/fgfr1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/hpv 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/jag1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/map2k1 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/rad51c 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/ras%2Fbraf%2Fegfr%2Fpik3ca%2Fmap2k1%2Fmet%2Fret%2Falk%2Fros1%2Fntrk%2F 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/smad2 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/stk11 2026-09-01 monthly 0.7 https://crcwarriors.org/eficacia/vegfr 2026-09-01 monthly 0.7 https://crcwarriors.org/nuestra-historia 2026-09-01 monthly 0.7 https://crcwarriors.org/contacto 2026-09-01 monthly 0.6 https://crcwarriors.org/ayuda 2026-09-01 monthly 0.6 https://crcwarriors.org/colabora 2026-09-01 monthly 0.6 https://crcwarriors.org/donar 2026-09-01 monthly 0.8 https://crcwarriors.org/hazte-socio 2026-09-01 monthly 0.7 https://crcwarriors.org/voluntarios 2026-09-07 monthly 0.7 https://crcwarriors.org/asociacion 2026-09-01 monthly 0.7 https://crcwarriors.org/transparencia 2026-09-01 monthly 0.6 https://crcwarriors.org/informacion-economica 2026-09-01 yearly 0.5 https://crcwarriors.org/legal-privacidad 2026-09-01 yearly 0.4 https://crcwarriors.org/ensayo/NCT07487168/seguridad-y-eficacia-de-la-administracion-intraperitoneal-de-quimioterapia-pipac-con-mitomicina-como-agente-unico-en-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04443543/un-estudio-de-cohorte-prospectivo-con-diseno-adaptativo-sobre-la-estrategia-de-observacion-y-espera-en-pacientes-con-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06337552/intervencion-con-alimentos-altamente-fermentados-en-pacientes-con-cancer-colorrectal-localmente-avanzado-el-estudio-feed 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05484024/radioterapia-de-corta-duracion-seguida-de-quimioterapia-e-inhibidor-de-pd-1-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06729736/implementacion-del-programa-eras-en-pacientes-con-cancer-colorrectal-un-estudio-de-un-solo-brazo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04589468/investigando-el-efecto-del-ejercicio-en-el-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06124378/tislelizumab-neoadyuvante-en-combinacion-con-quimioterapia-para-el-tratamiento-del-cancer-colorrectal-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06293625/personalizacion-y-optimizacion-de-la-quimioterapia-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado-pero-resecable-en-pacientes-de-edad-avanzada-de-70-anos-o-mas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07297030/sib-rt-combinado-con-capox-y-un-inhibidor-de-pd-1-para-el-cancer-colorrectal-de-alto-riesgo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06368141/quimioterapia-neoadyuvante-combinada-con-terapia-secuencial-con-inhibidores-de-puntos-de-control-inmunitario-ici-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05463796/inadvance-vigilancia-prevencion-e-intervencion-en-una-poblacion-con-riesgo-de-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07264556/efecto-de-la-analgesia-con-opioides-la-analgesia-con-opioides-y-antiinflamatorios-no-esteroideos-aine-frente-a-la-analgesia-basada-en-opioides-en-los-tumores-neuroendocrinos-tne-y-la-malignidad-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06714318/smarter-utilizando-muestras-de-sangre-para-mejorar-el-cribado-del-cancer-colorrectal-basado-en-la-prueba-fit 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07503639/ensayo-clinico-umbrella-de-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07108127/eficacia-y-seguridad-de-los-biosimilares-de-trastuzumab-y-los-biosimilares-de-pertuzumab-en-combinacion-con-quimioterapia-para-el-tratamiento-neoadyuvante-de-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04678648/un-ensayo-clinico-de-rsc-1255-para-el-tratamiento-de-pacientes-con-tumores-malignos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07509424/radioterapia-neoadyuvante-de-corta-duracion-seguida-de-una-combinacion-de-disitamab-vedotina-sintilimab-y-capecitabina-en-el-cancer-colorrectal-localmente-avanzado-con-expresion-de-her2 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07622017/kortuc-krc-01-mas-radioterapia-para-la-preservacion-de-organos-en-el-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06204094/radioterapia-que-preserva-los-ganglios-linfaticos-combinada-con-quimioterapia-neoadyuvante-total-con-capox-y-sintilimab-para-el-cancer-colorrectal-medio-y-bajo-con-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06738225/microarn-sericos-como-biomarcadores-diagnosticos-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02008656/ensayo-que-evalua-la-supervivencia-libre-de-enfermedad-a-3-anos-en-pacientes-con-cancer-colorrectal-localmente-avanzado-tratados-con-quimiorradiacion-mas-quimioterapia-de-induccion-o-consolidacion-y 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06337760/jovenes-adultos-con-canceres-gastrointestinales-y-neuroendocrinos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07755124/privacion-dietetica-de-arginina-combinada-con-quimiorradioterapia-para-el-tratamiento-neoadyuvante-del-cancer-de-recto-un-ensayo-clinico-aleatorizado-y-controlado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05856305/terapia-de-radiacion-estereotactica-en-tumores-del-tracto-nervioso-con-o-sin-clorofilina 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07636382/ablacion-del-plexo-celiaco-para-el-dolor-mediante-radioterapia-estereotactica-sin-necesidad-de-simulacion-en-pacientes-con-dolor-celiaco-relacionado-con-el-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07528209/quimioterapia-neoadyuvante-con-capox-con-o-sin-pucotenlimab-mas-radioterapia-selectiva-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07528937/aplicacion-de-la-reconstruccion-tridimensional-para-la-planificacion-preoperatoria-del-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07200141/aumento-simultaneo-de-la-dosis-en-la-radioterapia-neoadyuvante-para-el-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06098560/el-adn-tumoral-circulante-ctdna-como-biomarcador-predictivo-para-la-inmunoterapia-en-pacientes-con-cancer-colorrectal-avanzado-o-localmente-avanzado-con-dmmr-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05571644/tratamiento-neoadyuvante-con-mfolfoxiri-mas-cadonilimab-ak104-frente-a-mfolfox6-en-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05973487/un-estudio-basket-de-terapias-celulares-autologas-de-tcr-t-personalizadas-en-pacientes-con-tumores-solidos-metastasicos-o-localmente-avanzados-irresecables 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07644286/un-estudio-de-fase-ii-de-pirfenidona-mas-un-inhibidor-de-pd-1-con-o-sin-radioterapia-hipofraccionada-para-el-cancer-colorrectal-refractario-pmmr-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04833387/anticuerpo-anti-pd-1-tras-quimiorradioterapia-neoadyuvante-en-cancer-colorrectal-localmente-avanzado-pmmr-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07153458/identificacion-de-nuevos-biomarcadores-no-invasivos-predictivos-y-diagnosticos-para-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05723562/un-estudio-de-dostarlimab-en-pacientes-con-cancer-colorrectal-localmente-avanzado-dmmr-msi-h-no-tratados-previamente 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06843655/marcadores-radiologicos-en-el-cancer-de-recto-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06252142/estudio-que-evalua-si-la-estrategia-de-esperar-y-observar-es-adecuada-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07071961/regorafenib-reg-y-lorigerlimab-lor-regimen-relo-en-el-tratamiento-de-pacientes-de-alto-riesgo-con-cancer-colorrectal-con-enfermedad-residual-molecular-oculta-radiograficamente-tras-la-finalizacion-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04024917/impacto-de-la-coherencia-cardiaca-en-la-ansiedad-de-pacientes-sometidos-a-cirugia-por-carcinomatosis-peritoneal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07347951/un-estudio-de-fase-ii-realizado-en-un-unico-centro-sobre-la-eficacia-y-la-seguridad-de-la-combinacion-de-radioterapia-estereotactica-scrt-con-quimioterapia-capox-serplulimab-y-bevacizumab-en 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07020468/terapia-neoadyuvante-nalirifox-para-el-cancer-colorrectal-localmente-avanzado-y-el-cancer-del-recto-superior 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05601505/estrategia-de-tratamiento-neoadyuvante-guiada-por-el-adn-tumoral-circulante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07788079/el-efecto-de-la-educacion-sobre-el-cuidado-de-la-ostomia-aplicada-con-el-metodo-de-ensenanza-y-confirmacion-en-pacientes-con-ostomia-sobre-la-capacidad-de-autocuidado-la-adaptacion-a-la-ostomia-y-la 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05663775/mesalazina-como-tratamiento-profilactico-para-prevenir-la-colitis-tras-el-tratamiento-con-ipilimumab-nivolumab-ipi-nivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06662643/un-ensayo-clinico-que-compara-la-anastomosis-de-turnbull-cutait-escalonada-con-la-anastomosis-directa-mas-ileostomia-profilactica-en-el-tratamiento-del-cancer-rectal-bajo-despues-de-la-reseccion-del 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06806046/adc-anti-ceacam5-precemtabart-tocentecan-m9140-en-participantes-chinos-con-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06271941/reduccion-de-la-recurrencia-de-la-neoplasia-tras-la-reseccion-endoscopica-de-polipos-colorrectales-grandes 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06052332/eficacia-y-seguridad-de-la-terapia-neoadyuvante-convencional-frente-a-la-terapia-neoadyuvante-total-en-pacientes-de-edad-avanzada-con-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07362823/un-estudio-sobre-la-eficacia-del-modelo-de-educacion-sobre-habitos-saludables-en-el-metaverso-basado-en-el-modelo-transteorico-para-mejorar-la-calidad-de-vida-y-modificar-el-estilo-de-vida-en 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05914766/una-intervencion-informativa-y-de-apoyo-para-pacientes-con-cancer-de-recto-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05210283/estudio-correct-sobre-la-deteccion-de-la-enfermedad-residual-minima-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07555210/estudio-piloto-de-los-cambios-en-la-densidad-mineral-osea-durante-la-inmunoterapia-anti-pd-1 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07365592/quimioterapia-neoadyuvante-anticuerpo-anti-pd-1-y-sitagliptina-para-el-cancer-colorrectal-localmente-avanzado-con-pmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07366554/factores-epigeneticos-del-adenoma-colorrectal-en-la-poblacion-coreana 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07549906/iparomlimab-tuvonralimab-neoadyuvante-mas-capeox-frente-a-iparomlimab-tuvonralimab-mas-capeox-y-propranolol-para-el-cancer-colorrectal-localmente-avanzado-pmmr-un-estudio-prospectivo-unicentrico-y 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06698757/diferentes-ciclos-de-sintilimab-neoadyuvante-preoperatorio-en-cancer-colorrectal-localmente-avanzado-con-deficiencia-en-la-reparacion-de-errores-de-emparejamiento-alta-inestabilidad-de-microsatelites 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07363863/patron-de-tratamiento-y-resultados-en-el-carcinoma-rectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06210971/quimiorradiacion-neoadyuvante-con-nal-iri-y-capecitabina-guiada-por-el-estado-de-ugt1a1-en-pacientes-con-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07371273/estudio-comparativo-sobre-la-eficacia-a-corto-y-largo-plazo-de-q-isr-isr-tradicional-y-t-isr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05426005/cadonilimab-para-el-cancer-colorrectal-avanzado-msi-h-dmmr-que-no-responde-al-bloqueo-de-pd-1-pd-l1 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07132008/quimioterapia-neoadyuvante-con-capox-mas-tislelizumab-frente-a-capox-en-cancer-colorrectal-localmente-avanzado-de-alto-riesgo-con-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02572141/quimioterapia-perioperatoria-con-folfox-o-capox-frente-a-quimioterapia-postoperatoria-para-el-cancer-colorrectal-localmente-avanzado-optical 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05118724/atezolizumab-en-pacientes-con-cancer-colorrectal-en-estadio-ii-de-alto-riesgo-y-estadio-iii-con-msi-h-dmmr-que-no-son-candidatos-para-recibir-oxaliplatino 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03466424/radioterapia-de-corta-duracion-5-x-6-gy-7-gy-8-gy-seguida-de-quimioterapia-neoadyuvante-para-el-cancer-de-recto-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06244537/estudio-sobre-la-seguridad-y-la-eficacia-de-la-tecnica-mr-linac-en-pacientes-con-cancer-colorrectal-localmente-avanzado-irresecable 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06645301/bgt007-tratamiento-para-tumores-gastrointestinales-recurrentes-o-refractarios 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04304209/anticuerpo-anti-pd1-sintilimab-en-combinacion-con-quimiorradioterapia-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05576480/scrt-penpulimab-en-combinacion-con-capeox-en-el-tratamiento-neoadyuvante-del-cancer-colorrectal-localmente-avanzado-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04512937/cirugia-asistida-por-navegacion-computarizada-para-el-cancer-colorrectal-localmente-avanzado-y-recurrente 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06369259/estudio-de-fase-2-abierto-con-avutometinib-inhibidor-de-raf-mek-en-combinacion-con-defactinib-inhibidor-de-fak-y-cetuximab-en-pacientes-con-cancer-colorrectal-avanzado-irresecable-y-resistente-a-los 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07394192/radioterapia-de-corta-duracion-con-preservacion-de-los-ganglios-linfaticos-que-drenan-el-tumor-seguida-de-inhibidores-de-pd-1-en-el-cancer-de-recto-en-estadio-ii-iii-con-pmmr-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06879899/vigilancia-guiada-por-la-enfermedad-residual-minima-en-el-cancer-de-recto-localmente-avanzado-de-localizacion-media-o-baja-surveillance-iii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07581912/tratamiento-neoadyuvante-con-fulzerasib-mas-cetuximab-n01-en-cancer-colorrectal-localmente-avanzado-con-mutacion-kras-g12c-con-o-sin-metastasis-resecables 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06762405/prodige-90-ffcd-2204-dostarlimab-neoadyuvante-con-radioterapia-de-corta-duracion-en-una-estrategia-de-observacion-y-espera-para-pacientes-con-cancer-colorrectal-localmente-avanzado-inestable-en 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05731726/serplulimab-en-combinacion-con-capeox-y-celecoxib-como-tratamiento-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07580027/radioterapia-preoperatoria-adaptativa-concomitante-con-quimioterapia-para-el-adenocarcinoma-rectal-ensayo-adaptativo-de-cancer-rectal-02 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05646511/tnt-de-quimiorradioterapia-qrt-capox-frente-a-qrt-capoxiri-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05528783/aplicacion-de-la-deteccion-mediante-fit-adn-en-el-seguimiento-tras-la-reseccion-de-cancer-colorrectal-implicaciones-para-la-vigilancia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04223102/microbioma-y-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03926338/toripalimab-como-tratamiento-neoadyuvante-con-o-sin-celecoxib-en-cancer-colorrectal-con-dmmr-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05136326/quimiorradioterapia-preoperatoria-con-capecitabina-y-temozolomida-en-cancer-colorrectal-localmente-avanzado-con-expresion-de-mgmt-silenciada-y-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06220617/estudio-multi-omico-para-la-deteccion-temprana-del-cancer-colorrectal-moed-crc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07210502/efectos-secundarios-de-la-braquiterapia-de-baja-dosis-y-la-radioterapia-ultrafraccionada-en-el-cancer-de-prostata-de-riesgo-bajo-a-intermedio 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06207981/estudio-de-fase-iii-que-evalua-la-quimioterapia-de-induccion-seguida-de-quimiorradioterapia-en-comparacion-con-la-quimiorradioterapia-estandar-para-el-carcinoma-de-celulas-escamosas-localmente 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06229041/tratamiento-neoadyuvante-total-inmunoterapia-para-cancer-colorrectal-localmente-avanzado-de-alto-riesgo-tnti 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06853769/terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT01696981/deteccion-del-cancer-colorrectal-en-pacientes-de-edad-avanzada-ensayo-de-deteccion-plco 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03997435/folfoxiri-con-o-sin-intensificacion-para-el-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07407647/dhea-vaginal-para-mejorar-la-salud-vaginal-despues-de-la-radioterapia-en-mujeres-con-cancer-ginecologico-anal-o-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07405476/zanidatamab-antes-de-la-cirugia-para-el-tratamiento-del-cancer-colorrectal-her2-positivo-en-pacientes-candidatos-a-tratamiento-con-intencion-curativa 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05239741/estudio-de-pembrolizumab-mk-3475-frente-a-quimioterapia-en-participantes-chinos-con-cancer-colorrectal-en-estadio-iv-mk-3475-c66 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07425054/quimiocirradiacion-adaptada-a-la-respuesta-del-adn-tumoral-circulante-de-vph-tratamiento-con-retifanlimab-en-cancer-anal-en-estadio-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05148767/terapia-con-irinotecan-basada-en-ugt1a1-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05984485/la-eficacia-de-la-cirugia-primaria-de-reseccion-total-del-mesorrecto-tme-frente-a-la-quimioterapia-neoadyuvante-combinada-con-la-cirugia-tme-en-el-cancer-colorrectal-localmente-avanzado-de-bajo-riesgo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03875781/estudio-de-no-inferioridad-de-la-quimioterapia-preoperatoria-sin-irradiacion-pelvica-para-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07553234/estudio-para-comprender-la-relacion-entre-la-salud-intestinal-y-las-toxicidades-del-tratamiento-hormonal-del-cancer-de-mama 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06424522/un-programa-de-manejo-intestinal-enema-rectal-retrogrado-para-el-tratamiento-del-sindrome-de-reseccion-anterior-baja-en-pacientes-con-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06812728/quimioterapia-neoadyuvante-con-folfirinox-y-quimiorradioterapia-preoperatoria-para-pacientes-con-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07080411/la-eficacia-de-la-radioterapia-adaptativa-en-linea-guiada-por-resonancia-magnetica-para-el-cancer-de-recto-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06380101/evaluacion-de-un-alimento-medico-con-restriccion-de-aminoacidos-no-esenciales-neaar-en-combinacion-con-terapia-neoadyuvante-total-para-el-cancer-colorrectal-localmente-avanzado-larc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05201430/quimioterapia-neoadyuvante-con-folfoxiri-frente-a-capeox-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06443671/fruquintinib-neoadyuvante-mas-tislelizumab-en-combinacion-con-mcapeox-frente-a-capeox-para-el-cancer-colorrectal-localmente-avanzado-de-pmmr-mss-intermedio-alto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05450029/quimiorradioterapia-neoadyuvante-mas-sintilimab-para-el-cancer-colorrectal-localmente-avanzado-de-riesgo-intermedio-alto-segun-el-indice-de-inmunidad 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06640049/un-estudio-de-dostarlimab-en-participantes-con-cancer-colorrectal-localmente-avanzado-no-tratado-en-china 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06542588/radioterapia-de-corta-duracion-seguida-de-quimioterapia-neoadyuvante-hlx07-y-serplulimab-en-el-cancer-colorrectal-localmente-avanzado-larc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07134101/terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado-en-el-recto-inferior-smarti-rc01 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06911684/radioterapia-mas-iparolimab-y-tuvonalimab-ql1706-regorafenib-y-capox-como-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado-con-pmmr-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03104439/nivolumab-e-ipilimumab-junto-con-radioterapia-en-cancer-colorrectal-y-de-pancreas-mss-y-msi-h 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06441565/fruquintinib-solo-o-en-combinacion-con-hai-folfox-para-el-cancer-colorrectal-refractario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06965166/tomografia-computarizada-con-detector-de-fotones-de-conteo-y-contraste-pcd-ct-para-la-estadificacion-local-del-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05722288/alimentacion-con-horarios-restringidos-frente-a-asesoramiento-nutricional-para-la-reduccion-de-los-efectos-secundarios-del-tratamiento-con-radioterapia-o-quimiorradioterapia-en-pacientes-con-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07176182/ensayo-clinico-de-mfolfox-neoadyuvante-mas-alvenor-en-pacientes-con-cancer-colorrectal-localmente-avanzado-larc-con-alta-expresion-de-ywhab 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02983578/danvatirsen-y-durvalumab-en-el-tratamiento-de-pacientes-con-cancer-de-pancreas-avanzado-y-refractario-cancer-de-pulmon-no-microcitico-y-cancer-colorrectal-con-deficiencia-en-la-reparacion-de-errores 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04291105/ensayo-de-fase-ii-de-voyager-v1-en-combinacion-con-cemiplimab-en-pacientes-con-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07594925/radioterapia-de-corta-duracion-seguida-de-inmunoterapia-combinada-con-quimioterapia-para-el-cancer-colorrectal-localmente-avanzado-con-estabilidad-de-microsatelites-un-ensayo-clinico-prospectivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06254521/los-efectos-del-tratamiento-neoadyuvante-con-tislelizumab-en-combinacion-con-quimioterapia-en-el-cancer-colorrectal-localmente-avanzado-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06949111/radioterapia-terapia-sistemica-como-terapia-de-conversion-para-cancer-de-colon-pmmr-mss-t4m0-neo-color 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07283939/estudio-del-algoritmo-pagoda-para-ajustar-las-dosis-de-quimioterapia-y-prevenir-retrasos-no-previstos-en-el-tratamiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05245786/un-estudio-de-investigacion-anticuerpo-m5a-marcado-con-64cu-en-combinacion-con-quimioterapia-y-radioterapia-estandar-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06402864/evaluacion-del-contacto-con-rayos-x-y-la-braquiterapia-para-la-preservacion-del-recto-en-el-adenocarcinoma-rectal-de-estadio-intermedio 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07224789/biopsia-liquida-para-la-deteccion-temprana-del-cancer-colorrectal-mediante-el-uso-de-arn-circular 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05969847/preservacion-de-organos-tras-la-terapia-neoadyuvante-total-basada-en-enverolimab-para-el-cancer-colorrectal-localmente-avanzado-en-estadio-muy-temprano 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06890624/mfolfoxiri-mas-inhibidor-de-pd-1-frente-a-mfolfox6-como-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07533227/trasplante-de-la-microbiota-intestinal-para-el-tratamiento-de-la-caquexia-tumoral-avanzada 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05605353/aprovechando-el-potencial-del-microbioma-intestinal-y-sus-metabolitos-en-el-cancer-pelvico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02843191/quimioterapia-de-consolidacion-para-el-cancer-de-recto-localmente-avanzado-ya-sea-de-localizacion-media-o-baja-tras-la-quimiorradioterapia-neoadyuvante-concurrente 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06696534/analisis-de-las-preferencias-de-los-participantes-en-relacion-con-los-metodos-de-deteccion-y-su-experiencia-en-un-programa-de-deteccion-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06783491/eficacia-del-uso-de-la-quimioterapia-neoadyuvante-con-o-sin-hipertermia-intraabdominal-en-el-tratamiento-del-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07478731/tratamiento-neoadyuvante-con-shr-1701-mas-quimiorradioterapia-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06616870/estudio-del-papel-predictivo-y-pronostico-de-las-variantes-farmacogeneticas-y-radiogenicas-en-la-respuesta-al-tratamiento-neoadyuvante-con-quimiorradiacion-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07472868/quimioterapia-neoadyuvante-con-folfoxiri-y-quimiorradioterapia-frente-a-quimioterapia-neoadyuvante-con-capox-folfox-y-quimiorradioterapia-seguida-de-cirugia-o-una-estrategia-de-observacion-activa-en 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03840239/tnt-para-aumentar-la-tasa-de-respuesta-completa-clinica-en-el-cancer-colorrectal-localizado-en-la-parte-distal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06014944/radioterapia-de-corta-duracion-combinada-con-furoquintinib-y-anticuerpo-monoclonal-anti-pd-1 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04701476/tate-y-pembrolizumab-mk3475-en-el-tratamiento-del-mcrc-y-el-nsclc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04041310/nous-209-vacuna-genetica-para-el-tratamiento-de-tumores-solidos-con-inestabilidad-de-microsatelites 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05945901/un-estudio-de-fase-ii-iii-de-hr070803-en-combinacion-con-oxaliplatino-5-fluorouracilo-folinato-de-calcio-y-bevacizumab-frente-a-folfox-en-combinacion-con-bevacizumab-para-el-tratamiento-de-primera 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06563388/radioterapia-ablativa-estereotactica-sabr-para-el-tratamiento-de-pacientes-con-cancer-metastasico-ensayo-id-comet 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07224841/desarrollo-de-un-panel-de-biomarcadores-basado-en-la-metilacion-de-la-cfdna-5mc-5hmc-para-predecir-la-eficacia-de-las-terapias-dirigidas-en-el-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07260058/terapia-con-celulas-inmunitarias-para-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07720115/ensayo-de-fase-ii-de-s-531011-en-combinacion-con-radscopal-en-pacientes-con-cancer-colorrectal-metastasico-previamente-tratados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05806931/administracion-secuencial-de-tas-ox-en-combinacion-con-tas-iri-alternada-con-bevacizumab-para-el-tratamiento-de-pacientes-con-cancer-colorrectal-metastasico-en-lineas-de-tratamiento-avanzadas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07722754/bevacizumab-sintilimab-cetuximab-e-irinotecan-en-el-cancer-colorrectal-metastasico-refractario-con-ras-de-tipo-salvaje-ensayo-bond-4 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04329494/pipac-para-el-tratamiento-de-la-carcinomatosis-peritoneal-en-pacientes-con-cancer-de-ovario-utero-apendice-colon-o-estomago 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05425940/estudio-de-xl092-atezolizumab-frente-a-regorafenib-en-participantes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07050394/un-ensayo-de-expansion-de-dosis-de-hnf4-srrna-intravenoso-para-el-cancer-colorrectal-irresecable-o-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05959356/cetuximab-y-envafolimab-mas-mfolfoxiri-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-metastasico-irresecable-del-lado-izquierdo-con-ras-braf-de-tipo-salvaje-y-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07494578/estudio-observacional-sobre-la-combinacion-de-fluoropirimidina-y-bevacizumab-en-pacientes-con-mcrc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07612007/hrx215-un-farmaco-inhibidor-de-mkk4-de-primera-generacion-para-el-tratamiento-de-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-despues-de-someterse-a-una-embolizacion-de-la-vena-porta 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07224022/cemiplimab-en-combinacion-con-fianlimab-para-el-cancer-colorrectal-no-metastasico-que-puede-ser-extirpado-quirurgicamente 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06826092/metformina-para-el-tratamiento-de-pacientes-con-mcrc-que-reciben-folfiri-mas-terapia-dirigida 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07007689/un-estudio-multi-omico-del-cancer-colorrectal-con-mutacion-braf-v600e 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07610707/ymn-a02-para-el-cancer-colorrectal-avanzado-con-pmmr-y-metastasis-hepaticas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06513221/un-estudio-prospectivo-de-cancer-colorrectal-metastasico-de-tipo-mss-que-recibe-multiples-lineas-de-quimioterapia-estandar-bevacizumab-en-combinacion-con-adebrelimab 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06992648/trifluridina-tipiracil-mas-regorafenib-frente-a-trifluridina-tipiracil-mas-bevacizumab-para-el-cancer-colorrectal-metastasico-refractario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT01762813/evaluacion-de-los-resultados-clinicamente-relevantes-y-analisis-de-biomarcadores-para-su-integracion-traslacional-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07503808/un-estudio-de-ide034-en-participantes-adultos-con-tumores-solidos-avanzados-localmente-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07007728/iparolimab-tuvonralimab-en-combinacion-con-bevacizumab-y-capeox-como-terapia-de-conversion-para-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03493048/cetuximab-mas-folfoxiri-frente-a-cetuximab-mas-folfox-en-el-tratamiento-del-cancer-colorrectal-metastasico-crclm 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03947385/estudio-de-ide196-en-pacientes-con-tumores-solidos-que-presentan-mutaciones-en-gnaq-11-o-fusiones-en-prkc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07619859/impacto-de-fusobacterium-nucleatum-en-la-respuesta-al-tratamiento-anti-egfr-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07621159/un-estudio-de-fase-ib-ii-de-hdm2017-en-combinacion-con-el-tratamiento-estandar-en-el-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07623902/evaluacion-de-la-eficacia-de-gixam-para-predecir-la-presencia-de-neoplasia-colorrectal-avanzada-y-no-avanzada-en-una-poblacion-con-resultados-negativos-en-la-prueba-de-sangre-oculta-en-heces-fit 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06111105/guia-mrd-01-crc-validacion-clinica-y-evaluacion-comparativa-de-los-mejores-diagnosticos-de-ctadn-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04564898/trifluridina-tipiracil-en-combinacion-con-capecitabina-y-bevacizumab-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05854498/irinotecan-liposomal-en-combinacion-con-tas102-y-bevacizumab-para-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05185245/trasplante-hepatico-para-metastasis-hepaticas-de-cancer-colorrectal-no-susceptibles-de-reseccion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06547385/estudio-de-ono-4578-y-xelox-folfox-mas-bevacizumab-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06470178/un-estudio-en-el-mundo-real-sobre-la-terapia-neoadyuvante-de-conversion-para-el-cancer-colorrectal-con-quimioterapia-y-agentes-dirigidos-antiangiogenicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07192068/ensayo-clinico-que-evalua-la-actividad-de-zanidatamab-en-el-tratamiento-de-pacientes-con-tumores-solidos-que-presentan-una-alteracion-en-el-gen-her2 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07752875/un-estudio-de-lg00313112-en-participantes-con-tumores-solidos-avanzados-que-presentan-una-mutacion-y220c-en-el-gen-tp53 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06699836/ensayo-de-fase-ii-clover-que-evalua-el-uso-de-leronlimab-un-farmaco-dirigido-al-ccr5-en-combinacion-con-quimioterapia-oral-y-un-regimen-enriquecido-con-un-inhibidor-del-vegf 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03303495/un-estudio-comparativo-de-folfiri-en-segunda-linea-bevacizumab-frente-a-irinotecan-bevacizumab-en-pacientes-con-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06343116/nimotuzumab-en-combinacion-con-trifluridina-tipiracil-en-el-tratamiento-del-cancer-colorrectal-metastasico-refractario 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06255379/estudio-de-fruquintinib-en-combinacion-con-tegafur-gimeracil-y-oteracil-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07042685/ensayo-clinico-de-una-terapia-basada-en-5-fluorouracilo-5-fu-en-combinacion-con-fruquintinib-en-pacientes-con-cancer-colorrectal-localmente-avanzado-irresecable-o-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07333651/implante-de-semillas-de-125i-mas-terapia-sistemica-para-el-cancer-de-pulmon-de-celulas-no-pequenas-cpcnp-u-el-cancer-colorrectal-oligoprogresivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02012699/repositorio-integral-de-cancer-para-la-investigacion-oncologica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06934018/efecto-del-ancho-del-margen-quirurgico-en-la-recurrencia-y-la-supervivencia-en-pacientes-con-oligometastasis-hepatica-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06907342/evaluacion-de-un-enfoque-de-medicina-de-precision-funcional-para-seleccionar-la-quimioterapia-en-el-cancer-colorrectal-metastasico-cosense-1 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05462236/inhibidor-de-mnk-aum001-en-combinacion-con-pembrolizumab-o-irinotecan-para-el-tratamiento-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06980532/glumetinib-en-combinacion-con-fruquintinib-en-el-tratamiento-de-la-amplificacion-de-met-o-la-sobreexpresion-de-la-proteina-en-el-cancer-colorrectal-metastasico-irresecable-en-tercera-linea-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05201352/evaluacion-de-la-eficacia-de-trifluridina-tipiracil-mas-un-anticuerpo-humano-verdadero-anti-il-1-frente-a-trifluridina-tipiracil-mas-placebo-en-pacientes-con-cancer-colorrectal-metastasico-despues 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06012734/lb-100-inhibidor-de-pp2a-y-atezolizumab-inhibidor-de-pd-l1-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06593548/lvosidenib-ak112-en-combinacion-con-capeox-y-radioterapia-en-pacientes-con-cancer-colorrectal-metastasico-irresecable-de-tipo-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05007132/trifluridina-tipiracil-mas-panitumumab-frente-a-trifluridina-tipiracil-mas-bevacizumab-como-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07536113/evaluacion-de-la-eficacia-y-la-seguridad-de-la-seleccion-basada-en-el-adn-tumoral-circulante-ctdna-para-un-nuevo-tratamiento-con-anti-egfr-en-una-cohorte-de-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04230187/bevacizumab-mas-mfolfoxiri-como-tratamiento-de-primera-linea-para-pacientes-con-cancer-colorrectal-metastasico-irresecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06728072/adicion-de-antibioticos-al-regimen-de-tratamiento-inicial-para-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04222413/metarrestin-ml-246-en-pacientes-con-tumores-solidos-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT01815359/icarus-quimioterapia-intraperitoneal-postoperatoria-epic-y-quimioterapia-intraperitoneal-hiperermica-hipec-tras-una-cirugia-citoreductora-optima-crs-para-neoplasias-del-apendice-colon-o-recto-con 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03451370/tratamiento-de-primera-linea-con-la-combinacion-de-capecitabina-y-oxaliplatino-mas-bevacizumab-en-pacientes-ancianos-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07021950/ak112-mas-folfiri-frente-a-bevacizumab-mas-folfiri-como-tratamiento-de-segunda-linea-del-cancer-colorrectal-metastasico-mss-pmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07790510/comprimidos-de-hsk42360-na-en-combinacion-con-cetuximab-con-o-sin-quimioterapia-en-el-cancer-colorrectal-metastasico-con-mutacion-braf-v600 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05755672/biomarcadores-durante-el-tratamiento-en-el-cancer-colorrectal-metastasico-para-mejorar-la-calidad-de-vida 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04796818/una-exploracion-de-investigacion-imagen-por-difusion-ponderada-con-el-modelo-de-movimiento-incoherente-intravoxel-para-la-evaluacion-de-la-respuesta-al-tratamiento-de-las-metastasis-hepaticas-del 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05382442/un-estudio-de-ak112-con-o-sin-ak117-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06849362/estudio-retrospectivo-multicentrico-sobre-la-optimizacion-de-las-estrategias-de-inmunoterapia-combinada-en-el-cancer-colorrectal-avanzado-mss-msi-l-pmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06590259/un-estudio-sobre-la-eficacia-y-la-seguridad-de-la-ablacion-multimodal-combinada-con-terapia-sistemica-en-el-tratamiento-de-la-crclm 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06974110/estudio-de-moma-341-administrado-por-via-oral-en-participantes-con-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07268677/un-estudio-clinico-de-un-solo-brazo-que-evalua-la-combinacion-de-pirfenidona-y-sintilimab-con-la-quimioterapia-neoadyuvante-estandar-en-pacientes-con-cancer-colorrectal-y-metastasis-peritoneal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07353268/estudio-de-fase-ib-ii-de-ql1706-fruquintinib-terapia-de-radiacion-concurrente-scrt-frente-a-la-terapia-estandar-de-tercera-linea-en-cancer-colorrectal-irresecable-con-metastasis-hepaticas-y-estado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05129787/ablacion-frente-a-reseccion-de-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03526835/un-estudio-del-anticuerpo-bispecifico-mcla-158-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07271355/quimioterapia-intraabdominal-en-aerosol-a-presion-con-mitomicina-para-el-tratamiento-del-cancer-de-apendice-o-de-colon-recto-irresecable-con-metastasis-peritoneales-el-ensayo-impact 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07543744/un-estudio-comparativo-de-la-farmacocinetica-la-seguridad-y-la-inmunogenicidad-de-rph-030-y-vectibix-r-en-pacientes-con-cancer-colorrectal-metastasico-con-ras-de-tipo-salvaje-como-terapia-de-primera 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05787587/un-estudio-del-inhibidor-de-parg-ide161-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05775146/radioterapia-estereotactica-ablativa-sbrt-de-metastasis-tras-el-tratamiento-neoadyuvante-para-el-cancer-colorrectal-con-metastasis-hepaticas-sincronicas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06551207/cadonilimab-en-combinacion-con-fruquintinib-y-radioterapia-estereotactica-ablativa-sbrt-como-tratamiento-de-tercera-linea-y-en-lineas-posteriores-en-pacientes-con-crc-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05747716/terapia-de-radiacion-estereotactica-sbrt-combinada-con-fruquintinib-mas-un-anticuerpo-anti-pd-1-ctla-4-como-tratamiento-de-tercera-linea-en-pacientes-con-mcrc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07355764/ma-crc-ii-016-shr-1811 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06484153/fruquintinib-y-pirfenidona-en-combinacion-con-un-anticuerpo-anti-pd-1-en-el-tratamiento-del-carcinoma-colorrectal-avanzado-o-metastasico-pmmr-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05501353/exploracion-de-biomarcadores-asociados-con-el-pronostico-del-cancer-colorrectal-recurrente-y-metastasico-tras-la-cirugia-mediante-metodos-multiomicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07550088/bal-bot-agent-797-en-crc-con-pmmr-y-metastasis-hepaticas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06829355/estudio-de-inmunoterapia-con-timalfasina-y-regimen-triple-en-cancer-colorrectal-avanzado-mss-pmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06505551/estudio-de-fase-i-ii-de-celulas-t-con-receptores-de-celulas-t-autologas-scg142-en-pacientes-con-carcinoma-positivo-para-hpv16-52 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07261709/trifluridina-tipiracil-mas-fruquintinib-frente-a-trifluridina-tipiracil-mas-bevacizumab-en-cancer-colorrectal-metastasico-refractario-un-ensayo-aleatorizado-controlado-de-etiqueta-abierta-de-no 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07359456/evaluacion-de-ivonescimab-en-combinacion-con-quimioterapia-en-pacientes-con-cancer-colorrectal-metastasico-sin-metastasis-hepaticas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04587128/terapia-anti-egfr-en-lineas-tempranas-para-facilitar-el-retratamiento-en-pacientes-seleccionados-con-mcrc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07551778/terapia-con-celulas-nk-alogenicas-combinada-con-el-tratamiento-de-mantenimiento-estandar-en-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07025239/ql1706-en-inyeccion-combinado-con-bevacizumab-y-xelox-frente-a-placebo-combinado-con-bevacizumab-y-xelox-como-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico-irresecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07553572/aplicacion-digital-para-la-monitorizacion-remota-y-el-manejo-de-los-sintomas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05759728/un-estudio-de-cna3103-celulas-car-t-autologas-dirigidas-a-lgr5-administrado-a-sujetos-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02595957/programa-de-investigacion-en-servicios-genomicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06202001/irinotecan-tas-102-mas-bevacizumab-como-terapia-de-segunda-linea-en-pacientes-con-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06980454/comparacion-de-la-farmacocinetica-en-la-fase-i-de-hlx05-frente-a-erbitux-r-en-hombres-chinos-sanos-seguridad-inmunogenicidad-y-farmacocinetica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05359393/una-terapia-combinada-que-incluye-inmunoterapia-anti-pd-1-en-cancer-de-recto-mss-con-metastasis-distal-resecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07559760/nueva-terapia-combinada-de-segunda-linea-para-el-cancer-colorrectal-metastasico-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06645236/dhf-20-1839-2-protocolo-del-estudio-clinico-de-rendimiento-para-el-kit-therascreen-r-kras-rgq-pcr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05884723/dieta-cetogenica-preoperatoria-para-la-reduccion-de-la-esteatosis-hepatica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07171554/evaluacion-de-una-prueba-diagnostica-para-identificar-los-mejores-farmacos-para-el-tratamiento-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06043466/un-ensayo-clinico-dirigido-a-las-celulas-t-con-receptor-quimerico-de-antigeno-car-t-contra-el-antigeno-cea-para-el-tratamiento-de-tumores-solidos-malignos-avanzados-cea-positivos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06268015/optimizacion-de-botensilimab-y-balstilimab-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06848465/terapia-de-radiacion-intrahepatica-guiada-por-imagenes-combinada-con-inmunoterapia-y-quimioterapia-para-el-cancer-colorrectal-con-metastasis-hepaticas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03485209/estudio-de-eficacia-y-seguridad-de-tisotumab-vedotina-en-pacientes-con-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05314400/gadoxetato-resonancia-magnetica-abreviada-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03428477/epa-para-el-ensayo-clinico-sobre-metastasis-2 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06669923/comprendiendo-las-bebidas-azucaradas-ssb-y-el-cancer-colorrectal-crc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT00722228/vacuna-contra-el-cancer-con-celulas-tumorales-completas-tanto-autologa-como-alogenica-para-tumores-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05797077/terapia-de-mantenimiento-postoperatoria-para-metastasis-hepaticas-resecables-del-cancer-colorrectal-guiada-por-ctdna 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06496919/investigacion-en-el-mundo-real-sobre-la-prevencion-y-el-tratamiento-de-la-metastasis-peritoneal-y-la-ascitis-maligna-mediante-la-infusion-intraperitoneal-de-rmhtnf-en-tumores-malignos-gastricos-y 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06456515/regorafenib-y-sintilimab-en-combinacion-con-electroacupuntura-en-crc-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07167446/potencial-neuroprotector-del-cannabidiol-cbd-en-la-prevencion-de-la-neuropatia-inducida-por-oxaliplatino-ox 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT01763125/creacion-de-un-biobanco-de-tumores-a-partir-de-muestras-de-sangre 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06208397/resonancia-magnetica-para-la-evaluacion-de-los-patrones-de-crecimiento-histopatologicos-en-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05913674/viabilidad-tecnica-de-la-quimioterapia-intraperitoneal-modificada-en-las-primeras-etapas-del-periodo-postoperatorio-mepic 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06218888/un-estudio-clinico-de-fase-ii-sobre-la-eficacia-y-la-seguridad-de-tislelizumab-en-combinacion-con-fruquintinib-y-chidamide-en-el-tratamiento-del-cancer-colorrectal-irresecable-o-avanzado-con 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07583381/un-estudio-prospectivo-sobre-una-tecnologia-de-estimacion-de-la-presion-asistida-por-subarmonicos-para-la-prediccion-temprana-de-la-respuesta-a-la-terapia-sistemica-en-metastasis-hepaticas-del-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03350126/relevancia-de-la-evaluacion-irecist-para-la-tasa-de-respuesta-global-dcr-en-pacientes-con-cancer-colorrectal-metastasico-mmr-msi-tratados-con-nivolumab-e-ipilimumab 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07587827/estudio-que-evalua-la-seguridad-la-viabilidad-y-la-eficacia-de-la-vacuna-odi-2001-una-inmunoterapia-personalizada-en-pacientes-con-cancer-colorrectal-metastasico-o-localmente-avanzado-o-cancer-de 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07409805/vacuna-ymn-136-para-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-que-presentan-progresion-tras-el-tratamiento-en-tercera-linea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05354674/firma-de-aprendizaje-profundo-multimodal-para-la-evaluacion-de-la-respuesta-al-bevacizumab-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02917707/analisis-integrativo-de-la-metastasis-hepatica-del-ccrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06229340/leflunomida-o-combinacion-de-un-inhibidor-de-mek-e-hidroxicloroquina-para-pacientes-con-mutaciones-en-ras-que-no-responden-al-tratamiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06259552/un-estudio-de-spx-303-un-anticuerpo-bispecifico-dirigido-contra-lilrb2-y-pd-l1-en-pacientes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07277322/dupilumab-y-toripalimab-como-tratamiento-neoadyuvante-en-sujetos-con-crc-mss-y-metastasis-hepaticas-resecables 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06191120/imagenes-moleculares-con-fapi-para-el-diagnostico-del-subtipo-desfavorable-cms4-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06130826/activacion-de-la-respuesta-inmune-para-el-tratamiento-del-cancer-colorrectal-metastasico-irresecable-o-del-cancer-de-mama-metastasico-con-niveles-elevados-de-cea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06977373/el-valor-de-la-tomografia-computarizada-espectral-en-la-estadificacion-precisa-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04585035/estudio-para-evaluar-d-1553-en-sujetos-con-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06967155/un-estudio-de-irinotecan-con-dabrafenib-mas-trametinib-y-anti-egfr-en-la-segunda-linea-de-tratamiento-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT01505400/ensayo-sobre-la-aplicacion-integrada-de-la-elaboracion-de-perfiles-moleculares-en-canceres-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07193862/estudio-piloto-de-un-microdispositivo-implantable-para-la-evaluacion-in-situ-de-la-respuesta-a-farmacos-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07653685/un-estudio-clinico-de-tqb2930-inyectable-y-quimioterapia-con-o-sin-bevacizumab-en-el-tratamiento-del-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02980510/comparacion-de-folfirinox-con-panitumumab-frente-a-mfolfox6-con-panitumumab-en-pacientes-con-cancer-colorrectal-metastasico-con-ras-b-raf-de-tipo-salvaje 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06226857/otras-mutaciones-en-oncogenes-que-podrian-influir-en-la-eficacia-de-los-tratamientos-anti-egfr-en-pacientes-con-cancer-colorrectal-metastasico-de-lado-izquierdo-y-con-ras-de-tipo-salvaje 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05863195/evaluacion-de-la-quimioterapia-con-bomba-de-infusion-como-complemento-a-la-quimioterapia-estandar-en-comparacion-con-la-quimioterapia-estandar-sola-en-pacientes-con-metastasis-hepaticas-irresecables 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05999370/prehabilitacion-para-pacientes-con-cancer-colorrectal-con-baja-capacidad-funcional-y-desnutricion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04714957/pitcher-heterogeneidad-de-la-carcinomatosis-peritoneal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07430527/revision-del-protocolo-para-el-tratamiento-del-cancer-colorrectal-en-atencion-secundaria 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05379595/un-estudio-de-amivantamab-en-monoterapia-y-en-combinacion-con-la-quimioterapia-estandar-en-participantes-con-cancer-colorrectal-avanzado-o-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05963490/regorafenib-solo-o-en-combinacion-con-radioterapia-hipofraccionada-de-baja-dosis-mas-toripalimab-para-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05768503/comparacion-de-chidamide-sintilimab-bevacizumab-con-el-regimen-estandar-de-segunda-linea-folfiri-bevacizumab-en-pacientes-con-mcrc-avanzado-mss-pmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06630624/determinacion-de-la-dosis-eficacia-y-respuesta-inmunologica-de-ip-001-tras-ablacion-por-microondas-mwa-o-ablacion-por-radiofrecuencia-irreversible-ire-en-pacientes-con-metastasis-hepaticas-de-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07669454/un-estudio-aleatorizado-doble-ciego-controlado-con-placebo-de-grupos-paralelos-comparativo-de-fase-iii-para-evaluar-la-eficacia-y-la-seguridad-de-las-capsulas-de-nuvastatic-r-de-300-mg-en-la 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07435584/everolimus-en-cancer-colorrectal-metastasico-con-deficiencia-de-cdk12-ever-recode 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07220174/uso-del-software-gi-genius-tm-xr-en-un-visor-de-realidad-virtual-durante-una-colonoscopia-de-rutina 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03692429/alloshrink-regimen-estandar-de-quimioterapia-e-inmunoterapia-con-celulas-t-receptor-de-antigeno-quimerico-alogenicas-basadas-en-nkg2d-cyad-101 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05838768/estudio-de-hro761-en-monoterapia-o-en-combinacion-en-pacientes-con-cancer-que-presenten-alteraciones-especificas-en-el-adn-denominadas-inestabilidad-de-microsatelites-o-deficiencia-en-la-reparacion 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07001592/inyeccion-intratumoral-it-de-vvdd-hil2-2-rg-1-para-tumores-metastasicos-gastrointestinales-y-peritoneales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07204574/estudio-de-fase-1b-iia-abierto-de-escalada-y-expansion-de-dosis-para-evaluar-la-seguridad-la-tolerabilidad-y-la-eficacia-preliminar-de-la-combinacion-de-hcb101-cetuximab-bevacizumab-y-folfox-folfiri 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03694938/deteccion-de-metastasis-cerebrales-mediante-resonancia-magnetica-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04294264/tas-102-y-oxaliplatino-para-el-tratamiento-del-cancer-colorrectal-en-estadio-iv-refractario 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06883084/relevancia-clinica-de-la-regresion-patologica-en-los-ganglios-linfaticos-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05240950/celulas-car-t-anti-cea-para-el-tratamiento-de-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05954429/un-estudio-para-evaluar-el-tratamiento-de-tercera-linea-con-fruquintinib-en-combinacion-con-serplulimab-en-pacientes-con-cancer-colorrectal-metastasico-avanzado-no-limitado-al-higado-un-estudio-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04854668/un-estudio-de-la-combinacion-de-anlotinib-clorhidrato-en-capsulas-con-quimioterapia-como-tratamiento-de-primera-linea-en-sujetos-con-cancer-colorrectal-metastasico-ras-braf-tipo-salvaje 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06300463/estudio-de-plataforma-sobre-combinaciones-de-inmunoterapia-en-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07448662/estrategias-de-tratamiento-local-para-las-metastasis-cerebrales-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04157322/marcadores-plasmaticos-de-5hmc-como-indicador-de-metastasis-peritoneal-en-cancer-colorrectal-apendicular 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07202364/un-estudio-de-yl202-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06856837/ikf-aio-quintis-evaluacion-de-fruquintinib-en-combinacion-con-tislelizumab-en-cancer-colorrectal-metastasico-con-microsatelites-estables-reparacion-deficiente-de-errores-de-apareamiento-mss-pmmr-sin 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07457541/imagenes-moleculares-de-la-expresion-de-la-proteina-de-activacion-de-fibroblastos-mediante-el-uso-de-fapi-marcado-con-tecnecio-99m-hynic 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06252649/estudio-de-sotorasib-panitumumab-y-folfiri-frente-a-folfiri-con-o-sin-bevacizumab-en-participantes-con-cancer-colorrectal-metastasico-con-mutacion-kras-p-g12c-que-no-han-recibido-tratamiento-previo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07058012/un-estudio-de-fase-ii-con-diseno-de-plataforma-para-evaluar-el-tratamiento-con-cemiplimab-en-monoterapia-o-cemiplimab-mas-fianlimab-u-otras-combinaciones-novedosas-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03829462/evaluacion-de-la-combinacion-de-regorafenib-e-irinotecan-frente-a-regorafenib-en-monoterapia-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07463599/seguridad-y-eficacia-de-tegavivint-en-pacientes-con-carcinoma-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06115733/estudio-de-fuquinitinib-en-combinacion-con-capecitabina-como-tratamiento-de-mantenimiento-de-primera-linea-en-el-tratamiento-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07700719/shr-a1904-en-el-cancer-colorrectal-avanzado-un-estudio-exploratorio 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06873763/nelmastobart-en-combinacion-con-trifluridina-tipiracil-y-bevacizumab-en-el-cancer-colorrectal-metastasico-recurrente 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05848739/un-estudio-de-fase-1-2-de-st316-en-pacientes-con-tumores-solidos-avanzados-irresecables-y-metastasicos-seleccionados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07284849/un-estudio-para-evaluar-la-eficacia-y-la-seguridad-de-la-quimioterapia-estandar-y-el-bevacizumab-con-o-sin-inca33890-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico-con 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06663839/un-estudio-de-nilk-2301-en-pacientes-con-cancer-colorrectal-localmente-avanzado-o-metastasico-con-bajo-volumen-tumoral-ltv 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05727163/folfox-administrado-por-via-hai-mas-irinotecan-intravenoso-con-o-sin-bevacizumab-frente-a-folfoxiri-sistemico-con-o-sin-bevacizumab-en-pacientes-con-metastasis-hepaticas-colorrectales-crlm 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05171660/combinacion-con-sintilimab-y-xelox-bevacizumab-como-terapia-de-primera-linea-en-el-cancer-colorrectal-metastasico-con-mutacion-en-los-genes-ras 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05967143/estudio-observacional-sir-spheres-para-el-tratamiento-de-tumores-hepaticos-irresecables-registro-sirtain 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04847063/respuesta-individual-al-tratamiento-con-quimioterapia-hipertermica-intraperitoneal-hipec-de-la-carcinomatosis-peritoneal-procedente-de-mesotelioma-peritoneal-o-proliferacion-mesotelial-atipica-o-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06525428/terapia-sistemica-estandar-combinada-con-radioterapia-en-dosis-altas-bajas-mas-toripalimab-para-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06682247/un-estudio-en-el-mundo-real-de-chidamide-en-combinacion-con-anticuerpos-anti-pd-1-pd-l1-y-agentes-antiangiogenicos-en-el-cancer-colorrectal-avanzado-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05129774/quimiorradioterapia-seguida-de-cirugia-radical-en-pacientes-con-cancer-colorrectal-con-palnm 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07211230/estudio-del-biobanco-de-colagenasa 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05933876/el-impacto-de-la-radioterapia-en-el-cancer-oligometastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06972498/estudio-multicentrico-prospectivo-ivosimab-quimioterapia-como-tratamiento-neoadyuvante-para-metastasis-hepaticas-de-crc-pmmr-mss-resecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07718490/inmunoterapia-combinada-con-simvastatina-y-terapia-dirigida-y-quimioterapia-para-el-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06493760/un-estudio-de-fase-ii-de-ssgj-707-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07255664/un-ensayo-de-fase-i-iia-fih-que-evalua-la-viabilidad-de-la-administracion-de-inmunoterapia-basada-en-til-en-pacientes-con-crc-metastasico-y-cancer-de-pancreas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02246634/deteccion-de-metastasis-sincronicas-en-el-cancer-colorrectal-mediante-resonancia-magnetica-con-difusion-serenade 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05694936/combinacion-de-valproato-sodico-con-el-tratamiento-estandar-con-anticuerpos-monoclonales-dirigidos-al-egfr-receptor-del-factor-de-crecimiento-epidermico-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07502014/un-estudio-clinico-de-iparomlimab-y-tuvonralimab-en-combinacion-con-fruquintinib-y-radioterapia-heterogenea-en-comparacion-con-fruquintinib-como-tratamiento-de-tercera-linea-y-en-lineas-posteriores 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07500298/estudio-de-fase-i-de-sar445877-en-combinacion-con-folfox6-y-bevacizumab-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-metastasico-con-estabilidad-de-microsatelites 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07030257/estudio-de-cp-383-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07228832/estudio-de-fase-iii-con-ivonescimab-o-bevacizumab-en-combinacion-con-folfox-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06944548/evaluacion-del-efecto-de-la-actividad-fisica-adaptada-sobre-la-modificacion-del-metabolismo-lipidico-durante-la-quimioterapia-para-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07221357/un-estudio-para-evaluar-la-seguridad-y-la-eficacia-de-pumitamig-en-combinacion-con-quimioterapia-frente-a-bevacizumab-en-combinacion-con-quimioterapia-en-participantes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07506109/un-estudio-de-fase-ii-de-sintilimab-en-combinacion-con-ipilimumab-n01-cetuximab-y-dabrafenib-en-pacientes-con-cancer-colorrectal-metastasico-con-microsatelites-estables-y-mutacion-braf-v600e 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06625775/estudio-abierto-con-bbo-10203-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07504523/terapia-celular-t-personalizada-ineo-vac-t01-en-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06258525/same-en-la-prevencion-de-la-lesion-hepatica-asociada-a-oxaliplatino 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04798898/mejora-de-la-supervivencia-en-metastasis-hepaticas-de-cancer-colorrectal-mediante-la-inmunostimulacion-inducida-por-ablacion-por-radiofrecuencia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07509398/fmt-en-combinacion-con-la-terapia-estandar-de-primera-linea-en-el-cancer-colorrectal-inicialmente-irresecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07743723/un-estudio-de-iov-5001-en-adultos-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07622550/un-estudio-clinico-multicentrico-de-un-solo-brazo-que-evalua-la-combinacion-de-fruquintinib-con-serplulimab-y-quimioterapia-como-tratamiento-de-primera-linea-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07750041/un-estudio-de-fase-ib-ii-sobre-la-terapia-combinada-con-sys6090-en-el-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04188145/un-estudio-aleatorizado-de-fase-iii-que-compara-el-tratamiento-de-mantenimiento-con-fluoropirimidina-bevacizumab-frente-a-fluoropirimidina-despues-de-la-quimioterapia-de-induccion-en-pacientes-con 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06282445/eficacia-y-seguridad-de-la-quimioterapia-con-xelox-oxaliplatino-capecitabina-y-bevacizumab-en-combinacion-con-adebrelimab-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07515963/fuliri-mas-terapia-dirigida-como-tratamiento-de-primera-linea-para-la-terapia-de-conversion-de-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07328087/colonyvaq-tm-una-vacuna-neoantigenica-personalizada-guiada-por-metodos-cuanticos-y-clasicos-para-el-cancer-colorrectal-en-estadio-iii-con-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04595747/evaluacion-del-farmaco-antitumoral-rogaratinib-bay-1163877-para-el-tratamiento-del-sarcoma-avanzado-con-alteracion-en-el-receptor-del-factor-de-crecimiento-de-fibroblastos-fgfr-1-4-y-en-pacientes-con 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06992258/un-ensayo-aleatorizado-de-fase-ii-que-compara-fruquintinib-y-tas-102-con-fruquintinib-en-pacientes-con-cancer-colorrectal-avanzado-metastasico-refractario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06787105/fruquintinib-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06749015/un-estudio-sobre-el-tratamiento-de-pacientes-con-cancer-colorrectal-metastasico-mcrc-con-mutacion-brafv600e 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03494946/trasplante-hepatico-en-comparacion-con-quimioterapia-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06107413/estudio-para-evaluar-los-eventos-adversos-y-los-cambios-en-la-actividad-de-la-enfermedad-en-participantes-adultos-previamente-tratados-que-reciben-abbv-400-por-via-intravenosa-iv-en-combinacion-con 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07334587/comparacion-de-la-eficacia-y-la-seguridad-entre-folfox-6-y-capox-en-el-carcinoma-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07035886/un-estudio-para-monitorizar-el-tratamiento-con-fruzaqla-en-adultos-con-cancer-colorrectal-metastasico-mcrc-en-corea-del-sur 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05427487/estudio-de-ivx037-administrado-intratumoralmente-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05093907/un-estudio-para-evaluar-la-seguridad-y-la-eficacia-de-bey1107-en-combinacion-con-capecitabina-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06195111/un-estudio-en-el-mundo-real-de-un-regimen-que-contiene-trifluridina-tipiracil-para-el-tratamiento-de-pacientes-con-mcrc-estudio-reflect 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06665087/radioterapia-ultrafraccionada-guiada-por-cga-y-tratamiento-sistemico-de-primera-linea-en-pacientes-ancianos-o-fragiles-con-cmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07775287/estudio-de-petosemtamab-mas-quimioterapia-frente-a-cetuximab-o-bevacizumab-mas-quimioterapia-en-pacientes-con-cancer-colorrectal-recurrente-irresecable-o-metastasico-con-mutaciones-ras-y-braf-de-tipo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06654037/evaluacion-de-la-adicion-de-un-farmaco-antitumoral-abemaciclib-al-tratamiento-quimioterapeutico-habitual-5-fluorouracilo-para-el-cancer-colorrectal-metastasico-y-refractario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05057052/crioablacion-combinada-con-sintilimab-mas-regorafenib-en-metastasis-hepaticas-de-cancer-colorrectal-previamente-tratadas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06270017/evaluacion-de-la-enfermedad-metastasica-y-del-tratamiento-oncologico-en-pacientes-con-cancer-de-colon-mediante-el-uso-de-avatares-de-pez-cebra 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07649655/emb-01-en-combinacion-con-quimioterapia-para-el-cancer-colorrectal-irresecable-o-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07535632/radioterapia-estereotactica-ablativa-sbrt-seguida-de-un-inhibidor-de-pd-1-bevacizumab-y-tas-102-como-terapia-de-tercera-linea-para-el-cancer-colorrectal-recurrente-o-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02394834/un-estudio-exploratorio-de-la-sensibilidad-al-tratamiento-y-los-factores-pronosticos-en-un-estudio-de-eficacia-y-seguridad-de-mfolfox6-bevacizumab-frente-a-mfolfox6-panitumumab-en-pacientes-con 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05652894/un-estudio-de-hx008-en-comparacion-con-la-quimioterapia-en-el-tratamiento-de-primera-linea-de-pacientes-con-cancer-colorrectal-metastasico-msi-h-dmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03426904/quimioterapia-neoadyuvante-con-folfox-para-pacientes-con-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07543471/un-estudio-de-fase-i-multicentrico-aleatorizado-doble-ciego-y-controlado-en-paralelo-que-compara-hlx05-n-con-erbitux-r-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07154173/analisis-exhaustivo-de-las-caracteristicas-de-la-microbiota-intestinal-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07004413/cetuximab-en-administracion-continua-o-intermitente-combinado-con-folfiri-como-tratamiento-de-primera-linea-en-pacientes-con-cancer-colorrectal-metastasico-mcrc-con-ras-braf-tipo-salvaje 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07128355/botensilimab-balstilimab-y-radioterapia-estereotactica-ablativa-sbrt-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05870800/ensayo-de-fase-ii-abierto-y-no-aleatorizado-sobre-quimioinmunoterapia-neoadyuvante-para-el-cancer-colorrectal-no-metastasico-y-resecable-nicer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06555133/y-90-capecitabina-y-atezolizumab-para-el-cancer-colorrectal-oligo-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06185556/ensayo-coldfire-iii-eficacia-de-la-electroforesis-irreversible-y-la-radioterapia-estereotactica-corporal-en-metastasis-hepaticas-de-cancer-colorrectal-perivasculares-y-peribiliares 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06643793/evaluacion-del-liposoma-de-irinotecan-ii-en-combinacion-con-5-fu-lv-y-bevacizumab-para-el-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06922383/un-estudio-clinico-de-arfolitixorina-en-pacientes-con-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07085169/trifluridina-tipiracil-a-dosis-bajas-con-bevacizumab-en-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06423937/fruquintinib-mas-camrelizumab-y-haic-en-el-tratamiento-del-cancer-colorrectal-avanzado-no-msi-h 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06698146/metastasis-colorrectal-en-el-higado-extraccion-con-trasplante-auxiliar-y-reseccion-tardia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07365527/sonoporacion-y-respuesta-del-microambiente-tumoral-en-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05985954/estudio-de-fase-1b-abierto-con-ulixertinib-y-cetuximab-o-ulixertinib-en-combinacion-con-cetuximab-y-encorafenib-en-pacientes-con-cancer-colorrectal-irresecable-o-metastasico-que-previamente-han 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07061210/un-estudio-exploratorio-de-hrs-2189-en-combinacion-con-adebrelimab-y-bp102-para-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05639413/una-cohorte-prospectiva-clinico-biologica-de-pacientes-con-cancer-colorrectal-metastasico-con-mutacion-brafv600e 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06858969/chidamida-en-combinacion-con-un-inhibidor-de-pd-1-bevacizumab-y-xelox-para-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05556473/pet-ct-con-f-triptofano-en-canceres-humanos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07224815/biomarcadores-de-cfdna-5mc-5hmc-para-predecir-la-respuesta-a-la-quimioterapia-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07262619/eik1005-002-un-estudio-de-investigacion-clinica-que-evalua-eik1005-un-inhibidor-de-la-helicasa-de-werner-como-monoterapia-y-en-combinacion-con-pembrolizumab-en-participantes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05489211/estudio-de-dato-dxd-como-monoterapia-y-en-combinacion-con-agentes-antineoplasicos-en-pacientes-con-tumores-solidos-avanzados-tropion-pantumor03 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05513716/caracterizacion-molecular-de-las-metastasis-peritoneales-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07011576/un-estudio-de-fruquintinib-mas-folfiri-como-tratamiento-de-segunda-linea-para-participantes-con-cancer-colorrectal-metastasico-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06540326/estudio-clinico-del-tratamiento-de-segunda-linea-en-el-cancer-colorrectal-avanzado-con-quimioterapia-con-bevacizumab-o-cetuximab 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07389265/continuacion-del-tratamiento-con-cetuximab-tras-la-progresion-en-primera-linea-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07395063/un-estudio-clinico-sobre-el-tratamiento-del-cancer-colorrectal-metastasico-en-segunda-linea-o-posterior 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05962502/cetuximab-mas-irinotecan-en-pacientes-con-cancer-colorrectal-metastasico-con-tipo-salvaje-de-neoras-en-terapia-de-tercera-linea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06940778/biopsia-liquida-centrada-en-las-celulas-tumorales-circulantes-y-el-adn-tumoral-circulante-como-herramienta-de-medicina-de-precision-en-los-tumores-gastrointestinales 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07397338/estudio-de-inhibidores-de-ras-on-en-combinacion-con-ivonescimab-en-pacientes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06412198/un-estudio-multicentrico-de-fase-1b-2-con-adagrasib-cetuximab-y-cemiplimab-para-el-cancer-colorrectal-metastasico-que-presenta-mutaciones-kras-g12c 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03941080/dinamica-del-microbioma-intestinal-en-el-cancer-colorrectal-metastasico-o-irresecable 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06999252/rimegepant-en-combinacion-con-un-inhibidor-de-pd-1-en-pacientes-con-cancer-colorrectal-con-metastasis-hepaticas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06047015/electroforesis-irreversible-nanoknife-r-e-inmunoterapia-para-el-tratamiento-del-cancer-colorrectal-en-estadio-iv 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06547203/cetuximab-irinotecan-y-toripalimab-en-un-estudio-de-cancer-colorrectal-derecho-ultra-seleccionado-con-mutaciones-ras-braf-de-tipo-salvaje 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07133750/pm8002-bnt327-en-combinacion-con-quimioterapia-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04743102/biopsia-multipunto-y-de-espesor-total-en-el-diagnostico-de-respuesta-clinica-completa-ccr-tras-la-terapia-neoadyuvante-para-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT01174121/inmunoterapia-con-linfocitos-infiltrantes-tumorales-para-pacientes-con-cancer-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06978400/un-estudio-de-dabrafenib-mas-cetuximab-panitumumab-con-folfox-en-la-primera-linea-de-tratamiento-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07054047/mejorando-el-diagnostico-y-el-tratamiento-de-los-pacientes-con-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06997458/biopsia-liquida-cancer-de-pulmon-y-cancer-de-colon-en-andalucia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06218810/cadonilimab-en-combinacion-con-bevacizumab-y-el-regimen-folfox-para-el-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico-avanzado-irresecable-y-de-tipo-mss-con-mutacion-en-los-genes-ras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT01531595/estudio-de-bevacizumab-en-combinacion-con-esquemas-alternos-de-xeliri-y-xelox-en-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT00569127/octreotido-acetato-e-interferon-alfa-2b-recombinante-o-bevacizumab-en-el-tratamiento-de-pacientes-con-tumor-neuroendocrino-metastasico-o-localmente-avanzado-de-alto-riesgo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06621173/un-ensayo-clinico-que-evalua-la-seguridad-y-la-eficacia-del-srrna-intravenoso-hnf4-en-el-tratamiento-de-pacientes-con-crc-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02314169/nivolumab-con-o-sin-ipilimumab-en-el-tratamiento-de-pacientes-con-cancer-metastasico-del-conducto-anal-refractario 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06959589/eficacia-y-seguridad-de-ibi351-cetuximab-en-combinacion-con-folfiri-como-tratamiento-de-primera-linea-y-de-ibi351-cetuximab-como-tratamiento-de-segunda-linea-en-el-tratamiento-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02888743/durvalumab-y-tremelimumab-con-o-sin-radioterapia-en-dosis-altas-o-bajas-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-metastasico-o-cancer-de-pulmon-no-microcitico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07066657/un-estudio-de-mrg007-arr-217-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04938986/interes-del-immunoscore-r-como-herramienta-complementaria-postoperatoria-para-la-deteccion-del-riesgo-de-recurrencia-en-pacientes-con-cancer-colorrectal-no-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05322590/bxq-350-en-pacientes-con-carcinoma-colorrectal-metastasico-de-diagnostico-reciente 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03635021/estudio-para-evaluar-la-eficacia-de-folfox-panitumumab-seguido-de-folfiri-bevacizumab-secuencia-1-frente-a-folfox-bevacizumab-seguido-de-folfiri-panitumumab-secuencia-2-en-pacientes-no-tratados-con 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06934538/ensayo-clinico-de-fase-i-de-stc-1010-una-inmunoterapia-en-pacientes-con-cancer-colorrectal-localmente-avanzado-o-metastasico-irresecable 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06446557/desescalada-o-cambio-de-tratamiento-segun-la-variacion-del-adn-tumoral-circulante-tras-2-ciclos-de-quimioterapia-combinada-mas-terapia-dirigida-en-el-cancer-colorrectal-metastasico-irresecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07253896/eficacia-y-seguridad-de-ak104-en-combinacion-con-quimioterapia-y-cetuximab-o-bevacizumab 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03965234/perfusion-pulmonar-para-el-control-de-la-enfermedad-residual-minima-en-pacientes-con-sarcoma-o-metastasis-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06275958/estudio-de-dosis-quimioterapia-con-dosis-reducidas-en-primera-linea-en-pacientes-de-edad-avanzada-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07201194/acupuntura-holistica-para-pacientes-con-nauseas-inducidas-por-la-quimioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06253520/celulas-t-autologas-modificadas-geneticamente-para-expresar-receptores-reactivos-contra-las-mutaciones-de-kras-en-combinacion-con-una-vacuna-dirigida-contra-estos-antigenos-en-participantes-con 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06500052/un-estudio-de-bl-m17d1-en-pacientes-con-cancer-gastrointestinal-her2-positivo-de-baja-expresion-localmente-avanzado-o-metastasico-y-otros-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07150247/seguridad-y-eficacia-de-ib-folfiri-en-el-cancer-colorrectal-metastasico-con-mutacion-braf-v600e 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07453875/ldrt-quimioterapia-inmunologica-secuencial-con-nips-para-metastasis-peritoneales-de-cancer-gastrico-y-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04430725/ablacion-por-microondas-o-reseccion-en-cuna-para-el-tratamiento-de-lesiones-pulmonares-de-sarcoma-y-colorrectales-estudio-allume 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07150403/quimioterapia-combinada-de-segunda-linea-folfox-o-folfiri-mas-fruquintinib-frente-a-quimioterapia-combinada-folfox-o-folfiri-mas-bevacizumab-en-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06760819/un-estudio-para-obtener-mas-informacion-sobre-la-eficacia-y-la-seguridad-del-tratamiento-con-tabletas-de-sevabertinib-bay-2927088-en-participantes-que-tienen-un-tumor-solido-con-mutaciones-del 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05248581/trasplante-hepatico-de-donante-vivo-para-metastasis-hepaticas-irresecables-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06079242/estudio-observacional-sobre-la-terapia-con-sir-spheres-para-el-tratamiento-de-tumores-hepaticos-metastasicos-irresecables-procedentes-de-cancer-colorrectal-primario 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04068610/columbia-1-nuevas-terapias-oncologicas-en-combinacion-con-quimioterapia-y-bevacizumab-como-terapia-de-primera-linea-en-el-crc-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07594626/bms-986504-en-combinacion-con-pemetrexed-para-el-tratamiento-de-tumores-solidos-metastasicos-con-delecion-de-mtap 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07693751/un-estudio-que-evalua-el-farmaco-sot109-por-primera-vez-en-pacientes-con-el-objetivo-de-determinar-su-seguridad-eficacia-y-como-el-organismo-lo-metaboliza-en-pacientes-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06462963/oligocare-twics-ensayos-dentro-de-cohortes-ensayo-comparativo-de-la-toxicidad-aguda-en-la-radioterapia-estereotactica-ablativa-sbrt-en-una-sola-fraccion-frente-a-multiples-fracciones-para-el 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05843188/estudio-de-hidroxicloroquina-con-folfiri-y-bevacizumab-en-cancer-colorrectal-metastasico-con-alto-nivel-de-dtp 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03654131/ablacion-por-microondas-frente-a-radioterapia-estereotactica-para-metastasis-hepaticas-de-cancer-colorrectal-en-enfermedad-oligometastasica-un-ensayo-prospectivo-aleatorizado-de-fase-ii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06896162/progreso-oncologia-de-precision-mediante-evaluaciones-genomicas-reflexivas-para-la-seleccion-de-estudios-y-la-supervivencia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07051785/fruquintinib-frente-a-bevacizumab-en-combinacion-con-irinotecan-liposomal-y-capecitabina-como-terapia-de-segunda-linea-para-el-cancer-colorrectal-metastasico-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07283575/uso-de-la-metilacion-del-ctdna-para-monitorizar-el-tratamiento-del-cancer-colorrectal-metastasico-promet 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05283330/seguridad-y-tolerabilidad-de-212pb-dotam-grpr1-en-sujetos-adultos-con-tumores-recurrentes-o-metastasicos-que-expresan-grpr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03164486/primer-estudio-en-humanos-mediante-tomografia-por-emision-de-positrones-que-utiliza-el-peptido-18f-v6 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04868877/estudio-de-fase-i-ii-que-evalua-mcla-129-un-anticuerpo-humano-bispecifico-anti-egfr-y-anti-c-met-en-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-avanzado-y-otros-tumores-solidos-tanto-en 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07702032/estudio-de-petosemtamab-mas-quimioterapia-frente-a-cetuximab-mas-quimioterapia-en-cancer-colorrectal-irresecable-o-metastasico-del-lado-izquierdo-con-ras-y-braf-de-tipo-salvaje 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07286695/fruquintinib-en-combinacion-con-trifluridina-tipiracil-frente-a-bevacizumab-en-combinacion-con-trifluridina-tipiracil-para-el-cancer-colorrectal-metastasico-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05262491/un-estudio-de-bl-b01d1-en-pacientes-con-tumor-gastrointestinal-localmente-avanzado-o-metastasico-y-otros-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07229872/un-estudio-clinico-de-fase-ii-de-aipalolitovorelizumab-ql1706-en-combinacion-con-fruquintinib-para-el-tratamiento-del-cancer-colorrectal-metastasico-pmmr-mss-inmunodominante-que-ha-mostrado-falta-de 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06242067/tratamiento-de-segunda-linea-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05832138/ensayo-onloop-evaluacion-de-un-nuevo-sistema-de-seguimiento-y-apoyo-para-los-supervivientes-de-cancer-infantil-en-ontario 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06053996/radioesterilizacion-hepatopulmonar-combinada-con-inmunoterapia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07244705/un-estudio-de-abt-301-mas-tislelizumab-con-bevacizumab-en-pacientes-con-cancer-colorrectal-localmente-avanzado-o-metastasico-pmmr-no-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07161115/radioterapia-dirigida-al-tumor-primario-combinada-con-quimioterapia-e-inmunoterapia-como-tratamiento-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05704010/endoscopia-con-capsula-en-el-sindrome-de-lynch 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT01915225/obtencion-de-muestras-de-tejido-tumoral-solido-de-pacientes-que-se-someten-a-una-biopsia-o-cirugia-por-determinados-tipos-de-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05197322/pembrolizumab-neoadyuvante-en-la-medicina-estratificada-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06445062/estudio-de-inhibidores-de-ras-on-en-pacientes-con-tumores-solidos-gastrointestinales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06464692/estudio-para-evaluar-los-eventos-adversos-y-como-el-telisotuzumab-adizutecan-abbv-400-administrado-por-via-intravenosa-iv-se-distribuye-por-el-organismo-de-los-participantes-adultos-con-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07610798/un-estudio-para-evaluar-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-la-actividad-antitumoral-preliminar-de-inv-8989-en-pacientes-con-tumores-solidos-avanzados-que-presentan-mutaciones-kras-g12d 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04771520/avapritinib-para-el-tratamiento-de-tumores-solidos-malignos-localmente-avanzados-o-metastasicos-con-mutacion-en-ckit-o-pdgfra 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06090994/prevencion-de-la-recurrencia-y-la-metastasis-del-cancer-colorrectal-mediante-la-comparacion-de-huaier-con-la-monoterapia-con-capecitabina 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03539822/cabozantinib-mas-durvalumab-con-o-sin-tremelimumab-en-pacientes-con-cancer-gastroesofagico-y-otras-neoplasias-gastrointestinales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03175224/estudio-apl-101-en-pacientes-con-cpncp-que-presentan-mutaciones-de-salto-del-exon-14-del-gen-c-met-y-desregulacion-de-c-met-asi-como-en-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07310537/viabilidad-del-analisis-del-adn-tumoral-circulante-ctdna-mediante-la-extraccion-automatizada-de-muestras-de-sangre-capilar 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02432963/terapia-con-vacunas-y-pembrolizumab-en-el-tratamiento-de-pacientes-con-tumores-solidos-que-no-han-respondido-a-terapias-previas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06536127/estudio-prospectivo-monocentrico-que-evalua-el-fenotipo-de-las-celulas-nk-circulantes-y-el-immunoscore-r-en-pacientes-con-cancer-colorrectal-no-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03594630/vigilancia-activa-y-quimioterapia-antes-de-la-cirugia-en-el-tratamiento-de-participantes-con-cancer-de-recto-en-estadio-ii-iii 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05931445/estudio-de-resultados-informados-por-el-paciente-mediante-un-sistema-de-monitorizacion-electronica-para-cancer-solido-avanzado-o-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06882915/eficacia-y-seguridad-de-trifluridina-tipiracil-tas-102-en-combinacion-con-bevacizumab-y-putalimab-en-el-tratamiento-de-pacientes-con-cmmr-despues-de-una-cirugia-citoreductora-un-estudio-clinico-de-un 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03678883/9-ing-41-en-pacientes-con-canceres-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06895031/estudio-de-jyp0015-en-pacientes-con-tumores-solidos-avanzados-que-presentan-mutaciones-especificas-en-ras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06287723/estudio-frances-sobre-la-evaluacion-de-la-enfermedad-residual-minima-mediante-biopsias-liquidas-en-pacientes-con-cancer-colorrectal-y-metastasis-hepaticas-french-mrd-crlm 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06995898/el-estudio-vanguard-evaluacion-de-una-nueva-forma-de-deteccion-del-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03872947/un-estudio-de-trk-950-en-combinacion-con-regimenes-de-tratamiento-contra-el-cancer-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04147078/vacuna-dendritica-personalizada-para-el-tratamiento-postoperatorio-del-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02293954/el-uso-del-anticuerpo-monoclonal-marcado-con-cobre-64-cu-64-anti-cea-m5a-en-la-tomografia-por-emision-de-positrones-pet-para-el-diagnostico-de-pacientes-con-cancer-cea-positivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07147231/evaluacion-de-la-eficacia-del-farmaco-antitumoral-pidnarulex-cx-5461-en-combinacion-con-otro-farmaco-antitumoral-cemiplimab-regn2810-en-el-tratamiento-del-cancer-colorrectal-refractario-con 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07124000/destiny-pantumour04 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07636785/un-estudio-de-fase-1-y-2-de-vmd-102-en-carcinoma-hepatocelular-y-otros-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07768358/estudio-de-continuacion-de-tucatinib 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06997497/un-estudio-clinico-de-calderasib-mk-1084-con-terapia-dirigida-y-quimioterapia-en-pacientes-con-cancer-colorrectal-mk-1084-012-kandlelit-012 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04430738/tucatinib-mas-trastuzumab-y-quimioterapia-basada-en-oxaliplatino-o-combinaciones-que-contengan-pembrolizumab-para-canceres-gastrointestinales-her2 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07341737/sl-28-para-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04557449/estudio-para-evaluar-la-seguridad-y-la-tolerabilidad-de-pf-07220060-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07780305/analisis-retrospectivo-y-prospectivo-multicentrico-de-pacientes-con-cancer-de-recto-localizado-y-no-metastasico-en-austria 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT00492999/infusion-intraarterial-hepatica-con-floxuridina-y-dexametasona-combinada-con-quimioterapia-combinada-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-que-ha-hecho-metastasis-en-el-higado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02595931/m6620-e-hidrocloruro-de-irinotecan-en-el-tratamiento-de-pacientes-con-tumores-solidos-metastasicos-o-que-no-pueden-ser-extirpados-mediante-cirugia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06342401/deteccion-temprana-del-cancer-colorrectal-en-pacientes-jovenes 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06867822/ensayo-clinico-de-proagio-en-cancer-colorrectal-avanzado-o-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06850090/radioterapia-neoadyuvante-para-el-adenocarcinoma-rectal-con-capecitabina-frente-a-tas-102-neo-react-un-ensayo-multicentrico-aleatorizado-de-fase-iii 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05629442/ctdna-y-preservacion-de-organos-respuesta-completa-patologica-en-el-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05520099/ensayo-observacional-de-multiples-cohortes-para-recolectar-muestras-de-tejido-con-el-fin-de-desarrollar-y-entrenar-una-plataforma-de-diagnostico-tumoral-en-tiempo-real 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03452774/synergy-ai-ensayo-clinico-y-registro-de-oncologia-de-precision-basados-en-inteligencia-artificial 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07361016/comparacion-de-la-reseccion-total-mesocolica-laparoscopica-y-abierta-con-ligadura-vascular-central-para-el-carcinoma-de-colon-derecho 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06652672/cirugia-conservadora-del-ganglio-centinela-y-de-los-organos-en-el-carcinoma-de-colon-en-estadio-i 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04963283/estudio-de-cabozantinib-y-nivolumab-en-cancer-colorrectal-metastasico-refractario-y-con-estabilidad-de-microsatelites-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05710406/evaluacion-del-uso-de-terapia-dirigida-a-braf-despues-de-la-cirugia-y-la-quimioterapia-estandar-en-el-cancer-de-colon-con-mutacion-braf 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05988645/eficacia-y-seguridad-de-la-colonoscopia-asistida-por-miwendo-miwendo-ii 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06314958/cancer-colorrectal-en-estadio-ii-iii-con-recurrencia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07376707/un-estudio-de-fase-i-de-tgi-5-como-monoterapia-y-en-combinacion-con-nivolumab-en-sujetos-con-tumores-solidos-avanzados-localmente-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT00335816/radioterapia-y-fluorouracilo-con-o-sin-quimioterapia-combinada-seguido-de-cirugia-en-el-tratamiento-de-pacientes-con-cancer-de-recto-en-estadio-ii-o-estadio-iii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04981119/analisis-de-tumores-solidos-para-detectar-la-perdida-de-heterocigosidad-loh-de-hla-y-aferesis-para-la-fabricacion-de-celulas-car-t 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03599752/quimioterapia-y-o-metastectomia-en-el-tratamiento-de-pacientes-con-adenocarcinoma-colorrectal-metastasico-con-metastasis-pulmonares 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05277051/estudio-de-fase-inicial-en-humanos-de-gsk4381562-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06835179/radioterapia-estereotactica-ablativa-sbrt-combinada-con-capeox-bevacizumab-e-inhibidor-de-pd-1-para-el-tratamiento-del-cancer-colorrectal-metastasico-irresecable-con-mutacion-en-ras-y-de-tipo-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07107815/un-estudio-sobre-la-prediccion-de-la-eficacia-neoadyuvante-en-el-cancer-de-recto-basado-en-la-citometria-por-resonancia-magnetica-y-la-radiomica-profunda 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07566897/un-estudio-de-fase-i-para-evaluar-la-seguridad-y-la-eficacia-de-l19il2-en-combinacion-con-ruxolitinib-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06764680/quimioterapia-oral-terapia-dirigida-e-inmunoterapia-con-o-sin-radioterapia-como-terapia-de-tercera-linea-o-posterior-para-el-cancer-colorrectal-avanzado-mss-pmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04117087/vacuna-combinada-de-peptidos-largos-dirigidos-a-kras-mutado-junto-con-nivolumab-e-ipilimumab-para-pacientes-con-cancer-colorrectal-y-cancer-de-pancreas-que-han-sido-sometidos-a-cirugia-y-presentan 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06265285/comparacion-de-la-administracion-de-nivolumab-subcutaneo-en-el-domicilio-del-paciente-frente-a-la-administracion-en-la-clinica-a-traves-del-programa-cancer-care-acceso-conectado-y-experiencia-remota 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06266832/eficacia-y-seguridad-de-la-radioterapia-de-corta-duracion-combinada-con-adebrelimab-y-la-terapia-neoadyuvante-capeox-para-la-preservacion-de-organos-en-pacientes-con-adenocarcinoma-rectal-ultra-bajo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06245356/seguridad-de-trifluridina-tipiracil-en-pacientes-con-deficiencia-de-dihidropirimidina-deshidrogenasa-diagnosticados-con-cancer-colorrectal-metastasico-o-cancer-gastroesofagico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06105021/estudio-de-fase-i-de-celulas-t-receptor-de-celulas-t-autologas-cd8-y-cd4-modificadas-geneticamente-en-sujetos-con-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06991465/preservacion-de-organos-en-el-adenocarcinoma-rectal-mediante-radioterapia-pelvica-hipofraccionada-hypo-opra 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06917079/bbo-11818-en-pacientes-adultos-con-cancer-con-mutacion-en-el-gen-kras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06936488/un-estudio-clinico-prospectivo-de-un-solo-brazo-de-etiqueta-abierta-de-fase-ii-sobre-la-eficacia-y-la-seguridad-de-ivonescimab-ak112-en-combinacion-con-tas-102-en-el-tratamiento-del-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07576725/nivolumab-a-dosis-bajas-y-con-menor-frecuencia-para-el-tratamiento-del-cancer-irresecable-o-metastasico-ensayo-afford-io 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06553885/estudio-de-fase-ii-de-enfortumab-vedotina-en-pacientes-con-cancer-colorrectal-avanzado-o-metastasico-o-carcinoma-hepatocelular 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06059963/un-estudio-observacional-prospectivo-y-multicentrico-para-la-evaluacion-del-test-signal-c 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04547166/un-estudio-clinico-para-evaluar-la-eficacia-y-la-seguridad-de-serplulimab-hlx10-en-combinacion-con-bevacizumab-hlx04-y-quimioterapia-xelox-en-pacientes-con-cancer-colorrectal-metastasico-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05627635/folfox-y-bevacizumab-en-combinacion-con-botensilimab-y-balstilimab-3b-folfox-para-el-tratamiento-del-cancer-colorrectal-metastasico-con-estabilidad-de-microsatelites-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07406126/radioembolizacion-con-itrio-90-como-terapia-neoadyuvante-con-analisis-del-perfil-de-marcadores-inmunitarios-y-dosimetria-para-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-que-podrian-ser 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04258813/creacion-de-una-red-de-atencion-oncologica-primaria-para-apoyar-la-atencion-basada-en-equipos-multidisciplinarios 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05382364/seguridad-y-farmacocinetica-de-tucatinib-mk-7119-en-participantes-chinos-con-cancer-mk-7119-002 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04607421/un-estudio-de-encorafenib-mas-cetuximab-con-o-sin-quimioterapia-en-pacientes-con-cancer-colorrectal-metastasico-no-tratado-previamente 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03587480/reseccion-mesorrectal-total-rmt-con-diseccion-de-los-ganglios-linfaticos-laterales-frente-a-rmt-tras-quimiorradioterapia-neoadyuvante 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06130280/un-estudio-sobre-la-radioterapia-estereotactica-de-cuerpo-unico-sbrt-guiada-por-resonancia-magnetica-rm-en-pacientes-con-metastasis-hepaticas-procedentes-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03715933/estudio-de-fase-i-de-inbrx-109-en-sujetos-con-tumores-solidos-avanzados-localmente-o-metastasicos-incluidos-los-sarcomas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03978078/una-base-de-datos-clinicobiologica-en-canceres-digestivos-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06067620/hemicolectomia-derecha-robotica-frente-a-hemicolectomia-derecha-laparoscopica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07417488/vacunacion-con-gucy2c-mediante-estrategia-prime-boost-para-adenocarcinoma-colorrectal-avanzado-y-adenocarcinoma-de-intestino-delgado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04684862/sistema-de-infusion-para-el-cancer-hepatico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06818812/un-estudio-para-evaluar-incb186748-en-participantes-con-tumores-solidos-avanzados-o-metastasicos-con-mutacion-kras-g12d 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05379985/estudio-de-rmc-6236-en-pacientes-con-tumores-solidos-avanzados-que-presentan-mutaciones-especificas-en-ras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06983743/un-estudio-de-eras-0015-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03087071/panitumumab-solo-o-en-combinacion-con-trametinib-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-en-estadio-iv 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07172282/infinitive-inmunoterapia-para-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07429487/evaluacion-de-la-adherencia-al-seguimiento-remoto-de-la-actividad-fisica-mediante-un-reloj-inteligente-y-su-impacto-en-la-reduccion-de-la-fatiga-3-meses-despues-de-la-quimioterapia-adyuvante-para-el 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06400160/ensayo-clinico-de-tb511-en-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07108348/nivel-de-expresion-de-adar1-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05620134/estudio-de-jk08-en-pacientes-con-cancer-localmente-avanzado-o-metastasico-irresecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07594067/celulas-tcr1188-abc-en-canceres-con-mutacion-en-el-gen-kras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06885424/un-estudio-de-seguimiento-a-largo-plazo-de-los-participantes-tratados-con-productos-de-terapia-genica-tg-de-a2-biotherapeutics-a2-bio 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07140679/inmunoterapia-toripalimab-para-reducir-el-riesgo-de-recurrencia-tras-la-cirugia-en-pacientes-con-cancer-de-colon-estadio-iib-iic-o-iii-con-deficiencia-en-la-reparacion-de-errores-de-emparejamiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06657144/un-estudio-de-chs-114-tagmokitug-en-combinacion-con-toripalimab-y-u-otros-tratamientos-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06599827/radioterapia-neoadyuvante-con-hipofraccionamiento-moderado-combinada-con-quimioterapia-e-inmunoterapia-para-el-cancer-colorrectal-localmente-avanzado-de-alto-riesgo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07435038/estudio-de-bpi-572270-en-pacientes-con-tumores-solidos-avanzados-que-presentan-mutaciones-especificas-en-ras 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04929223/un-estudio-que-evalua-la-seguridad-y-la-eficacia-de-las-terapias-dirigidas-en-subpoblaciones-de-pacientes-con-cancer-colorrectal-metastasico-intrinsic 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07673393/mejorando-la-prediccion-del-pronostico-en-el-cancer-de-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT01479608/trasplante-hepatico-y-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04616495/trasplante-hepatico-en-pacientes-con-metastasis-hepaticas-irresecables-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03755739/infusion-transarterial-intratumoral-de-inhibidores-de-puntos-de-control-mas-quimioterapia-para-la-inmunoterapia-de-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07213791/un-estudio-de-ly4337713-en-participantes-con-tumores-solidos-fap-positivos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06783569/un-estudio-de-escalada-y-expansion-en-humanos-el-primero-de-su-tipo-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03851614/estudio-del-dano-en-el-adn-la-angiogenesis-y-los-inhibidores-de-pd-l1-en-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07259304/salud-social-habitos-de-actividad-y-calidad-de-vida-en-jovenes-adultos-supervivientes-de-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05433142/estudio-de-xmab-r-819-en-pacientes-con-carcinoma-de-celulas-renales-de-tipo-claro-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06885034/un-estudio-para-evaluar-la-seguridad-y-eficacia-de-gsk5764227-solo-o-en-combinacion-con-otros-tratamientos-en-participantes-con-canceres-gastrointestinales-avanzados-que-no-pueden-ser-tratados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06789172/un-estudio-de-fase-i-el-primero-en-humanos-de-okn4395-y-pembrolizumab-en-pacientes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07695519/scarlet-estudio-observacional-italiano-prospectivo-y-multicentrico-sobre-el-tratamiento-del-cancer-de-recto-pt1 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06640166/encorafenib-cetuximab-administracion-continuada-tras-la-progresion-en-combinacion-con-folfiri-en-pacientes-con-cancer-colorrectal-metastasico-con-mutacion-braf-v600e-que-progresa-tras-el-tratamiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03740503/investigacion-genomica-de-pacientes-con-respuestas-inusuales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06823323/estudio-sobre-la-eficacia-y-la-seguridad-de-lactobacillus-johnsonii-en-combinacion-con-capeox-y-pembrolizumab-para-el-tratamiento-del-cancer-colorrectal-metastasico-mss-pmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06872606/radioterapia-de-corta-duracion-combinada-con-braquiterapia-intracavitaria-seguida-de-pucotenlimab-bevacizumab-oxaliplatino-y-trifluridina-tipiracil-tas-102-para-la-terapia-neoadyuvante-total-del 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07143487/comunicacion-familiar-tras-las-pruebas-geneticas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06792435/estudio-xnw27011-en-pacientes-con-tumores-solidos-avanzados-que-no-respondieron-a-las-terapias-estandar 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07702292/imagenes-pet-con-68ga-bed003-de-la-proteina-de-activacion-de-fibroblastos-en-indicaciones-oncologicas-seleccionadas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05947838/un-estudio-prospectivo-de-factibilidad-que-utiliza-el-ctdna-para-personalizar-la-quimioterapia-neoadyuvante-en-pacientes-con-adenocarcinoma-colorrectal-o-apendicular 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05759923/estudio-de-fase-i-el-primero-en-humanos-para-evaluar-la-seguridad-la-tolerabilidad-y-la-actividad-antineoplasica-de-oatd-02-en-pacientes-con-tumores-solidos-avanzados-y-o-metastasicos-seleccionados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02505750/seguridad-de-una-dosis-de-refuerzo-cxb-o-radioterapia-con-haz-externo-en-combinacion-con-quimiorradioterapia-neoadyuvante-para-el-adenocarcinoma-rectal-en-estadio-temprano 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06756035/ct-95-en-canceres-avanzados-asociados-con-la-expresion-de-mesotelina 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05768178/ensayo-determine-rama-de-tratamiento-05-vemurafenib-en-combinacion-con-cobimetinib-en-pacientes-adultos-con-canceres-braf-positivos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06051695/un-estudio-para-evaluar-la-seguridad-y-la-eficacia-de-la-terapia-con-celulas-car-t-dirigidas-contra-mesotelina-y-con-activacion-logica-en-participantes-con-tumores-solidos-que-expresan-msln-y-que-han 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03326791/aspirina-en-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03833700/un-estudio-de-e7386-en-participantes-con-tumores-solidos-avanzados-incluido-el-cancer-colorrectal-crc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07472686/capsuloscopia-del-intestino-delgado-en-el-sindrome-de-lynch 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04439292/evaluacion-de-trametinib-y-dabrafenib-como-un-posible-tratamiento-dirigido-en-canceres-con-alteraciones-geneticas-en-el-gen-braf-subprotocolo-h-del-estudio-match 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06631443/base-de-datos-asiatica-de-seguimiento-y-observacion-awwd 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07605702/protocolo-del-registro-clinico-del-canopy-cancer-collective 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06864338/estudio-piloto-para-la-deteccion-del-cancer-colorrectal-y-los-adenomas-avanzados-mediante-la-prueba-de-cancer-colorrectal-de-mainz-biomed 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07715903/infusion-intraarterial-hepatica-de-carfilzomib-en-participantes-con-enfermedad-metastasica-hepatica-que-previamente-recibieron-tratamiento-con-bomba-de-infusion-intraarterial-hepatica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04622423/terapias-avanzadas-para-metastasis-hepaticas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04421820/bold-100-en-combinacion-con-folfox-para-el-tratamiento-de-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04802876/eficacia-de-tislelizumab-y-spartalizumab-en-diversos-tipos-de-cancer-en-pacientes-con-tumores-que-expresan-altos-niveles-de-arnm-de-pd1 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04729322/trasplante-de-microbiota-fecal-y-reintroduccion-de-la-terapia-anti-pd-1-pembrolizumab-o-nivolumab-para-el-tratamiento-del-cancer-colorrectal-metastasico-en-pacientes-que-no-responden-a-la-terapia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05029882/estudio-para-evaluar-los-eventos-adversos-y-los-cambios-en-la-actividad-de-la-enfermedad-en-participantes-adultos-con-tumores-solidos-avanzados-que-reciben-abbv-400-intravenoso-iv-como-monoterapia-y 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03740256/adenovirus-oncolitico-bivalente-en-combinacion-con-terapia-car-vst-autologa-especifica-para-her2-tumores-solidos-avanzados-her2-positivos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07620574/estudio-de-extension-a-largo-plazo-para-participantes-que-ya-participaron-en-un-estudio-patrocinado-por-exelixis 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05059444/oracle-observacion-de-enfermedad-residual-mediante-evaluacion-con-biopsia-liquida 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06131840/un-estudio-de-sgn-ceacam5c-en-adultos-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06971848/evaluacion-de-las-pruebas-cutaneas-en-las-alergias-a-la-bioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07082439/pembrolizumab-y-odetiglucano-en-el-adenocarcinoma-colorrectal-metastasico-con-predominio-hepatico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06242470/un-estudio-de-mgc026-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07627191/agonistas-del-receptor-de-glp-1-mas-tratamiento-estandar-en-primera-linea-para-cancer-metastasico-de-pancreas-colon-o-higado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07629960/un-ensayo-clinico-de-fase-i-con-blu-924-sar449336-en-tumores-solidos-avanzados-que-presentan-mutaciones-en-el-gen-kras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04616183/ly3214996-y-cetuximab-solos-o-en-combinacion-con-abemaciclib-para-el-tratamiento-del-cancer-colorrectal-irresecable-o-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05726864/un-estudio-de-eli-002-7p-en-sujetos-con-tumores-solidos-con-mutaciones-en-kras-nras 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06462183/estudio-de-seguridad-y-eficacia-de-rgt-61159-en-adultos-con-carcinoma-adenoide-quistico-caq-o-carcinoma-colorrectal-ccr-recidivante-o-refractario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07776353/comprension-de-los-nuevos-subtipos-de-caquexia-a-traves-de-la-investigacion-epidemiologica-observacional 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03432806/un-estudio-de-imagenes-muestras-de-sangre-y-tejido-para-guiar-el-tratamiento-del-cancer-de-colon-y-los-tumores-hepaticos-relacionados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04083599/ensayo-de-seguridad-gen1042-y-actividad-antitumoral-en-participantes-con-tumores-solidos-malignos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04111172/una-vacuna-ad5-f35-hgcc-padre-para-el-tratamiento-del-adenocarcinoma-gastrointestinal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06047379/seguridad-y-eficacia-de-neo212-en-pacientes-con-astrocitoma-idh-mutado-glioblastoma-idh-silvestre-o-metastasis-cerebrales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05677113/un-estudio-de-qbeco-frente-a-placebo-en-el-tratamiento-del-cancer-colorrectal-que-se-ha-extendido-al-higado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07544589/un-estudio-de-fase-i-que-evalua-disp-10-en-participantes-con-canceres-gastrointestinales-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02073500/neoplasias-malignas-de-la-superficie-peritoneal-caracterizacion-modelos-y-estrategias-de-tratamiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07127497/estudio-clinico-sobre-la-seguridad-y-la-relacion-entre-el-uso-de-sintilimab-en-combinacion-con-quimioterapia-en-el-tratamiento-neoadyuvante-del-adenocarcinoma-rectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04704661/evaluacion-de-la-combinacion-de-dos-farmacos-antineoplasicos-ds-8201a-y-azd6738-para-el-tratamiento-de-tumores-solidos-avanzados-que-expresan-la-proteina-o-el-gen-her2-ensayo-dash 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06349642/respuesta-a-los-inhibidores-de-los-puntos-de-control-inmunitario-en-tumores-solidos-mediante-una-plataforma-de-diagnostico-tumoral-en-tiempo-real 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07358884/estudio-de-fase-i-con-qls5316-en-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04485013/ttx-080-antagonista-de-hla-g-en-sujetos-con-canceres-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07358585/un-estudio-de-fase-ib-ii-para-evaluar-hlx43-en-combinacion-con-hlx07-o-serplulimab-en-pacientes-con-cancer-colorrectal-avanzado-o-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06197425/investigar-la-eficacia-de-la-quimioterapia-en-pacientes-con-ctdna-positivo-tras-la-cirugia-y-la-quimioterapia-adyuvante-para-un-cancer-colorrectal-en-estadio-iii 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06569368/ensayo-clinico-que-utiliza-metronidazol-para-optimizar-el-microbioma-del-adenocarcinoma-rectal-que-se-somete-a-terapia-neoadyuvante 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06225011/fluoxetina-para-la-modificacion-de-las-celulas-inmunitarias-del-tumor-colorrectal-antes-de-la-cirugia-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05056077/mejorar-la-nutricion-y-la-actividad-fisica-en-pacientes-supervivientes-de-cancer-herramientas-para-mantenerse-en-forma 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06101277/terapia-ablativa-local-para-tumores-malignos-oligoprogresivos-del-tracto-gastrointestinal-livelong 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06940102/estudio-en-el-mundo-real-sobre-el-acetato-de-megestrol-nanocristalino-para-la-caquexia-en-tumores-digestivos-avanzados-tratados-con-inhibidores-de-la-tirosina-quinasa-itq 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05504252/metimmox-2-cancer-colorrectal-metastasico-pmmr-mss-potenciacion-de-la-inmunidad-antitumoral-mediante-oxaliplatino 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06703632/evaluacion-de-la-eficacia-de-prevecol-como-metodo-de-segunda-linea-para-la-deteccion-precoz-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04969315/tt-10-port-6-y-tt-4-port-7-como-agentes-unicos-y-en-combinacion-en-sujetos-con-tumores-solidos-avanzados-seleccionados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06147037/un-estudio-de-fase-i-de-escalada-de-dosis-de-225ac-fpi-2068-en-pacientes-adultos-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06717295/el-estudio-ccaned-cipher-deteccion-temprana-del-cancer-y-monitorizacion-de-la-respuesta-al-tratamiento-mediante-el-analisis-transcriptomico-basado-en-inteligencia-artificial-de-las-plaquetas-y-las 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06040541/estudio-de-rmc-9805-en-participantes-con-tumores-solidos-con-mutacion-kras-g12d 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02874885/celulas-tumorales-circulantes-en-pacientes-con-cancer-de-recto-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06793137/modulacion-del-microbioma-intestinal-con-antibioticos-en-el-tratamiento-neoadyuvante-del-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06330064/un-estudio-para-evaluar-la-eficacia-y-la-seguridad-de-ifinatamab-deruxtecan-i-dxd-en-sujetos-con-tumores-solidos-recurrentes-o-metastasicos-ideate-pantumor02 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05482516/evaluacion-de-nuevas-terapias-en-canceres-gastrointestinales-con-ctdna-positivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04094688/vitamina-d3-en-combinacion-con-quimioterapia-y-bevacizumab-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-avanzado-o-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07397442/radioterapia-de-corta-duracion-combinada-con-quimioterapia-e-inmunoterapia-en-el-cancer-de-recto-localmente-avanzado-de-estadio-intermedio-bajo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06709885/combinacion-de-un-inhibidor-de-hdac-con-quimioinmunoterapia-en-el-tratamiento-neoadyuvante-del-cancer-colorrectal-localmente-avanzado-con-pmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07020117/un-estudio-de-225ac-ac-aky-1189-en-pacientes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07129512/hemostasia-con-clipaje-ultrasonico-frente-al-clipaje-convencional-en-la-cirugia-laparoscopica-de-colon-y-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04980287/metastasis-en-el-mesogastrio-en-el-cancer-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05277766/irinotecano-nano-liposomal-aerosolizado-administrado-por-via-intraperitoneal-nal-iri-en-la-carcinomatosis-peritoneal-secundaria-al-cancer-gastrointestinal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06879873/vigilancia-guiada-por-la-enfermedad-residual-minima-en-el-adenocarcinoma-de-colon-operable-estadios-i-iii-surveillance-i 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05610163/evaluacion-de-la-adicion-de-un-farmaco-antitumoral-el-irinotecan-al-tratamiento-de-quimioterapia-estandar-folfox-tras-la-radioterapia-prolongada-en-pacientes-con-cancer-de-recto-en-estadio-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07261631/estudio-de-fase-i-de-177lu-lu-dfc413-en-pacientes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06619886/terapia-con-celulas-t-modificadas-con-tcr-dirigido-a-tp53-r248-para-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06028724/un-estudio-sobre-la-prevalencia-de-mutaciones-clinicamente-relevantes-en-tumores-solidos-caracterizados-mediante-metodos-de-secuenciacion-de-nueva-generacion-en-el-analisis-de-biopsia-liquida-popcorn 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07670312/evaluacion-de-xya02-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06926374/evaluacion-prospectiva-del-sistema-quirurgico-sentire-de-cornerstone-robotics-en-cirugias-mayores-gastrointestinales-y-urologicas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07159048/seguridad-eficacia-y-respuesta-inmune-de-la-terapia-termica-multimodal-en-el-tratamiento-de-tumores-hepaticos-malignos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07258797/radioterapia-de-ciclo-corto-o-de-ciclo-largo-como-terapia-neoadyuvante-total-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05789069/un-estudio-de-hfb200603-como-agente-unico-y-en-combinacion-con-tislelizumab-en-pacientes-adultos-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07468630/tolecizumab-mas-quimioinmunoterapia-para-el-adenocarcinoma-colorrectal-localmente-avanzado-con-pmmr-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06919510/un-estudio-de-fase-ii-sobre-radioterapia-neoadyuvante-de-corta-duracion-seguida-de-ivonescimab-y-quimioterapia-en-cancer-colorrectal-localmente-avanzado-pmmr-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07714538/validacion-limitada-de-la-investigacion-sobre-el-aliento-para-la-deteccion-del-cancer-gastrointestinal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04017650/encorafenib-cetuximab-y-nivolumab-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-irresecable-o-metastasico-con-microsatelites-estables-y-mutacion-brafv600e 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04907643/realidad-virtual-para-el-manejo-del-dolor-en-pacientes-con-cancer-gastrointestinal-con-el-fin-de-mejorar-los-resultados-informados-por-los-pacientes 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06523582/bases-geneticas-de-los-tumores-neuroendocrinos-en-pacientes-mexicanos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02688712/estudio-exist-de-ly2157299-galunisertib-en-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07160647/eficacia-y-seguridad-de-la-terapia-neoadyuvante-con-iparomlimab-y-tuvonralimab-en-el-cancer-colorrectal-localmente-avanzado-msi-h-dmmr-un-estudio-prospectivo-de-un-solo-brazo-neo-it 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07732686/analisis-de-los-compuestos-organicos-volatiles-presentes-en-el-aliento-mediante-espectrometria-de-masas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07733817/impacto-de-la-suplementacion-con-probioticos-en-la-neuropatia-inducida-por-la-quimioterapia-adyuvante-en-pacientes-con-cancer-de-colon-un-estudio-aleatorizado-de-fase-iii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05673148/estudio-erasur-evaluacion-de-la-adicion-de-terapia-ablativa-total-al-tratamiento-sistemico-habitual-en-pacientes-con-cancer-colorrectal-metastasico-limitado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05443087/monitorizacion-de-la-terapia-dirigida-con-farmacos-en-la-oncologia-digestiva 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07454642/ava6103-en-pacientes-con-tumores-solidos-avanzados-localmente-o-metastasicos-seleccionados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07623369/un-estudio-de-fase-i-en-humanos-con-hh160-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06077591/validacion-clinica-prospectiva-de-la-secuenciacion-de-nueva-generacion-ngs-y-la-terapia-guiada-mediante-organoides-tumorales-derivados-del-paciente-pdo-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06010862/estudio-clinico-de-terapia-car-t-dirigida-contra-el-cea-para-tumores-solidos-malignos-avanzados-metastasicos-cea-positivos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05215574/estudio-de-ngm831-como-monoterapia-y-en-combinacion-con-pembrolizumab-o-pembrolizumab-y-ngm438-en-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07145255/estudio-de-fase-i-ii-para-determinar-la-dosis-evaluar-la-seguridad-y-la-farmacocinetica-en-tumores-solidos-avanzados-y-refractarios 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07623642/un-estudio-de-fase-ii-de-gv20-0251-en-combinacion-con-anticuerpos-monoclonales-anti-pd-1-en-pacientes-con-tumores-solidos-irresecables-localmente-avanzados-o-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04535401/evaluacion-de-la-adicion-de-un-farmaco-antitumoral-bay-1895344-a-la-quimioterapia-estandar-con-folfiri-en-canceres-avanzados-o-metastasicos-del-estomago-e-intestinos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07318805/un-estudio-para-evaluar-el-medicamento-pf-08032562-en-personas-con-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06839105/un-estudio-clinico-para-evaluar-la-seguridad-y-la-tolerabilidad-de-awt020-en-pacientes-con-tumores-malignos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06342440/deteccion-temprana-de-adenomas-avanzados-y-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05736731/un-estudio-para-evaluar-la-seguridad-y-la-eficacia-de-a2b530-una-terapia-car-t-con-activacion-logica-en-participantes-con-tumores-solidos-que-expresan-cea-y-que-han-perdido-la-expresion-de-hla-a-02 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05334069/recopilacion-de-muestras-de-sangre-de-pacientes-con-y-sin-cancer-para-evaluar-pruebas-de-deteccion-temprana-del-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02628067/estudio-de-pembrolizumab-mk-3475-en-participantes-con-tumores-solidos-avanzados-mk-3475-158-keynote-158 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02568267/estudio-basket-de-entrectinib-rxdx-101-para-el-tratamiento-de-pacientes-con-tumores-solidos-que-presentan-reordenamientos-fusiones-en-los-genes-ntrk-1-2-3-trk-a-b-c-ros1-o-alk 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02292641/mas-alla-del-origen-en-el-microentorno-tumoral 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07339904/ensayo-prolars-estudio-prospectivo-y-longitudinal-de-seguimiento-del-sindrome-de-reseccion-anterior-baja-lars-y-la-puntuacion-corefo-tras-la-cirugia-de-recto-en-pacientes-sometidos-a-cirugia-primaria 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07795749/fase-ii-paclitaxel-intratecal-mas-terapia-sistemica-en-cancer-gastrointestinal-con-carcinomatosis-peritoneal-stopgap-b 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07543848/un-estudio-exploratorio-prospectivo-multicentrico-de-un-solo-brazo-de-fase-ii-para-evaluar-la-combinacion-de-serplulimab-con-el-virus-oncolitico-h101-radioterapia-de-corta-duracion-y-quimioterapia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07795528/monitoreo-de-ctdna-mrd-en-pacientes-con-adenocarcinoma-de-colon-en-estadio-i-iii-susceptible-de-reseccion-quirurgica-y-con-mutaciones-oncogenicas-un-estudio-de-cohortes-multicentrico-y-prospectivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07549399/terapia-neoadyuvante-inmunooncologica-dirigida-con-radioterapia-estereotactica-y-quimioterapia-para-pacientes-con-cancer-de-vejiga-de-alto-riesgo-con-pmmr-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05531045/18ffdg-pet-ct-para-la-evaluacion-temprana-de-la-eficacia-de-la-quimioterapia-en-el-adenocarcinoma-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06711211/registro-espanol-de-tumores-digestivos-retud 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03228667/quilt-3-055-un-estudio-sobre-la-combinacion-de-inmunoterapias-en-pacientes-que-previamente-han-recibido-tratamiento-con-inhibidores-de-puntos-de-control-inmunitario 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06281678/un-estudio-de-ibi363-en-sujetos-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05731271/un-estudio-de-fase-1-primero-en-humanos-de-tst003-en-sujetos-con-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05108428/radioterapia-adaptativa-para-el-adenocarcinoma-rectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04281667/preparacion-mecanica-del-intestino-y-antibioticos-orales-frente-a-la-preparacion-mecanica-del-intestino-unicamente-en-pacientes-sometidos-a-cirugia-rectal-previa 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04693377/crioablacion-combinada-con-radioterapia-estereotactica-de-cuerpo-completo-para-el-tratamiento-de-metastasis-oseas-dolorosas-el-ensayo-crome 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06764771/un-estudio-de-bms-986488-como-terapia-unica-y-en-combinacion-en-participantes-con-tumores-malignos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06951503/ak112-y-quimioterapia-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03303547/concordancia-entre-el-diagnostico-por-imagen-y-el-diagnostico-patologico-de-depositos-tumorales-extranodales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05706129/un-estudio-para-evaluar-la-seguridad-la-tolerabilidad-y-las-caracteristicas-de-imagen-de-68ga-ga-dpi-4452-y-para-evaluar-la-seguridad-la-tolerabilidad-y-la-eficacia-de-177lu-lu-dpi-4452-en 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05462717/estudio-de-escalada-de-dosis-y-expansion-de-dosis-de-rmc-6291-en-monoterapia-en-sujetos-con-tumores-solidos-avanzados-con-mutacion-krasg12c 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06728358/el-tratamiento-futuro-de-los-pacientes-con-neoplasias-del-tracto-gastrointestinal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04920032/estudio-del-cambio-en-el-tratamiento-guiado-por-ctdna-en-casos-de-enfermedad-residual-minima-refractaria-en-adenocarcinomas-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04282044/estudio-de-crx100-como-monoterapia-y-en-combinacion-con-pembrolizumab-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02863107/cancer-colorrectal-de-inicio-temprano 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04165772/estudio-de-la-administracion-de-un-tratamiento-de-bloqueo-de-pd-1-como-terapia-de-induccion-en-sujetos-con-tumores-solidos-avanzados-localmente-y-con-deficiencia-en-la-reparacion-de-errores-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07432633/imagen-pet-con-18f-fpyqcp-de-la-proteina-de-activacion-de-fibroblastos-en-indicaciones-oncologicas-seleccionadas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07014254/estudio-terapeutico-de-177lu-ctr-fapi-en-tumores-malignos-avanzados-metastasicos-del-sistema-digestivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06307925/un-estudio-de-fase-i-para-evaluar-la-seguridad-la-farmacocinetica-y-la-actividad-antitumoral-de-hc010-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05877599/un-estudio-de-nt-175-en-sujetos-adultos-con-tumores-solidos-avanzados-irresecables-y-o-metastasicos-que-son-positivos-para-hla-a-02-01-y-la-mutacion-tp53-r175h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07227168/un-estudio-de-stro-004-en-adultos-con-cancer-metastasico-refractario-recurrente 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04606472/un-estudio-de-si-b003-un-anticuerpo-bispecifico-anti-pd-1-ctla-4-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07223424/preferencias-del-paciente-con-respecto-a-la-administracion-subcutanea-frente-a-la-intravenosa-de-inmunoterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03368963/tas102-en-combinacion-con-nal-iri-en-canceres-avanzados-del-tracto-gastrointestinal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07691632/serplulimab-mas-decitabina-y-capox-antes-de-la-cirugia-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07281768/quimioterapia-con-capecitabina-oxaliplatino-y-cemiplimab-con-o-sin-fianlimab-o-regn7075-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06588569/estudio-multi-o-mico-de-ablacion-multimodal-y-de-imagen-molecular-en-tumores-hepaticos-malignos-de-origen-digestivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07284394/quimioterapia-dirigida-al-higado-tras-la-cirugia-de-metastasis-hepaticas-del-cancer-colorrectal-en-pacientes-con-alto-riesgo-de-recurrencia-de-la-enfermedad 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02997228/estudio-commit-evaluacion-de-la-adicion-de-atezolizumab-a-la-quimioterapia-combinada-o-de-atezolizumab-en-monoterapia-para-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07156682/ql1706-mas-xelox-como-terapia-neoadyuvante-para-el-cancer-de-colon-en-estadio-clinico-iii-con-msi-s-pmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07292298/estudio-de-fase-ii-ensayo-de-un-solo-brazo-sobre-braquiterapia-en-pacientes-con-cancer-de-recto-y-adenocarcinoma-residual-localizado-en-la-parte-inferior-tras-la-terapia-neoadyuvante-total-con-el 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06685276/seguridad-y-eficacia-de-fruquintinib-mas-chidamide-y-sintilimab-en-el-tratamiento-de-tercera-linea-o-posterior-del-cancer-colorrectal-metastasico-mss-pmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07488676/un-estudio-de-asp546c-en-adultos-con-cancer-gastroesofagico-cancer-de-pancreas-u-otros-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06679673/shr-1701-en-combinacion-con-shr2554-y-bp102-para-el-cmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07721181/escalada-de-la-dosis-de-radioterapia-para-el-manejo-no-quirurgico-del-cancer-colorrectal-localmente-recurrente-no-susceptible-de-reseccion-step-up 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06449989/comparacion-de-la-concordancia-molecular-genetica-del-tumor-primario-y-las-metastasis-cerebrales-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06938490/estudio-de-los-fallos-en-la-anastomosis-de-la-reseccion-de-cancer-colorrectal-con-preservacion-de-la-primera-arteria-sigmoidea-o-de-la-arteria-colica-izquierda-y-linfadenectomia-d3 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07300631/estudio-de-registro-postcomercializacion-de-spaceoar 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07722442/intervencion-conductual-personalizada-en-los-programas-de-deteccion-del-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04991948/estudio-del-tratamiento-con-pembrolizumab-tras-la-administracion-de-cyad-101-con-acondicionamiento-previo-con-folfox-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07616297/una-dosis-de-radiacion-mas-alta-dirigida-al-tumor-podria-ayudar-a-evitar-la-cirugia-en-pacientes-con-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05676190/estudio-clinico-sobre-la-eficacia-de-las-celulas-asesinas-inducidas-por-factores-celulares-autologas-en-el-tratamiento-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02864485/trasplante-hepatico-de-donante-vivo-para-metastasis-hepaticas-de-cancer-colorrectal-irresecable 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07737600/un-estudio-de-la-terapia-combinada-con-mrg007-para-el-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06118658/quimioterapia-secuencial-seguida-de-tislelizumab-tras-reseccion-radical-en-pacientes-con-dmmr-msi-h-o-mutaciones-en-los-genes-pole-pold1 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07738042/para-evaluar-un-estudio-de-fase-ii-en-un-unico-brazo-sobre-el-trasplante-de-microbiota-intestinal-combinado-con-inmunoterapia-neoadyuvante-y-quimiorradioterapia-para-el-cancer-colorrectal-localmente 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07230639/radioterapia-hipofraccionada-que-preserva-los-ganglios-combinada-con-quimioterapia-e-inhibidor-de-pd-1-en-cancer-colorrectal-localmente-avanzado-de-alto-riesgo-con-pmmr-mss-un-ensayo-prospectivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06308445/estudio-de-seguridad-sobre-el-uso-de-rapamicina-en-ninos-con-poliposis-adenomatosa-familiar 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07512232/lavado-intraoperatorio-del-recto-para-prevenir-la-recurrencia-local-tras-la-reseccion-laparoscopica-del-cancer-de-recto-medio-a-bajo-un-ensayo-aleatorizado-multicentrico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07510932/fruquintinib-en-pacientes-con-cancer-colorrectal-metastasico-refractario-a-las-quimioterapias-estandar-en-corea-del-sur-first-k 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07031570/eficacia-y-seguridad-de-la-combinacion-de-deb-tace-con-haic-frente-a-haic-sola-en-pacientes-con-metastasis-hepaticas-irresecables-de-cancer-colorrectal-crlm 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07511413/galenos-1-en-pacientes-con-cancer-de-cabeza-y-cuello-pulmon-y-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06995924/mejora-de-la-adherencia-a-los-programas-de-vigilancia-en-pacientes-supervivientes-de-cancer-colorrectal-mediante-la-implementacion-de-programas-de-apoyo-y-educacion-en-linea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07750951/estudio-clinico-de-fase-ii-de-un-solo-brazo-para-evaluar-la-seguridad-y-la-eficacia-de-sintilimab-en-combinacion-con-ibi-310-y-quimioterapia-como-terapia-neoadyuvante-para-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02107105/evaluacion-de-la-calidad-de-vida-y-las-utilidades-tras-el-tratamiento-quirurgico-del-cancer-de-recto-en-estadio-i-iv 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT01696994/deteccion-del-cancer-de-ovario-en-pacientes-de-edad-avanzada-ensayo-de-deteccion-plco 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05969860/terapia-dirigida-contra-el-cancer-administrada-en-el-domicilio-del-paciente-frente-a-la-administracion-en-clinica-para-el-tratamiento-de-pacientes-con-cancer-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03179540/manejo-no-quirurgico-del-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07138859/errores-tecnicos-intraoperatorios-en-la-hemicolectomia-radical-derecha-realizada-con-cirugia-robotica-frente-a-la-laparoscopica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07514754/galenos-2-inmunonutricion-en-pacientes-con-cancer-de-cabeza-y-cuello-pulmon-y-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07522320/costos-de-la-endoscopia-superior-de-deteccion-y-la-carga-economica-del-tratamiento-del-cancer-gastrico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04889742/reirradiacion-con-hipertermia-en-tumores-recurrentes-locorregionales 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06126419/aplicacion-de-la-terapia-con-insulina-en-dosis-altas-para-mejorar-la-funcion-y-regeneracion-hepatica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07759960/reseccion-endoscopica-de-la-mucosa-mediante-tecnica-subacuatica-versus-diseccion-endoscopica-submucosa-para-el-tratamiento-de-tumores-neuroendocrinos-rectales-pequenos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06678919/registro-agmt-de-cancer-colorrectal-metastasico-mcrc-en-tercera-linea-de-tratamiento-y-posteriores 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05479240/quimiorradioterapia-neoadyuvante-combinada-con-tislelizumab-en-el-tratamiento-del-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07522294/optimizacion-y-estandarizacion-de-la-cirugia-robotica-transanal-minimamente-invasiva-mediante-un-unico-puerto-para-la-reseccion-de-tumores-rectales 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07007767/evaluacion-de-sintilimab-bevacizumab-decitabina-para-el-cancer-colorrectal-avanzado-pmmr-mss-tras-dos-o-mas-tratamientos-previos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07521605/radioterapia-de-corta-duracion-nal-iri-capecitabina-y-camrelizumab-para-el-cancer-colorrectal-localmente-avanzado-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07644910/fomentar-las-pruebas-de-deteccion-preventiva-mediante-la-formulacion-y-agrupacion-de-mensajes 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07116577/radioterapia-combinada-con-ql1706-tas-102-y-bevacizumab-en-mcrc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07068763/radioterapia-de-curso-corto-con-preservacion-de-los-ganglios-linfaticos-combinada-con-capecitabina-y-pd-1-ctla-4-para-el-cancer-colorrectal-en-estadio-temprano-con-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06647680/quimioterapia-neoadyuvante-e-inhibidor-de-pd-1-para-el-cancer-colorrectal-localmente-avanzado-control-01 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07038122/reduccion-del-margen-de-reseccion-tras-la-terapia-neoadyuvante-en-canceres-localmente-avanzados-de-la-union-rectosigmoidea-y-del-recto-superior 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06756672/hpi-en-la-cirugia-colorrectal-laparoscopica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06276686/ejercicio-para-mejorar-la-eficacia-de-la-quimiorradioterapia-prolongada-en-pacientes-con-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07537491/kia-korekt-evaluacion-por-etapas-desde-un-enfoque-unimodal-hasta-un-enfoque-multimodal-mediante-inteligencia-artificial-para-la-prediccion-del-riesgo-perioperatorio-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07786493/braquiterapia-endorrectal-de-alta-dosis-con-guia-impresa-en-3d-y-proteccion-local-para-la-preservacion-de-organos-en-el-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07536321/precision-diagnostica-y-valor-pronostico-de-la-tomografia-por-emision-de-positrones-con-18f-fdg-18f-fdg-pet-ct-en-el-seguimiento-de-pacientes-con-carcinoma-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07789210/un-estudio-clinico-multicentrico-de-fase-ii-y-de-un-solo-brazo-para-evaluar-el-uso-neoadyuvante-de-encorafenib-mas-cetuximab-n01-y-mfolfox6-en-pacientes-con-cancer-colorrectal-localmente-avanzado-con 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05038254/mejora-de-la-gestion-de-los-sintomas-en-el-ambito-ambulatorio-para-reducir-las-visitas-a-los-servicios-de-atencion-aguda-debidas-a-acontecimientos-adversos-relacionados-con-la-quimioterapia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07540572/un-estudio-para-investigar-la-seguridad-la-farmacocinetica-y-la-eficacia-preliminar-de-la-terapia-con-ide574-en-participantes-adultos-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05102981/funcion-y-calidad-de-vida-tras-la-creacion-de-una-ostomia-de-emergencia-frente-a-una-ostomia-programada 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07194616/ensayo-clinico-sobre-celulas-tumorales-circulantes-en-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06820463/un-estudio-para-evaluar-los-eventos-adversos-y-la-eficacia-de-la-administracion-intravenosa-iv-de-telisotuzumab-adizutecan-en-combinacion-con-oxaliplatino-iv-fluorouracilo-acido-folinico-leucovorina 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05428735/el-ensayo-dragon-2 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07353632/que-factores-influyen-en-la-reincorporacion-al-programa-de-deteccion-del-cancer-colorrectal-en-dinamarca 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05720910/evaluacion-geriatrica-y-oncologica-optimizada-basada-en-la-tecnologia-ic 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07359989/leucina-mas-quimiorradioterapia-para-el-tratamiento-neoadyuvante-del-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06174233/el-estudio-frances-gut-colo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05585814/capeox-en-combinacion-con-bevacizumab-mas-un-anticuerpo-anti-pd1-como-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado-con-estabilidad-microsatelital 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04940546/seguridad-del-tratamiento-neoadyuvante-con-sintilimab-xelox-bevacizumab-en-pacientes-con-metastasis-colorrectales-mcrlm-con-pmmr-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07552207/comparacion-de-la-pet-rm-con-68ga-ga-ctr-fapi-y-18f-fdg-para-la-estadificacion-de-los-ganglios-linfaticos-en-el-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04927897/detect-volumen-objetivo-para-la-radioterapia-de-refuerzo-endoluminal-en-el-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04899908/radioterapia-estereotactica-dirigida-al-cerebro-con-o-sin-nanoparticulas-de-gadolinio-aguix-en-metastasis-cerebrales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06831669/metabolomica-para-predecir-la-respuesta-al-tratamiento-y-las-toxicidades-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06682793/un-estudio-para-evaluar-la-seguridad-y-la-eficacia-de-a2b395-una-terapia-car-t-alogenica-con-activacion-logica-en-participantes-con-tumores-solidos-que-expresan-egfr-y-que-han-perdido-la-expresion-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07012954/cetuximab-o-bevacizumab-guiados-por-ctdna-mas-trifluridina-tipiracil-en-pacientes-con-mcrc-con-ras-braf-de-tipo-salvaje 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06835569/un-estudio-para-evaluar-el-farmaco-alta3263-en-adultos-con-tumores-solidos-avanzados-con-mutaciones-en-el-gen-kras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06521827/el-papel-de-un-ciclo-corto-de-radioterapia-paliativa-en-el-cancer-de-recto-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06312982/una-serie-de-casos-de-quimiorradioterapia-neoadyuvante-combinada-con-inmunoterapia-para-el-cancer-de-recto-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07372300/electrohipertermia-modulada-en-combinacion-con-terapia-multimodal-para-el-cancer-de-recto-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05752136/radioterapia-preoperatoria-de-corta-duracion-seguida-de-envafolimab-mas-capeox-para-el-adenocarcinoma-rectal-localmente-avanzado-con-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07802002/un-estudio-clinico-prospectivo-de-un-solo-brazo-para-evaluar-un-suplemento-dietetico-en-la-prevencion-de-lesiones-rectales-agudas-inducidas-por-la-radiacion-durante-la-quimiorradioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05642819/revolution-surgery-revolution-surgery 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06234007/radioterapia-de-corta-duracion-seguida-de-fruquintinib-mas-adebrelimab-y-capox-en-el-tratamiento-neoadyuvante-completo-del-cancer-colorrectal-localmente-avanzado-un-estudio-multicentrico-de-un-solo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06915350/el-papel-de-la-maspina-en-el-carcinoma-colorrectal-un-estudio-inmunohistoquimico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06126406/estudio-clinico-de-linfocitos-t-con-receptores-quimericos-de-antigenos-car-t-dirigidos-contra-el-cea-para-tumores-solidos-malignos-avanzados-con-expresion-de-cea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03038568/evaluacion-del-impacto-de-las-variaciones-normales-en-las-tomografias-computarizadas-tc-en-su-interpretacion 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05772481/interes-de-la-pet-rm-en-la-evaluacion-de-la-respuesta-tras-el-tratamiento-neoadyuvante-del-adenocarcinoma-rectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05991102/tratamiento-con-campos-electromagneticos-de-radiofrecuencia-de-modulacion-de-amplitud-combinado-con-tas-102-lonsurf-y-bevacizumab-en-el-cancer-colorrectal-metastasico-refractario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07116668/estudio-pivotal-de-evaluacion-del-dispositivo-de-proteccion-de-anastomosis-safeheal-colovac 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07381777/xelox-mas-dostarlimab-frente-a-xelox-solo-como-tratamiento-de-consolidacion-tras-la-quimiorradiacion-estandar-en-pacientes-con-cancer-colorrectal-localmente-avanzado-ccl-pmmr-mss-o-msi-bajo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05228431/regimen-terapeutico-sandwich-modificado-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03711110/estrategias-de-prevencion-cardiovascular-en-pacientes-oncologicos-de-edad-avanzada-ensayo-clinico-cartier 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04184973/eficacia-y-seguridad-del-dispositivo-de-derivacion-intraluminal-cg-100 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07381400/quimioterapia-neoadyuvante-con-mfolfox6-combinada-con-terapia-anti-pd-1-en-cancer-colorrectal-localmente-avanzado-mss-pmmr-estudio-firm02 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05360277/tratamiento-de-mantenimiento-con-tislelizumab-y-capecitabina-para-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05692596/el-centro-de-intercepcion-del-pancreas-pic-para-la-deteccion-temprana-la-prevencion-y-las-nuevas-terapias 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT00001823/evaluacion-para-los-protocolos-de-investigacion-clinica-de-la-rama-de-cirugia-del-nci 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05674526/un-estudio-de-fase-1b-de-wu-nk-101-en-combinacion-con-cetuximab 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07391007/estratificacion-integrada-del-riesgo-clinico-molecular-para-la-deteccion-temprana-de-recurrencia-en-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04464668/concienciacion-investigacion-educacion-y-deteccion-del-cancer-colorrectal-ampliacion-acceso-y-mejora-de-la-capacidad-en-zonas-rurales 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT01792934/quimioterapia-y-reseccion-quirurgica-maxima-de-las-metastasis-de-cancer-colorrectal-multiorganico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07109440/el-papel-de-la-imagenologia-fapi-pet-ct-en-la-exploracion-del-microambiente-de-las-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04288999/cirugia-combinada-con-quimioterapia-frente-a-quimiorradioterapia-seguida-de-cirugia-combinada-con-quimioterapia-para-el-cancer-de-recto-localmente-recurrente 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06765616/inyeccion-de-adebrelimab-pd-l1-combinada-con-radioterapia-de-corta-duracion-y-quimioterapia-para-la-terapia-neoadyuvante-del-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07389863/evaluacion-de-las-secuelas-ginecologicas-y-sexuales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02215889/estudio-de-trasplante-parcial-de-los-segmentos-2-3-del-higado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07253298/los-efectos-del-ejercicio-de-kegel-combinado-con-terapia-de-biofeedback-en-la-recuperacion-de-la-funcion-intestinal-el-malestar-emocional-y-la-calidad-de-vida-en-pacientes-que-se-someten-a-una 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04245683/viabilidad-del-tratamiento-no-quirurgico-del-cancer-de-recto-en-una-poblacion-rural 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07079462/comparacion-de-la-radioterapia-abdominal-guiada-por-pet-con-68ga-fapi-combinada-con-la-terapia-estandar-de-segunda-linea-y-cadonilimab-frente-a-la-terapia-estandar-de-segunda-linea-en-el-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05850559/evaluacion-del-papel-diagnostico-de-la-proteina-fijadora-del-factor-de-crecimiento-similar-a-la-insulina-en-suero-como-posible-biomarcador-para-el-cancer-colorrectal-crc-en-egipto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05312398/estudio-capri-2-goim-investigacion-de-la-eficacia-y-la-seguridad-de-un-regimen-de-tratamiento-basado-en-cetuximab-guiado-por-biomarcadores 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06822413/modelo-de-aprendizaje-profundo-basado-en-espectroscopia-raman-para-el-diagnostico-precoz-de-multiples-tipos-de-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06834126/papaverina-en-combinacion-con-radioterapia-para-el-tratamiento-del-cancer-colorrectal-localmente-avanzado-ensayo-dinomite 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02834013/nivolumab-e-ipilimumab-en-el-tratamiento-de-pacientes-con-tumores-poco-frecuentes 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07588386/el-valor-de-la-colonoscopia-temprana-postoperatoria-en-el-diagnostico-precoz-de-la-dehiscencia-de-la-anastomosis-tras-la-cirugia-de-cancer-colorrectal-localizado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07589517/celulas-car-nk-con-doble-diana-terapeutica-en-el-cancer-colorrectal-avanzado-seleccionados-en-funcion-de-biomarcadores 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06446050/celulas-madre-mesenquimales-modificadas-con-quimiocinas-y-moleculas-coestimuladoras-para-el-tratamiento-del-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07020247/radioterapia-de-larga-duracion-personalizada-combinada-con-quimioterapia-con-o-sin-inmunoterapia-para-el-cancer-colorrectal-localmente-avanzado-estudio-palace 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03525262/terapia-oncologica-para-el-cancer-de-prostata-que-garantiza-la-preservacion-de-los-nervios-y-los-vasos-sanguineos-poten-c 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07146334/anastomosis-colorrectal-de-baja-energia-tras-la-reseccion-rectal-oasis 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07220239/copa-menstrual-para-la-deteccion-temprana-del-cancer-de-endometrio-en-el-sindrome-de-lynch 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07183865/radioterapia-hipofraccionada-combinada-con-nalirif-anticuerpo-anti-pd-1-en-el-cancer-colorrectal-localmente-recurrente-novelty-r 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05704413/biobanco-digestivo-para-el-estudio-de-las-interacciones-entre-la-microbiota-y-el-huesped 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06253871/un-estudio-de-fase-i-ib-de-iam1363-en-canceres-her2 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06194708/razones-para-la-no-reversion-de-las-ostomias-temporales-tras-las-cirugias-del-cancer-de-recto-medio-inferior-estudio-noresto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06894797/quimiorradioterapia-preoperatoria-combinada-con-nalirifox-en-consolidacion-o-induccion-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06982664/efecto-de-la-preservacion-de-la-arteria-colica-izquierda-sobre-la-perfusion-del-intestino-proximal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06496256/ensayo-clinico-barrigel-r-pprt-radioterapia-postprostatectomia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05785780/objetivo-3-optimizacion-del-cribado-del-cancer-colorrectal-en-pacientes-con-diabetes-en-entornos-de-atencion-primaria-de-referencia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07118800/estudio-que-evalua-dos-estrategias-de-tratamiento-para-el-cancer-de-recto-en-pacientes-75-anos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04793958/estudio-de-fase-iii-de-mrtx849-en-combinacion-con-cetuximab-frente-a-quimioterapia-en-pacientes-con-cancer-colorrectal-avanzado-con-mutacion-kras-g12c-krystal-10 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07259681/microbiota-intestinal-en-pacientes-con-cancer-ginecologico-y-toxicidad-pelvica-comparacion-entre-un-grupo-control-y-un-tratamiento-con-ozono-microzoginetox 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07104604/estudio-sobre-la-eficacia-y-la-seguridad-de-la-radioterapia-neoadyuvante-combinada-con-toripalimab-irinotecan-liposomal-y-capecitabina-en-el-tratamiento-del-adenocarcinoma-rectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05398380/trasplante-hepatico-para-metastasis-hepaticas-de-cancer-colorrectal-no-susceptibles-de-reseccion-investigacion-traslacional 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05972655/radioterapia-de-corta-duracion-con-preservacion-de-los-ganglios-combinada-con-capox-y-tislelizumab-para-el-cancer-colorrectal-medio-y-bajo-con-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07040098/optimizacion-de-la-inmunoterapia-combinada-con-quimiorradioterapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06889610/un-estudio-clinico-de-fase-ii-sobre-la-ablacion-multimodal-combinada-con-terapia-sistemica-en-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07059949/radioterapia-de-corta-duracion-seguida-de-capox-y-carrilizumab-y-bevacizumab-o-cetuximab-para-el-tratamiento-inicial-del-cancer-colorrectal-metastasico-irresecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05429216/reseccion-endoscopica-de-tumores-neuroendocrinos-rectales-pequenos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07656038/nelmastobart-en-combinacion-con-tas-102-y-bevacizumab-en-el-cancer-colorrectal-recurrente-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05296681/producto-microbiano-para-promover-la-salud-del-microbioma-y-mejorar-la-administracion-de-la-quimioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06760520/radioterapia-de-corta-duracion-seguida-de-capox-e-ivonescimab-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07277842/pd-1-folfoxiri-frente-a-capox-como-terapia-neoadyuvante-total-para-cancer-de-recto-pmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07090031/tratamiento-perioperatorio-con-tas-102-en-combinacion-con-oxaliplatino-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07269249/eficacia-y-seguridad-en-la-practica-clinica-de-dostarlimab-como-tratamiento-neoadyuvante-en-pacientes-con-cancer-colorrectal-localmente-avanzado-dmmr-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06843434/un-estudio-de-botensilimab-y-balstilimab-para-el-adenocarcinoma-rectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06146946/seguridad-de-la-cirugia-para-el-cancer-de-recto-medio-e-inferior-sin-diseccion-del-ganglio-linfatico-numero-253-s-m-o-o-t-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07135115/intervenciones-dirigidas-al-estilo-de-vida-para-mejorar-el-cribado-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07440290/estudio-determine-rama-de-tratamiento-07-dabrafenib-en-combinacion-con-trametinib-en-pacientes-adultos-pediatricos-y-adolescentes-jovenes-con-canceres-braf-v600-mutacion-positivos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07662278/rsifn-co-en-combinacion-con-terapia-neoadyuvante-total-en-sujetos-con-cancer-de-recto-localmente-avanzado-de-grado-medio-a-bajo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04999007/la-inteligencia-artificial-ayuda-a-los-cirujanos-en-la-toma-de-decisiones 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05319314/gcc19cart-para-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07668284/coq10-y-vitamina-e-para-la-toxicidad-por-radiacion-fuera-del-objetivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07279454/el-estudio-eat-fibre 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07432542/cierre-peritoneal-del-suelo-pelvico-para-prevenir-el-ileo-postoperatorio-en-la-cirugia-de-cancer-de-recto-medio-inferior 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06459869/ng-350a-mas-quimiorradioterapia-para-el-cancer-de-recto-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04339374/ecografia-e-imagen-fotoacustica-para-mejorar-el-diagnostico-diferencial-del-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07112690/neurocirugia-del-ganglio-impar-para-mejorar-el-dolor-inducido-por-la-radioterapia-durante-el-tratamiento-localizado-del-cancer-de-piel-anal-o-perianal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06719414/aplicacion-de-la-imagen-ponderada-en-la-transferencia-de-protones-de-amida-para-predecir-la-respuesta-patologica-completa-tras-la-terapia-neoadyuvante-del-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07674732/radioterapia-de-curso-corto-con-quimio-pd-1-bevacizumab-y-radioterapia-de-curso-corto-con-quimioterapia-como-terapia-neoadyuvante-en-cancer-colorrectal-localmente-avanzado-con-pmmr-mss-con-el 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07441369/abemaciclib-en-combinacion-con-los-regimenes-folfox-folfiri-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07446387/un-estudio-clinico-de-iparomlimab-y-tuvonralimab-en-combinacion-con-bevacizumab-y-un-regimen-de-capox-mcapiri-alternado-cada-tres-semanas-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07239466/un-estudio-piloto-que-evalua-la-suplementacion-con-hidroxibutirato-en-combinacion-con-radioterapia-de-corta-duracion-seguida-de-inmunoterapia-combinada-con-terapia-neoadyuvante-con-capeox-en 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07450612/biopsia-liquida-y-aprendizaje-automatico-para-la-deteccion-temprana-del-cancer-colorrectal-adenomas-canceres-de-lynch-y-enfermedad-residual 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07219238/estudio-para-evaluar-el-rendimiento-diagnostico-de-la-inyeccion-de-geh300079-68ga-para-pet-tc-en-la-deteccion-de-metastasis-de-cancer-de-pancreas-en-pacientes-con-cancer-colorrectal-gastrico-ovarico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06718543/radioterapia-neoadyuvante-de-corta-duracion-con-o-sin-quimioterapia-y-ak112-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07448142/radioterapia-a-dosis-bajas-para-sensibilizar-a-pucotenlimab-mas-capeox-en-el-tratamiento-del-cancer-colorrectal-localmente-avanzado-con-pmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05338866/quimioterapia-combinada-con-radioterapia-a-altas-dosis-para-el-cancer-de-recto-inferior-mediante-un-acelerador-lineal-guiado-por-resonancia-magnetica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05904665/estrategia-de-seguimiento-postoperatorio-guiada-por-la-metilacion-del-adn-tumoral-circulante-en-el-cancer-colorrectal-no-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07223047/un-estudio-para-evaluar-la-seguridad-la-tolerabilidad-y-la-eficacia-de-bms-986523-tanto-en-monoterapia-como-en-combinacion-con-agentes-antineoplasicos-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06279299/diseccion-de-los-ganglios-linfaticos-pelvicos-laterales-en-pacientes-con-neoplasias-neuroendocrinas-rectales-sometidos-a-reseccion-mesenterica-total-laparoscopica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04867525/plataforma-de-registro-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07026422/iparolimab-tuvonralimab-en-combinacion-con-terapia-neoadyuvante-total-para-cancer-colorrectal-localmente-avanzado-pmmr-mss-it-tnt 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05794971/regorafenib-en-combinacion-con-irinotecan-administrado-mediante-microesferas-de-liberacion-de-farmacos-para-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07686796/anticuerpo-anti-pcsk9-tafolecimab-y-anticuerpo-anti-pd-1-sintilimab-en-combinacion-con-quimiorradioterapia-neoadyuvante-para-cancer-colorrectal-localmente-avanzado-pmmr-mss-un-ensayo-prospectivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06333314/dostarlimab-para-el-cancer-localmente-avanzado-o-metastasico-no-colorrectal-no-endometrial-con-tumores-dmmr-msi 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07458529/quimiorradioterapia-neoadyuvante-mas-tislelizumab-con-o-sin-probio-m9-en-cancer-colorrectal-localmente-avanzado-pmmr-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06929013/cinetica-de-eliminacion-del-nucleosoma-y-ctcf-en-sangre-en-el-cancer-colorrectal-con-metastasis-peritoneales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07130903/campos-electromagneticos-de-radiofrecuencia-de-amplitud-modulada-am-rf-emf-en-combinacion-con-fruquintinib-en-el-cancer-colorrectal-metastasico-refractario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07268846/uso-de-la-suplementacion-preoperatoria-con-probioticos-en-la-cirugia-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05597852/uso-de-un-espaciador-de-hidrogel-rectal-para-la-radioterapia-estereotactica-ablativa-sabr-de-rescate-en-el-cancer-de-prostata 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07213570/stream-2-tratamiento-de-segunda-linea-con-regorafenib-en-cancer-colorrectal-avanzado-con-mutacion-en-ras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07463261/resultados-de-las-resecciones-anteriores-bajas-con-o-sin-ostomia-profilactica-en-el-servicio-de-urgencias 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04815694/aplicaciones-terapeuticas-y-diagnosticas-en-las-neoplasias-rectales-mediante-radioterapia-guiada-por-resonancia-magnetica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07696793/eficacia-y-tolerabilidad-de-una-solucion-evacuante-que-contiene-simeticona-para-la-colonoscopia-de-cribado-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT00867464/seguimiento-a-largo-plazo-de-mujeres-jovenes-en-costa-rica-que-recibieron-la-vacuna-contra-los-tipos-16-y-18-del-virus-del-papiloma-humano-y-de-un-grupo-de-control-no-vacunado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04130516/estudio-para-evaluar-la-dosis-maxima-tolerada-dmt-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-los-efectos-antitumores-de-lns8801-en-monoterapia-y-en-combinacion-con-pembrolizumab 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07702799/dieta-baja-en-residuos-frente-a-enema-rectal-antes-de-la-cirugia-laparoscopica-para-el-cancer-de-endometrio 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07596290/yang-et-al-inmunoterapia-dual-anti-pd-1-ctla-4-para-el-cancer-colorrectal-localmente-avanzado-larc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06840665/radioterapia-adaptativa-guiada-por-resonancia-magnetica-combinada-con-un-anticuerpo-anti-pd-1-y-capox-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07469306/radioterapia-de-corta-duracion-mas-capox-y-tislelizumab-frente-a-radioterapia-de-larga-duracion-mas-tislelizumab-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06753721/un-estudio-clinico-abierto-multicentrico-de-un-solo-brazo-sobre-el-uso-de-doxorrubicina-liposomal-en-combinacion-con-el-regimen-capox-y-bevacizumab-para-el-tratamiento-de-primera-linea-del 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07474103/scrt-nalirixelox-sintilimab-como-terapia-neoadyuvante-en-cancer-colorrectal-localmente-avanzado-de-alto-riesgo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07474025/integracion-de-los-patrones-de-crecimiento-histologico-peritoneal-en-la-toma-de-decisiones-preoperatorias-para-las-metastasis-peritoneales-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04703101/radioterapia-de-curso-corto-y-quimioterapia-combinada-para-el-tratamiento-del-cancer-de-recto-en-estadio-ii-iii 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06949982/eficacia-y-seguridad-de-la-hidroxicloroquina-en-combinacion-con-metotrexato-capecitabina-y-bevacizumab-frente-a-regorafenib-en-participantes-con-cancer-colorrectal-metastasico-refractario-con 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06324357/beamion-bcgc-1-un-estudio-para-determinar-una-dosis-adecuada-de-zongertinib-utilizado-solo-o-en-combinacion-con-otros-tratamientos-y-evaluar-si-es-beneficioso-para-personas-con-diferentes-tipos-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03891953/estudio-de-seguridad-y-eficacia-de-dky709-en-monoterapia-o-en-combinacion-con-pdr001-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07291180/un-estudio-de-viabilidad-sobre-el-cribado-farmacologico-basado-en-la-respuesta-masiva-para-guiar-la-quimioterapia-intraperitoneal-hiperermica-personalizada-en-el-adenocarcinoma-apendicular-y 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07491159/fruquintinib-mas-un-inhibidor-de-puntos-de-control-en-combinacion-o-de-forma-secuencial-junto-con-tas-102-en-pacientes-con-cancer-colorrectal-que-han-progresado-tras-recibir-una-terapia-estandar-de 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT01570010/el-estudio-noruego-sobre-las-directrices-dieteticas-y-la-supervivencia-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03869892/estudio-de-fase-iii-sobre-el-tratamiento-de-primera-linea-en-pacientes-con-cancer-colorrectal-metastasico-que-no-son-candidatos-para-recibir-terapia-intensiva 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05705492/olanzapina-para-el-manejo-de-la-perdida-de-apetito-asociada-al-cancer-en-pacientes-con-cancer-avanzado-de-esofago-estomago-higado-pancreas-vias-biliares-colon-recto-o-pulmon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07299071/eficacia-de-la-deteccion-asistida-por-ordenador-cad-en-la-colonoscopia-de-cribado-para-reducir-el-riesgo-de-adenoma-avanzado-a-los-3-anos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05080673/colonoscopia-a-los-cinco-o-diez-anos-para-1-2-polipos-adenomatosos-no-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT00034216/recoleccion-de-muestras-de-sangre-de-pacientes-con-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02487992/estudio-de-cik-mas-s-1-y-bevacizumab-como-tratamiento-de-mantenimiento-para-pacientes-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07504263/estudio-de-fase-1-2a-de-rp-001-en-participantes-con-tumores-malignos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06584318/estudio-exploratorio-de-la-intervencion-con-hipoxia-intermitente-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06959693/un-estudio-clinico-para-evaluar-la-eficacia-y-la-seguridad-de-envafolimab-en-combinacion-con-cetuximab-y-mfolfox6-en-pacientes-con-cancer-colorrectal-metastasico-mcrc-mss-y-ras-braf-de-tipo-salvaje 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05577143/deteccion-de-cancer-colorrectal-en-adultos-mediante-analisis-de-sangre 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03885817/actividad-fisica-durante-el-tratamiento-del-cancer-fakt 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07319104/biopsia-liquida-en-lesiones-tempranas-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03516942/evaluacion-de-la-carga-economica-en-pacientes-con-cancer-de-colon-o-recto-en-estadio-i-iii-que-reciben-tratamiento 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05786716/ensayo-determine-rama-de-tratamiento-04-trastuzumab-en-combinacion-con-pertuzumab-en-pacientes-adultos-pediatricos-y-adolescentes-jovenes-con-canceres-con-amplificacion-de-her2-o-mutaciones 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07230795/navegacion-para-la-deteccion-del-cancer-colorrectal-ccr-basada-en-inteligencia-artificial-frente-al-tratamiento-estandar-en-pacientes-de-45-a-49-anos-de-penn-medicine-que-nunca-se-han-sometido-a 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06222255/seguridad-y-eficacia-del-lavado-transanal-en-pacientes-con-trastornos-del-sueno-causados-por-el-sindrome-de-la-reseccion-anterior-baja-tras-la-cirugia-de-cancer-de-recto-tralars 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06665334/para-explorar-el-efecto-del-huaier-granule-en-la-tasa-de-conversion-a-negativo-despues-de-que-los-niveles-de-cea-vuelvan-a-aumentar-tras-la-cirugia-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03981497/ablacion-por-microondas-para-el-tratamiento-de-tumores-renales-pequenos-y-neoplasias-hepaticas-primarias-y-secundarias 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04624555/la-utilidad-y-viabilidad-del-uso-de-la-molecula-de-adn-tumoral-circulante-mt-sdna-como-procedimiento-de-seguimiento-en-pacientes-supervivientes-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02912559/quimioterapia-combinada-con-o-sin-atezolizumab-en-el-tratamiento-de-pacientes-con-cancer-de-colon-en-estadio-iii-y-deficiencia-en-la-reparacion-del-desajuste-de-bases-del-adn 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05310643/nivolumab-e-ipilimumab-en-pacientes-con-mcrc-dmmr-msi-refractarios-a-anti-pd1 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04221893/radioterapia-para-el-tratamiento-de-canceres-gastrointestinales-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06136949/el-valor-terapeutico-diagnostico-de-stard3-en-el-cancer-colorrectal-el-estudio-star 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07362836/fruquintinib-frente-a-bevacizumab-mas-quimioterapia-en-el-tratamiento-de-segunda-linea-del-cancer-colorrectal-metastasico-con-mutacion-en-los-genes-ras-fru-ras 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07790718/evaluacion-de-los-efectos-del-ejercicio-en-el-desarrollo-del-cancer-colorrectal-tras-el-tratamiento-con-radioterapia-pelvica-para-el-cancer-de-prostata 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06508307/un-estudio-clinico-de-fase-i-sobre-la-inyeccion-intratumoral-del-virus-oncolitico-vaccinia-gc001-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07564284/reseccion-hepatica-inicial-reseccion-intestinal-inicial-o-reseccion-simultanea-para-metastasis-hepaticas-sincronicas-de-cancer-colorrectal-resultados-calidad-de-vida-y-rentabilidad 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06808685/estudio-nacional-multicentrico-en-el-mundo-real-para-evaluar-la-eficacia-y-la-seguridad-del-bevacizumab-biosimilar-elovie 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06809660/efectos-de-los-disruptores-endocrinos-en-la-microbiota-intestinal-y-evaluacion-de-su-impacto-en-el-desarrollo-del-cancer-colorrectal-permica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04612309/estudio-retrospectivo-sobre-el-uso-de-inmunoterapia-en-pacientes-con-cancer-colorrectal-metastasico-msi-h 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04087421/comparacion-de-la-irrigacion-transanal-y-los-supositorios-de-glicerol-en-el-tratamiento-del-sindrome-de-reseccion-anterior-baja 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07574502/estimulacion-electrica-transcutanea-acustica-para-la-recuperacion-de-la-funcion-intestinal-postoperatoria-en-pacientes-ancianos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02134925/terapia-con-vacunas-en-el-tratamiento-de-pacientes-con-polipos-colorrectales-avanzados-de-reciente-diagnostico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04916990/mejorando-la-atencion-a-pacientes-rurales-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04440735/un-estudio-de-dsp107-solo-y-en-combinacion-con-atezolizumab-para-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06373133/shr-8068-en-combinacion-con-adbelizumab-y-bp102-en-el-tratamiento-del-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06358430/estudio-de-escalada-de-dosis-y-expansion-de-celulas-nk-derivadas-de-sangre-de-cordon-umbilical-modificadas-con-car-para-trop2-e-il-15-en-combinacion-con-cetuximab-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03050268/investigacion-de-casos-familiares-de-predisposicion-al-cancer-infantil 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06509126/panitumumab-administrado-de-forma-intermitente-o-continua-en-combinacion-con-folfiri-para-el-cancer-colorrectal-metastasico-de-lado-izquierdo-con-mutaciones-ras-b-raf-de-tipo-salvaje 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04657068/un-estudio-de-art0380-para-el-tratamiento-de-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06940947/terapia-endoscopica-o-cirugia-para-el-cancer-de-colon-en-estadio-temprano 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT00579514/alteraciones-en-la-linea-germinal-de-los-genes-de-susceptibilidad-tumoral-en-pacientes-con-cancer-de-nueva-york 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06405776/efecto-de-la-lidocaina-sobre-el-dolor-postoperatorio-y-la-supervivencia-a-largo-plazo-en-pacientes-geriatricos-sometidos-a-cirugia-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05672108/ensayo-de-fase-ii-de-quimioembolizacion-pulmonar 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05142033/protocolo-de-secuenciacion-y-analisis-oncologico-de-avera-asap 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03844620/pruebas-de-adn-tumoral-libre-circulante-en-sangre-para-guiar-el-tratamiento-de-pacientes-con-cancer-colorrectal-avanzado-o-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06458998/pasando-a-la-implementacion-mejorando-las-pruebas-de-deteccion-del-cancer-para-los-veteranos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05551052/deteccion-del-cancer-colorrectal-evaluacion-fiable-mediante-analisis-sanguineo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04699188/estudio-de-jdq443-en-pacientes-con-tumores-solidos-avanzados-que-presentan-la-mutacion-kras-g12c 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05239143/p-muc1c-allo1-celulas-car-t-alogenicas-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03597204/eficacia-de-la-prueba-inmunoquimica-fecal-y-la-colonoscopia-como-metodos-de-cribado-en-hong-kong 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05396560/prueba-inmunoquimica-fecal-para-la-vigilancia-tras-la-polipectomia-con-el-fin-de-reducir-las-endoscopias-innecesarias 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06117241/reduccion-de-la-desregulacion-metabolica-en-parejas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07720505/coloflow-imagenologia-de-contraste-de-motas-laser-frente-a-imagenologia-de-fluorescencia-en-el-infrarrojo-cercano-con-verde-de-indocianina 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05636085/rendimiento-clinico-del-test-de-deteccion-de-cancer-colorrectal-de-mainz-biomed-para-el-cancer-colorrectal-y-el-adenoma-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05185388/desigualdades-socioeconomicas-en-el-diagnostico-y-el-tratamiento-del-cancer-de-colon-y-de-ovario-en-inglaterra-entre-2016-y-2017 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06965335/cancer-colorrectal-de-inicio-temprano-un-estudio-observacional-retrospectivo-y-prospectivo-multicentrico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03828227/calidad-de-vida-en-pacientes-ancianos-con-cancer-colorrectal-metastasico-que-reciben-terapia-de-primera-linea-basada-en-parametros-geriatricos-simplificados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06265025/inyeccion-intratumoral-de-gm103-en-pacientes-con-tumores-solidos-avanzados-localmente-irresecables-refractarios-y-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02222844/mejorar-el-tratamiento-radical-mediante-la-evaluacion-por-resonancia-magnetica-de-los-canceres-sigmoideos-pelvicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04373564/efecto-sobre-la-movilidad-corporal-y-las-habilidades-cognitivas-en-pacientes-que-recibieron-medios-de-contraste-a-base-de-gadolinio-para-examenes-de-resonancia-magnetica-en-multiples-ocasiones-en-un 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05239650/estudio-clinico-de-fase-ii-para-evaluar-la-eficacia-y-la-seguridad-de-hlx07-hlx10-mfolfox6-o-hlx07-en-monoterapia-en-pacientes-con-mcrc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04130971/prediccion-del-cancer-colorrectal-analisis-de-muestras-de-tejido-para-evaluar-las-caracteristicas-del-tumor-y-la-respuesta-al-tratamiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06501417/ec-italynch-facilitando-el-diagnostico-del-sindrome-de-lynch 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06331988/microbioma-interaccion-entre-el-sistema-inmunitario-y-el-tumor-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07609680/manejo-hemodinamico-guiado-por-el-indice-cardiaco-versus-el-indice-de-perfusion-en-la-cirugia-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05793593/un-estudio-sobre-el-uso-de-las-redes-sociales-para-fomentar-que-tres-personas-de-un-mismo-grupo-completen-las-pruebas-de-deteccion-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06356714/esqueleto-de-la-pared-celular-de-nocardia-rubra-en-combinacion-con-regimenes-previos-de-segunda-o-tercera-linea-para-el-tratamiento-del-cancer-colorrectal-en-estadio-de-enfermedad-estable-sd-con 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05714124/enfoques-de-embolizacion-hepatica-para-el-tratamiento-de-tumores 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07114601/un-estudio-de-ly4257496-en-participantes-con-cancer-omniray 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06681038/tratamiento-antitumoral-sistemico-con-o-sin-quimioterapia-en-aerosol-intraabdominal-a-presion-para-metastasis-peritoneales-de-cancer-de-colon-pipox02 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04919824/cuchillo-de-corte-con-corriente-monopolar-frente-a-cuchillo-de-ablacion-por-radiofrecuencia-bipolar 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07617610/resistencia-primaria-y-adquirida-al-tratamiento-dirigido-en-el-cancer-colorrectal-metastasico-con-mutacion-braf-v600e 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03093116/un-estudio-de-repotrectinib-tpx-0005-en-pacientes-con-tumores-solidos-avanzados-que-presentan-reordenamientos-de-alk-ros1-o-ntrk1-3 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04511039/trifluridina-tipiracil-y-talazoparib-para-el-tratamiento-de-pacientes-con-cancer-colorrectal-o-gastroesofagico-localmente-avanzado-o-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07620444/imagen-de-precision-espectral-en-el-cancer-de-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07618273/aplicacion-alex-para-el-seguimiento-y-la-monitorizacion-de-la-salud-gastrointestinal-ensayo-piloto-smart-horizons 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06776757/sintilimab-en-combinacion-con-cetuximab-y-quimioterapia-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-avanzado-con-ras-braf-de-tipo-salvaje 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06607614/un-modelo-predictivo-basado-en-la-prueba-inmunoquimica-cuantitativa-de-heces-puede-estratificar-el-riesgo-de-crc-en-un-programa-de-deteccion-organizado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05742425/serplulimab-en-combinacion-con-folfiri-y-bevacizumab-en-el-tratamiento-de-metastasis-peritoneales-del-cancer-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06796296/irrigacion-transanal-para-el-sindrome-de-la-reseccion-anterior-baja 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04556253/ak104-en-el-carcinoma-gastrico-y-el-cancer-colorrectal-localmente-avanzado-msi-h-dmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05890742/un-ensayo-clinico-que-evalua-la-eficacia-y-la-seguridad-de-ibi310-en-combinacion-con-sintilimab-para-el-tratamiento-neoadyuvante-del-cancer-colorrectal-resecable-msi-h-dmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06600295/oncologia-desnutricion-y-sensorialidad-vinculos-mecanismos-y-estrategias-de-intervencion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04141449/una-intervencion-multidimensional-para-mejorar-la-deteccion-oportuna-del-cancer-y-el-inicio-del-tratamiento 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07041255/comparacion-de-las-tecnicas-de-reseccion-con-asa-fria-y-asa-caliente-para-la-extirpacion-de-tumores-benignos-de-colon-de-tamano-mediano 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07740720/un-estudio-sobre-la-duracion-del-tratamiento-con-dostarlimab-en-pacientes-no-tratados-con-cancer-colorrectal-localmente-avanzado-con-deficiencia-en-la-reparacion-de-desajustes-dmmr-y-alta 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06206707/fmt-en-la-diarrea-y-la-colitis-mediadas-por-inhibidores-de-puntos-de-control-inmunitario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07744139/perfilado-radiogenomico-de-las-celulas-dendriticas-y-los-macrofagos-para-predecir-la-recurrencia-en-las-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07624214/estudio-de-lt-010391-en-participantes-con-tumores-solidos-con-mutacion-kras-g12d 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07748377/aumento-de-la-deteccion-de-cancer-de-mama-y-cancer-colorrectal-en-la-comunidad 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07515820/shr-3821-en-el-cancer-colorrectal-avanzado-un-estudio-exploratorio 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04008797/un-estudio-de-e7386-en-combinacion-con-otros-farmacos-antineoplasicos-en-participantes-con-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04584008/evaluacion-de-agentes-dirigidos-en-canceres-digestivos-en-china-basada-en-las-caracteristicas-moleculares 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06590506/medicina-de-alta-definicion-para-tumores-solidos-en-oncologia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07525206/un-estudio-para-evaluar-el-uso-de-telisotuzumab-adizutecan-intravenoso-iv-en-combinacion-con-bevacizumab-iv-en-comparacion-con-el-tratamiento-estandar-con-bevacizumab-iv-en-combinacion-con 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05746897/un-estudio-de-fase-i-abierto-multicentrico-y-de-primera-administracion-en-humanos-de-nm1f-anti-pvrig-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07320989/impacto-del-chicle-en-la-preparacion-intestinal-en-pacientes-sometidos-a-colonoscopia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04689347/5fu-lv-irinotecan-temozolomida-y-bevacizumab-para-el-cancer-colorrectal-metastasico-con-metilacion-del-gen-mgmt-y-estabilidad-de-microsatelites 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05272709/tt-702-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05396846/mi-mejor-estudio-sobre-alimentacion-para-el-sistema-gastrointestinal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06614192/un-estudio-que-evalua-los-eventos-adversos-y-la-actividad-de-la-enfermedad-al-comparar-la-administracion-intravenosa-iv-de-abbv-400-con-los-comprimidos-orales-de-trifluridina-y-tipiracil-lonsurf-mas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07646106/the-0504-en-pacientes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07341217/proyecto-de-rehabilitacion-preoperatoria-para-mitigar-los-efectos-de-la-quimioterapia-en-el-cerebro 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06449937/tratamiento-local-hepatico-para-metastasis-de-cancer-colorrectal-multiorganico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07136077/un-ensayo-de-fase-ii-con-fruquintinib-y-tislelizumab-en-pacientes-con-enfermedad-residual-minima-definida-por-ctdna-tras-la-finalizacion-de-la-quimioterapia-adyuvante-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03803553/identificacion-y-tratamiento-de-la-enfermedad-micrometastasica-en-el-cancer-de-colon-en-estadio-iii 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05424692/deteccion-de-la-sensibilidad-a-farmacos-en-microtumores-ptc-para-guiar-la-estrategia-de-tratamiento-adyuvante-postoperatorio-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06723236/un-estudio-de-mgc028-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04754672/entrenamiento-de-aptitud-aerobica-o-de-masa-muscular-para-mejorar-el-resultado-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07337590/seguridad-y-vigilancia-de-la-anastomosis-mediante-el-uso-de-sensores-mejorados-en-tiempo-real-con-xbar 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03657641/regorafenib-y-pembrolizumab-en-el-tratamiento-de-participantes-con-cancer-colorrectal-avanzado-o-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04668872/biopsia-tras-la-radioembolizacion-para-identificar-cambios-en-las-celulas-tumorales-inducidos-por-la-radiacion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02758951/terapia-sistemica-perioperatoria-para-metastasis-peritoneales-aisladas-de-cancer-colorrectal-susceptibles-de-reseccion 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06911970/impacto-del-ejercicio-aerobico-en-la-respuesta-inmune-antitumoral-en-pacientes-que-reciben-tratamiento-contra-el-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06218914/estudio-de-fase-i-para-investigar-las-terapias-con-celulas-t-receptoras-quimericas-tcrt-dirigidas-a-la-mutacion-kras-en-tumores-solidos-avanzados-irresecables-y-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07542262/estudio-clinico-de-fase-ii-abierto-de-un-unico-centro-para-evaluar-la-eficacia-y-la-seguridad-de-la-inmunoterapia-a-dosis-bajas-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-y-cancer-gastrico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07546565/preparacion-mecanica-del-intestino-en-la-hemicolectomia-derecha-laparoscopica-con-anastomosis-intracorporea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06879886/vigilancia-guiada-por-la-enfermedad-residual-minima-en-el-cancer-colorrectal-metastasico-en-estadio-iv-susceptible-de-reseccion-surveillance-ii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07542171/resultados-clinicos-tras-la-reseccion-endoscopica-no-curativa-en-el-cancer-colorrectal-en-estadio-temprano-un-estudio-multicentrico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02497820/encontrar-la-dosis-optima-de-aspirina-para-prevenir-el-cancer-en-el-sindrome-de-lynch 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06856187/tratamiento-estandar-de-segunda-linea-tratamiento-secuencial-con-tas-102-y-bevacizumab-combinado-con-tratamiento-local-en-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03702309/evaluacion-de-la-biopsia-liquida-y-desarrollo-de-un-repositorio-en-el-princess-margaret 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06413212/estudio-exploratorio-de-terapia-de-precision-para-pacientes-con-tumores-avanzados-que-presentan-derrame-pleural-maligno-o-ascitis-mediante-el-uso-de-pruebas-de-sensibilidad-a-farmacos-ptc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02838836/deteccion-de-celulas-tumorales-y-adn-en-la-sangre-la-orina-y-la-medula-osea-de-pacientes-con-canceres-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05288205/estudio-de-fase-1-2a-de-jab-21822-mas-jab-3312-en-pacientes-con-tumores-solidos-avanzados-que-presentan-la-mutacion-kras-p-g12c 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07545122/un-estudio-de-fase-1a-1b-el-primero-en-humanos-de-ct-202-un-anticuerpo-biespecifico-dirigido-contra-nectin-4-en-participantes-con-cancer-de-mama-triple-negativo-recurrente-cancer-colorrectal-y-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07541352/el-hugo-ras-colorectal-collaborative 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06695845/un-estudio-de-fase-2-de-zanidatamab-en-pacientes-con-tumores-que-expresan-her2 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03819296/papel-del-microbioma-intestinal-y-del-trasplante-fecal-en-las-complicaciones-gastrointestinales-inducidas-por-medicamentos-en-pacientes-con-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07361003/un-estudio-de-fase-ib-iii-de-suvemcitug-mas-ftd-tpi-en-participantes-con-cancer-colorrectal-metastasico-refractario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02781337/registro-epidemiologico-y-molecular-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06475560/endoscopia-con-capsula-en-el-ambito-del-diagnostico-de-rutina-para-las-enfermedades-colorrectales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07551596/evaluacion-de-la-combinacion-de-farmacos-antineoplasicos-botensilimab-agen1181-y-balstilimab-agen2034-tras-el-tratamiento-estandar-para-el-cancer-colorrectal-ensayo-combat 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04739072/evaluacion-de-la-enfermedad-residual-minima-en-pacientes-con-cancer-colorrectal-el-estudio-mirda-c 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06338332/cancer-de-colon-obstructivo-una-opcion-para-la-cirugia-en-el-cancer-de-colon-derecho-obstructivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06616259/tratamiento-de-primera-linea-con-mcapox-cetuximab-frente-a-mfolfox6-cetuximab-en-pacientes-con-cmmr-no-operable-del-lado-izquierdo-con-ras-braf-tipo-salvaje-y-mss-un-estudio-multicentrico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06938971/ensayo-clinico-aleatorizado-y-controlado-para-evaluar-los-efectos-del-ejercicio-combinado-de-resistencia-y-aerobico-en-la-calidad-de-vida-relacionada-con-la-salud-en-pacientes-que-reciben 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04117100/estudio-observacional-basado-en-un-registro-de-un-procedimiento-endoscopico-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06846268/adg126-y-pembrolizumab-como-tratamiento-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT00899626/biomarcadores-gastrointestinales-en-muestras-de-tejido-y-fluidos-biologicos-de-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06119867/comparacion-entre-el-estudio-patologico-europeo-y-japones-para-el-cancer-de-colon-space 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06134687/nuevo-tubo-guia-rigido-para-la-diseccion-endoscopica-submucosa-en-el-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07557225/imagenes-pet-tc-con-18f-t2-para-tumores-solidos-positivos-para-caix 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02381561/ropidoxuridina-en-el-tratamiento-de-pacientes-con-cancer-gastrointestinal-avanzado-que-reciben-radioterapia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07208786/la-terapia-endoscopica-con-vacio-profilactico-reduce-la-incidencia-de-fugas-anastomoticas-tras-la-cirugia-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05969899/folfiri-a-base-de-irinotecan-liposomal-con-bevacizumab-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03471403/polipectomia-con-asa-fria-para-adenomas-duodenales-en-la-poliposis-adenomatosa-familiar 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05225428/educacion-en-video-con-divulgacion-dependiente-de-los-resultados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06050200/tango-liver-estudio-de-tres-brazos-que-evalua-la-observacion-del-crecimiento-tumoral-mediante-metodos-nucleares-en-la-cirugia-hepatica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05929820/impacto-de-protect-your-colon-tm-en-la-deteccion-del-ccrc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05492682/seguridad-y-actividad-antitumoral-de-pepticrad-1-en-el-tratamiento-del-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04124406/voyage-impacto-en-la-practica-clinica-de-la-prueba-de-adn-fecal-multianalitica-en-la-deteccion-del-ccrc-y-la-mortalidad 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07124858/estudio-prospectivo-multicentrico-a-nivel-nacional-para-evaluar-los-factores-pronosticos-relacionados-con-la-eficacia-del-tratamiento-con-fruquintinib-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03125980/quimioterapia-perioperatoria-frente-a-quimioterapia-perioperatoria-con-capox-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05402696/cohorte-del-centro-de-reseccion-avanzada-de-st-paul-para-neoplasias-colorrectales-sparc-c 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07564908/correlacion-y-heterogeneidad-del-microambiente-inmunitario-y-los-patrones-de-crecimiento-histopatologicos-en-las-metastasis-hepaticas-del-cancer-colorrectal-que-pueden-ser-extirpadas-quirurgicamente 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07376668/efectos-de-un-programa-de-prehabilitacion-asistido-por-whatsapp-en-pacientes-que-se-someten-a-una-cirugia-electiva-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07565831/estudio-sobre-la-prediccion-de-metastasis-en-los-ganglios-linfaticos-regionales-en-el-cancer-colorrectal-mediante-tomografia-computarizada-espectral-combinada-con-msi 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05927584/reseccion-local-para-la-preservacion-del-organo-en-el-cancer-colorrectal-temprano-sin-tratamiento-adyuvante 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06696768/ensayo-clinico-de-un-farmaco-antitumoral-ca-4948-emavusertib-en-combinacion-con-quimioterapia-folfox-mas-bevacizumab-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05239338/estudio-sobre-la-preservacion-de-la-fertilidad-tras-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05275374/xp-102-y-xp-102-en-combinacion-con-trametinib-en-pacientes-con-tumores-solidos-avanzados-y-una-mutacion-braf-v600 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06179602/estudio-de-cohorte-prospectivo-sobre-la-ablacion-termica-de-tumores-hepaticos-malignos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06321081/estudio-ice-combinacion-de-irinotecan-mas-cetuximab-y-envafolimab-como-regimen-de-retreatment-en-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06085560/elige-usalo-eleccion-intenciones-de-implementacion-y-deteccion-domiciliaria-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07254156/un-estudio-sobre-la-deteccion-de-la-enfermedad-residual-minima-erm-independiente-del-tipo-de-tumor-en-el-cancer-colorrectal-en-estadio-iii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06462521/reseccion-por-partes-con-asa-fria-versus-reseccion-endoscopica-de-la-mucosa-con-asa-fria 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07387263/integracion-de-la-genetica-en-la-practica-clinica-evaluacion-de-una-aplicacion-digital-para-ampliar-y-facilitar-la-realizacion-de-pruebas-geneticas-iniciadas-por-los-oncologos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06865521/akkermansia-probioticos-y-anticuerpo-monoclonal-anti-pd-1-en-cancer-colorrectal-avanzado-mss-pmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06833866/ensayo-de-fase-i-de-una-terapia-basada-en-5-fluorouracilo-5fu-en-combinacion-con-hidroxitirosol-ht-en-pacientes-con-cancer-colorrectal-avanzado-o-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06889844/estudio-observacional-de-reactividad-cruzada-para-el-diagnostico-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06989814/medicion-inteligente-del-adn-tumoral-circulante 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06753136/electroquimioterapia-ect-en-pacientes-con-tumores-viscerales-primarios-y-o-localizaciones-viscerales-secundarias-de-cualquier-histotipo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05700656/galunisertib-en-combinacion-con-capecitabina-en-el-tratamiento-del-cancer-colorrectal-avanzado-con-microsatelites-estables-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06598007/un-estudio-para-determinar-el-efecto-de-ct3001-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03957902/evaluacion-de-biomarcadores-directos-de-la-accion-del-acido-acetilsalicilico-para-desarrollar-una-terapia-de-quimioprevencion-de-precision-contra-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07000474/caracterizacion-multiparametrica-de-los-canceres-colorrectales-metrad 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05999396/fih-anticuerpo-bispecifico-cc-3-anti-cd276-cd3-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03364621/analisis-genomico-exhaustivo-de-pacientes-con-cancer-colorrectal-y-metastasis-hepaticas-aisladas-para-comprender-la-respuesta-y-la-resistencia-a-la-terapia-contra-el-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05686499/desarrollo-de-capacidades-para-la-deteccion-y-el-diagnostico-precoz-del-cancer-colorrectal-mediante-un-programa-integral-de-formacion-en-colonoscopia-en-nigeria 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07398456/identificacion-hibrida-mediante-telefono-inteligente-del-cancer-colorrectal-en-etapas-tempranas-utilizando-pruebas-de-deteccion-basadas-en-sangre-en-todo-el-estado-de-texas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06298916/64cu-lnth-1363s-en-pacientes-con-sarcoma-o-cancer-del-tracto-gastrointestinal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04912765/vacuna-de-celulas-dendriticas-neoantigenicas-y-nivolumab-en-el-carcinoma-hepatocelular-y-las-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07255729/una-firma-de-microarn-exosomal-para-la-estadificacion-preoperatoria-en-el-cancer-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03972956/obtencion-de-muestras-para-el-cancer-colorrectal-el-cancer-gastrico-y-enfermedades-no-malignas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06652412/radioterapia-ultrafraccionada-guiada-por-cga-y-tratamiento-sistemico-en-pacientes-ancianos-o-fragiles-con-cancer-colorrectal-localizado-no-operable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07070518/estudio-de-gv20-0251-en-participantes-con-tumores-solidos-malignos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07060443/mapeo-de-los-ganglios-linfaticos-mediante-fluorescencia-para-la-cirugia-del-cancer-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06958926/un-estudio-traslacional-sobre-la-recurrencia-locorregional-del-cancer-de-colon-t4 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07237438/anestesia-con-propofol-en-infusion-continua-frente-a-anestesia-equilibrada-en-la-cirugia-de-cancer-colorrectal-efecto-sobre-la-masa-muscular 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06615583/una-nueva-tecnica-adaptativa-de-anastomosis-para-la-reseccion-de-la-porcion-izquierda-del-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07410494/terapia-con-celulas-car-nk-alogenicas-dirigidas-a-un-unico-objetivo-o-a-objetivos-duales-guiada-por-biomarcadores-para-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05844514/analisis-del-aliento-en-pacientes-con-cancer-colorrectal-cobra2 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05999812/ensayo-clinico-de-acido-al-trans-retinoico-bevacizumab-y-atezolizumab-en-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04125914/intervencion-sobre-el-control-del-peso-y-los-habitos-de-salud-para-reducir-el-riesgo-de-cancer-en-familias-con-mutaciones-en-los-genes-brca-y-con-sindrome-de-lynch 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05308446/evaluacion-de-la-adicion-de-nivolumab-al-tratamiento-estandar-para-pacientes-con-cancer-colorrectal-metastasico-o-irresecable-que-presentan-una-mutacion-en-el-gen-braf 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06567782/un-estudio-de-dostarlimab-neoadyuvante-mas-capecitabina-mas-oxaliplatino-capeox-frente-a-capeox-en-pacientes-con-cancer-colorrectal-en-estadio-t4n0-o-estadio-iii-con-reparacion-de-errores-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05881746/reseccion-anatomica-frente-a-reseccion-no-anatomica-en-metastasis-hepaticas-de-cancer-colorrectal-con-mutacion-genetica-o-localizacion-en-el-lado-derecho 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06269744/programa-de-deteccion-proactiva-mediante-la-prueba-de-sangre-oculta-en-heces-fit 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07228000/servicios-integrados-de-orientacion-para-la-deteccion-del-cancer-y-pruebas-geneticas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05726136/administracion-de-liquidos-y-volumen-plasmatico-durante-la-cirugia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07422974/resultados-perioperatorios-tras-la-terapia-neoadyuvante-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04776655/estudio-en-pacientes-con-mcrc-cancer-colorrectal-metastasico-que-compara-el-analisis-de-tejidos-ras-braf-salvajes-y-biopsias-liquidas-ras-mutadas-y-evalua-el-tratamiento-con-folfiri-mas-cetuximab-o 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06792695/un-estudio-de-nuevas-intervenciones-y-combinaciones-terapeuticas-en-participantes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06341296/estudio-de-fase-ii-de-liposomas-de-irinotecan-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06920082/ejercicios-de-relajacion-muscular-progresiva-para-mejorar-el-sueno-reducir-la-fatiga-y-aliviar-el-dolor-en-pacientes-con-cancer-de-pancreas-y-cancer-de-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06349590/manipulacion-de-la-microbiota-intestinal-mediante-una-dieta-preoperatoria-estandarizada-para-prevenir-la-recurrencia-y-la-metastasis-del-cancer-colorrectal-tras-la-cirugia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07429760/preparacion-mecanica-del-intestino-con-o-sin-antibioticos-orales-en-la-cirugia-de-cancer-colorrectal-izquierdo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06937567/terapia-car-t-con-cdh17-en-tumores-solidos-malignos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07041229/comparacion-de-metodos-para-la-reseccion-de-grandes-neoplasias-epiteliales-benignas-de-base-ancha-en-el-colon-esd-y-emr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07148128/estudio-de-fase-1-2a-para-evaluar-la-seguridad-tolerabilidad-farmacocinetica-y-eficacia-preliminar-de-wef-001-como-monoterapia-en-tumores-solidos-avanzados-con-mutacion-en-el-gen-kras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06530303/terapia-con-linfocitos-infiltrantes-tumorales-mediante-inmunoterapia-para-el-cancer-de-colon-y-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02194387/intervenciones-sobre-el-equilibrio-energetico-para-aumentar-la-actividad-fisica-en-pacientes-con-cancer-de-mama-con-mutaciones-geneticas-especificas-pacientes-con-sindrome-de-lynch-supervivientes-de 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03637686/improve-analisis-del-adn-tumoral-circulante-para-optimizar-el-tratamiento-de-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07272642/un-estudio-de-fase-i-multicentrico-y-basado-en-imagenes-de-lnth-2403-en-participantes-con-tumores-solidos-localmente-avanzados-o-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05491434/sarcopenia-en-pacientes-con-cancer-colorrectal-estudio-de-intervencion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05544929/un-estudio-de-seguridad-y-eficacia-de-kfa115-solo-y-en-combinacion-con-pembrolizumab-en-pacientes-con-canceres-avanzados-seleccionados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07433673/gemcitabina-cisplatino-nab-paclitaxel-gap-y-cemiplimab-para-el-cancer-de-las-vias-biliares-localmente-avanzado-btc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02843425/ensayo-clinico-be-gone-legumbres-para-enriquecer-la-microbiota-intestinal-frente-a-los-efectos-negativos-de-la-obesidad 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06613165/explorando-la-duracion-del-tratamiento-con-terapia-neoadyuvante-anti-pd-1-en-el-cancer-colorrectal-en-estadio-ii-iii-con-dmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06225843/sotevtamab-ab-16b5-en-combinacion-con-folfox-como-tratamiento-neoadyuvante-previo-a-la-reseccion-de-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04735198/colecistectomia-profilactica-en-pacientes-con-tumores-neuroendocrinos-de-intestino-medio-que-requieren-cirugia-del-tumor-primario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07279077/radioterapia-de-baja-dosis-con-conservacion-de-los-ganglios-linfaticos-administrada-de-forma-concurrente-con-quimioterapia-e-inhibidor-de-pd-1-en-pacientes-con-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07451483/hernias-ventrales-tras-la-cirugia-citorreductora-incidencia-factores-de-riesgo-y-tratamiento-quirurgico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04008030/un-estudio-de-nivolumab-nivolumab-mas-ipilimumab-o-quimioterapia-a-eleccion-del-investigador-para-el-tratamiento-de-participantes-con-cancer-colorrectal-metastasico-mcrc-con-deficiencia-en-la 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06307548/cirugia-guiada-por-imagen-de-fluorescencia-seguida-de-terapia-fotodinamica-intraoperatoria-para-mejorar-el-control-tumoral-local-en-pacientes-con-cancer-colorrectal-localmente-avanzado-o-recurrente 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05903885/una-colaboracion-transversal-para-mejorar-la-prevencion-y-la-equidad-en-salud-entre-los-afroamericanos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07186842/un-ensayo-clinico-para-evaluar-si-el-farmaco-en-investigacion-bnt329-es-seguro-y-potencialmente-beneficioso-para-pacientes-con-tumores-solidos-avanzados-que-expresan-el-marcador-tumoral-ca19-9 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06638502/seguridad-de-hrx215-en-pacientes-despues-de-una-reseccion-hepatica-menor-o-mayor 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06193356/la-deteccion-de-cicatrices-de-reseccion-endoscopica-y-la-delimitacion-de-la-recurrencia-son-habilidades-que-se-pueden-adquirir-mediante-entrenamiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07153614/eficacia-de-las-tecnicas-de-reduccion-del-uso-de-opioides-en-el-periodo-perioperatorio-sobre-el-tiempo-de-inicio-de-la-quimioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07045207/evaluacion-de-las-decisiones-tomadas-por-la-inteligencia-artificial-y-por-expertos-humanos-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07263178/un-estudio-sobre-la-quimioterapia-paliativa-en-segunda-linea-y-posteriores-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05068531/deteccion-temprana-del-fracaso-del-tratamiento-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06931808/trasplante-de-microbiota-intestinal-radioterapia-combinada-con-quimioterapia-y-sintilimab-en-cancer-colorrectal-avanzado-localizado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04449874/un-estudio-para-evaluar-la-seguridad-la-farmacocinetica-y-la-actividad-de-gdc-6036-en-monoterapia-o-en-combinacion-en-participantes-con-tumores-solidos-avanzados-o-metastasicos-con-una-mutacion-kras 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07003022/ensayo-clinico-de-fase-ii-de-cadonilimab-en-combinacion-con-agentes-antiangiogenicos-en-el-cancer-colorrectal-metastasico-dmmr-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05647122/estudio-de-fase-i-con-azd9592-en-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07033156/un-estudio-exploratorio-sobre-la-deteccion-de-la-metilacion-de-genes-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06971107/resultados-actuales-de-la-estabilidad-de-microsatelites-en-el-cancer-de-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07602504/base-de-datos-del-registro-clinico-chino-de-pacientes-con-cancer-de-higado-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04258137/adn-circulante-para-mejorar-el-pronostico-de-los-pacientes-oncologicos-un-estudio-aleatorizado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02185443/radioterapia-estereotactica-de-cuerpo-completo-sbrt-para-metastasis-hepaticas-irresecables 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06287671/omica-del-cancer-colorrectal-y-proteoglicanos-de-la-matriz-extracelular-ofcs 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06089590/i-care-2-enfermedad-inflamatoria-intestinal-cancer-e-infecciones-graves-en-francia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06614660/imagenologia-metabolica-y-genomica-para-predecir-los-resultados-quirurgicos-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06558773/inhibidor-de-la-sintetasa-gsl-en-combinacion-con-un-inhibidor-del-punto-de-control-inmunitario-y-o-regorafenib-en-pacientes-con-cancer-colorrectal-pmmr-mss-previamente-tratados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07035600/dificultad-para-caminar-y-sentarse-despues-de-la-cirugia-de-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07486492/utilizando-bacterias-beneficiosas-del-intestino-para-potenciar-el-tratamiento-inmunologico-del-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07486180/aplicacion-de-un-nuevo-sistema-robotico-endoluminal-para-la-diseccion-endoscopica-submucosa-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06929481/deteccion-mediante-un-analisis-de-sangre-para-identificar-el-adn-con-el-fin-de-abordar-las-desigualdades-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05495776/estudio-prospectivo-multicentrico-y-de-registro-para-evaluar-la-frecuencia-del-sindrome-de-lynch-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04713007/mejorar-la-calidad-de-vida-de-los-pacientes-con-cancer-de-colon-y-sus-cuidadores 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05608044/un-estudio-de-botensilimab-y-balstilimab-para-el-tratamiento-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04147494/estudios-experimentales-con-tomografias-por-emision-de-positrones-pet-realizadas-antes-de-la-cirugia-del-cancer-para-analizar-la-cantidad-de-trazador-pet-acumulado-en-los-tejidos-normales-y-cancerosos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05963191/sistema-cad-eye-para-la-deteccion-de-lesiones-neoplasicas-en-pacientes-con-sindrome-de-lynch 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05457244/seguridad-y-rendimiento-del-sistema-quirurgico-da-vinci-sp-r-en-procedimientos-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07494201/estudio-mimicc-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03144765/estudio-multicentrico-de-fase-ii-sobre-la-reseccion-transanal-del-mesenterio-tatme 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06638931/terapia-agnostica-en-tumores-solidos-poco-frecuentes 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07304063/superando-las-barreras-para-la-implementacion-del-cribado-en-cascada 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07615036/ap-noses-un-registro-multicentrico-prospectivo-sobre-la-extraccion-de-muestras-a-traves-de-orificios-naturales-en-la-cirugia-minimamente-invasiva-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06821048/estudio-de-la-terapia-car-t-dirigida-contra-el-cea-ptc13-en-el-tratamiento-de-tumores-solidos-malignos-avanzados-cea-positivos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06366841/estigma-y-perfil-psicologico-en-pacientes-con-cancer-colorrectal-y-anal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06555003/quimioterapia-con-debiri-mas-otros-farmacos-frente-a-quimioterapia-sola-en-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06881303/impacto-de-la-identificacion-y-la-educacion-previas-de-los-pacientes-que-requieren-un-estoma-digestivo-para-la-derivacion-fecal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07307664/aumento-de-las-pruebas-geneticas-en-la-linea-germinal-para-pacientes-con-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07730489/un-estudio-que-compara-bl-m07d1-con-la-terapia-elegida-por-el-medico-en-pacientes-con-cancer-colorrectal-avanzado-her2-ihc3-que-no-respondieron-a-un-tratamiento-previo-con-oxaliplatino-fluorouracilo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05628038/la-combinacion-de-radioterapia-hipofraccionada-e-inmunoterapia-en-el-cancer-de-recto-localmente-recurrente 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06731998/control-optimo-del-dolor-perioperatorio-en-la-cirugia-abdominal-minimamente-invasiva-para-el-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06985316/un-estudio-clinico-exploratorio-que-evalua-la-eficacia-y-la-seguridad-de-tunlametinib-en-combinacion-con-fruquintinib-en-el-tratamiento-de-tercera-linea-de-pacientes-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06283134/un-estudio-clinico-de-biottt001-en-combinacion-con-toripalimab-y-regorafenib-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03823144/microscopia-intravital-en-tumores-solidos-humanos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07222800/symbiotic-gi-03-un-estudio-para-obtener-mas-informacion-sobre-el-farmaco-de-estudio-denominado-pf-08634404-en-combinacion-con-quimioterapia-en-participantes-adultos-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04314401/banco-de-muestras-biologicas-del-programa-cancer-moonshot-del-instituto-nacional-del-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07314294/estudio-de-fase-ii-de-emb-01-en-pacientes-con-cancer-colorrectal-recurrente-o-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06167967/la-metilacion-del-adn-tumoral-circulante-como-guia-para-la-quimioterapia-adyuvante-postoperatoria-en-el-cancer-colorrectal-en-estadio-iii 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07509632/prediccion-de-la-respuesta-patologica-completa-en-el-cancer-de-recto-mediante-el-aprendizaje-automatico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05669430/un-estudio-de-la-monoterapia-con-gv20-0251-y-la-combinacion-de-gv20-0251-con-pembrolizumab-en-participantes-con-tumores-solidos-malignos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05524012/evaluacion-longitudinal-multimodal-de-la-respuesta-durante-el-tratamiento-neoadyuvante-del-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07314996/cirugia-laparoscopica-frente-a-cirugia-abierta-para-el-cancer-de-colon-en-pacientes-con-obesidad-visceral 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05299840/impacto-del-uso-del-dispositivo-oncogramme-r-en-la-seleccion-del-tratamiento-de-primera-linea-para-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06960291/implementacion-sostenible-del-programa-excel-de-oncologia-y-ejercicio-en-todo-canada 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07510321/fl-261-imagenologia-para-el-diagnostico-y-la-estadificacion-del-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05990543/combinacion-de-nelmastobart-y-capecitabina-en-el-tratamiento-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07318389/ascend-crc-perfilado-y-abordaje-de-la-resistencia-tumoral-dinamica-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03170960/estudio-de-cabozantinib-solo-o-en-combinacion-con-atezolizumab-en-sujetos-con-tumores-solidos-avanzados-localmente-o-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06730750/un-estudio-de-bms-986490-con-o-sin-bevacizumab-en-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02328677/estudio-colocare-cohorte-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07630961/estudio-de-fase-i-de-jfi447-68ga-ga-dfc413-y-comparacion-con-ffg233-68ga-ga-nns309-en-pacientes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07094204/un-estudio-para-determinar-una-dosis-adecuada-de-asp5834-en-adultos-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07754513/vesiculas-extracelulares-tumorales-circulantes-para-el-seguimiento-no-invasivo-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07759921/nueva-intervencion-basada-en-la-atencion-plena-para-parejas-dirigida-a-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07527858/estudio-de-denikitug-gs-1811-administrado-solo-o-en-combinacion-con-nivolumab-o-con-quimioterapia-en-adultos-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06522919/tratamiento-secuencial-con-inmunoterapia-y-quimioterapia-que-consiste-en-la-administracion-de-pembrolizumab-mas-vacuna-de-celulas-dendriticas-seguido-de-trifluridina-tipiracil-mas-bevacizumab-en 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06935734/colonoscopia-robotica-con-el-sistema-triton-4-0-en-adultos-para-el-cribado-la-vigilancia-y-el-diagnostico-de-patologias-del-tracto-gastrointestinal-inferior 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05078047/estudio-que-compara-la-administracion-estandar-de-inmunoterapia-io-frente-a-la-misma-inmunoterapia-administrada-cada-3-meses-en-pacientes-que-responden-despues-de-6-meses-de-inmunoterapia-estandar 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06609434/el-papel-y-la-seguridad-de-la-ablacion-por-radiofrecuencia-en-las-metastasis-hepaticas-recurrentes-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07337876/preservacion-de-organos-en-el-cancer-de-recto-mediante-radioterapia-adaptativa-guiada-por-resonancia-magnetica-con-dosis-escaladas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06475352/individualizacion-de-la-dosis-de-quimioterapia-en-pacientes-con-canceres-gastrointestinales-que-carecen-de-una-enzima-hepatica-especifica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05858736/seguridad-farmacocinetica-y-eficacia-de-ai-061-en-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02804815/add-aspirin-un-ensayo-clinico-que-evalua-los-efectos-de-la-aspirina-sobre-la-recurrencia-de-la-enfermedad-y-la-supervivencia-tras-la-terapia-primaria-en-tumores-solidos-no-metastasicos-comunes 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07535112/un-estudio-para-obtener-mas-informacion-sobre-la-seguridad-de-bay-3771249-y-su-eficacia-en-personas-con-cancer-colorrectal-avanzado-o-metastasico-que-presenta-una-mutacion-kras-g12d 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07646639/diferentes-dosis-de-radioterapia-estereotactica-scrt-mas-capox-bloqueo-de-pd-1-e-il-2-en-el-cancer-colorrectal-localmente-avanzado-larc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07091032/estableciendo-conexiones 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05765214/impacto-de-un-programa-de-educacion-sobre-el-cancer-colorrectal-y-la-nutricion-en-pacientes-de-minorias-con-diabetes-tipo-2 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06133439/deteccion-del-cancer-colorrectal-en-zonas-rurales-de-indiana 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05219734/el-ensayo-de-enfermedad-residual-minima-erm-evalua-la-recurrencia-y-la-respuesta-mediante-una-evaluacion-basada-en-el-tumor 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04851119/tegavivint-para-el-tratamiento-de-tumores-solidos-recurrentes-o-refractarios-incluidos-los-linfomas-y-los-tumores-desmoides 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04603287/un-estudio-de-si-b001-un-anticuerpo-bispecifico-anti-egfr-her3-en-tumores-epiteliales-localmente-avanzados-o-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07775209/reduccion-de-la-duracion-del-tratamiento-con-radioterapia-mediante-el-uso-de-una-tecnica-de-refuerzo-integrado-simultaneo-con-una-dosis-de-radiacion-mas-baja-para-los-ganglios-linfaticos-electivos-y 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07523763/inmunoterapia-neoadyuvante-a-dosis-bajas-en-el-cancer-colorrectal-localmente-avanzado-con-deficiencia-de-mmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06440902/exploracion-de-estrategias-terapeuticas-para-el-cancer-colorrectal-metastasico-con-mutacion-nras-de-tipo-salvaje-basada-en-el-adn-tumoral-circulante 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06400472/un-estudio-de-ly4170156-en-participantes-con-tumores-solidos-avanzados-seleccionados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07134205/estudio-de-jmt101-en-combinacion-con-irinotecan-como-tratamiento-en-3a-linea-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02319928/estudio-europeo-de-vigilancia-de-polipos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07792980/analisis-del-microbioma-asistido-por-inteligencia-artificial-para-evaluar-la-eficacia-de-mpro3-y-los-cambios-en-el-entorno-intestinal-en-pacientes-sometidos-a-cirugia-por-cancer-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06149481/estudio-de-fase-i-ii-del-regimen-de-inmunoterapia-combinada-sx-682-vacuna-triadeno-retifanlimab-y-agonista-de-il-15-n-803-star15-para-el-cancer-colorrectal-metastasico-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05447611/papel-de-la-empatia-en-los-resultados-del-tratamiento-curativo-del-cancer-colorrectal-no-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06711939/validacion-del-dispositivo-vocorder-en-entornos-clinicos-monitorizacion-continua-de-pacientes-validacion-clinica-del-vocorder-vcv 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04751370/evaluacion-de-nivolumab-e-ipilimumab-en-combinacion-con-radioterapia-de-corta-duracion-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06958432/radioterapia-de-curso-corto-con-preservacion-de-los-ganglios-linfaticos-seguida-de-quimioterapia-secuencial-e-inhibidor-de-pd-1-para-el-cancer-colorrectal-de-etapa-intermedia-baja-con-pmmr-mss-modifi 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06734156/care-crc-analisis-del-microbioma-y-correlaciones-para-evaluar-el-riesgo-y-los-resultados-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05411718/un-ensayo-clinico-aleatorizado-doble-ciego-de-fase-iia-para-evaluar-naproxeno-o-aspirina-en-la-modulacion-de-la-respuesta-inmune-contra-el-cancer-en-el-sindrome-de-lynch 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07132463/quimiorradioterapia-neoadyuvante-seguida-de-quimioterapia-con-o-sin-tislelizumab-para-el-cancer-de-recto-ultra-bajo-resecable-el-estudio-relieve-02 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05846867/un-estudio-clinico-de-fase-ib-ii-sobre-ak112-administrado-solo-o-en-combinacion-con-ak119-en-pacientes-con-cancer-colorrectal-pmmr-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06076811/danish-mrd-evaluacion-danesa-de-la-enfermedad-residual-minima-mediante-biopsias-liquidas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07239479/ensayo-dexdes-combinacion-de-dexmedetomidina-y-desflurano-en-la-colectomia-laparoscopica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04013152/base-de-datos-clinica-de-la-cirugia-robotica-para-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05868226/programa-pre-ispy-plataforma-de-ensayos-clinicos-oncologicos-de-fase-i-ii 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07801352/capeox-en-combinacion-con-un-anticuerpo-anti-pd1-mas-dihidroartemisinina-como-terapia-neoadyuvante-o-de-conversion-para-el-cancer-colorrectal-localmente-avanzado-y-metastasico-con-estabilidad 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05994482/colonoscopia-de-vigilancia-en-adultos-mayores-el-estudio-survolderadults 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07802847/via-innovadora-y-colaborativa-que-integra-la-oncogeriatria-el-seguimiento-farmaceutico-y-farmacologico-en-pacientes-ancianos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06061874/ga68-fapi-46-pet-tc-para-la-evaluacion-preoperatoria-de-la-carcinomatosis-peritoneal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07183124/modelado-tridimensional-para-la-deteccion-del-cancer-colorrectal-localmente-avanzado-con-margenes-de-reseccion-circunferencial-positivos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05944237/htl0039732-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07001085/monitorizacion-del-ctdna-en-pacientes-con-chc-y-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07386431/la-asociacion-entre-la-endometriosis-profunda-y-la-aparicion-de-carcinoma-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07158671/la-eficacia-del-programa-de-salud-movil-para-supervivientes-mhealth-en-la-mejora-de-la-calidad-de-vida-relacionada-con-la-salud-en-supervivientes-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05571293/inmunoterapia-combinada-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06612281/evaluacion-del-rendimiento-de-gixam-en-una-poblacion-con-resultados-negativos-en-la-prueba-de-sangre-oculta-en-heces-fit 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07149623/distribucion-de-los-ganglios-linfaticos-metastasicos-en-el-mesenterio-ileal-en-el-cancer-de-ciego-y-del-colon-ascendente-proximal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06390982/preservacion-de-organos-con-tislelizumab-y-terapia-neoadyuvante-total-en-pacientes-con-cancer-de-recto-en-estadio-temprano-estudio-relieve-01 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06528353/deteccion-mediante-biomarcadores-sanguineos-en-el-cribado-de-cpc-impulsado-por-el-vph 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05652361/sistema-de-guia-quirurgica-basado-en-aprendizaje-automatico-para-la-cirugia-rectal-asistida-por-robot 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04745754/el-estudio-epics-engaging-primary-care-in-cancer-survivorship-que-involucra-a-la-atencion-primaria-en-el-seguimiento-de-pacientes-supervivientes-de-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06710067/metabolitos-urinarios-en-el-diagnostico-de-enfermedades 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06710756/terapia-con-plomo-212-psv359-para-pacientes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05220800/efectos-de-la-administracion-intravenosa-de-hierro-en-pacientes-con-deficiencia-de-hierro-y-cancer-colorrectal-que-no-presentan-anemia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03623464/ensayo-clinico-aleatorizado-comparando-el-uso-de-aplicaciones-moviles-y-dispositivos-fitbit-frente-a-la-atencion-habitual 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07403877/inmunoterapia-neoadyuvante-radioterapia-en-cancer-colorrectal-localmente-avanzado-msi-h-dmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07044921/estudio-clinico-de-un-tratamiento-combinado-basado-en-irinotecan-liposomal-ii-para-el-cancer-colorrectal-resistente-al-irinotecan 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03787056/valor-predictivo-de-la-concentracion-de-progastrina-en-el-momento-del-diagnostico-y-de-la-cinetica-de-la-progastrina-durante-el-tratamiento-en-pacientes-con-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05212012/d-l-metadona-y-mfolfox6-en-el-tratamiento-del-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06776120/prueba-inmunoquimica-fecal-en-el-diagnostico-del-cancer-colorrectal-en-pacientes-vietnamitas-con-sintomas-del-tracto-gastrointestinal-inferior 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07406087/intervencion-de-apoyo-para-pacientes-adolescentes-y-adultos-jovenes-supervivientes-de-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06398743/primer-estudio-correcto-sobre-la-deteccion-de-la-enfermedad-residual-minima-erm-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06814093/cirugia-robotica-frente-a-cirugia-laparoscopica-para-el-cancer-de-recto-medio-e-inferior-una-emulacion-de-ensayo-dirigido 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06568679/deteccion-temprana-y-optimizacion-del-tratamiento-y-el-pronostico-en-pacientes-con-cancer-colorrectal-de-inicio-temprano 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04767984/evaluacion-de-atorvastatina-para-reducir-el-riesgo-de-cancer-de-colon-en-pacientes-con-colitis-ulcerosa-cronica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06717880/un-estudio-de-ibi363-en-combinacion-con-bevacizumab-o-furuitinib-en-sujetos-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05985707/kn026-mas-quimioterapia-kn-046-en-cancer-colorrectal-y-carcinoma-biliar-her2-positivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05624138/el-posible-papel-protector-del-ketotifeno-contra-la-neuropatia-periferica-inducida-por-oxaliplatino 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05985109/kn-046-regorafenib-mas-otro-tratamiento-en-cancer-colorrectal-metastasico-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06035133/tratamiento-del-cancer-colorrectal-localmente-avanzado-con-radioterapia-eliminacion-de-la-terapia-tnt-y-terapia-neoadyuvante 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04726800/adn-tumoral-circulante-ctdna-como-marcador-pronostico-y-predictivo-en-el-cancer-colorrectal-un-estudio-piloto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06567756/cirugia-de-preservacion-del-esfinter-con-tecnica-de-reseccion-conformada-frente-a-reseccion-interesfinter-en-el-cancer-rectal-bajo-impacto-en-la-funcion-anal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06617858/ensayo-clinico-de-amb-05x-en-pacientes-con-cancer-colorrectal-ctdna-tras-un-tratamiento-con-intencion-curativa 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07076823/seguridad-y-eficacia-de-canagliflozina-en-pacientes-con-cancer-colorrectal-metastasico-con-alta-inestabilidad-de-microsatelites-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06853496/estudio-de-un-inhibidor-de-la-tanquirasa-el-rk-582-en-pacientes-con-cancer-colorrectal-metastasico-irresecable 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02579278/adn-tumoral-circulante-ctdna-en-pacientes-con-cancer-colorrectal-y-su-relacion-con-las-caracteristicas-de-imagen-de-la-invasion-venosa-extramural 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04172753/viabilidad-de-la-radioterapia-guiada-por-resonancia-magnetica-en-linea-en-un-sistema-de-resonancia-magnetica-lineal-de-1-5-t 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07427901/calidad-de-vida-en-supervivientes-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05850130/acupuntura-para-la-neuropatia-periferica-inducida-por-oxaliplatino-en-pacientes-con-cancer-gastrointestinal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07658196/inmunoterapia-tlr9-para-la-carcinomatosis-peritoneal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07137000/el-efecto-de-la-terapia-artistica-en-pacientes-sometidos-a-tratamiento-para-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06228209/nivel-cuidados-paliativos-para-pacientes-con-insuficiencia-cardiaca-avanzada-o-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07192627/reseccion-endoscopica-con-dispositivo-de-corte-esd-en-el-cancer-colorrectal-localmente-avanzado-tras-quimiorradioterapia-qrt 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06642844/quimioterapia-basada-en-bevacizumab-adaptada-a-la-farmacocinetica-del-bevacizumab-en-el-tratamiento-de-primera-linea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06562543/un-ensayo-para-evaluar-la-seguridad-y-la-actividad-del-fruquintinib-en-poblaciones-minoritarias-con-cancer-colorrectal-avanzado-previamente-tratado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06769828/pet-con-ga-68-fapi-46-para-la-deteccion-de-recurrencia-del-ccrc-en-pacientes-con-niveles-elevados-de-cea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07000305/un-estudio-de-cetuximab-combinado-con-envolimab-y-mfolfox6-en-sujetos-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05964530/reseccion-radical-frente-a-reseccion-local-en-el-cancer-de-recto-con-remision-clinica-completa 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06209099/estrategia-inicial-de-preservacion-de-organos-e-intencion-de-adoptar-una-actitud-de-observacion-y-espera-en-el-cancer-de-recto-de-bajo-riesgo-definido-por-resonancia-magnetica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06758830/terapia-neoadyuvante-total-y-preservacion-de-organos-frente-a-cirugia-para-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05611034/perfusion-pulmonar-in-vivo-ivlp-para-el-cancer-colorrectal-metastasico-en-pulmon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06885385/un-estudio-de-fase-ii-que-evalua-la-seguridad-y-la-eficacia-de-js207-con-o-sin-js015-en-combinacion-con-quimioterapia-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07024225/canceres-colorrectales-un-estudio-retrospectivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04296630/redes-sociales-para-la-deteccion-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05501379/comparacion-de-la-actividad-fisica-en-pacientes-con-cancer-evaluada-mediante-cuestionario-y-monitor-de-movimiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07445828/evaluacion-de-la-colonoscopia-con-capsula-en-pacientes-con-sindrome-de-lynch 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07675967/estudio-sobre-los-efectos-de-la-quimioterapia-y-la-radioterapia-en-la-hematopoyesis-clonal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06008119/eficacia-y-seguridad-de-tunlametinib-mas-vemurafenib-en-pacientes-con-cancer-colorrectal-metastasico-con-mutacion-braf-v600e 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05715255/estudio-de-inmunoterapia-con-autogestion-adaptativa-de-los-sintomas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04450758/reseccion-colonica-aguda-versus-estrategia-de-puente-a-la-cirugia-colonica-con-colocacion-de-stent-o-estoma 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07677579/nimble-crc-neoinmunomodulacion-antes-de-la-cirugia-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07183046/guia-de-planificacion-de-la-intencion-de-implementacion-para-la-deteccion-del-cancer-colorrectal-mediante-la-prueba-de-sangre-oculta-en-heces-fit 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07683403/savolitinib-mas-cetuximab-y-quimioterapia-con-folfox-para-el-cancer-colorrectal-metastasico-con-mutacion-ras-braf-silvestre 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06607185/un-estudio-del-inhibidor-pan-kras-ly4066434-en-participantes-con-tumores-solidos-con-mutacion-en-el-gen-kras 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07166263/seguridad-y-eficacia-de-nk510-en-el-tratamiento-del-cancer-gastrico-y-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07191548/estudio-internacional-sobre-el-tratamiento-de-pacientes-con-lesiones-hepaticas-metastasicas-de-cancer-colorrectal-pacientes-con-ire 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04677413/radioterapia-ultrafraccionada-para-el-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07686133/educacion-digital-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04749108/estudio-que-evalua-el-tratamiento-personalizado-del-carcinoma-rectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07687875/viroterapia-oncolitica-para-mejorar-la-eficacia-de-la-inmunoterapia-preoperatoria-en-pacientes-con-cancer-colorrectal-con-reparacion-de-errores-de-emparejamiento-pmmr-funcional 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05008809/quimioterapia-post-reseccion-ablacion-en-pacientes-con-cancer-colorrectal-metastasico-fire-9-port-aio-krk-0418 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06899477/tratamiento-preoperatorio-en-pacientes-con-cancer-de-colon-resecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05984576/radioterapia-y-terapia-neoadyuvante-total-para-el-cancer-colorrectal-recurrente-en-pacientes-previamente-irradiados-un-estudio-observacional-prospectivo-multicentrico-de-la-plataforma-airo-gi 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05321134/evaluacion-de-la-tecnologia-robotica-de-un-solo-puerto-single-port-sp-en-la-cirugia-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07691489/un-estudio-de-trastuzumab-deruxtecan-t-dxd-y-cetuximab-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07020221/un-estudio-de-fase-1-2-de-vs-7375-en-pacientes-con-tumores-solidos-con-mutacion-kras-g12d 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06788171/pulsar-en-combinacion-con-un-anticuerpo-anti-pd-1-y-quimioterapia-mas-bevacizumab-para-el-tratamiento-del-cancer-colorrectal-metastasico-ccrm 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07281716/inmunoterapia-combinada-para-el-tratamiento-del-cancer-colorrectal-metastasico-mss-resistente-a-la-quimioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06649825/eficacia-de-la-vitamina-b1-en-pacientes-con-poliposis-adenomatosa-familiar 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07085091/un-estudio-de-fase-i-en-humanos-con-alx2004-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos-seleccionados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07692152/sintilimab-frente-a-mitomicina-en-combinacion-con-capecitabina-y-radioterapia-de-intensidad-modulada-imrt-para-el-carcinoma-de-celulas-escamosas-anal-en-estadio-temprano 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06243393/sacituzumab-govitecan-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07094893/agentes-anti-egfr-en-pacientes-con-cancer-colorrectal-avanzado-del-lado-derecho-con-ras-de-tipo-salvaje-y-alto-nivel-de-expresion-de-areg-ereg 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07236827/comparacion-de-la-inyeccion-endoscopica-sincronica-y-la-diseccion-submucosa-esisd-y-la-diseccion-submucosa-endoscopica-convencional-cesd-para-el-tumor-nodular-mixto-granular-de-extension-lateral-en 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07470658/estrategia-optima-de-seguimiento-tras-un-resultado-positivo-en-la-prueba-de-sangre-oculta-en-heces-fit-y-una-colonoscopia-negativa 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05148494/estudio-clinico-aleatorizado-eca-tes-enema-fleet-frente-a-preparacion-intestinal-oral 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT00582296/recomendaciones-para-la-deteccion-en-multiples-organos-en-pacientes-con-sindrome-de-lynch 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05286814/pds01adc-en-combinacion-con-una-bomba-de-infusion-en-la-arteria-hepatica-haip-y-terapia-sistemica-para-sujetos-con-cancer-colorrectal-metastasico-colangiocarcinoma-intrahepatico-o-carcinoma 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07467434/quimioterapia-de-induccion-con-folfirinox-para-metastasis-hepaticas-sincronicas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05961709/el-ensayo-phoenix-ensayo-de-fase-ii-de-cemiplimab-para-el-tratamiento-no-quirurgico-del-cancer-colorrectal-localizado-con-dmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06904677/utilizacion-de-la-proteomica-urinaria-4d-para-predecir-y-evaluar-la-respuesta-al-tratamiento-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04245865/tocotrienol-y-bevacizumab-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07587619/uso-intraoperatorio-de-la-imagen-de-saturacion-de-oxigeno-para-evaluar-la-perfusion-intestinal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04780477/alimentos-ricos-en-fibra-para-tratar-la-obesidad-y-prevenir-el-cancer-de-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04599140/sx-682-y-nivolumab-para-el-tratamiento-del-cancer-colorrectal-irresecable-o-metastasico-con-mutacion-en-ras-y-mss-ensayo-stoptraffic-1 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06129604/ensayo-piloto-de-ventana-de-oportunidad-poet 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06636864/efecto-de-la-morfina-intratecal-en-la-calidad-de-la-recuperacion-tras-la-cirugia-laparoscopica-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06792292/colonoscopia-asistida-por-inteligencia-artificial-en-la-deteccion-del-cancer-colorrectal-en-un-hospital-general 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07604909/un-ensayo-aleatorizado-de-fase-ii-que-evalua-serplulimab-en-combinacion-con-quimioterapia-terapia-dirigida-de-segunda-linea-para-el-cancer-colorrectal-en-estadio-temprano-con-recurrencia-precoz-tras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05404230/prevencion-del-dano-nervioso-inducido-por-oxaliplatino-en-las-extremidades-del-cuerpo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05378919/terapia-neoadyuvante-frente-a-terapia-estandar-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06664567/impacto-de-una-estrategia-proactiva-de-los-medicos-de-atencion-primaria-en-la-deteccion-del-ccrc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06972160/proyecto-de-intervencion-para-mejorar-el-cumplimiento-de-las-pruebas-de-deteccion-del-cancer-colorrectal-en-barcelos-esposende 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06791512/mfolfox6-bevacizumab-anticuerpo-monoclonal-anti-pd-1-frente-a-mfolfox6-en-el-cancer-colorrectal-localmente-avanzado-pmmr-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07490119/becotatug-vedotina-en-combinacion-con-cetuximab-en-el-tratamiento-en-lineas-posteriores-del-cancer-colorrectal-metastasico-con-ras-tipo-salvaje 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07492238/deteccion-multiomica-en-plasma-para-evaluar-la-eficacia-y-el-riesgo-de-recurrencia-en-la-terapia-de-conversion-en-el-cancer-colorrectal-oligo-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06586515/moonray-01-un-estudio-de-ly3962673-en-participantes-con-tumores-solidos-con-mutacion-kras-g12d 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04490733/desarrollo-de-un-modelo-de-prediccion-de-riesgo-y-evaluacion-del-efecto-de-la-marcha-con-tareas-duales-para-mejorar-la-funcion-cognitiva-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07724223/fruquintinib-mas-anticuerpo-anti-egfr-para-el-tratamiento-en-tercera-linea-del-mcrc-con-ras-tipo-salvaje 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06905782/la-tecnologia-de-la-inteligencia-artificial-ia-podria-ayudar-a-los-pacientes-a-comprender-mejor-la-preparacion-intestinal-antes-de-someterse-a-una-colonoscopia-este-estudio-intenta-utilizar-un 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07504198/neuroproteccion-con-memantina-y-rosuvastatina 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04161092/el-estudio-sueco-sobre-el-trasplante-hepatico-para-metastasis-de-cancer-colorrectal-no-susceptibles-de-reseccion 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05651022/estudio-de-decoy20-con-o-sin-tislelizumab-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06041945/inteligencia-artificial-para-implementar-estrategias-de-reduccion-de-costes-en-el-cribado-por-colonoscopia-basadas-en-la-prediccion-in-vivo-de-la-histologia-de-los-polipos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06441487/mpath-cloud-para-la-deteccion-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07506005/hemorragia-anastomotica-en-la-anastomosis-colorrectal-relacionada-con-la-posicion-de-los-clips-de-la-grapadora-con-respecto-a-la-linea-de-grapado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04674267/resiliencia-e-igualdad-en-el-envejecimiento-el-cancer-y-la-salud-reach 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06845306/el-uso-de-la-fluorescencia-en-el-infrarrojo-cercano-con-verde-de-indocianina-para-la-evaluacion-cuantitativa-de-la-perfusion-intestinal-con-el-fin-de-prevenir-las-fugas-anastomoticas-en-la-cirugia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06973343/sintilimab-mas-bevacizumab-y-quimioterapia-en-pacientes-con-cancer-colorrectal-mss-pmmr-sin-metastasis-hepaticas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06750094/un-estudio-de-amivantamab-y-folfiri-frente-a-cetuximab-bevacizumab-y-folfiri-en-participantes-con-cancer-colorrectal-kras-nras-y-braf-de-tipo-salvaje-que-previamente-han-recibido-quimioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03961776/monitorizacion-de-la-respuesta-al-tratamiento-mediante-la-tecnica-de-difusion-ponderada-en-imagen-dwi-durante-la-quimiorradiacion-neoadyuvante-para-el-cancer-de-recto-utilizando-sistemas-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07622771/radioterapia-neoadyuvante-combinada-con-nalirifox-y-adebrelimab-en-cancer-colorrectal-localmente-avanzado-pmmr-mss-un-ensayo-clinico-prospectivo-aleatorizado-de-fase-ii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06276140/anemia-por-deficiencia-de-hierro-y-su-impacto-en-la-recuperacion-tras-la-cirugia-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04046445/estudio-de-fase-1b-para-evaluar-atp128-vsv-gp128-y-bi-754091-en-pacientes-con-cancer-colorrectal-en-estadio-iv 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07321847/inyeccion-de-ip-001-en-tumores-hepaticos-sometidos-a-ablacion-termica-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07254910/viabilidad-de-una-intervencion-multicanal-para-promover-la-deteccion-del-cancer-colorrectal-entre-los-nativos-americanos-de-oklahoma 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06751940/vacuna-con-celulas-dendriticas-cargadas-con-neoantigenos-y-terapia-convencional-de-segunda-linea-para-el-ccrc-que-progresa-tras-el-tratamiento-de-primera-linea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05786924/ensayo-de-fase-i-ii-de-s241656-en-malignidades-seleccionadas-con-mutaciones-ras-mapk 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05131919/pembrolizumab-para-el-tratamiento-de-cancer-colorrectal-localmente-avanzado-irresecable-y-no-metastasico-con-dmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02394769/intervencion-con-aspirina-para-la-reduccion-del-riesgo-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06784947/ensayo-clinico-de-atezolizumab-bevacizumab-y-tiragolumab-en-pacientes-con-cancer-colorrectal-metastasico-con-estabilidad-microsatelital 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06887218/5-fluorouracilo-leucovorina-5fu-lv-en-combinacion-con-regorafenib-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07774754/radioterapia-combinada-con-quimioterapia-con-capecitabina-y-oxaliplatino-sintilimab-y-suvemcitug-en-cancer-colorrectal-localmente-avanzado-con-estado-pmmr-un-ensayo-clinico-prospectivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07151040/estudio-de-fase-i-ii-para-evaluar-th9619-en-el-tratamiento-de-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06962670/prediccion-del-riesgo-de-cancer-mediante-marcadores-digitales-y-moleculares 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07779694/ayuno-de-16-horas-mas-serplulimab-y-capeox-como-terapia-neoadyuvante-en-cancer-colorrectal-avanzado-de-localizacion-media-a-baja-con-pmmr-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07340567/personalizacion-de-la-seleccion-de-la-quimioterapia-tras-la-cirugia-en-pacientes-con-cancer-colorrectal-en-estadio-iii-mediante-un-analisis-de-sangre 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06026410/ko-2806-en-monoterapia-y-en-combinacion-con-otras-terapias-en-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06200831/reseccion-simultanea-frente-a-reseccion-escalonada-del-cancer-colorrectal-con-metastasis-hepaticas-sincronicas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05057013/un-ensayo-de-fase-i-iia-con-hmbd-001-en-tumores-solidos-avanzados-her3-positivos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06549907/un-estudio-exploratorio-de-biomarcadores-sobre-el-bloqueo-dual-de-pd1-pdl1-y-ctla4-y-la-terapia-antiangiogenica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06490536/el-ensayo-clinico-sagittarius 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07186296/estudio-clinico-exopert-emerald 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06337773/desarrollo-del-programa-de-formacion-en-cuidados-de-enfermeria-de-precision-para-jovenes-supervivientes-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04894370/combinacion-de-spartalizumab-mdcf-y-radioterapia-en-pacientes-con-carcinoma-anal-de-celulas-escamosas-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07158203/diagnostico-optico-de-neoplasias-mediante-inteligencia-artificial 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06609551/seleccion-de-regimenes-de-quimioterapia-adyuvante-guiada-por-ctdna-en-pacientes-ancianos-con-cancer-de-colon-tras-la-cirugia-un-estudio-aleatorizado-controlado-y-realizado-en-un-unico-centro 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07790601/muestras-obtenidas-mediante-hisopado-en-el-cribado-para-la-deteccion-del-vph-swish 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05732623/factores-de-riesgo-exogenos-y-endogenos-para-el-cancer-colorrectal-de-inicio-temprano 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05163028/un-estudio-de-escalada-de-dosis-de-un-inhibidor-de-shp2-en-pacientes-con-tumores-solidos-que-presentan-mutaciones-en-kras-o-egfr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07216105/ft836-con-o-sin-quimioterapia-y-o-anticuerpos-monoclonales-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06910670/implementacion-de-un-ensayo-clinico-aleatorizado-y-controlado-para-evaluar-una-herramienta-de-apoyo-a-la-toma-de-decisiones-en-linea-ampliada 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03449914/el-estudio-gold-g8-en-pacientes-de-edad-avanzada 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06746012/diseno-de-una-intervencion-de-msalud-basada-en-diadas-para-mejorar-el-cumplimiento-de-las-recomendaciones-sobre-habitos-de-vida-en-pacientes-supervivientes-de-cancer-colorrectal-y-sus-cuidadores 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05725200/estudio-para-investigar-los-resultados-de-un-tratamiento-individualizado-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04895709/un-estudio-de-bms-986340-como-monoterapia-y-en-combinacion-con-nivolumab-o-docetaxel-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06848842/ivonescimab-mas-quimioterapia-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-inicialmente-irresecable 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04804956/el-microbioma-mesorrectal-como-factor-pronostico-en-pacientes-con-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05253651/un-estudio-de-tucatinib-en-combinacion-con-trastuzumab-y-mfolfox6-frente-al-tratamiento-estandar-en-el-cancer-colorrectal-metastasico-her2-en-primera-linea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03157128/un-estudio-de-selpercatinib-loxo-292-en-participantes-con-tumores-solidos-avanzados-tumores-solidos-con-fusion-de-ret-y-cancer-de-tiroides-medular-libretto-001 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07066046/colonoscopia-asistida-por-inteligencia-artificial-en-la-deteccion-y-caracterizacion-de-lesiones-colorrectales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05954078/quimioterapia-adyuvante-postoperatoria-guiada-por-la-metilacion-del-adn-tumoral-circulante-en-pacientes-con-cancer-colorrectal-en-estadio-ii-iii-de-alto-riesgo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07796334/programa-de-promocion-de-la-salud-del-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06279351/el-talidomida-potencia-la-eficacia-clinica-del-cetuximab-en-combinacion-con-la-quimioterapia-estandar-para-el-cancer-colorrectal-izquierdo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06524245/un-modelo-predictivo-para-la-recurrencia-del-cancer-colorrectal-basado-en-el-analisis-multi-omico-de-la-sangre-de-la-vena-porta 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04779554/dosis-fija-versus-quimioterapia-intraoperatoria-basada-en-el-peso-para-el-tratamiento-de-la-enfermedad-peritoneal-carcinomatosa-con-citoreduccion-y-quimioterapia-intraoperatoria-hipertermia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06037954/un-estudio-sobre-la-atencion-de-la-salud-mental-en-pacientes-con-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07377487/estudio-precomercializacion-de-therasphere-en-japon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06314022/una-aplicacion-movil-para-mejorar-la-calidad-de-la-colonoscopia-en-un-programa-de-deteccion-del-cancer-colorrectal-aplicacion-prepcolon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04429542/estudio-de-seguridad-y-tolerabilidad-de-la-monoterapia-con-bca101-y-de-la-terapia-combinada-en-pacientes-con-tumores-solidos-avanzados-con-alteracion-en-el-gen-egfr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06444815/un-estudio-de-vet3-tgi-en-pacientes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06825624/artemis-102-combinaciones-con-hs-20093-en-pacientes-con-cancer-colorrectal-metastasico-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06195670/estudio-clinico-de-radioterapia-de-corta-duracion-seguida-de-fruquintinib-mas-sintilimab-frente-a-bevacizumab-mas-capecitabina-como-tratamiento-de-primera-linea-en-pacientes-con-mcrc-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05056896/aspired-xt-intervencion-con-aspirina-para-la-reduccion-del-riesgo-de-cancer-colorrectal-extension 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07385521/el-uso-de-la-inteligencia-artificial-para-la-prediccion-de-la-recurrencia-tras-la-reseccion-de-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05993923/impacto-de-un-enfoque-multidisciplinario-en-la-unidad-de-geriatria-perioperatoria-sobre-el-estado-funcional-de-pacientes-de-70-anos-o-mas-sometidos-a-cirugia-por-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04592003/cohorte-francesa-de-pacientes-con-cancer-colorrectal-sometidos-a-reseccion-endoscopica-con-dispositivo-de-corte-esd-en-centros-especializados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04643041/observacion-y-espera-en-pacientes-con-cancer-de-recto-distal-dmmr-msi-h-tratados-con-anticuerpos-monoclonales-anti-pd-1 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05706779/encorafenib-mas-cetuximab-en-un-entorno-neoadyuvante-en-pacientes-con-cancer-de-colon-o-recto-superior-localizado-con-mutacion-braf 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06709170/seguridad-y-eficacia-de-una-nueva-grapadora-lineal-asimetrica-nals-para-asegurar-el-margen-de-reseccion-distal-en-la-cirugia-laparoscopica-del-cancer-de-recto-estudio-piloto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07399236/prediccion-basada-en-inteligencia-artificial-de-la-metastasis-hepatica-en-el-cancer-colorrectal-un-estudio-retrospectivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05081024/establecimiento-de-un-biomarcador-de-ctdna-para-mejorar-las-estrategias-de-preservacion-de-organos-en-pacientes-con-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06866574/un-ensayo-de-fase-iii-para-evaluar-la-eficacia-inmunogenicidad-y-seguridad-de-una-vacuna-recombinante-contra-el-virus-del-papiloma-humano-9-valente-tipos-6-11-16-18-31-33-45-52-58-e-coli-en-hombres 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07577505/suplementacion-con-histidina-para-potenciar-la-inmunidad-antitumoral-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07391956/atencion-paliativa-de-nivel-superior-para-pacientes-con-insuficiencia-cardiaca-avanzada-o-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07584486/desarrollo-de-una-nueva-herramienta-simplificada-para-predecir-la-histologia-de-las-lesiones-neoplasicas-polipoideas-colorrectales-no-cancerosas-lnpcp-y-evaluar-el-riesgo-de-cancer-invasivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07586293/histidina-y-respuesta-a-la-inmunoterapia-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04478851/excel-ejercicio-para-pacientes-con-cancer-con-el-fin-de-mejorar-su-calidad-de-vida 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06865638/eficacia-y-seguridad-de-las-pruebas-para-detectar-fugas-anastomoticas-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06682650/implementacion-de-una-herramienta-de-deteccion-del-cancer-colorrectal-en-centros-de-atencion-primaria-de-los-estados-unidos-mejora-de-la-calidad-habitual-10-centros-frente-al-proceso-de-normalizacion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07410676/ebnk-001-celulas-nk-alogenicas-con-dosis-bajas-de-il-15-pembrolizumab-en-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07411781/pin-en-combinacion-con-sintilimab-en-pacientes-con-cancer-colorrectal-crc-pmmr-mss-previamente-tratados-y-con-metastasis-hepaticas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06594692/radioterapia-de-curso-corto-con-preservacion-de-los-ganglios-junto-con-capox-y-sintilimab-para-el-cancer-colorrectal-localmente-avanzado-mss-un-estudio-aleatorizado-prospectivo-y-multicentrico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04670679/un-estudio-de-escalada-de-dosis-expansion-de-eras-601-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07412197/vacunacion-preventiva-con-celulas-dendriticas-para-el-sindrome-de-lynch 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06880055/protocolo-del-estudio-post-comercializacion-de-shield 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06927011/diarrea-cronica-tras-la-hemicolectomia-derecha-por-cancer-de-colon-y-su-asociacion-con-la-malabsorcion-de-acidos-biliares-y-el-sobrecrecimiento-bacteriano-en-el-intestino-delgado-utilizando-un-nuevo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04486378/un-ensayo-clinico-de-fase-ii-que-compara-la-eficacia-de-ro7198457-frente-a-la-observacion-vigilante-en-pacientes-con-cancer-colorrectal-en-estadio-ii-de-alto-riesgo-y-estadio-iii-con-tumores 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06634875/isunakinra-en-monoterapia-y-en-combinacion-con-pembrolizumab-en-pacientes-con-cancer-colorrectal-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05936931/intervencion-dirigida-a-jovenes-adultos-para-aumentar-la-tasa-de-deteccion-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05038358/participacion-del-microambiente-tumoral-inmunitario-en-los-mecanismos-de-resistencia-a-la-quimioterapia-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05639972/e7-terapia-de-induccion-basada-en-el-receptor-de-celulas-t-tcr-para-el-tratamiento-de-canceres-localmente-avanzados-asociados-al-vph 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07639554/optimizacion-de-la-participacion-en-los-programas-de-deteccion-del-cancer-colorrectal-mediante-la-invitacion-directa-de-los-pacientes-que-no-responden-a-las-invitaciones-iniciales-realizada-por-los 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07419490/transposicion-utero-ovarica-en-pacientes-con-neoplasias-pelvicas-que-se-someten-a-radioterapia-pelvica-total 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07235293/un-estudio-para-evaluar-dsp107-en-combinacion-con-atezolizumab-en-comparacion-con-fruquintinib-como-un-nuevo-tratamiento-para-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07430540/optimizando-los-itinerarios-asistenciales-para-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06304545/tratamiento-del-cancer-de-recto-con-quimiorradioterapia-concurrente-a-largo-plazo-combinada-con-camrelizumab 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07662031/tovecimig-mas-folfiri-en-segunda-linea-para-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07009145/ql1706-mas-bevacizumab-para-el-cancer-colorrectal-irresecable-o-metastasico-msi-h-dmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07277270/un-estudio-de-gsk5764227-en-combinacion-con-el-tratamiento-estandar-soc-u-otros-agentes-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04893876/el-estudio-opera-evaluacion-de-la-calidad-de-vida-tras-la-cirugia-de-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06830239/estudio-de-fase-ii-de-dostarlimab-como-tratamiento-neoadyuvante-en-pacientes-con-cancer-colorrectal-t3-4n0-2-o-estadio-iii-pmmr-mss-que-puede-ser-sometido-a-cirugia-y-que-no-ha-recibido-tratamiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07591597/un-ensayo-clinico-multicentrico-de-fase-ib-ii-para-evaluar-la-eficacia-y-la-seguridad-de-la-terapia-combinada-concurrente-de-s-531011-mas-fruquintinib-o-s-531011-mas-fruquintinib-mas-pembrolizumab-en 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07669220/un-estudio-multicentrico-aleatorizado-y-controlado-de-fase-ii-que-evalua-una-pauta-de-radioterapia-de-corta-duracion-seguida-de-un-inhibidor-de-pd-1-y-quimioterapia-con-folfox-en-secuencia-frente-a 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07189871/177lu-betabart-en-pacientes-con-tumores-solidos-metastasicos-o-localmente-avanzados-inoperables-o-tumores-solidos-recurrentes-refractarios 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07068529/desarrollo-y-validacion-de-biomarcadores-metabolicos-para-el-diagnostico-precoz-el-pronostico-y-la-deteccion-de-la-recurrencia-del-cancer-colorrectal-metbio-crc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05563922/estrategia-de-preservacion-organica-mediante-quimiorradioterapia-neoadyuvante-total-para-el-carcinoma-rectal-bajo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07134218/quimiorradioterapia-neoadyuvante-combinada-con-inmunoterapia-y-terapia-antiangiogenica-en-el-tratamiento-del-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06308354/conjunto-de-datos-de-cancer-colorrectal-del-hospital-xijing-correspondiente-al-periodo-2011 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07059884/ejercicio-basado-en-la-distancia-para-preservar-la-funcion-y-prevenir-la-discapacidad 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07683949/ensayo-clinico-que-evalua-la-eficacia-de-capecitabina-mas-lenvatinib-en-pacientes-con-cancer-colorrectal-avanzado-refractario-a-irinotecan-oxaliplatino-y-fluoropirimidina 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05649072/identificacion-de-individuos-desatendidos-en-texas-con-riesgo-hereditario-de-cancer-mediante-unidades-moviles-de-mamografia-y-telegenetica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06903325/un-estudio-clinico-multicentrico-prospectivo-sobre-el-seguimiento-dinamico-de-los-marcadores-de-metilacion-del-ctdna-plasmatico-para-predecir-la-recurrencia-del-cancer-colorrectal-tras-la-reseccion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05581004/un-estudio-para-evaluar-la-seguridad-la-farmacocinetica-y-la-actividad-de-enzelkitug-como-agente-unico-y-en-combinacion-con-un-inhibidor-de-puntos-de-control-en-participantes-con-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07079631/un-estudio-clinico-para-evaluar-si-un-tratamiento-experimental-denominado-bnt314-utilizado-en-combinacion-con-otro-tratamiento-experimental-bnt327-y-quimioterapia-es-beneficioso-y-seguro-para 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07453797/un-estudio-prospectivo-que-evalua-la-tecnologia-activsight-para-la-evaluacion-intraoperatoria-de-la-perfusion-en-la-colectomia-izquierda 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05677048/estudio-de-factibilidad-ignite-tx-identificacion-de-individuos-para-pruebas-geneticas-y-tratamiento 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07458347/un-ensayo-de-fase-i-de-escalada-de-dosis-de-kst-6051-en-participantes-con-tumores-solidos-avanzados-con-mutacion-en-el-gen-kirsten-rat-sarcoma-viral-oncogene-homolog-kras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03051464/ensayo-sin-cirugia-dos-estrategias-de-aumento-de-dosis 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05612347/colonoscopia-frente-a-pruebas-de-deteccion-en-heces-para-adultos-mayores-con-polipos-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06577194/un-estudio-de-un-solo-centro-de-un-solo-brazo-sobre-radioterapia-neoadyuvante-de-curso-corto-con-il-2-seguida-de-inmunoterapia-secuencial-con-capox-combinada-con-un-anticuerpo-anti-pd-1-e-il-2-para 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07596732/red-unificada-estatal-para-la-intervencion-remota-del-fortalecimiento-y-el-ejercicio 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04428905/atencion-integral-al-superviviente-mediante-el-autocuidado-en-el-cancer-de-pulmon-no-microcitico-o-cancer-colorrectal-en-estadio-i-iii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03908788/deteccion-de-la-aparicion-de-mutaciones-en-el-gen-ras-homologo-del-oncogen-viral-del-sarcoma-de-rata-en-el-adn-circulante-acido-desoxirribonucleico-en-pacientes-con-ccrc-metastasico-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07464769/terapia-de-compresion-de-manos-y-pies-para-la-prevencion-de-la-neuropatia-periferica-inducida-por-taxanos-u-oxaliplatino 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07042243/el-estudio-florida-ascent 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04444921/ea2176-ensayo-clinico-de-fase-iii-con-carboplatino-y-paclitaxel-nivolumab-en-pacientes-con-cancer-anal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04498767/radioterapia-estereotactica-de-cuerpo-completo-en-pacientes-con-canceres-oligometastasicos-poco-frecuentes-oligorare 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07467590/combinacion-de-radioterapia-en-dosis-altas-y-bajas-con-inmunoterapia-y-tki-en-cancer-colorrectal-avanzado-un-estudio-de-fase-ii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06751914/vacuna-peptidica-basada-en-neoantigenos-y-terapia-convencional-de-segunda-linea-para-el-ccrc-que-progresa-tras-el-tratamiento-de-primera-linea 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07289568/resultados-quirurgicos-en-canceres-de-la-flexura-esplenica-un-estudio-comparativo-multicentrico-de-hemicolectomia-segmentaria-frente-a-hemicolectomia-extendida-estudio-sparrow 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03401294/conversion-de-cancer-colorrectal-metastasico-irresecable-a-resecable 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07290309/supervivientes-unidos-a-traves-de-ejercicios-guiados-a-distancia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07714291/cpharm-estudio-sobre-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05861505/ensayo-collision-relapse 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04708470/un-estudio-de-fase-i-ii-sobre-inmunoterapia-combinada-para-canceres-avanzados-incluidos-los-tumores-asociados-al-vph-los-canceres-de-intestino-delgado-y-los-canceres-de-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06840977/cancer-de-colon-en-pacientes-de-la-tercera-edad-dosis-baja 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07283367/un-ensayo-de-fase-ib-ii-con-terapias-combinadas-de-hs-20110-en-pacientes-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05384444/efecto-de-la-fmd-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07105631/resultados-informados-por-los-pacientes-pro-y-resultados-del-tratamiento-de-pacientes-chinos-con-cancer-colorrectal-avanzado-de-tipo-mss-que-recibieron-el-regimen-de-combinacion-con-zidovudina-en-la 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05719558/un-estudio-de-asp1002-en-adultos-para-el-tratamiento-de-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06614699/efecto-predictivo-de-la-grasa-abdominal-y-el-area-muscular-calculados-a-partir-de-una-tomografia-computarizada-tc-abdominal-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06223022/seguimiento-telefonico-proactivo-dirigido-por-enfermeras-a-los-pacientes-tras-la-finalizacion-del-tratamiento-primario-del-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06629051/datos-de-seguimiento-a-los-6-anos-tras-el-ensayo-de-intervencion-con-berberina 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07504367/los-modelos-de-lenguaje-de-gran-tamano-llm-ayudan-en-las-reuniones-multidisciplinares-sobre-tumores 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07090291/ensayo-chino-sobre-la-deteccion-del-cancer-colorrectal-1-c-cost1 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07735624/rectify-1-botensilimab-balstilimab-como-tratamiento-neoadyuvante-en-el-cancer-colorrectal-en-estadio-temprano-mss-pmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07224724/deteccion-de-metastasis-extrahepaticas-derivadas-de-exosomas-mediante-biopsia-liquida-en-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07611266/modelo-de-prediccion-de-la-recurrencia-de-adenomas-colorrectales-y-del-riesgo-de-carcinogenesis-mediante-la-fusion-multimodal-de-caracteristicas-de-la-medicina-tradicional-china-y-la-medicina 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06863038/valor-predictivo-de-premm5-mmrpredict-y-el-cribado-universal-de-tumores-para-el-sindrome-de-lynch-en-vietnam 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT00996710/variacion-estructural-genomica-en-la-susceptibilidad-al-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07620743/diagnostico-precoz-no-invasivo-del-cancer-colorrectal-mediante-la-captura-dirigida-a-olores-pruebas-diagnosticas-en-el-punto-de-atencion-y-analisis-inteligente 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04291755/desarrollo-y-analisis-de-un-banco-de-muestras-fecales-para-pacientes-con-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07623174/un-estudio-de-fruquintinib-en-adultos-con-cancer-colorrectal-metastasico-en-polonia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07209384/eficacia-clinica-de-la-quimioembolizacion-transarterial-en-pacientes-ancianos-con-cancer-colorrectal-avanzado-irresecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06923345/radioterapia-de-larga-duracion-modificada-seguida-de-quimioterapia-e-inhibidor-de-pd-1-para-pacientes-con-cancer-colorrectal-localmente-avanzado-de-riesgo-alto-y-con-msi-pmmr-estudio-modifi-rc-i 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07751783/desarrollo-y-difusion-de-programas-de-prescripcion-y-aplicacion-de-ejercicio-fisico-para-pacientes-con-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02465060/terapia-dirigida-basada-en-pruebas-geneticas-para-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados-refractarios-linfomas-o-mieloma-multiple-el-ensayo-de-cribado-match 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07257653/seguridad-y-eficacia-de-cetuximab-beta-mas-fruquintinib-con-o-sin-inhibidores-de-los-puntos-de-control-inmunitario-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico-irresecable 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07141901/deteccion-de-cancer-colorrectal-basada-en-la-esperanza-de-vida 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05419011/evaluacion-de-una-combinacion-de-vacunas-para-la-prevencion-del-cancer-en-el-sindrome-de-lynch 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05919264/fog-001-en-tumores-solidos-localmente-avanzados-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06780423/caracteristicas-estructurales-de-los-musculos-del-tronco-y-las-extremidades-en-pacientes-con-cancer-colorrectal-y-caquexia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06663319/un-estudio-de-jnj-89402638-para-cancer-colorrectal-y-gastrico-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07337551/acetato-de-gossipol-folfiri-bevacizumab-en-pacientes-con-cancer-colorrectal-metastasico-mcrc-con-mutacion-en-tp53-y-expresion-positiva-de-lrpprc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02600949/vacuna-peptidica-personalizada-en-el-tratamiento-de-pacientes-con-cancer-de-pancreas-avanzado-o-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07172503/aplicacion-clinica-de-la-imagen-pet-dirigida-a-gpa33-en-tumores-malignos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02965703/aspirina-en-la-prevencion-del-cancer-colorrectal-en-pacientes-con-adenoma-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04730544/dos-esquemas-de-tratamiento-combinados-con-nivolumab-e-ipilimumab-en-pacientes-con-mcrc-dmmr-y-o-msi 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05523245/prediccion-de-la-eficacia-de-la-terapia-neoadyuvante-en-pacientes-con-cancer-colorrectal-localmente-avanzado-mediante-una-plataforma-de-inteligencia-artificial-basada-en-la-resonancia-magnetica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06614751/dat-2645-un-inhibidor-de-parg-como-monoterapia-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos-que-presenten-alteraciones-de-perdida-de-funcion-en-brca1-2-y-o-otros-defectos-en-la-via-de 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05231850/un-estudio-de-fase-ii-de-tislelizumab-como-terapia-adyuvante-para-pacientes-con-cancer-de-colon-en-estadio-ii-y-estadio-iii-y-con-dmmr-msi 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06336902/botensilimab-mas-balstilimab-y-dieta-que-imita-el-ayuno-mas-vitamina-c-para-pacientes-con-cancer-colorrectal-metastasico-con-mutacion-en-el-gen-kras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07786818/marcadores-metatranscriptomicos-de-la-neoplasia-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07792109/implementacion-de-un-programa-de-telecirugia-en-un-centro-de-referencia-para-cirugia-robotica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05733000/cpi-613-devimistat-en-combinacion-con-hidroxicloroquina-y-5-fluorouracilo-o-gemcitabina-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados-refractarios-a-la-quimioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06841159/radioterapia-estereotactica-adaptativa-ultrafraccionada-y-personalizada-pulsar-combinada-con-terapia-anti-pd1-quimioterapia-y-terapia-dirigida-para-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07346586/efecto-de-una-gestion-individualizada-del-cateter-en-la-retirada-temprana-tras-la-cirugia-de-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05855200/estudio-de-dostarlimab-en-el-periodo-perioperatorio-en-participantes-con-cancer-colorrectal-t4n0-o-estadio-iii-dmmr-msi-h-susceptible-de-reseccion-quirurgica-que-no-ha-recibido-tratamiento-previo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07549412/un-estudio-de-precemtabart-tocentecan-con-o-sin-bevacizumab-en-comparacion-con-trifluridina-tipiracil-mas-bevacizumab-en-participantes-con-cancer-colorrectal-metastasico-previamente-tratado-proceade 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04560712/acupuntura-para-el-manejo-del-dolor-postoperatorio-en-pacientes-con-cancer-de-pancreas-o-cancer-colorrectal-sometidos-a-cirugia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06399757/un-estudio-para-investigar-apl-5125-en-adultos-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06655142/estudio-oscar-ii-el-estudio-oncobind-sobre-la-eliminacion-de-ctc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05638542/comparacion-de-la-expresion-de-marcadores-moleculares-relacionados-con-la-carcinogenesis-en-pacientes-con-cancer-de-colon-y-polipos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05517811/indices-de-la-teg-preoperatorios-y-postoperatorios-en-pacientes-con-o-sin-adenocarcinoma-que-se-someten-a-reseccion-quirurgica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03659448/eficacia-de-sgm-101-para-la-delimitacion-del-tumor-primario-y-de-las-recurrencias-tumorales-y-metastasis-en-pacientes-sometidos-a-cirugia-por-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07361614/prueba-piloto-de-un-programa-de-educacion-sobre-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07802197/radioterapia-neoadyuvante-frente-a-cirugia-temprana-en-el-cancer-colorrectal-proximal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06332274/tislelizumab-en-pacientes-con-cancer-que-presentan-enfermedad-residual-molecular 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07056374/anastomosis-adaptativa-para-la-reseccion-anterior-en-el-cancer-sigmoideo-y-del-recto-proximal-o-en-lesiones-premalignas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06910657/idov-inmune-para-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07047560/irinotecan-liposomal-ii-administrado-en-dosis-fraccionadas-en-combinacion-con-5-fu-lv-folfirinali-3-y-bevacizumab-en-el-tratamiento-de-segunda-linea-del-cancer-colorrectal-avanzado-un-estudio-clinico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03874559/exosomas-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03283540/reseccion-total-mesorrectal-transanal-para-el-cancer-de-recto-en-pacientes-con-alteraciones-de-la-fisiologia-anal-e-incontinencia-fecal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06447064/estudio-2-del-programa-de-fidelizacion-para-pacientes-con-cancer-clocs-2 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07388953/bloqueo-periferico-autonomico-bap-combinado-con-bloqueo-del-plano-del-musculo-transverso-del-abdomen-tap-para-la-analgesia-postoperatoria-tras-la-reseccion-minimamente-invasiva-de-un-tumor 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06963502/un-estudio-de-fase-ib-de-hs-10370-en-combinacion-con-otras-terapias-antineoplasicas-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04852653/un-estudio-prospectivo-de-factibilidad-que-evalua-las-vesiculas-extracelulares-obtenidas-mediante-biopsia-liquida-para-la-evaluacion-de-la-respuesta-al-tratamiento-neoadyuvante-en-el-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07393048/aplicacion-y-exploracion-de-la-tecnologia-de-deteccion-personalizada-de-ctdna-mrd-para-predecir-la-eficacia-de-la-terapia-neoadyuvante-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06559059/evaluacion-de-la-implementacion-de-un-programa-integral-virtual-de-oncologia-a-multiples-niveles-en-veteranos-diagnosticados-con-cancer-de-pulmon-cancer-colorrectal-cancer-de-prostata-y-cancer-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06937177/optimizacion-segura-del-peso-corporal-con-tcmcb07-en-pacientes-con-cancer-colorrectal-metastasico-de-reciente-diagnostico-que-reciben-quimioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05391126/genocare-un-ensayo-clinico-prospectivo-aleatorizado-que-compara-la-administracion-de-dosis-guiada-por-el-genotipo-frente-a-la-atencion-habitual 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04140526/seguridad-farmacocinetica-y-eficacia-de-onc-392-en-monoterapia-y-en-combinacion-con-un-anti-pd-1-en-tumores-solidos-avanzados-y-en-cancer-de-pulmon-no-microcitico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06557668/resultados-clinicos-del-tratamiento-con-inmunomoduladores-y-terapias-contra-el-cancer-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05592626/un-estudio-de-star0602-una-molecula-de-fusion-bifuncional-de-anticuerpos-que-se-dirige-selectivamente-al-receptor-de-celulas-t-tcr-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07407465/trastuzumab-deruxtecan-mas-capecitabina-y-bevacizumab-como-tratamiento-inicial-en-pacientes-con-cancer-colorrectal-metastasico-her2-positivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07113275/un-ensayo-clinico-que-compara-la-radioterapia-de-ciclo-largo-frente-a-la-radioterapia-de-ciclo-corto-seguida-de-inmunoterapia-combinada-con-terapia-neoadyuvante-total-tnt-frente-a-la-radioterapia-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06821009/eficacia-de-un-programa-de-navegacion-digital-basado-en-la-nube-para-la-deteccion-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07582003/un-ensayo-de-fase-i-de-s-adenosilmetionina-same-para-la-quimioprevencion-de-adenomas-colorrectales 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07086833/el-entorno-alimentario-el-metabolismo-de-la-cisteina-mediado-por-microorganismos-y-las-disparidades-en-el-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06888843/estudio-para-evaluar-el-uso-de-capecitabina-en-monoterapia-y-en-combinacion-con-oxaliplatino-en-pacientes-ancianos-como-quimioterapia-adyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02906943/evaluacion-de-acidos-nucleicos-dirigida-a-tumores-en-toda-la-provincia-de-ontario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03975049/combinacion-triple-o-regimen-de-doble-farmaco-frente-a-quimiorradiacion-como-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05254327/ensayo-sobre-la-eficacia-y-la-seguridad-de-la-radioterapia-de-curso-corto-y-largo-con-o-sin-bmx-001 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06222645/ppg-frente-a-icg-en-resecciones-gastrointestinales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04516681/combinacion-de-acido-ascorbico-intravenoso-y-adebrelimab-en-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04949646/monitorizacion-neurofisiologica-intraoperatoria-del-plexo-nervioso-autonomo-pelvico-durante-la-reseccion-total-del-mesorrecto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07650409/una-intervencion-dietetica-palitos-de-pretzel-de-soja-para-reducir-la-inflamacion-cronica-en-individuos-obesos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06596343/evaluacion-de-los-beneficios-de-la-medicina-tradicional-china-personalizada-en-el-tratamiento-postoperatorio-del-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07431892/evaluacion-del-dolor-en-la-cirugia-robotica-y-laparoscopica-para-procedimientos-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05009069/un-estudio-de-atezolizumab-con-o-sin-tiragolumab-tras-la-quimiorradioterapia-neoadyuvante-en-participantes-con-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05708599/un-estudio-para-comparar-las-biopsias-tisulares-y-liquidas-en-personas-con-diferentes-tipos-de-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04763915/mejorando-la-atencion-al-paciente-tras-las-pruebas-geneticas-para-detectar-predisposicion-hereditaria-al-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07432399/efecto-de-la-lidocaina-perioperatoria-o-la-dexametasona-en-dosis-altas-sobre-la-respuesta-inmune-en-la-cirugia-de-cancer-de-colon-estudio-pildi 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04812912/cambios-en-la-salud-reproductiva-y-sexual-en-personas-con-cancer-colorrectal-de-inicio-temprano 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07673861/utilidad-clinica-del-ctdna-en-la-deteccion-de-mecanismos-de-resistencia-y-en-la-aplicacion-de-la-medicina-de-precision-a-pacientes-con-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06128551/estudio-de-elironrasib-y-daraxonrasib-como-terapias-de-monoterapia-y-terapia-combinada-en-participantes-con-tumores-solidos-avanzados-con-mutacion-kras-g12c 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04215731/mfolfoxiri-neoadyuvante-mas-bevacizumab-en-pacientes-con-cancer-colorrectal-localmente-avanzado-de-alto-riesgo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05250648/ensayo-clinico-sobre-la-administracion-de-hipec-con-mitomicina-c-en-metastasis-peritoneales-del-cancer-de-colon-gecop-mmc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03615599/dietas-basadas-en-plantas-y-riesgo-de-cancer-en-el-adventist-health-study-2 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07198165/radioterapia-estereotactica-scrt-seguida-de-quimioterapia-capox-bevacizumab-inhibidor-de-pd-1-para-el-tratamiento-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado-larc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04687631/terapia-de-conversion-en-pacientes-con-cancer-colorrectal-ras-braf-tipo-salvaje-y-metastasis-hepaticas-inicialmente-irresecables 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07070713/eficacia-y-seguridad-de-folfox-cetuximab-frente-a-folfoxiri-bevacizumab-ambos-en-combinacion-con-ql1706-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico-mcrc-localizado-en-el 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07462143/un-ensayo-clinico-de-fase-ii-iii-con-rc148-mas-quimioterapia-como-terapia-de-primera-linea-para-el-cancer-colorrectal-irresecable-o-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04824053/efectos-de-los-productos-lacteos-unicla-a2-en-pacientes-con-alto-riesgo-de-desarrollar-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05848609/estado-funcional-y-calidad-de-vida-en-pacientes-de-edad-avanzada-sometidos-a-cirugia-robotica-para-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06830018/megestrol-nanocristalino-para-el-tratamiento-de-primera-linea-del-cancer-gastrico-o-colorrectal-avanzado-con-fatiga-relacionada-con-el-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04246684/radioterapia-de-corta-duracion-frente-a-radioterapia-convencional-seguida-de-quimioterapia-y-tratamiento-conservador-de-organos-en-pacientes-con-cancer-de-recto-de-riesgo-intermedio-y-alto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06885697/celulas-car-t-anti-mesotelina-tnaive-scm-hyp218-tnhyp218-en-participantes-con-tumores-solidos-que-expresan-mesotelina-incluidos-los-mesoteliomas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06697964/estudio-de-anoscopia-de-alta-resolucion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03168737/18f-fluoroazomicina-arabinosida-pet-tc-en-el-diagnostico-de-tumores-solidos-en-pacientes 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06718738/estudio-clinico-de-la-terapia-con-celulas-car-t-im96-en-pacientes-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07600125/evaluacion-de-biomarcadores-fecales-multiobjetivo-en-el-cribado-de-canceres-del-tracto-digestivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04050345/seguimiento-de-las-mutaciones-en-el-adn-tumoral-libre-en-sangre-para-predecir-la-recurrencia-en-el-cancer-colorrectal-en-estadio-temprano 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03349762/huaier-granules-para-la-prevencion-de-la-recurrencia-y-la-metastasis-en-pacientes-con-cancer-colorrectal-tras-la-cirugia-radical 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05815082/quimioterapia-adyuvante-guiada-por-ctdna-en-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05630794/evaluacion-de-la-seguridad-y-los-efectos-preventivos-del-onc201-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06709144/limite-de-la-diseccion-cme-d3-en-el-cancer-colorrectal-localmente-avanzado-del-lado-derecho 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06435689/estudio-y-modulacion-de-las-respuestas-inmunitarias-en-los-canceres-colorrectales-primarios-y-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06936527/xs-03-en-combinacion-con-folfox-o-folfiri-y-bevacizumab-para-el-tratamiento-de-pacientes-con-cancer-colorrectal-metastasico-con-mutacion-en-el-gen-ras 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07300150/un-estudio-de-pt0511-en-participantes-con-tumores-solidos-avanzados-con-mutacion-o-amplificacion-de-kras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05902533/ensayo-redel-reduccion-de-la-dosis-de-radioterapia-ganglionar-electiva-para-mitigar-la-toxicidad-en-el-cancer-anal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07248020/un-estudio-de-fase-ii-de-un-solo-brazo-sobre-la-administracion-de-curcumina-de-alta-biodisponibilidad-como-quimiorradioterapia-neoadyuvante-en-el-cancer-de-recto-medio-a-bajo-analisis-clinico-y 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07494669/proteomica-y-parametros-fisiologicos-que-predicen-complicaciones-tras-la-cirugia-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04098471/reseccion-local-transanal-simple-reseccion-local-transanal-tras-radioterapia-frente-a-reseccion-total-del-mesorrecto-para-el-tratamiento-del-cancer-rectal-ultra-bajo-t2n0m0 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07044908/tqb2922-y-comprimidos-de-tas-102-para-inyeccion-con-o-sin-bevacizumab-en-el-tratamiento-del-cancer-colorrectal-avanzado-con-mutacion-ras-braf-de-tipo-salvaje-y-que-ha-progresado-tras-la-quimioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02966483/reseccion-total-mesorrectal-transanal-frente-a-laparoscopica-para-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07201012/determinacion-de-la-prevalencia-del-sindrome-de-muir-torre-en-pacientes-con-sindrome-de-lynch 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06414122/estimulacion-electromiositimuladora-de-frecuencia-media-modulada-en-todo-el-cuerpo-y-terapia-nutricional-en-pacientes-con-cancer-gastrointestinal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06301386/everolimus-en-combinacion-con-un-inhibidor-de-pd-1-en-pacientes-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07730541/resonancia-magnetica-con-13c-hiperpolarizado-y-radiomica-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07505472/comparacion-de-la-eficacia-y-la-seguridad-de-un-ciclo-corto-de-radioterapia-seguido-de-quimioterapia-con-capeox-mas-toripalimab-con-o-sin-surufatinib-concomitante-en-la-terapia-neoadyuvante-para-el 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07499921/analisis-clinicos-y-biologicos-de-tumores-rectales 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04959604/mapeo-de-los-ganglios-linfaticos-mediante-un-tinte-fluorescente-en-el-cancer-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06589440/estudio-de-fase-ii-de-sr-8541a-en-combinacion-con-botensilimab-y-balstilimab-en-sujetos-con-cancer-colorrectal-metastasico-resistente-al-tratamiento-y-con-estabilidad-de-microsatelites-mss-crc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04889456/estandarizacion-de-la-hemicolectomia-derecha-para-el-cancer-de-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06770270/pucotenlimab-mas-radioterapia-y-quimioterapia-para-el-tratamiento-neoadyuvante-del-cancer-de-recto-localmente-avanzado-pucrt 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07624916/bloqueo-del-plano-del-musculo-transverso-del-abdomen-y-de-la-vaina-del-musculo-recto-para-la-colectomia-robotica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07631884/estudio-exploratorio-sobre-la-eficacia-y-la-seguridad-del-trastuzumab-rezetecan-en-el-tratamiento-de-tumores-solidos-avanzados-con-expresion-de-her2 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07520578/eficacia-de-la-informacion-temprana-y-el-apoyo-por-parte-del-medico-de-cabecera-para-aumentar-el-seguimiento-mediante-colonoscopia-y-reducir-los-retrasos-en-personas-con-un-resultado-positivo-en-la 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07620535/asesoramiento-y-seguimiento-de-los-pacientes-que-participan-en-el-estudio-shield 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06395519/un-estudio-del-inhibidor-de-parg-etx-19477-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07169734/un-estudio-para-investigar-ale-p03-como-terapia-unica-en-pacientes-adultos-con-tumores-solidos-avanzados-o-metastasicos-cldn1-seleccionados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07328308/colonoscopia-de-vigilancia-diferida-tras-la-reseccion-endoscopica-mucosal-por-segmentos-emr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03667170/kn035-para-tumores-solidos-avanzados-con-dmmr-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06205836/cemiplimab-con-o-sin-fianlimab-para-el-tratamiento-de-pacientes-de-edad-avanzada-con-cancer-colorrectal-localizado-o-localmente-avanzado-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07071844/between-bevacizumab-y-trifluridina-tipiracil-administrados-cada-dos-semanas-para-reducir-la-neutropenia-de-grado-3-4-en-pacientes-con-mcrc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07643857/grapadoras-circulares-y-fistula-anastomotica-tras-la-cirugia-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07046585/evaluacion-de-la-prueba-de-deteccion-de-cancer-colorrectal-de-natera-en-una-poblacion-con-riesgo-promedio-find-crc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07345273/informe-de-los-depositos-tumorales-en-el-cancer-colorrectal-mediante-radiologia-y-patologia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06958419/radioterapia-de-curso-corto-con-preservacion-de-los-ganglios-linfaticos-combinada-con-quimioterapia-bevacizumab-e-inhibidor-de-pd-1-en-cancer-colorrectal-metastasico-pmmr-mss-modifi-crc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07349537/estudio-de-rmc-5127-en-pacientes-con-tumores-solidos-avanzados-con-mutacion-kras-g12v 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07781774/mejora-de-la-tasa-de-participacion-en-los-programas-de-deteccion-del-cancer-colorrectal-mediante-la-educacion-y-la-divulgacion-de-pruebas-basadas-en-el-analisis-de-heces 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04673955/investigacion-en-la-practica-clinica-del-inhibidor-de-braf-encorafenib-y-el-cetuximab-como-tratamiento-de-nueva-generacion-para-el-ccrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07043387/optimizando-la-radioembolizacion-para-el-cancer-colorrectal-intrahepatico-y-el-cancer-hepatico-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06645808/imagen-pet-de-dos-vartumabs-en-pacientes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02298959/evaluacion-del-anticuerpo-anti-pd-1-mk3475-administrado-junto-con-ziv-aflibercept-en-pacientes-con-cancer-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07153016/asesoramiento-juridico-y-defensa-de-los-derechos-de-los-cuidadores-legacy-care-un-ensayo-clinico-piloto-para-los-cuidadores-de-personas-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06700317/imagenologia-hiperespectral-intraoperatoria-para-la-cirugia-laparoscopica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02359565/pembrolizumab-en-el-tratamiento-de-pacientes-jovenes-con-gliomas-de-alto-grado-recurrentes-progresivos-o-refractarios-gliomas-intrinsecos-del-tronco-encefalico-difusos-tumores-cerebrales-hipermutados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06227728/analisis-de-la-dinamica-de-pd-l1-tmb-msi-y-ctdna-para-predecir-y-monitorizar-la-respuesta-a-la-inmunoterapia-en-el-cancer-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06501053/radioterapia-de-contacto-para-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05772923/preservacion-de-organos-en-el-cancer-de-recto-braquiterapia-de-contacto-con-rayos-x-frente-a-la-prolongacion-del-intervalo-de-espera-y-la-escision-local 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07352280/terapia-neoadyuvante-con-tislelizumab-para-cancer-colorrectal-en-estadio-ii-iii-con-dmmr-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02403505/ensayo-clinico-de-fase-inicial-sobre-una-combinacion-de-productos-biologicos-terapeuticos-para-el-tratamiento-del-cancer-colorrectal-cea-positivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06428409/un-estudio-clinico-de-mk-2870-solo-o-en-combinacion-con-otros-tratamientos-para-el-tratamiento-de-canceres-gastrointestinales-mk-9999-02a 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06411600/terapia-combinada-para-el-crcm-metastasico-con-mutacion-braf-v600e 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06628388/modelo-de-intervencion-en-atencion-primaria-liderada-por-enfermeras-en-el-manejo-de-la-salud-de-la-mujer-en-hong-kong 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07361575/estudio-que-compara-la-calidad-de-la-limpieza-del-colon-con-una-dieta-preestablecida-de-bajo-contenido-en-residuos-lrd-frente-a-una-dieta-guiada-pog 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06914245/vias-de-atencion-personalizadas-para-los-sintomas-intestinales-en-pacientes-con-cancer-de-recto-factores-contribuyentes-tratables 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06740357/implementacion-de-un-programa-de-evaluacion-de-la-respuesta-tumoral-que-integre-la-toma-de-decisiones-compartida-en-la-estrategia-de-preservacion-de-organos-para-pacientes-con-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07088393/diagnostico-mediante-inteligencia-artificial-de-los-diferentes-patrones-de-crecimiento-histopatologico-de-las-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05688280/inyeccion-intratumoral-de-ip-001-tras-ablacion-termica-en-pacientes-con-crc-nsclc-y-sts 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07796763/un-ensayo-clinico-global-de-trastuzumab-rezetecan-shr-a1811-en-combinacion-con-quimioterapia-y-bevacizumab-como-tratamiento-de-primera-linea-en-pacientes-con-cancer-colorrectal-avanzado-que-expresa 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05176483/estudio-de-zanzalitinib-en-combinacion-con-agentes-de-inmunooncologia-en-participantes-con-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06780787/folfox-botensilimab-y-balstilimab-para-el-tratamiento-del-cancer-de-recto-localizado-antes-de-la-cirugia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06896578/latitude-estudio-sobre-la-actitud-de-los-ganglios-linfaticos-laterales 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06192680/irinotecano-liposomal-y-capecitabina-mas-bevacizumab-como-terapia-de-segunda-linea-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07797244/un-estudio-de-fase-ii-de-un-solo-brazo-que-evalua-retlirafusp-alfa-en-combinacion-con-xelox-y-bevacizumab-para-el-tratamiento-de-primera-linea-del-cancer-colorrectal-avanzado-con-mutaciones-en-ras-y 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT00339495/ensayo-de-deteccion-de-cancer-de-prostata-pulmon-colon-y-ovario-plco 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07381309/virus-oncolitico-h101-radioterapia-estereotactica-ablativa-sbrt-quimioterapia-terapia-dirigida-inmunoterapia-para-metastasis-hepaticas-irresecables-de-cancer-colorrectal-crlm 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07378930/vigilancia-de-altisimo-riesgo-para-prevenir-futuros-eventos-el-ensayo-ultra-safe 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04136002/evaluacion-del-test-ctdna-lunar-en-un-episodio-de-cribado-en-pacientes-de-riesgo-promedio 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06999512/impacto-de-un-programa-integral-de-atencion-geriatrica-en-la-morbilidad-y-la-calidad-de-vida-de-pacientes-ancianos-sometidos-a-una-hepatectomia-mayor-y-una-pancreaticoduodenectomia-por-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05663502/recopilacion-de-donaciones-de-muestras-de-sangre-y-tejido-para-la-investigacion-de-canceres-relacionados-con-el-vih-sida 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03151564/evaluacion-de-la-deteccion-de-lesiones-en-el-higado-dosis-estandar-frente-a-dosis-baja-de-radiacion-utilizando-diversas-tecnicas-de-postprocesamiento 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02671435/un-estudio-de-durvalumab-medi4736-y-monalizumab-en-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02885753/oxaliplatino-sistemico-o-quimioterapia-intraarterial-combinada-con-lv5fu2-irinotecan-y-una-terapia-dirigida-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico-restringido-al-higado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06713824/radioterapia-neoadyuvante-antes-de-la-cirugia-para-el-cancer-de-recto-analisis-de-los-resultados-quirurgicos-y-oncologicos-estudio-retrospectivo-de-casos-y-controles-realizado-en-un-unico-centro 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07580339/combinacion-de-dcsz11-con-radioterapia-y-quimioterapia-como-tratamiento-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado-con-pmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05898789/rehabilitacion-virtual-para-supervivientes-de-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06562192/estudio-de-fase-i-de-177lu-lu-nns309-en-pacientes-con-cancer-de-pancreas-pulmon-mama-y-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06391749/validacion-clinica-de-una-prueba-de-deteccion-de-celulas-tumorales-circulantes-mced-en-poblaciones-sintomaticas-k-accelerate 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07410767/resecciones-endoscopicas-avanzadas-para-neoplasias-rectales 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07095439/eficacia-y-toxicidad-del-tratamiento-neoadyuvante-en-sandwich-completo-mediante-radioterapia-de-corta-duracion-en-el-tratamiento-de-pacientes-con-cancer-de-recto-en-estadio-ii-y-iii 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06778863/un-estudio-de-clsp-1025-en-pacientes-adultos-con-tumores-solidos-que-presentan-la-mutacion-p53-r175h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06560671/comparacion-de-la-satisfaccion-del-paciente-y-la-eficacia-tras-la-aplicacion-de-un-nuevo-metodo-o-de-un-metodo-convencional-de-educacion-sanitaria-para-la-preparacion-intestinal-antes-de-la 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06566755/cadonilimab-ak104-en-combinacion-con-quimioterapia-y-bevacizumab-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-metastasico-con-mutacion-en-ras-o-con-metastasis-en-el-lado-derecho-y-con 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06783153/eficacia-y-seguridad-del-uso-complementario-de-rifaximina-para-prevenir-la-diarrea-inducida-por-radioterapia-en-pacientes-con-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03955510/alteraciones-en-los-horarios-de-las-comidas-y-disincronia-circadiana-en-la-carcinogenesis-del-colon-inducida-por-el-alcohol 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06949098/reseccion-local-del-tumor-quimiorradioterapia-adyuvante-postoperatoria-para-cancer-rectal-t1-2n0m0-de-riesgo-bajo-muy-bajo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05807984/terapia-de-reirradiacion-en-el-cancer-de-recto-localmente-recurrente-con-iones-de-carbono 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05692024/el-cafe-y-sus-metabolitos-modulan-el-microbioma-intestinal-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07201519/estudio-de-seguridad-factibilidad-de-un-modelo-hibrido-de-administracion-de-quimioterapia-por-infusion-en-la-arteria-hepatica-que-combine-la-atencion-terciaria-y-la-atencion-comunitaria 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03285230/el-estudio-de-cohortes-prospectivo-frances-e3n 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07436312/impacto-del-consumo-de-alimentos-ultraprocesados-en-individuos-con-alto-riesgo-de-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04482309/un-estudio-de-fase-ii-de-t-dxd-en-pacientes-con-tumores-her2-positivos-seleccionados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07260617/asociacion-entre-la-composicion-de-la-microbiota-intestinal-y-el-estado-nutricional-en-pacientes-con-cancer-digestivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06656936/el-estudio-pharmfit 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03921684/ensayo-clinico-de-nivolumab-en-combinacion-con-folfox-tras-quimiorradioterapia-en-pacientes-con-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06745700/impacto-de-la-activacion-conductual-en-la-depresion-y-la-calidad-de-vida-en-pacientes-con-cancer-de-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04707365/microambiente-e-inmunidad-de-los-canceres-digestivos-estudio-multicentrico-de-la-cohorte-de-paris-este 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04230759/radioterapia-y-quimioterapia-con-o-sin-durvalumab-para-el-carcinoma-anal-localmente-avanzado-un-ensayo-multicentrico-aleatorizado-de-fase-ii-del-grupo-de-estudio-del-cancer-anal-aleman 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06799793/modelos-de-deteccion-basados-en-inteligencia-artificial-para-la-prevencion-y-la-deteccion-precoz-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05674422/estudio-gemcad-reveal-el-adn-tumoral-circulante-como-predictor-de-recurrencia-en-pacientes-con-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06433349/una-investigacion-multicentrica-sobre-la-salud-familiar 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07259590/un-estudio-de-gfh375-en-combinacion-con-cetuximab-o-quimioterapia-en-participantes-con-tumores-solidos-que-presentan-la-mutacion-kras-g12d 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07243938/ensayo-de-fase-ii-diseno-cesta-zanidatamab-mas-tislelizumab-en-tumores-gastrointestinales-her2-positivos-union-her2-basket 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05771181/vitamina-e-en-combinacion-con-fruquintinib-y-tislelizumab-en-pacientes-con-cancer-colorrectal-metastasico-con-microsatelites-estables 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07224750/una-firma-de-microarn-no-invasiva-para-el-cribado-del-cancer-gastrointestinal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06362369/un-estudio-de-7hp349-alintegimod-administrado-por-via-oral-en-combinacion-con-ipilimumab-seguido-de-monoterapia-con-nivolumab 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07233850/un-estudio-clinico-de-fase-ii-que-evalua-el-farmaco-ssgj-706-en-terapia-combinada-para-canceres-gastrointestinales-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04780256/reseccion-endoscopica-de-neoplasias-gastrointestinales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06854679/radioterapia-con-dosis-escalada-para-canceres-rectales-mediante-radioterapia-guiada-por-resonancia-magnetica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06745895/acciones-integrales-para-la-educacion-y-el-cribado-del-cancer-colorrectal-y-la-hepatitis-c 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03983954/naptumomab-estafenatox-en-combinacion-con-durvalumab-en-sujetos-con-tumores-solidos-avanzados-o-metastasicos-seleccionados-incluido-un-estudio-de-ampliacion-en-cancer-de-esofago 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04680260/optimizacion-de-la-seleccion-del-tratamiento-y-el-seguimiento-en-el-cancer-colorrectal-oligo-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03127111/determinantes-geneticos-y-epigeneticos-de-la-respuesta-a-la-quimioterapia-adyuvante-basada-en-fluorouracilo-en-pacientes-con-cancer-colorrectal-en-estadio-iii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03516708/se-anade-epacadostat-incb024360-a-la-quimiorradiacion-preoperatoria-en-pacientes-con-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04068103/pruebas-de-adn-tumoral-circulante-para-predecir-el-tratamiento-en-pacientes-con-cancer-de-colon-en-estadio-iia-despues-de-la-cirugia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06964438/estimulacion-electrica-muscular-postoperatoria-segunda-sesion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04166604/lonsurf-y-uso-de-g-csf-mantener-la-dosis-e-intensidad-adecuadas-para-optimizar-la-eficacia-del-tratamiento 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03976960/base-de-datos-clinica-y-biologica-en-cancer-de-colon-y-tumores-colicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06033976/registro-de-disecciones-endoscopicas-submucosas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06335420/propiedades-profilacticas-del-zumo-de-zanahoria-en-pacientes-con-polipos-colorrectales-de-alto-riesgo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07489833/vias-metabolicas-y-la-constitucion-corporal-segun-la-medicina-tradicional-china-en-la-fatiga-relacionada-con-el-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05107674/un-estudio-de-nx-1607-en-adultos-con-tumores-malignos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03548961/preservacion-de-organos-en-pacientes-con-cancer-de-recto-en-estadio-temprano 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05879783/biopsia-optica-para-nodulos-peritoneales-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07722494/ibi363-en-combinacion-con-bevacizumab-para-el-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03776591/colecolectomia-derecha-abierta-versus-colecolectomia-minimamente-invasiva-laparoscopica-para-el-cancer-de-colon-derecho 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07178717/un-estudio-para-caracterizar-el-uso-de-encorafenib-mas-cetuximab-como-tratamiento-de-reintroduccion-en-pacientes-con-cancer-colorrectal-metastasico-con-mutacion-braf-v600e-tras-una-terapia-previa-con 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07306390/distribucion-y-analisis-de-los-ganglios-linfaticos-metastasicos-en-pacientes-con-cancer-colorrectal-diamond 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07503756/js212-terapias-combinadas-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06741293/mejora-del-cribado-precoz-del-cancer-colorrectal-en-portugal-identificacion-de-biomarcadores-del-microbioma-intestinal-en-heces-gutbiome-pt 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07309289/nalirifox-mas-terapia-dirigida-frente-a-folfox-mas-terapia-dirigida-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07497789/reorganizacion-metabolica-impulsada-por-smyd3-en-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07740343/remimazolam-para-el-sueno-postoperatorio-en-pacientes-ancianos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04525989/radioterapia-preoperatoria-de-corta-duracion-con-protones-en-comparacion-con-fotones-en-cancer-de-recto-de-alto-riesgo-prorect 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03983993/niraparib-y-panitumumab-en-pacientes-con-cancer-colorrectal-avanzado-o-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07310446/recopilacion-de-muestras-de-la-poblacion-de-los-estados-unidos-para-la-optimizacion-y-evaluacion-del-rendimiento-del-panel-de-biomarcadores-de-adn-libre-circulante-en-plasma-cfdna-para-el-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05824975/un-estudio-para-evaluar-la-seguridad-y-la-actividad-terapeutica-de-gi-102-como-agente-unico-y-en-combinacion-con-farmacos-antineoplasicos-convencionales-pembrolizumab-o-trastuzumab-deruxtecan-t-dxd 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05787197/ctdna-en-pacientes-con-crc-sometidos-a-cirugia-con-intencion-curativa-para-metastasis-hepaticas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03303833/el-estudio-de-cohorte-geolynch 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07738939/regimen-iks04-en-tumores-solidos-avanzados-que-expresan-ca242 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04503694/regorafenib-neoadyuvante-en-combinacion-con-nivolumab-y-radioterapia-de-corta-duracion-en-el-cancer-de-recto-en-estadio-ii-iii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07261059/atencion-integral-asistida-por-inteligencia-artificial-para-fomentar-la-realizacion-de-colonoscopias 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03874026/estudio-de-folfiri-cetuximab-en-pacientes-con-cancer-colorrectal-en-estadio-iv-y-genotipo-v-v-del-receptor-fcgammariiia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05916040/tratamiento-neoadyuvante-total-del-cancer-de-recto-mediante-radioterapia-guiada-por-resonancia-magnetica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07512674/radioterapia-de-curso-corto-modificada-combinada-con-inmunoterapia-quimioterapia-y-terapia-dirigida-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-metastasico-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT01696968/deteccion-del-cancer-de-pulmon-en-pacientes-de-edad-avanzada-ensayo-de-deteccion-plco 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04014530/pembrolizumab-en-combinacion-con-ataluren-en-pacientes-con-carcinoma-colorrectal-metastasico-pmmr-y-dmmr-o-carcinoma-endometrial-metastasico-dmmr-el-estudio-atapembro 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07516210/radioterapia-adaptativa-para-una-hipofraccion-segura 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06184698/irinotecan-liposomal-y-leucovorina-5-fluorouracilo-mas-bevacizumab-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07088341/papel-del-ligando-de-muerte-programada-1-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06340646/centro-de-participacion-de-pacientes-y-secuenciacion-genomica-del-cancer-de-la-universidad-de-washington-wu-pe-cgs 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07369219/el-impacto-de-una-intervencion-de-asistencia-de-enfermeria-basada-en-inteligencia-artificial-dentro-del-programa-de-recuperacion-mejorada-en-los-resultados-de-los-pacientes-sometidos-a-cirugia-de 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07529808/estudio-de-fase-1-2-de-bhb810-en-adenocarcinoma-gastrico-avanzado-y-de-la-union-gastroesofagica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07764120/calidad-de-vida-de-los-pacientes-despues-de-la-reseccion-de-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07764497/quimioterapia-por-infusion-intraarterial-hepatica-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-irresecable 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07527520/radioterapia-neoadyuvante-con-hipofraccionamiento-moderado-combinada-con-quimioterapia-e-inmunoterapia-para-el-cancer-colorrectal-localmente-avanzado-de-alto-riesgo-con-pmmr-mss-un-ensayo-de-fase-ii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02869503/base-de-datos-del-instituto-paoli-calmettes-sobre-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06646341/emvi-como-factor-determinante-de-la-metastasis-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07638956/icg-en-el-cancer-de-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04224779/biopsias-liquidas-e-imagenologia-para-mejorar-la-atencion-oncologica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07775950/investigacion-sobre-el-seguimiento-de-la-recurrencia-del-cancer-colorrectal-y-el-tratamiento-individualizado-basado-en-la-enfermedad-residual-minima-erm 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05803382/evaluacion-de-la-adicion-de-un-farmaco-antitumoral-zen003694-al-tratamiento-de-quimioterapia-habitual-capecitabina-para-canceres-metastasicos-o-irresecables 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07781306/estudio-prospectivo-de-imagenes-de-metastasis-poem 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04854213/prelude-1-evaluacion-prospectiva-de-los-efectos-biologicos-inducidos-por-la-radioterapia-en-pacientes-con-enfermedad-oligo-metastasica-de-cancer-colorrectal-y-enfermedad-limitada-a-los-pulmones 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05086614/timosina-alfa-1-como-tratamiento-adyuvante-tras-la-reseccion-radical-del-cancer-colorrectal-en-estadio-ii-y-iii-de-alto-riesgo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06477991/eficacia-de-la-estrategia-de-observacion-y-espera-o-de-la-cirugia-tras-la-inmunoterapia-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado-con-dmmr-msi-h-guiada-por-el-seguimiento-dinamico-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07535021/el-efecto-de-la-terapia-artistica-con-mandalas-la-resiliencia-psicologica-y-el-afrontamiento-del-cancer-en-pacientes-sometidos-a-cirugia-por-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06950385/ensayo-de-fase-iii-de-erapa-en-pacientes-con-poliposis-adenomatosa-familiar 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07349043/ensayo-clinico-prospectivo-de-seguridad-y-eficacia-sobre-la-terapia-con-aerosol-intraperitoneal-presurizado-para-la-metastasis-peritoneal-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06613113/fruquintinib-en-combinacion-con-adebrelimab-y-radioterapia-en-dosis-altas-y-bajas-en-el-tratamiento-del-cancer-colorrectal-metastasico-con-mss-que-ha-progresado-tras-tratamientos-previos-segunda 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05507112/time-en-inmunoterapia-combinada-con-quimiorradioterapia-neoadyuvante-en-el-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07345676/programa-de-divulgacion-para-la-deteccion-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02816879/procedimientos-de-recoleccion-de-muestras-citologicas-anales-para-predecir-la-displasia-anal-de-alto-grado-en-hombres-que-tienen-relaciones-sexuales-con-hombres 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06839092/profilaxis-con-pipac-en-pacientes-con-cancer-colorrectal-de-alto-riesgo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06607458/evaluacion-de-la-seguridad-y-la-eficacia-del-tratamiento-con-melfalan-a-dosis-altas-administrado-directamente-en-el-higado-seguido-de-tratamiento-con-un-farmaco-oncologico-aprobado-o-con-el-farmaco 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04999761/estudio-de-la-plataforma-ab122 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05845450/tratamientos-neoadyuvantes-dirigidos-en-el-cancer-colorrectal-resecable-seleccionado-molecularmente-unicorn 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05860322/el-efecto-de-la-suplementacion-con-inulina-en-los-resultados-de-la-cirugia-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06134388/sulfasalazina-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05686226/inmunoterapia-con-celulas-t-modificadas-con-e7-para-el-tratamiento-de-los-canceres-asociados-al-virus-del-papiloma-humano-vph 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07795801/programa-de-bienestar-sexual-y-mental-para-pacientes-que-han-superado-un-cancer-gastrointestinal-mujeres 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07559825/pacientes-con-cancer-colorrectal-de-inicio-temprano-demasiado-jovenes-para-los-programas-de-deteccion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07366047/probioticos-autologos-en-pacientes-con-ileostomia-de-derivacion-tras-reseccion-abdominoperineal-rap-para-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05174169/quimioterapia-adyuvante-para-el-cancer-de-colon-basada-en-la-evaluacion-de-la-enfermedad-residual 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03935893/transferencia-adoptiva-de-linfocitos-infiltrantes-tumorales-para-canceres-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT01365169/asociacion-entre-el-estado-funcional-ecog-evaluado-por-el-profesional-sanitario-y-la-supervivencia-global-y-la-medicion-objetiva-de-los-niveles-de-actividad-fisica-en-pacientes-con-cancer-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06451497/este-es-un-ensayo-de-fase-i-de-zm008-un-anticuerpo-anti-llt1-que-se-utiliza-como-agente-unico-seguido-de-un-tratamiento-combinado-con-toripalimab-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07562490/un-ensayo-clinico-aleatorizado-y-controlado-sobre-el-uso-de-la-metilacion-del-ctdna-plasmatico-para-guiar-la-toma-de-decisiones-sobre-la-quimioterapia-adyuvante-en-pacientes-con-cancer-colorrectal-en 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07799740/evaluacion-del-suministro-sanguineo-rectal-durante-la-cirugia-de-cancer-de-recto-mediante-la-tecnica-de-imagen-de-contraste-de-moteado-laser 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06305247/un-estudio-para-evaluar-ipn01194-cuando-se-administra-solo-en-adultos-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07805369/un-estudio-de-fase-i-de-dem301-en-participantes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06356584/fruquintinib-en-combinacion-con-sintilimab-radioterapia-para-el-tratamiento-en-tercera-linea-del-cancer-colorrectal-con-metastasis-hepaticas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06032338/ensayo-sobre-la-entrega-directa-a-domicilio-de-un-kit-de-deteccion-de-cancer-colorrectal-sin-necesidad-de-realizar-un-pedido-previo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06710314/un-estudio-basado-en-la-metabolomica-para-explorar-el-mecanismo-de-la-remision-del-sindrome-metabolico-tras-la-reseccion-radical-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04144907/estudio-sobre-las-necesidades-de-proteinas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06242418/adn-tumoral-circulante-en-la-quimioterapia-adyuvante-del-cancer-de-colon-en-estadio-iii-ensayo-revise 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06775951/pertinencia-de-la-indicacion-para-la-colonoscopia-una-evaluacion-del-impacto-clinico-y-economico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03919461/ensayo-internacional-sobre-la-prevencion-de-metastasis-del-cancer-colorrectal-2 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07382635/protocolo-de-ensayo-clinico-para-evaluar-la-eficacia-y-la-seguridad-del-sistema-de-cirugia-toracoabdominal-endoscopica-en-la-cirugia-laparoscopica-remota-para-urologia-cirugia-general-ginecologia-y 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03923335/el-valor-predictivo-del-panel-de-guangzhou-para-la-recurrencia-en-el-cancer-colorrectal-en-estadio-temprano 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03845166/un-estudio-de-xl092-como-terapia-en-monoterapia-y-en-combinacion-en-sujetos-con-tumores-solidos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06521866/estudio-de-fase-ii-de-serplulimab-en-combinacion-con-terapia-dirigida-de-primera-linea-quimioterapia-y-radioterapia-en-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06008054/un-estudio-de-si-b003-bl-b01d1-si-b003-y-bl-b01d1-anticuerpo-monoclonal-anti-pd-1-en-pacientes-con-cancer-de-esofago-localmente-avanzado-o-metastasico-cancer-gastrico-cancer-colorrectal-y-otros 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07391566/lpm6690176-en-combinacion-con-quimioterapia-y-bevacizumab-en-pacientes-con-cancer-colorrectal-metastasico-con-mutacion-en-ras 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05770102/estudio-determine-rama-de-tratamiento-02-atezolizumab-en-pacientes-adultos-pediatricos-y-adolescentes-jovenes-con-canceres-con-alta-carga-mutacional-tumoral-tmb-o-inestabilidad-de-microsatelites-alta 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06121089/cancer-local-de-ciego-optimizacion-del-tratamiento-quirurgico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06555588/implementar-una-intervencion-psicosocial-para-los-sintomas-del-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05129605/estudio-de-evaluacion-y-cribado-del-riesgo-genetico-del-cancer-de-prostata 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07063550/microplasticos-en-tejidos-paraneoplasicos-e-intratumorales-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02754115/una-auditoria-de-la-cirugia-citorreductora-y-la-quimioterapia-intraperitoneal-hipertermica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05722327/ensayo-de-fase-i-de-adagrasib-mrtx849-en-combinacion-con-cetuximab-e-irinotecan-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06002789/seguridad-y-eficacia-de-la-terapia-neoadyuvante-con-pd-1-mfolfox6-en-pacientes-con-carcinoma-de-celulas-de-merkel-localmente-avanzado-smpcc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05141721/un-estudio-de-una-vacuna-neoantigenica-especifica-para-el-paciente-en-combinacion-con-el-bloqueo-de-los-puntos-de-control-inmunitario-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06940388/tratamiento-neoadyuvante-total-con-o-sin-tislelizumab-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06688110/evaluacion-de-la-eficacia-de-gixam-para-predecir-polipos-colorrectales-precancerosos-y-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05653960/resultados-clinicos-tras-la-reseccion-endoscopica-con-extirpacion-en-bloque-erb-o-la-reseccion-endoscopica-con-diseccion-submucosa-res-de-neoplasias-colorrectales-un-registro-multicentrico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05186116/trasplante-de-higado-de-donante-vivo-con-metastasis-hepaticas-de-cancer-colorrectal-no-operable 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07177742/estudio-de-cohorte-prospectivo-sobre-la-relacion-entre-la-peroxiredoxina-1-exosomal-prdx1-y-la-metastasis-hepatica-postoperatoria 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06087718/viabilidad-del-aplicador-maastro-en-el-cancer-de-recto 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07585279/un-estudio-clinico-de-irinotecan-liposomal-para-la-terapia-de-segunda-linea-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04808323/radioterapia-adaptativa-guiada-por-resonancia-magnetica-para-la-preservacion-de-organos-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03391843/quimioterapia-neoadyuvante-combinada-con-cetuximab-para-el-cancer-colorrectal-localmente-avanzado-con-egfr-de-tipo-salvaje 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06371768/manejo-de-los-sintomas-y-transicion-hacia-la-participacion-en-el-seguimiento-y-la-atencion-postratamiento-para-supervivientes-de-cancer-adolescentes-y-jovenes 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05195710/radioembolizacion-preoperatoria-con-y-90-para-el-control-tumoral-y-la-hipertrofia-del-futuro-remanente-hepatico-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07003776/evaluacion-de-la-formacion-de-brotes-tumorales-en-el-adenocarcinoma-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07417358/tecnica-de-sutura-unica-para-la-anastomosis-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06823297/se-puede-omitir-la-quimiorradioterapia-neoadyuvante-en-el-cancer-de-recto-medio 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05049317/estudio-multicentrico-sobre-la-funcion-urinaria-y-sexual-postoperatoria-tras-la-reseccion-total-mesorrectal-funcional-por-laparoscopia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05914389/quimioterapia-de-induccion-combinada-con-inmunoterapia-neoadyuvante-para-cancer-de-colon-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07198958/registro-de-eventos-adversos-inmunologicos-en-pacientes-onco-hematologicos-tratados-con-inmunoterapia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02371135/evaluacion-metagenomica-de-la-microbiota-intestinal-en-pacientes-con-sindrome-de-lynch-y-otros-sindromes-hereditarios-de-poliposis-colica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05054959/quimioterapia-de-consolidacion-frente-a-quimioterapia-de-induccion-en-la-terapia-neoadyuvante-total-del-cancer-de-recto-con-alto-riesgo-de-recurrencia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06819280/linfocitos-tumorales-infiltrantes-autologos-gt307-para-el-tratamiento-de-pacientes-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06614738/factores-microbianos-y-ambientales-asociados-con-el-desarrollo-de-polipos-en-la-poliposis-adenomatosa-familiar-microbenvironment-en-fap 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07160010/validacion-clinica-del-ensayo-de-sophia-genetics 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06998758/megestrol-acetato-para-mejorar-la-perdida-de-peso-relacionada-con-la-quimioterapia-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05943210/el-ensayo-de-caracterizacion-molecular-mct-de-la-red-de-integracion-de-la-radiooncologia-y-la-biologia-robin-para-el-tratamiento-estandar-con-radioterapia-de-curso-corto-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06983639/ensayo-aleatorizado-que-compara-la-prueba-de-deteccion-de-sangre-oculta-en-heces-fit-con-la-colonoscopia-para-la-vigilancia-tras-la-polipectomia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03190941/administracion-de-linfocitos-de-sangre-periferica-modificados-geneticamente-con-un-receptor-de-celulas-t-murino-que-reconoce-la-variante-g12v-de-ras-mutado-en-pacientes-hla-a-11-01 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06746545/un-estudio-clinico-prospectivo-de-etiqueta-abierta-de-un-solo-brazo-de-fase-ii-para-evaluar-la-combinacion-de-fruquintinib-con-s-1-en-el-tratamiento-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05024097/un-estudio-de-fase-i-ii-para-evaluar-la-seguridad-y-la-eficacia-de-los-antagonistas-de-pd1-ab122-y-del-receptor-de-adenosina-ab928-en-combinacion-con-quimioterapia-tras-una-radioterapia-de-corta 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07648589/homeostasis-de-la-glucosa-y-factores-geneticos-compartidos-en-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06959550/estudio-de-fase-ii-del-anticuerpo-biespecifico-anti-pd-1-vegf-ivonescimab-en-pacientes-con-cancer-colorrectal-metastasico-previamente-tratado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05579340/ejercicio-fisico-postoperatorio-y-metastasis-hepatica-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06024837/rendimiento-de-la-tomografia-computarizada-espectral-en-pacientes-con-cancer-colorrectal-metastasico-un-estudio-multicentrico-prospectivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04579380/estudio-basket-con-tucatinib-y-trastuzumab-en-tumores-solidos-con-alteraciones-de-her2 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05673772/radioterapia-secuencial-preoperatoria-de-corta-duracion-y-folfox-para-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02000089/el-estudio-caps5-cancer-of-the-pancreas-screening-5 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07632196/eficacia-y-seguridad-de-la-estimulacion-transcutanea-del-nervio-tibial-posterior-en-la-continencia-fecal-en-pacientes-sometidos-a-cirugia-por-neoplasia-rectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05044689/estudio-de-casos-y-controles-para-identificar-factores-de-riesgo-modificables-para-el-cancer-colorrectal-y-el-cancer-de-mama-en-nigeria 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04751448/colon-md-estudio-longitudinal-del-cancer-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04190589/estudio-prospectivo-de-la-hemicolectomia-robotica-derecha-extendida-con-reseccion-mesocolica-completa-para-el-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07663162/estudio-observacional-retrospectivo-y-prospectivo-unicentrico-de-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06552117/evaluacion-mediante-elastografia-por-resonancia-magnetica-de-las-metastasis-hepaticas-en-el-cancer-colorrectal-metairm 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04200027/cirugia-rectal-robotica-frente-a-cirugia-rectal-minimamente-invasiva-transanal-estudio-rota 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07272772/diagnostico-del-cancer-de-colon-mediante-imagen-pet-con-fapi 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04861558/eficacia-de-la-quimioterapia-intraperitoneal-hiperermica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07446322/folfiri-y-bevacizumab-con-o-sin-pelareorep-para-el-tratamiento-de-segunda-linea-del-cancer-colorrectal-metastasico-con-mutacion-en-ras-y-estable-en-microsatelites 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06633133/ileoestomia-virtual-frente-a-ileostomia-de-derivacion-en-pacientes-sometidos-a-reseccion-total-del-mesorrecto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06979908/un-estudio-clinico-sobre-la-eficacia-y-la-seguridad-de-fruquintinib-en-combinacion-con-un-anticuerpo-monoclonal-anti-pd-1-y-chidamide-en-el-cancer-colorrectal-metastasico-refractario-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06653478/desarrollo-y-demostracion-de-una-evaluacion-inteligente-basada-en-la-fusion-de-informacion-multimodal-para-la-evaluacion-del-riesgo-tumoral-el-diagnostico-y-el-tratamiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07446270/eficacia-de-tunlametinib-en-combinacion-con-un-anticuerpo-monoclonal-anti-egfr-en-pacientes-con-tumores-gastrointestinales-avanzados-con-mutaciones-en-ras 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04595266/quimioembolizacion-lifepearls-irinotecan-en-pacientes-con-cancer-colorrectal-y-enfermedad-metastasica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06794086/radioterapia-estereotactica-ablativa-sbrt-anticuerpo-monoclonal-anti-pd-1-en-metastasis-hepaticas-irresecables-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07685236/un-estudio-de-exploracion-de-biomarcadores-para-predecir-la-localizacion-de-la-recurrencia-y-la-metastasis-en-el-cancer-colorrectal-estudio-probe 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06097416/quimiorradioterapia-neoadyuvante-frente-a-terapia-neoadyuvante-total-en-el-tratamiento-del-cancer-de-recto-t3 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06904365/radioterapia-adaptativa-con-preservacion-ovarica-en-mujeres-jovenes 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06715839/imagen-in-vivo-mediante-inmunopet-dirigida-a-antigenos-especificos-en-el-carcinoma-del-sistema-digestivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06649123/analisis-triple-de-la-mucosa-rectal-en-el-diagnostico-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06763029/irinotecano-en-liposomas-combinado-con-cetuximab-y-vermofenib-en-pacientes-con-cancer-colorrectal-avanzado-que-han-fracasado-en-la-primera-linea-de-tratamiento 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04120935/ensayo-observacional-alfaomega-master 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07209215/manejo-del-cancer-colorrectal-en-estadio-temprano-basado-en-el-analisis-del-ctdna 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04936581/resultados-informados-por-el-paciente-tras-el-tratamiento-del-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05205330/vorbipiprant-cr6086-balstilimab-agen2034-en-combinacion-en-el-tratamiento-del-cancer-colorrectal-metastasico-pmmr-mss-en-estadio-iv-resistente-al-tratamiento-y-en-otros-canceres-metastasicos-del 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07199127/clasificacion-de-la-poliposis-duodenal-en-la-poliposis-adenomatosa-familiar-paf 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07462650/celulas-car-nk-de-doble-diana-para-el-tratamiento-del-cancer-colorrectal-avanzado-seleccionando-a-los-pacientes-en-funcion-de-biomarcadores 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03748485/quimioterapia-adyuvante-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-localmente-avanzado-tras-la-administracion-de-terapias-preoperatorias-y-con-un-diagnostico-de-pt0-3n0m0 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06542835/asociacion-comunitaria-para-soluciones-de-telemedicina-que-permitan-transmitir-informacion-y-mejorar-la-atencion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07595874/botensilimab-y-balstilimab-como-tratamiento-neoadyuvante-para-el-cancer-colorrectal-avanzado-susceptible-de-reseccion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07595276/comparacion-de-la-eficacia-y-la-seguridad-de-enlituo-r-frente-a-erbitux-r-mas-folfox-en-el-cancer-colorrectal-localmente-avanzado-metastasico-con-estado-ras-braf-de-tipo-salvaje-y-mss-pmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07463690/diseno-y-evaluacion-de-un-modelo-de-alta-hospitalaria-invertida-para-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06411691/vacuna-dirigida-a-kras-combinada-con-balstilimab-y-botensilimab-para-pacientes-con-cancer-colorrectal-y-cancer-de-pancreas-ductal-en-estadio-iv-con-deficiencia-de-reparacion-de-errores-dmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06637462/un-estudio-sobre-la-respuesta-al-tratamiento-estandar-previo-a-la-cirugia-en-pacientes-con-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02649647/reseccion-con-margenes-amplios-en-el-cancer-de-recto-tras-quimiorradioterapia-neoadyuvante 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05496491/quimiorradioterapia-neoadyuvante-y-quimioterapia-de-consolidacion-para-el-cancer-de-recto-un-ensayo-clinico-aleatorizado-y-controlado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06580574/inhibidores-de-los-puntos-de-control-inmunitario-para-la-preservacion-de-organos-en-canceres-gastricos-o-de-colon-no-metastasicos-con-dmmr-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06269978/oxaliplatino-y-fluorouracilo-administrados-por-via-intraperitoneal-para-el-tratamiento-de-pacientes-con-metastasis-peritoneales-procedentes-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04575922/nivolumab-ipilimumab-radioterapia-en-pacientes-con-mcrc-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02732860/modelado-personalizado-de-xenoinjertos-derivados-del-paciente-ppdx-para-evaluar-la-respuesta-a-farmacos-en-un-huesped-compatible 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06418204/evaluacion-de-los-beneficios-y-riesgos-del-uso-de-cannabis-canabinoides-en-pacientes-con-cancer-tratados-en-clinicas-de-oncologia-comunitarias 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07059338/bloqueo-dual-de-egfr-her2-combinado-con-irinotecan-para-el-tratamiento-del-cancer-colorrectal-metastasico-her2-positivo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07483060/next-generation-star-trec-ng-st-preservacion-de-organos-en-el-cancer-de-recto-en-estadio-temprano 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07606963/sistema-robotico-triton-1-5-para-la-colonoscopia-diagnostica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07168876/investigacion-sobre-la-biopsia-liquida-en-el-cancer-de-colon-evaluacion-de-biomarcadores-basados-en-la-metilacion-mediante-delta-hld-climbed 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05909423/combinacion-de-una-vacuna-intratumoral-y-pembrolizumab-sistemico-en-pacientes-con-cancer-colorrectal-en-estadio-temprano-y-pmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05691491/evaluacion-de-la-combinacion-de-los-farmacos-antineoplasicos-temozolomida-y-m1774-para-determinar-su-seguridad-y-eficacia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05041478/reseccion-endoscopica-de-la-mucosa-emr-con-asa-fria-frente-a-emr-con-asa-fria-y-electrocoagulacion-suave-en-el-borde-stsc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07500259/evaluacion-clinica-exploratoria-del-perfilado-funcional-personalizado-en-tumores-del-tracto-gastrointestinal-prediccion-de-la-respuesta-a-los-farmacos-en-el-ccrc-y-el-pdac 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05652348/prediccion-de-la-respuesta-a-la-quimioterapia-intraperitoneal-hiperermica-en-el-cancer-gastrointestinal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07071987/efecto-de-la-acupuntura-con-insercion-de-hilo-en-la-recuperacion-de-la-ileo-postoperatoria-tras-la-cirugia-de-cancer-colorrectal-un-ensayo-clinico-aleatorizado-y-multicentrico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06061432/procedimiento-de-reversion-de-hartmann-guiado-por-ecografia-endoscopica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07302126/eficacia-preventiva-del-enema-de-bergmann-para-la-lesion-rectal-aguda-inducida-por-la-radiacion-en-pacientes-con-cancer-de-recto-sometidos-a-radioterapia-de-corta-duracion 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05894694/beneficio-en-la-supervivencia-del-tratamiento-con-la-inyeccion-de-kushen-en-el-tratamiento-del-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07729605/folfiri-mas-bevacizumab-y-ql1706-como-tratamiento-de-segunda-linea-para-el-mcrc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06943820/terapia-combinada-con-ak129-para-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06578559/estudio-de-fase-ii-de-encorafenib-mas-cetuximab-con-retratamiento-guiado-por-ctdna-en-pacientes-con-mcrc-con-mutacion-braf-v600e 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06011772/terapia-antigeno-egf-cimavax-egf-en-combinacion-con-la-terapia-estandar-para-el-cancer-colorrectal-metastasico-con-mutaciones-ras-y-braf-no-detectables 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04103372/evaluacion-preterapeutica-mediante-resonancia-magnetica-de-pacientes-con-cancer-de-recto-en-estadio-temprano-y-polipos-rectales-significativos-para-evitar-la-necesidad-de-una-cirugia-reseccional-mayor 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07284992/scrt-frente-a-lcrt-seguido-de-un-inhibidor-de-pd-l1-mas-capeox-como-terapia-neoadyuvante-en-pacientes-con-cancer-colorrectal-localmente-avanzado-larc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04117945/regorafenib-en-combinacion-con-cetuximab-o-panitumumab-para-el-tratamiento-del-cancer-colorrectal-no-operable-localmente-avanzado-o-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06790212/quimioterapia-neoadyuvante-con-capox-mas-ivonescimab-frente-a-capox-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06952101/un-enfoque-terapeutico-multimodal-personalizado-integrado-y-adaptado-al-estadio-a-nivel-mundial-para-el-adenocarcinoma-rectal-basado-en-la-preservacion-de-organos-y-la-minima-invasion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06073431/lotus-cc-un-estudio-observacional-para-identificar-los-subtipos-de-la-caquexia-cancerosa 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07312786/evaluacion-de-la-viabilidad-de-una-aplicacion-virtual-para-brindar-apoyo-a-pacientes-supervivientes-de-cancer-de-mama-y-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06202183/ejercicio-fisico-y-microbiota-intestinal-en-pacientes-con-cancer-colorrectal-de-inicio-temprano-que-reciben-quimioterapia-el-ensayo-courage 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07502963/eficacia-de-un-programa-multimodal-de-actividad-fisica-supervisada-en-regimen-ambulatorio-para-mejorar-la-tolerancia-y-la-eficacia-de-la-quimioterapia-en-adultos-con-cancer-de-mama-pulmon-y-colon 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06440005/un-estudio-para-evaluar-la-seguridad-la-tolerabilidad-y-la-actividad-preliminar-de-agx101-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07315412/sabores-de-chicle-para-reducir-las-nauseas-y-los-vomitos-postoperatorios-tras-la-administracion-de-pipac 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06236373/las-necesidades-insatisfechas-de-los-supervivientes-de-cancer-en-ausl-irccs-reggio-emilia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07501845/registro-maastro-applicator 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07510308/estudio-clinico-de-vacunas-contra-celulas-tumorales-msh2-para-pacientes-con-cancer-colorrectal-avanzado-pmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06055439/un-estudio-de-fase-1-2-para-evaluar-chm-2101-una-terapia-celular-t-con-receptor-quimerico-de-antigeno-17-car-autologa 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07746830/evaluacion-prospectiva-de-la-concordancia-entre-la-inteligencia-artificial-multimodal-y-las-decisiones-del-equipo-multidisciplinario-en-oncologia-gastrointestinal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07328516/estudio-de-la-historia-natural-de-la-exposicion-temprana-a-factores-ambientales-en-la-agricultura-elea 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06662786/un-estudio-de-amivantamab-y-mfolfox6-o-folfiri-frente-a-cetuximab-y-mfolfox6-o-folfiri-como-tratamiento-de-primera-linea-en-participantes-con-cancer-colorrectal-irresecable-o-metastasico-del-lado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07761169/ensayo-clinico-aleatorizado-y-controlado-del-modelo-surgdiff-para-predecir-la-dificultad-quirurgica-y-ayudar-a-elegir-el-abordaje-en-el-cancer-de-recto-medio-inferior 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06403540/el-impacto-de-la-laparotomia-y-los-metodos-de-analgesia-en-el-diafragma 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04494945/identificacion-y-atencion-a-pacientes-con-sindromes-hereditarios-de-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05239546/estudio-de-un-solo-brazo-que-evalua-el-uso-de-dostarlimab-como-tratamiento-neoadyuvante-en-cancer-de-colon-en-estadio-ii-y-iii-con-deficiencia-en-la-reparacion-de-errores-de-emparejamiento-dmmr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06582914/sindrome-de-lynch-epidemiologia-e-investigacion-genetica-integradas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06485609/estudio-clinico-de-hemicolectomia-derecha-radical-frente-a-hemicolectomia-derecha-radical-combinada-con-la-diseccion-linfatica-guiada-por-la-imagen-de-fluorescencia-con-verde-de-indocianina-para-el 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05672524/un-estudio-de-tucatinib-y-trastuzumab-en-pacientes-con-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06176885/eficacia-y-seguridad-de-la-combinacion-con-inmunoterapia-tras-la-terapia-de-induccion-con-quimioterapia-y-terapia-dirigida-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07765667/nct-inhibidor-de-pd1-dieta-cetogenica-y-o-vitamina-c-para-el-cancer-colorrectal-avanzado-larc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05704985/evaluacion-de-la-seguridad-y-los-biomarcadores-mediante-el-uso-de-dk210-egfr-en-tumores-localmente-avanzados-o-metastasicos-egfr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05938322/cumplimiento-de-la-dieta-cetogenica-en-pacientes-que-reciben-radioterapia-por-canceres-pelvicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07341126/uso-de-una-camara-novedosa-para-la-exploracion-del-intestino-despues-de-la-extirpacion-de-un-polipo-o-tumor 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05773144/aleatorizacion-adaptativa-del-ejercicio-aerobico-durante-la-quimioterapia-en-el-cancer-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06794931/estudio-sobre-el-impacto-de-una-dieta-mediterranea-modificada-en-pacientes-con-cancer-colorrectal-que-reciben-tratamiento-oncologico-activo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05808790/metastasis-pulmonares-de-cancer-colorrectal-metastasis-pulmonar-versus-radioterapia-ablativa-estereotactica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07346469/exploracion-de-los-efectos-de-los-iones-de-magnesio-en-la-neuropatia-periferica-la-concentracion-serica-de-iones-de-magnesio-la-calidad-del-sueno-y-la-calidad-de-vida-en-pacientes-con-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07782164/eficacia-de-la-electroforesis-irreversible-ire-para-el-tratamiento-de-tumores-pelvicos-recurrentes-estudio-pelfire 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07537998/reinfusion-anterograda-de-fluidos-intestinales-para-la-prevencion-del-sindrome-de-reseccion-anterior-baja-tras-una-reseccion-anterior-baja-un-ensayo-clinico-aleatorizado-prospectivo-y-controlado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07348211/primer-estudio-en-humanos-de-sim0610-en-tumores-solidos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06724263/un-estudio-clinico-multicentrico-abierto-de-fase-iia-para-evaluar-la-eficacia-y-la-seguridad-de-la-inyeccion-de-b1962-en-el-tratamiento-de-tumores-solidos-malignos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06350370/resultados-a-corto-y-largo-plazo-del-cancer-colorrectal-tratado-con-cirugia-de-extraccion-de-muestras-a-traves-de-orificios-naturales-un-estudio-basado-en-un-registro-nacional 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07247396/terapia-con-celulas-car-t-dirigidas-contra-el-antigeno-carcinoembrionario-cea-tras-citoreduccion-en-pacientes-con-cancer-colorrectal-y-metastasis-peritoneales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04928807/radioterapia-de-corta-duracion-seguida-de-quimioterapia-neoadyuvante-y-camrelizumab-en-el-cancer-colorrectal-localmente-avanzado-union 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07175636/ql1706-radioterapia-y-quimioterapia-a-corto-plazo-para-el-cancer-colorrectal-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07791758/un-estudio-clinico-de-fase-ib-ii-con-lbl-024-en-combinacion-para-el-tratamiento-de-pacientes-con-carcinoma-colorrectal-metastasico 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06838338/jab-21822-en-combinacion-con-quimioterapia-y-bevacizumab-en-el-tratamiento-de-segunda-linea-del-ccrc-con-mutacion-kras-g12c 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06601075/el-papel-del-pet-tc-con-18f-fdg-y-68ga-fapi-en-el-diagnostico-y-la-evaluacion-de-la-eficacia-del-cancer-colorrectal-avanzado-metastasis-peritoneal-con-o-sin-otras-metastasis 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06353854/cohorte-nacional-prospectiva-para-evaluar-biomarcadores-predictivos-de-resistencia-a-la-inmunoterapia-en-pacientes-con-cancer-colorrectal-metastasico-msi-dmmr-coresim 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06215677/inmunoterapia-neoadyuvante-para-el-cancer-de-colon-t4-dmmr 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06293014/tas-102-en-combinacion-con-bevacizumab-para-el-tratamiento-de-mantenimiento-en-segunda-linea-del-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07035587/diagnostico-de-multiples-tipos-de-cancer-y-seguimiento-de-tumores-residuales-minimos-tras-el-tratamiento-mediante-el-analisis-de-sangre-y-tecnicas-geneticas-de-alta-sensibilidad 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04025541/analisis-de-los-marcadores-tumorales-circulantes-en-sangre 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07249333/complicaciones-perioperatorias-tras-la-radioterapia-neoadyuvante-para-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07154316/ensayo-clinico-fase-ii-aleatorizado-y-controlado-que-compara-la-quimiorradioterapia-neoadyuvante-lcrt-frente-a-la-radioterapia-neoadyuvante-de-corta-duracion-scrt-combinada-con-capox-un-inhibidor-de 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05969041/estudio-de-mt-302-en-adultos-con-tumores-epiteliales-avanzados-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06328361/ensayo-piloto-no-aleatorizado-de-un-solo-brazo-de-enfoque-nordico-para-la-preservacion-de-organos-en-el-manejo-no-quirurgico-del-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07363408/ivonescimab-y-adg126-solos-y-en-combinacion-con-leucovorina-y-fluorouracilo-o-el-regimen-folfiri-para-el-tratamiento-del-cancer-colorrectal-avanzado-metastasico-con-estabilidad-microsatelital 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03233711/nivolumab-tras-la-terapia-combinada-en-el-tratamiento-de-pacientes-con-cancer-anal-de-estadio-ii-iiib-de-alto-riesgo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07364656/analisis-de-la-presencia-y-los-efectos-sobre-la-funcion-cardiaca-de-los-autoanticuerpos-anti-nav1-5-en-pacientes-con-tumores-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07556835/resultados-tras-la-reseccion-hepatica-y-biliar-en-un-centro-de-gran-volumen 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07044362/histotripsia-mas-quimioterapia-frente-a-quimioterapia-sola-en-metastasis-hepaticas-avanzadas-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06955767/medicion-de-la-proteina-mmp-14-un-posible-nuevo-marcador-para-la-deteccion-del-cancer-colorrectal-en-vesiculas-plasmaticas-denominadas-exosomas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04510129/un-estudio-multicentrico-de-recoleccion-de-bioespecimenes-de-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06784258/comparacion-de-los-factores-inflamatorios-la-escala-de-dolor-y-la-calidad-de-la-recuperacion-postoperatoria-qor-15-en-pacientes-sometidos-a-cirugia-de-cancer-colorrectal-con-tecnicas-de-anestesia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06919068/exploracion-del-intestino-grueso-mediante-capsula-endoscopica-en-pacientes-con-infeccion-de-la-corriente-sanguinea-causada-por-bacterias-asociadas-al-intestino 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07172087/construccion-e-investigacion-empirica-de-un-protocolo-de-baduanjin-aplicable-a-pacientes-con-enterostomia-por-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05194878/quimioterapia-neoadyuvante-con-folfoxiri-frente-a-cirugia-inmediata-en-cancer-de-colon-en-estadio-ii-y-iii 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04404777/recurrencia-local-por-cancer-de-recto-en-suecia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06903858/toripalimab-mas-celecoxib-como-tratamiento-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado-con-dmmr-msi-h 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06940921/sbrt-ldrt-cadonilimab-para-el-cancer-gastrico-colorrectal-y-ovarico-avanzado-con-metastasis-peritoneales 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05217446/un-estudio-de-encorafenib-mas-cetuximab-administrados-en-combinacion-con-pembrolizumab-en-comparacion-con-pembrolizumab-solo-en-pacientes-con-cancer-colorrectal-metastasico-no-tratado-previamente 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05672316/botensilimab-balstilimab-y-regorafenib-para-el-tratamiento-de-pacientes-con-cancer-colorrectal-metastasico-con-estabilidad-de-microsatelites-que-han-presentado-progresion-tras-una-quimioterapia-previa 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03488953/trasplante-de-higado-con-donante-vivo-y-hepatectomia-en-dos-etapas-para-pacientes-con-metastasis-hepaticas-irresecables-aisladas-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07392567/validacion-prospectiva-de-un-modelo-de-inteligencia-artificial-para-predecir-la-metastasis-hepatica-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06935708/morfina-intratecal-frente-a-analgesia-epidural-en-la-cirugia-de-colon-abierta 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06154538/inhibidores-de-los-puntos-de-control-inmunitario-quimioterapia-frente-a-quimioterapia-en-el-tratamiento-neoadyuvante-del-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07570914/infusion-intraarterial-hepatica-de-irinotecan-liposomal-mas-oxaliplatino-y-capecitabina-como-terapia-adyuvante-para-metastasis-hepaticas-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06244771/un-estudio-que-evalua-el-farmaco-fmc-376-en-participantes-con-tumores-solidos-que-presentan-la-mutacion-kras-g12c 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07573371/comprension-y-tratamiento-personalizado-del-sindrome-de-la-reseccion-anterior-baja 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07046468/una-pildora-inteligente-para-medir-la-salud-intestinal-en-la-inflamacion-del-colon-y-el-cancer-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06136026/cohorte-especializada-en-medicina-china-y-occidental-integrada-para-el-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06714357/acido-valproico-para-potenciar-la-eficacia-del-tratamiento-anti-egfr-y-prevenir-revertir-la-resistencia-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07229846/un-estudio-clinico-de-fase-ii-de-un-solo-brazo-y-en-un-solo-centro-para-evaluar-aipalolitovorelizumab-ql1706-en-combinacion-con-bevacizumab-y-quimioterapia-estandar-como-tratamiento-de-primera-linea 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06092242/eficacia-y-seguridad-de-tas-102-suyuan-en-combinacion-con-bevacizumab-como-terapia-de-primera-linea-en-pacientes-con-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06251297/factibilidad-y-beneficios-de-la-reflexologia-en-la-prevencion-de-la-neuropatia-inducida-por-oxaliplatino-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07404228/estudio-multidimensional-disenado-para-desarrollar-un-marco-metodologico-basado-en-datos-de-resonancia-magnetica-rm-con-el-fin-de-predecir-la-respuesta-patologica-completa-pcr-en-pacientes-con-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07405736/lubiprostone-en-combinacion-con-terapia-de-mantenimiento-para-la-prevencion-de-la-recurrencia-postoperatoria-en-cancer-colorrectal-con-metastasis-peritoneales 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT02584244/viabilidad-del-sistema-de-imagen-lum-para-la-deteccion-de-canceres-gastrointestinales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07221058/radioterapia-de-refuerzo-adaptativa-para-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05444491/aplicacion-de-marcadores-de-metilacion-poligenica-en-el-seguimiento-postoperatorio-de-la-recurrencia-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06957626/desarrollo-y-validacion-de-un-modelo-de-prediccion-basado-en-la-microbiota-y-los-metabolitos-para-la-recurrencia-de-polipos-colorrectales-de-alto-riesgo-tras-la-polipectomia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06057350/cirugia-frente-a-reseccion-endoscopica-para-el-cancer-de-colon-en-estadio-inicial-que-no-se-ha-eliminado-por-completo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06680739/analisis-del-perfil-de-celulas-individuales-para-predecir-la-persistencia-de-la-respuesta-a-la-inmunoterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05346757/validacion-de-un-test-fecal-basado-en-microarn-mirfec-para-el-cribado-la-vigilancia-y-el-diagnostico-del-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07229443/ensayo-clinico-aleatorizado-y-controlado-ecac-cogenes 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06118762/estudio-clinico-de-fruquintinib-en-combinacion-con-raltitrexed-para-el-tratamiento-del-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07413146/quimioterapia-neoadyuvante-con-capeox-frente-a-cirugia-inicial-en-cancer-colorrectal-localmente-avanzado-con-niveles-elevados-de-cea-un-ensayo-clinico-aleatorizado-abierto-y-de-un-solo-centro 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04491929/terapia-de-radiacion-interna-selectiva-con-microesferas-de-resina-de-90y-para-metastasis-hepaticas-de-cancer-colorrectal-refractario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05655780/el-papel-del-perfil-molecular-tumoral-cms-el-genotipo-ugt1a1-y-la-actividad-de-la-beta-glucuronidasa-de-la-microbiota-intestinal-en-la-eficacia-del-tratamiento-la-toxicidad-la-supervivencia-y-la 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT03001362/pacientes-con-cancer-de-recto-un-enfoque-de-esperar-y-observar 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07276048/especialistas-en-orientacion-genetica-comunitaria-para-aumentar-el-conocimiento-sobre-la-genetica-del-cancer-colorrectal-en-las-comunidades-hispanas-latinas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07656766/sintilimab-mas-acetato-de-gossipol-en-el-cancer-colorrectal-avanzado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05883800/tratamiento-neoadyuvante-total-combinado-con-radioterapia-adaptativa-para-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06831981/hipertermia-con-quimiorradioterapia-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06374173/un-estudio-de-fase-i-para-evaluar-tgi-6-en-sujetos-con-tumores-solidos-localmente-avanzados-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07661641/un-estudio-de-177lu-lu-a9-0631-y-225ac-ac-a9-0642-con-68ga-ga-a9-6217-o-imagen-con-177lu-lu-a9-0631-en-tumores-solidos-grpr 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05568420/un-estudio-sobre-los-posibles-efectos-de-la-medicacion-en-el-cancer-colorrectal-de-inicio-temprano-yocrc 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06333392/colonoscopia-total-sumergida-tuc-para-mejorar-el-cribado-del-cancer-colorrectal-un-ensayo-clinico-aleatorizado-y-controlado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04585750/evaluacion-de-pc14586-en-pacientes-con-tumores-solidos-avanzados-que-presentan-una-mutacion-y220c-en-el-gen-tp53-pynnacle 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06589830/tl938-y-trastuzumab-para-pacientes-con-cancer-colorrectal-metastasico-her2-positivo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07241143/tecnica-de-tunel-extraperitoneal-frente-a-la-fijacion-convencional-del-drenaje-tras-una-reseccion-anterior-o-baja-anterior 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07132970/tasa-de-fuga-de-la-anastomosis-ileo-colica-suturada-tras-la-hemicolectomia-derecha 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06733038/folfoxiri-mas-bevacizumab-con-o-sin-atezolizumab-como-tratamiento-de-primera-linea-en-pacientes-con-cancer-colorrectal-metastasico-pmmr-e-ic-alto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07446465/quimioterapia-folfox-combinada-con-fruquintinib-y-serplulimab-como-terapia-de-conversion-de-primera-linea-para-cancer-colorrectal-pmmr-mss-inicialmente-irresecable 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06811454/intervencion-basada-en-la-atencion-plena-para-los-sintomas-depresivos-administrada-a-traves-de-mensajes-de-texto-mindset 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04857528/deteccion-del-adn-del-vph-en-canceres-anales-y-cervicales 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05794750/evaluar-la-eficacia-de-la-radioterapia-y-la-quimioterapia-secuencial-asi-como-de-ak104-antes-de-la-cirugia-de-reseccion-mesenterica-total-tme-en-el-cancer-colorrectal-local-ak104-iit-13 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05014399/deterioro-cognitivo-en-pacientes-con-cancer-colorrectal-que-reciben-quimioterapia-citotoxica 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07070622/reseccion-programada-de-organos-para-el-cancer-de-recto-inferior-tras-la-quimioterapia-neoadyuvante-oplar 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06099951/tratamiento-neoadyuvante-total-para-cancer-colorrectal-localmente-avanzado-con-pmmr-anticuerpo-anti-pd-1-con-folfoxiri-y-radioterapia-preoperatoria 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07680088/estudio-de-fase-ii-de-pembrolizumab-y-lenvatinib-en-el-cancer-de-celulas-escamosas-anal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05780684/escalada-de-dosis-individualizada-de-5-fu-para-el-cancer-gastrointestinal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05965531/tratamiento-del-cancer-colorrectal-localmente-avanzado-con-quimioterapia-con-tas-102-mas-radioterapia-neoadyuvante 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07689812/un-ensayo-aleatorizado-multicentrico-y-de-etiqueta-abierta-que-evalua-la-interrupcion-guiada-por-la-enfermedad-residual-minima-erm-frente-al-tratamiento-estandar-con-inhibidores-de-puntos-de-control 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05174286/trabajadores-comunitarios-de-la-salud-unidos-para-reducir-el-cancer-colorrectal-y-las-enfermedades-cardiovasculares-en-personas-con-mayor-riesgo 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06563986/ftd-tpi-bevacizumab-y-radioembolizacion-con-microsferas-de-166ho-en-el-cancer-colorrectal-metastasico-refractario 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06860685/ensayo-clinico-sobre-el-uso-de-chicle-para-mejorar-la-recuperacion-de-la-motilidad-intestinal-en-la-cirugia-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06855849/un-estudio-de-fase-ii-abierto-de-un-solo-brazo-y-multicentrico-para-evaluar-la-eficacia-de-amivantamab-en-combinacion-con-folfiri-como-tratamiento-de-segunda-linea-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06605430/cannabis-medicinal-en-pacientes-con-cancer-avanzado-de-pancreas-y-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06272461/comparacion-de-la-lidocaina-intravenosa-frente-a-la-cetamina-en-la-cirugia-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07144683/fistula-anastomotica-tras-la-cirugia-de-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT04527861/resultados-oncologicos-de-la-cirugia-laparoscopica-convencional-frente-a-la-cirugia-laparoscopica-con-una-sola-incision-en-el-cancer-colorrectal 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05086692/un-estudio-de-inmunoterapia-con-il-2-solo-beta 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07285044/el-programa-cancer-connected-access-and-remote-expertise-beyond-walls-tiene-como-objetivo-proporcionar-tratamiento-oncologico-en-el-domicilio-de-los-pacientes-y-mejorar-la-satisfaccion-con-el 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06507371/radioterapia-de-curso-corto-que-preserva-los-ganglios-combinada-con-capox-y-tislelizumab-para-el-cancer-colorrectal-mss 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07701707/comidas-personalizadas-segun-las-necesidades-medicas-para-reducir-el-consumo-de-alimentos-ultraprocesados-en-supervivientes-de-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07705334/un-estudio-de-shy-onc6-un-nuevo-inhibidor-del-proteasoma-en-adultos-con-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06832917/radioterapia-de-corta-duracion-scrt-seguida-de-6-ciclos-de-cadonilimab-mas-mfolfox6-como-terapia-neoadyuvante-para-pacientes-con-cancer-colorrectal-localmente-avanzado-larc-un-ensayo-multicentrico-de 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07286539/ejercicio-fisico-de-precision-para-una-onco-hematologia-personalizada 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07474727/un-estudio-de-fase-ii-sobre-terapias-combinadas-con-amt-676-en-cancer-colorrectal-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07705880/una-nueva-herramienta-de-apoyo-a-la-toma-de-decisiones-clinicas-para-predecir-la-presencia-de-cancer-invasivo-subepitelial-en-polipos-colorrectales-grandes-y-no-pediculados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07118176/determinacion-de-la-biodistribucion-de-un-trazador-de-imagen-68ga-fapi-46-en-pacientes-con-tumores-solidos-o-canceres-hematologicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04109755/pembrolizumab-y-radioterapia-neoadyuvantes-en-el-cancer-de-recto-localizado-mss 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT00648635/relacion-entre-la-calidad-de-vida-las-modalidades-de-tratamiento-y-las-expectativas-de-los-pacientes-con-respecto-al-tratamiento-y-los-resultados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04495088/quimioterapia-folfox-preoperatoria-frente-a-quimioterapia-postoperatoria-adaptada-al-riesgo-en-pacientes-con-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05856981/estudio-de-fase-i-para-evaluar-la-seguridad-y-la-farmacocinetica-de-adu-1805-en-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06405139/irinotecano-nanoliposomal-oxaliplatino-mas-capecitabina-como-terapia-de-conversion-en-el-cancer-colorrectal-localmente-avanzado 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05783622/estudio-de-janx008-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06930118/el-objetivo-de-este-estudio-es-evaluar-la-eficacia-y-la-seguridad-de-chidamide-regorafenib-en-combinacion-con-iparomlimab-y-tuvonralimab-para-el-tratamiento-del-cancer-colorrectal-avanzado-en-tercera 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07621497/folfox8-frente-a-mfolfox6-con-bevacizumab-o-cetuximab-para-el-cancer-colorrectal-metastasico-irresecable-en-primera-linea-fase-ii 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06443203/prehabilitacion-multimodal-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06833021/deteccion-de-la-proteina-x-del-virus-de-la-hepatitis-b-hbx-en-el-cancer-asociado-a-la-colitis-cac 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04678583/reseccion-anatomica-de-metastasis-hepaticas-en-pacientes-con-cancer-colorrectal-con-mutaciones-en-los-genes-ras 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07321106/un-estudio-para-investigar-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-la-actividad-antitumoral-de-cbi-1214-un-activador-de-celulas-t-en-participantes-con-cancer-colorrectal-avanzado-o 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07515729/concienciacion-sobre-la-deteccion-del-cancer-colorrectal-en-las-comunidades-de-nativos-americanos 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06447662/un-estudio-para-evaluar-el-medicamento-pf-07934040-administrado-solo-o-en-combinacion-con-otras-terapias-contra-el-cancer-en-pacientes-con-tumores-solidos-avanzados-que-presentan-una-mutacion-genetica 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06106308/estudio-de-onvansertib-en-combinacion-con-folfiri-y-bevacizumab-o-folfox-y-bevacizumab-en-comparacion-con-folfiri-y-bevacizumab-o-folfox-y-bevacizumab-para-el-tratamiento-de-primera-linea-del-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07642323/seguridad-y-eficacia-de-la-quimioterapia-neoadyuvante-y-la-observacion-frente-a-la-cirugia-para-los-canceres-gastrointestinales-con-dmmr-msi-h-o-mutacion-en-el-gen-pole 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07781852/evaluacion-de-la-distribucion-del-cm500-marcado-con-64cu-68ga-en-voluntarios-sanos-y-pacientes-con-cancer 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04185272/el-papel-de-las-butirofilinas-en-el-cancer-de-colon 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06632886/tac-sin-contraste-asistida-por-ia-para-la-deteccion-de-multiples-tipos-de-cancer 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06043947/seguimiento-de-la-supervivencia-en-los-registros-de-cancer-de-rusia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT05462613/regorafenib-combinado-con-quimioterapias-a-dosis-bajas-y-aspirina-seguido-de-quimioterapias-estandar-en-el-cancer-colorrectal-metastasico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05609370/un-estudio-que-investiga-la-eficacia-y-la-seguridad-de-lbl-007-mas-tislelizumab-en-combinacion-con-bevacizumab-mas-fluoropirimidina-en-comparacion-con-bevacizumab-mas-fluoropirimidina-en 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06882746/un-estudio-para-evaluar-diferentes-dosis-de-bi-765049-en-pacientes-con-cancer-avanzado-de-colon-recto-estomago-o-pancreas 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07544784/ak104-mas-radioterapia-en-combinacion-con-la-terapia-estandar-frente-a-la-terapia-estandar-como-tratamiento-de-primera-linea-para-crlm-pmmr-mss-apsoc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06274190/vias-de-atencion-personalizadas-para-los-sintomas-intestinales-en-pacientes-con-cancer-de-recto-desarrollo-de-un-diario-electronico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02945566/podemos-preservar-el-recto-mediante-una-estrategia-de-vigilancia-estrecha-o-cirugia-transanal-despues-de-la-quimio-radioterapia-en-comparacion-con-la-reseccion-mesorrectal-total-en-el-cancer-rectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07173985/estrategias-para-optimizar-un-programa-de-deteccion-de-sangre-oculta-en-heces-fobt-basado-en-pruebas-realizadas-en-el-domicilio-en-la-region-de-los-apalaches 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05776381/el-impacto-de-una-herramienta-de-apoyo-a-la-toma-de-decisiones-en-las-elecciones-de-tratamiento-para-pacientes-con-un-polipo-colorrectal-maligno-inesperado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07381764/romance-irinotecan-mas-cetuximab-en-un-nuevo-ciclo-de-tratamiento-versus-trifluridina-tipiracil-mas-bevacizumab-en-cancer-colorrectal-metastasico-molecularmente-seleccionado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06720987/un-estudio-para-investigar-la-seguridad-y-la-eficacia-de-kqb365-como-monoterapia-y-en-combinacion-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07237984/estudio-de-la-omica-del-cancer-colorrectal-y-de-los-proteoglicanos-del-cancer-colorrectal-coco-en-el-cribado-y-en-un-programa-de-diagnostico 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07380867/confirmacion-de-la-precision-del-marcado-endoscopico-mediante-un-nuevo-marcador-un-novedoso-luminomarcador-para-el-marcado-de-lesiones-antes-de-la-cirugia-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06425133/regorafenib-en-combinacion-con-quimioterapia-metronomica-multimodal-para-cancer-colorrectal-metastasico-resistente-a-la-quimioterapia 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT05121038/cend-1-en-combinacion-con-folfirinox-neoadyuvante-con-o-sin-panitumumab 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07398326/anlotinib-en-combinacion-con-sintilimab-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-metastasico-avanzado-excluyendo-las-metastasis-hepaticas 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06162650/terapia-neoadyuvante-total-en-el-cancer-de-recto 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07589205/estudio-de-ibi3028-en-participantes-con-tumores-solidos-avanzados-localmente-irresecables-o-metastasicos 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07416552/un-estudio-para-investigar-cea-prit-2-0-en-participantes-con-cancer-colorrectal-metastasico-mcrc 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT06824064/evaluacion-de-rbs2418-en-pacientes-con-cancer-colorrectal-avanzado-metastasico-y-en-progresion 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT07255066/optimizacion-del-tratamiento-del-paciente-mediante-una-nutricion-enriquecida-con-epa-un-ensayo-clinico-aleatorizado-y-controlado 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04739696/desarrollo-de-una-intervencion-virtual-para-el-manejo-del-estres-dirigida-a-los-cuidadores-de-pacientes-con-cancer-de-tumores-solidos-que-tienen-pareja-o-conyuge 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07659795/un-estudio-de-fase-ii-de-vs-7375-en-pacientes-con-cancer-colorrectal-con-mutacion-kras-g12d 2026-09-07 weekly 0.7 https://crcwarriors.org/ensayo/NCT02113384/cancer-colorrectal-localmente-avanzado-celulas-tumorales-exfoliadas-del-peritoneo 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT04713618/cambios-en-la-salud-pelvica-la-funcion-sexual-y-la-calidad-de-vida-en-mujeres-con-cancer-pelvico-que-se-someten-a-radioterapia 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06544655/un-estudio-de-bms-986484-en-monoterapia-y-en-combinacion-con-otras-terapias-en-participantes-con-tumores-solidos-avanzados 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06540261/estudio-de-ono-7913-ono-4538-y-el-tratamiento-estandar-como-terapia-de-primera-linea-en-pacientes-con-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT03821935/estudio-para-determinar-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-la-dosis-recomendada-para-la-fase-2-rp2d-de-livmoniplimab-abbv-151-como-agente-unico-y-en-combinacion-con-budigalimab-abbv 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT06666166/shr-a1811-en-combinacion-con-apatinib-en-el-tratamiento-del-adenocarcinoma-gastrico-o-de-la-union-gastroesofagica-avanzado-y-del-cancer-colorrectal 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07714447/eficacia-y-seguridad-de-la-terapia-combinada-con-tunlametinib-en-el-tratamiento-del-cancer-colorrectal-metastasico-en-segunda-linea-o-posterior 2026-09-07 weekly 0.6 https://crcwarriors.org/ensayo/NCT07718165/un-estudio-de-fase-i-de-absk211-en-participantes-con-tumores-solidos-avanzados-con-alteracion-de-kras 2026-09-06 weekly 0.7 https://crcwarriors.org/ensayo/NCT06337084/eficacia-diagnostica-y-dosimetria-de-mnpr-101-dfo-89zr-en-pacientes-con-tumores-solidos 2026-09-06 weekly 0.6 https://crcwarriors.org/ensayo/NCT06557733/un-farmaco-en-investigacion-tpst-1495-en-pacientes-con-poliposis-adenomatosa-familiar 2026-09-06 weekly 0.7 https://crcwarriors.org/ensayo/NCT05538130/un-estudio-para-evaluar-el-medicamento-pf-07799544-tanto-en-monoterapia-como-en-combinacion-en-pacientes-con-tumores-solidos-avanzados 2026-09-06 weekly 0.6 https://crcwarriors.org/ensayo/NCT04913285/un-estudio-para-evaluar-kin-2787-en-participantes-con-tumores-solidos-braf-y-o-nras-positivos 2026-09-06 weekly 0.7 https://crcwarriors.org/ensayo/NCT05688605/un-estudio-de-mrg003-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados-o-metastasicos-egfr-positivos 2026-09-05 weekly 0.7 https://crcwarriors.org/ensayo/NCT07805551/un-estudio-de-la-terapia-combinada-con-hdm2017-en-el-cancer-colorrectal-avanzado 2026-09-05 weekly 0.7 https://crcwarriors.org/ensayo/NCT06337695/vedolizumab-para-la-prevencion-de-la-diarrea-o-la-colitis-relacionadas-con-los-inhibidores-de-los-puntos-de-control-inmunitario-en-pacientes-con-cancer 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07201259/analisis-de-las-diferencias-en-el-microbioma-intestinal-de-pacientes-con-cancer-y-diferentes-niveles-de-funcion-ovarica-y-resultados-de-fertilidad-tras-la-terapia-con-inhibidores-de-puntos-de-control 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05101382/un-protocolo-retrospectivo-que-impulsa-la-investigacion-de-precision-en-el-cancer-colorrectal-alfaomega-retro 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07236983/biodiversidad-de-la-microbiota-intestinal-en-pacientes-con-tumores-solidos-tratados-con-inhibidores-de-puntos-de-control-inmunitario-icpi-un-estudio-prospectivo-monocentrico-para-identificar-las 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07018869/evaluacion-de-si-un-sitio-web-educativo-denominado-current-together-after-cancer-ctac-mejora-la-atencion-de-seguimiento-para-los-supervivientes-de-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07496528/el-ensayo-acure-acupuntura-para-la-recuperacion-tras-una-cirugia-de-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05853094/efectos-postoperatorios-de-diferentes-tecnicas-de-enterostomia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06645015/el-ensayo-clinico-aidpro-crc 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04235114/evaluacion-de-89zr-dfo-nimotuzumab-para-la-obtencion-de-imagenes-no-invasivas-de-canceres-egfr-mediante-tomografia-por-emision-de-positrones-tep 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07541924/el-impacto-del-colonoscopio-con-asistencia-de-imagen-en-la-experiencia-del-paciente-la-carga-de-trabajo-del-medico-y-la-calidad-del-examen 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06109961/terapia-con-oxigeno-hiperbarico-para-la-enfermedad-de-crohn-perianal-fistulizante-que-no-responde-o-es-intolerante-al-tratamiento-convencional-estudio-piloto-hypnotic 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT03796884/linaclotida-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-en-estadios-0-3 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT03465982/momento-optimo-para-la-cirugia-minimamente-invasiva-tras-la-quimiorradioterapia-neoadyuvante-para-el-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07099924/cateteres-en-la-vaina-del-musculo-recto-tras-una-laparotomia-media 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06267378/evaluacion-de-la-fragilidad-y-sus-efectos-en-pacientes-que-se-someten-a-una-cirugia-mayor-del-tracto-gastrointestinal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05462496/modulacion-de-la-microbiota-intestinal-con-pembrolizumab-tras-la-quimioterapia-en-el-cancer-de-pancreas-resecable 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07661017/gutcheck-optimizacion-de-una-aplicacion-movil-de-salud-personalizada-para-pacientes-que-han-sobrevivido-a-un-cancer-gastrointestinal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07067385/vacuna-de-arnm-personalizada-contra-el-cancer-para-el-tratamiento-de-tumores-solidos-gastrointestinales 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05187338/terapia-con-triple-inhibidor-de-puntos-de-control-para-tumores-solidos-avanzados 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05485974/un-estudio-de-escalamiento-de-dosis-de-hbi-2438-en-pacientes-con-tumores-solidos-que-presentan-la-mutacion-kras-g12c 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07692555/desarrollo-y-validacion-de-un-modelo-de-diagnostico-para-el-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT01061515/oxaliplatino-intraperitoneal-administrado-cada-dos-semanas-junto-con-capecitabina-y-bevacizumab-por-via-sistemica-para-pacientes-con-carcinomatosis-peritoneal-procedente-de-cancer-de-apendice-o 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07415031/un-estudio-de-tumores-solidos-para-el-tratamiento-a-largo-plazo-de-pacientes-con-cancer-que-participaron-en-estudios-con-adagrasib 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06657222/primer-estudio-en-humanos-de-tub-030-en-pacientes-con-tumores-solidos-avanzados 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07608120/bebida-electrolitica-combinada-con-polietilenglicol-para-la-preparacion-intestinal-previa-a-la-colonoscopia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07636174/asistencia-para-la-solicitud-de-recordatorios-preventivos-de-deteccion-del-cancer-colorrectal-a-traves-de-mensajes-de-texto-con-el-fin-de-mejorar-la-calidad-de-las-consultas-medicas 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04462042/terapia-con-protones-frente-a-terapia-con-fotones-en-el-carcinoma-de-celulas-escamosas-anal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06805045/cirugia-guiada-por-imagen-en-el-tratamiento-del-cancer-de-recto-ar-crc 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06974500/implementacion-de-un-protocolo-de-estimulacion-del-asa-eferente-antes-del-cierre-de-la-ileostomia-en-el-hospital-universitario-la-paz 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07558083/ensayo-folicolor-seguimiento-de-la-respuesta-terapeutica-mediante-biopsia-liquida-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06767046/terapia-con-celulas-t-autologas-especificas-para-kras-en-tumores-solidos-avanzados-con-mutacion-kras 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05536089/aplicacion-de-la-metilacion-del-ctdna-en-la-evaluacion-de-la-recurrencia-postoperatoria-y-la-eficacia-de-la-quimioterapia-adyuvante 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06756295/un-estudio-de-fase-i-ii-de-inmunoterapia-con-celulas-t-estimuladas-por-autoantigenos-fragmentados-combinada-con-radioterapia-fast-cr 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT03713229/cohorte-de-sevilla-de-personas-que-viven-con-el-vih-y-que-presentan-riesgo-de-cancer-anal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06199973/inyeccion-de-shr-a1811-frente-al-tratamiento-elegido-por-el-medico-en-pacientes-con-cancer-colorrectal-avanzado-que-no-habian-respondido-a-oxaliplatino-5-fu-e-irinotecan 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT03837782/resultados-de-la-reseccion-quirurgica-en-el-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06136897/evaluacion-de-trastuzumab-y-pertuzumab-en-pacientes-con-un-numero-de-copias-del-gen-her2-superior-al-normal-detectado-en-sus-tumores-match-subprotocolo-j 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07234968/ensayo-clinico-para-evaluar-los-resultados-postoperatorios-de-la-colocacion-de-un-cateter-ureteral-frente-a-la-cistectomia-radical-sin-cateter-ureteral 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05194995/jab-21822-en-combinacion-con-cetuximab-en-pacientes-con-crc-avanzado-y-otros-tumores-solidos-con-mutacion-kras-g12c 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07291401/radioterapia-mas-capox-e-iparolimab-y-tuvonalimab-ql1706-como-terapia-neoadyuvante-para-el-cancer-colorrectal-avanzado-localizado-larc 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT03386500/estudio-de-seguridad-de-bmx-001-radioprotector-en-pacientes-con-cancer-anal-de-reciente-diagnostico 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07607990/efectos-del-supositorio-de-indometacina-rectal-sobre-la-enfermedad-inflamatoria-intestinal-recurrente-postoperatoria-en-pacientes-sometidos-a-proctocolectomia-izquierda 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07736495/papel-protector-del-acido-alfa-lipoico-en-la-mucositis-inducida-por-la-quimioterapia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07106892/estudio-de-fase-ii-abierto-multicentrico-para-evaluar-la-eficacia-y-la-seguridad-de-hlx43-un-anticuerpo-monoclonal-conjugado-adc-anti-pd-l1-en-sujetos-con-cancer-colorrectal-avanzado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07074353/lirposomas-de-irinotecan-en-la-terapia-neoadyuvante-total-en-el-cancer-colorrectal-localmente-avanzado 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07189780/comparacion-de-diferentes-enfoques-quirurgicos-en-el-cancer-de-recto-femenino 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06824688/cirugia-robotica-con-un-solo-puerto-frente-a-cirugia-robotica-con-multiples-puertos-para-el-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07527026/un-estudio-clinico-de-fase-ii-de-un-solo-brazo-que-evalua-el-camrelizumab-en-combinacion-con-quimiorradioterapia-de-larga-duracion-como-terapia-neoadyuvante-total-en-cancer-colorrectal-localmente 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05877352/radioterapia-intraoperatoria-con-electrones-en-el-cancer-de-recto-un-estudio-de-factibilidad 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07542405/un-programa-en-linea-kindred-para-mejorar-la-comprension-del-riesgo-genetico-de-cancer-y-las-pruebas-geneticas-para-el-cancer-en-familias-afroamericanas 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06688786/un-ensayo-clinico-prospectivo-de-un-solo-brazo-multicentrico-que-evalua-la-quimioterapia-neoadyuvante-preoperatoria-mfolfox6-en-combinacion-con-un-anticuerpo-monoclonal-anti-pd1-en-pacientes-con 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05555888/la-combinacion-de-inmunoterapia-y-radioterapia-neoadyuvante-de-corta-duracion-en-el-cancer-de-recto-en-estadio-temprano 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06808412/para-evaluar-la-eficacia-de-sintilimab-en-combinacion-con-bevacizumab-en-el-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07269912/aplicacion-de-la-resonancia-magnetica-multimodal-en-la-clasificacion-histologica-y-la-evaluacion-pronostica-del-cancer-de-recto 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07551479/itnt-basado-en-terapia-de-radiacion-de-intensidad-modulada-volumetrica-scrt-frente-a-terapia-neoadyuvante-total-tnt-basada-en-terapia-de-radiacion-conformacional-lcrt-para-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06455124/radioterapia-de-corta-duracion-combinada-con-capeox-e-inhibidor-de-pd-1-tras-la-reseccion-local-en-el-cancer-colorrectal-temprano-de-alto-riesgo-torch-le 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07217171/un-estudio-que-evalua-la-seguridad-la-eficacia-y-la-farmacocinetica-pk-de-evolve104-en-participantes-con-carcinomas-uroteliales-y-de-celulas-escamosas-avanzados 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05689775/reconstruccion-tras-la-reseccion-abdominoperineal-con-la-obtencion-del-colgajo-vram-mediante-cirugia-robotica 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06802666/radioterapia-de-corta-duracion-seguida-de-ak112-y-capox-como-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05112016/estudio-de-cohortes-a-largo-plazo-sobre-la-reseccion-mesorrectal-en-el-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06574087/determinar-la-frecuencia-de-aparicion-y-definir-la-prueba-de-deteccion-mas-adecuada-para-la-neoplasia-intraepitelial-anal-nia-en-pacientes-con-enfermedades-ginecologicas-relacionadas-con-el-virus-del 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07581626/radioterapia-adaptativa-en-linea-de-corta-duracion-combinada-con-quimioterapia-terapia-dirigida-e-inmunoterapia-como-terapia-neoadyuvante-total-tnt-para-el-cancer-colorrectal-localmente-avanzado 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06615648/eficacia-de-una-intervencion-de-terapia-motivacional-para-reducir-el-consumo-de-alcohol-en-adultos-jovenes 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06761287/optimizacion-de-la-seleccion-de-pacientes-para-la-cirugia-mediante-el-analisis-patologico-tras-la-terapia-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04643366/terapia-neoadyuvante-total-con-mfolfox-y-radioterapia-de-corta-duracion-en-el-cancer-de-recto-operable 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05253846/radioterapia-de-corta-duracion-seguida-de-quimioterapia-de-consolidacion-2021-001206-29 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT01349881/s0820-ensayo-sobre-la-prevencion-de-adenomas-y-de-un-segundo-tumor-primario 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06933251/inhibidor-de-pcsk9-e-inhibidor-de-pd-1-combinados-con-quimiorradioterapia-neoadyuvante-para-cancer-colorrectal-localmente-avanzado-pmmr-mss 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07651007/radioterapia-de-corta-duracion-seguida-de-nalirifox-mas-pucotenlimab-como-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado-de-alto-riesgo-con-mss-pmmr 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06364371/modelo-dinamico-de-integracion-multiomica-para-predecir-la-respuesta-al-tratamiento-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07430696/investigacion-del-efecto-antineoplasico-de-trishul-agente-ayurvedico-sobre-la-regresion-tumoral-del-cancer-de-recto-un-estudio-piloto 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06928584/radioterapia-hipofraccionada-combinada-con-inmunoterapia-frente-a-radioterapia-convencional-en-el-cancer-de-recto-localmente-recurrente 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07448077/radioterapia-de-corta-duracion-en-el-regimen-tnt-combinada-con-enlonstobart-para-el-cancer-colorrectal-localmente-avanzado-con-pmmr 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06653452/aplicacion-de-la-pet-rm-en-la-evaluacion-de-la-eficacia-de-la-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07686640/radioterapia-de-corta-duracion-seguida-de-capox-con-o-sin-iparomlimab-y-tuvonralimab-en-cancer-colorrectal-localmente-avanzado-pmmr-mss 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05245474/quimiorradiacion-neoadyuvante-prolongada-combinada-con-bloqueo-de-pd-1-para-el-cancer-colorrectal-localmente-avanzado-de-estadio-intermedio-bajo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06218433/deteccion-de-cancer-urotelial-en-individuos-con-sindrome-de-lynch-mediante-un-panel-de-adn-tumoral-en-orina-estudio-ls-uro 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04678011/un-protocolo-de-vigilancia-e-intervencion-personalizado-para-pacientes-con-poliposis-adenomatosa-familiar-que-se-han-sometido-a-procto-colectomia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07720245/eficacia-de-una-aplicacion-movil-de-autoevaluacion-de-la-salud-en-adultos-jovenes-y-de-mediana-edad-en-hong-kong 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07285356/estudio-para-evaluar-el-uso-de-guantes-quirurgicos-en-la-prevencion-de-la-neuropatia-periferica-inducida-por-oxaliplatino 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07089771/colonoscopia-virtual-frente-a-cromoendoscopia-con-tincion-en-la-colonoscopia-de-vigilancia-de-la-enfermedad-inflamatoria-intestinal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07503847/toma-de-decisiones-compartida-para-la-deteccion-del-cancer-colorrectal-en-familiares-de-primer-grado-de-alto-riesgo-de-entre-40-y-49-anos 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07741435/prueba-de-perfil-de-metilacion-methylscape-en-fluidos-corporales-para-la-deteccion-y-el-seguimiento-de-multiples-tipos-de-cancer-en-colombia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07198581/gestion-de-los-efectos-secundarios-de-la-quimioterapia-con-ayuda-de-la-inteligencia-artificial 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07631871/un-estudio-exploratorio-de-zanidatamab-en-tumores-avanzados-her2-positivos-tras-al-menos-una-linea-de-terapia-estandar 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07632313/intervencion-sobre-habitos-de-salud-para-pacientes-con-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06504901/evaluacion-de-la-eficacia-y-la-seguridad-de-un-anticuerpo-monoclonal-anti-pd-1-en-combinacion-con-rhg-csf-il-2-y-capeox-en-metastasis-hepaticas-sincronicas-de-cancer-colorrectal-inicialmente 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07638410/prehabilitacion-en-cirugia-oncologica-de-alto-riesgo 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05710809/el-proyecto-save-sarcopenia-y-vertigo-en-pacientes-ancianos-con-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06625788/caracterizacion-clinica-y-endoscopica-de-pacientes-con-multiples-adenomas-colorrectales-un-estudio-multicentrico-en-espana-estudio-espapolyp 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07775859/nomad-gi-estrategia-de-manejo-no-quirurgico-y-preservacion-de-organos-guiada-por-biomarcadores-tras-terapia-de-precision-en-canceres-gastrointestinales 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06973564/jab-23e73-en-participantes-adultos-con-tumores-solidos-avanzados-con-alteracion-de-kras 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07115875/mejora-de-las-tasas-de-colonoscopia-diagnostica-en-la-poblacion-nativa-americana 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04767568/estudio-exploratorio-sobre-la-relevancia-de-un-analisis-de-sangre-en-el-manejo-de-pacientes-en-el-contexto-del-cribado-del-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT03089268/caracteristicas-moleculares-e-histologicas-de-las-lesiones-serradas-del-colon 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07552467/subtema-cuatro-traslacion-clinica-de-farmacos-radiactivos-originales-para-el-diagnostico-y-tratamiento-de-precision-de-tumores-gastrointestinales-valor-de-la-aplicacion-clinica-de-la-imagen-pet 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07371832/evaluacion-en-un-solo-centro-del-sistema-de-grapado-robotico-sureform-habilitado-con-inteligencia-artificial-sureformtm-en-comparacion-con-el-sistema-de-grapado-convencional-para-procedimientos-de 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07194551/evaluacion-del-riesgo-de-cancer-de-utero-en-portadoras-del-sindrome-de-lynch-mediante-autotoma-de-muestras-vaginales-y-un-cuestionario-de-salud 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05902520/terapia-celular-adoptiva-que-utiliza-linfocitos-infiltrantes-tumorales-cd8-especificos-del-cancer-en-pacientes-adultos-con-tumores-solidos 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05935384/sibyl-observacion-de-la-respuesta-al-tratamiento-mediante-la-evaluacion-de-la-biopsia-liquida 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05696002/base-de-datos-prospectiva-y-observacional-de-cirugia-oncologica-avanzada-de-la-pelvis 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06154785/neumoperitoneo-de-baja-presion-estable-en-la-cirugia-de-cancer-colorrectal-estudio-cross 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT00843375/evaluacion-de-marcadores-en-heces-para-la-deteccion-temprana-de-cancer-colorrectal-y-adenomas 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07035002/estudio-sobre-la-seguridad-y-tolerabilidad-de-las-celulas-t-infiltrantes-tumorales-til-con-la-expresion-genica-pd-1-desactivada-en-el-tratamiento-del-cancer-colorrectal-avanzado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07412613/ak104-como-tratamiento-neoadyuvante-adyuvante-en-cancer-colorrectal-resecable-con-alta-inestabilidad-de-microsatelites-o-deficiencia-en-la-reparacion-de-errores-de-emparejamiento 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05643859/impacto-de-la-suplementacion-con-fibra-dietetica-en-el-microbioma-colonico 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05327452/evaluacion-de-estrategias-de-ejercicio-en-el-hogar-en-pacientes-con-cancer-pertenecientes-a-minorias-etnicas-y-con-pocos-recursos-que-estan-recibiendo-quimioterapia-el-estudio-thrive 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06824623/prevencion-de-las-reingresos-y-la-deshidratacion-en-pacientes-sometidos-a-ileostomia-electiva 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06643429/impacto-de-los-factores-ambientales-y-la-metabolomica-en-el-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06501482/quimioterapia-adyuvante-basada-en-folfiri-tras-la-reseccion-de-metastasis-hepaticas-que-responden-a-la-quimioterapia-neoadyuvante-con-folfiri 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05592886/una-nueva-formula-oral-sinbiotica-para-reducir-la-recurrencia-de-adenomas-avanzados-y-los-marcadores-geneticos-bacterianos-relacionados-con-la-neoplasia-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07696169/evolucion-de-la-enfermedad-y-factores-de-riesgo-de-los-canceres-prevalentes-relacionados-con-el-sida 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07705139/la-importancia-de-los-ruidos-intestinales-en-la-evaluacion-de-la-recuperacion-de-la-funcion-intestinal-postoperatoria-en-pacientes-con-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04364373/diseccion-de-ganglios-linfaticos-d2-frente-a-d3-en-el-cancer-de-colon-izquierdo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07711509/trasplante-autologo-de-microbiota-fecal-para-la-recuperacion-de-la-funcion-anal-tras-la-reconexion-intestinal-despues-de-una-ileostomia-en-pacientes-con-cancer-de-recto 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06722209/diferentes-protocolos-de-preparacion-intestinal-mediante-colonoscopia-realizados-el-mismo-dia-impacto-en-la-adherencia-del-paciente-la-tolerabilidad-y-la-calidad-de-la-limpieza-intestinal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05713903/colecistectomia-derecha-laparoscopica-frente-a-colecistectomia-abierta-en-el-cancer-de-colon-derecho 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07307690/programas-de-ejercicio-fisico-de-8-semanas-frente-a-12-semanas-en-pacientes-con-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07732894/ejercicio-aerobico-e-imagenes-guiadas-en-el-sindrome-de-la-reseccion-anterior-baja 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07226115/aprendizaje-predictivo-basado-en-el-empalme-para-la-evaluacion-individual-de-la-quimioterapia-en-el-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06391905/inhibidores-de-pcsk9-en-combinacion-con-estrategias-de-tratamiento-avanzadas-para-el-tratamiento-del-cancer-colorrectal-avanzado-con-pmmr-mss 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT02000141/el-estudio-australiano-sobre-neoplasias-mucosas-avanzadas-del-colon-y-reseccion-endoscopica 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07076966/comparacion-de-la-tasa-de-deteccion-de-adenomas-en-la-colonoscopia-de-vigilancia-en-3d-frente-a-la-colonoscopia-de-vigilancia-en-2d 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05645510/estudio-living-with-chronic-cancer-treatments-longeviti 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07317505/un-estudio-de-fase-i-de-jmt108-en-participantes-con-tumores-solidos-avanzados 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07179692/terapia-car-t-dirigida-contra-el-cea-en-tumores-solidos-avanzados-cea-positivos 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05338307/investigacion-preliminar-sobre-la-suplementacion-con-hidroxibutirato-en-la-prevencion-del-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT03853733/radioterapia-paliativa-hipofraccionada-en-pacientes-con-cancer-de-recto-avanzado-no-operable 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07152886/los-efectos-de-clostridium-butyricum-sobre-los-eventos-adversos-durante-la-quimioterapia-adyuvante-para-el-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07338643/el-efecto-complementario-de-la-inteligencia-artificial-en-la-deteccion-de-lesiones-precancerosas-en-el-cancer-de-colon-proximal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06886022/diagnostico-tratamiento-y-prevencion-del-cancer-colorrectal-en-el-contexto-de-un-metabolismo-lipidico-anormal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04313114/el-ensayo-prime-crc-para-promover-la-deteccion-del-cancer-colorrectal-en-comunidades-rurales 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT02078804/colonoscopia-y-prueba-de-sangre-oculta-en-heces-fit-como-pruebas-de-deteccion-del-cancer-colorrectal-en-la-poblacion-con-riesgo-promedio 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06637215/investigacion-clinica-sobre-el-modelo-de-tratamiento-de-la-cirugia-ambulatoria-para-el-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06646445/pembrolizumab-neoadyuvante-con-una-estrategia-de-observacion-y-espera-para-el-cancer-colorrectal-localizado-con-dmmr-msi-h-estudio-premices 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07245173/ensayo-clinico-aleatorizado-y-controlado-que-compara-la-incidencia-de-formacion-de-asas-en-las-tecnicas-de-colonoscopia 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07361107/evaluacion-de-la-respuesta-inmune-circulatoria-tras-el-tratamiento-con-histosonics-en-el-cancer-colorrectal-echo-crc 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06986538/amplitud-de-la-diseccion-de-los-ganglios-linfaticos-en-el-cancer-colorrectal-avanzado-del-lado-derecho 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06049758/diseccion-de-los-ganglios-linfaticos-en-los-niveles-d2-frente-a-d3-en-la-hemicolectomia-derecha-laparoscopica 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05109468/evaluacion-de-la-calidad-de-vida-sexual-de-los-pacientes-despues-del-tratamiento-del-cancer-anal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06881563/morfina-intratecal-frente-a-analgesia-epidural-para-la-cirugia-laparoscopica-de-colon 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06990633/sindrome-de-lynch-en-la-cirugia-del-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06329102/base-de-datos-de-colectomia-derecha-para-el-cancer-de-colon-rcc-tecnica-quirurgica-via-de-acceso-y-calidad-de-la-muestra 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07562711/estudio-aleatorizado-sobre-la-metilacion-del-ctdna-plasmatico-para-guiar-las-decisiones-sobre-la-quimioterapia-adyuvante-en-pacientes-con-cancer-colorrectal-t3n0-de-alto-riesgo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05534087/estudio-de-plataforma-sobre-quimioterapia-adyuvante-dirigida-por-el-adn-tumoral-circulante-en-el-cancer-de-colon-kcsg-co22-12 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07167420/reconstruccion-funcional-de-la-valvula-ileocecal-mediante-la-tecnica-rise 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06577610/el-impacto-de-un-programa-de-seguimiento-mediante-colonoscopia-en-el-desempeno-de-los-endoscopistas 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05943444/comparacion-de-la-funcion-anal-postoperatoria-entre-las-tecnicas-de-parks-y-bacon-en-el-cancer-de-recto-inferior 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07391618/estudio-clinico-sobre-el-tratamiento-de-primera-linea-del-cancer-colorrectal-avanzado-con-la-administracion-simultanea-de-levozolinato-para-inyeccion-y-5-fu 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT03708952/estilo-de-vida-y-habitos-alimenticios-en-relacion-con-las-lesiones-precursoras-del-cancer-colorrectal-y-las-enfermedades-cardiometabolicas 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06685497/colorectum-sistema-digital-para-la-mejora-de-la-calidad-en-el-seguimiento-postoperatorio-del-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04103567/determinacion-de-los-factores-microbiologicos-asociados-con-una-respuesta-deficiente-al-tratamiento-neoadyuvante-en-los-canceres-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT03413254/laparoscopia-de-segunda-y-tercera-evaluacion-en-pacientes-con-cancer-de-colon-pt4-para-la-deteccion-temprana-de-metastasis-peritoneales 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05952947/hryz-t101-inyeccion-para-tumores-solidos-positivos-para-el-vph-18 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06143644/valor-predictivo-del-seguimiento-postoperatorio-del-adn-tumoral-circulante-para-la-recurrencia-del-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06443996/asociacion-entre-la-calidad-del-sueno-y-el-estado-mental-con-la-recurrencia-temprana-y-el-pronostico-del-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05493033/anastomosis-intracorporea-frente-a-anastomosis-extracorporea-tras-colectomia-derecha-laparoscopica 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07656740/manejo-no-quirurgico-y-seguimiento-tras-la-inmunoterapia-en-el-cancer-colorrectal-y-otros-canceres-del-tracto-gastrointestinal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07433283/nanoparticulas-de-carbono-cargadas-con-hierro-en-el-tratamiento-de-tumores-solidos-avanzados 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06710847/un-estudio-para-investigar-la-seguridad-la-farmacocinetica-y-la-eficacia-preliminar-de-gsk4418959-solo-o-en-combinacion-con-otros-agentes-antineoplasicos-en-participantes-con-tumores-solidos 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06601985/exploracion-del-efecto-del-reservorio-ileocolico-j-pouch-en-la-cirugia-de-preservacion-anorrectal-para-el-cancer-de-recto-ultra-bajo 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07447050/riluzol-para-prevenir-la-disfuncion-cognitiva-en-pacientes-con-cancer-que-reciben-quimioterapia-refocus-ensayo-piloto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06923787/efecto-de-la-infusion-intravenosa-de-lidocaina-en-el-periodo-perioperatorio-sobre-el-curso-postoperatorio-y-la-respuesta-inmune-en-pacientes-sometidos-a-cirugia-para-el-tratamiento-del-cancer-de 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT03765450/farmacocinetica-del-infliximab-y-concentraciones-de-tnf-en-suero-heces-y-mucosa-colonica-en-la-colitis-ulcerosa-aguda-y-grave 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06738173/herramienta-de-diagnostico-basada-en-el-microbioma-para-la-deteccion-del-cancer-colorrectal-guilti 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07204665/este-estudio-se-ha-disenado-para-respaldar-la-hipotesis-de-que-la-cirugia-de-emergencia-en-un-tumor-que-causa-obstruccion-del-colon-es-mejor-que-la-colocacion-de-un-stent-paliativo-debido-a-mejores 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06583564/el-efecto-pronostico-de-la-cirugia-guiada-por-fluorescencia-con-verde-de-indocianina-icg-en-la-supervivencia-libre-de-enfermedad-dfs-del-cancer-colorrectal-en-estadio-iii 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05511688/cohorte-nacional-de-canceres-colorrectales-con-inestabilidad-de-microsatelites 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06759844/eficacia-de-un-programa-de-gestion-de-la-salud-a-traves-de-dispositivos-moviles-para-pacientes-supervivientes-de-cancer-colorrectal-con-enfermedades-cronicas 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07523152/evaluacion-de-la-calidad-de-vida-sexual-tras-el-tratamiento-local-radioterapia-con-o-sin-cirugia-en-pacientes-con-cancer-pelvico-hpv-positivo-un-estudio-descriptivo-longitudinal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06403735/un-estudio-clinico-de-fase-i-de-qlc1101-en-pacientes-con-tumores-solidos-avanzados 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05364489/estudio-clinico-de-eficacia-seguridad-y-exploracion-del-uso-de-bevacizumab-en-combinacion-con-oxaliplatino-y-tas-102-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-avanzado 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06973083/eficacia-y-seguridad-de-la-diseccion-endoscopica-submucosa-asistida-por-robot-para-neoplasias-colorrectales 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05694559/conectando-a-las-familias-negras-de-houston-texas-con-el-asesoramiento-genetico-sobre-cancer-hereditario-las-pruebas-geneticas-y-las-pruebas-en-cascada-mediante-el-uso-de-una-herramienta-sencilla-de 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06452745/diagnostico-precoz-del-cancer-colorrectal-basado-en-un-perfil-metabolomico-no-invasivo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06069960/salt-para-metastasis-hepaticas-irresecables-de-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05663203/una-intervencion-diadica-basada-en-la-web-para-el-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06617169/escalado-de-dosis-de-mnpr-101-pcta-177lu-en-tumores-solidos 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04701853/entrenamiento-especifico-tras-la-cirugia-de-estoma 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04929028/terapia-adaptada-para-el-cancer-anal-asociado-al-vih-de-alto-riesgo-y-de-bajo-riesgo 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07797361/evaluacion-de-la-tecnologia-de-tincion-inteligente-y-versatil-vist-y-la-imagenologia-espectral-flexible-sfi-para-la-deteccion-y-la-caracterizacion-optica-de-lesiones-colorrectales-un-estudio 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07113717/programa-de-hospitalizacion-domiciliaria-postoperatoria-tras-cirugia-de-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05955196/estudio-de-los-inhibidores-de-cd47-sirp-en-el-microambiente-inmunitario-del-cancer-de-colon 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07376980/el-ensayo-smart-anastomosis-modificada-con-un-solo-punto-de-sutura-en-la-reseccion-anterior-baja-laparoscopica-o-robotica-para-el-cancer-de-recto 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04644068/estudio-de-azd5305-como-terapia-unica-y-en-combinacion-con-agentes-antineoplasicos-en-pacientes-con-tumores-solidos-avanzados 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04593407/reseccion-endoscopica-de-la-mucosa-frente-a-diseccion-endoscopica-submucosa-para-lesiones-colorectales-laterales-de-gran-extension 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05485077/un-estudio-de-cohortes-prospectivo-sobre-el-cribado-del-cancer-colorrectal-en-la-poblacion-comunitaria 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06751966/vacuna-peptidica-basada-en-neoantigenos-y-terapia-convencional-de-tercera-linea-para-el-ccrc-que-progresa-tras-el-tratamiento-de-segunda-linea 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05224518/intervencion-con-ejercicio-para-mejorar-la-calidad-de-vida-en-pacientes-con-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07106359/evaluacion-inicial-de-una-intervencion-conductual-sobre-los-servicios-de-asesoramiento-genetico-para-familias-con-riesgo-de-sindrome-de-lynch 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06407518/midazolam-oral-preoperatorio-para-el-alivio-del-dolor-postoperatorio-en-pacientes-con-cancer-colorrectal-que-presentan-trastornos-del-sueno-o-ansiedad 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06715332/estudio-prospectivo-sobre-el-uso-de-unas-nuevas-tijeras-bipolares-en-la-diseccion-endoscopica-submucosa-del-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06191185/mejorando-el-cumplimiento-de-la-colonoscopia-mediante-equipos-y-tecnologia 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07414082/talin-1-serico-y-cripto-1-en-el-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06822634/avances-en-las-tecnicas-de-imagen-para-evaluar-la-respuesta-en-el-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05662020/un-estudio-para-evaluar-la-inmunogenicidad-y-la-seguridad-de-la-vacuna-contra-el-vph-en-participantes-femeninas-sanas-de-entre-9-y-26-anos-en-china 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07050485/postbioticos-para-mitigar-la-disbiosis-postoperatoria-en-la-cirugia-de-cancer-gastrointestinal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05929365/enfoque-innovador-para-detectar-lesiones-recurrentes-de-cancer-colorrectal-mediante-la-vigilancia-a-traves-del-analisis-de-mutaciones-y-el-fenotipo-clinico 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06946615/estudio-clinico-exploratorio-de-terapia-car-dc-y-car-t-dirigida-contra-claudin18-2-en-cancer-colorrectal-avanzado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05939661/un-estudio-multicentrico-de-un-solo-brazo-de-fase-ii-para-evaluar-la-seguridad-y-la-eficacia-de-la-terapia-neoadyuvante-total-en-pacientes-con-cancer-de-recto-ct2 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05464030/adc-anti-ceacam5-m9140-en-tumores-solidos-avanzados-proceade-crc-01 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07134296/programa-de-preservacion-del-recto-en-el-cancer-colorrectal-guiado-por-resonancia-magnetica-rm 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04403022/estudio-de-exencion-para-dispositivos-de-investigacion-da-vinci-sp-r-en-procedimientos-de-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06914726/apoyo-a-la-toma-de-decisiones-clinicas-centrado-en-el-paciente-para-sindromes-hereditarios-de-cancer 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05217940/deteccion-de-mujeres-con-antecedentes-de-infeccion-por-vph-para-el-cribado-de-neoplasias-anales 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT00451022/estudio-de-seguimiento-de-sujetos-que-participaron-previamente-en-estudios-de-transferencia-genica-mediante-vectores-poxvirales 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07595107/concordancia-entre-las-recomendaciones-de-un-modelo-de-lenguaje-extenso-y-las-de-un-equipo-multidisciplinario-en-el-cancer-de-recto 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07464626/terapia-artistica-virtual-frente-a-terapia-artistica-presencial-para-la-ansiedad-el-bienestar-psicologico-y-la-calidad-del-sueno-en-pacientes-con-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07192055/la-autotoma-de-muestras-para-optimizar-los-resultados-en-lesiones-anales 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05007015/irrigacion-transanal-para-el-manejo-del-sindrome-de-evacuacion-incompleta-del-recto-lars 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT02448173/un-estudio-multicentrico-de-inmunoterapia-activa-especifica-con-oncovax-r-en-pacientes-con-cancer-de-colon-en-estadio-ii 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06710639/efectos-del-entrenamiento-cognitivo-sobre-el-deterioro-cognitivo-inducido-por-la-quimioterapia-en-pacientes-con-cancer-de-colon-sometidos-a-tratamiento-quimiocerebro-en-pacientes-oncologicos-con 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05961969/reseccion-interesfinterica-mediante-tecnica-robotica-abordando-el-tumor-desde-la-parte-superior 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06057831/pet-mri-en-el-cancer-de-recto 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06520683/bloqueo-adyuvante-de-pd-1-para-el-cancer-colorrectal-en-estadio-ii-de-alto-riesgo-con-dmmr-msi-h 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05448846/programa-de-ejercicios-para-pacientes-de-edad-avanzada-con-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06907095/evaluacion-de-una-cohorte-para-la-deteccion-temprana-del-cancer-en-individuos-de-alto-riesgo-mediante-el-analisis-de-fluidos-corporales 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07369531/el-impacto-de-la-anastomosis-coloanal-de-dos-etapas-segun-la-tecnica-de-turnbull-cutait-en-la-supervivencia-sin-ostomia-en-la-cirugia-rectal-baja-con-preservacion-del-ano 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05748145/metronidazol-como-terapia-preoperatoria-en-el-ccrc-fusometro-001 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06751329/un-estudio-de-dm002-en-pacientes-con-tumores-solidos-avanzados 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06287814/evaluacion-francesa-de-la-enfermedad-residual-minima-mediante-biopsias-liquidas-en-pacientes-con-cancer-colorrectal-en-estadio-iii-french-mrd-crc 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07427537/exploracion-de-los-microarn-circulantes-como-biomarcadores-de-la-neuropatia-periferica-inducida-por-la-quimioterapia-un-estudio-en-pacientes-con-cancer 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06236633/seguridad-y-eficacia-del-preacondicionamiento-isquemico-mediante-la-embolizacion-de-la-arteria-mesenterica-inferior-en-la-cirugia-de-tumores-del-recto-inferior-y-medio 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06043999/quimioterapia-de-rescate-frente-a-reseccion-mesorrectal-total-en-pacientes-con-cancer-de-recto-en-estadio-local-que-requieren-reseccion-quirurgica 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06712095/examen-con-capsula-endoscopica-en-pacientes-con-sindrome-de-lynch 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06889883/desarrollo-y-validacion-de-un-analisis-de-sangre-para-el-diagnostico-precoz-del-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05623787/valor-diagnostico-de-la-resonancia-magnetica-con-ponderacion-en-difusion-en-neoplasias-colorrectales-y-apendiculares-de-alto-riesgo 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07124884/5-fluorouracilo-mas-panitumumab-anti-egfr-y-sotorasib-inhibidor-de-kras-g12c-en-el-tratamiento-de-primera-linea-de-pacientes-que-no-son-candidatos-para-una-quimioterapia-doble-o-triple-en-el-caso-de 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06529523/tislelizumab-en-pacientes-con-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04842812/tils-car-tils-modificadas-geneticamente-para-el-tratamiento-de-tumores-solidos-avanzados 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05234177/estudio-de-seguimiento-del-cancer-colorrectal-de-tempus-un-estudio-de-elaboracion-de-perfiles-de-biomarcadores-de-ctdna-en-pacientes-con-cancer-colorrectal-mediante-ensayos-de-ngs 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT02172651/vitamina-d-en-pacientes-con-cancer-de-colon-en-estadio-i-iii-o-metastasis-hepaticas-resecables-de-cancer-de-colon 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07108517/una-intervencion-manualizada-para-promover-el-crecimiento-postraumatico-en-personas-con-cancer-en-grecia-ic-growth 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05000697/quimiorradiacion-y-quimioterapia-de-consolidacion-con-o-sin-oxaliplatino-para-el-cancer-de-recto-distal-y-estrategia-de-observacion-y-espera 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06746298/un-estudio-prospectivo-sobre-la-evaluacion-basada-en-el-perfilado-de-expresion-genica-de-la-eficacia-de-la-terapia-neoadyuvante-para-el-cancer-de-recto 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT03908684/espectroscopia-por-ultrasonido-como-indicadores-tempranos-de-la-respuesta-al-tratamiento-con-radiacion-en-cancer-de-prostata-recto-y-cabeza-y-cuello 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07189663/estudio-sobre-la-correlacion-entre-los-niveles-de-acido-sialico-en-suero-y-heces-y-las-caracteristicas-del-tumor-asi-como-la-dehiscencia-de-la-anastomosis-postoperatoria-en-pacientes-con-tumores 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07566559/estudio-observacional-sobre-la-terapia-neoadyuvante-en-el-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05202314/camrelizumab-en-combinacion-con-quimioterapia-neoadyuvante-tras-la-colocacion-de-un-stent-en-pacientes-con-cancer-colorrectal-obstructivo-del-lado-izquierdo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05732389/inmunoterapia-en-pacientes-con-cancer-de-recto-en-estadio-temprano-y-dmmr 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT03925662/mebendazol-como-tratamiento-adyuvante-para-el-cancer-de-colon 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05434026/base-de-datos-china-de-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT03200834/comparacion-de-la-diseccion-de-ganglios-linfaticos-d2-frente-a-d3-en-el-cancer-de-colon-derecho-ricon 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06280495/serplulimab-y-bevacizumab-como-tratamiento-neoadyuvante-en-combinacion-con-folfox-frente-a-folfox-solo-en-pacientes-con-cancer-colorrectal-ccr-ras-braf-wt-y-pmmr-mss 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05051046/cribado-del-cancer-colorrectal-mediante-colonoscopia-bajo-hipnosis 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT02997293/impacto-del-sistema-de-recuperacion-mejorada-tras-la-cirugia-en-la-cirugia-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06534762/milaberon-en-tumores-solidos-avanzados-un-estudio-clinico-abierto-multicentrico 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04666727/papel-de-la-dieta-en-el-microbioma-del-sistema-digestivo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07296887/estudio-de-la-herramienta-care-objetivo-3 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05529615/quimioterapia-adyuvante-guiada-por-el-adn-tumoral-circulante-en-el-cancer-de-colon 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04006951/desarrollo-de-una-base-de-datos-clinica-y-biologica-en-el-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07612436/ainc-intervencion-basada-en-inteligencia-artificial-para-mejorar-la-realizacion-de-colonoscopias 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05779553/evaluacion-del-marcador-tumoral-endotelial-serico-1-como-posible-biomarcador-para-el-diagnostico-del-cancer-colorrectal-y-la-progresion-tumoral 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07069556/estudio-de-seguimiento-de-colosense-tras-su-aprobacion 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06827366/intervencion-sobre-el-estilo-de-vida-en-participantes-del-programa-frances-de-deteccion-del-cancer-colorrectal-life-screen 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06356597/tislelizumab-con-fruquintinib-y-metronidazol-en-pacientes-con-cancer-colorrectal-avanzado-con-reparacion-del-desajuste-de-apareamiento-funcional-o-estabilidad-de-microsatelites-un-ensayo-clinico 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06434376/pacientes-con-cancer-colorrectal-mrd-positivo-tratados-con-una-combinacion-de-inmunomodulacion-personalizada 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05579353/el-papel-del-circ-lrba-exosomico-y-del-eje-de-senalizacion-451-crtc2-en-el-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07766044/seguimiento-de-un-ano-de-la-formacion-de-hernias-incisionales-en-comparacion-entre-el-cierre-laparotomico-manual-y-el-asistido-por-dispositivo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06686576/un-estudio-de-ql1706-como-tratamiento-neoadyuvante-en-participantes-con-cancer-colorrectal-dmmr-msi-h-susceptible-de-reseccion-quirurgica-y-que-no-han-recibido-tratamiento-previo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07529301/predictores-funcionales-y-respiratorios-de-los-resultados-tempranos-postoperatorios 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07347158/eficacia-de-la-educacion-sanitaria-como-intervencion-de-enfermeria-para-mejorar-la-calidad-de-vida-y-reducir-los-sintomas-de-ansiedad-y-depresion-en-pacientes-con-ostomia-tras-una-cirugia-digestiva 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06878131/precision-mrd-estudio-observacional-prospectivo-sobre-terapia-sistemica-dirigida-por-biomarcadores-en-pacientes-con-cancer-colorrectal-y-enfermedad-residual-minima 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07548736/efecto-beneficioso-del-enema-de-dexametasona-en-la-lesion-rectal-aguda-inducida-por-la-radiacion 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04201717/anastomosis-intracorporea-frente-a-anastomosis-extracorporea-en-el-cancer-de-colon-izquierdo 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06326879/un-estudio-comparativo-entre-pacientes-con-cancer-colorrectal-de-inicio-temprano-y-pacientes-con-cancer-colorrectal-de-inicio-tardio 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT03975491/el-ensayo-clinico-sobre-el-ejercicio-y-el-tratamiento-del-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07219537/un-estudio-sobre-la-obtencion-de-imagenes-del-tracto-gastrointestinal-inferior-mediante-una-capsula-retro-tce 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07576049/cancer-colorrectal-experiencia-en-un-unico-centro 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04956640/estudio-de-ly3537982-en-pacientes-con-cancer-que-presentan-una-mutacion-genetica-especifica-kras-g12c 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07198945/seguimiento-de-seis-o-doce-meses-tras-la-reseccion-de-un-polipo-grande-de-colon 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT02955940/un-estudio-abierto-para-facilitar-el-acceso-continuado-al-tratamiento-para-los-sujetos-que-participaron-previamente-en-estudios-de-ruxolitinib 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT03793335/estrategias-individualizadas-y-personalizadas-para-la-prevencion-de-precision-del-cancer-gastrico-y-del-cancer-colorrectal-en-la-comunidad 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT01538550/estudio-piloto-de-un-programa-nacional-de-deteccion-del-cancer-colorrectal-en-noruega 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07402486/un-estudio-prospectivo-de-fase-ii-sobre-la-braquiterapia-con-el-aplicador-maastro-para-el-cancer-de-recto 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06096688/descubriendo-nuevos-objetivos-para-la-reduccion-del-riesgo-de-cancer-colorrectal-y-de-endometrio 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07420010/un-estudio-clinico-abierto-de-un-solo-brazo-para-evaluar-la-seguridad-la-tolerabilidad-el-perfil-farmacocinetico-y-la-eficacia-preliminar-de-la-inyeccion-de-celulas-kt032-en-pacientes-con-tumores 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT02945033/estudio-comparativo-de-aspirina-frente-a-placebo-en-pacientes-con-cancer-de-colon-en-estadio-iii-o-ii-de-alto-riesgo-y-con-mutacion-en-pi3k-tras-reseccion-quirurgica 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05215535/resonancia-magnetica-hepatica-antes-del-tratamiento-del-cancer-de-recto-un-ensayo-clinico-aleatorizado-y-controlado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04075305/el-estudio-momentum-evaluacion-de-multiples-resultados-de-la-radioterapia-con-el-acelerador-lineal-guiado-por-resonancia-magnetica-mr-linac 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06905925/el-efecto-del-programa-de-capacitacion-impartido-a-pacientes-con-colostomia-permanente-sobre-la-autoeficacia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06396806/un-estudio-clinico-prospectivo-aleatorizado-abierto-con-control-paralelo-disenado-para-evaluar-la-superioridad-de-la-sigmoidectomia-radical-para-el-cancer-de-sigmoide-frente-a-la-sigmoidectomia 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05257135/una-base-de-datos-clinico-biologica-sobre-la-caquexia-en-pacientes-con-cancer-de-colon 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07688135/estudio-piloto-quicksilver-ii 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07260526/terapia-neoadyuvante-total-adaptada-a-la-respuesta-guiada-por-la-quimioterapia-de-induccion-en-el-cancer-de-recto-inferior-de-riesgo-temprano-e-intermedio-para-la-implementacion-de-una-estrategia-de 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06528990/intervencion-de-telemedicina-para-el-autocuidado-de-pacientes-con-ostomia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07031011/celulas-pd-1-m1-nk-en-el-tratamiento-del-cancer-gastrico-o-colorrectal-avanzado 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04832763/aspectos-medicos-y-psicosociales-en-adolescentes-y-adultos-jovenes-con-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06772844/dynamics-lynch-analisis-de-la-metilacion-del-adn-en-heces-para-el-cribado-del-cancer-colorrectal-asociado-al-sindrome-de-lynch 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT02704520/grado-de-regresion-tumoral-mediante-resonancia-magnetica-mrtrg-como-un-nuevo-biomarcador-ensayo-no-ctimp-de-fase-iii 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05693649/enfoques-de-economia-conductual-para-la-deteccion-del-cancer-colorrectal-a-nivel-poblacional 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04967183/polyprev-estudio-para-comparar-la-prueba-inmunoquimica-fecal-con-la-vigilancia-endoscopica-tras-la-reseccion-de-adenomas-avanzados-en-los-programas-de-deteccion-del-cancer-colorrectal-mediante-la 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06641310/ensayo-clinico-sobre-terapia-con-ejercicio-en-poliposis-adenomatosa-familiar-paf 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05793554/classica-validacion-de-la-ia-en-la-clasificacion-de-cancer-en-tiempo-real-durante-la-cirugia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07523035/cohorte-de-adenomas-colorrectales 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07649473/ql1706-en-combinacion-con-la-terapia-estandar-para-la-terapia-de-conversion-de-metastasis-hepaticas-sincronicas-procedentes-del-cancer-de-colon-un-estudio-exploratorio-multicentrico-y-de-un-solo-brazo 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07106034/terapia-estandar-de-segunda-linea-con-ongericimab-y-toripalimab-en-cancer-colorrectal-pmmr-mss-un-ensayo-de-fase-ii-de-un-solo-brazo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT03191110/el-estudio-colon-cohorte-de-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT03551951/deteccion-de-celulas-tumorales-y-adn-en-sangre-orina-y-medula-osea 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06606912/efecto-predictivo-de-la-grasa-abdominal-y-el-area-muscular-calculados-a-partir-de-una-tomografia-computarizada-tc-abdominal-en-pacientes-con-cancer-gastrico 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT02813824/efecto-de-la-quimioprevencion-con-aspirina-a-dosis-bajas-sobre-la-aparicion-de-nuevos-o-recurrentes-adenomas-colorrectales-en-pacientes-con-sindrome-de-lynch 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05939687/colocacion-profilactica-de-malla-durante-el-cierre-del-estoma-tras-una-reseccion-anterior-baja 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05401318/adaptacion-del-tratamiento-en-el-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05750329/trasplante-hepatico-con-reseccion-hepatica-en-dos-etapas-en-cancer-de-higado-irresecable-metastasis-o-enfermedad-hepatica-en-etapa-terminal-ltlr-lc 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04871399/reseccion-mesocolica-completa-en-comparacion-con-la-cirugia-convencional-para-el-cancer-de-colon-derecho 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05908643/un-ensayo-clinico-de-fase-i-en-humanos-con-pttl-en-cancer-colorrectal-avanzado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06107920/quimioterapia-neoadyuvante-para-el-cancer-de-colon-obstructivo-en-pacientes-que-reciben-tratamiento-inicial-con-colostomia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07579780/bloqueo-del-plexo-hipogastrico-superior-durante-la-cirugia-laparoscopica-del-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT01937780/estudio-de-radioterapia-en-el-cancer-anal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07178613/evaluacion-de-la-seguridad-y-eficacia-de-la-administracion-de-serina-en-combinacion-con-farmacos-a-base-de-fluorouracilo 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07669298/vigilancia-activa-frente-a-quimiorradioterapia-adyuvante-en-cancer-de-recto-t1-de-riesgo-intermedio-tras-reseccion-local 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07676461/atlas-del-microbioma-oral-fecal-e-intratumoral-en-pacientes-colombianos-con-tumores-solidos-avanzados-que-reciben-inmunoterapia-de-primera-linea 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04815525/el-riesgo-a-largo-plazo-de-neoplasia-colorrectal-avanzada-despues-de-la-colonoscopia-un-estudio-de-cohorte-basado-en-la-poblacion-en-hong-kong 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06751953/vacuna-con-celulas-dendriticas-cargadas-con-neoantigenos-y-terapia-convencional-de-tercera-linea-para-el-ccrc-que-progresa-tras-el-tratamiento-de-segunda-linea 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06090643/investigacion-sobre-la-implementacion-de-estrategias-para-aumentar-las-tasas-de-deteccion-del-cancer-colorrectal-en-grupos-de-bajos-ingresos-y-minorias-etnicas 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06791616/intervalos-de-seguimiento-tras-la-reseccion-por-partes-de-lesiones-colorrectales-no-pediculadas-20-mm 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06815406/tasa-de-recurrencia-tras-la-reseccion-endoscopica-de-tumores-de-crecimiento-lateral-de-tipo-granular-lst-g-del-colon-y-el-recto-reseccion-endoscopica-de-la-mucosa-frente-a-diseccion-endoscopica 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07469709/un-estudio-de-factores-biologicos-geneticos-y-constitucionales-y-de-la-monitorizacion-no-invasiva-para-evaluar-los-riesgos-de-cancer-individuales 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07189520/1-safe-ai-onco-track-genai-multimodal-para-la-deteccion-temprana-de-la-enfermedad-residual-minima-y-la-recurrencia-en-la-oncologia-gastrointestinal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05826743/evaluacion-de-la-seguridad-y-eficacia-del-colo-bt-como-tratamiento-alternativo-a-la-ileostomia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06208371/tratamiento-local-frente-a-quimioterapia-paliativa-en-pacientes-con-cancer-colorrectal-y-10-o-mas-metastasis-hepaticas 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06040632/improve-pt1-asignacion-precisa-de-la-reseccion-complementaria-en-el-cancer-colorrectal-en-estadio-temprano 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06710561/seguridad-tolerabilidad-farmacocinetica-y-eficacia-preliminar-del-spn01-inyectable-en-la-fase-i 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT00883792/la-iniciativa-del-norte-de-europa-sobre-el-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06917794/desarrollo-de-puntuaciones-de-riesgo-poligenico-en-pacientes-con-cancer-de-colon-mediante-el-estudio-de-la-ascendencia-y-la-diversidad-en-los-mapas-geneticos-de-la-poblacion-brasilena-proyecto-origem 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07726966/betacianina-para-el-diagnostico-precoz-y-la-recuperacion-de-las-fugas-anastomoticas-tras-la-cirugia-de-cancer-de-recto-un-ensayo-prospectivo-controlado-y-realizado-en-un-solo-centro 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07609901/vacunacion-preventiva-con-celulas-dendriticas-para-portadores-del-sindrome-de-lynch 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04008407/eus-fna-para-la-lesion-submucosa-lateral-lsl-del-cancer-colorrectal-mediante-una-estrategia-selectiva-un-estudio-de-cohorte-prospectivo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07114627/impacto-del-genotipo-ces1-en-la-exposicion-a-capecitabina-en-pacientes-con-cancer 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06004245/un-estudio-para-evaluar-la-seguridad-la-farmacocinetica-y-la-actividad-antitumoral-de-vvd-133214-como-monoterapia-y-en-combinacion-en-participantes-con-tumores-solidos-avanzados 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06802172/efecto-del-horario-de-las-comidas-durante-el-tratamiento-del-cancer-en-pacientes-de-alaska-un-ensayo-clinico-aleatorizado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04137107/duloxetina-para-prevenir-la-neuropatia-periferica-inducida-por-oxaliplatino-en-pacientes-con-cancer-colorrectal-en-estadio-ii-iii 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07343791/estudio-de-eficacia-y-seguridad-de-la-terapia-con-celulas-dc-cik-combinada-con-epaloliposida-vortexil-y-regorafenib-como-tratamiento-de-tercera-linea-para-el-cancer-colorrectal-avanzado 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07649057/un-estudio-sobre-una-prueba-de-orina-para-la-deteccion-del-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT02647099/aspirina-a-baja-dosis-como-terapia-adyuvante-en-el-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05495048/cirugia-laparoscopica-convencional-versus-cirugia-laparoscopica-transvaginal-asistida-por-robot-noses-para-la-hemicolectomia-derecha 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07071454/prevencion-del-cancer-colorrectal-de-inicio-temprano-en-el-sistema-de-salud-para-veteranos-va 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06497985/un-estudio-de-tucidinostat-en-combinacion-con-sintilimab-y-bevacizumab-en-pacientes-con-cancer-colorrectal-mss-pmmr 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07562659/estudio-controlado-aleatorizado-de-la-quimioterapia-adyuvante-guiada-por-la-metilacion-del-ctdna-plasmatico-en-el-cancer-colorrectal-en-estadio-i-estadio-ii-de-bajo-riesgo 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07215000/ensayo-coop-sit-opciones-de-limpieza-en-el-entorno-ambulatorio-para-mejorar-la-tolerancia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05410977/recoleccion-de-muestras-de-sangre-y-heces-para-detectar-cancer-colorrectal-o-neoplasia-avanzada-en-pacientes-con-sindrome-de-lynch 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05362344/deteccion-del-cancer-colorrectal-en-la-fibrosis-quistica 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT02669992/cierre-de-la-ileostomia-en-asa-anastomosis-realizada-con-grapadora-o-sutura-manual-cierre-de-la-zona-de-la-ostomia-con-sutura-o-malla 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06589388/monitorizacion-del-ctdna-para-predecir-la-eficacia-de-tnt-en-el-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06385418/tratamiento-con-fluorouracilo-mediante-enema-para-el-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04751435/desarrollo-de-nuevos-materiales-educativos-sobre-las-pruebas-geneticas-para-un-grupo-diverso-de-pacientes-con-cancer 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06819215/estudio-clinico-de-fase-i-ii-para-evaluar-las-tabletas-de-vb15010-en-pacientes-con-tumores-solidos-avanzados 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT03731130/ensayo-observacional-prospectivo-para-evaluar-la-calidad-de-vida-tras-la-radioterapia-o-quimiorradioterapia-neoadyuvante-seguida-de-cirugia-en-pacientes-con-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06358053/crte7a2-01-celulas-tcr-t-para-canceres-avanzados-positivos-para-el-vph-16 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06314646/transseccion-transanal-y-anastomosis-con-un-solo-grapado-ttss-en-pacientes-con-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06063928/unidos-contra-el-cancer 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06214988/defuncion-selectiva-de-la-ostomia-en-la-reseccion-anterior-baja-para-el-cancer-de-recto 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT05355701/un-estudio-para-evaluar-el-medicamento-de-investigacion-pf-07799933-en-personas-con-tumores-solidos-avanzados-con-alteraciones-en-el-gen-braf 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT06968221/refuerzo-bovino-en-la-cirugia-de-estomago-colon-y-pulmon 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06959849/cirugia-asistida-por-robot-para-la-reseccion-de-cancer-colorrectal-un-analisis-poblacional-de-la-prevalencia-las-tendencias-y-los-resultados 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07198321/un-estudio-clinico-de-fase-i-ii-abierto-multicentrico-y-de-un-solo-brazo-para-evaluar-el-farmaco-gfh276-en-pacientes-con-tumores-solidos-avanzados-con-mutaciones-en-el-gen-ras 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07454993/el-efecto-de-la-musica-durante-la-colonoscopia 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07262840/cambio-de-conducta-en-relacion-con-la-salud-en-individuos-con-alto-riesgo-de-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07464236/mejora-de-la-prestacion-de-servicios-de-salud-anal-relacionados-con-el-vih-en-los-centros-de-atencion 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05245331/irrigacion-transanal-para-el-sindrome-de-la-reseccion-anterior-baja 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05355363/riesgo-de-hallazgos-metacronicos-tras-la-deteccion-de-lesiones-serradas-y-displasia-de-alto-grado-con-un-intervalo-de-seguimiento 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07280143/la-evolucion-de-la-esteatohepatitis-metabolica-asociada-a-la-obesidad-masld-en-supervivientes-de-cancer-de-mama-o-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT01239082/colonoscopia-frente-a-prueba-inmunoquimica-fecal-para-reducir-la-mortalidad-por-cancer-colorrectal-confirm 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07708415/la-correlacion-entre-la-recurrencia-de-polipos-postoperatorios-y-el-cancer-colorrectal 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07047482/valor-clinicopatologico-de-la-expresion-de-p16-en-el-carcinoma-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06976710/ensayo-priority-connect-2 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06421974/eficacia-de-la-cirugia-robotica-para-el-cancer-de-colon-derecho 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07590856/resultados-preliminares-de-eficacia-de-sna028-en-pacientes-con-cancer-colorrectal-avanzado-con-expresion-positiva-de-gpa33 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07410546/prueba-inmunoquimica-cuantitativa-de-heces-para-la-deteccion-de-cancer-colorrectal-y-lesiones-precancerosas-en-sohag 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07429110/estudio-pivotal-del-sistema-coloseal-tm-icd-para-la-proteccion-de-la-anastomosis 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07148297/analisis-de-cancer-colorrectal-para-la-evaluacion-mediante-la-prueba-delta-hld 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT04074538/el-estudio-del-consorcio-nacional-de-investigacion-sobre-el-cancer-colorrectal-ncrcc-consorcio-nacional-de-investigacion-sobre-el-cancer-colorrectal 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06948448/un-estudio-para-evaluar-la-seguridad-y-la-eficacia-de-dos-dosis-de-ono-4578-en-combinacion-con-opdivo-r-mas-mfolfox6-y-bevacizumab-en-comparacion-con-el-tratamiento-estandar-en-participantes-con 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06961149/imagenes-con-contraste-combinado-versus-la-aplicacion-de-un-aerosol-de-azul-de-indol-en-la-deteccion-de-adenomas-colorrectales 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT00579163/obtencion-de-muestras-de-sangre-periferica-o-saliva-para-estudios-de-epidemiologia-genetica-de-canceres-familiares 2026-09-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05871762/seleccion-de-las-estrategias-de-tratamiento-optimas-para-el-cancer-colorrectal-medio-inferior 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06802991/atencion-optimizada-despues-del-alta-hospitalaria-en-pacientes-mayores-tras-la-cirugia-de-cancer-de-colon-eras-3-0 2026-09-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07788729/prescripcion-social-y-microaprendizaje-para-mejorar-la-atencion-a-los-pacientes-con-cancer-y-a-sus-cuidadores 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07406633/kqb198-en-combinacion-con-imatinib-en-participantes-con-gist-avanzado-metastasico-en-primera-linea-de-tratamiento 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07730970/bloqueo-neuromuscular-profundo-y-una-dieta-baja-en-residuos-para-optimizar-el-campo-quirurgico-en-la-histerectomia-vnotes 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07745023/intervenciones-mente-cuerpo-para-mejorar-la-calidad-de-vida-el-estres-y-la-calidad-del-sueno-en-supervivientes-de-cancer-de-mama-prostata-endometrio-o-colon-y-recto 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05740956/un-estudio-de-hansoh-hs-10502-en-pacientes-con-tumores-solidos-avanzados 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07123441/un-estudio-sobre-la-eficacia-y-la-seguridad-del-liposoma-de-irinotecan-ii-5-fu-lv-en-combinacion-con-bevacizumab-para-el-tratamiento-del-cancer-colorrectal-avanzado 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07025850/estudio-de-eficacia-de-la-digoxina-en-combinacion-con-serplulimab-y-quimioterapia-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-avanzado-mss 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04719988/anti-pd-1-y-mdcf-seguidos-de-quimiorradioterapia-en-pacientes-con-carcinoma-de-celulas-escamosas-anal-en-estadio-iii 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06998745/el-impacto-del-modelo-mtm-en-la-eficacia-y-la-seguridad-de-la-terapia-anticoagulante-en-pacientes-con-cancer-colorrectal-en-el-periodo-postoperatorio 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06946745/exploracion-de-los-cambios-dinamicos-y-los-mecanismos-del-microambiente-inmunitario-en-el-cancer-colorrectal-avanzado-tratado-con-terapia-combinada-con-ibi363 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06943690/estudio-de-seguridad-y-eficacia-de-la-cirugia-robotica-radical-para-el-cancer-de-recto-mediante-un-unico-puerto-frente-a-multiples-puertos 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05841134/tislelizumab-en-combinacion-con-quimioterapia-capox-en-el-tratamiento-perioperatorio-del-cancer-colorrectal-en-estadio-ii-o-iii-con-msi-h-dmmr 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05412082/smart-tnt-para-el-tratamiento-conservador-del-cancer-colorrectal-localmente-avanzado 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT00548236/el-ensayo-clinico-active-after-cancer-trial-aact 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05236972/pace-anticuerpo-anti-pd-1-para-el-cancer-colorrectal-en-estadio-iii-con-dmmr-msi-h 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07612748/dos-enfoques-diferentes-para-el-tratamiento-endoscopico-de-las-neoplasias-neuroendocrinas-rectales 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07314528/evaluacion-del-impacto-de-los-agonistas-del-receptor-glp-1-en-combinacion-con-terapia-neoadyuvante-total-en-el-cancer-de-recto 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07242820/reduccion-de-la-recurrencia-de-la-neoplasia-tras-la-reseccion-endoscopica-no-termica-de-polipos-colorrectales-grandes 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07740122/analisis-de-imagenes-de-heces-basado-en-inteligencia-artificial-para-la-evaluacion-del-riesgo-de-neoplasia-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07337811/reseccion-total-selectiva-del-mesorrecto-basada-en-el-estudio-histopatologico-intraoperatorio-de-la-pieza-obtenida-mediante-reseccion-local-en-pacientes-con-cancer-de-recto-que-reciben 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07227636/un-estudio-de-botensilimab-y-balstilimab-para-el-cancer-colorrectal-con-ctdna-tras-la-cirugia-y-la-quimioterapia 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07637565/sistema-de-atencion-dietetica-basado-en-inteligencia-artificial 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07769853/iparolimab-y-tuvonralimab-en-combinacion-con-quimioterapia-y-bevacizumab-como-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06035471/podemos-utilizar-una-sencilla-prueba-de-sangre-para-reducir-los-efectos-adversos-innecesarios-de-la-radioterapia-mediante-la-identificacion-temprana-de-los-canceres-de-recto-resistentes-a-la 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05977621/ecografia-transrectal-de-la-pelvis-femenina-para-el-seguimiento-en-tiempo-real-mediante-fusion-de-imagenes-de-resonancia-magnetica-y-ecografia-guiada-por-aguja 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07346248/complicaciones-postoperatorias-tras-quimiorradioterapia-neoadyuvante-o-radioterapia-de-corta-duracion-y-tratamiento-neoadyuvante-total-un-estudio-de-cohortes-retrospectivo-multicentrico 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05912075/radioterapia-preoperatoria-y-astx660-en-el-cancer-de-recto 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06462053/radioterapia-de-corta-duracion-combinada-con-capox-y-anticuerpo-anti-pd-1-frente-a-quimiorradioterapia-de-larga-duracion-combinada-con-capox-para-el-cancer-de-recto-localmente-avanzado-en-estadio 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07555639/un-enfoque-genomico-integrado-para-evaluar-el-riesgo-genetico-y-la-sensibilidad-a-los-farmacos 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04166318/quimioterapia-y-radioterapia-a-dosis-mas-bajas-en-el-tratamiento-de-pacientes-con-cancer-anal-en-estadio-temprano-el-estudio-decrease 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06931860/ensayo-comparativo-directo-de-cologuard-enviado-por-correo-frente-a-fit-enviado-por-correo 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07383285/capox-y-bevacizumab-con-o-sin-radioterapia-primaria-del-tumor-y-iparomlimab-y-tuvonralimab-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-metastasico-ras-mutado-mss 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06578637/investigacion-sobre-la-suplementacion-con-hidroxibutirato-como-estrategia-de-quimioprevencion-en-la-poliposis-adenomatosa-familiar 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05862051/el-ensayo-resolute-tiene-como-objetivo-investigar-el-valor-de-anadir-un-tratamiento-ablativo-local-al-tratamiento-sistemico-estandar-para-el-cancer-colorrectal-oligo-metastasico-irresecable 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06767007/radioterapia-estereotactica-ablativa-sbrt-combinada-con-un-anticuerpo-anti-pd-1-en-el-cancer-colorrectal-localmente-recurrente-no-susceptible-de-reseccion-estudio-sparkle 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05114798/restriccion-horaria-de-la-alimentacion-frente-a-la-restriccion-calorica-continua-diaria-efectos-sobre-el-peso-corporal-y-los-marcadores-de-riesgo-de-cancer-colorrectal 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06502275/programa-de-nutricion-y-ejercicio-para-pacientes-ancianos-con-cancer-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06588166/pruebas-del-microbioma-para-el-cribado-del-cancer-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07150949/quimiorradioterapia-de-larga-duracion-o-radioterapia-de-corta-duracion-combinada-con-capox-anticuerpo-anti-pd-1-e-inhibidor-de-la-cox-2-para-el-cancer-colorrectal-localmente-avanzado-mss-serrac 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06385925/un-estudio-de-tsn1611-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados-que-presentan-la-mutacion-kras-g12d 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06123156/interes-de-la-rehabilitacion-temprana-de-la-funcion-erectil-con-sildenafilo-tras-la-radioterapia-y-la-proctectomia-en-pacientes-con-cancer-de-recto 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06599476/separadores-rectales-en-pacientes-con-cancer-de-prostata-sometidos-a-radioterapia 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT03064646/preservacion-de-organos-en-el-cancer-colorrectal-localmente-avanzado 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05730595/navegacion-laparoscopica-por-fluorescencia-para-el-cancer-de-recto-y-el-cancer-de-colon-sigmoide 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT02438839/quimiorradioterapia-curativa-para-el-cancer-de-recto-en-estadio-temprano 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05300269/shr-1701-en-combinacion-con-quimioterapia-y-radioterapia-en-el-cancer-colorrectal-localmente-avanzado 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07276529/seguridad-inicial-de-sfm-mas-otoloc-para-la-creacion-de-anastomosis-colorrectales-en-configuracion-lado-a-lado-o-extremo-a-lado 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05970900/imatinib-mesilato-preoperatorio-combinado-con-cirugia-conservadora-del-recto-en-pacientes-con-gist-rectal-con-mutacion-en-el-gen-c-kit 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07454720/un-estudio-clinico-aleatorizado-doble-ciego-controlado-con-placebo-multicentrico-de-fase-ii-iii-para-evaluar-el-uso-de-adebrelimab-en-combinacion-con-shr-8068-y-quimiorradioterapia-como-terapia 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06168786/cadonilimab-en-combinacion-con-fruquintinib-y-radioterapia-estereotactica-ablativa-sbrt-como-tratamiento-de-tercera-linea-y-en-lineas-posteriores-en-pacientes-con-crc-mss 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05627934/cuantificacion-del-flujo-sanguineo-anastomico-mediante-imagenologia-de-fluorescencia-en-la-reseccion-anterior-baja-para-el-cancer-de-recto 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06621563/ensayo-de-fase-ib-de-hs-20117-en-combinacion-con-otros-farmacos-en-tumores-solidos-avanzados 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06157463/fapi-en-el-cancer-de-recto-tnt 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06923150/un-estudio-clinico-aleatorizado-para-evaluar-la-eficacia-del-lavado-transanal-de-bajo-volumen-con-qufora-r-irrisedo-minigo-en-comparacion-con-el-tratamiento-conservador-en-pacientes-con-sindrome-de 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04307901/seguridad-de-la-evaluacion-del-cancer-colorrectal-y-la-valoracion-tumoral-mediante-la-colonoscopia-con-capsula 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT03816345/aim-nivo-evaluacion-de-un-farmaco-inmunoterapeutico-antitumoral-nivolumab-para-el-tratamiento-de-canceres-avanzados-en-pacientes-con-trastornos-autoinmunes 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07314554/recurrencia-tras-la-reseccion-de-polipos-gastricos-e-intestinales 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06534918/intervenciones-precisas-en-oncologia-a-traves-de-la-nutricion-y-el-entrenamiento-onpoint 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07207317/ensayo-lirrh-para-el-cancer-de-colon-derecho 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT03795311/evaluacion-de-la-eficacia-y-la-seguridad-del-tratamiento-con-folfirinox-mas-bevacizumab-en-pacientes-con-cancer-colorrectal-folfirinox-3 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05394714/un-estudio-de-fase-i-sobre-la-infusion-de-celulas-nk-autologas-expandidas-y-activadas-ex-vivo-magicell-nk-para-el-cancer-de-colon-tras-la-reseccion 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06688383/fistula-anastomotica-tras-hemicolectomia-derecha-por-cancer-un-estudio-multicentrico-prospectivo-de-la-red-sico-cc 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT02070146/iniciativa-de-recopilacion-de-datos-prospectivos-sobre-el-cancer-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05366881/estudio-prospectivo-observacional-de-validacion-del-ensayo-de-cfdna-para-la-deteccion-temprana-del-cancer-y-la-enfermedad-residual-minima 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT03141437/sitio-web-de-apoyo-a-la-toma-de-decisiones-para-ayudar-a-los-participantes-con-cancer-a-tomar-decisiones-sobre-su-fertilidad 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07095517/vias-de-senalizacion-factores-de-riesgo-y-moleculas-para-prevenir-los-tumores-colorrectales-de-inicio-temprano 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06801665/fmt-ql1706-bevacizumab-xelox-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-avanzado-de-tipo-mss-con-metastasis-hepaticas 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06065371/sacituzumab-govitecan-en-combinacion-con-capecitabina-para-el-tratamiento-de-canceres-gastrointestinales-avanzados-despues-de-la-progresion-tras-recibir-la-terapia-estandar 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07562503/ensayo-aleatorizado-de-terapia-adyuvante-guiada-por-la-metilacion-del-ctdna-plasmatico-en-pacientes-con-cancer-colorrectal-en-estadio-t4n0-y-estadio-iii-de-bajo-riesgo 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06220045/comparacion-de-mallas-de-polipropileno-pp-y-de-fluoruro-de-polivinilideno-pvdf-en-el-cierre-de-laparotomias-medianas-en-cirugias-colorrectales-de-alto-riesgo-impacto-en-la-hernia-incisional-y-la 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT01460589/inicio-temprano-de-la-quimioterapia-adyuvante-para-el-cancer-de-colon 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05923255/ensayo-lish-para-el-cancer-de-la-flexura-hepatica-y-el-colon-transverso-proximal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04407247/infliximab-o-vedolizumab-en-el-tratamiento-de-la-colitis-relacionada-con-los-inhibidores-de-los-puntos-de-control-inmunitario-en-pacientes-con-cancer-genitourinario-o-melanoma 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04259398/estudio-sobre-la-anestesia-y-el-cancer-cancer-de-colon 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05179824/estudio-tempus-priority-un-estudio-observacional-en-diversos-tipos-de-tumores 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06719206/reduccion-del-comportamiento-sedentario-durante-el-tratamiento-del-cancer-el-estudio-redsedcan 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06202131/uso-de-ctdna-en-pacientes-con-tumores-del-tracto-gastrointestinal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07714278/eficacia-de-la-rehabilitacion-personalizada-guiada-por-el-analisis-de-movimientos-mediante-video-en-pacientes-con-neuropatia-inducida-por-quimioterapia-un-ensayo-multicentrico 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07728019/eficacia-y-seguridad-de-retlirafusp-alfa-mas-bevacizumab-y-quimioterapia-con-o-sin-radioterapia-de-corta-duracion-en-pacientes-con-crclm 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06852495/el-efecto-de-los-factores-ambientales-en-el-cancer-colorrectal-segun-el-analisis-de-macrogenomas 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07534852/estudio-nima-sobre-el-cancer-de-colon 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04925154/consideraciones-en-la-toma-de-decisiones-por-parte-del-paciente-sobre-el-tratamiento-del-cancer-de-recto-beneficios-en-comparacion-con-la-calidad-de-vida 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT03464305/ensayo-aspirin-belgica 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04842006/control-sistemico-neoadyuvante-y-adyuvante-mediante-medicina-de-precision-en-el-cancer-de-recto 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06630962/evaluacion-del-impacto-de-la-orientacion-financiera-en-el-riesgo-de-catastrofe-financiera-y-la-angustia-economica-en-la-atencion-oncologica 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06757192/deteccion-de-cancer-colorrectal-en-individuos-no-examinados-de-45-a-54-anos 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06328738/elvn-002-trastuzumab-quimioterapia-en-tumores-solidos-her2-cancer-colorrectal-y-cancer-de-mama 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07669519/evaluacion-de-nuvastatictm-para-reducir-la-fatiga-relacionada-con-el-cancer-en-pacientes-con-cancer-de-colon-en-estadio-iv-que-reciben-quimioterapia-de-primera-linea 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07227077/dosis-de-actividad-fisica-en-pacientes-oncologicos-mayores-de-edad-que-sufren-dolor-cronico-un-ensayo-de-microaleatorizacion 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07209787/anastomosis-reforzada-con-sis-frente-a-anastomosis-convencional-en-el-cancer-de-recto-medio-a-bajo-un-ensayo-clinico-aleatorizado-multicentrico-sobre-la-dehiscencia-anastomotica 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05566249/un-estudio-para-validar-la-seguridad-y-la-viabilidad-de-artisential-en-la-cirugia-de-cancer-colorrectal-mediante-el-uso-de-un-registro-multicentrico-construido-de-forma-prospectiva 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06417476/radioterapia-de-corta-duracion-o-quimiorradiacion-de-larga-duracion-seguida-de-quimioterapia-de-consolidacion-con-mfolfoxiri-para-la-preservacion-de-organos-en-el-cancer-de-recto-inferior 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06886282/radiomica-espacial-y-transcriptomica-para-el-descubrimiento-de-la-relacion-entre-el-cancer-de-colon-y-la-enfermedad-renal-cronica 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06603519/impacto-de-la-intervencion-dietetica-en-la-inflamacion-y-la-composicion-del-microbioma-tras-la-colonoscopia 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06783244/presion-intraabdominal-baja-frente-a-presion-intraabdominal-estandar-en-la-cirugia-robotica-del-cancer-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT03671252/ensayo-clinico-prospectivo-aleatorizado-y-controlado-que-evalua-la-quimioterapia-neoadyuvante-con-folfoxiri-en-monoterapia-en-pacientes-con-cancer-de-recto-localmente-avanzado-comparandola-con-la 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07523919/determinantes-funcionales-y-respiratorios-de-los-resultados-a-largo-plazo-en-el-cancer-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06868849/un-estudio-de-jmt203-en-pacientes-con-caquexia-cancerosa 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04354064/adn-tumoral-circulante-ctdna-para-la-evaluacion-temprana-de-la-respuesta-al-tratamiento-en-tumores-solidos 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06946004/terapia-con-oxigeno-normobarico-en-pacientes-con-cancer-colorrectal 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07216560/estudio-de-fase-i-con-7mw4911-en-cancer-gastrointestinal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06881537/capeox-combinado-con-bevacizumab-mas-un-anticuerpo-anti-pd1-como-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-recurrente 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06856447/el-papel-de-la-coenzima-q10-en-la-profilaxis-de-la-neuropatia-periferica-inducida-por-oxaliplatino-en-pacientes-con-cancer-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06787625/desarrollo-de-organoides-a-partir-de-tumores-primarios-de-cancer-colorrectal-y-metastasis-hepaticas-sincronicas 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05358249/estudio-de-plataforma-de-jdq443-en-combinacion-con-otros-farmacos-en-pacientes-con-tumores-solidos-avanzados-que-presentan-la-mutacion-kras-g12c 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05797467/quimioterapia-adyuvante-combinada-con-terapia-dirigida-o-no-en-pacientes-con-cancer-colorrectal-t3-4n2 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04677998/un-protocolo-de-vigilancia-e-intervencion-personalizado-para-la-poliposis-duodenal-y-gastrica-en-pacientes-con-poliposis-adenomatosa-familiar 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06690606/eocrcpred-un-modelo-de-ia-para-predecir-la-supervivencia-en-pacientes-con-cancer-colorrectal-epitelioide-eocrc-despues-de-la-cirugia 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04062721/inmunomodulacion-local-tras-ablacion-por-radiofrecuencia-de-metastasis-hepaticas-irresecables-de-cancer-colorrectal 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07220018/deteccion-del-cancer-colorrectal-en-personas-sin-hogar 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06936774/mejora-de-los-resultados-funcionales-y-la-calidad-de-vida-en-pacientes-con-cancer-de-recto-despues-de-la-cirugia-mediante-un-seguimiento-y-una-vigilancia-mas-intensivos 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07333053/eficacia-clinica-de-la-quimioterapia-por-infusion-transarterial-en-el-cancer-colorrectal-irresecable 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06380816/un-ensayo-de-fase-i-ii-de-ucb4594-en-participantes-con-cancer-avanzado 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07384377/jskn003-frente-al-tratamiento-elegido-por-el-medico-en-pacientes-con-cancer-colorrectal-avanzado-her2-positivo-que-no-habian-respondido-a-oxaliplatino-5-fu-e-irinotecan 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04486131/recurrencia-de-la-enfermedad-en-los-ganglios-linfaticos-laterales-en-el-cancer-de-recto 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06310564/pacientes-con-cancer-colorrectal-oligometastasico-de-riesgo-bajo-e-intermedio-tratados-con-radioterapia-estereotactica-ablativa 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT03125343/observacion-y-espera-como-tratamiento-para-pacientes-con-cancer-de-recto 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06565052/el-impacto-del-ejercicio-preoperatorio-y-la-optimizacion-nutricional-en-los-resultados-perioperatorios-de-los-pacientes-sometidos-a-tratamiento-para-el-cancer-de-recto-el-ensayo-propel 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT01558921/cancer-de-recto-y-terapia-de-induccion-preoperatoria-seguida-de-cirugia-especifica-el-ensayo-rapido 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06307249/terapia-de-precision-para-tumores-solidos-inhibicion-sinergica-de-cdk4-6-y-terapia-dirigida-anti-vegf-mediante-arn-no-codificante-largo-lncrna 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04489238/recopilacion-de-informacion-para-comprender-mejor-el-cancer-colorrectal-de-inicio-temprano 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07106463/microbiota-su-papel-en-la-inflamacion-cronica-la-enfermedad-inflamatoria-intestinal-y-el-riesgo-de-cancer-colorrectal-evaluacion-de-un-modelo-predictivo-pronostico-con-implicaciones-terapeuticas 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07697170/frecuencia-de-los-cuidados-para-los-cateteres-venosos-centrales-de-insercion-periferica-en-la-prevencion-de-la-marsi 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07701408/adn-tumoral-circulante-ctdna-y-niveles-de-tep-en-el-cancer-de-colon 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06184594/evaluacion-de-la-eficacia-del-conjunto-de-herramientas-enav-para-mejorar-el-cribado-del-cancer-colorrectal 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04898504/hai-floxuridina-o-liver-tx-en-combinacion-con-quimioterapia-de-segunda-linea-frente-a-quimioterapia-de-segunda-linea-en-monoterapia-para-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-y-una 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07158164/farmacogenomica-de-dpyd-y-ajuste-de-la-dosis-de-fluoropirimidinas-fp 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07239063/validacion-del-preprocesamiento-de-tejidos-a-gran-escala-y-de-alto-rendimiento-para-el-cancer-de-pulmon-y-el-cancer-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT03026140/inhibicion-de-los-puntos-de-control-inmunitario-neoadyuvante-y-nuevas-combinaciones-de-inmunoterapia-en-el-cancer-de-colon-en-estadio-temprano 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06673329/brodalumab-en-el-tratamiento-de-las-reacciones-adversas-relacionadas-con-el-sistema-inmunitario 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05552755/evaluar-rec-4881-en-participantes-con-poliposis-adenomatosa-familiar-paf 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04230499/ensayo-clinico-de-erapa-para-prevenir-la-progresion-en-pacientes-con-poliposis-adenomatosa-familiar-que-se-encuentran-bajo-vigilancia-activa 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06619743/infeccion-por-vph-y-microecologia-vaginal-en-mujeres-inmunosuprimidas 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT03860272/anticuerpo-monoclonal-anti-ctla-4-modificado-mediante-ingenieria-de-la-region-fc-en-cancer-avanzado 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04722341/la-alimentacion-restringida-en-el-tiempo-y-el-cancer-resultados-clinicos-mecanismos-y-factores-moduladores 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05005403/estudio-para-evaluar-los-eventos-adversos-y-la-farmacocinetica-en-participantes-adultos-con-cancer-de-pulmon-no-microcitico-carcinoma-de-celulas-escamosas-de-cabeza-y-cuello-y-otros-tumores-solidos 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06778382/terapia-sistemica-diferida-tras-un-tratamiento-local-destructivo-de-las-oligometastasis-pulmonares-despues-de-haber-confirmado-la-ausencia-de-enfermedad-ned-en-el-cancer-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07381322/un-estudio-sobre-la-evaluacion-precisa-de-la-pseudoprogresion-en-la-inmunoterapia-del-cancer-de-recto-basado-en-la-resonancia-magnetica-multiparametrica-y-multitemporal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06850103/scrt-capeox-serplulimab-para-el-cancer-colorrectal-mss-pmmr-con-oligometastasis 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06066931/reconstruccion-del-suelo-pelvico-y-de-la-herida-perineal-tras-la-reseccion-en-bloque-abdominoperineal-elape-del-recto 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06576986/efecto-de-la-suplementacion-con-un-sinbiotico-en-la-prevencion-de-la-mucositis-en-pacientes-con-cancer-que-reciben-quimioterapia 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT01941641/estudio-de-folfoxiri-neoadyuvante-en-cancer-colorrectal 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05102110/estudio-de-factibilidad-para-investigar-el-moco-rectal-en-el-cancer-del-tracto-aerodigestivo 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04889820/resultados-de-la-quimioterapia-neoadyuvante-en-el-cancer-de-colon-obstructivo 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07655856/abordaje-combinado-inicial-de-la-arteria-mesenterica-inferior-seguido-de-un-abordaje-medial-completo-para-la-movilizacion-laparoscopica-de-la-flexura-esplenica-en-el-cancer-colorrectal-izquierdo 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07224854/firma-epigenetica-para-la-deteccion-precoz-del-ccrc 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06807073/cierre-completo-tras-la-reseccion-endoscopica-de-la-mucosa-de-polipos-colorrectales-grandes-no-pediculados 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05015296/el-impacto-de-los-cambios-en-las-celulas-inmunitarias-durante-el-periodo-perioperatorio-en-el-pronostico-de-los-pacientes-con-cancer-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04084249/vigilancia-guiada-por-ctdna-en-pacientes-con-cancer-colorrectal-en-estadio-iii-un-ensayo-clinico-aleatorizado 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06628674/desarrollo-y-evaluacion-del-efecto-de-videos-interactivos-en-linea-para-mejorar-el-sindrome-de-la-reseccion-anterior-baja 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04895722/evaluacion-de-la-combinacion-de-pembrolizumab-quavonlimab-mk-1308a-en-comparacion-con-otros-tratamientos-en-participantes-con-cancer-colorrectal-crc-en-estadio-iv-con-inestabilidad-de-microsatelites 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06614647/respuesta-atencion-de-seguimiento-para-supervivientes-de-cancer-colorrectal-ahora-es-digital-y-se-basa-en-las-necesidades 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06972667/intervenciones-para-reducir-la-evitacion-de-la-informacion-sobre-la-salud 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT02484404/estudio-de-fase-i-ii-del-anticuerpo-anti-ligando-de-muerte-programada-1-durvalumab-medi4736-en-combinacion-con-olaparib-y-o-cediranib-para-tumores-solidos-avanzados-y-cancer-de-ovario-cancer-de-mama 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07095309/estudio-de-seguridad-y-eficacia-del-artesunato-preoperatorio-en-el-cancer-colorrectal-en-estadio-ii-iii 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05948826/primer-estudio-en-humanos-de-torl-3-600-en-participantes-con-cancer-avanzado 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07381985/estrategia-para-el-manejo-de-pacientes-con-sindromes-de-cancer-hereditarios-sch-en-un-entorno-rural 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04792684/recopilacion-de-muestras-estudio-usoptival 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06397651/un-ensayo-clinico-aleatorizado-y-controlado-para-evaluar-el-impacto-del-programa-de-entrenamiento-fisico-coactive-en-vivo-y-la-aplicacion-digital-personalizada-de-complement-theory-en-la-calidad-de 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT03255434/normalizacion-de-la-masa-magra-corporal-en-la-quimioterapia-basada-en-oxaliplatino 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07650357/un-estudio-de-clsp-5282-en-pacientes-adultos-con-tumores-solidos-positivos-para-hla-a-03-01-sentinel-101 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07089017/manejo-anestesico-guiado-por-el-dispositivo-medstrom 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06956976/preservacion-frente-a-diseccion-de-los-ganglios-linfaticos-n-o-253-en-la-reseccion-robotica-para-el-cancer-de-recto-medio-inferior 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05030493/un-analisis-adicional-de-los-datos-del-estudio-exploratorio-paradigm-nct02394834-en-pacientes-con-cancer-colorrectal-avanzado-o-recurrente 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT03958240/descifrando-los-mecanismos-que-subyacen-a-la-inmunogenicidad-del-cancer 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04095299/dosis-estandar-frente-a-dosis-alta-de-radioterapia-en-la-preservacion-del-recto-con-quimiorradioterapia-en-pacientes-con-cancer-de-recto 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06239194/estudio-de-escalada-de-dosis-y-expansion-de-dosis-de-mdx2001-en-pacientes-con-tumores-solidos-avanzados 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06769087/comparacion-entre-la-extraccion-inmediata-y-la-extraccion-a-las-24-horas-tras-la-cirugia-del-cateter-urinario-en-pacientes-sometidos-a-cirugia-por-cancer-colorrectal 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06991452/diagnostico-precoz-y-seguimiento-de-la-recurrencia-del-cancer-colorrectal 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06204484/terapia-adyuvante-diferida-guiada-por-la-enfermedad-residual-minima-en-el-cancer-colorrectal-en-estadio-temprano-y-resecable 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06465914/un-estudio-de-fase-iii-para-evaluar-la-eficacia-inmunogenicidad-y-seguridad-de-la-vacuna-contra-el-vph-9-valente-en-hombres-chinos 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06263088/equity-gi-un-estudio-prospectivo-para-mejorar-la-calidad-la-inclusion-y-la-participacion-en-ensayos-clinicos-en-pacientes-negros-con-cancer-gastrointestinal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07213609/un-estudio-para-investigar-la-seguridad-y-la-eficacia-preliminar-de-gsk5460025-administrado-solo-o-en-combinacion-con-otros-agentes-antineoplasicos-en-participantes-con-tumores-solidos 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07676162/un-estudio-clinico-aleatorizado-de-etiqueta-abierta-controlado-y-multicentrico-de-fase-iii-para-evaluar-el-farmaco-shr-a1811-en-combinacion-con-quimioterapia-y-bevacizumab-en-comparacion-con-la 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07215936/esquema-de-capecitabina-a-dosis-mas-intensiva-7-dias-de-tratamiento-7-dias-de-descanso-en-el-cancer-colorrectal-en-comparacion-con-el-regimen-estandar 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06930586/valor-pronostico-de-las-redes-neurometabolicas-en-el-ccrc-pvnm-ccrc 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07729371/un-estudio-de-seguridad-de-st316-en-participantes-con-poliposis-adenomatosa-familiar-paf 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07077447/el-estudio-23-del-grupo-danes-sobre-cancer-de-vejiga-un-estudio-europeo-sobre-el-cancer-del-tracto-urinario-superior 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT04585516/utilidad-diagnostica-de-los-diferentes-tipos-de-exploraciones-endoscopicas-gastrointestinales 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05970133/cirugia-robotica-frente-a-laparoscopia-en-la-reseccion-oncologica-de-la-porcion-ascendente-del-colon-nose-en-el-cancer-de-colon-izquierdo-en-estadios-i-iii 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06838546/un-estudio-clinico-multicentrico-abierto-de-fase-iib-para-evaluar-la-eficacia-y-la-seguridad-de-la-inyeccion-de-b1962-en-el-tratamiento-del-cancer-colorrectal-avanzado 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04631692/evaluacion-de-una-intervencion-para-mejorar-la-alfabetizacion-en-salud-con-el-fin-de-optimizar-la-deteccion-del-cancer-colorrectal-en-zonas-desfavorecidas 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07453706/aplicacion-del-sistema-quirurgico-sentire-surgical-system-plus-con-brazo-unico-para-el-lado-del-paciente-en-la-cirugia-robotica-de-cancer-colorrectal 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04007770/estudio-piloto-sobre-la-acupuntura-para-la-funcion-cognitiva-relacionada-con-el-cancer 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05807646/reduccion-de-la-diseminacion-de-celulas-tumorales-mediante-la-ligadura-primaria-de-la-vena-mesenterica-inferior-en-pacientes-con-cancer-de-recto 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07163403/primer-estudio-clinico-en-humanos-para-evaluar-la-seguridad-y-eficacia-de-las-celulas-dendriticas-cargadas-con-neoepitopos-derivados-de-mutaciones-de-desplazamiento-de-la-fase-de-lectura-para-la 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05877456/validacion-de-la-herramienta-global-de-evaluacion-de-la-polipectomia-gpat 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06666192/el-programa-comunitario-screen-de-la-universidad-estatal-de-ohio-osu 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07104877/un-estudio-de-sys6010-en-combinacion-con-syh2051-en-pacientes-con-cancer-colorrectal-avanzado-y-otros-tumores-gastrointestinales 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06751394/quimiorradioterapia-preoperatoria-y-toripalimab-en-el-cancer-de-recto-localmente-recurrente 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06920680/coloreg-un-registro-para-informes-de-endoscopia-gastrointestinal-y-videos-de-examenes 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT03998202/miopatia-y-mecanismos-de-toxicidad-de-la-quimioterapia-en-adultos-mayores-con-cancer-colorrectal 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06402188/estudio-de-seguridad-y-viabilidad-del-sistema-icd-coloseal-tm 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05427669/mfolfoxiri-adyuvante-frente-a-mfolfox6-en-cancer-colorrectal-en-estadio-ii-iii-con-enfermedad-residual-microscopica-erm-positiva-afford 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05827471/estudio-clinico-de-qsox1-como-biomarcador-para-el-cancer-de-colon 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05230329/colecistectomia-minimamente-invasiva-versus-colecistectomia-estandar-por-via-abierta-para-canceres-localizados-en-el-lado-derecho-del-colon 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06689293/estudio-sobre-el-uso-de-pruebas-inmunoquimicas-fecales-fit-para-la-vigilancia-tras-el-cancer-colorrectal-crc 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06931873/radiocuemioterapia-neoadyuvante-combinada-con-ql1706-para-el-cancer-de-recto-inferior 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07098182/contribucion-de-la-preservacion-de-la-arteria-colica-izquierda-superior-a-la-vascularizacion-del-colon-descendente-antes-de-la-anastomosis-colorrectal-durante-las-resecciones-izquierdas-o-rectales 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT06898996/pruebas-no-invasivas-adecuadas-para-la-vigilancia-del-sindrome-de-lynch 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT05447923/abordando-las-disparidades-en-la-deteccion-del-cancer-colorrectal-en-las-comunidades-negras-y-desfavorecidas-de-phoenix 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT03841799/colon-im-microbiota-e-infiltrado-inmunitario-en-tejido-colorrectal-normal-displasico-y-neoplasico 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07683312/mecanismos-de-recurrencia-del-adenoma-colorrectal-tras-la-reseccion-y-un-protocolo-de-investigacion-multi-omica 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT04416490/quimioterapia-adyuvante-con-oxaliplatino-tras-la-reseccion-curativa-del-cancer-colorrectal-primario 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT05565417/estudio-del-anticuerpo-monoclonal-imt-009-en-pacientes-con-tumores-solidos-avanzados-o-linfomas 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07360834/estudio-que-tiene-como-objetivo-evaluar-si-las-biopsias-liquidas-no-invasivas-pueden-reducir-de-forma-segura-la-necesidad-de-metodos-de-vigilancia-invasivos-en-el-sindrome-de-lynch 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT06787807/analisis-proteomico-de-pacientes-sometidos-a-cirugia-bariatrica 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07405931/evaluacion-de-la-eficacia-de-la-gestion-de-los-efectos-secundarios-de-la-quimioterapia-mediante-el-uso-de-cuestionarios-electronicos-para-pacientes-epro-y-un-programa-de-teleasistencia-estandarizado 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07023289/un-estudio-para-evaluar-los-eventos-adversos-y-los-cambios-en-la-actividad-de-la-enfermedad-en-participantes-adultos-que-reciben-telisotuzumab-adizutecan-en-infusion-intravenosa-solo-o-en-combinacion 2026-09-03 weekly 0.7 https://crcwarriors.org/ensayo/NCT07709429/ejercicio-de-qigong-para-mejorar-la-fuerza-muscular-y-la-calidad-de-vida-en-pacientes-con-cancer-colorrectal-que-reciben-quimioterapia 2026-09-03 weekly 0.6 https://crcwarriors.org/ensayo/NCT07406594/cambios-en-el-microbioma-intestinal-durante-la-terapia-con-abemaciclib-en-el-cancer-de-mama 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07357220/un-estudio-de-ak112-en-combinacion-con-vg2025-en-el-cancer-colorrectal-con-metastasis-hepaticas 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06979882/investigacion-de-la-dinamica-de-la-metilacion-multigenica-en-la-vigilancia-de-la-respuesta-al-tratamiento-en-el-carcinoma-intestinal 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06690593/caracteristicas-y-relevancia-clinica-de-la-microbiota-intestinal-en-pacientes-con-gammapatia-monoclonal 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT04046133/ensayo-de-fase-ib-ii-con-pembrolizumab-mas-imrt-en-el-carcinoma-de-ano-en-estadio-iii-iv 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06183736/cvl237-en-comprimidos-para-el-tratamiento-de-tumores-solidos-avanzados-con-deficiencia-de-pten 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06869096/gluconato-de-clorhexidina-frente-a-solucion-salina-para-la-limpieza-del-area-quirurgica-durante-la-cirugia-de-cancer-colorrectal 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06902701/diseccion-endoscopica-submucosa-frente-a-cirugia-endoscopica-transanal-para-neoplasias-rectales 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07393906/estudio-de-investigacion-sobre-la-prevencion-del-cancer-colorrectal-alimentacion-saludable-y-deteccion-precoz 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07663071/radioterapia-de-corta-duracion-combinada-con-retlirafusp-alfa-y-quimioterapia-capox-como-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado-un-estudio-clinico-prospectivo-de-un-solo 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06207656/estudio-para-evaluar-la-eficacia-y-la-seguridad-del-cetuximab-en-combinacion-con-encorafenib-mas-binimetinib-como-tratamiento-de-induccion-en-pacientes-con-cancer-colorrectal-avanzado-con-mutacion 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06652529/fase-1-de-escalada-de-dosis-y-expansion-para-evaluar-arog4-01-en-pacientes-con-tumores-solidos-avanzados 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT04038619/trasplante-de-microbiota-fecal-en-el-tratamiento-de-la-diarrea-o-la-colitis-inducidas-por-inhibidores-de-puntos-de-control-inmunitario-en-pacientes-con-cancer-genitourinario 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06281145/intervencion-para-la-reduccion-del-estres-en-pacientes-con-cancer-colorrectal-y-de-mama 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07214142/terapia-neoadyuvante-total-con-pd-1-para-el-cancer-colorrectal-localmente-avanzado 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06708429/sindrome-de-lynch-interaccion-entre-la-mucosa-enteral-y-el-sistema-inmunitario 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06858956/estudio-en-el-mundo-real-de-chidamide-en-combinacion-con-inhibidores-de-pd-l-1-y-terapia-antiangiogenica-para-el-cancer-colorrectal-avanzado-de-tipo-mss 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT05064124/sistema-de-atencion-medica-en-tiempo-real-para-el-diagnostico-precoz-en-el-ensayo-clinico-sobre-el-cancer 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT05403177/estudio-de-la-red-de-centros-oncologicos-marathon-of-hope-para-ontario-mohccn-o 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07406958/clasificacion-avanzada-de-tumores-de-colon-a-partir-de-tomografias-computarizadas-mediante-aprendizaje-profundo-para-optimizar-la-toma-de-decisiones-terapeuticas 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT03781323/terapia-neoadyuvante-con-folfox-radioterapia-de-corta-duracion-y-seguimiento-activo-en-el-cancer-colorrectal-localmente-avanzado 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07409844/inmunoterapia-neoadyuvante-y-tratamiento-conservador-de-organos-en-pacientes-con-cancer-de-colon-en-estadio-i-iii-con-dmmr 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06613581/seguimiento-en-el-domicilio-del-paciente-tras-la-cirugia-para-el-carcinoma-colorrectal 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07162337/modificacion-del-eje-acido-biliar-microbiota-intestinal-mediante-educacion-dietetica-para-la-prevencion-del-cancer-colorrectal 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06901856/reseccion-endoscopica-de-tumores-neuroendocrinos-rectales-de-pequeno-tamano 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06693375/evaluar-la-dosis-y-la-seguridad-de-nanoecho-particle-1-mediante-examenes-con-el-dispositivo-de-imagen-nanoecho-de-los-ganglios-linfaticos-rectales-en-voluntarios-sanos-y-pacientes-con-cancer-de-recto 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06376565/mejorar-la-vigilancia-mediante-colonoscopia-en-pacientes-con-polipos-de-colon-de-alto-riesgo 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07453173/onco-ret-entrenamiento-de-fuerza-supervisado-durante-la-terapia-neoadyuvante-total-para-el-cancer-colorrectal-localmente-avanzado 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06864013/radioterapia-estereotactica-ablativa-scrt-combinada-con-quimioterapia-e-iparolimab-y-tuvonalimab-en-pacientes-con-cancer-colorrectal-localmente-avanzado-con-estado-msi-h-o-pmmr 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07696689/evaluacion-del-momento-optimo-para-realizar-la-irrigacion-transanal-en-el-sindrome-de-reseccion-anterior-baja-tras-la-cirugia-de-cancer-de-recto 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07281157/irinotecano-liposomal-mas-capecitabina-y-enronsubemab-en-combinacion-con-radioterapia-de-corta-duracion-para-el-tratamiento-neoadyuvante-del-cancer-colorrectal-localmente-avanzado 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07599501/suplementacion-nutricional-para-mejorar-la-cirugia-en-el-cancer-colorrectal 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06857773/tratamiento-de-induccion-para-metastasis-hepaticas-de-cancer-colorrectal-inicialmente-irresecables-terapia-combinada-con-bomba-de-infusion-intraarterial-hepatica-y-terapia-sistemica 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06023004/el-estudio-sobre-la-diverticulitis 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT02919644/vacunacion-con-celulas-dendriticas-autologas-cargadas-con-homogenado-tumoral-autologo-tras-la-reseccion-curativa-del-cancer-colorrectal-en-estadio-iv 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06159634/traccion-frente-a-ausencia-de-traccion-en-la-reseccion-endoscopica-con-diseccion-submucosa-esd-de-lesiones-colorrectales 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT01882205/comparacion-entre-la-cromoendoscopia-y-la-cromoendoscopia-virtual-nbi-i-scan-fice-para-la-deteccion-de-neoplasias-en-la-colitis-ulcerosa-cronica 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07029464/comparacion-de-los-resultados-a-corto-y-largo-plazo-entre-la-hemicolectomia-robotica-y-la-laparoscopica-en-el-cancer-de-colon-derecho-un-analisis-multicentrico-de-concordancia-por-puntuacion-de 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06573723/registro-institucional-de-enfermedades-raras 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT04646187/desintensificacion-de-la-terapia-anti-tnf-en-la-enfermedad-inflamatoria-intestinal 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07351071/estudio-postcomercializacion-de-la-grapadora-circular-signia-con-tecnologia-de-triple-grapado-en-resecciones-de-colon-sigmoide-y-recto-izquierdos 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT03124212/pruebas-geneticas-en-cascada-para-el-cancer-hereditario-de-mama-ovario-y-el-sindrome-de-lynch-en-suiza 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06205485/quimioterapia-neoadyuvante-reseccion-quirurgica-y-seguimiento-versus-quimiorradioterapia-para-el-cancer-de-recto 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT04816292/comparacion-de-la-tasa-de-reseccion-en-la-polipectomia-de-polipos-colorrectales-de-10-a-15-mm-realizada-con-asa-caliente-y-asa-fria 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06538402/diez-centimetros-versus-quince-centimetros-de-longitud-del-neumocolon-en-la-cirugia-de-ipaa 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07395505/resultados-y-evolucion-tras-la-exenteracion-pelvica-quirurgica 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT05656326/seguimiento-tras-la-cirugia-del-cancer-colorrectal 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07676383/navegacion-de-precision-para-mejorar-la-participacion-en-los-programas-de-deteccion-de-cancer-a-nivel-comunitario-un-ensayo-aleatorizado-de-grupos-dobles 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06917963/estudio-del-tratamiento-con-omeprazol-a-dosis-mas-intensas-para-prevenir-la-aparicion-de-una-ostomia-de-alto-volumen 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT04389086/quimioterapia-de-induccion-para-el-cancer-de-recto-localmente-recurrente 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT03822572/abcsg-c08-ejercicio-ii-ensayo-sobre-el-ejercicio-de-resistencia-tras-la-quimioterapia-adyuvante-para-el-cancer-colorrectal 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT05078866/vacuna-preventiva-contra-el-cancer-nous-209-para-pacientes-con-sindrome-de-lynch 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07014878/un-estudio-de-la-inyeccion-de-dcty1102-en-pacientes-con-tumores-solidos-avanzados 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07555678/quimiorradioterapia-y-anticuerpo-anti-pd-1-en-el-cancer-de-celulas-escamosas-anal-estudio-chase 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06887673/mediadores-lipidicos-y-cancer-montelukast-spm-y-almendras 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT02842203/uso-del-ctdna-para-el-seguimiento-del-cancer-colorrectal-en-estadio-iii 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT03523546/modelo-de-pago-por-episodio-oncologico-en-hawai 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07087561/mejora-nutricional-a-corto-plazo-combinada-con-educacion-sobre-la-salud-en-pacientes-con-cancer-colorrectal-en-el-periodo-postoperatorio-un-ensayo-clinico-aleatorizado-y-controlado 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT05671809/efectos-de-los-diferentes-tratamientos-sobre-la-funcion-anorrectal-de-los-pacientes-con-cancer-de-recto 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT05734300/el-estudio-sparcol 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07561060/cancer-de-recto-inferior-tratado-con-terapia-neoadyuvante-total-mas-inmunoterapia-concomitante-con-tislelizumab 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07041515/intervencion-digital-basada-en-el-conocimiento-para-prevenir-el-sindrome-de-la-reseccion-anterior-baja 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06773832/ia-en-la-prediccion-de-la-patologia-de-los-polipos-y-la-clasificacion-endoscopica 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT05345613/acido-tranexamico-durante-los-procedimientos-de-reseccion-endoscopica-de-lesiones-colonicas 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT03573791/biomarcadores-para-predecir-la-resistencia-a-la-quimiorradioterapia-neoadyuvante-en-el-cancer-de-recto-avanzado-de-grado-medio-bajo 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06580002/reutilizacion-de-riluzol-para-el-deterioro-cognitivo-relacionado-con-el-cancer-un-ensayo-piloto 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07188025/quimioterapia-adyuvante-basada-en-ctdna-para-el-cancer-colorrectal-de-alto-riesgo 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07703709/estudio-observacional-sobre-los-resultados-en-el-mundo-real-del-cancer-colorrectal-supervivencia-con-un-inmunomodulador-mas-terapias-oncologicas-estandar 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06504875/aplicacion-de-un-anticuerpo-monoclonal-anti-pd-1-en-combinacion-con-il-2-y-capeox-en-la-terapia-de-preservacion-de-organos-para-el-cancer-colorrectal-avanzado-localizado-ultra-temprano 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07403981/promocion-colaboracion-divulgacion-y-obtencion-de-resultados-optimos-en-la-atencion-de-pacientes-con-cancer 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06074536/impacto-de-la-formacion-en-un-enfoque-centrado-en-el-paciente-sobre-la-toma-de-decisiones-compartida-en-la-deteccion-del-cancer-colorrectal 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06943612/resecciones-de-cancer-colorrectal-en-pacientes-con-sarcoma-retroperitoneal 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06993402/desi-estudio-de-dusseldorf-sobre-la-ablacion-endoscopica-con-corriente-de-radiofrecuencia 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT04531930/carcinogenesis-de-adenomas-colorrectales-en-la-poliposis-adenomatosa-familiar-paf 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07307547/eficacia-de-la-colonoscopia-asistida-por-inteligencia-artificial-para-la-deteccion-de-neoplasias-colorrectales-ai-coloscreen 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06568016/una-intervencion-a-nivel-de-toda-la-clinica-programa-de-conexion-entre-atencion-primaria-y-gastroenterologia-para-mejorar-las-tasas-de-colonoscopia-tras-la-obtencion-de-resultados-anormales-en-la 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07750158/zanzalintinib-en-monoterapia-o-en-combinacion-con-pembrolizumab-y-berahyaluronidasa-alfa-en-participantes-con-cancer-colorrectal-con-enfermedad-residual-molecular 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07162714/radioterapia-estereotactica-scrt-seguida-de-ak112-en-cancer-colorrectal-medio-o-bajo-con-pmmr-mss 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06515821/estudio-multicentrico-para-la-recopilacion-el-desarrollo-y-la-evaluacion-de-metodos-novedosos-de-deteccion-y-diagnostico-del-ccrc 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06822530/una-intervencion-en-multiples-niveles-para-aumentar-el-numero-de-pruebas-de-deteccion-de-cancer-colorrectal-en-pacientes-con-resultados-anormales-en-la-prueba-inmunoquimica-fecal-ensayo-proact 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT05168839/angiografia-por-fluorescencia-con-verde-de-indocianina-intraoperatoria-en-la-cirugia-colorrectal-para-prevenir-las-fugas-anastomoticas 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06765252/efecto-del-polimorfismo-genetico-en-la-toxicidad-inducida-por-capecitabina-en-pacientes-egipcios-con-cancer 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06827639/caracterizacion-exhaustiva-de-los-subconjuntos-inmunitarios-circulantes-e-infiltrantes-y-las-celulas-tumorales-en-pacientes-con-cancer 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07189312/analisis-espacio-temporal-multiescala-de-datos-de-investigacion 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT05524428/eliminando-las-barreras-para-la-deteccion-del-cancer-colorrectal-mediante-pruebas-de-ciclo-rapido-un-estudio-piloto 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07621757/la-implementacion-del-riesgo-genetico-en-el-cribado-del-cancer-colorrectal 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07327489/prediccion-de-la-respuesta-a-la-inmunoterapia-a-partir-del-analisis-de-biopsias-tumorales-obtenidas-in-vivo 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07628998/impacto-de-los-mensajes-de-texto-sms-en-la-participacion-en-los-programas-de-deteccion-del-cancer-colorrectal 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07205965/el-efecto-de-la-psicoeducacion-basada-en-el-enfoque-de-aceptacion-y-compromiso-en-supervivientes-de-cancer 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07519681/efectos-de-la-berberina-en-el-microbioma-intestinal-humano 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07776548/desarrollo-y-validacion-de-un-marcador-de-adn-tumoral-circulante-para-tumores-colorrectales-preneoplasicos 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT03280511/quimioterapia-intraperitoneal-en-aerosol-a-presion-adyuvante-pipac-en-pacientes-con-cancer-de-colon-de-alto-riesgo-sometidos-a-reseccion-quirurgica 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06868095/protocolo-de-estudio-multicentrico-impacto-de-la-sarcopenia-en-el-cancer-colorrectal-de-inicio-temprano 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07035262/impacto-de-la-dinamica-del-metaboloma-serico-preoperatorio-y-posoperatorio-en-los-resultados-de-la-reseccion-de-cancer-colorrectal 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06249672/resultados-funcionales-a-largo-plazo-en-pacientes-sometidos-a-tratamiento-conservador-de-organos-para-el-cancer-de-recto-con-o-sin-reseccion-local-despues-de-quimiorradioterapia 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT04544046/ensayo-clinico-aleatorizado-sobre-cuidados-paliativos-oncologicos-en-el-domicilio-del-paciente 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07436637/guardant-shield-prueba-de-deteccion-de-cancer-colorrectal 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06116019/radioterapia-adaptativa-en-linea-mediante-un-nuevo-acelerador-lineal-ethos 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT05316103/biopsia-optica-dirigida-para-cicatrices-rectales-localizadas-en-pacientes-con-cancer-de-recto-despues-de-quimiorradioterapia-neoadyuvante 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07483684/un-estudio-clinico-para-evaluar-la-inyeccion-tqb2102-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-avanzado-her2-ihc3-que-han-presentado-progresion-tras-el-tratamiento-con-oxaliplatino 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT01416714/obtencion-de-muestras-de-tejido-para-el-cancer-gastrico-tumores-del-estroma-gastrointestinal-gist-cancer-de-esofago-cancer-de-pancreas-cancer-hepatocelular-cancer-biliar-tumores-neuroendocrinos 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06434896/quimioterapia-adyuvante-basada-en-el-adn-tumoral-circulante-en-pacientes-con-cancer-de-colon-en-estadio-ii-el-ensayo-medocc-create 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT04920149/programa-de-prevencion-del-cancer-colorrectal-con-mesalamina-en-el-sindrome-de-lynch 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT06731894/fitocannabinoides-para-reducir-la-neuropatia-periferica-cronica-inducida-por-la-quimioterapia-en-supervivientes-de-cancer-de-mama-y-de-colon 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT05343013/tas-102-con-o-sin-celecoxib-en-pacientes-con-enfermedad-residual-minima-definida-por-ctdna-tras-la-finalizacion-de-la-quimioterapia-adyuvante-para-el-cancer-colorrectal 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07318051/recoleccion-de-muestras-para-el-estudio-de-investigacion-y-evaluacion-de-productos-en-curso 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07651553/reseccion-total-mesorrectal-transanal-frente-a-reseccion-total-mesorrectal-robotica 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT02863172/base-molecular-de-las-variaciones-en-los-sindromes-hereditarios-de-cancer-colorrectal 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT07542704/un-estudio-para-investigar-la-seguridad-y-la-eficacia-de-kqb368-como-terapia-unica-en-participantes-con-tumores-solidos-avanzados 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT06729645/radioterapia-externa-combinada-con-braquiterapia-endorrectal-de-alta-dosis-en-pacientes-ancianos-y-fragiles-con-cancer-de-recto 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07035691/nuevos-biomarcadores-para-la-estratificacion-de-los-pacientes-con-cancer-colorrectal-que-son-remitidos-para-su-evaluacion 2026-09-02 weekly 0.7 https://crcwarriors.org/ensayo/NCT00002540/deteccion-del-cancer-de-prostata-en-pacientes-de-edad-avanzada-ensayo-de-deteccion-plco 2026-09-02 weekly 0.6 https://crcwarriors.org/ensayo/NCT07703163/seguridad-y-eficacia-de-canagliflozina-en-pacientes-con-cancer-solido-localmente-avanzado-o-metastasico 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07702955/estudio-de-fase-i-de-kgx105-como-agente-unico-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07750132/estudio-de-fase-i-de-la-inyeccion-de-sm2275-en-pacientes-con-tumores-solidos-avanzados 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07686445/un-estudio-de-an4035-en-canceres-avanzados-con-mutaciones-en-ras-y-alta-expresion-de-ceacam5 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07723482/ml-016-en-cancer-avanzado-con-afectacion-pulmonar-y-o-hepatica 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT05087745/un-estudio-clinico-sobre-las-celulas-infiltrantes-tumorales-til-para-el-tratamiento-de-tumores-solidos-avanzados 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07660432/un-estudio-de-sim0689-en-participantes-adultos-con-tumores-solidos-localmente-avanzados-o-metastasicos 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07705035/dbc-664-en-pacientes-adultos-con-tumores-solidos 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07762703/tratamiento-con-inmunoterapia-combinada-para-el-cancer-de-mama-triple-negativo-localmente-avanzado-irresecable-o-metastasico-pd-l1-negativo-cps-10-gbrca-negativo-que-incluye-breakvax-inmunoterapia 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07789327/estudio-clinico-de-fase-1-2-de-hy07121-para-inyeccion-subcutanea-en-pacientes-con-tumores-solidos-avanzados 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07722806/un-programa-de-nutricion-y-ejercicio-combinado-con-olanzapina-en-comparacion-con-olanzapina-sola-un-ensayo-en-pacientes-con-tumores-avanzados 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07767474/un-estudio-para-evaluar-atx-898-en-participantes-con-tumores-solidos-avanzados 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07698587/un-estudio-de-fase-ib-ii-de-bm230-en-combinacion-con-un-inhibidor-de-pd-1-para-tumores-solidos-avanzados-relacionados-con-her2 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07681297/tislelizumab-en-combinacion-con-bevacizumab-y-capecitabina-en-tumores-solidos-avanzados-con-evaluacion-en-pacientes-con-enfermedad-resistente-a-la-inmunoterapia-y-enfermedad-del-sistema-nervioso 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07787520/un-estudio-de-lae118-como-monoterapia-y-en-combinacion-con-agentes-antitumorales-en-tumores-solidos-avanzados 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07664150/estudio-cw-301-fih-de-can016 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07704658/estudio-de-dosis-escalada-de-pralsetinib-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06722534/celecoxib-para-la-prevencion-de-la-progresion-en-el-sindrome-de-peutz-jeghers 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06434597/un-estudio-clinico-de-comprimidos-de-sph5030-en-el-tratamiento-de-pacientes-con-cancer-de-las-vias-biliares-o-cancer-colorrectal-her2-positivo-mutado 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06763432/resultados-positivos-en-la-prueba-de-deteccion-fecal-superando-las-limitaciones 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT05167071/estudio-de-hbm4003-en-combinacion-con-toripalimab-en-pacientes-con-tumores-neuroendocrinos-avanzados-y-otros-tumores-solidos 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT00119912/norccap-ensayo-noruego-para-la-prevencion-del-cancer-colorrectal 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT06620627/recopilacion-prospectiva-de-muestras-para-permitir-el-desarrollo-del-ensayo-de-deteccion-temprana-del-cancer-de-natera 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT05426135/sistema-de-inteligencia-artificial-para-la-evaluacion-del-riesgo-tumoral-y-el-diagnostico-y-tratamiento 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT05933122/estudio-de-la-prevalencia-de-la-disfuncion-sexual-en-mujeres-despues-de-la-cirugia-de-cancer-de-recto-y-analisis-del-impacto-de-una-intervencion-de-un-sexologo 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06769061/el-uso-de-la-acupuntura-para-reducir-la-neuropatia-periferica-inducida-por-la-quimioterapia-en-pacientes-con-cancer-ginecologico 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07373015/reseccion-endoscopica-con-doble-lazo-modificado-mds-emr-frente-a-esd-para-tumores-neuroendocrinos-rectales-de-menos-de-1-cm 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT05998122/quimiorradioterapia-neoadyuvante-total-mas-anti-pd-1-en-pacientes-con-cancer-colorrectal-localmente-avanzado-y-afectacion-subperitoneal-un-estudio-prospectivo-de-un-solo-brazo-y-exploratorio 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT06617052/quimiorradioterapia-preoperatoria-para-el-cancer-de-recto-localmente-recurrente 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07005570/radioterapia-de-corta-duracion-seguida-de-quimioterapia-secuencial-con-o-sin-anticuerpo-monoclonal-anti-pd-1-y-bevacizumab-como-terapia-neoadyuvante-total-en-cancer-colorrectal-localmente-avanzado 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07687433/quimiorradioterapia-concurrente-de-larga-duracion-con-adebrelimab-y-apatinib-como-terapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado-de-bajo-grado-que-requiere-preservacion-del 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT04695782/terapia-con-haz-de-protones-para-el-tratamiento-de-recurrencias-pelvicas-en-pacientes-con-cancer-de-recto-que-previamente-recibieron-radioterapia 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06056804/quimiorradioterapia-neoadyuvante-combinada-con-un-inhibidor-de-pd-1-y-timalfasina-para-el-cancer-colorrectal-localmente-avanzado-de-localizacion-media-inferior-con-pmmr-mss 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07742410/la-estrategia-de-cribado-mediante-endoscopia-con-imagenes-secuenciales-vinculadas-que-combina-la-prueba-de-inmunoensayo-fecal-para-la-deteccion-de-sangre-oculta-y-la-calprotectina-para-el-seguimiento 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07346534/anastomosis-reforzada-frente-a-anastomosis-convencional-en-la-reseccion-laparoscopica-de-cancer-de-recto-bajo-un-estudio-comparativo 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07578571/un-estudio-de-fase-i-de-im-1617-en-participantes-con-cancer-avanzado 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT05818865/prueba-principal-para-el-aislamiento-y-la-caracterizacion-de-celulas-tumorales-circulantes-ctc-cxcr4 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07411599/administracion-combinada-de-terapia-car-nk-dirigida-a-trop2-por-via-intraperitoneal-e-intravenosa-con-la-eliminacion-ko-del-receptor-2-del-tgf-beta-tgfbr2-para-la-carcinomatosis-peritoneal 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT05784688/estudio-de-tu2218-en-combinacion-con-keytruda-r-pembrolizumab-en-pacientes-con-tumores-solidos-avanzados 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT04305145/infliximab-para-el-tratamiento-de-la-colitis-inducida-por-inhibidores-de-los-puntos-de-control-inmunitario 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07071714/un-estudio-de-fase-ii-de-la-inyeccion-de-shr-8068-en-combinacion-con-terapias-antineoplasicas-en-el-cancer-colorrectal 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT06957015/un-estudio-prospectivo-para-evaluar-el-rendimiento-de-un-sistema-en-tiempo-real-en-la-estimacion-del-tamano-de-los-polipos-colorrectales 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT04749862/vigilancia-y-apoyo-al-paciente-con-cancer 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07225309/un-estudio-sobre-la-terapia-centrada-en-el-significado-en-adultos-mexicanos-con-cancer-avanzado 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06220058/comparacion-de-la-malla-de-polipropileno-y-la-tecnica-de-pequenos-fragmentos-en-el-cierre-de-la-laparotomia-media-en-la-cirugia-colorrectal-de-emergencia-estudio-para-la-prevencion-de-la-hernia 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06710860/screentalk-para-mejorar-la-participacion-en-los-programas-de-deteccion-del-cancer-colorrectal-entre-los-familiares-de-primer-grado-de-los-pacientes-un-protocolo-de-estudio 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07574957/prediccion-de-la-diseminacion-peritoneal-de-tumores-digestivos-mediante-el-estudio-del-adn-tumoral-circulante 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT06855355/cbm588-reduce-la-recurrencia-de-polipos-colorrectales 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT06082648/estudio-de-la-reconstruccion-de-la-funcion-cerebro-intestinal-tras-la-reseccion-interesfinter-para-tumores-rectales-ultra-bajos 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07107230/un-estudio-de-jnj-95437446-en-participantes-con-tumores-solidos-en-estadio-avanzado 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06105203/ratme-frente-a-latme-en-el-cancer-de-recto-medio-e-inferior 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT05984589/entrenamiento-en-el-autocuidado-y-la-gestion-de-la-salud-personalizada-para-supervivientes-de-cancer-colorrectal 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06948539/evaluar-la-tolerabilidad-y-la-farmacocinetica-de-tqb2101-para-inyeccion-en-pacientes-con-tumores-malignos-avanzados 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07125729/pruebas-de-enfermedad-residual-minima-para-la-deteccion-temprana-de-la-recurrencia-del-cancer-en-pacientes-con-cancer-colorrectal-en-estadio-ii-iv-que-puede-ser-extirpado-quirurgicamente 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07291414/una-plataforma-de-automonitoreo-para-el-seguimiento-de-la-seguridad-de-los-medicamentos-y-las-posibles-complicaciones-en-pacientes-con-cancer 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT04095195/registro-de-sujetos-con-riesgo-de-cancer-de-pancreas 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07276932/estudio-clinico-sobre-la-aplicacion-de-acupuntura-para-aliviar-la-deficiencia-de-qi-y-el-estrenimiento-en-pacientes-sometidos-a-quimioterapia 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07036185/un-ensayo-clinico-de-kj015-en-pacientes-con-tumores-solidos-que-expresan-her2 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT06753903/papel-de-la-tomografia-computarizada-con-deteccion-de-fotones-en-la-deteccion-de-metastasis-hepaticas-del-cancer-colorrectal 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT00582621/identificacion-de-familias-para-estudios-geneticos-de-trastornos-linfoproliferativos-familiares 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07563907/terapia-neoadyuvante-total-con-quimioterapia-de-consolidacion-adicional-seguida-de-reseccion-local-frente-a-terapia-neoadyuvante-total-seguida-de-reseccion-local-en-el-cancer-de-recto-en-estadio-i 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT06231576/prehabilitacion-digital-en-el-domicilio-del-paciente-antes-de-la-cirugia 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT06544720/celulas-scg142-tcr-t-para-carcinomas-asociados-al-virus-del-papiloma-humano 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06401174/navegacion-del-paciente-para-la-deteccion-del-cancer-colorrectal 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT06603376/inyeccion-liposomal-de-irinotecan-clorhidrato-ii-combinada-con-fluorouracilo-acido-folinico-vermofenib-y-cetuximab-en-el-tratamiento-de-primera-linea-del-cancer-colorrectal-avanzado-con-mutacion 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07470827/evaluacion-de-waymed-endo-cl-cs-para-la-deteccion-y-el-diagnostico-automatizados-de-adenomas-y-lesiones-no-adenomatosas-de-cancer-colorrectal 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07219745/irrigacion-transanal-para-el-manejo-del-sindrome-de-baja-reseccion-anterior-temprana-lars 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07611071/entrenamiento-en-granularidad-emocional-integrado-con-inteligencia-artificial-para-mejorar-la-resiliencia-y-la-calidad-de-vida-en-supervivientes-de-cancer-colorrectal 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT05336539/un-estudio-de-cohorte-poblacional-para-la-deteccion-de-cancer-colorrectal-en-yangzhou-basado-en-la-deteccion-de-metilacion-poligenica 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT06597955/implementacion-a-gran-escala-de-una-herramienta-de-apoyo-a-la-toma-de-decisiones-sobre-la-deteccion-del-cancer-colorrectal 2026-09-01 weekly 0.6 https://crcwarriors.org/ensayo/NCT07353645/nanovacuna-neoantigenica-contra-kras-como-terapia-adyuvante-para-el-cancer-colorrectal-cancer-de-pancreas 2026-09-01 weekly 0.7 https://crcwarriors.org/ensayo/NCT07617727/un-estudio-de-fase-i-de-jskn021-en-tumores-solidos-avanzados 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT07622524/un-estudio-de-fase-i-de-cs5007-en-participantes-con-tumores-solidos-avanzados 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT07524140/estudio-de-ze94-0605-en-pacientes-con-tumores-solidos-avanzados-con-cohortes-de-expansion-de-dosis 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT07492680/un-estudio-de-bms-986504-en-monoterapia-y-en-combinacion-con-otros-agentes-en-participantes-con-tumores-solidos-avanzados-y-o-metastasicos-con-delecion-homocigotica-de-mtap-mountaintap-5 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT06160752/seguridad-y-actividad-antitumoral-de-tyra-200-en-el-colangiocarcinoma-avanzado-con-alteraciones-activadoras-del-gen-fgfr2 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT06244485/un-estudio-de-valemetostat-tosilato-en-combinacion-con-anticuerpos-farmaco-conjugados-adc-dirigidos-a-dxd-en-sujetos-con-tumores-solidos 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT06239467/estudio-de-fase-i-en-humanos-de-oki-219-en-tumores-solidos-avanzados-y-cancer-de-mama-avanzado 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT06084481/estudio-para-evaluar-los-eventos-adversos-y-los-cambios-en-la-actividad-de-la-enfermedad-en-participantes-adultos-con-indicaciones-especificas-de-tumores-solidos-avanzados-que-reciben-abbv-400-por 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT05887492/estudio-de-tng260-y-un-anticuerpo-anti-pd-en-tumores-solidos-con-mutacion-en-stk11 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT05307705/un-estudio-de-loxo-783-en-pacientes-con-cancer-de-mama-otros-tumores-solidos 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT05238922/estudio-de-incb123667-en-pacientes-con-tumores-solidos-avanzados 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT05108298/mejora-de-los-datos-autoinformados-por-adolescentes-y-adultos-jovenes-en-los-ensayos-clinicos-de-ecog-acrin 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT01060371/estudio-de-la-historia-natural-y-de-los-modificadores-geneticos-en-las-ataxias-espinocerebelosas 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT02521844/un-estudio-para-evaluar-la-seguridad-y-la-tolerabilidad-de-etc-1922159-como-agente-unico-y-en-combinacion-con-pembrolizumab-en-tumores-solidos-avanzados 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT07297004/radioterapia-estereotactica-de-cuerpo-completo-para-el-cancer-colorrectal-localmente-recurrente-no-susceptible-de-reseccion-quirurgica 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT07522177/narracion-de-historias-animadas-para-promover-la-deteccion-del-cancer-colorrectal 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT07567027/mejora-de-la-eficacia-de-la-criocirugia-mediante-la-aplicacion-de-barrigel-para-crear-espacio-en-el-recto-ice-barr 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT06787183/radioterapia-de-corta-duracion-scrt-combinada-con-capox-mas-ql1706-para-metastasis-hepaticas-del-cancer-de-recto 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT07112937/el-efecto-del-tratamiento-multimodal-del-cancer-de-recto-sobre-las-celulas-tumorales-circulantes-un-estudio-observacional-prospectivo 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT02301286/un-ensayo-clinico-sobre-el-uso-de-aspirina-para-reducir-la-recurrencia-y-mejorar-la-supervivencia-en-pacientes-con-cancer-de-colon 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT06583395/estudio-para-analizar-a-mil-personas-practicando-meditacion 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT05179889/quimioterapia-adyuvante-con-mfolfirinox-para-el-cancer-de-colon-en-estadio-iii-de-alto-riesgo 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT05699746/capeox-frente-a-observacion-en-pacientes-con-cancer-colorrectal-y-enfermedad-residual-detectable-mrd-positiva 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT06286956/reseccion-de-tumor-rectal-mediante-el-dispositivo-de-acceso-transanal-multicanal-uni-vec 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT05539677/biobanco-y-registro-de-pacientes-con-tumores-agresivos-para-la-investigacion-traslacional-y-analitica 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT07005453/precision-y-sostenibilidad-de-la-evaluacion-scale-eye-para-medir-el-tamano-de-los-polipos-de-forma-fiable 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT06225609/sin-estoma-frente-a-estoma-fantasma-en-pacientes-sometidos-a-reseccion-mesorrectal-total-para-el-cancer-de-recto 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT05950503/papel-de-la-resonancia-magnetica-en-la-evaluacion-de-las-metastasis-hepaticas-del-cancer-colorrectal 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT07342998/podria-la-tomografia-computarizada-ser-una-alternativa-a-las-colonoscopias-para-la-deteccion-del-cancer-colorrectal 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT07436078/adaptacion-cultural-de-una-intervencion-para-aumentar-la-realizacion-de-pruebas-geneticas-en-supervivientes-de-cancer-afroamericanos 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT02775461/registro-de-pacientes-con-cancer-de-pancreas-y-registro-de-pacientes-de-alto-riesgo 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT06583330/un-ensayo-clinico-multicentrico-aleatorizado-y-controlado-de-etiqueta-abierta-para-evaluar-la-no-inferioridad-de-la-profilaxis-postoperatoria-de-la-trombosis-venosa-profunda-y-la-embolia-pulmonar-en 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT03445936/ensayo-preloop-malla-sintetica-frente-a-malla-biologica-para-la-prevencion-de-la-hernia-incisional-tras-el-cierre-de-una-ileostomia-en-asa 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT05005117/abordaje-laparoscopico-para-la-reseccion-de-colon-en-situaciones-de-emergencia 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT04922853/comparacion-del-efecto-patologico-entre-2-y-4-ciclos-de-quimioterapia-neoadyuvante-con-capox-en-pacientes-con-cancer-colorrectal-de-estadio-ii-iii-de-riesgo-bajo-intermedio 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT04905082/hope-intervencion-genomica-para-mejorar-el-conocimiento-de-la-genomica-en-pacientes-con-cancer 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT07033026/evaluacion-de-ngm120-en-un-estudio-aleatorizado-doble-ciego-y-controlado-con-placebo-en-participantes-con-cancer-colorrectal-que-presentan-caquexia-cancerosa 2026-08-31 weekly 0.7 https://crcwarriors.org/ensayo/NCT07713472/masaje-abdominal-despues-de-la-cirugia-de-colon-por-cancer 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT07078656/efecto-de-la-formacion-en-video-sobre-la-autoeficacia-de-los-pacientes-tras-la-cirugia-de-cancer-colorrectal 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT06730035/prediccion-de-resultados-y-radioterapia-personalizada-mediante-biomarcadores-y-tecnicas-de-imagen-funcional 2026-08-31 weekly 0.6 https://crcwarriors.org/ensayo/NCT05789433/efectos-del-ejercicio-aerobico-en-la-remodelacion-del-musculo-esqueletico-en-el-cancer-colorrectal 2026-08-28 weekly 0.7 https://crcwarriors.org/ensayo/NCT07036588/ensayo-parlar-02-uso-de-un-tubo-de-drenaje-transanal-modificado-para-prevenir-las-fugas-anastomoticas 2026-08-28 weekly 0.7 https://crcwarriors.org/ensayo/NCT07557316/reduccion-de-la-afectacion-ganglionar-frente-a-regresion-del-tumor-primario-como-factores-predictivos-de-supervivencia-tras-la-terapia-neoadyuvante-total-para-el-cancer-de-recto-un-estudio 2026-08-28 weekly 0.6 https://crcwarriors.org/ensayo/NCT07369830/el-impacto-de-la-intervencion-con-probioticos-en-la-microbiota-intestinal-y-la-funcion-intestinal 2026-08-28 weekly 0.7 https://crcwarriors.org/ensayo/NCT06281405/capox-y-anticuerpo-anti-pd-1-combinados-con-o-sin-radioterapia-para-el-cancer-colorrectal-localmente-avanzado-con-mss 2026-08-28 weekly 0.7 https://crcwarriors.org/ensayo/NCT04017455/tratamiento-neoadyuvante-en-el-cancer-de-recto-con-radioterapia-seguido-de-atezolizumab-y-bevacizumab-tarzan 2026-08-28 weekly 0.6 https://crcwarriors.org/ensayo/NCT07404527/analisis-de-la-bioimpedancia-para-la-evaluacion-de-la-hidratacion-en-el-periodo-perioperatorio-en-la-cirugia-de-cancer-colorrectal 2026-08-28 weekly 0.6 https://crcwarriors.org/ensayo/NCT04120701/toma-de-decisiones-basada-en-el-adn-tumoral-circulante-para-el-tratamiento-adyuvante-en-el-cancer-de-colon-en-estadio-ii 2026-08-28 weekly 0.7 https://crcwarriors.org/ensayo/NCT06906952/ensayo-clinico-prospectivo-aleatorizado-y-controlado-realizado-en-un-unico-centro-que-compara-la-cirugia-robotica-con-la-obtencion-de-muestras-de-reseccion-transrectal-noses-iv-y-la-cirugia-robotica 2026-08-28 weekly 0.6 https://crcwarriors.org/ensayo/NCT06887244/eficacia-de-la-teleconsulta-con-enfermera-en-la-calidad-de-la-colonoscopia-electiva-la-ansiedad-relacionada-con-el-procedimiento-y-la-toxicidad-financiera 2026-08-28 weekly 0.7 https://crcwarriors.org/ensayo/NCT06450574/quimiorradioterapia-preoperatoria-y-cirugia-endoscopica-transanal-versus-cirugia-endoscopica-transanal-en-el-cancer-de-recto-t1-n0-m0-estudio-tautem-t1 2026-08-28 weekly 0.6 https://crcwarriors.org/ensayo/NCT07090304/ensayo-chino-sobre-la-deteccion-del-cancer-colorrectal-2-c-cost2 2026-08-28 weekly 0.6 https://crcwarriors.org/ensayo/NCT07461246/red-italiana-de-poliposis-adenomatosa-familiar-rete-italiana-poliposi-adenomatosa-familiare 2026-08-28 weekly 0.6 https://crcwarriors.org/ensayo/NCT05865002/un-estudio-que-evalua-la-seguridad-y-la-eficacia-de-aur107-en-pacientes-con-neoplasias-avanzadas-y-recurrentes-shakti-1 2026-08-28 weekly 0.7 https://crcwarriors.org/ensayo/NCT07605611/somatostatina-mas-dieta-liquida-clara-versus-ostomia-de-derivacion-en-pacientes-con-cancer-de-recto-sometidos-a-reseccion-anterior-ultra-baja 2026-08-28 weekly 0.7 https://crcwarriors.org/ensayo/NCT07358247/resultados-postoperatorios-de-la-anastomosis-realizada-con-una-sola-grapa-combinada-con-la-extraccion-transanal-del-especimen-a-traves-de-un-orificio-natural 2026-08-28 weekly 0.6 https://crcwarriors.org/ensayo/NCT05953662/seguridad-y-eficacia-de-la-cirugia-laparoscopica-con-un-numero-reducido-de-puertos-en-pacientes-con-cancer-de-colon-y-cancer-del-tercio-superior-del-recto 2026-08-28 weekly 0.6 https://crcwarriors.org/ensayo/NCT01789229/creacion-de-un-banco-de-tumores-para-muestras-de-tejido 2026-08-28 weekly 0.7 https://crcwarriors.org/ensayo/NCT05709249/la-formula-optimizada-xian-lian-jie-du-como-tratamiento-adyuvante-para-la-prevencion-de-la-recurrencia-del-cancer-de-colon 2026-08-28 weekly 0.7 https://crcwarriors.org/ensayo/NCT06837831/apositos-mepilex-lite-para-el-tratamiento-de-la-dermatitis-aguda-por-radiacion-de-la-piel-del-canal-anal 2026-08-27 weekly 0.7 https://crcwarriors.org/ensayo/NCT06722183/futibatinib-en-combinacion-con-quimio-inmunoterapia-en-el-cancer-colorrectal-y-otras-entidades-tumorales-solidas 2026-08-27 weekly 0.7 https://crcwarriors.org/ensayo/NCT07569250/mejora-de-la-deteccion-del-cancer-colorrectal-en-los-centros-de-salud-comunitarios-mediante-la-optimizacion-de-los-mensajes-enviados-por-dispositivos-moviles 2026-08-27 weekly 0.6 https://crcwarriors.org/ensayo/NCT07127874/un-estudio-de-phn-012-en-pacientes-con-tumores-solidos-avanzados 2026-08-27 weekly 0.7 https://crcwarriors.org/ensayo/NCT07645118/braquiterapia-seguida-de-nivolumab-antes-de-la-cirugia-en-el-cancer-de-recto 2026-08-26 weekly 0.6 https://crcwarriors.org/ensayo/NCT05365412/caracteristicas-clinicopatologicas-del-cancer-de-colon-en-pacientes-jovenes 2026-08-26 weekly 0.7 https://crcwarriors.org/ensayo/NCT07541105/conocimiento-sobre-el-cancer-entre-los-inmigrantes-sirios 2026-08-26 weekly 0.6 https://crcwarriors.org/ensayo/NCT07592793/estudio-comunitario-sobre-el-acceso-a-la-atencion-medica 2026-08-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT02705846/analisis-de-los-resultados-tras-el-diagnostico-y-el-tratamiento-del-cancer-de-prostata-en-portadores-de-mutaciones-germinales-raras 2026-08-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07726771/evaluacion-del-reservorio-ileo-anal-en-la-poliposis-adenomatosa-familiar-endopol 2026-08-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT03779009/cirugia-minimamente-invasiva-para-el-cancer-de-colon-mediante-inmunomica-y-mapeo-optico-del-ganglio-linfatico-centinela 2026-08-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06613399/reseccion-total-del-mesorrecto-integrada-con-multiples-tecnologias-frente-a-la-reseccion-total-del-mesorrecto-convencional-para-el-tratamiento-del-cancer-de-recto-medio-y-distal 2026-08-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT04930432/estudio-de-mcla-129-un-anticuerpo-humano-bispecifico-dirigido-a-egfr-y-cmet-en-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-avanzado-y-otros-tumores-solidos 2026-08-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07294690/el-efecto-del-entrenamiento-preoperatorio-con-realidad-virtual-sobre-la-ansiedad-la-preparacion-para-la-cirugia-y-el-proceso-de-recuperacion-de-los-pacientes-sometidos-a-cirugia-de-cancer-colorrectal 2026-08-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06962293/guia-magnetica-para-la-contraccion-durante-la-diseccion-submucosa-endoscopica 2026-08-24 weekly 0.7 https://crcwarriors.org/ensayo/NCT06307938/adn-tumoral-circulante-en-pacientes-citados-para-una-colonoscopia-una-biopsia-liquida-para-la-deteccion-caracterizacion-tratamiento-individualizado-y-seguimiento-del-cancer-colorrectal 2026-08-21 weekly 0.7 https://crcwarriors.org/ensayo/NCT06081647/eficacia-y-seguridad-del-dispositivo-combo-endoscopy-oropharyngeal-airway-en-los-procedimientos-de-endoscopia-gastrointestinal 2026-08-20 weekly 0.7 https://crcwarriors.org/ensayo/NCT07161713/sbu-reset-ensayo-sobre-la-relajacion-la-reduccion-del-estres-y-la-epigenetica-en-supervivientes-de-cancer 2026-07-16 weekly 0.7 https://crcwarriors.org/ensayo/NCT07600749/estudio-clinico-de-mk-4884-en-participantes-con-tumores-solidos-avanzados-o-metastasicos-mk-4884-001 2026-07-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT07473726/un-estudio-clinico-de-fase-i-para-evaluar-la-seguridad-la-tolerabilidad-y-la-farmacocinetica-de-hlx48-en-tumores-solidos-avanzados-o-metastasicos 2026-07-04 weekly 0.7 https://crcwarriors.org/ensayo/NCT06157892/un-estudio-de-disitamab-vedotina-con-otros-farmacos-antineoplasicos-en-tumores-solidos 2026-07-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05143970/un-estudio-de-fase-i-el-primero-en-humanos-del-anti-cd73-iph5301-administrado-solo-o-en-combinacion-con-quimioterapia-y-trastuzumab-en-pacientes-con-tumores-solidos-avanzados 2026-07-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT05111574/uso-de-nivolumab-solo-o-en-combinacion-con-cabozantinib-para-prevenir-la-recurrencia-del-melanoma-mucoso-tras-la-cirugia 2026-07-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT04626635/un-ensayo-clinico-para-determinar-la-seguridad-de-regn7075-y-su-eficacia-en-combinacion-con-cemiplimab-en-participantes-adultos-con-cancer-avanzado 2026-07-04 weekly 0.6 https://crcwarriors.org/ensayo/NCT07514065/capsulas-de-tsl2109-en-pacientes-con-tumores-solidos-avanzados-seguridad-tolerabilidad-farmacocinetica-y-eficacia-preliminar 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06993844/estudio-de-fase-1-2-de-etx-636-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04561362/estudio-bt8009-100-en-pacientes-con-tumores-malignos-avanzados-que-expresan-nectin-4 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05768139/estudio-de-fase-i-en-humanos-de-tersolisib-stx-478-como-monoterapia-y-en-combinacion-con-otros-agentes-antineoplasicos-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04492488/un-estudio-de-mrg002-en-pacientes-con-tumores-solidos-avanzados-her2-positivos-y-cancer-gastrico-de-la-union-gastroesofagica-gej-localmente-avanzado-o-metastasico 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06414733/vacuna-peptidica-her-2-para-celulas-b 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05458219/un-estudio-de-fase-i-en-humanos-con-ibi343-en-sujetos-con-tumores-solidos-localmente-avanzados-irresecables-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04495296/un-ensayo-para-evaluar-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-la-eficacia-preliminar-de-tst001-en-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT02453620/entinostat-nivolumab-e-ipilimumab-en-el-tratamiento-de-pacientes-con-tumores-solidos-metastasicos-o-que-no-pueden-ser-extirpados-quirurgicamente-o-con-cancer-de-mama-her2-negativo-localmente-avanzado 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07142837/estudio-de-zg005-en-combinacion-con-gecacitinib-y-quimioterapia-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06504732/para-evaluar-iah0968-en-combinacion-con-capeox-en-el-cancer-gastrico-her2-positivo 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04389632/un-estudio-de-sigvotatug-vedotina-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06311214/terapia-personalizada-con-conjugados-anticuerpo-farmaco-basada-en-pruebas-de-arn-y-proteinas-para-el-tratamiento-de-tumores-solidos-avanzados-o-metastasicos-el-ensayo-de-deteccion-y-tratamiento-adc 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05245058/comprimidos-de-sph5030-en-pacientes-con-tumores-solidos-avanzados-her2-positivos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05150691/un-estudio-de-fase-1-2a-de-db-1303-bnt323-en-tumores-solidos-avanzados-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06120283/bgb-43395-ya-sea-como-tratamiento-unico-o-como-parte-de-terapias-combinadas-en-participantes-con-cancer-de-mama-y-otros-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06299839/pas-004-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06536400/estudio-de-fase-i-de-hsk42360-en-tumores-solidos-con-mutacion-braf-v600 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07244835/un-estudio-de-deg6498-en-participantes-con-tumores-solidos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06262919/vigilancia-de-los-resultados-del-uso-especial-de-tafinlar-mekinist 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT02304809/estudio-de-fase-ii-para-evaluar-el-acceso-garantizado-a-vemurafenib-para-pacientes-con-tumores-que-presentan-alteraciones-genomicas-en-el-gen-braf 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT03839342/binimetinib-y-encorafenib-para-el-tratamiento-de-tumores-solidos-avanzados-con-mutaciones-de-braf-que-no-son-v600e 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07561554/estudio-de-fase-i-de-hsk42360-na-en-tumores-solidos-con-mutacion-braf-v600 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07407504/gensci145-como-terapia-unica-o-en-combinacion-en-participantes-con-tumores-solidos-avanzados-localmente-o-metastasicos-con-mutacion-en-pik3ca 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06208410/un-estudio-clinico-de-js105-en-combinacion-con-otras-terapias-antitumorales-en-pacientes-con-tumores-solidos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04317105/evaluacion-de-la-adicion-de-un-farmaco-antitumoral-copanlisib-al-tratamiento-inmunoterapeutico-habitual-nivolumab-con-o-sin-ipilimumab-en-pacientes-con-canceres-solidos-avanzados-que-presentan 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT03772561/estudio-de-fase-i-de-azd5363-olaparib-durvalumab-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05142423/un-estudio-de-ak109-en-combinacion-con-ak104-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05366478/un-estudio-clinico-de-la-inyeccion-de-lm103-en-el-tratamiento-de-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07069062/un-estudio-clinico-de-fase-i-ii-en-humanos-con-hy0001a-para-inyeccion-en-participantes-adultos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06184035/un-estudio-de-escalada-de-dosis-y-expansion-de-177lu-lu-sn201-en-participantes-con-cancer-avanzado 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05689853/estudio-de-ak119-en-combinacion-con-ak112-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06928363/un-estudio-de-primera-administracion-en-humanos-de-ky-0301-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT03682289/ceralasertib-azd6738-en-monoterapia-y-en-combinacion-con-olaparib-o-durvalumab-en-pacientes-con-tumores-solidos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06345482/un-estudio-de-mhb039a-en-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07582822/jh021-en-pacientes-con-tumores-solidos-avanzados-o-cpnp-con-mutacion-en-el-egfr 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05156203/estudio-de-seguridad-y-tolerabilidad-de-las-capsulas-de-t-1301-para-el-tratamiento-de-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04967833/un-estudio-de-las-celulas-til-gc101-en-tumores-solidos-avanzados-tr 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06936735/un-estudio-de-fase-i-de-hs-20108-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06589596/un-estudio-de-investigacion-de-bgb-58067-como-agente-unico-y-en-combinacion-con-agentes-antineoplasicos-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06929663/un-estudio-de-ak146d1-para-inyeccion-en-el-tratamiento-de-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07196644/un-estudio-para-evaluar-los-eventos-adversos-y-los-cambios-en-la-actividad-de-la-enfermedad-en-participantes-de-12-anos-o-mas-con-tumores-solidos-avanzados-localmente-o-metastasicos-que-presenten 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06166888/un-estudio-de-ak131-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06939270/celulas-hyposti-car-t-dirigidas-contra-cd73-axl-en-tumores-solidos-avanzados-metastasicos-positivos-para-cd73-axl 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07181681/un-estudio-de-fase-i-en-humanos-con-bg-c0902-administrado-en-monoterapia-y-en-combinacion-con-otros-agentes-terapeuticos-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05038150/estudio-de-sgn1-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT02332668/un-estudio-de-pembrolizumab-mk-3475-en-participantes-pediatricos-con-un-tumor-solido-avanzado-o-linfoma-mk-3475-051-keynote-051 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06270706/un-estudio-de-fase-i-de-pln-101095-en-adultos-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07372625/un-estudio-para-investigar-los-efectos-de-multiples-dosis-de-rezatapopt-sobre-la-farmacocinetica-de-metformina-rosuvastatina-repaglinida-y-midazolam-en-pacientes-con-tumores-solidos-avanzados-que 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05940116/un-estudio-clinico-de-fase-i-de-hs-20117-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07106814/seguridad-y-eficacia-de-los-linfocitos-infiltrantes-tumorales-metabolicamente-potenciados-meta10-til-para-el-tratamiento-de-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT03440450/un-estudio-de-fase-i-de-escalada-de-dosis-de-ff-10832-para-el-tratamiento-de-tumores-solidos-incluidos-los-canceres-del-tracto-biliar 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06132217/un-estudio-de-simitinib-mas-sg001-en-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05954091/oh2-administrado-mediante-inyeccion-intratumoral 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06724042/estudio-de-ism5939-en-pacientes-con-tumores-solidos-avanzados-y-o-metastasicos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07083323/un-estudio-de-fase-i-ii-de-hy05350-en-tumores-solidos-avanzados-positivos-para-mesotelina-msln 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06639256/estudio-clinico-de-fase-1-2-de-hy07121-polvo-para-solucion-para-infusion-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06170294/terapia-con-celulas-t-modificadas-con-receptores-de-celulas-t-dirigidos-contra-mage-a4-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05693844/terapia-celular-car-t-que-sobreexpresa-msln-y-se-utiliza-como-refuerzo-en-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06672523/un-estudio-para-evaluar-el-balance-de-masas-el-metabolismo-la-eliminacion-y-los-niveles-del-farmaco-14c-bms-986504-mrtx1719-en-participantes-con-tumores-solidos-avanzados-con-delecion-homocigotica 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07583316/un-estudio-de-fase-i-el-primero-en-humanos-de-crpa1a2-un-activador-bispecifico-de-linfocitos-t-dirigido-a-mage-a1-hla-a-02-01-en-pacientes-con-tumores-solidos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06625593/un-estudio-de-primera-administracion-en-humanos-fih-de-bg-c137-un-conjugado-anticuerpo-farmaco-dirigido-al-receptor-2b-del-factor-de-crecimiento-de-fibroblastos-fgfr2b-en-participantes-con-tumores 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05882292/inhibidor-de-c-met-en-tumores-solidos-avanzados-con-alteraciones-en-el-gen-c-met 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05867251/estudio-de-avzo-021-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT03842228/evaluacion-de-la-combinacion-de-los-farmacos-anticancerosos-copanlisib-olaparib-y-medi4736-durvalumab-en-pacientes-con-tumores-solidos-avanzados-con-mutaciones-seleccionadas 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07029399/un-estudio-con-nkt5097-en-adultos-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06548672/un-estudio-para-evaluar-la-seguridad-la-farmacocinetica-y-la-actividad-antitumoral-de-bc3195-en-pacientes-con-cancer-avanzado-o-metastasico 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06726148/estudio-de-eci830-como-agente-unico-o-en-combinacion-en-pacientes-con-cancer-de-mama-avanzado-hr-her2-y-otros-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05378425/un-estudio-de-ntx-1088-un-anticuerpo-monoclonal-dirigido-al-receptor-del-poliovirus-pvr-cd155-como-monoterapia-y-en-combinacion-con-pembrolizumab 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06586957/un-estudio-con-nkt3964-en-adultos-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06695689/un-estudio-clinico-iniciado-por-el-investigador-sobre-la-inyeccion-de-lm303-para-el-tratamiento-de-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07288359/estudio-de-gvv858-como-agente-unico-o-en-combinacion-con-terapia-endocrina-en-pacientes-con-cancer-de-mama-hr-her2-y-otros-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06188702/s095035-como-agente-unico-y-en-combinacion-en-participantes-adultos-con-tumores-solidos-avanzados-o-metastasicos-con-delecion-de-mtap 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT04616534/evaluacion-de-la-adicion-de-un-farmaco-antitumoral-elimusertib-bay-1895344-un-inhibidor-de-atr-al-tratamiento-de-quimioterapia-gemcitabina-para-el-cancer-avanzado-de-pancreas-y-ovario-y-para-tumores 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05918445/pm8002-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT03810339/toripalimab-js001-como-terapia-unica-en-participantes-con-tumores-solidos-avanzados-con-mutaciones-en-los-genes-pole-o-pold-1-y-que-no-presentan-msi-h 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06669117/ensayo-fih-de-vert-002-en-pacientes-con-tumores-solidos-avanzados-localmente-o-metastasicos-con-alteraciones-en-met 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT02715284/estudio-de-tsr-042-un-anticuerpo-monoclonal-anti-receptor-de-muerte-celular-programada-1-pd-1-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06730581/utidelona-en-capsulas-como-monoterapia-para-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT03767075/un-ensayo-modular-multi-cestas-para-mejorar-la-medicina-personalizada-en-pacientes-con-cancer-ensayo-de-multiples-cestas 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07030712/un-estudio-clinico-de-mk-8294-en-participantes-con-tumores-solidos-avanzados-mk-8294-001 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05525858/estudio-kpmng-sobre-terapia-guiada-por-el-perfilado-molecular-basada-en-alteraciones-genomicas-en-tumores-solidos-avanzados-ii 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06298058/un-ensayo-clinico-de-sibp-a13-inyectable-en-el-tratamiento-de-pacientes-con-tumores-solidos-malignos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04606381/un-estudio-sobre-la-administracion-subcutanea-de-amivantamab-para-el-tratamiento-de-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT03556228/vmd-928-en-monoterapia-y-en-combinacion-con-pembrolizumab-para-el-tratamiento-de-tumores-solidos-o-linfomas-con-sobreexpresion-de-trka 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04785196/apg-115-en-combinacion-con-un-inhibidor-de-pd-1-en-pacientes-con-liposarcoma-avanzado-o-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT03155620/terapia-dirigida-basada-en-pruebas-geneticas-para-el-tratamiento-de-pacientes-pediatricos-con-tumores-solidos-avanzados-recurrentes-o-refractarios-linfomas-no-hodgkin-u-otros-trastornos-histiociticos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05269381/vacuna-basada-en-peptidos-neoantigenicos-personalizados-en-combinacion-con-pembrolizumab-para-el-tratamiento-de-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04320888/selpercatinib-para-el-tratamiento-de-tumores-solidos-avanzados-linfomas-u-otros-trastornos-histiociticos-con-alteraciones-activadoras-del-gen-ret-un-ensayo-de-tratamiento-pediatrico-match 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT02029001/adaptacion-del-tratamiento-a-las-alteraciones-moleculares-del-tumor-en-pacientes-con-tumores-solidos-avanzados-myownspecifictreatment 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07253116/un-estudio-clinico-de-fase-i-ii-de-wj22096-en-comprimidos-en-pacientes-con-tumores-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05265091/un-estudio-de-kl590586-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06156332/un-estudio-de-surufatinib-en-combinacion-con-serplulimab-en-el-tratamiento-de-tumores-solidos-avanzados-con-diferenciacion-neuroendocrina-que-no-respondieron-a-la-terapia-estandar 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06169579/un-estudio-abierto-de-fase-i-para-determinar-la-dosis-maxima-tolerada-de-nd-003-en-pacientes-con-canceres-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05103345/estudio-de-sgn1-administrado-mediante-inyeccion-intratumoral-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04683250/estudio-del-inhibidor-de-ret-tas0953-hm06-en-pacientes-con-tumores-solidos-avanzados-con-alteraciones-en-el-gen-ret 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04898543/quilt-3-076-estudio-de-celulas-m-cenk-autologas-en-sujetos-con-tumores-solidos-avanzados-localmente-o-metastasicos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07349160/seguridad-y-eficacia-de-los-linfocitos-infiltrantes-tumorales-metabolicamente-potenciados-meta10-til-para-el-tratamiento-de-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04280081/un-estudio-de-selpercatinib-ly3527723-en-participantes-con-tumores-solidos-avanzados-incluidos-los-tumores-solidos-con-fusion-de-ret-el-cancer-de-tiroides-medular-y-otros-tumores-con-activacion-de-ret 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06636435/un-estudio-de-fase-i-el-primero-en-humanos-de-cba-1205-un-anticuerpo-monoclonal-anti-dlk1-en-pacientes-con-tumores-solidos-avanzados-carcinoma-hepatocelular-chc-melanoma-y-cancer-pediatrico 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07252661/estudio-de-acc-1898-en-participantes-adultos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT04299191/estudio-de-lam561-en-pacientes-pediatricos-con-glioma-maligno-y-otros-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05451602/hec169096-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06943521/un-estudio-de-mt-4561-en-pacientes-con-diversos-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05653869/un-estudio-de-aps03118-en-tumores-solidos-avanzados-que-presentan-mutaciones-o-fusiones-en-el-gen-ret 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06712680/un-estudio-de-fase-i-ii-de-la-monoterapia-con-hyp-6589-en-el-tratamiento-de-tumores-solidos-avanzados-y-en-combinacion-con-inhibidores-de-la-tirosina-quinasa-en-el-tratamiento-de-pacientes-con-cpnp 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06656390/un-estudio-para-evaluar-la-seguridad-la-tolerabilidad-la-farmacocinetica-pk-y-la-actividad-antitumoral-de-alk201-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04693468/talazoparib-y-palbociclib-axitinib-o-crizotinib-para-el-tratamiento-de-tumores-solidos-avanzados-o-metastasicos-ensayo-talacom 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07359820/un-estudio-de-lirafugratinib-en-tumores-solidos-no-derivados-del-colangiocarcinoma-con-fusion-o-reordenamiento-de-fgfr2 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07645742/estudio-piloto-sobre-el-ayuno-intermitente-en-combinacion-con-inhibidores-de-los-puntos-de-control-inmunitario 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06561685/un-estudio-de-ly4050784-en-participantes-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06777316/un-estudio-de-un-inhibidor-de-fgfr2-3-cgt4859-en-pacientes-con-colangiocarcinoma-y-otros-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06233942/estudio-de-fase-1a-1b-el-primero-en-humanos-de-bg-c9074-en-monoterapia-y-en-combinacion-con-otras-terapias-antineoplasicas-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06302621/pemigatinib-afatinib-en-tumores-solidos-avanzados-refractarios 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05812027/un-estudio-de-cribado-para-recolectar-muestras-de-taa-hla-y-perdida-de-heterocigosidad-de-hla-en-pacientes-con-tumores-solidos-metastasicos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05614739/forager-1-un-estudio-de-loxo-435-ly3866288-en-participantes-con-cancer-que-presentan-una-alteracion-en-un-gen-denominado-fgfr3 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07251166/un-estudio-para-evaluar-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-la-eficacia-preliminar-de-gensci140-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06915753/seguridad-y-actividad-antitumoral-preliminar-de-tyra-430-en-carcinoma-hepatocelular-avanzado-y-otros-tumores-solidos-con-alteraciones-activadoras-de-la-via-fgf-fgfr 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05174637/un-estudio-de-fda018-adc-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05544552/seguridad-y-actividad-antitumoral-preliminar-de-tyra-300-en-carcinoma-urotelial-avanzado-y-otros-tumores-solidos-con-alteraciones-en-el-gen-fgfr3 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06049212/sacituzumab-tirumotecan-mk-2870-como-monoterapia-y-en-combinacion-con-pembrolizumab-en-participantes-con-tumores-solidos-avanzados-mk-2870-008 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06874335/un-estudio-de-fase-i-de-bhv-1530-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05888857/medi5752-en-pacientes-con-tumores-solidos-que-presentan-estructuras-linfoides-terciarias-maduras 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06500676/un-estudio-de-gfh375-en-pacientes-con-tumores-solidos-avanzados-con-mutaciones-kras-g12d 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07448116/estudio-de-mcla-129-en-combinacion-con-ensartinib-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05067283/un-estudio-de-calderasib-mk-1084-en-tumores-solidos-avanzados-con-mutacion-de-kras-mk-1084-001 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06787950/estudio-clinico-de-asn-3186-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05533463/estudio-de-fase-i-de-hrs-4642-en-pacientes-con-tumores-solidos-avanzados-que-presentan-la-mutacion-kras-g12d 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07265622/estudio-de-fase-i-con-7mw4911-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06963398/un-estudio-de-hs-10529-en-pacientes-con-tumores-solidos-avanzados-y-mutacion-kras-g12d 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07439094/un-estudio-de-fase-i-en-humanos-con-ckd-703-en-tumores-solidos-avanzados-y-cancer-de-pulmon-no-microcitico 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07441174/in10018-en-combinacion-con-rnk08954-para-el-tratamiento-de-tumores-solidos-avanzados-localmente-o-metastasicos-con-mutacion-krasg12d 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06428331/un-estudio-de-skb518-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT03785249/estudio-de-fase-1-2-de-mrtx849-en-pacientes-con-cancer-que-presentan-una-mutacion-kras-g12c-krystal-1 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07231081/estudio-de-fase-i-de-las-celulas-car-t-tx103-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06424665/un-estudio-de-fz-ad005-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07474168/terapia-celular-con-receptores-de-celulas-t-modificados-geneticamente-y-receptores-de-tgf-dominantes-negativos-dirigida-a-las-mutaciones-de-kras-en-el-tratamiento-de-sujetos-con-tumores-solidos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05914545/un-estudio-de-fz-ad004-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07354711/un-estudio-de-fase-i-con-3h-10000-en-pacientes-con-tumores-solidos-irresecables-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06956261/nw-301-terapia-con-celulas-t-modificadas-con-receptores-quimericos-tcr-t-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT02079740/trametinib-y-navitoclax-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07067567/un-estudio-de-ak146d1-para-inyeccion-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07456046/un-estudio-de-fase-i-de-d3s-003-como-monoterapia-en-participantes-con-tumores-solidos-avanzados-con-una-mutacion-kras-p-g12d 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05662397/un-estudio-de-hst-1011-administrado-como-monoterapia-y-en-combinacion-con-un-anticuerpo-anti-pd1 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07558200/estudio-de-fase-ia-ib-con-fxb0871-en-monoterapia-en-tumores-solidos-avanzados-localmente-o-metastasicos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06947811/un-estudio-de-almonertinib-en-combinacion-con-palbociclib-en-pacientes-con-tumores-solidos-avanzados-que-presentan-mutaciones-en-el-gen-kras 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06598800/estudio-de-bg-t187-en-monoterapia-y-en-combinacion-con-otros-agentes-terapeuticos-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07247110/un-estudio-clinico-de-mk-4716-en-pacientes-con-determinados-tumores-solidos-mk-4716-001 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07541001/prl3-zumab-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05638295/evaluacion-del-uso-de-amg-510-sotorasib-y-panitumumab-como-tratamiento-dirigido-para-canceres-de-tumores-solidos-con-mutacion-kras-g12c-ensayo-clinico-combomatch 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07292038/seguridad-y-farmacocinetica-de-nm6603-en-pacientes-chinos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06949761/un-estudio-clinico-para-evaluar-la-seguridad-la-tolerabilidad-y-la-eficacia-de-qlc1101-en-combinacion-con-otras-terapias-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados-que-presentan-una 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06373406/un-estudio-de-mhb036c-para-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06803680/un-estudio-de-bgb-b455-en-adultos-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06715124/qtx3544-en-pacientes-con-tumores-solidos-avanzados-con-mutaciones-kras-g12v 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05979155/un-estudio-de-nwy001-en-sujetos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06596473/un-estudio-de-bg-c477-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05585320/un-estudio-de-fase-1-2a-de-imm-1-104-en-participantes-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05382559/un-estudio-de-asp3082-en-adultos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04093466/un-estudio-de-fase-i-de-cx1003-kanitinib-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06179160/un-estudio-para-evaluar-incb161734-en-participantes-con-tumores-solidos-avanzados-o-metastasicos-con-mutacion-kras-g12d 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT02099058/un-estudio-que-evalua-la-seguridad-la-farmacocinetica-pk-y-la-eficacia-preliminar-de-abbv-399-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07417189/un-estudio-de-fase-i-ii-de-absk141-en-pacientes-con-tumores-solidos-avanzados-absk141-101 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05951608/un-estudio-clinico-de-fase-ib-ii-de-ak127-en-combinacion-con-ak112-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06385678/un-estudio-de-hrs-4642-en-pacientes-con-tumores-solidos-avanzados-que-presentan-la-mutacion-kras-g12d 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06820424/seguridad-y-eficacia-preliminar-de-la-terapia-con-celulas-car-t-anti-cdh17-en-pacientes-con-tumores-solidos-avanzados-cdh17-positivos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06970132/estudio-de-sy-5933-mas-ct-707-en-tumores-solidos-avanzados-con-mutacion-kras-p-g12c 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07382531/inyeccion-de-oh2-en-combinacion-con-inyeccion-de-bs006-para-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06991478/inyeccion-de-sk-nk-en-pacientes-con-tumores-solidos-avanzados-que-presentan-ascitis-maligna 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07342738/terapia-con-celulas-t-modificadas-con-receptores-de-celulas-t-tcr-para-tumores-solidos-avanzados-con-mutacion-en-el-gen-kras 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT04370587/un-estudio-clinico-de-mvr-t3011-t3011-administrado-intratumoralmente-ya-sea-como-agente-unico-o-en-combinacion-con-pembrolizumab-intravenoso-en-participantes-con-tumores-solidos-avanzados-o 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06804824/un-estudio-de-fase-inicial-en-humanos-fih-para-evaluar-la-seguridad-y-la-tolerabilidad-de-vvd-159642-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06694480/estudio-de-fid-022-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05009329/un-estudio-de-jab-21822-en-pacientes-adultos-con-tumores-solidos-avanzados-que-presentan-la-mutacion-kras-p-g12c-en-china 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07436728/un-estudio-de-tak-505-en-adultos-con-tumores-solidos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05410145/un-estudio-de-la-monoterapia-con-d3s-001-o-la-terapia-combinada-en-sujetos-con-tumores-solidos-avanzados-con-una-mutacion-kras-p-g12c 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04794699/estudio-de-ide397-en-participantes-con-tumores-solidos-que-presentan-delecion-de-mtap 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT03875820/ensayo-de-fase-i-con-defactinib-y-vs-6766 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05417321/un-estudio-que-evalua-la-seguridad-y-la-eficacia-de-hb0036-en-sujetos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06096974/inhibidor-pan-ras-yl-17231-en-pacientes-con-tumores-solidos-avanzados-que-presentan-mutaciones-en-kras-hras-o-nras 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06707610/un-estudio-para-evaluar-la-seguridad-la-tolerabilidad-la-farmacocinetica-pk-y-la-actividad-antitumoral-de-alk202-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06944457/ensayo-clinico-para-evaluar-la-seguridad-la-tolerabilidad-y-la-farmacocinetica-de-mpd-1-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06414460/estudio-de-ism3412-en-participantes-con-tumores-solidos-avanzados-localmente-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07021898/un-estudio-de-eras-4001-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06928922/vacuna-en-polvo-seca-de-arnm-inhalable-que-contiene-antigenos-tumorales-en-pacientes-con-cancer-de-pulmon-avanzado-y-metastasis-pulmonares-de-tumores-solidos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07134998/estudio-de-fase-i-de-hrs-6093-en-participantes-con-tumores-solidos-avanzados-que-presentan-mutaciones-kras-g12d 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT03993873/estudio-de-tpx-0022-en-pacientes-con-cancer-de-pulmon-no-microcitico-avanzado-cancer-gastrico-o-tumores-solidos-que-presenten-alteraciones-geneticas-en-met 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06090266/un-estudio-de-or502-un-anticuerpo-monoclonal-dirigido-contra-lilrb2-en-monoterapia-y-en-combinacion-con-agentes-antineoplasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06162221/estudio-de-inhibidores-de-ras-on-en-pacientes-con-cancer-de-pulmon-no-microcitico-cpnm-avanzado-con-mutacion-en-el-gen-ras 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05919537/estudio-de-un-anticuerpo-anti-her3-hmbd-001-con-o-sin-quimioterapia-en-pacientes-con-tumores-solidos-que-presenten-una-fusion-de-nrg1-o-una-mutacion-de-her3 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06243354/estudio-de-fase-i-ii-de-hyp-2090ptsa-en-pacientes-con-tumores-solidos-avanzados-que-presentan-la-mutacion-kras 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06171750/estudio-de-fase-i-de-tolododequina-alfa-ank-101-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06484790/terapia-celular-con-celulas-t-modificadas-geneticamente-para-expresar-el-receptor-de-celulas-t-dirigida-a-las-mutaciones-de-kras-en-el-tratamiento-de-sujetos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06488950/un-estudio-de-los-linfocitos-infiltrantes-tumorales-en-tumores-solidos-avanzados-dfgd 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06008288/un-estudio-de-fase-ii-que-evalua-la-monoterapia-con-jab-21822-en-pacientes-adultos-con-cancer-de-pancreas-y-otros-tumores-solidos-que-presentan-la-mutacion-kras-p-g12c 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07417501/lenvatinib-mas-un-inhibidor-de-pd-1-para-tumores-solidos-avanzados-con-amplificacion-de-11q13 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06166836/un-estudio-para-evaluar-la-seguridad-y-la-eficacia-de-d-1553-en-combinacion-con-in10018-en-tumores-solidos-con-mutacion-kras-g12c 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06992687/un-estudio-para-evaluar-la-seguridad-y-la-eficacia-de-hb0052-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06959615/un-estudio-de-fase-i-iia-de-jab-23e73-en-pacientes-con-tumores-solidos-avanzados-que-presentan-alteraciones-en-el-gen-kras 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07345637/estudio-de-fase-i-de-fxs887-en-el-tratamiento-de-tumores-solidos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06435455/gh21-en-combinacion-con-d-1553-en-tumores-solidos-avanzados-con-mutacion-kras-g12c 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05541822/evaluar-la-eficacia-la-seguridad-la-tolerabilidad-y-el-perfil-farmacocinetico-de-abn401-en-pacientes-con-tumores-solidos-avanzados-que-presenten-alteraciones-en-c-met 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07252479/evaluacion-del-tratamiento-con-un-inhibidor-de-ras-en-participantes-con-tumores-solidos-avanzados-o-metastasicos-que-presenten-mutaciones-en-ras 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06384352/un-estudio-de-fase-i-para-evaluar-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-la-eficacia-de-yl211-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07615413/estudio-de-fase-i-de-hs-10541-como-monoterapia-o-en-combinacion-con-otras-terapias-antineoplasicas-en-pacientes-con-tumores-solidos-avanzados-con-mutacion-kras-g12c 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05981703/un-estudio-que-investiga-el-uso-de-bgb-26808-en-monoterapia-o-en-combinacion-con-tislelizumab-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05785741/un-estudio-de-db-1310-en-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05341492/terapia-car-t-anti-egfr-b7h3-en-cancer-de-pulmon-y-cancer-de-mama-triple-negativo 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07612137/estudio-de-la-terapia-combinada-con-ibi3005-en-participantes-con-tumores-solidos-irresecables-localmente-avanzados-o-metastasicos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06667544/un-estudio-de-rnk08954-en-sujetos-con-tumores-solidos-avanzados-con-mutacion-kras-g12d-del-gen-kirsten-rat-sarcoma 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05327010/evaluacion-de-la-combinacion-de-los-farmacos-antineoplasicos-zen003694-zen-3694-y-talazoparib-en-pacientes-con-tumores-solidos-avanzados-ensayo-combet 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06758557/un-estudio-para-evaluar-la-seguridad-y-la-eficacia-de-la-inyeccion-de-hb0025-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04973163/un-estudio-para-evaluar-diferentes-dosis-de-bi-1823911-solo-y-en-combinacion-con-otros-medicamentos-en-pacientes-con-diferentes-tipos-de-cancer-avanzado-con-mutacion-en-el-gen-kras 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06115642/un-estudio-de-fase-i-para-evaluar-la-seguridad-la-tolerabilidad-y-la-farmacocinetica-de-hlx43-en-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06797336/un-estudio-de-pt0253-en-participantes-con-tumores-solidos-avanzados-con-mutacion-kras-g12d 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06619587/un-estudio-para-evaluar-la-seguridad-la-farmacocinetica-y-la-actividad-de-gdc-7035-como-agente-unico-y-en-combinacion-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07327411/cetuximab-combinado-con-el-regimen-prag-en-el-tratamiento-de-tumores-solidos-avanzados-y-refractarios-egfr-positivos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06520488/un-estudio-de-hrs-4642-en-combinacion-con-agentes-antineoplasicos-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT00045201/erlotinib-clorhidrato-e-irinotecan-clorhidrato-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06478251/terapia-celular-con-celulas-t-modificadas-geneticamente-para-expresar-el-receptor-de-celulas-t-dirigida-a-las-mutaciones-de-kras-en-el-tratamiento-de-sujetos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06960395/seguridad-y-eficacia-preliminar-de-vir-5525-y-vir-5525-pembrolizumab-en-participantes-con-tumores-solidos-localmente-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04185883/actividad-de-sotorasib-en-sujetos-con-tumores-solidos-avanzados-con-mutacion-kras-p-g12c-codebreak-101 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07136779/ensayo-clinico-de-fase-i-con-vbc101-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06594874/un-estudio-de-fase-ib-de-hs-10370-en-combinacion-con-otras-terapias-antineoplasicas-en-participantes-con-tumores-solidos-avanzados-con-mutacion-kras-g12c 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05533697/estudio-de-mrna-4359-administrado-solo-y-en-combinacion-con-bloqueo-de-puntos-de-control-inmunitarios-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05631899/vacuna-car-dc-e-inhibidores-de-puntos-de-control-inmunitario-en-tumores-solidos-avanzados-localmente-o-metastasicos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07181473/un-estudio-para-evaluar-la-seguridad-la-farmacocinetica-y-la-eficacia-de-tj101-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05367778/estudio-de-fase-1-2-de-hs-10370-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05498428/un-estudio-de-amivantamab-en-participantes-con-tumores-solidos-avanzados-o-metastasicos-incluidos-los-canceres-de-pulmon-no-microcitico-con-mutaciones-en-el-receptor-del-factor-de-crecimiento 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07038343/aventine-1-estudio-de-avzo-1418-como-agente-unico-y-en-combinacion-terapeutica-en-pacientes-con-tumores-solidos-avanzados-localmente-o-metastasicos-avzo-1418-1001 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07094113/amg-410-en-monoterapia-y-en-combinacion-con-otros-farmacos-en-participantes-con-tumores-solidos-avanzados-o-metastasicos-con-alteraciones-en-el-gen-kras 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07510841/inyeccion-de-jy016-en-pacientes-con-tumores-solidos-avanzados-que-expresan-egfr 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06484556/terapia-celular-con-celulas-t-modificadas-geneticamente-para-expresar-el-receptor-de-celulas-t-dirigida-a-las-mutaciones-de-kras-en-el-tratamiento-de-sujetos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05948865/un-estudio-de-fase-i-de-cpo301-en-pacientes-adultos-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06172478/un-estudio-de-her3-dxd-en-sujetos-con-tumores-solidos-avanzados-localmente-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06710132/estudio-del-adc-anti-ceacam5-m9140-en-participantes-con-tumores-solidos-avanzados-proceade-pantumor 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05765851/un-estudio-de-la-terapia-combinada-con-ds-1103a-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04305795/un-estudio-abierto-que-utiliza-la-fotoinmunoterapia-asp-1929-en-combinacion-con-terapia-anti-pd1-en-tumores-solidos-avanzados-que-expresan-egfr 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07309770/trastuzumab-rezetecan-en-tumores-solidos-avanzados-refractarios-a-las-terapias-estandar 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06210815/un-estudio-de-hlx42-en-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07287995/un-estudio-de-asp2998-administrado-solo-y-en-combinacion-con-terapias-estandar-en-pacientes-con-tumores-solidos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04412616/zz06-en-pacientes-adultos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06784193/estudio-de-fase-i-de-op-3136-en-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05914376/seguridad-de-la-inyeccion-con-virus-vaccinia-oncolitico-recombinante-que-expresa-il-21-humana-hv01-en-tumores-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05417594/estudio-de-azd9574-como-monoterapia-y-en-combinacion-con-agentes-antineoplasicos-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06415487/ace2016-en-pacientes-adultos-con-tumores-solidos-localmente-avanzados-o-metastasicos-que-expresan-el-receptor-del-factor-de-crecimiento-epidermico-egfr 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07109726/un-ensayo-de-fase-i-ii-de-ter-2013-en-pacientes-con-tumores-solidos-que-presentan-alteraciones-en-la-via-akt-pi3k-pten 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07444814/estudio-que-evalua-la-seguridad-y-la-eficacia-de-hwk-007-un-conjugado-anticuerpo-farmaco-dirigido-a-ptk7-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06112041/estudio-clinico-prospectivo-de-terapia-prag-de-precision-en-pacientes-ancianos-con-tumores-solidos-malignos-avanzados-prag9-0 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06014502/estudio-para-evaluar-el-tratamiento-con-imgs-001-en-pacientes-con-tumores-solidos-avanzados-recurrentes-o-refractarios 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06188520/un-estudio-de-fase-i-de-escalada-de-dosis-y-expansion-para-evaluar-la-seguridad-y-la-tolerabilidad-de-azd8421-en-monoterapia-o-en-combinacion-en-participantes-con-tumores-solidos-avanzados-o 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05687682/seguridad-de-la-infusion-de-am-928-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07612891/un-estudio-para-evaluar-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-la-actividad-antitumoral-preliminar-de-inv-6452-en-pacientes-adultos-con-cancer-de-mama-avanzado-o-metastasico-receptor 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07124793/un-estudio-de-la-terapia-combinada-con-ibi363-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06907043/un-estudio-de-un-inhibidor-selectivo-de-parp1-eik1004-imp1707-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07539285/un-estudio-de-hdm2024-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07523529/celulas-car-t-dirigidas-a-dos-dianas-y-guiadas-por-biomarcadores-para-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06431594/un-estudio-para-evaluar-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-la-actividad-clinica-de-gsk5733584-para-inyeccion-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07361562/un-estudio-de-un-inhibidor-selectivo-de-erbb2-cgt4255-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06618287/un-estudio-para-evaluar-la-seguridad-la-tolerabilidad-los-niveles-del-farmaco-y-la-eficacia-preliminar-de-las-combinaciones-de-bms-986507-en-participantes-adultos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07038369/un-estudio-de-fase-i-de-atv-1601-en-pacientes-con-cancer-avanzado-que-presentan-mutaciones-e17k-en-el-gen-akt1 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06101082/un-estudio-clinico-que-evalua-la-seguridad-y-la-eficacia-de-la-inyeccion-de-celulas-car-t-anti-her2-en-pacientes-con-tumores-solidos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05720117/un-estudio-de-pyx-201-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07387068/ensayo-para-evaluar-la-seguridad-y-la-eficacia-preliminar-de-gen1079-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05423977/estudio-de-zv0203-en-pacientes-con-tumores-solidos-avanzados-her2-positivos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06950086/estudio-de-las-tabletas-de-tyk-00540-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04997993/leflunomida-en-pacientes-con-tumores-solidos-avanzados-con-alteraciones-en-el-gen-pten-y-cancer-de-mama-her2-negativo 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05627960/estudio-de-fase-i-el-primero-en-humanos-del-anticuerpo-anti-progranulina-gp88-ag01-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04294628/evaluacion-de-los-efectos-biologicos-de-ds-8201a-en-pacientes-con-cancer-avanzado 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06616766/un-estudio-de-fase-1-2-abierto-multicentrico-de-investigacion-del-investigador-fih-para-evaluar-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-la-actividad-antitumoral-de-yh42946 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05593094/un-ensayo-de-fase-i-con-capsulas-entericas-de-zn-a-1041-o-en-combinacion-en-participantes-con-tumores-solidos-avanzados-her2-positivos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06027983/celulas-t-con-receptores-quimericos-y-trastuzumab-en-cancer-de-mama-avanzado-her2-y-otros-tumores-solidos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT04606446/estudio-de-pf-07248144-en-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06644300/estudio-de-bm230-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06998407/orion-1-estudio-de-avzo-023-como-agente-unico-y-en-combinacion-con-avzo-021-y-o-terapia-endocrina-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04639219/un-estudio-de-t-dxd-para-el-tratamiento-de-tumores-solidos-que-presentan-mutaciones-activadoras-de-her2 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06003231/un-estudio-de-disitamab-vedotina-en-tumores-solidos-previamente-tratados-que-expresan-her2 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06431243/un-estudio-clinico-de-purinostat-mesilato-para-inyeccion-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06719362/un-ensayo-clinico-para-evaluar-la-seguridad-la-tolerabilidad-y-la-eficacia-clinica-de-la-monoterapia-con-m3t01-y-en-combinacion-con-pembrolizumab-y-otras-terapias-sistemicas 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05275777/un-estudio-de-fase-ib-para-evaluar-la-seguridad-seguido-de-un-estudio-de-fase-ii-de-adg106-en-combinacion-con-quimioterapia-neoadyuvante-en-cancer-de-mama-her2-negativo 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07601334/seguridad-y-actividad-de-hf50-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05940896/rc48-adc-en-combinacion-con-radioterapia-en-el-tratamiento-de-tumores-solidos-localmente-avanzados-con-expresion-de-her2 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07122063/estudio-clinico-para-evaluar-la-seguridad-la-tolerabilidad-la-farmacocinetica-y-la-eficacia-preliminar-de-sys6045-en-pacientes-con-tumores-solidos-malignos-avanzados-her2-positivos-que-expresen-o 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05985655/estudio-para-evaluar-gtaexs617-en-participantes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05101096/estudio-de-sacituzumab-govitecan-sg-en-participantes-japoneses-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07646626/ssgj-705-mas-ssgj-612-quimioterapia-en-tumores-solidos-avanzados-her2-positivos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06512116/un-ensayo-clinico-de-la-inyeccion-sibp-a17-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06376136/un-estudio-clinico-abierto-multicentrico-para-evaluar-la-seguridad-tolerabilidad-el-perfil-farmacocinetico-y-la-eficacia-clinica-inicial-de-bat-8010-para-inyeccion-en-combinacion-con-bat-1006-en-el 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05933265/estudio-de-lp-184-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05311397/un-estudio-de-a166-en-pacientes-con-tumores-solidos-malignos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06769425/hs-10502-tratamiento-combinado-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05251714/cfi-402257-un-inhibidor-de-ttk-potente-y-selectivo-en-tumores-solidos-y-en-combinacion-con-fulvestrant-en-el-cancer-de-mama 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07383506/un-estudio-de-un-inhibidor-selectivo-de-mutaciones-cgt6297-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05898399/estudio-de-art6043-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos-polka 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05523947/ensayo-clinico-de-yh32367-en-pacientes-con-tumores-solidos-her2-positivos-localmente-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07504445/estudio-clinico-sobre-la-eficacia-y-la-seguridad-de-car-dc-en-el-tratamiento-de-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07230977/gensci139-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06257264/un-estudio-para-examinar-la-seguridad-de-diferentes-dosis-de-bg-68501-administradas-a-participantes-con-tumores-en-estadio-avanzado 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05804864/un-estudio-de-km501-en-pacientes-con-tumores-solidos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT04152499/fase-i-ii-fih-adc-dirigido-a-trop2-tumores-solidos-avanzados-irresecables-metastasicos-refractarios-a-las-terapias-estandar-kl264-01 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06658951/inyeccion-de-celulas-car-t-anti-her2-en-pacientes-con-tumores-solidos-malignos-avanzados-her2-positivos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05216432/estudio-de-fase-i-en-humanos-de-un-inhibidor-de-pi3k-selectivo-para-mutaciones-rly-2608-como-agente-unico-en-pacientes-con-tumores-solidos-avanzados-y-en-combinacion-con-terapia-endocrina-un 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07512583/estudios-clinicos-de-tqb2930-inyectable-para-el-tratamiento-de-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05315700/estudio-de-oric-114-en-pacientes-con-tumores-solidos-avanzados-que-presentan-una-alteracion-en-egfr-o-her2 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07032298/un-estudio-de-fase-i-de-ssgj-612-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07070232/un-estudio-clinico-para-evaluar-si-un-tratamiento-experimental-denominado-bnt326-es-seguro-y-potencialmente-beneficioso-cuando-se-utiliza-solo-o-en-combinacion-con-otros-tratamientos-experimentales 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05564377/terapia-dirigida-basada-en-pruebas-geneticas-en-el-tratamiento-de-pacientes-con-tumores-solidos-avanzados-o-localmente-avanzados-el-ensayo-de-cribado-combomatch 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06299124/un-estudio-de-fase-i-de-rgt-419b-en-pacientes-con-cancer-de-mama-avanzado-her2-negativo-y-receptor-hormonal-positivo-u-otros-tumores-solidos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05861895/hf158k1-en-pacientes-con-tumores-solidos-avanzados-que-expresan-her-2 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT04872166/un-estudio-de-btx-a51-en-pacientes-con-tumores-solidos-avanzados-y-cancer-de-mama 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05957536/un-estudio-de-d3l-001-como-monoterapia-en-sujetos-con-tumores-solidos-avanzados-her2-positivos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06669975/un-estudio-de-ap402-en-pacientes-con-tumores-solidos-her2-positivos-localmente-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05872295/iks014-en-tumores-solidos-avanzados-que-expresan-her2 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07524322/estudio-de-rgt-490-en-pacientes-con-tumores-solidos-avanzados-con-mutacion-en-pik3ca 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05681650/celulas-car-t-hyposti-dirigidas-contra-her2-en-tumores-solidos-avanzados-her2-positivos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06241456/ft825-ono-8250-una-terapia-car-t-anti-her2-lista-para-usar-con-o-sin-anticuerpos-monoclonales-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05579366/rinatabart-sesutecan-rina-s-pro1184-gen1184-para-tumores-solidos-avanzados-gct1184-01-pro1184-001 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT07424547/estudio-de-fase-i-de-sys6043-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06822998/hf50-en-tumores-solidos-avanzados-her2-positivos-y-con-baja-expresion-de-her2 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06714617/evaluar-bl-m17d1-en-pacientes-con-tumores-solidos-avanzados-o-metastasicos-que-expresan-o-presentan-mutaciones-en-her2 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT06015048/un-ensayo-clinico-de-shr-a1811-en-combinacion-con-otras-terapias-antitumorales-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06827613/un-estudio-de-invikafusp-alfa-star0602-una-molecula-de-fusion-bifuncional-de-anticuerpos-que-se-dirige-selectivamente-al-receptor-de-celulas-t-tcr-en-combinacion-con-sacituzumab-govitecan-en 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06334432/estudio-de-seguridad-y-eficacia-de-nuv-1511-en-pacientes-adultos-con-tumores-solidos-avanzados 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07287917/estudio-de-amxt-1501-y-dfmo-en-combinacion-con-terapias-estandar-en-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT02264678/dosis-crecientes-de-ceralasertib-en-combinacion-con-quimioterapia-y-o-nuevos-agentes-antineoplasicos 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT07110883/un-estudio-clinico-de-sys6023-en-pacientes-con-tumores-solidos-avanzados 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT05081609/un-estudio-para-investigar-la-seguridad-y-la-tolerabilidad-de-transcon-il-2-solo-o-en-combinacion-con-pembrolizumab-y-o-un-agonista-de-transcon-tlr7-8-u-otras-terapias-contra-el-cancer-en 2026-06-25 weekly 0.6 https://crcwarriors.org/ensayo/NCT05636215/un-estudio-de-fase-i-en-humanos-con-ibi354-en-sujetos-con-tumores-solidos-localmente-avanzados-irresecables-o-metastasicos 2026-06-25 weekly 0.7 https://crcwarriors.org/ensayo/NCT06899789/seguimiento-a-largo-plazo-de-la-ileocolitis-inducida-por-inhibidores-de-puntos-de-control-inmunitario 2026-05-23 weekly 0.7 https://crcwarriors.org/ensayo/NCT07249021/este-es-un-estudio-internacional-multicentrico-que-evalua-la-igabt-basada-en-tc-con-o-sin-trus-durante-la-braquiterapia-rm-pre-braquiterapia-segun-las-recomendaciones-de-ibs-gecestro-abs-para-la 2026-05-19 weekly 0.6 https://crcwarriors.org/ensayo/NCT03805919/hombres-con-alto-riesgo-genetico-de-cancer-de-prostata 2026-05-19 weekly 0.7 https://crcwarriors.org/ensayo/NCT06726642/cfdna-en-las-neoplasias-hereditarias-y-de-alto-riesgo-2 2026-05-19 weekly 0.7 https://crcwarriors.org/ensayo/NCT05186493/exenteracion-pelvica-laparoscopica-asistida-por-robot-para-tumores-primarios-y-recurrentes-de-la-pelvis 2026-05-15 weekly 0.7 https://crcwarriors.org/ensayo/NCT05431530/evaluacion-de-la-calidad-de-vida-tras-la-reseccion-anterior-baja-durante-la-cirugia-citorreductora-para-el-cancer-de-ovario-avanzado 2026-05-15 weekly 0.7 https://crcwarriors.org/ensayo/NCT06953323/un-estudio-de-fase-i-ii-sobre-la-terapia-combinada-con-wjb001-para-evaluar-su-seguridad-y-eficacia-en-tumores-solidos-avanzados 2026-05-14 weekly 0.7 https://crcwarriors.org/ensayo/NCT04520737/prehabilitacion-multimodal-durante-la-quimioterapia-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT05062317/quimioterapia-posthepatectomia-dirigida-al-ctdna-en-pacientes-con-metastasis-hepaticas-resecables-de-cancer-colorrectal 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT07007559/aspen-09-un-estudio-de-evorpacept-en-combinacion-con-terapias-antineoplasicas-en-tumores-avanzados-metastasicos 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT05902988/un-estudio-de-fase-i-ii-de-vls-1488-en-sujetos-con-cancer-avanzado 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT06358677/profilaxis-topica-con-tretinoina-para-la-toxicidad-cutanea-inducida-por-anti-egfr-en-el-cancer-colorrectal-metastasico 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT07117435/paclitaxel-en-liposomas-cationicos-infusion-intraarterial-hepatica-en-combinacion-con-terapia-sistemica-como-tratamiento-de-primera-linea-en-metastasis-hepaticas-de-cancer-colorrectal 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT07073430/evaluacion-de-un-sistema-de-inteligencia-artificial-en-el-diagnostico-de-lesiones-de-adenoma-tubular-colorrectal 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT07027605/ensayo-multicentrico-con-multiples-lectores-y-casos-que-evalua-una-herramienta-de-apoyo-informatico-para-la-prediccion-pronostica-de-las-metastasis-hepaticas-del-cancer-colorrectal 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT02399995/calidad-de-vida-relacionada-con-la-salud-tras-la-hepatectomia-por-metastasis-hepaticas-de-cancer-colorrectal-cambios-globales-y-especificos-de-la-enfermedad-a-lo-largo-del-tiempo 2026-05-09 weekly 0.6 https://crcwarriors.org/ensayo/NCT04742621/trasplante-hepatico-para-metastasis-colorrectales-limitadas-al-higado-que-no-pueden-ser-extirpadas-quirurgicamente 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT05265169/ablacion-con-confirmacion-de-metastasis-hepaticas-de-cancer-colorrectal-acclaim 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT06364384/quimiorradioterapia-concurrente-radical-con-ddp-5-fu-y-anticuerpo-anti-pd-1-para-el-carcinoma-de-celulas-escamosas-del-recto-no-metastasico 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT06406062/sistema-de-asistencia-basado-en-inteligencia-artificial-en-la-colonoscopia 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT05935124/luz-blanca-frente-a-imagen-de-banda-estrecha-en-el-diagnostico-de-polipos-colicos-del-lado-derecho-en-sujetos-asintomaticos-sometidos-a-una-colonoscopia-de-cribado 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT06205862/eficacia-y-seguridad-del-trasplante-de-microbiota-fecal-tmf-para-reducir-la-recurrencia-de-adenoma-colorrectal-acr 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT06143774/estudio-de-trx-920-en-pacientes-con-tumores-solidos-avanzados 2026-05-09 weekly 0.7 https://crcwarriors.org/ensayo/NCT06779474/laparoscopia-con-particion-hepatica-asociada-y-ligadura-de-la-vena-porta-para-la-hepatectomia-escalonada-alpps-en-metastasis-hepaticas-de-cancer-colorrectal-crlm 2026-05-09 weekly 0.6 https://crcwarriors.org/ensayo/NCT06656312/estudio-prospectivo-de-endoaim-solucion-de-ia-asus-para-el-diagnostico-de-polipos-colorrectales 2026-05-09 weekly 0.7 https://crcwarriors.org/medicamento/oxaliplatin 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/oxaliplatin/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/uracil 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/uracil/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/fluorouracil 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/fluorouracil/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/5-fluorouracil 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/5-fluorouracil/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/leucovorin 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/leucovorin/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/bevacizumab 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/bevacizumab/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/capecitabine 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/capecitabine/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/irinotecan 2026-08-28 weekly 0.7 https://crcwarriors.org/medicamento/irinotecan/ensayos 2026-08-28 weekly 0.6 https://crcwarriors.org/medicamento/cetuximab 2026-08-28 weekly 0.7 https://crcwarriors.org/medicamento/cetuximab/ensayos 2026-08-28 weekly 0.6 https://crcwarriors.org/medicamento/pembrolizumab 2026-09-02 weekly 0.7 https://crcwarriors.org/medicamento/pembrolizumab/ensayos 2026-09-02 weekly 0.6 https://crcwarriors.org/medicamento/met 2026-07-24 weekly 0.7 https://crcwarriors.org/medicamento/met/ensayos 2026-07-24 weekly 0.6 https://crcwarriors.org/medicamento/panitumumab 2026-06-23 weekly 0.7 https://crcwarriors.org/medicamento/panitumumab/ensayos 2026-06-23 weekly 0.6 https://crcwarriors.org/medicamento/nivolumab 2026-07-16 weekly 0.7 https://crcwarriors.org/medicamento/nivolumab/ensayos 2026-07-16 weekly 0.6 https://crcwarriors.org/medicamento/regorafenib 2026-08-07 weekly 0.7 https://crcwarriors.org/medicamento/regorafenib/ensayos 2026-08-07 weekly 0.6 https://crcwarriors.org/medicamento/rego 2026-08-07 weekly 0.7 https://crcwarriors.org/medicamento/rego/ensayos 2026-08-07 weekly 0.6 https://crcwarriors.org/medicamento/tislelizumab 2026-09-04 weekly 0.7 https://crcwarriors.org/medicamento/tislelizumab/ensayos 2026-09-04 weekly 0.6 https://crcwarriors.org/medicamento/fruquintinib 2026-08-29 weekly 0.7 https://crcwarriors.org/medicamento/fruquintinib/ensayos 2026-08-29 weekly 0.6 https://crcwarriors.org/medicamento/trastuzumab 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/trastuzumab/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/paclitaxel 2026-09-04 weekly 0.7 https://crcwarriors.org/medicamento/paclitaxel/ensayos 2026-09-04 weekly 0.6 https://crcwarriors.org/medicamento/trifluridine 2026-07-30 weekly 0.7 https://crcwarriors.org/medicamento/trifluridine/ensayos 2026-07-30 weekly 0.6 https://crcwarriors.org/medicamento/cyclophosphamid 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/cyclophosphamid/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/cyclophosphamide 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/cyclophosphamide/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/atezolizumab 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/atezolizumab/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/carboplatin 2026-07-24 weekly 0.7 https://crcwarriors.org/medicamento/carboplatin/ensayos 2026-07-24 weekly 0.6 https://crcwarriors.org/medicamento/cisplatin 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/cisplatin/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/sintilimab 2026-07-31 weekly 0.7 https://crcwarriors.org/medicamento/sintilimab/ensayos 2026-07-31 weekly 0.6 https://crcwarriors.org/medicamento/ipilimumab 2026-09-02 weekly 0.7 https://crcwarriors.org/medicamento/ipilimumab/ensayos 2026-09-02 weekly 0.6 https://crcwarriors.org/medicamento/durvalumab 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/durvalumab/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/gemcitabine 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/gemcitabine/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/pemetrexed 2026-07-24 weekly 0.7 https://crcwarriors.org/medicamento/pemetrexed/ensayos 2026-07-24 weekly 0.6 https://crcwarriors.org/medicamento/celecoxib 2026-05-15 weekly 0.7 https://crcwarriors.org/medicamento/celecoxib/ensayos 2026-05-15 weekly 0.6 https://crcwarriors.org/medicamento/cele 2026-05-15 weekly 0.7 https://crcwarriors.org/medicamento/cele/ensayos 2026-05-15 weekly 0.6 https://crcwarriors.org/medicamento/s-1 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/s-1/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/aldesleukin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/aldesleukin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/aspirin 2026-09-02 weekly 0.7 https://crcwarriors.org/medicamento/aspirin/ensayos 2026-09-02 weekly 0.6 https://crcwarriors.org/medicamento/fludarabine 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/fludarabine/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/fulvestrant 2026-09-02 weekly 0.7 https://crcwarriors.org/medicamento/fulvestrant/ensayos 2026-09-02 weekly 0.6 https://crcwarriors.org/medicamento/encorafenib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/encorafenib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/docetaxel 2026-08-06 weekly 0.7 https://crcwarriors.org/medicamento/docetaxel/ensayos 2026-08-06 weekly 0.6 https://crcwarriors.org/medicamento/aflibercept 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/aflibercept/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/palbociclib 2026-09-02 weekly 0.7 https://crcwarriors.org/medicamento/palbociclib/ensayos 2026-09-02 weekly 0.6 https://crcwarriors.org/medicamento/binimetinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/binimetinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/trametinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/trametinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/tori 2026-06-26 weekly 0.7 https://crcwarriors.org/medicamento/tori/ensayos 2026-06-26 weekly 0.6 https://crcwarriors.org/medicamento/toripalimab 2026-06-26 weekly 0.7 https://crcwarriors.org/medicamento/toripalimab/ensayos 2026-06-26 weekly 0.6 https://crcwarriors.org/medicamento/erlotinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/erlotinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/everolimus 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/everolimus/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/nab-paclitaxel 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/nab-paclitaxel/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/serplulimab 2026-08-22 weekly 0.7 https://crcwarriors.org/medicamento/serplulimab/ensayos 2026-08-22 weekly 0.6 https://crcwarriors.org/medicamento/balstilimab 2026-07-31 weekly 0.7 https://crcwarriors.org/medicamento/balstilimab/ensayos 2026-07-31 weekly 0.6 https://crcwarriors.org/medicamento/botensilimab 2026-07-31 weekly 0.7 https://crcwarriors.org/medicamento/botensilimab/ensayos 2026-07-31 weekly 0.6 https://crcwarriors.org/medicamento/cadonilimab 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cadonilimab/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vemurafenib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/vemurafenib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/avelumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/avelumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cemiplimab 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/cemiplimab/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/sargramostim 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/sargramostim/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/metformin 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/metformin/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/olaparib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/olaparib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/temozolomide 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/temozolomide/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/dostarlimab 2026-08-04 weekly 0.7 https://crcwarriors.org/medicamento/dostarlimab/ensayos 2026-08-04 weekly 0.6 https://crcwarriors.org/medicamento/adebrelimab 2026-07-23 weekly 0.7 https://crcwarriors.org/medicamento/adebrelimab/ensayos 2026-07-23 weekly 0.6 https://crcwarriors.org/medicamento/trastuzumab+deruxteca 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/trastuzumab+deruxteca/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/trastuzumab+deruxtecan 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/trastuzumab+deruxtecan/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/tucatinib 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/tucatinib/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/adagrasib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/adagrasib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/dexamethasone 2026-05-19 weekly 0.7 https://crcwarriors.org/medicamento/dexamethasone/ensayos 2026-05-19 weekly 0.6 https://crcwarriors.org/medicamento/tremelimumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tremelimumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/apatinib 2026-07-09 weekly 0.7 https://crcwarriors.org/medicamento/apatinib/ensayos 2026-07-09 weekly 0.6 https://crcwarriors.org/medicamento/cabozantinib 2026-06-03 weekly 0.7 https://crcwarriors.org/medicamento/cabozantinib/ensayos 2026-06-03 weekly 0.6 https://crcwarriors.org/medicamento/peg 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/peg/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/mitomycin 2026-07-14 weekly 0.7 https://crcwarriors.org/medicamento/mitomycin/ensayos 2026-07-14 weekly 0.6 https://crcwarriors.org/medicamento/sorafenib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/sorafenib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ribociclib 2026-09-02 weekly 0.7 https://crcwarriors.org/medicamento/ribociclib/ensayos 2026-09-02 weekly 0.6 https://crcwarriors.org/medicamento/tipiracil 2026-07-24 weekly 0.7 https://crcwarriors.org/medicamento/tipiracil/ensayos 2026-07-24 weekly 0.6 https://crcwarriors.org/medicamento/lidocaine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lidocaine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/abemaciclib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/abemaciclib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/camrelizumab 2026-04-16 weekly 0.7 https://crcwarriors.org/medicamento/camrelizumab/ensayos 2026-04-16 weekly 0.6 https://crcwarriors.org/medicamento/ivonescimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ivonescimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/metronidazole 2026-05-19 weekly 0.7 https://crcwarriors.org/medicamento/metronidazole/ensayos 2026-05-19 weekly 0.6 https://crcwarriors.org/medicamento/raltitrexed 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/raltitrexed/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pertuzumab 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/pertuzumab/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ramucirumab 2026-07-24 weekly 0.7 https://crcwarriors.org/medicamento/ramucirumab/ensayos 2026-07-24 weekly 0.6 https://crcwarriors.org/medicamento/amg 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/amg/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ql1706 2026-07-28 weekly 0.7 https://crcwarriors.org/medicamento/ql1706/ensayos 2026-07-28 weekly 0.6 https://crcwarriors.org/medicamento/sirolimus 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sirolimus/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/envafolimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/envafolimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sotorasib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/sotorasib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/selumetinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/selumetinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/letrozole 2026-09-01 weekly 0.7 https://crcwarriors.org/medicamento/letrozole/ensayos 2026-09-01 weekly 0.6 https://crcwarriors.org/medicamento/dabrafenib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/dabrafenib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/sunitinib 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/sunitinib/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/tas 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/tas/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ak112 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/ak112/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/lenvatinib 2026-07-08 weekly 0.7 https://crcwarriors.org/medicamento/lenvatinib/ensayos 2026-07-08 weekly 0.6 https://crcwarriors.org/medicamento/hydroxychloroquine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/hydroxychloroquine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/osimertinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/osimertinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/gefitinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gefitinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bortezomib 2026-05-06 weekly 0.7 https://crcwarriors.org/medicamento/bortezomib/ensayos 2026-05-06 weekly 0.6 https://crcwarriors.org/medicamento/lapatinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/lapatinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/axitinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/axitinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/filgrastim 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/filgrastim/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/iparomlimab 2026-08-20 weekly 0.7 https://crcwarriors.org/medicamento/iparomlimab/ensayos 2026-08-20 weekly 0.6 https://crcwarriors.org/medicamento/infliximab 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/infliximab/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/amivantamab 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/amivantamab/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/vandetanib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/vandetanib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cediranib 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/cediranib/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/chidamide 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/chidamide/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sulindac 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sulindac/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/dasatinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/dasatinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/melphala 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/melphala/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/retifanlimab 2026-07-02 weekly 0.7 https://crcwarriors.org/medicamento/retifanlimab/ensayos 2026-07-02 weekly 0.6 https://crcwarriors.org/medicamento/vorinosta 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/vorinosta/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/zanidatamab 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/zanidatamab/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/vorinostat 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/vorinostat/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/melphalan 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/melphalan/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/midazolam 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/midazolam/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/afatinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/afatinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/tuvonralimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tuvonralimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cobimetinib 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/cobimetinib/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/doxorubicin 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/doxorubicin/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/indocyanine+green 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/indocyanine+green/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tegafu 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tegafu/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/sasanlimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sasanlimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/temsirolimus 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/temsirolimus/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/veliparib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/veliparib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/azacitidine 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/azacitidine/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/tegafur 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tegafur/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/chemo 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/chemo/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/enzalutamide 2026-06-03 weekly 0.7 https://crcwarriors.org/medicamento/enzalutamide/ensayos 2026-06-03 weekly 0.6 https://crcwarriors.org/medicamento/pumitamig 2026-07-02 weekly 0.7 https://crcwarriors.org/medicamento/pumitamig/ensayos 2026-07-02 weekly 0.6 https://crcwarriors.org/medicamento/other 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/other/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/g17dt 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/g17dt/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/eflornithine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/eflornithine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/decitabine 2026-07-10 weekly 0.7 https://crcwarriors.org/medicamento/decitabine/ensayos 2026-07-10 weekly 0.6 https://crcwarriors.org/medicamento/bkm120 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/bkm120/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/moviprep 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/moviprep/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/g17d 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/g17d/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/jab-21822 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/jab-21822/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/propofol 2026-08-01 weekly 0.7 https://crcwarriors.org/medicamento/propofol/ensayos 2026-08-01 weekly 0.6 https://crcwarriors.org/medicamento/trifluridine-tipiracil 2026-07-24 weekly 0.7 https://crcwarriors.org/medicamento/trifluridine-tipiracil/ensayos 2026-07-24 weekly 0.6 https://crcwarriors.org/medicamento/sol 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/sol/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/entinostat 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/entinostat/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/nw-301v 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/nw-301v/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/adc 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/adc/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/pdr001 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pdr001/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tno155 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/tno155/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/hlx10 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/hlx10/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/pazopanib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/pazopanib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/t3011 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/t3011/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/anlotinib 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/anlotinib/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/hrs-4642 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/hrs-4642/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/nktr 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/nktr/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/omeprazole 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/omeprazole/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rmc-6236 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/rmc-6236/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/crizotinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/crizotinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/dexmedetomidine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/dexmedetomidine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hdm201 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/hdm201/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/tocilizumab 2026-05-19 weekly 0.7 https://crcwarriors.org/medicamento/tocilizumab/ensayos 2026-05-19 weekly 0.6 https://crcwarriors.org/medicamento/fianlimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/fianlimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/etrumadenant 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/etrumadenant/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ropivacaine 2026-06-05 weekly 0.7 https://crcwarriors.org/medicamento/ropivacaine/ensayos 2026-06-05 weekly 0.6 https://crcwarriors.org/medicamento/ts-1 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ts-1/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/shr-8068 2026-04-02 weekly 0.7 https://crcwarriors.org/medicamento/shr-8068/ensayos 2026-04-02 weekly 0.6 https://crcwarriors.org/medicamento/nintedanib 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/nintedanib/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/lenalidomide 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lenalidomide/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/methotrexate 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/methotrexate/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/prednisone 2026-08-06 weekly 0.7 https://crcwarriors.org/medicamento/prednisone/ensayos 2026-08-06 weekly 0.6 https://crcwarriors.org/medicamento/vedolizumab 2026-08-28 weekly 0.7 https://crcwarriors.org/medicamento/vedolizumab/ensayos 2026-08-28 weekly 0.6 https://crcwarriors.org/medicamento/itraconazole 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/itraconazole/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/sym004 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sym004/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/penpulimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/penpulimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ruxolitinib 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/ruxolitinib/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/lorigerlimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lorigerlimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/spartalizumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/spartalizumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nw-301d 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/nw-301d/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/riluzole 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/riluzole/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tiragolumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tiragolumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pegfilgrastim 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pegfilgrastim/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/zanzalintinib 2026-08-11 weekly 0.7 https://crcwarriors.org/medicamento/zanzalintinib/ensayos 2026-08-11 weekly 0.6 https://crcwarriors.org/medicamento/saline 2026-06-05 weekly 0.7 https://crcwarriors.org/medicamento/saline/ensayos 2026-06-05 weekly 0.6 https://crcwarriors.org/medicamento/nktr- 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/nktr-/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/sevoflurane 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sevoflurane/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/daraxonrasib 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/daraxonrasib/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/epacadostat 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/epacadostat/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/imatinib 2026-05-27 weekly 0.7 https://crcwarriors.org/medicamento/imatinib/ensayos 2026-05-27 weekly 0.6 https://crcwarriors.org/medicamento/tivozanib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tivozanib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/shr-a1811 2026-07-01 weekly 0.7 https://crcwarriors.org/medicamento/shr-a1811/ensayos 2026-07-01 weekly 0.6 https://crcwarriors.org/medicamento/sgm-101 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sgm-101/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bbi608 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bbi608/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bi-1701963 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/bi-1701963/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/bp102 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bp102/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pf-07220060 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/pf-07220060/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/imiquimod 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/imiquimod/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/naliri 2026-06-03 weekly 0.7 https://crcwarriors.org/medicamento/naliri/ensayos 2026-06-03 weekly 0.6 https://crcwarriors.org/medicamento/abbv-400 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/abbv-400/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/hmn14 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/hmn14/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/allostim 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/allostim/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/neratinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/neratinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/bibf 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bibf/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/pralsetinib 2026-09-02 weekly 0.7 https://crcwarriors.org/medicamento/pralsetinib/ensayos 2026-09-02 weekly 0.6 https://crcwarriors.org/medicamento/radiotherapy 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/radiotherapy/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/inavolisib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/inavolisib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ganitumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ganitumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/e7386 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/e7386/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/semaxanib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/semaxanib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ibi363 2026-07-28 weekly 0.7 https://crcwarriors.org/medicamento/ibi363/ensayos 2026-07-28 weekly 0.6 https://crcwarriors.org/medicamento/osi-906 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/osi-906/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/rmc-9805 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/rmc-9805/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/etbx-011 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/etbx-011/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bupivacain 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bupivacain/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/thymalfasin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/thymalfasin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hs-20093 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/hs-20093/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/tucidinosta 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tucidinosta/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/indomethacin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/indomethacin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tucidinostat 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tucidinostat/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/doxycycline 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/doxycycline/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/enadenotucirev 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/enadenotucirev/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/regn7075 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/regn7075/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/defactinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/defactinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/romidepsi 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/romidepsi/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/calderasib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/calderasib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/amg-655 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/amg-655/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mk-2206 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/mk-2206/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/eniluracil 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/eniluracil/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/indomethaci 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/indomethaci/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/fleet 2026-07-11 weekly 0.7 https://crcwarriors.org/medicamento/fleet/ensayos 2026-07-11 weekly 0.6 https://crcwarriors.org/medicamento/nilotinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/nilotinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/plenvu 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/plenvu/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pucotenlimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pucotenlimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rosuvastati 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/rosuvastati/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/selpercatinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/selpercatinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/romidepsin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/romidepsin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gvax 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gvax/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/panobinosta 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/panobinosta/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/mangafodipir 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/mangafodipir/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/relatlimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/relatlimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hsk42360 2026-08-28 weekly 0.7 https://crcwarriors.org/medicamento/hsk42360/ensayos 2026-08-28 weekly 0.6 https://crcwarriors.org/medicamento/m9140 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/m9140/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/mcla-129 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/mcla-129/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/flucytosine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/flucytosine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/thymalfasi 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/thymalfasi/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/talazoparib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/talazoparib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/etrolizumab 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/etrolizumab/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/nimotuzumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nimotuzumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cs-1008 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cs-1008/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/dalotuzumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/dalotuzumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/selinexo 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/selinexo/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ulixertinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/ulixertinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/vismodegib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/vismodegib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/zimberelimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/zimberelimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/egfr 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/egfr/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/selinexor 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/selinexor/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/amg-479 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/amg-479/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/niraparib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/niraparib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/incb001158 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/incb001158/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gv20-0251 2026-06-04 weekly 0.7 https://crcwarriors.org/medicamento/gv20-0251/ensayos 2026-06-04 weekly 0.6 https://crcwarriors.org/medicamento/bibf-1120 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/bibf-1120/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/n-803 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/n-803/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/e7820 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/e7820/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/abx-egf 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/abx-egf/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/onvansertib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/onvansertib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pd-0325901 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pd-0325901/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/chemoradiotherapy 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/chemoradiotherapy/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/brivanib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/brivanib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sg001 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/sg001/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/cyclosporine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cyclosporine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rosuvastatin 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/rosuvastatin/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ner1006 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ner1006/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/alectinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/alectinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/panobinostat 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/panobinostat/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mangafodipi 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/mangafodipi/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hs-10370 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/hs-10370/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/mw4911 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/mw4911/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/neomyci 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/neomyci/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/maraviroc 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/maraviroc/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/eribulin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/eribulin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/magrolimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/magrolimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bbo-10203 2026-06-03 weekly 0.7 https://crcwarriors.org/medicamento/bbo-10203/ensayos 2026-06-03 weekly 0.6 https://crcwarriors.org/medicamento/rnk08954 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/rnk08954/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ci-1040 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ci-1040/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nis793 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/nis793/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/cv301 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cv301/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ivosidenib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/ivosidenib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/imc-a12 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/imc-a12/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tinzaparin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tinzaparin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/napabucasi 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/napabucasi/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hs-10502 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/hs-10502/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/rimiducid 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rimiducid/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/calmangafodipir 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/calmangafodipir/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gdc-1971 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gdc-1971/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/reolysi 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/reolysi/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/st316 2026-07-30 weekly 0.7 https://crcwarriors.org/medicamento/st316/ensayos 2026-07-30 weekly 0.6 https://crcwarriors.org/medicamento/conatumumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/conatumumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/s-531011 2026-07-23 weekly 0.7 https://crcwarriors.org/medicamento/s-531011/ensayos 2026-07-23 weekly 0.6 https://crcwarriors.org/medicamento/ceralasertib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/ceralasertib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/masitinib 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/masitinib/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/d-1553 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/d-1553/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/rec-4881 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/rec-4881/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/budigalimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/budigalimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bms-986340 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bms-986340/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/inc280 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/inc280/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/kd018 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/kd018/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/arfolitixorin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/arfolitixorin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hdm2017 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/hdm2017/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/sgn1 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/sgn1/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ca102n 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ca102n/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/canagliflozin 2026-09-02 weekly 0.7 https://crcwarriors.org/medicamento/canagliflozin/ensayos 2026-09-02 weekly 0.6 https://crcwarriors.org/medicamento/udenafil 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/udenafil/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/volrustomig 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/volrustomig/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/foxy-5 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/foxy-5/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cmab009 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cmab009/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/anastrozole 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/anastrozole/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/amt2003 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/amt2003/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/exemestane 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/exemestane/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/alt-803 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/alt-803/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/imlunestrant 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/imlunestrant/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pro95780 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pro95780/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/azd5305 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/azd5305/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ak119 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/ak119/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/e7070 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/e7070/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/elimusertib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/elimusertib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/bevacizumab-irdye800cw 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bevacizumab-irdye800cw/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pirfenidone 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/pirfenidone/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/enzastaurin 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/enzastaurin/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/nv1020 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nv1020/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/entrectinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/entrectinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/bibw-2992 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bibw-2992/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/erdafitinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/erdafitinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ssgj-612 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ssgj-612/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/dovitinib 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/dovitinib/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/enoxaparin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/enoxaparin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/denosumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/denosumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/vatalanib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/vatalanib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/fmt 2026-05-27 weekly 0.7 https://crcwarriors.org/medicamento/fmt/ensayos 2026-05-27 weekly 0.6 https://crcwarriors.org/medicamento/floxuridine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/floxuridine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rivaroxaba 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/rivaroxaba/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/xilonix 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/xilonix/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/artesunate 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/artesunate/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bms-986016 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bms-986016/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bli850 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bli850/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hs-20117 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/hs-20117/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/hlx208 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/hlx208/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nns309 2026-06-06 weekly 0.7 https://crcwarriors.org/medicamento/nns309/ensayos 2026-06-06 weekly 0.6 https://crcwarriors.org/medicamento/fluzoparib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/fluzoparib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/capivasertib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/capivasertib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/copanlisib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/copanlisib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rezatapop 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/rezatapop/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/leflunomide 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/leflunomide/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ipatasertib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/ipatasertib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/camizestrant 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/camizestrant/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/larotrectinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/larotrectinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/dato-dxd 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/dato-dxd/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/rmc-4630 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/rmc-4630/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/bi-765049 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bi-765049/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/dulanermin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/dulanermin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cannabidiol 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/cannabidiol/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ridaforolimus 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ridaforolimus/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ga-nns309 2026-06-06 weekly 0.7 https://crcwarriors.org/medicamento/ga-nns309/ensayos 2026-06-06 weekly 0.6 https://crcwarriors.org/medicamento/naproxen 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/naproxen/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/lubiprostone 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/lubiprostone/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/neomycin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/neomycin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/nalirifox 2026-06-03 weekly 0.7 https://crcwarriors.org/medicamento/nalirifox/ensayos 2026-06-03 weekly 0.6 https://crcwarriors.org/medicamento/bupivacaine 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bupivacaine/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ufox 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ufox/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/mrg007 2026-07-31 weekly 0.7 https://crcwarriors.org/medicamento/mrg007/ensayos 2026-07-31 weekly 0.6 https://crcwarriors.org/medicamento/dsp107 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/dsp107/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gi-4000 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gi-4000/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/oleclumab 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/oleclumab/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/trk-950 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/trk-950/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hua33 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/hua33/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bisacodyl 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bisacodyl/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hf50 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hf50/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/jab-3312 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/jab-3312/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bgb-43395 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bgb-43395/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/cb-839 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cb-839/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pm8002 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/pm8002/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/pemigatinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/pemigatinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/gastrografin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gastrografin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/plerixafo 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/plerixafo/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/sgi-110 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sgi-110/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/citrafleet 2026-07-11 weekly 0.7 https://crcwarriors.org/medicamento/citrafleet/ensayos 2026-07-11 weekly 0.6 https://crcwarriors.org/medicamento/mm-151 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/mm-151/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/carmustine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/carmustine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/abiraterone 2026-06-03 weekly 0.7 https://crcwarriors.org/medicamento/abiraterone/ensayos 2026-06-03 weekly 0.6 https://crcwarriors.org/medicamento/ompenaclid 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ompenaclid/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mm-398 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/mm-398/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rivaroxaban 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rivaroxaban/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/js207 2026-05-06 weekly 0.7 https://crcwarriors.org/medicamento/js207/ensayos 2026-05-06 weekly 0.6 https://crcwarriors.org/medicamento/thalidomide 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/thalidomide/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/il2 2026-05-06 weekly 0.7 https://crcwarriors.org/medicamento/il2/ensayos 2026-05-06 weekly 0.6 https://crcwarriors.org/medicamento/silymarin 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/silymarin/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/desflurane 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/desflurane/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hsk42360-na 2026-08-28 weekly 0.7 https://crcwarriors.org/medicamento/hsk42360-na/ensayos 2026-08-28 weekly 0.6 https://crcwarriors.org/medicamento/rapamyci 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/rapamyci/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/utidelone 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/utidelone/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/loperamide 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/loperamide/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gh21 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/gh21/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/si-b003 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/si-b003/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/etbx-051 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/etbx-051/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/can04 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/can04/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/etbx-061 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/etbx-061/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gi-6301 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gi-6301/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/grt-c901 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/grt-c901/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/grt-r902 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/grt-r902/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nc410 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nc410/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/a166 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/a166/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/rifaximi 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/rifaximi/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ly3214996 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ly3214996/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/rapamycin 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/rapamycin/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/avzo-021 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/avzo-021/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/famitinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/famitinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bmx-001 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bmx-001/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/shr-1701 2026-04-02 weekly 0.7 https://crcwarriors.org/medicamento/shr-1701/ensayos 2026-04-02 weekly 0.6 https://crcwarriors.org/medicamento/prexasertib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/prexasertib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/tovorafenib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tovorafenib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/flox 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/flox/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/sph5030 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/sph5030/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/plerixafor 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/plerixafor/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/simvastatin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/simvastatin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/resveratrol 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/resveratrol/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/cm-24 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cm-24/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cp-675 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/cp-675/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/g-csf 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/g-csf/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gemnabp 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/gemnabp/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/rezatapopt 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/rezatapopt/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ono-4578 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/ono-4578/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/piritramid 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/piritramid/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mm-121 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/mm-121/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/curcumin 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/curcumin/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/savolitinib 2026-07-07 weekly 0.7 https://crcwarriors.org/medicamento/savolitinib/ensayos 2026-07-07 weekly 0.6 https://crcwarriors.org/medicamento/bms-986504 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bms-986504/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/dtx 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/dtx/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/pds0101 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pds0101/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/acetaminophen 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/acetaminophen/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/m7824 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/m7824/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/silymari 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/silymari/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/simvastati 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/simvastati/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/golytely 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/golytely/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bl-b01d1 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bl-b01d1/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/byl719 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/byl719/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/aipalolitovorelizumab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/aipalolitovorelizumab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/mgd007 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/mgd007/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/vactosertib 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/vactosertib/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/sym021 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sym021/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/xl092 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/xl092/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/adalimumab 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/adalimumab/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/incb106385 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/incb106385/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/interferon 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/interferon/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ly3023414 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/ly3023414/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/tegavivint 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tegavivint/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rp2 2026-05-27 weekly 0.7 https://crcwarriors.org/medicamento/rp2/ensayos 2026-05-27 weekly 0.6 https://crcwarriors.org/medicamento/levoleucovori 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/levoleucovori/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/mesalamine 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/mesalamine/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/tg6002 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tg6002/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/jab-23e73 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/jab-23e73/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/yl-17231 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/yl-17231/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/alpelisib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/alpelisib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ropidoxuridine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ropidoxuridine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/citraflee 2026-07-11 weekly 0.7 https://crcwarriors.org/medicamento/citraflee/ensayos 2026-07-11 weekly 0.6 https://crcwarriors.org/medicamento/cyad-101 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cyad-101/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/glutamine 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/glutamine/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/kqb198 2026-05-27 weekly 0.7 https://crcwarriors.org/medicamento/kqb198/ensayos 2026-05-27 weekly 0.6 https://crcwarriors.org/medicamento/lazertinib 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/lazertinib/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/ezabenlimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ezabenlimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ngm438 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ngm438/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/isis 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/isis/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/vs-7375 2026-06-23 weekly 0.7 https://crcwarriors.org/medicamento/vs-7375/ensayos 2026-06-23 weekly 0.6 https://crcwarriors.org/medicamento/epinephrine 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/epinephrine/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/propranolol 2026-05-01 weekly 0.7 https://crcwarriors.org/medicamento/propranolol/ensayos 2026-05-01 weekly 0.6 https://crcwarriors.org/medicamento/naproxe 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/naproxe/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/nsaid 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/nsaid/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/sc-201 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/sc-201/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/tegavivi 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/tegavivi/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/ethynyluracil 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ethynyluracil/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gsk5764227 2026-08-04 weekly 0.7 https://crcwarriors.org/medicamento/gsk5764227/ensayos 2026-08-04 weekly 0.6 https://crcwarriors.org/medicamento/avx701 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/avx701/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tinzapari 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tinzapari/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hmbd-001 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/hmbd-001/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/surufatinib 2026-05-19 weekly 0.7 https://crcwarriors.org/medicamento/surufatinib/ensayos 2026-05-19 weekly 0.6 https://crcwarriors.org/medicamento/ixabepilone 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ixabepilone/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/selenium 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/selenium/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hlx07 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/hlx07/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/jdq443 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/jdq443/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tazemetostat 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/tazemetostat/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/pds01adc 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pds01adc/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/krn330 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/krn330/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/inca33890 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/inca33890/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ensartinib 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/ensartinib/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/rmc-6291 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/rmc-6291/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/levoleucovorin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/levoleucovorin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/pf-07799933 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/pf-07799933/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/rifaximin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rifaximin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/jx-594 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/jx-594/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/reolysin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/reolysin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tas-102 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tas-102/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/star0602 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/star0602/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ferumoxytol 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ferumoxytol/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/jmt101 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/jmt101/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bl-m17d1 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/bl-m17d1/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/b1962 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/b1962/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cibisatamab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cibisatamab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/elironrasib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/elironrasib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/obinutuzumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/obinutuzumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ibrutinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ibrutinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ngr-htnf 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ngr-htnf/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/venetoclax 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/venetoclax/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/petosemtamab 2026-08-21 weekly 0.7 https://crcwarriors.org/medicamento/petosemtamab/ensayos 2026-08-21 weekly 0.6 https://crcwarriors.org/medicamento/si-b001 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/si-b001/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gm-ct-01 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/gm-ct-01/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/napabucasin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/napabucasin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tnt 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/tnt/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/dfmo 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/dfmo/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/platinum 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/platinum/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/isunakinra 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/isunakinra/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/tu2218 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tu2218/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/trisulfate 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/trisulfate/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ibi343 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ibi343/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/repaglinide 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/repaglinide/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/liverpearls-irinotecan 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/liverpearls-irinotecan/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/dkn-01 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/dkn-01/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/icrucumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/icrucumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/treatme 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/treatme/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/cnto-328 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/cnto-328/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/es104 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/es104/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tc-510 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tc-510/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cu-tz-sara 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/cu-tz-sara/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/somatostatin 2026-05-28 weekly 0.7 https://crcwarriors.org/medicamento/somatostatin/ensayos 2026-05-28 weekly 0.6 https://crcwarriors.org/medicamento/fda018-adc 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/fda018-adc/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/bevacizumab-awwb 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bevacizumab-awwb/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/xl888 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/xl888/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pep503 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pep503/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/fda022-bb05 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/fda022-bb05/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/lirafugratinib 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/lirafugratinib/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/rgt-419b 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/rgt-419b/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/gen1079 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/gen1079/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ga-102 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/ga-102/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/kzr-261 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/kzr-261/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bms-986490 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bms-986490/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/atv-1601 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/atv-1601/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/lm303 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/lm303/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/rgt-490 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/rgt-490/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/kgx105 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/kgx105/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/metarresti 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/metarresti/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/eo2040 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/eo2040/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/tak-186 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tak-186/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/inulin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/inulin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mgd009 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/mgd009/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/qs21 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/qs21/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/amg-706 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/amg-706/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/fid-022 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/fid-022/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/gen1042 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gen1042/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bempegaldesleukin 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bempegaldesleukin/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-05212384 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-05212384/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/catumaxomab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/catumaxomab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/mva-209 2026-05-27 weekly 0.7 https://crcwarriors.org/medicamento/mva-209/ensayos 2026-05-27 weekly 0.6 https://crcwarriors.org/medicamento/bnt314 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bnt314/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pb101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pb101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cp-751 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cp-751/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nktr-262 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nktr-262/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nktr-102 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nktr-102/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/golimumab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/golimumab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/prasterone 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/prasterone/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gi-102 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gi-102/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tinodasertib 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tinodasertib/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/danvatirsen 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/danvatirsen/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/gen-011 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gen-011/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/menthol 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/menthol/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/eco-4601 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/eco-4601/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/jmt108 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/jmt108/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/esg401 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/esg401/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/glucagon 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/glucagon/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/trastuzumab-deruxtecan 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/trastuzumab-deruxtecan/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/tas102 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/tas102/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/devimistat 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/devimistat/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ak117 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ak117/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/wnt974 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/wnt974/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-06946860 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-06946860/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/kqb368 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/kqb368/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/loxo-435 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/loxo-435/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/lt-002 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/lt-002/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/gdc-0994 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gdc-0994/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/disp-10 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/disp-10/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lp-184 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/lp-184/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/clsp-1025 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/clsp-1025/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/paricalcitol 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/paricalcitol/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/alt803 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/alt803/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/dexpantenol 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/dexpantenol/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/midostauri 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/midostauri/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/ramosetron 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ramosetron/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rph-030 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/rph-030/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/eci830 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/eci830/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/prednisolone 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/prednisolone/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/falimarev 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/falimarev/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pixatimod 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pixatimod/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tecemotide 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tecemotide/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rnk08954-01 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/rnk08954-01/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/xnw27011 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xnw27011/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rilvegostomig 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/rilvegostomig/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/inalimarev 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/inalimarev/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pexa-vec 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pexa-vec/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mirabegro 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/mirabegro/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/sgx201 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sgx201/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/avzo-023 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/avzo-023/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tew-7197 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tew-7197/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tsc-200-a0201 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tsc-200-a0201/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/avzo-1418 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/avzo-1418/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/atx-898 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/atx-898/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/kj015 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/kj015/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mithramyci 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/mithramyci/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/tsc-201-b0702 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tsc-201-b0702/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hst-1011 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hst-1011/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/a2b530 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/a2b530/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ocz103-os 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ocz103-os/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tsc-202-a0201 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tsc-202-a0201/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/or502 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/or502/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ik-595 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ik-595/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/a2b694 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/a2b694/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/c225 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/c225/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/cdx-585 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cdx-585/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tsc-203-a0201 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tsc-203-a0201/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/plx8394 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/plx8394/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/imm-101 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/imm-101/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/tsc-204-a0101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tsc-204-a0101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ip-001 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ip-001/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bgb-3245 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bgb-3245/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/promitil 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/promitil/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tsc-204-a0201 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tsc-204-a0201/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lucitanib 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/lucitanib/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/monalizumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/monalizumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tsc-204-c0702 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tsc-204-c0702/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mcla-158 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mcla-158/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/solution 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/solution/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/agen1423 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/agen1423/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cp-383 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cp-383/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/zw25 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/zw25/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/shr-1210 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/shr-1210/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/azirkitug 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/azirkitug/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/the-0504 2026-06-14 weekly 0.7 https://crcwarriors.org/medicamento/the-0504/ensayos 2026-06-14 weekly 0.6 https://crcwarriors.org/medicamento/ssgj-707 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ssgj-707/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tilmanocept 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/tilmanocept/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/ga-68-fapi-46 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ga-68-fapi-46/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/h101 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/h101/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/m3t01 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/m3t01/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/loxo-292 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/loxo-292/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ponsegromab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/ponsegromab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/gfh276 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/gfh276/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bms-247550 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bms-247550/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/lu-3bp-227 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/lu-3bp-227/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/omp-21m18 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/omp-21m18/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/dibiri 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/dibiri/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/cetuximab-beta 2026-07-26 weekly 0.7 https://crcwarriors.org/medicamento/cetuximab-beta/ensayos 2026-07-26 weekly 0.6 https://crcwarriors.org/medicamento/gen1029 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gen1029/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/galunisertib 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/galunisertib/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/gti-2040 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gti-2040/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vv1 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/vv1/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/op-3136 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/op-3136/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/s095035 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/s095035/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/anisodamine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/anisodamine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ly2157299 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ly2157299/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hydroxystaurosporine 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hydroxystaurosporine/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/xeno 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/xeno/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tils 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tils/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/palazestrant 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/palazestrant/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tng462 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/tng462/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/monotherapy 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/monotherapy/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vicriviroc 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/vicriviroc/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/acz885 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/acz885/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ondansetro 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/ondansetro/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/rintatolimod 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rintatolimod/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nadunolimab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/nadunolimab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/rly-2608 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/rly-2608/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/cjm112 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cjm112/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/idov-immune 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/idov-immune/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/afm24 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/afm24/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ter-2013 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ter-2013/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/s-adenosylmethionine 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/s-adenosylmethionine/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/gdc-6036 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gdc-6036/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sns-101 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sns-101/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/egf816 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/egf816/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/snk01 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/snk01/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ibi3028 2026-05-17 weekly 0.7 https://crcwarriors.org/medicamento/ibi3028/ensayos 2026-05-17 weekly 0.6 https://crcwarriors.org/medicamento/tmt212 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tmt212/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/donafenib 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/donafenib/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/eik1005 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/eik1005/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lymphodepletion 2026-05-18 weekly 0.7 https://crcwarriors.org/medicamento/lymphodepletion/ensayos 2026-05-18 weekly 0.6 https://crcwarriors.org/medicamento/trc102 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/trc102/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/irofulven 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/irofulven/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pexidartinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pexidartinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/kd-025 2026-05-17 weekly 0.7 https://crcwarriors.org/medicamento/kd-025/ensayos 2026-05-17 weekly 0.6 https://crcwarriors.org/medicamento/avapritinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/avapritinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/v941 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/v941/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/zr-dfo-n-suc-c9scfv 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/zr-dfo-n-suc-c9scfv/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/i-tm-601 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/i-tm-601/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nab-rapamyci 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/nab-rapamyci/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/candonilimab 2026-05-17 weekly 0.7 https://crcwarriors.org/medicamento/candonilimab/ensayos 2026-05-17 weekly 0.6 https://crcwarriors.org/medicamento/incb099318 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/incb099318/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sc-006 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sc-006/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/zr-dfo-n-suc-f8scfv 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/zr-dfo-n-suc-f8scfv/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fxs887 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/fxs887/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/etc-1922159 2026-05-17 weekly 0.7 https://crcwarriors.org/medicamento/etc-1922159/ensayos 2026-05-17 weekly 0.6 https://crcwarriors.org/medicamento/bdc-1001 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/bdc-1001/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/enlituo 2026-05-26 weekly 0.7 https://crcwarriors.org/medicamento/enlituo/ensayos 2026-05-26 weekly 0.6 https://crcwarriors.org/medicamento/in-idec-159 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/in-idec-159/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fz-ad004 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/fz-ad004/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tub-030 2026-05-17 weekly 0.7 https://crcwarriors.org/medicamento/tub-030/ensayos 2026-05-17 weekly 0.6 https://crcwarriors.org/medicamento/saracatinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/saracatinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/y-idec-159 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/y-idec-159/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/navarixi 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/navarixi/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/qlc1101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/qlc1101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/azd8421 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/azd8421/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/fz-ad005 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/fz-ad005/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hrs-7058 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/hrs-7058/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/brodalumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/brodalumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/polypepi1018 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/polypepi1018/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rgt-61159 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/rgt-61159/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tas-109 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tas-109/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/gamma-interferon-1b 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gamma-interferon-1b/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bay-3771249 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/bay-3771249/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/simmitinib 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/simmitinib/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/ineo-vac-t01 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/ineo-vac-t01/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/cvl218 2026-05-17 weekly 0.7 https://crcwarriors.org/medicamento/cvl218/ensayos 2026-05-17 weekly 0.6 https://crcwarriors.org/medicamento/mirabegron 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/mirabegron/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bms-986416 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bms-986416/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/azd9574 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/azd9574/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/dj-927 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/dj-927/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/aplitabart 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/aplitabart/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bms-936558-01 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bms-936558-01/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ciforadenant 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ciforadenant/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/amifostine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/amifostine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tate 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tate/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lutel 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lutel/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tafolecimab 2026-07-10 weekly 0.7 https://crcwarriors.org/medicamento/tafolecimab/ensayos 2026-07-10 weekly 0.6 https://crcwarriors.org/medicamento/cpi-006 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cpi-006/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/panitumumbab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/panitumumbab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hh160 2026-06-08 weekly 0.7 https://crcwarriors.org/medicamento/hh160/ensayos 2026-06-08 weekly 0.6 https://crcwarriors.org/medicamento/bo-112 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bo-112/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lyl273 2026-06-08 weekly 0.7 https://crcwarriors.org/medicamento/lyl273/ensayos 2026-06-08 weekly 0.6 https://crcwarriors.org/medicamento/medi5752 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/medi5752/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/sibp-a17 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/sibp-a17/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/edrecolomab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/edrecolomab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/reconval 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/reconval/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/i-hua33 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/i-hua33/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ava6103 2026-06-08 weekly 0.7 https://crcwarriors.org/medicamento/ava6103/ensayos 2026-06-08 weekly 0.6 https://crcwarriors.org/medicamento/sgn-cd228a 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sgn-cd228a/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/lt-010391 2026-06-08 weekly 0.7 https://crcwarriors.org/medicamento/lt-010391/ensayos 2026-06-08 weekly 0.6 https://crcwarriors.org/medicamento/lae118 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/lae118/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/emb-01 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/emb-01/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/dcsz11 2026-05-14 weekly 0.7 https://crcwarriors.org/medicamento/dcsz11/ensayos 2026-05-14 weekly 0.6 https://crcwarriors.org/medicamento/psma 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/psma/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ct-322 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ct-322/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bempegaldesleuki 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/bempegaldesleuki/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/kst-6051 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/kst-6051/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bc3195 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bc3195/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/mk-4716 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/mk-4716/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/fulzerasib 2026-05-14 weekly 0.7 https://crcwarriors.org/medicamento/fulzerasib/ensayos 2026-05-14 weekly 0.6 https://crcwarriors.org/medicamento/pegvisoma 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pegvisoma/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/procrit 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/procrit/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/detoxpc 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/detoxpc/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tamoxifen 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/tamoxifen/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/benfi 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/benfi/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/sk-nk 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/sk-nk/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pf-07934040 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-07934040/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/seribantumab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/seribantumab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/calcitriol 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/calcitriol/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/skb264 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/skb264/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ganciclovir 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ganciclovir/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gm102 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gm102/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ckd-516 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ckd-516/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/linifanib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/linifanib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/zm008 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/zm008/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tipifarnib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/tipifarnib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ns-9 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ns-9/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/gecacitinib 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/gecacitinib/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/iov-5001 2026-08-06 weekly 0.7 https://crcwarriors.org/medicamento/iov-5001/ensayos 2026-08-06 weekly 0.6 https://crcwarriors.org/medicamento/dacarbazine 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/dacarbazine/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/vls-1488 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/vls-1488/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pegilodecaki 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/pegilodecaki/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/zg005 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/zg005/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pico-salax 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pico-salax/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ab122 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ab122/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ltt462 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ltt462/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/stx-478 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/stx-478/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/bl-m07d1 2026-07-31 weekly 0.7 https://crcwarriors.org/medicamento/bl-m07d1/ensayos 2026-07-31 weekly 0.6 https://crcwarriors.org/medicamento/tas-116 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tas-116/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nt219 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nt219/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lxh254 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/lxh254/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cfi-402257 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/cfi-402257/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ser-155 2026-05-22 weekly 0.7 https://crcwarriors.org/medicamento/ser-155/ensayos 2026-05-22 weekly 0.6 https://crcwarriors.org/medicamento/tas-120 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tas-120/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cu-tz-sarar 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cu-tz-sarar/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/loxo-783 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/loxo-783/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/bendamustine 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bendamustine/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/cgt4255 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/cgt4255/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tas-115 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tas-115/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/anakinra 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/anakinra/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/pf-07921585 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-07921585/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nb1011 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nb1011/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ft825 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ft825/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/cgt4859 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/cgt4859/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/mhb036c 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/mhb036c/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ab154 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ab154/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sonovue 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sonovue/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mdx-1106 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mdx-1106/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/adh300004 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/adh300004/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/cgt6297 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/cgt6297/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/gensci139 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/gensci139/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/mhb039a 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/mhb039a/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/dupilumab 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/dupilumab/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/apx005m 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/apx005m/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cdx-1307 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cdx-1307/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/adecatumumab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/adecatumumab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/xmab819 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/xmab819/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gensci145 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/gensci145/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/vvd-159642 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/vvd-159642/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hlx05 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hlx05/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lcl161 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/lcl161/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/streptozoci 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/streptozoci/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/qbm076 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/qbm076/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/i-nm404 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/i-nm404/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/grapiprant 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/grapiprant/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gfh375 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/gfh375/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/mt-102 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mt-102/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fu-1000 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/fu-1000/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/odetigluca 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/odetigluca/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/bg-c9074 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bg-c9074/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ft536 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ft536/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/palifermin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/palifermin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/g17dt-irinoteca 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/g17dt-irinoteca/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/evorpacept 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/evorpacept/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sl-279252 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sl-279252/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/melcancervac 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/melcancervac/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gad20-209-fsp 2026-05-28 weekly 0.7 https://crcwarriors.org/medicamento/gad20-209-fsp/ensayos 2026-05-28 weekly 0.6 https://crcwarriors.org/medicamento/ssgj-705 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ssgj-705/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/magnesia 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/magnesia/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cb-103 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cb-103/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hr070803 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hr070803/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mva-209-fsp 2026-05-28 weekly 0.7 https://crcwarriors.org/medicamento/mva-209-fsp/ensayos 2026-05-28 weekly 0.6 https://crcwarriors.org/medicamento/hbm4003 2026-05-21 weekly 0.7 https://crcwarriors.org/medicamento/hbm4003/ensayos 2026-05-21 weekly 0.6 https://crcwarriors.org/medicamento/fexagratinib 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/fexagratinib/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/nt-175 2026-07-16 weekly 0.7 https://crcwarriors.org/medicamento/nt-175/ensayos 2026-07-16 weekly 0.6 https://crcwarriors.org/medicamento/egen-001-301 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/egen-001-301/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/px-866 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/px-866/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/niclosamide 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/niclosamide/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/rp2d 2026-05-28 weekly 0.7 https://crcwarriors.org/medicamento/rp2d/ensayos 2026-05-28 weekly 0.6 https://crcwarriors.org/medicamento/ab680 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ab680/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-08046049 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-08046049/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/incagn02385 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/incagn02385/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/medi7247 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/medi7247/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/radspherin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/radspherin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/megf0444a 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/megf0444a/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/asp1002 2026-07-25 weekly 0.7 https://crcwarriors.org/medicamento/asp1002/ensayos 2026-07-25 weekly 0.6 https://crcwarriors.org/medicamento/ism5939 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ism5939/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/cytalux 2026-05-20 weekly 0.7 https://crcwarriors.org/medicamento/cytalux/ensayos 2026-05-20 weekly 0.6 https://crcwarriors.org/medicamento/hu5b1-tco 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hu5b1-tco/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cddp 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/cddp/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/trebananib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/trebananib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hbi-2438 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hbi-2438/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/scrt 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/scrt/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/abn401 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/abn401/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/futibatinib 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/futibatinib/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/mk-4884 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/mk-4884/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/incb057643 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/incb057643/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/romiplostim 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/romiplostim/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/palifermi 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/palifermi/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/absk141 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/absk141/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/mk-8294 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/mk-8294/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/vet3-tgi 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/vet3-tgi/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ab928 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ab928/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rnf43-721 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rnf43-721/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gevokizumab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/gevokizumab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/incb059872 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/incb059872/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nk012 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nk012/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/imrt 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/imrt/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mdna11 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mdna11/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ly3962673 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/ly3962673/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/cdx-527 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cdx-527/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/o6-benzylguanine 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/o6-benzylguanine/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ckd-703 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ckd-703/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/fluoxetine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/fluoxetine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bgb-53038 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bgb-53038/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ino-1400 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ino-1400/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lymphoseek 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lymphoseek/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/dat-2645 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/dat-2645/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/oncovax 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/oncovax/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/fpi-2053 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/fpi-2053/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/son-dp 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/son-dp/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/men1611 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/men1611/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ly2523355 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ly2523355/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ino-1401 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ino-1401/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/syh2051 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/syh2051/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/htl0039732 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/htl0039732/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/adu-1805 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/adu-1805/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bms-986253 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bms-986253/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cbp-1019 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/cbp-1019/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ino-9012 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ino-9012/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sys6010 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sys6010/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ls-11 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ls-11/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/zongertinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/zongertinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/rina-s 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/rina-s/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pb-dotam 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pb-dotam/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/iah0968 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/iah0968/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/sta-9090 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sta-9090/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tbio-6517 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tbio-6517/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lnth-2403 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lnth-2403/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/acc-1898 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/acc-1898/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/sys6023 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/sys6023/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hc-7366 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hc-7366/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nrl0706 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/nrl0706/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/mk0683 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mk0683/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ace2016 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ace2016/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/sys6043 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/sys6043/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/absk211 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/absk211/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/incb161734 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/incb161734/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/decoy20 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/decoy20/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/zibotentan 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/zibotentan/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/medi6469 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/medi6469/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vorbipiprant 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/vorbipiprant/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/sys6045 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/sys6045/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hydroxytyrosol 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/hydroxytyrosol/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/adavosertib 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/adavosertib/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/js004 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/js004/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/load703 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/load703/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ep2101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ep2101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/osi-7904l 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/osi-7904l/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/suprpep 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/suprpep/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/muzastotug 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/muzastotug/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/t-1301 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/t-1301/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/gvv858 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/gvv858/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ly2880070 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ly2880070/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cp-4055 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cp-4055/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ef5 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ef5/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/figitumumab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/figitumumab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/yl202 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/yl202/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/grt-c903 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/grt-c903/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/iam1363 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/iam1363/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pegvisomant 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pegvisomant/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/l-tryptopha 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/l-tryptopha/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gsk5733584 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/gsk5733584/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/grt-r904 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/grt-r904/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/allomem 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/allomem/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pf-03446962 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-03446962/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sonoporation 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/sonoporation/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/dky709 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/dky709/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/sm2275 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/sm2275/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/dm002 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/dm002/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hx008 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hx008/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tl938 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tl938/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tak-164 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tak-164/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tki258 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tki258/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/enzelkitug 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/enzelkitug/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/furoquintinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/furoquintinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gtaexs617 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/gtaexs617/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tak-505 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/tak-505/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/secretin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/secretin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/tst003 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tst003/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bca101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bca101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-07265807 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-07265807/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/zr-tak-164 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/zr-tak-164/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/pttl 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pttl/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sitagliptin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/sitagliptin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/mpd-1 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/mpd-1/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/impact 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/impact/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/mga012 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mga012/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mrg002 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/mrg002/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/linaclotide 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/linaclotide/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/a2b395 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/a2b395/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/omp-305b83 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/omp-305b83/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/chemoradiation 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/chemoradiation/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ironisomaltoside 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ironisomaltoside/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/second 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/second/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hs-20089 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hs-20089/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/memantine 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/memantine/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/livmoniplimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/livmoniplimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pimasertib 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pimasertib/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/phn-012 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/phn-012/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/perflutre 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/perflutre/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/kn026 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/kn026/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rp-001 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/rp-001/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/lomustine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lomustine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sapanisertib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sapanisertib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pregabalin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pregabalin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cdx1307 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/cdx1307/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/ide034 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/ide034/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/mebendazole 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/mebendazole/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/taselisib 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/taselisib/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ag-013726 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ag-013726/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ferinjec 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/ferinjec/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/mk-0752 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mk-0752/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/abbv-221 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/abbv-221/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/h-10000 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/h-10000/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/asp5834 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/asp5834/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/thor-707 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/thor-707/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/toca-511 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/toca-511/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rifampicin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/rifampicin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/digoxin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/digoxin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/dronabinol 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/dronabinol/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/okn4395 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/okn4395/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fuquinitinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/fuquinitinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/electroacupuncture 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/electroacupuncture/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/cpo301 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/cpo301/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tuvusertib 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tuvusertib/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vgt-309 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/vgt-309/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cvl237 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cvl237/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/eft508 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/eft508/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/lu-dfc413 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/lu-dfc413/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tgi-5 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tgi-5/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/albumin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/albumin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/abi-1968 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/abi-1968/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/crpa1a2 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/crpa1a2/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hb0036 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hb0036/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/mt-4561 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/mt-4561/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/emavusertib 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/emavusertib/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pantoprazole 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pantoprazole/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/yyb101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/yyb101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nitrogen 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nitrogen/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/car-t 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/car-t/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/cryopreserved 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/cryopreserved/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hb0052 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hb0052/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tcmcb07 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/tcmcb07/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/simtuzumab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/simtuzumab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/prolgolimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/prolgolimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hcb101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hcb101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sildenafil 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/sildenafil/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/m-cenk 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/m-cenk/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tovecimig 2026-06-26 weekly 0.7 https://crcwarriors.org/medicamento/tovecimig/ensayos 2026-06-26 weekly 0.6 https://crcwarriors.org/medicamento/alta3263 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/alta3263/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/phn-010 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/phn-010/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/kin-2787 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/kin-2787/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/becatecarin 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/becatecarin/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ispinesib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ispinesib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/chs-114 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/chs-114/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/m9466 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/m9466/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/cs5007 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/cs5007/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/lederfoli 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/lederfoli/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/zalutumumab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/zalutumumab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hro761 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hro761/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-07826390 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-07826390/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/oxycodone 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/oxycodone/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sgn-stnv 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sgn-stnv/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/amr101 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/amr101/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/esomeprazole 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/esomeprazole/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/laxabon 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/laxabon/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/thymopentin 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/thymopentin/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/nitazoxanide 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nitazoxanide/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/lum015 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/lum015/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vtx002 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/vtx002/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/ft500 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ft500/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/idasanutlin 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/idasanutlin/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/blyg8824a 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/blyg8824a/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/inuli 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/inuli/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/rtx-321 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rtx-321/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/isis-183750 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/isis-183750/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mdx2001 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mdx2001/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/awt020 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/awt020/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/isatuximab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/isatuximab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/incb024360 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/incb024360/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/midostaurin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/midostaurin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gic-1001 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/gic-1001/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/ide574 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ide574/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ct-707 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ct-707/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hdm2024 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hdm2024/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/cbi-1214 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cbi-1214/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/olanzapine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/olanzapine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ipn01194 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ipn01194/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/gsk4418959 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/gsk4418959/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/selicrelumab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/selicrelumab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/cs7017 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cs7017/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bms-908662 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bms-908662/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/jnj-78306358 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/jnj-78306358/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pentamidine 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pentamidine/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/sy-5933 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/sy-5933/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hec169096 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hec169096/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ml-016 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/ml-016/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/pf-08032562 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pf-08032562/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/eras-007 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/eras-007/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/amb-05x 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/amb-05x/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/pf-07820435 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-07820435/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nefopam 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nefopam/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sc-007 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sc-007/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mcla-128 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mcla-128/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mesalazine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/mesalazine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/navitoclax 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/navitoclax/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/nm21-1480 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nm21-1480/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lvonescimab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/lvonescimab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/belinostat 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/belinostat/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/arog4-01 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/arog4-01/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rechalange 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rechalange/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/her3-dxd 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/her3-dxd/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tj101 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/tj101/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/xmab20717 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xmab20717/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fentanyl 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/fentanyl/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/rofecoxib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rofecoxib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/imt-009 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/imt-009/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/krc-01 2026-06-07 weekly 0.7 https://crcwarriors.org/medicamento/krc-01/ensayos 2026-06-07 weekly 0.6 https://crcwarriors.org/medicamento/lyl845 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/lyl845/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tomox 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/tomox/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/iohexol 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/iohexol/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sl-28 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/sl-28/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/vgx-3100 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/vgx-3100/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/kfa115 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/kfa115/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pld 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pld/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/vb15010 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/vb15010/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/medi-522 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/medi-522/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bevacizumab-800cw 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/bevacizumab-800cw/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/rituximab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/rituximab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/erapa 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/erapa/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tolecizumab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tolecizumab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/nd-003 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/nd-003/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hai 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/hai/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/atrc-101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/atrc-101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lurbinectedin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lurbinectedin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/xl999 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xl999/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tobramycin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tobramycin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/amt-676 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/amt-676/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bg-68501 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bg-68501/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/papaverine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/papaverine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ly3499446 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ly3499446/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/oncos-102 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/oncos-102/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hmpl 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hmpl/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tas0728 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tas0728/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/omegaven 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/omegaven/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/aur107 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/aur107/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tirzepatide 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tirzepatide/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/etrozulimab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/etrozulimab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/zibotenta 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/zibotenta/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nt-i7 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nt-i7/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ertapenem 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ertapenem/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/so-crc 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/so-crc/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bg-89894 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bg-89894/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/gt307 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/gt307/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/cd-ga-102 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cd-ga-102/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tadalafil 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tadalafil/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/norepinephrine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/norepinephrine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/picoplati 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/picoplati/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/jnj-74699157 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/jnj-74699157/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pacritinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pacritinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bgb-58067 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bgb-58067/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hlx43 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hlx43/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/magnesiumoxid 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/magnesiumoxid/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/phenylephrine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/phenylephrine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ocv-103 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ocv-103/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lbh589 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/lbh589/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bg-c0902 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bg-c0902/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/rk-582 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/rk-582/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/methylprednisolone 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/methylprednisolone/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ye-neo-001 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ye-neo-001/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ocv-104 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ocv-104/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/amg-355 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/amg-355/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tqb2102 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tqb2102/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bg-c137 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bg-c137/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/cx1003 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/cx1003/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hlx42 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hlx42/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/mnpr-101-pcta-177lu 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mnpr-101-pcta-177lu/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cend-1 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cend-1/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/prucalopride 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/prucalopride/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mm-141 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mm-141/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/yfmt 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/yfmt/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bg-c477 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bg-c477/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hlx48 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hlx48/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/mnpr-101 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/mnpr-101/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/bay2927088 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bay2927088/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/prgn-2009 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/prgn-2009/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ursodiol 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/ursodiol/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/sc0191 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sc0191/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/aquamin 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/aquamin/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/fdg 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/fdg/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/bg-t187 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bg-t187/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ly4257496 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ly4257496/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/etx-19477 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/etx-19477/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/guselkumab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/guselkumab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/tolinapant 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/tolinapant/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/bgb-26808 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bgb-26808/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/wm-a1-3389 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/wm-a1-3389/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/erythromycin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/erythromycin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gsk525762 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/gsk525762/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/renvastinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/renvastinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/jnj-89402638 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/jnj-89402638/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/wef-001 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/wef-001/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/streptozocin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/streptozocin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tkm-080301 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tkm-080301/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/metoclopramide 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/metoclopramide/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pregabali 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pregabali/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bdtx-189 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bdtx-189/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/amg-228 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/amg-228/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/elacestrant 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/elacestrant/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hrs-6093 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hrs-6093/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tpst-1495 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tpst-1495/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/amp-224 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/amp-224/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fapi-46 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/fapi-46/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/lu-j591 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lu-j591/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/senna 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/senna/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/azd4635 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/azd4635/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sgn-cd47m 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sgn-cd47m/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/shr-9839 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/shr-9839/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/bms-986466 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bms-986466/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/epidural 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/epidural/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hmpl- 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/hmpl-/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/tivantinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tivantinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/adg106 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/adg106/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/bgb-b455 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bgb-b455/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/kras-epha-2-car-dc 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/kras-epha-2-car-dc/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/hs-10529 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hs-10529/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/rogaratinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rogaratinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/famotidine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/famotidine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cy-503 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cy-503/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vegfr1 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/vegfr1/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/teysuno 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/teysuno/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fufa 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/fufa/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hs-10541 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hs-10541/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/rucaparib 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/rucaparib/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/js015 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/js015/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/xl281 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xl281/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tsa-ctl 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/tsa-ctl/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/vegfr2 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/vegfr2/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/antioxidants 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/antioxidants/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/pri-724 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/pri-724/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/bhv-1530 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bhv-1530/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/elvn-002 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/elvn-002/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pladd 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pladd/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ibi351 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ibi351/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bi-1823911 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bi-1823911/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/rivoceranib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rivoceranib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/xenon 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/xenon/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/g17dt-irinotecan 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/g17dt-irinotecan/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/immune 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/immune/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/cyclophosphosphamide 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/cyclophosphosphamide/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/nkt3964 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/nkt3964/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/picoplatin 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/picoplatin/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/perflutren 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/perflutren/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rigosertib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rigosertib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nm6603 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/nm6603/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/astx727 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/astx727/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/r115777 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/r115777/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/misoprostol 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/misoprostol/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/idasanutli 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/idasanutli/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/hwk-007 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hwk-007/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/kpt-8602 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/kpt-8602/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pv701 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pv701/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sqz-pbmc-hpv 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/sqz-pbmc-hpv/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/grapipra 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/grapipra/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/radspheri 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/radspheri/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/bxq-350 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bxq-350/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/e-602 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/e-602/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mva-fcu1 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mva-fcu1/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/etbx-021 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/etbx-021/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nsaids 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nsaids/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/clindamycin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/clindamycin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/remzistotug 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/remzistotug/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/acm-cpg 2026-06-20 weekly 0.7 https://crcwarriors.org/medicamento/acm-cpg/ensayos 2026-06-20 weekly 0.6 https://crcwarriors.org/medicamento/mlf-541 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/mlf-541/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/hydrocortisone 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/hydrocortisone/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/d1553 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/d1553/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/sotevtamab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/sotevtamab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/cbx-12 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cbx-12/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/metarrestin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/metarrestin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cialis 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cialis/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cue-102 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cue-102/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/in111 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/in111/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/denikitug 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/denikitug/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/d3l-001 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/d3l-001/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/sotigalimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sotigalimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/art0380 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/art0380/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sgn-2ff 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sgn-2ff/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/gi-6207 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gi-6207/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nm1f 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nm1f/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lu177 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/lu177/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bhb810 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/bhb810/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/d3s-003 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/d3s-003/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/onm-100 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/onm-100/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tf2 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tf2/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/jsi-1187 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/jsi-1187/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tt125-802 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/tt125-802/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pt0511 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pt0511/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/lut014 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/lut014/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/asimadoline 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/asimadoline/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hank 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hank/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/halflytely 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/halflytely/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bms-754807 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bms-754807/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sulfasalazine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sulfasalazine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/azd9592 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/azd9592/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nx-13 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nx-13/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/dms-612 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/dms-612/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lorlatinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/lorlatinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ad-p53 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ad-p53/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ze94-0605 2026-05-08 weekly 0.7 https://crcwarriors.org/medicamento/ze94-0605/ensayos 2026-05-08 weekly 0.6 https://crcwarriors.org/medicamento/low-dose 2026-05-21 weekly 0.7 https://crcwarriors.org/medicamento/low-dose/ensayos 2026-05-21 weekly 0.6 https://crcwarriors.org/medicamento/benfin 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/benfin/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/ro7515629 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ro7515629/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pf-07284892 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-07284892/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hryz-t101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hryz-t101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hlx26 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hlx26/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/amg-386 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/amg-386/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/incb099280 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/incb099280/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ntx-1088 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ntx-1088/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/bmf-219 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/bmf-219/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/abgn-107 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/abgn-107/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ono-7913 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ono-7913/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/dose-reduced 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/dose-reduced/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/gnp 2026-06-11 weekly 0.7 https://crcwarriors.org/medicamento/gnp/ensayos 2026-06-11 weekly 0.6 https://crcwarriors.org/medicamento/ak131 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ak131/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ibi354 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ibi354/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/nuv-1511 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/nuv-1511/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tyk-00540 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/tyk-00540/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/sm04755 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/sm04755/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/tyra-300 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/tyra-300/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/mrtx0902 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mrtx0902/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/anti-vegf 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/anti-vegf/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/tyra-430 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/tyra-430/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/jr8603 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/jr8603/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-07062119 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-07062119/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rimegepa 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/rimegepa/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ide397 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ide397/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/s095029 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/s095029/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hy-0102 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/hy-0102/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/-l-tryptophan 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/-l-tryptophan/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/nw-301vt 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/nw-301vt/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/colo-ad1 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/colo-ad1/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/qbs10072s 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/qbs10072s/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/f-fludeoxyglucose 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/f-fludeoxyglucose/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/np-g2-044 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/np-g2-044/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nwy001 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/nwy001/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/cdx-1127 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cdx-1127/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/f-fpprgd2 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/f-fpprgd2/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/s95029 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/s95029/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/iks014 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/iks014/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/cyp2c8 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/cyp2c8/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/msc-l 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/msc-l/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/alx2004 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/alx2004/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/npx267 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/npx267/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/birinapant 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/birinapant/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bavituximab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bavituximab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/lyt-200 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/lyt-200/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cyp3a4 2026-09-02 weekly 0.7 https://crcwarriors.org/medicamento/cyp3a4/ensayos 2026-09-02 weekly 0.6 https://crcwarriors.org/medicamento/sar445877 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/sar445877/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/lg00313112 2026-08-10 weekly 0.7 https://crcwarriors.org/medicamento/lg00313112/ensayos 2026-08-10 weekly 0.6 https://crcwarriors.org/medicamento/ltc004 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ltc004/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/alisertib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/alisertib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ipalolimab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/ipalolimab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/com701 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/com701/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tovorilimab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/tovorilimab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/ralimetinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ralimetinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bm230 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bm230/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/imgs-001 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/imgs-001/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/alintegimod 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/alintegimod/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/agx101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/agx101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nir178 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nir178/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ondansetron 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/ondansetron/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/genistein 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/genistein/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/fog-001 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/fog-001/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/crlx101 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/crlx101/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/immu-130 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/immu-130/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/xmab22841 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xmab22841/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-07209960 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-07209960/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/imm2902 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/imm2902/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/vbc101 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/vbc101/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/adg126 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/adg126/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mesothelin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/mesothelin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ide196 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ide196/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/xmab808 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xmab808/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/electrochemotherapy 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/electrochemotherapy/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/injection 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/injection/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/psca 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/psca/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/eras-601 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/eras-601/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-07263689 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-07263689/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/asp1951 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/asp1951/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/injectio 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/injectio/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/vancomycin 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/vancomycin/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/muc1 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/muc1/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/revumenib 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/revumenib/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/hbi-2376 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hbi-2376/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nab-rapamycin 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nab-rapamycin/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mdcf 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mdcf/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vert-002 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/vert-002/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/incb186748 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/incb186748/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/lewis-y 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lewis-y/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ibi310 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ibi310/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/gpc3 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/gpc3/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/pf-07329640 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pf-07329640/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/axl 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/axl/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/isoquercetin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/isoquercetin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/lde225 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/lde225/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/sarcnu 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sarcnu/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mkc-1 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mkc-1/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nab-sirolimus 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nab-sirolimus/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/pegasys 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pegasys/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/incb-99280 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/incb-99280/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/emi-137 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/emi-137/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ror1 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ror1/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/odetiglucan 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/odetiglucan/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nelmastoba 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/nelmastoba/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/onartuzumab 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/onartuzumab/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gd1 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/gd1/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bey1107 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bey1107/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/amg-410 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/amg-410/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/l-tryptophan 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/l-tryptophan/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/cefmetazole 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/cefmetazole/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/alk201 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/alk201/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/oric-114 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/oric-114/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/duloxetine 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/duloxetine/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/trilaciclib 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/trilaciclib/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fate-nk100 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/fate-nk100/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mifl 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/mifl/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mt110 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mt110/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/alk202 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/alk202/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/bms-986507 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bms-986507/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pidnarulex 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pidnarulex/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/epo906 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/epo906/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/azithromycin 2026-05-23 weekly 0.7 https://crcwarriors.org/medicamento/azithromycin/ensayos 2026-05-23 weekly 0.6 https://crcwarriors.org/medicamento/kn035 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/kn035/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mithramycin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/mithramycin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/impac 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/impac/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/bnc-105 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bnc-105/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lederfolin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lederfolin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nhs-il12 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/nhs-il12/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/icis 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/icis/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/hextend 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/hextend/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bi-695502 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bi-695502/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/inositol 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/inositol/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/qls5316 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/qls5316/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/almonertinib 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/almonertinib/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/wj22096 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/wj22096/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ct-0508 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ct-0508/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/egfr-tkis 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/egfr-tkis/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ferinject 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ferinject/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/fpv-cv301 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/fpv-cv301/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/suvemcitug 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/suvemcitug/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ntrk-tki 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ntrk-tki/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mva-bn-cv301 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mva-bn-cv301/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sulfave 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sulfave/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bnt326 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bnt326/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/diprosone 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/diprosone/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sutab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sutab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/paroxetine 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/paroxetine/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/dbc-664 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/dbc-664/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/ataluren 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ataluren/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/belrestotug 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/belrestotug/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/weileshu 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/weileshu/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/isis-2503 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/isis-2503/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/topotecan 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/topotecan/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/amg820 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/amg820/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/am-928 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/am-928/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/invima-approved 2026-07-04 weekly 0.7 https://crcwarriors.org/medicamento/invima-approved/ensayos 2026-07-04 weekly 0.6 https://crcwarriors.org/medicamento/sy-5609 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sy-5609/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/mk-4830 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mk-4830/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nelistotug 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nelistotug/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/abt-165 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/abt-165/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tricom-cea 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tricom-cea/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/azd8853 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/azd8853/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/eras-0015 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/eras-0015/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/divarasib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/divarasib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bms-813160 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bms-813160/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/l-blp25 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/l-blp25/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sonoporatio 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/sonoporatio/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/etaracizumab 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/etaracizumab/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/pas-004 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/pas-004/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/s95005 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/s95005/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/vanucizumab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/vanucizumab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/dolcanatide 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/dolcanatide/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/hfb200603 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hfb200603/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rbs2418 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/rbs2418/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lb-100 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/lb-100/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pd-1 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/pd-1/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/sym024 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sym024/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sbt6050 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sbt6050/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/leukovorin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/leukovorin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/amg-404 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/amg-404/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/jmt203 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/jmt203/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/morab-066 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/morab-066/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rimegepant 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rimegepant/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/inca00186 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/inca00186/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/gsk5460025 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gsk5460025/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mvasi 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/mvasi/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ly3537982 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ly3537982/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/urelumab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/urelumab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/cmp-001 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cmp-001/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bpi-1178 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bpi-1178/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/yh32367 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/yh32367/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/bms-986488 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bms-986488/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tricom 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/tricom/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/xmab23104 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xmab23104/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fluorouracyl 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/fluorouracyl/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nk510 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nk510/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/levamisol 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/levamisol/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/yh42946 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/yh42946/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ly3039478 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ly3039478/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-02341066 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pf-02341066/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/dem301 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/dem301/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/sr-8541a 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sr-8541a/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/stc-1010 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/stc-1010/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/taladegib 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/taladegib/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rp3 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/rp3/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/rmc-5127 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/rmc-5127/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/sofe-m 2026-09-06 weekly 0.7 https://crcwarriors.org/medicamento/sofe-m/ensayos 2026-09-06 weekly 0.6 https://crcwarriors.org/medicamento/pf-08046050 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-08046050/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ct-011 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ct-011/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tas-ox 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/tas-ox/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/surami 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/surami/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ha35 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ha35/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ami-hc 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ami-hc/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/yl211 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/yl211/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/abbv-181 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/abbv-181/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rxc004 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rxc004/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ro5083945 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ro5083945/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/quinacrine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/quinacrine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/azd1775 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/azd1775/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mitomycin-pipac 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/mitomycin-pipac/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/elsiglutide 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/elsiglutide/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/cu-atsm 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/cu-atsm/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/blu-924 2026-06-08 weekly 0.7 https://crcwarriors.org/medicamento/blu-924/ensayos 2026-06-08 weekly 0.6 https://crcwarriors.org/medicamento/ami-hc-cf 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ami-hc-cf/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ct-95 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ct-95/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hrx215 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hrx215/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/f-fmau 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/f-fmau/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/msc1936369b 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/msc1936369b/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/raltitrexed-pipac 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/raltitrexed-pipac/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/d-methadone 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/d-methadone/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/tnferade 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tnferade/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ga-dfc413 2026-06-08 weekly 0.7 https://crcwarriors.org/medicamento/ga-dfc413/ensayos 2026-06-08 weekly 0.6 https://crcwarriors.org/medicamento/ami-lc 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ami-lc/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/sar245409 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sar245409/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/omp-131r10 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/omp-131r10/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ami-lc-md 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ami-lc-md/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/bs006 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bs006/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/inv-6452 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/inv-6452/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/vvd-133214 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/vvd-133214/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/mt-302 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mt-302/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/kqb365 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/kqb365/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cm4307 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cm4307/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/debiri 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/debiri/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/bt8009 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/bt8009/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pentoxifylline 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pentoxifylline/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nal-iri 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/nal-iri/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/gb1275 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gb1275/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/imc-11f8 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/imc-11f8/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/nktr-255 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nktr-255/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lonafarnib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/lonafarnib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gsk3745417 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/gsk3745417/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tng260 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/tng260/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/asp4396 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/asp4396/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/ing-41 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ing-41/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pipac 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pipac/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/combi 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/combi/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/navarixin 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/navarixin/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mk-8353 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/mk-8353/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/btx-a51 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/btx-a51/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/zn-a-1041 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/zn-a-1041/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ucb4594 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ucb4594/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/moma-341 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/moma-341/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mgn1703 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mgn1703/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/imo-2055 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/imo-2055/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/darizmetinib 2026-05-29 weekly 0.7 https://crcwarriors.org/medicamento/darizmetinib/ensayos 2026-05-29 weekly 0.6 https://crcwarriors.org/medicamento/xya02 2026-06-28 weekly 0.7 https://crcwarriors.org/medicamento/xya02/ensayos 2026-06-28 weekly 0.6 https://crcwarriors.org/medicamento/vxm01 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/vxm01/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/gtx-024 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/gtx-024/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/brontictuzumab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/brontictuzumab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/minnelidecapsules 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/minnelidecapsules/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/inv-8989 2026-05-30 weekly 0.7 https://crcwarriors.org/medicamento/inv-8989/ensayos 2026-05-30 weekly 0.6 https://crcwarriors.org/medicamento/chlorophyllin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/chlorophyllin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/agent-797 2026-04-25 weekly 0.7 https://crcwarriors.org/medicamento/agent-797/ensayos 2026-04-25 weekly 0.6 https://crcwarriors.org/medicamento/ds-1103a 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ds-1103a/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/e7046 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/e7046/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/daratumumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/daratumumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tak-931 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tak-931/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ymn-a02 2026-05-30 weekly 0.7 https://crcwarriors.org/medicamento/ymn-a02/ensayos 2026-05-30 weekly 0.6 https://crcwarriors.org/medicamento/ds-8273a 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ds-8273a/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ongericimab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ongericimab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ipg7236 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ipg7236/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/zv0203 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/zv0203/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/suramin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/suramin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/merestinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/merestinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/mrna-4359 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/mrna-4359/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/vir-5525 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/vir-5525/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/zz06 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/zz06/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/andrographolides 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/andrographolides/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/sequential-cmab009 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/sequential-cmab009/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tanespimyci 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/tanespimyci/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/caffeine 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/caffeine/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/vmd-928 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/vmd-928/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/asp546c 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/asp546c/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ebnk-001 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ebnk-001/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/azd0022 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/azd0022/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/etodolac 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/etodolac/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/cetuximab-irdye800 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/cetuximab-irdye800/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/il-15 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/il-15/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/kt032 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/kt032/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/clensia 2026-07-11 weekly 0.7 https://crcwarriors.org/medicamento/clensia/ensayos 2026-07-11 weekly 0.6 https://crcwarriors.org/medicamento/go-lytely 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/go-lytely/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/abt-869 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/abt-869/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/isotretinoin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/isotretinoin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/avx-470 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/avx-470/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/abx464 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/abx464/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/incb050465 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/incb050465/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/arg1-18 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/arg1-18/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/abm-168 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/abm-168/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fluorescein 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/fluorescein/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/carfilzomib 2026-07-22 weekly 0.7 https://crcwarriors.org/medicamento/carfilzomib/ensayos 2026-07-22 weekly 0.6 https://crcwarriors.org/medicamento/poly-iclc 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/poly-iclc/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/itacitinib 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/itacitinib/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/bax69 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bax69/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/syn004 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/syn004/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/shy-onc6 2026-07-17 weekly 0.7 https://crcwarriors.org/medicamento/shy-onc6/ensayos 2026-07-17 weekly 0.6 https://crcwarriors.org/medicamento/ji-101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ji-101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nelmastobart 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nelmastobart/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cdk-004 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cdk-004/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lobaplatin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/lobaplatin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/pelareorep 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/pelareorep/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/vofatamab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/vofatamab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/berzosertib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/berzosertib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/rc198 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/rc198/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nbt-nm108 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nbt-nm108/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/perindopril 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/perindopril/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ve800 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ve800/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cabazitaxel 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cabazitaxel/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/afnt-211 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/afnt-211/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/btg-002814 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/btg-002814/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/andecaliximab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/andecaliximab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rrx-001 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/rrx-001/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mb-6 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mb-6/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/atorvastatin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/atorvastatin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/vmd-102 2026-06-12 weekly 0.7 https://crcwarriors.org/medicamento/vmd-102/ensayos 2026-06-12 weekly 0.6 https://crcwarriors.org/medicamento/cr6086 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cr6086/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bbo-11818 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bbo-11818/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tetrathiomolybdate 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tetrathiomolybdate/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/dacomitinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/dacomitinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/phy906 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/phy906/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/agen2034 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/agen2034/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/incmga00012 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/incmga00012/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/eo4010 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/eo4010/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tilmanocep 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/tilmanocep/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/mk-1697 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mk-1697/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/huc242-dm4 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/huc242-dm4/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/jskn003 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/jskn003/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/dihydroartemisinin 2026-09-04 weekly 0.7 https://crcwarriors.org/medicamento/dihydroartemisinin/ensayos 2026-09-04 weekly 0.6 https://crcwarriors.org/medicamento/lurbinectedi 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/lurbinectedi/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/mk0457 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mk0457/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nelitolimod 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/nelitolimod/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/vx-680 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/vx-680/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ly3009120 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ly3009120/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ap402 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ap402/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/oatd-02 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/oatd-02/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mrtx1133 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mrtx1133/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/peposertib 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/peposertib/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bosutinib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bosutinib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/gm103 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/gm103/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hspe7 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hspe7/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/apg-115 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/apg-115/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/jnj-95437446 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/jnj-95437446/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/apr003 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/apr003/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/apg-2575 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/apg-2575/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/isa-720 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/isa-720/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ide-161 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ide-161/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ceritinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ceritinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ct-2106 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ct-2106/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/irofulve 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/irofulve/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/lu-betabart 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/lu-betabart/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/setidegrasib 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/setidegrasib/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/eik1004-001 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/eik1004-001/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/aur109 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/aur109/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pln-101095 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/pln-101095/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/evorpacep 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/evorpacep/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/topoteca 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/topoteca/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/tsn1611 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tsn1611/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ivx037 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ivx037/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/sindilizumab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/sindilizumab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/zn-c3 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/zn-c3/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/stro-004 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/stro-004/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/aps03118 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/aps03118/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ism3412 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ism3412/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/incb0123667 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/incb0123667/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/chemotherapy 2026-05-16 weekly 0.7 https://crcwarriors.org/medicamento/chemotherapy/ensayos 2026-05-16 weekly 0.6 https://crcwarriors.org/medicamento/v934-ep 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/v934-ep/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ly01008 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ly01008/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/isotretinoi 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/isotretinoi/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/ly4337713 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ly4337713/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tst001 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/tst001/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ucmym802 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ucmym802/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/v935 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/v935/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/db-1310 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/db-1310/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ak129 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ak129/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hc010 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hc010/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/fudr-dex 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/fudr-dex/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/oncr-177 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/oncr-177/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-06952229 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-06952229/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pep02 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pep02/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tgi-6 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/tgi-6/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/bpi-572270 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/bpi-572270/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/deg6498 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/deg6498/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/elzovantinib 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/elzovantinib/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/cddp-50 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/cddp-50/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bms-986523 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bms-986523/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/arm1 2026-07-21 weekly 0.7 https://crcwarriors.org/medicamento/arm1/ensayos 2026-07-21 weekly 0.6 https://crcwarriors.org/medicamento/im-1617 2026-05-15 weekly 0.7 https://crcwarriors.org/medicamento/im-1617/ensayos 2026-05-15 weekly 0.6 https://crcwarriors.org/medicamento/nuc-3373 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nuc-3373/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cddp-75 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cddp-75/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/enlonstobart 2026-05-15 weekly 0.7 https://crcwarriors.org/medicamento/enlonstobart/ensayos 2026-05-15 weekly 0.6 https://crcwarriors.org/medicamento/bms-986484 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bms-986484/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nufiri 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nufiri/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/in-imp-288 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/in-imp-288/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bnt329 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bnt329/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/art6043 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/art6043/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ritonavir 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/ritonavir/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/galinpepimut-s 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/galinpepimut-s/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nufox 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nufox/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/y-imp-288 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/y-imp-288/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/darlifarnib 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/darlifarnib/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/js105 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/js105/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pf-07799544 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/pf-07799544/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/interleukin-ene 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/interleukin-ene/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/diphenhydramine 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/diphenhydramine/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/arv-471 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/arv-471/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/xp-102 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xp-102/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/auy922 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/auy922/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ibuprofen 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ibuprofen/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/samotolisib 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/samotolisib/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/lpm6690176 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/lpm6690176/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/can016 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/can016/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/an0025 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/an0025/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/abt-751 2026-05-10 weekly 0.7 https://crcwarriors.org/medicamento/abt-751/ensayos 2026-05-10 weekly 0.6 https://crcwarriors.org/medicamento/rilotumumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/rilotumumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ap-12009 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ap-12009/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/desmopressin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/desmopressin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ffpe 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ffpe/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/pf-07248144 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/pf-07248144/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/inbrx-109 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/inbrx-109/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/atp128 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/atp128/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/perifosine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/perifosine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/evolve104 2026-02-16 weekly 0.7 https://crcwarriors.org/medicamento/evolve104/ensayos 2026-02-16 weekly 0.6 https://crcwarriors.org/medicamento/pf-07850327 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/pf-07850327/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/jh021 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/jh021/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pf-08046052 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-08046052/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vsv-gp128 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/vsv-gp128/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/tanespimycin 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tanespimycin/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/morab-004 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/morab-004/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tunlametinib 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/tunlametinib/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/s241656 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/s241656/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/vepdegestrant 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/vepdegestrant/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pf-07985045 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-07985045/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sr57746a 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sr57746a/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/campto 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/campto/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ro7198457 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/ro7198457/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ngm120 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ngm120/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tb511 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tb511/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/isovorin 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/isovorin/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/xmt-2056 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/xmt-2056/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/asn-3186 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/asn-3186/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/jk08 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/jk08/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/dk210 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/dk210/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/shr2554 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/shr2554/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/l-plat 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/l-plat/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/alx148 2026-09-04 weekly 0.7 https://crcwarriors.org/medicamento/alx148/ensayos 2026-09-04 weekly 0.6 https://crcwarriors.org/medicamento/alcestobart 2026-07-04 weekly 0.7 https://crcwarriors.org/medicamento/alcestobart/ensayos 2026-07-04 weekly 0.6 https://crcwarriors.org/medicamento/il-2 2026-05-19 weekly 0.7 https://crcwarriors.org/medicamento/il-2/ensayos 2026-05-19 weekly 0.6 https://crcwarriors.org/medicamento/tvb-2640 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tvb-2640/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/dnx-2440 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/dnx-2440/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/topotesin 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/topotesin/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/asp2998 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/asp2998/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ttx-mc138 2026-09-04 weekly 0.7 https://crcwarriors.org/medicamento/ttx-mc138/ensayos 2026-09-04 weekly 0.6 https://crcwarriors.org/medicamento/ngm831 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ngm831/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tepotinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/tepotinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/azd8931 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/azd8931/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hexaminolevulinate 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/hexaminolevulinate/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/rsifn-co 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/rsifn-co/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/chemoradiatio 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/chemoradiatio/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/pledox 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/pledox/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/abt-301 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/abt-301/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/ct-202 2026-04-25 weekly 0.7 https://crcwarriors.org/medicamento/ct-202/ensayos 2026-04-25 weekly 0.6 https://crcwarriors.org/medicamento/remimazolam 2026-08-01 weekly 0.7 https://crcwarriors.org/medicamento/remimazolam/ensayos 2026-08-01 weekly 0.6 https://crcwarriors.org/medicamento/utomilumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/utomilumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/fmc-376 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/fmc-376/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/emd 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/emd/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/cc-38 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cc-38/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/gadobutrol 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gadobutrol/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/bi-754091 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/bi-754091/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/prl3-zumab 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/prl3-zumab/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/sys6090 2026-08-08 weekly 0.7 https://crcwarriors.org/medicamento/sys6090/ensayos 2026-08-08 weekly 0.6 https://crcwarriors.org/medicamento/gadodiamide 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gadodiamide/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/uromitexan 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/uromitexan/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/jskn021 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/jskn021/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/gadoteridol 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/gadoteridol/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/lamivudine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/lamivudine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/eras-4001 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/eras-4001/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/jy016 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/jy016/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/sx-682 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/sx-682/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tamoxife 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/tamoxife/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/xs-03 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xs-03/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vvdd-hil-2-rg-1 2026-05-21 weekly 0.7 https://crcwarriors.org/medicamento/vvdd-hil-2-rg-1/ensayos 2026-05-21 weekly 0.6 https://crcwarriors.org/medicamento/apl-5125 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/apl-5125/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/nicotine 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/nicotine/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/tti-101 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tti-101/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/liverpearls-irinoteca 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/liverpearls-irinoteca/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/xaliproden 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xaliproden/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/erw316 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/erw316/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pt0253 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/pt0253/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/shr-3821 2026-04-18 weekly 0.7 https://crcwarriors.org/medicamento/shr-3821/ensayos 2026-04-18 weekly 0.6 https://crcwarriors.org/medicamento/ctx-009 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ctx-009/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cadvec 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cadvec/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/epic 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/epic/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/abbv-176 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/abbv-176/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ro5323441 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ro5323441/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/a2b543 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/a2b543/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/ttx-080 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ttx-080/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/xb2001 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/xb2001/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/e7766 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/e7766/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/debio1143 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/debio1143/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lgk974 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/lgk974/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pm060184 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pm060184/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/kl590586 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/kl590586/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ebc 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/ebc/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/qbeco 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/qbeco/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pf-08634404 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-08634404/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/imm-1-104 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/imm-1-104/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/km501 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/km501/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pyx-201 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/pyx-201/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/breakvax 2026-09-03 weekly 0.7 https://crcwarriors.org/medicamento/breakvax/ensayos 2026-09-03 weekly 0.6 https://crcwarriors.org/medicamento/mgc028 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mgc028/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/jnj-64251330 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/jnj-64251330/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/losartan 2026-09-02 weekly 0.7 https://crcwarriors.org/medicamento/losartan/ensayos 2026-09-02 weekly 0.6 https://crcwarriors.org/medicamento/zoldonrasib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/zoldonrasib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/jyp0015 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/jyp0015/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ai-061 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ai-061/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ro7122290 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ro7122290/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ptemizumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/ptemizumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/th9619 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/th9619/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/rc148 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/rc148/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/pepticrad-1 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/pepticrad-1/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/idelalisib 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/idelalisib/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/adct-301 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/adct-301/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/cdx-1140 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cdx-1140/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pallov-cc 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pallov-cc/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/dms 2026-03-29 weekly 0.7 https://crcwarriors.org/medicamento/dms/ensayos 2026-03-29 weekly 0.6 https://crcwarriors.org/medicamento/cdx-301 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/cdx-301/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/orectalip 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/orectalip/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/glp1-ra 2026-06-07 weekly 0.7 https://crcwarriors.org/medicamento/glp1-ra/ensayos 2026-06-07 weekly 0.6 https://crcwarriors.org/medicamento/d3s-001 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/d3s-001/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/nuvastatic 2026-06-26 weekly 0.7 https://crcwarriors.org/medicamento/nuvastatic/ensayos 2026-06-26 weekly 0.6 https://crcwarriors.org/medicamento/onc-392 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/onc-392/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/petrozumab 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/petrozumab/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/proagio 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/proagio/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/panvac-f 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/panvac-f/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tribenoside 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/tribenoside/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/shr-a1904 2026-07-16 weekly 0.7 https://crcwarriors.org/medicamento/shr-a1904/ensayos 2026-07-16 weekly 0.6 https://crcwarriors.org/medicamento/ky-0301 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ky-0301/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/scg142 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/scg142/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/atx-559 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/atx-559/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/avutometinib 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/avutometinib/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/panvac-v 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/panvac-v/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/futuximab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/futuximab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/brachyury 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/brachyury/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/semustine 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/semustine/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/qtx3544 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/qtx3544/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/tt-10 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tt-10/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/py314 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/py314/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/modotuximab 2026-04-23 weekly 0.7 https://crcwarriors.org/medicamento/modotuximab/ensayos 2026-04-23 weekly 0.6 https://crcwarriors.org/medicamento/emd-525797 2026-03-31 weekly 0.7 https://crcwarriors.org/medicamento/emd-525797/ensayos 2026-03-31 weekly 0.6 https://crcwarriors.org/medicamento/ft836 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ft836/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/sot109 2026-07-11 weekly 0.7 https://crcwarriors.org/medicamento/sot109/ensayos 2026-07-11 weekly 0.6 https://crcwarriors.org/medicamento/torl-3-600 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/torl-3-600/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tt-4 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tt-4/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mvt-5873 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mvt-5873/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/mln8054 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mln8054/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/ly4050784 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ly4050784/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ngm707 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ngm707/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/lam561 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/lam561/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/nx-1607 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/nx-1607/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/pegilodecakin 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pegilodecakin/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tsb-9-w1 2026-04-01 weekly 0.7 https://crcwarriors.org/medicamento/tsb-9-w1/ensayos 2026-04-01 weekly 0.6 https://crcwarriors.org/medicamento/trovax 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/trovax/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/hb0025 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/hb0025/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/janx008 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/janx008/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/bdc-3042 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/bdc-3042/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tezacitabine 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/tezacitabine/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/edp1503 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/edp1503/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tt-702 2026-08-14 weekly 0.7 https://crcwarriors.org/medicamento/tt-702/ensayos 2026-08-14 weekly 0.6 https://crcwarriors.org/medicamento/hrs-2189 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/hrs-2189/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/tqb2930 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/tqb2930/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ibi3005 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/ibi3005/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/ct3001 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/ct3001/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/alt-801 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/alt-801/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/dalteparin 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/dalteparin/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/her-2-neu 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/her-2-neu/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/clsp-5282 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/clsp-5282/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/limertinib 2026-06-18 weekly 0.7 https://crcwarriors.org/medicamento/limertinib/ensayos 2026-06-18 weekly 0.6 https://crcwarriors.org/medicamento/vabametkib 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/vabametkib/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/pf-08052666 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/pf-08052666/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vs-6766 2026-06-17 weekly 0.7 https://crcwarriors.org/medicamento/vs-6766/ensayos 2026-06-17 weekly 0.6 https://crcwarriors.org/medicamento/bi-765063 2026-04-19 weekly 0.7 https://crcwarriors.org/medicamento/bi-765063/ensayos 2026-04-19 weekly 0.6 https://crcwarriors.org/medicamento/l19il2 2026-05-06 weekly 0.7 https://crcwarriors.org/medicamento/l19il2/ensayos 2026-05-06 weekly 0.6 https://crcwarriors.org/medicamento/itnt-hx02 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/itnt-hx02/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/me-344 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/me-344/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/vg2025 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/vg2025/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/medicamento/js212 2026-05-06 weekly 0.7 https://crcwarriors.org/medicamento/js212/ensayos 2026-05-06 weekly 0.6 https://crcwarriors.org/medicamento/atirmociclib 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/atirmociclib/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/mehd7945a 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/mehd7945a/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/amxt1501 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/amxt1501/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/thermodox 2026-04-24 weekly 0.7 https://crcwarriors.org/medicamento/thermodox/ensayos 2026-04-24 weekly 0.6 https://crcwarriors.org/medicamento/oki-219 2026-06-19 weekly 0.7 https://crcwarriors.org/medicamento/oki-219/ensayos 2026-06-19 weekly 0.6 https://crcwarriors.org/medicamento/peg-rhg-csf 2026-03-30 weekly 0.7 https://crcwarriors.org/medicamento/peg-rhg-csf/ensayos 2026-03-30 weekly 0.6 https://crcwarriors.org/regimen/folfox 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/folfiri 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/capox 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/folfoxiri 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/folfox-bevacizumab 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/folfiri-bevacizumab 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/folfiri-cetuximab 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/folfiri-panitumumab 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/folfoxiri-bevacizumab 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/capecitabine-mono 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/pembrolizumab-mono 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/encorafenib-cetuximab 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/trastuzumab-pertuzumab 2026-02-13 monthly 0.8 https://crcwarriors.org/regimen/trifluridine-tipiracil 2026-02-13 monthly 0.8 https://crcwarriors.org/articulo/3076/vacunas-polivalentes-derivadas-de-celulas-ipsc-como-inmunogenos-basados-en-la-ontogenesis-para-superar-la-refractariedad-inmunitaria-en-el-cancer-colorrectal-con-estabilidad-de-microsatelites-una 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3085/un-analisis-bibliometrico-de-la-evolucion-de-la-investigacion-sobre-la-metastasis-peritoneal-en-el-cancer-colorrectal-2000-2026-avances-en-los-mecanismos-moleculares-y-las-estrategias-terapeuticas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3087/atezolizumab-lurbinectedina-tarlatamab-y-folfirnox-en-un-paciente-con-carcinoma-de-celulas-pequenas-metastasico-del-canal-anal-informe-de-un-caso-y-revision-de-la-literatura 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2835/el-foretinib-induce-la-muerte-celular-inmunogenica-y-potencia-la-eficacia-de-la-inmunoterapia-anti-cd47-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2847/fototerapia-inmunoterapia-del-carcinoma-de-colon-mediante-un-complejo-de-nanoparticulas-de-carbono-y-fe-ii-con-un-inmunoadyuvante 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2340/hidrogel-anaerobico-inyectable-que-contiene-clostridium-butyricum-para-la-administracion-local-de-hidrogeno-en-el-tratamiento-del-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2873/proceso-de-radiomica-de-tc-coclinica-para-identificar-posibles-biomarcadores-de-imagen-para-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2892/prediccion-de-la-inestabilidad-de-microsatelites-en-el-cancer-colorrectal-basada-en-fenotipos-tisulares-inferidos-a-partir-de-imagenes-histopatologicas-completas-mediante-autodestilacion 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1870/terapias-dirigidas-a-egfr-basadas-en-ingenieria-de-anticuerpos-y-nanotecnologia-para-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1874/el-aprendizaje-profundo-a-partir-del-genoma-completo-permite-predecir-la-respuesta-a-la-quimioterapia-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2394/un-modelo-clinico-radiologico-que-integra-la-composicion-corporal-basal-obtenida-mediante-tomografia-computarizada-para-predecir-el-pronostico-en-pacientes-con-cancer-colorrectal-metastasico-tratados 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2906/aspirina-tras-la-finalizacion-de-la-terapia-adyuvante-estandar-para-el-cancer-colorrectal-ascolt-una-revision-sistematica-y-metaanalisis 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2707/imagenes-multimodales-y-caracterizacion-tisular-mediante-ecografia-mejorada-con-inteligencia-artificial-para-predecir-la-eficacia-de-la-inmunoterapia-en-el-cancer-de-recto 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2971/la-emodinantrona-un-precursor-natural-de-la-emodina-potencia-la-actividad-antitumoral-de-las-celulas-t-a-traves-de-la-via-de-senalizacion-jak3-stat1-3-y-mejora-la-eficacia-de-los-inhibidores-de-pd-1 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3036/sarcoma-de-ewing-superficial-del-recto-informe-de-un-caso-y-utilidad-del-diagnostico-molecular 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3059/oncologia-de-precision-en-la-cirugia-de-cancer-gastrointestinal-y-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3060/analisis-de-coste-efectividad-y-aspectos-economicos-de-las-pruebas-genomicas-y-las-terapias-dirigidas-a-dianas-moleculares 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1794/administracion-gastrica-y-rectal-de-encorafenib-con-quimioterapia-dirigida-contra-el-cancer-rectal-mutante-para-braf-v600e-con-obstruccion-intestinal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2818/evaluacion-del-rendimiento-de-un-ensayo-de-genotipado-de-regiones-criticas-basado-en-massarray-para-el-diagnostico-de-cancer-colorrectal-que-analiza-los-genes-kras-nras-braf-y-pik3ca-utilizando 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2819/administracion-de-sirna-mediante-coacervados-peptidicos-para-el-bloqueo-dual-de-pd-1-pd-l1-con-el-fin-de-mejorar-la-inmunoterapia-del-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3077/biomarcadores-mecanisticos-para-el-desarrollo-de-vacunas-contra-el-cancer-de-la-biologia-de-las-celulas-cancerosas-a-la-inmunoterapia-de-precision-basada-en-neoantigenos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2054/pembrolizumab-en-un-unico-ciclo-como-tratamiento-neoadyuvante-para-el-cancer-de-colon-en-estadio-i-iii-con-deficiencia-de-mmr-el-ensayo-reset-c 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2055/el-panorama-de-las-variables-genomicas-y-socioeconomicas-en-pacientes-con-cancer-colorrectal-segun-su-origen-genetico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3079/desde-la-alteracion-de-la-barrera-mucosa-inducida-por-la-microbiota-intestinal-hasta-los-nichos-inmunosupresores-dominados-por-celulas-mieloides-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2056/microbiota-intestinal-y-dieta-en-el-cancer-colorrectal-factores-determinantes-convergentes-de-la-carcinogenesis 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2824/perfil-genomico-y-caracteristicas-clinicas-de-los-canceres-colorrectales-con-mutaciones-en-erbb2-her2 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3080/cancer-metastasico-de-recto-bilateral-con-amplificacion-del-gen-met-un-caso-clinico-poco-comun 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2313/la-modulacion-dirigida-del-tnf-potencia-la-actividad-de-los-anticuerpos-bispecificos-que-activan-las-celulas-t-en-tumores-solidos-transformando-tumores-frios-en-tumores-calientes 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3081/mecanismos-que-relacionan-la-microbiota-intestinal-con-el-desarrollo-y-la-progresion-del-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3082/biosensor-de-e-coli-modificado-geneticamente-con-deteccion-de-doble-modulo-y-amplificacion-de-la-senal-para-la-deteccion-no-invasiva-de-sales-de-acidos-biliares-fecales-en-el-cribado-del-cancer 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1547/comparacion-retrospectiva-de-los-indicadores-operativos-entre-los-diferentes-metodos-diagnosticos-utilizados-para-las-pruebas-moleculares-en-cancer-de-pulmon-y-cancer-de-colon-en-un-entorno 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3083/estrategias-de-biologia-sintetica-para-el-diseno-de-terapias-microbianas-en-enfermedades-metabolicas-y-cancer 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1292/diseno-sintesis-y-evaluacion-biologica-de-nuevos-inhibidores-de-kras-g12d 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3084/un-aditivo-industrial-y-una-fibra-dietetica-la-inulina-inducen-la-muerte-necrotica-selectiva-de-las-celulas-tumorales-a-traves-de-la-peroxidacion-lipidica-mitocondrial-un-proceso-en-el-que-participan 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2829/la-optimizacion-del-proceso-de-fabricacion-y-de-la-superficie-electrostatica-de-las-celulas-car-t-mejora-la-eficacia-terapeutica-en-las-neoplasias-hepaticas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3086/un-estudio-retrospectivo-multicentrico-sobre-las-caracteristicas-clinicas-de-pacientes-con-cancer-colorrectal-positivo-para-el-receptor-del-factor-de-crecimiento-epidermico-humano-2-hgcsg2304 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2834/asociacion-de-los-macrofagos-intratumorales-cd68-cd163-de-tipo-m2-con-la-supervivencia-en-el-cancer-colorrectal-metastasico-tratado-con-quimioterapia-mas-bevacizumab 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/532/expresion-del-antigeno-de-superficie-del-trofoblasto-2-en-neoplasias-digestivas-un-objetivo-prometedor-para-conjugados-anticuerpo-farmaco 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2838/el-analisis-especifico-de-variantes-del-fenomeno-de-exclusion-mutua-entre-los-oncogenes-braf-egfr-y-kras-revela-una-superposicion-con-pares-de-mutantes-funcionalmente-antagonicos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2839/adicion-de-altas-dosis-de-vitamina-d3-al-tratamiento-estandar-en-pacientes-con-cancer-colorrectal-metastasico-el-ensayo-clinico-aleatorizado-solaris-alliance-a021703 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1050/manejo-de-metastasis-pulmonares-potencialmente-curables-de-cancer-colorrectal-mediante-terapia-sistemica-sincronica-y-ablacion-termica-percutanea-guiada-por-imagen 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2330/terapia-con-celulas-t-modificadas-con-receptores-quimericos-dirigidos-a-la-guanilato-ciclasa-2c-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1820/respuestas-contrastadas-a-la-inmunoterapia-neoadyuvante-en-canceres-de-colon-transverso-sincronicos-con-estado-discordante-de-reparacion-de-desajustes 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2332/desarrollo-y-evaluacion-in-vivo-de-marcadores-de-pet-marcados-con-18-f-que-se-unen-de-forma-covalente-al-kras-g12c-para-el-diagnostico-no-invasivo-del-cancer-y-el-seguimiento-del-tratamiento 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2334/tratamiento-satisfactorio-del-cancer-colorrectal-metastasico-con-mutacion-braf-v600e-y-disfuncion-hepatica-mediante-una-terapia-basada-en-encorafenib 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2338/ausencia-de-coexistencia-entre-la-amplificacion-de-her2-y-la-inestabilidad-de-microsatelites-deficiencia-de-reparacion-de-errores-dmmr-msi-en-una-amplia-cohorte-multicentrica-de-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2852/un-modelo-de-radiomica-predice-la-eficacia-de-un-inhibidor-de-cdk4-6-en-primera-linea-combinado-con-terapia-endocrina-en-el-cancer-de-mama-avanzado-hr-her2 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2086/aprendizaje-profundo-basado-en-laminas-histologicas-de-cd3-para-la-prediccion-del-pronostico-del-cancer-de-colon-analisis-de-tres-cohortes-internacionales-de-cancer-de-colon-en-estadio-iii 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2858/panorama-genomico-e-implicaciones-terapeuticas-del-cancer-colorrectal-con-fusion-de-alk 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2349/la-combinacion-del-inhibidor-de-kras-g12c-adagrasib-con-inmunoterapia-anti-pd-1-mejora-la-supervivencia-global-y-previene-la-recurrencia-en-modelos-preclinicos-de-metastasis-cerebrales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2861/modulacion-de-la-microbiota-intestinal-en-los-canceres-gastrointestinales-desde-las-caracteristicas-de-la-disbiosis-hasta-las-intervenciones-terapeuticas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2863/panorama-de-los-ensayos-clinicos-y-perspectivas-traslacionales-de-la-inmunoterapia-basada-en-celulas-asesinas-naturales-un-analisis-basado-en-la-base-de-datos-informa 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2870/desde-la-inhibicion-de-kras-hasta-la-adaptacion-tumoral-mecanismos-de-resistencia-y-estrategias-terapeuticas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2872/el-lncrna-miat-modificado-con-m-6-a-promueve-la-resistencia-a-la-anoikis-y-la-metastasis-peritoneal-del-cancer-colorrectal-a-traves-del-eje-de-senalizacion-mir-181a-5p-mcl1 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2364/biomarcadores-predictivos-en-pacientes-con-cancer-colorrectal-metastasico-tratados-con-bevacizumab-un-estudio-del-grupo-de-oncologia-turco-tog 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2620/la-dihidroartemisinina-inhibe-la-forma-mutada-de-kras-para-potenciar-el-efecto-de-regorafenib-y-un-anticuerpo-anti-pd-1-en-metastasis-hepaticas-de-cancer-colorrectal-con-mutacion-en-el-gen-kras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2878/supresion-dirigida-de-kras-en-el-cancer-colorrectal-mediante-arn-de-interferencia-de-doble-cadena-siarn-autoensamblados-in-vivo-y-encapsulados-en-pequenas-vesiculas-extracelulares-endogenas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1855/convergencia-inmuno-citotoxica-integracion-de-conjugados-anticuerpo-farmaco-y-proteinas-de-inmunofusion-para-superar-la-resistencia-en-canceres-gastrointestinales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2111/optimizacion-de-la-terapia-con-pembrolizumab-para-el-cancer-colorrectal-metastasico-de-novo-msi-h-dmmr-mediante-el-uso-de-ecuaciones-integro-diferenciales-basadas-en-datos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2623/conjugados-anticuerpo-farmaco-en-el-cancer-colorrectal-panorama-actual-y-perspectivas-futuras-a-partir-de-los-ensayos-clinicos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2880/caracterizacion-molecular-de-las-metastasis-ovaricas-derivadas-del-cancer-colorrectal-mediante-el-analisis-del-adn-tumoral-circulante 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2113/panorama-genomico-completo-de-erbb2-en-tumores-gastrointestinales-chinos-panoramas-centrados-en-mutaciones-y-oportunidades-de-tratamiento-de-precision 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2114/ensayos-de-microscopia-de-inmunofluorescencia-multiple-para-la-evaluacion-farmacodinamica-de-la-activacion-de-la-tirosina-quinasa-met-en-la-membrana-plasmatica-y-el-nucleo 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2372/descubrimiento-de-un-nuevo-y-potente-peptido-dirigido-a-kras-g12v-con-actividad-antiproliferativa-contra-celulas-de-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2884/el-extracto-de-paliurus-ramosissimus-alivia-parcialmente-la-colitis-asociada-al-cancer-colorrectal-inducido-por-aom-dss-en-ratones-hallazgos-obtenidos-a-partir-de-analisis-transcriptomicos-y-del 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1093/terapia-dirigida-para-cancer-colorrectal-mutado-en-kras-g12c-avances-desafios-y-direcciones-futuras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1605/el-tratamiento-conjunto-de-cetuximab-con-inhibidores-de-kras-g12c-fulverasib-y-sotorasib-en-celulas-humanas-de-cancer-de-pulmon-no-pequenas-celulas-con-mutacion-kras-g12c 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2629/ivonescimab-mas-gemcitabina-y-cisplatino-como-terapia-de-primera-linea-para-el-cancer-avanzado-de-las-vias-biliares-un-ensayo-de-fase-2-multicentrico-y-de-etiqueta-abierta 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2885/estudio-exhaustivo-del-mecanismo-por-el-cual-xiao-chai-hu-tang-atenua-la-toxicidad-intestinal-inducida-por-irinotecan-y-mejora-la-inmunidad-antitumoral-a-traves-de-la-microbiota-intestinal-y-la 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2375/la-reprogramacion-transcripcional-de-las-celulas-treg-que-varia-segun-el-sitio-en-un-modelo-de-cancer-colorrectal-metastasico-tiene-importancia-pronostica 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2887/panorama-emergente-de-la-terapia-con-celulas-car-t-en-el-cancer-de-colon-aspectos-mecanisticos-avances-clinicos-desafios-y-perspectivas-futuras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2120/el-acido-urico-soluble-induce-el-agotamiento-de-los-linfocitos-t-cd8-al-provocar-una-hiperactivacion-mediada-por-ksr1-de-la-via-mapk 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2635/la-microbiota-y-los-metabolitos-intestinales-en-la-remodelacion-del-microambiente-tumoral-y-la-regulacion-de-la-eficacia-de-la-inmunoterapia-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2891/nanocables-de-adn-programables-que-median-la-dispersion-y-la-localizacion-en-el-ensamblaje-catalitico-de-horquillas-para-la-deteccion-y-la-obtencion-de-imagenes-de-alta-resolucion-de-microarn 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/844/informe-de-caso-t-dxd-mas-bevacizumab-en-un-paciente-con-metastasis-cerebrales-de-cancer-de-recto-con-amplitud-de-her2 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2638/dirigirse-a-las-celulas-similares-a-las-celulas-madre-del-cancer-colorrectal-superar-la-resistencia-terapeutica-y-reprogramar-el-microambiente-inmunosupresor 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2895/los-n-glicanos-presentes-en-las-celulas-del-microambiente-tumoral-no-maligno-disminuyen-la-funcion-de-las-celulas-car-t-en-tumores-solidos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/848/desbloqueo-de-nuevas-posibilidades-de-tratamiento-para-el-cancer-de-endometrio-metastasico-con-mutacion-kras-g12c 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2385/la-quimioinmunoterapia-permite-implementar-estrategias-adaptativas-en-el-cancer-colorrectal-localmente-avanzado-mss 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2643/seleccion-del-tratamiento-mas-alla-de-la-segunda-linea-en-el-cancer-colorrectal-metastasico-secuencia-practica-de-la-terapia-de-rescate-citotoxica-los-agentes-antiangiogenicos-las-estrategias-de 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2644/terapia-inmunologica-optima-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-metastasico-msi-h-dmmr-evidencia-lagunas-y-toma-de-decisiones-clinicas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2645/ensayo-aleatorizado-de-fase-ii-que-compara-surufatinib-mas-folfox-folfiri-con-folfoxiri-como-terapia-de-segunda-linea-para-el-cancer-colorrectal-metastasico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2646/asociacion-entre-la-exposicion-a-fluidos-intraoperatorios-y-el-tiempo-hasta-la-primera-emision-de-gases-tras-la-reseccion-laparoscopica-radical-del-cancer-colorrectal-un-estudio-de-cohortes 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2902/factores-asociados-con-el-momento-de-aparicion-de-metastasis-hepaticas-tras-la-cirugia-de-cancer-colorrectal-un-estudio-multicentrico-retrospectivo 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1112/estudio-aleatorizado-de-fase-iii-multicentrico-que-compara-el-regimen-adyuvante-folfiri-folfox-o-5-fu-leucovorina-en-pacientes-con-cancer-de-recto-en-estadio-ii-iii-ecog-acrin-e3201 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2904/secuenciacion-de-nueva-generacion-en-el-cancer-colorrectal-perfilado-molecular-en-la-practica-clinica-y-correlaciones-clinicas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2905/topografia-de-la-heterogeneidad-tumoral-global-wtht-un-nuevo-enfoque-para-la-evaluacion-de-la-heterogeneidad-mutacional-intratumoral-en-adenomas-colorrectales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2908/eficacia-y-seguridad-de-diferentes-tamanos-de-microesferas-liberadoras-de-farmacos-en-el-tratamiento-de-la-metastasis-hepatica-del-cancer-colorrectal-mediante-tace 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2909/modelado-de-los-resultados-clinicos-y-el-impacto-economico-de-la-inmunoterapia-anti-pd-1-pd-l1-en-los-paises-del-golfo-emiratos-arabes-unidos-oman-y-kuwait 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1118/cambios-dinamicos-en-la-mecanica-celular-y-la-micoviecidad-de-la-membrana-durante-la-migracion-de-celulas-cancerosas-de-colon-recto 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2654/terapias-anti-her2-en-el-cancer-colorrectal-metastasico-una-revision-sistematica-y-metaanalisis 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2659/identificacion-del-umbral-minimo-de-las-tasas-de-cambio-de-pacientes-entre-los-grupos-de-tratamiento-que-da-lugar-a-una-mejora-no-significativa-en-la-supervivencia-global-asociada-a-los-tratamientos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2148/un-modelo-basado-en-organoides-ortotopicos-para-estudiar-la-disfuncion-temprana-de-celulas-t-cd8-y-la-respuesta-a-la-inmunoterapia-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2916/las-soluciones-activadas-con-plasma-potencian-los-efectos-antitumorales-de-la-quimioterapia-hiperermica-intraperitoneal-hipec-a-traves-de-la-apoptosis-mediada-por-el-estres-del-reticulo-endoplasmico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2149/ensayo-de-adn-tumoral-circulante-libre-de-tejido-y-resultados-en-pacientes-en-un-ensayo-de-fase-iii-de-quimioterapia-adyuvante-basada-en-folfox-alliance-n0147 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2406/respuesta-completa-sostenida-al-tratamiento-con-la-plataforma-tmep-ci-m-en-un-cancer-de-pulmon-de-celulas-pequenas-refractario-con-metastasis-en-el-tronco-encefalico-informe-de-un-caso-con-mas-de-20 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2918/comunidades-microbianas-sinteticas-nuevas-terapias-biologicas-vivas-para-la-modulacion-dirigida-del-microbioma-intestinal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1895/descubrimiento-de-un-inhibidor-potente-y-biodisponible-por-via-oral-de-sos1-con-eficacia-antitumoral-en-canceres-colorectales-mutantes-de-kras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2407/un-nuevo-conjugado-anticuerpo-farmaco-disenado-para-dirigirse-a-b7-h3-demuestra-una-mayor-eficacia-terapeutica-en-una-amplia-gama-de-canceres 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2919/nanomedicamentos-bioactivos-para-el-cancer-colorrectal-resistente-a-multiples-farmacos-mecanismos-relevantes-nuevas-clases-de-particulas-y-obstaculos-para-la-traslacion-clinica 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2152/endometriosis-y-cancer-de-ovario-evidencia-epidemiologica-conocimientos-moleculares-y-toma-de-decisiones-clinicas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2408/los-fibroblastos-asociados-al-cancer-postn-forman-una-barrera-similar-a-una-fortaleza-que-contribuye-a-la-resistencia-a-la-inmunoterapia-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2409/avances-en-el-trasplante-hepatico-para-tumores-hepaticos-malignos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2665/el-efecto-de-pembrolizumab-sobre-la-cicatrizacion-de-la-anastomosis-colonica-un-estudio-preclinico-en-ratas-wistar 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2921/la-calibracion-de-la-senalizacion-de-las-celulas-car-promueve-la-division-celular-asimetrica-para-dirigir-el-destino-de-las-celulas-car-t-y-potenciar-su-actividad-antitumoral 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2154/prx5-como-un-factor-clave-en-la-regulacion-de-la-capacidad-de-auto-renovacion-y-la-tumorigenicidad-de-las-celulas-madre-del-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2410/sistema-de-administracion-de-vesiculas-extracelulares-tumorales-programado-mediante-ultrasonido-para-una-terapia-dual-inmuno-epigenetica-contra-la-metastasis-del-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2666/panorama-del-cancer-colorrectal-desde-la-perspectiva-de-la-microbiota-intestinal-informacion-sobre-mutaciones-alteraciones-epigeneticas-y-cambios-en-el-microambiente-inmunitario 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2667/un-chip-microfluidico-integrado-para-la-captura-migracion-y-fenotipificacion-molecular-de-celulas-tumorales-circulantes-individuales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1900/odisea-metastasica-descifrando-el-viaje-genomico-desde-el-cancer-colorrectal-primario-hasta-la-enfermedad-diseminada 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2668/los-sistemas-de-administracion-de-farmacos-basados-en-nanotecnologia-modifican-el-microambiente-inmunosupresor-del-cancer-colorrectal-estrategias-sinergicas-y-mecanismos-de-los-inhibidores-de-los 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2925/la-dihidropirimidina-deshidrogenasa-modula-la-respuesta-inmune-a-la-inhibicion-de-los-puntos-de-control-en-el-cancer-colorrectal-con-deficiencia-en-la-reparacion-del-desajuste-y-alta-inestabilidad-de 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2670/adenocarcinoma-rectal-con-diferenciacion-enteroblastica-y-metastasis-hepaticas-una-variante-rara-y-agresiva-del-carcinoma-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2926/nuevas-estrategias-inmunoterapeuticas-para-el-tratamiento-del-cancer-colorrectal-avances-desafios-y-perspectivas-futuras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2927/inmunoterapia-neoadyuvante-en-el-cancer-colorrectal-localizado-con-dmmr-msi-h-una-revision-sistematica-de-la-respuesta-patologica-y-los-resultados-quirurgicos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2672/barreras-para-lograr-contactos-satisfactorios-con-la-atencion-primaria-en-pacientes-suecos-que-han-sobrevivido-al-cancer-un-estudio-transversal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2929/cancer-colorrectal-metastasico-con-mutacion-kras-g12c-estrategias-terapeuticas-actuales-y-perspectivas-futuras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2418/analisis-conjunto-de-2-ensayos-clinicos-sobre-quimioinmunoterapia-de-primera-linea-para-el-cancer-colorrectal-metastasico-con-microsatelites-estables-estudios-meditreme-y-metimmox 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2931/capacidad-de-deteccion-de-biomarcadores-de-ctdna-en-diversos-tipos-de-cancer-en-poblaciones-asiaticas-implicaciones-para-la-deteccion-en-un-amplio-espectro-de-canceres 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2676/cdh3-en-tumores-humanos-biologia-tumoral-y-posible-diana-terapeutica 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2932/un-ensayo-de-fase-ii-multicohorte-y-basado-en-biomarcadores-que-evalua-una-terapia-neoadyuvante-total-personalizada-con-agentes-dirigidos-para-el-cancer-de-recto-de-alto-riesgo-el-estudio-trainer 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/373/terapia-anti-egfr-en-cancer-colorrectal-metastasico-identificando-rastreando-y-superando-la-resistencia 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2933/asociacion-entre-el-numero-de-ganglios-linfaticos-centinela-y-el-pronostico-en-pacientes-con-cancer-de-mama-en-estadio-ct1-2n0m0-y-ganglios-linfaticos-centinela-negativos-un-estudio-retrospectivo-de 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2422/la-gemcitabina-aumento-la-sensibilidad-del-cancer-colorrectal-a-la-terapia-anti-pd-l1-al-promover-la-lactilacion 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2424/mecanismos-y-estrategias-emergentes-para-superar-la-resistencia-a-la-inmunoterapia-en-tumores-frios-del-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/889/informe-de-caso-mutaciones-en-hgf-y-nf1-como-mecanismos-supuestos-de-bypass-de-resistencia-al-inhibidor-del-met-en-carcinoma-hepatocelular-un-estudio-de-caso 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2425/el-eje-adar1-circrab5a-bip-regula-la-resistencia-a-la-radioterapia-en-el-cancer-colorrectal-mediante-la-coordinacion-de-la-autofagia-protectora-y-la-apoptosis 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2681/xinguangcaracterizacion-preliminar-de-las-alteraciones-de-pi4k-pipk-en-tumores-solidos-un-marco-exploratorio-para-la-estratificacion-pronostica-y-terapeutica 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2937/seguridad-y-eficacia-de-sotorasib-en-combinacion-con-panitumumab-y-folfiri-en-pacientes-con-cancer-colorrectal-metastasico-con-mutacion-kras-g12c-previamente-tratados-en-el-estudio-codebreak-101-de 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2939/avances-y-retos-en-el-diseno-y-desarrollo-de-farmacos-selectivos-dirigidos-a-la-mutacion-kras-g12d-inhibidores-degradadores-y-estrategias-terapeuticas-emergentes 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1919/strategic-1-ensayo-aleatorizado-multicentrico-de-diseno-abierto-gercor-prodige-39-fase-iii-para-el-tratamiento-de-pacientes-con-cancer-colorrectal-metastasico-irresecable-con-ras-braf-tipo-salvaje 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2943/telisotuzumab-adizutecan-para-el-cancer-colorrectal-metastasico-un-conjugado-anticuerpo-farmaco-dirigido-a-c-met-con-una-carga-de-inhibidor-de-la-topoisomerasa 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1920/modulacion-de-la-microbiota-intestinal-para-mejorar-la-eficacia-de-los-inhibidores-de-los-puntos-de-control-inmunitario-en-el-cancer-colorrectal-mecanismos-estrategias-terapeuticas-y-perspectivas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2690/factores-pronosticos-y-predictivos-criticos-en-las-metastasis-hepaticas-del-cancer-colorrectal-un-analisis-exhaustivo-de-la-bibliografia-existente-y-perspectivas-de-futuro 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2946/mecanismo-de-generacion-de-neoantigenos-y-avances-en-las-inmunoterapias-basadas-en-neoantigenos-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2947/importancia-clinica-de-la-amplificacion-de-erbb2-detectada-mediante-wes-en-el-cancer-colorrectal-resecable 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2950/comparacion-del-analisis-de-la-curva-de-fusion-de-alta-resolucion-basado-en-pcr-y-la-inmunohistoquimica-en-la-deteccion-de-la-inestabilidad-de-microsatelites-en-el-cancer-colorrectal-un-estudio-de 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2440/analisis-de-coste-efectividad-de-las-pruebas-de-adn-fecal-multiobjetivo-para-la-deteccion-del-cancer-colorrectal-en-centros-de-atencion-primaria-chinos-un-estudio-de-modelizacion 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2442/la-autofagia-mediada-por-tmem184a-en-la-degradacion-de-mhc-i-favorece-la-evasion-inmunitaria-tumoral 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1675/la-polarizacion-de-los-macrofagos-infiltrados-en-el-tumor-predice-respuesta-completa-al-tratamiento-neoadiyuno-en-pacientes-con-cancer-de-recto 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2956/prevalencia-e-impacto-clinico-de-las-alteraciones-en-los-genes-pik3ca-y-pten-detectadas-mediante-analisis-genomicos-reflejos-en-pacientes-con-cancer-colorrectal-de-nuevo-diagnostico-una-serie-basada 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2702/respuesta-clinica-completa-a-serplulimab-mas-bevacizumab-y-quimioterapia-en-adenocarcinoma-sigmoide-metastasico-mss-kras-mutado-informe-de-un-caso-y-revision-de-la-literatura 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2703/impacto-pronostico-de-la-diseminacion-a-traves-de-los-espacios-aereos-y-su-asociacion-con-la-mutacion-kras-y-los-factores-histopatologicos-en-metastasis-pulmonares-de-cancer-colorrectal-resecadas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2959/un-ensayo-clinico-de-fase-ii-que-evalua-la-reintroduccion-de-la-quimioterapia-con-o-sin-terapia-dirigida-en-pacientes-con-cancer-colorrectal-metastasico-refractario 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2193/complete-remission-following-targeted-therapy-in-braf-v600e-mutant-pulmonary-lymphangitic-carcinomatosis-secondary-to-rectal-cancer-a-case-report 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1682/vector-nanoferritino-activado-por-el-microambiente-tumoral-permite-una-entrega-mejorada-a-la-tumor-de-inhibidores-y-desencadenantes-de-kras-g12c 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2194/analisis-de-la-eficacia-y-los-riesgos-de-la-monoterapia-y-la-inmunoterapia-combinada-en-el-cancer-colorrectal-metastasico-con-dmmr-msi-h-un-metaanalisis-basado-en-ensayos-clinicos-aleatorizados-y 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2706/serping1-facilita-la-metastasis-hepatica-del-cancer-colorrectal-al-modular-la-transicion-epitelio-mesenquimal-y-la-remodelacion-del-microambiente-tumoral 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2451/enfoque-indiferenciado-segun-el-tipo-de-tumor-en-tumores-solidos-un-metaanalisis-conforme-a-las-directrices-prisma-sobre-la-eficacia-la-seguridad-y-los-factores-determinantes-de-la-resistencia-en 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/916/la-infusion-arterial-hepatica-es-efectiva-en-pacientes-con-metastasis-hepaticas-de-carcinoma-colorrectal-inoperables-resistentes-a-la-quimioterapia-sistemica-estandar-un-estudio-de-cohorte 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2452/el-fenotipo-de-microsatelites-como-guia-para-la-inmunoterapia-en-el-cancer-colorrectal-estado-actual-y-perspectivas-futuras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2967/la-evolucion-clonal-desde-el-tumor-primario-hasta-el-cancer-de-recto-localmente-recurrente-revela-alteraciones-adquiridas-en-la-recurrencia-que-podrian-ser-susceptibles-de-tratamiento-en-tumores-que 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2456/conjugados-anticuerpo-farmaco-en-la-oncologia-de-tumores-solidos-y-la-frontera-de-la-inmunosupresion-de-precision-una-revision-mecanicista-traslacional-y-clinica 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2968/impacto-pronostico-de-la-dinamica-de-las-mutaciones-circulantes-de-los-genes-ras-y-braf-en-pacientes-con-cancer-colorrectal-metastasico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2460/un-nuevo-paradigma-de-los-anticuerpos-biespecificos-en-el-manejo-clinico-de-los-canceres-gastrointestinales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2972/emb-01-un-anticuerpo-bispecifico-anti-egfr-c-met-en-pacientes-con-cancer-colorrectal-metastasico-muy-avanzado-y-que-han-recibido-multiples-tratamientos-previos-en-un-estudio-de-fase-ib-ii-abierto 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2974/biomarcadores-moleculares-epigeneticos-microbianos-y-obtenidos-mediante-biopsia-liquida-integrados-en-el-cancer-colorrectal-implicaciones-para-el-pronostico-y-la-terapia-de-precision 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2719/prediccion-temprana-de-la-enfermedad-residual-minima-en-el-cancer-colorrectal-mediante-el-analisis-del-estado-de-metilacion-de-septin9-en-el-adn-tumoral-circulante 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2976/analisis-de-rentabilidad-de-la-terapia-triple-con-encorafenib-binimetinib-y-cetuximab-para-el-tratamiento-del-cancer-colorrectal-metastasico-con-mutacion-braf-v600e-en-china 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2721/la-terapia-con-celulas-car-t-dirigidas-contra-gcc-no-protegidas-demuestra-una-eficacia-significativa-en-pacientes-con-cancer-colorrectal-avanzado 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2977/se-retira-el-articulo-apoa5-atenua-los-niveles-de-especies-reactivas-de-oxigeno-para-promover-la-resistencia-al-oxaliplatino-en-el-cancer-colorrectal-con-mutaciones-en-pik3ca 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/674/actividad-de-inhibidores-directos-de-kras-g12c-en-modelos-preclinicos-de-cancer-pediatrico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2978/el-indice-de-masa-corporal-y-la-dislipidemia-influyen-en-la-respuesta-a-la-inmunoterapia-anti-pd-1-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2467/las-firmas-proteomicas-tisulares-del-cancer-colorrectal-con-mutacion-en-el-gen-braf-revelan-nuevos-conocimientos-sobre-la-agresividad-la-modulacion-inmune-y-la-reprogramacion-metabolica 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2723/evolucion-de-la-resistencia-a-la-inmunoterapia-mediada-por-macrofagos-de-la-cavidad-spp1-en-la-metastasis-peritoneal-del-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1444/una-nueva-bacteria-enterocloster-sp-m3-promueve-la-tumorigenesis-del-cancer-colorrectal-mediante-la-produccion-del-carcinogeno-estireno 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1700/mrtx1133-suprime-la-senalizacion-de-erk-pero-induce-respuestas-antiproliferativas-dependientes-del-contexto-en-celulas-cancerosas-con-kras-g12c 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2981/mas-alla-de-la-monoterapia-el-papel-en-evolucion-de-ctla-4-en-la-inmunoterapia-combinada-para-los-canceres-gastrointestinales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2982/nanodispositivos-disenados-y-programados-geneticamente-desencadenan-una-cascada-de-refuerzo-entre-la-activacion-de-ampk-y-cgas-sting-para-la-sonoinmunoterapia-del-cancer-de-colon 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2984/botensilimab-balstilimab-como-tratamiento-neoadyuvante-para-el-cancer-colorrectal-localizado-con-sistemas-de-reparacion-de-errores-de-emparejamiento-mismatch-repair-competentes-e-incompetentes 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2473/los-algoritmos-de-aprendizaje-automatico-desarrollan-una-firma-genica-relacionada-con-las-plaquetas-educadas-por-el-tumor-para-predecir-el-pronostico-del-cancer-colorrectal-y-la-respuesta-al 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1962/monoterapia-con-amivantamab-en-cancer-colorrectal-metastasico-quimiorrefractario-ras-braf-salvaje-resultados-del-estudio-origami-1-un-estudio-abierto-de-fase-ib-ii 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2474/es-fusobacterium-nucleatum-el-principal-mediador-entre-las-infecciones-orales-y-las-enfermedades-sistemicas-perspectivas-mecanisticas-e-implicaciones-terapeuticas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2220/la-nanomedicina-que-se-adhiere-a-los-macrofagos-y-coadministra-gemcitabina-e-inhibidor-de-kras-g12d-orquesta-una-quimioinmunoterapia-para-el-cancer-colorrectal-metastasico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2477/cartografia-del-panorama-anatomico-de-los-tumores-colorrectales-eficacia-especifica-segun-la-localizacion-de-los-anticuerpos-contra-el-receptor-del-factor-de-crecimiento-epidermico-analisis-combinado 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2989/dirigirse-al-gen-oncogenico-kras-mediante-oligomeros-de-acido-nucleico-peptidico-unidos-a-peptidos-de-penetracion-celular 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1966/desarrollo-y-validacion-de-un-modelo-de-prediccion-para-la-dermatitis-por-radiacion-de-moderada-a-grave-en-pacientes-con-carcinoma-nasofaringeo-un-estudio-de-aprendizaje-automatico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2990/deteccion-de-la-mutacion-kras-mediante-pcr-en-tiempo-real-y-pcr-digital-en-tejido-tumoral-y-plasma-y-su-asociacion-con-la-supervivencia-en-el-cancer-colorrectal-en-estadio-ii-iv-un-estudio-de-cohorte 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2991/un-ensayo-clinico-de-fase-ii-de-diseno-basket-con-ado-trastuzumab-emtansina-para-pacientes-con-canceres-con-amplificacion-de-her2-un-ensayo-clinico-no-aleatorizado 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2480/un-adenovirus-oncolitico-modificado-con-icosl-activa-las-celulas-t-cd4-para-potenciar-la-inmunidad-antitumoral-y-presenta-una-accion-sinergica-con-la-terapia-anti-pd-1-o-la-terapia-con-celulas-car-t 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/945/bacterias-entregando-drogas-la-entrega-de-citotoxinas-mediada-por-listeria-monocytogenes-potencia-la-actividad-antitumoral-en-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2737/primer-caso-descrito-de-mutaciones-duales-de-resistencia-kras-y96c-y96s-detectadas-mediante-biopsia-liquida-en-un-cancer-colorrectal-metastasico-con-mutacion-kras-g12c 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/946/eficacia-antitumoral-y-activacion-de-las-celulas-t-mediante-conjugados-anticuerpo-farmaco-dirigidos-contra-el-egfr-que-contienen-nuevos-aminobisfosfonatos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2485/diseno-y-sintesis-de-un-inhibidor-de-fak-altamente-eficaz-para-el-tratamiento-potencial-del-cancer-colorrectal-que-presenta-la-mutacion-kras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2231/analisis-de-costo-efectividad-del-encorafenib-en-cancer-colorrectal-metastasico-braf-v600e-no-tratado-en-china 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2487/el-analisis-multi-omico-de-la-suplementacion-con-saccharomyces-boulardii-revela-cambios-coordinados-en-el-microbioma-el-metabolismo-y-la-senalizacion-inmune-que-acompanan-a-la-supresion-tumoral 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2743/cancer-colorrectal-metastasico-diagnosticado-antes-de-los-35-anos-un-subgrupo-distinto-de-enfermedad-de-inicio-temprano 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1209/dirigirse-a-las-alteraciones-del-factor-de-crecimiento-epidermico-mesenquimal-met-en-el-cancer-de-pulmon-no-microcitico-desafios-actuales-y-avances-terapeuticos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3002/una-revision-exhaustiva-de-la-diarrea-tardia-inducida-por-irinotecan-desde-los-mecanismos-hasta-las-opciones-terapeuticas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2235/respuesta-duradera-a-selpercatinib-en-un-cancer-colorrectal-metastasico-que-presenta-una-nueva-fusion-timm23b-ret-informe-de-un-caso 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2492/aplicacion-de-los-resultados-del-estudio-cleopatra-en-la-practica-clinica-habitual-patrones-de-tratamiento-nacionales-y-supervivencia-en-pacientes-con-cancer-de-mama-metastasico-her2-positivo 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2749/conjugados-anticuerpo-farmaco-en-el-cancer-colorrectal-avances-desafios-y-perspectivas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2751/evaluacion-in-vitro-e-in-silico-del-potencial-antitumoral-del-extracto-etanolico-de-las-semillas-de-bryonia-laciniosa-contra-el-cancer-colorrectal-y-el-cancer-hepatocelular 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/704/clinicoomica-para-predecir-la-expresion-de-her2-en-cancer-colorrectal-metastasico-un-analisis-de-aprendizaje-automatico-multicentrico-en-datos-del-mundo-real 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2754/efectos-de-la-hipercapnia-permisiva-sobre-la-oxigenacion-cerebral-intraoperatoria-y-la-funcion-cognitiva-temprana-en-el-periodo-posoperatorio-en-pacientes-mayores-con-funcion-cerebral-fragil-durante 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2755/un-dihidrofenantreno-derivado-de-pholidota-chinensis-actua-como-un-componente-bioactivo-que-induce-la-ferroptosis-mediada-por-gpx4-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3011/regresion-de-un-polipo-colorrectal-tras-la-inmunoterapia-contra-el-cancer-con-nous-209-informe-de-un-caso-clinico-de-un-ensayo 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/708/identificacion-de-una-nueva-fusion-genica-prune2-ntrk2-en-pacientes-con-sarcomas-de-tejido-blando-amigo-o-enemigo-serie-de-casos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2756/revision-sistematica-y-comparacion-indirecta-ajustada-de-los-inhibidores-de-los-puntos-de-control-inmunitario-en-primera-linea-para-el-cancer-colorrectal-metastasico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3012/terapia-dirigida-a-her2-en-el-cancer-colorrectal-metastasico-evidencia-actual-seleccion-de-pacientes-y-secuencia-de-tratamiento-practica 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2757/el-potencial-terapeutico-de-los-conjugados-anticuerpo-farmaco-en-el-cancer-colorrectal-avanzado-una-revision-sistematica-y-metaanalisis 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1990/descubrimiento-de-apo-50815-un-potente-inhibidor-de-la-quinasa-wee1-con-una-eficacia-excepcional-contra-organoides-de-cancer-colorrectal-derivados-de-pacientes 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2758/la-inhibicion-de-kras-g12d-reprograma-el-microambiente-inmunosupresor-inducido-por-el-tumor-y-potencia-la-inmunidad-antitumoral-mediada-por-las-celulas-nk 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3014/seguimiento-prolongado-de-botensilimab-mas-balstilimab-en-una-cohorte-ampliada-de-cancer-colorrectal-metastasico-con-estabilidad-de-microsatelites-sin-metastasis-hepaticas-activas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2759/nueva-estrategia-de-tratamiento-y-lineas-de-investigacion-futuras-para-el-cancer-con-mutacion-en-el-gen-braf 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3015/proteinuria-como-causa-de-modificacion-temprana-de-la-dosis-en-pacientes-japoneses-con-cancer-colorrectal-metastasico-tratados-con-fruquintinib-un-estudio-multicentrico-de-la-practica-clinica-real 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1992/superacion-de-la-resistencia-a-los-adc-en-el-cancer-colorrectal-avanzado-mediante-la-inhibicion-dual-de-trop2-y-perk-para-suprimir-la-senalizacion-de-wnt-catenina 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3017/agathobacter-rectalis-suprime-la-tumorigenesis-del-cancer-colorrectal-a-traves-de-un-eje-epigallocatequina-srebf2-que-controla-el-metabolismo-del-colesterol 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3018/construccion-multicohorte-analisis-del-paisaje-inmunitario-y-validacion-funcional-de-pcolce2-en-un-modelo-pronostico-relacionado-con-la-inflamacion-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2765/remodelacion-inmune-sistemica-tras-la-reseccion-curativa-r0-de-metastasis-hepaticas-de-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2767/dhodh-es-un-objetivo-sintal-letal-en-el-cancer-colorrectal-con-mutacion-en-pik3ca 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2768/copanlisib-en-combinacion-con-nivolumab-para-el-tratamiento-del-cancer-colorrectal-con-microsatelites-estables-un-ensayo-de-fase-1-2 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3026/un-ecosistema-inmunitario-con-limitaciones-funcionales-en-el-cancer-colorrectal-con-estabilidad-de-microsatelites-identificado-mediante-analisis-de-celulas-individuales-y-perfiles-de-exoma 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3027/cancer-colorrectal-metastasico-con-mutacion-braf-v600e-tratamiento-practico-en-la-era-posterior-al-estudio-breakwater 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2773/un-nuevo-anticuerpo-monoclonal-anti-caderina-17-ca-17-mab-5-para-multiples-aplicaciones 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2774/las-celulas-t-derivadas-de-ipsc-alogenicas-demuestran-eficacia-antitumoral-frente-a-tejidos-derivados-de-pacientes 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2263/conjugados-anticuerpo-farmaco-en-el-cancer-colorrectal-diseno-molecular-avances-preclinicos-y-desafios-traslacionales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3031/estrategias-terapeuticas-emergentes-para-las-mutaciones-del-gen-kras-distintas-de-la-g12c-en-el-cancer-colorrectal-especial-atencion-a-las-mutaciones-g12d-y-g12v 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3032/cancer-colorrectal-primario-multiple-sincronico-con-estado-discordante-del-gen-ras-entre-las-lesiones-primarias-un-caso-clinico-en-un-paciente-de-edad-avanzada 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3033/resumen-visual-de-aso-inmunoterapia-neoadyuvante-en-el-cancer-colorrectal-localizado-con-dmmr-msi-h-una-revision-sistematica-de-la-respuesta-patologica-y-los-resultados-quirurgicos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3034/correccion-la-hipoxia-y-la-aspirina-aumentan-de-forma-aditiva-la-acumulacion-intracelular-de-glutamina-en-celulas-de-cancer-colorrectal-con-mutaciones-en-el-gen-pik3ca 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3035/de-la-disbiosis-a-la-oncologia-de-precision-el-papel-traslacional-del-microbioma-en-el-cancer-gastrointestinal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2013/ingenieria-genetica-del-microambiente-tumoral-con-load703-en-pacientes-con-tumores-solidos-ensayo-clinico-lokon002-de-fase-i-iib 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3037/el-anticuerpo-trispecifico-ibi3019-integra-el-antagonismo-de-egfr-potenciado-por-cdh17-con-una-interaccion-optimizada-con-cd16a-para-inducir-una-potente-actividad-antitumoral-con-una-toxicidad-minima 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2784/dirigirse-a-las-vias-moleculares-y-geneticas-que-impulsan-la-tumorigenesis-para-lograr-una-terapia-de-precision-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3040/el-microambiente-hepatico-como-impulsor-del-nicho-inmunosupresor-en-las-metastasis-hepaticas-del-cancer-colorrectal-y-su-remodelacion-terapeutica 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2017/heterogeneidad-molecular-de-los-canceres-con-erbb2-alterado-una-panoramica-del-cancer-en-cohortes-estadounidenses-y-japonesas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2273/descifrando-el-microbioma-avances-en-el-microambiente-intestinal-dirigidos-por-inteligencia-artificial-para-lograr-avances-en-la-terapia-oncologica-personalizada 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3041/mecanismos-mediados-por-miocinas-en-las-lesiones-y-la-reparacion-del-cancer-colorrectal-asociadas-con-los-inhibidores-de-los-puntos-de-control-inmunitario-en-el-cancer-de-recto 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3042/resistencia-a-los-inhibidores-de-los-puntos-de-control-inmunitario-en-el-adenocarcinoma-rectal-que-contiene-un-componente-de-deficiencia-en-la-reparacion-de-errores-de-emparejamiento-un-caso-clinico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1765/enfoque-molecular-de-la-senalizacion-de-egfr-braf-y-her2-en-el-cancer-colorrectal-avances-contemporaneos-con-panitumumab-encorafenib-y-tucatinib 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2789/avances-recientes-en-la-investigacion-clinica-y-de-biologia-molecular-sobre-las-lesiones-serriladas-rectales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2790/sobreexpresion-amplificacion-de-her2-en-el-cancer-colorrectal-la-heterogeneidad-espacial-intratumoral-como-factor-clave-de-la-discordancia-en-la-deteccion-y-la-respuesta-al-tratamiento 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2791/informe-de-la-27-a-conferencia-anual-de-consenso-sobre-el-cancer-gastrointestinal-del-oeste-de-canada-dedicada-al-cancer-colorrectal-celebrada-en-calgary-alberta-los-dias-26-y-27-de-septiembre-de 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3051/una-nanoplattaforma-para-inducir-la-ferroptosis-y-superar-la-radioresistencia-en-el-cancer-colorrectal-con-mutaciones-en-el-gen-kras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3052/her2-como-diana-terapeutica-en-el-cancer-rectal-con-mutacion-en-el-gen-kras-un-caso-de-respuesta-significativa-a-un-tratamiento-basado-en-zanidatamab 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3053/palbociclib-se-dirige-a-la-catenina-para-su-degradacion-y-presenta-una-accion-sinergica-con-la-inhibicion-de-kras-o-erk5-en-modelos-preclinicos-de-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2798/superar-la-resistencia-a-los-tratamientos-anti-egfr-mecanismos-de-resistencia-al-cetuximab-y-al-panitumumab-y-nuevas-estrategias-de-combinacion 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3054/carcinoma-urotelial-asociado-al-sindrome-de-lynch-hallazgos-clinicos-y-moleculares-de-una-cohorte-de-un-unico-centro 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3055/cultivo-en-co-cultivo-de-celulas-de-cancer-colorrectal-y-monocitos-como-modelo-de-las-interacciones-en-el-microambiente-tumoral 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1776/conjugados-anticuerpo-farmaco-dirigidos-a-la-ubiquitinacion-de-receptores-para-una-endocitosis-mejorada-y-entrega-lisosomica 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3056/vesiculas-extracelulares-en-farmacologia-innovaciones-en-la-administracion-de-farmacos-y-aplicaciones-terapeuticas-en-el-cancer 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3057/supervivencia-global-de-la-inmunoterapia-frente-al-tratamiento-estandar-en-el-cancer-colorrectal-metastasico-estable-en-microsatelites-y-refractario-a-la-quimioterapia-un-analisis-con-emparejamiento 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1266/un-caso-de-adenocarcinoma-pulmonar-enterico-refractario-con-mutacion-sensible-a-egfr 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2803/comparacion-de-la-eficacia-y-la-seguridad-de-las-diferentes-opciones-de-tratamiento-en-tercera-linea-para-pacientes-con-cancer-colorrectal-metastasico-una-revision-sistematica-y-un-metaanalisis-de 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2804/afinacion-y-caracterizacion-de-la-maduracion-del-nuevo-anticuerpo-monoclonal-mab-pb-223-dirigido-contra-los-o-glicanos-especificos-del-cancer-que-terminan-en-2-6-acidos-sialicos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3061/analisis-del-microambiente-inmunitario-en-el-adenocarcinoma-de-tipo-intestinal-de-los-senos-paranasales-nuevos-argumentos-a-favor-de-la-inmunoterapia 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3062/inmunoterapia-tumoral-en-neoplasias-solidas-y-hematologicas-avances-desafios-y-un-marco-de-referencia-practico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2807/commit-estudio-aleatorizado-de-mfolfox6-bevacizumab-atezolizumab-frente-a-atezolizumab-en-monoterapia-como-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico-con-deficiencia-en-la 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1530/estructuras-linfoidas-terciarias-guiaron-oportunidades-y-desafios-para-la-inmunoterapia-en-el-cancer-temprano-de-la-union-gastricoesofagica-y-del-recto-bajo 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3066/la-presencia-aumentada-de-bacteroides-acidifaciens-favorecida-por-la-mutacion-kras-promueve-la-tumorigenesis-del-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3067/nevus-melanociticos-eruptivos-asociados-al-tratamiento-con-encorafenib-y-cetuximab-en-dos-pacientes-con-cancer-colorrectal-con-mutacion-braf-v600e 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2044/panorama-genomico-terapias-dirigidas-y-mecanismos-de-resistencia-en-pacientes-con-cancer-colorrectal-metastasico-seleccionados-mediante-analisis-molecular 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3068/terapias-dirigidas-agnosticas-al-tipo-de-tumor-y-adaptadas-a-la-histologia-en-los-canceres-gastrointestinales-fusiones-de-ntrk-y-ret-y-el-papel-en-evolucion-de-las-estrategias-de-cestas-moleculares 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1789/un-conjugado-anticuerpo-farmaco-de-cadena-pesada-dirigido-a-ceacam6-glicosilada-inhibe-el-crecimiento-de-tumores-metastasicos-cerebrales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3069/angustia-psicologica-en-pacientes-adultos-con-cancer-colorrectal-papel-de-la-edad-biologica-y-la-privacion-socioeconomica-del-entorno 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3070/vacunas-basadas-en-celulas-dendriticas-para-el-cancer-colorrectal-mecanismos-avances-clinicos-y-perspectivas-futuras-revision 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1791/costes-y-beneficios-de-la-secuenciacion-del-exoma-completo-y-el-transcriptoma-completo-frente-a-los-paneles-de-50-genes-para-el-perfil-genomico-en-tumores-solidos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3071/la-paradoja-de-la-estabilidad-y-la-adaptacion-de-foxp3-redefiniendo-las-terapias-basadas-en-treg-para-las-enfermedades-intestinales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2305/avances-recientes-en-las-plataformas-de-biosensores-que-utilizan-la-caracterizacion-de-biomarcadores-exosomicos-para-el-diagnostico-del-cancer 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2314/papel-emergente-de-los-conjugados-anticuerpo-farmaco-en-las-neoplasias-gastrointestinales 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2846/prediccion-multimodelo-del-pronostico-especifico-por-estadio-del-cancer-colorrectal-mediante-el-aprendizaje-profundo-en-conjunto-basado-en-la-atencion-aplicado-a-datos-de-perfiles-genomicos 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2351/la-lidocaina-potencia-los-efectos-antitumorales-del-sorafenib-y-el-gw5074-en-celulas-de-cancer-colorrectal 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2893/edicion-precisa-de-las-mutaciones-de-tp53-mediante-la-tecnica-prime-editing-para-lograr-la-supresion-funcional-del-tumor-en-el-cancer-colorrectal 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2401/factores-de-riesgo-tipos-de-cancer-y-significado-pronostico-del-segundo-cancer-primario-tras-el-cancer-colorrectal-de-inicio-temprano-intermedio-y-tardio-un-estudio-retrospectivo-en-un-centro 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2945/interrupcion-de-la-interaccion-entre-kras-y-ago2-una-estrategia-doble-para-aumentar-la-sensibilidad-a-la-quimioinmunoterapia-en-el-cancer-colorrectal-con-mutacion-en-el-gen-kras 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2983/interaccion-molecular-de-los-probioticos-en-la-salud-intestinal-una-perspectiva-quimica-sobre-las-vias-mediadas-por-metabolitos 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/390/el-volumen-tumoral-total-predice-la-supervivencia-global-y-la-respuesta-a-la-quimioterapia-de-induccion-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-un-estudio-complementario-del 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2823/respuesta-prolongada-a-la-inhibicion-combinada-de-braf-y-mek-en-cancer-colorrectal-con-mutacion-braf-un-caso-clinico 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/2938/inhibicion-de-la-union-raf-mek-con-avutometinib-y-cetuximab-en-el-cancer-colorrectal-metastasico-con-mutacion-s257l-en-el-gen-raf1-y-refractario-al-anti-egfr-en-la-enfermedad-de-gaucher 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/2457/descubrimiento-mediante-inteligencia-artificial-de-celulas-car-t-dirigidas-a-gpnmb-como-terapia-para-multiples-tipos-de-cancer 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/3073/la-inhibicion-sinergica-de-los-coactivadores-ep300-cbp-y-eya-interrumpe-el-circuito-regulador-central-del-rabdomiosarcoma 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/3074/una-estrategia-combinada-de-multi-omicas-y-aprendizaje-supervisado-revela-una-firma-epitelial-de-la-respuesta-a-la-radioterapia-en-el-cancer-colorrectal 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2859/relacion-entre-los-sitios-de-mutacion-del-gen-kras-y-las-caracteristicas-clinicas-en-el-cancer-colorrectal 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/1899/senalizacion-de-egfr-en-cancer-colorrectal-estrategias-terapeuticas-novedosas-biomarcadores-predictivos-y-contrarrestando-la-resistencia-al-tratamiento 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2682/el-peculiar-panorama-genomico-del-carcinoma-colorrectal-de-celulas-en-anillo-de-sello-revela-alteraciones-frecuentes-en-la-familia-kmt2-y-la-inactivacion-de-smad4 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2176/establecimiento-de-una-radioinmunodiagnosis-predirigida-basada-en-68-ga-dota 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2198/un-modelo-de-deteccion-automatica-de-la-diseminacion-a-traves-de-los-espacios-aereos-en-secciones-patologicas-postoperatorias-basado-en-el-aprendizaje-profundo-en-el-cancer-de-pulmon-no-microcitico 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2461/objetivos-de-la-terapia-car-t-la-inteligencia-artificial-toma-el-control 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2717/dirigirse-al-ecosistema-espacial-metabolico-inmune-en-las-metastasis-hepaticas-del-cancer-colorrectal-estrategias-farmacologicas-y-el-paradigma-de-interrumpir-normalizar-restablecer 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2718/desde-la-fermentacion-hasta-los-farmabioticos-ingenieria-de-lactobacillus-derivado-del-kefir-para-una-inmunoterapia-intratumoral-dirigida-en-el-cancer-colorrectal 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2980/analisis-integrado-mediante-ngs-y-ddpcr-de-las-mutaciones-en-los-genes-ras-raf-en-el-cancer-colorrectal-metastasico-en-pacientes-de-kazajistan-un-estudio-piloto 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2986/validacion-de-la-eficacia-del-compuesto-fenolico-del-olivo-s-oleocantal-para-controlar-de-forma-efectiva-la-progresion-y-la-metastasis-del-cancer-colorrectal-con-mutacion-kras-g13d 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2761/resultados-de-supervivencia-y-factores-pronosticos-en-pacientes-con-cancer-colorrectal-metastasico-tratados-en-primera-linea-con-mfolfoxiri-mas-bevacizumab-un-estudio-observacional-en-vietnam 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2269/eficacia-del-bloqueo-dual-kras-g12d-egfr-frente-a-combinaciones-triples-en-modelos-derivados-de-pacientes-de-cancer-colorrectal-con-mutacion-kras-g12d 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/3039/las-redes-de-senalizacion-de-kras-la-heterogeneidad-mutacional-y-las-estrategias-terapeuticas-emergentes-para-el-tratamiento-del-cancer 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2913/inmunoterapia-en-el-cancer-colorrectal-nuevas-perspectivas-y-proximos-pasos 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/2160/oncologia-de-precision-facilitada-por-la-cirugia-en-un-sarcoma-de-la-arteria-pulmonar-msi-h-con-sindrome-de-lynch-un-caso-clinico 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/2928/los-niveles-basales-de-celulas-t-circulantes-y-tumorales-asi-como-la-expansion-temprana-de-celulas-cd8-pd1-circulantes-predicen-la-respuesta-a-atezolizumab-bevacizumab-en-el-carcinoma-hepatocelular 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/2987/una-formulacion-bioactivada-de-lepidium-latifolium-altera-la-bioenergetica-mitocondrial-y-la-adaptacion-metabolica-en-celulas-cancerosas-con-mutacion-en-el-gen-kras 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/3043/desde-la-vivienda-hasta-las-zonas-de-mayor-incidencia-integracion-de-un-indicador-basado-en-la-vivienda-para-medir-el-nivel-socioeconomico-individual-con-el-analisis-geoespacial-para-dirigir-las 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/3065/estimacion-de-las-escalas-de-tiempo-de-la-carcinogenesis-en-los-canceres-de-inicio-temprano-frente-a-los-de-inicio-tardio-y-cambios-entre-las-cohortes-de-nacimiento 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/3072/perfilamiento-genomico-de-los-objetivos-terapeuticos-del-cancer-nyu-lg-pact-para-el-diagnostico-molecular-y-el-tratamiento-de-los-pacientes-en-el-ambito-clinico 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/3075/la-senalizacion-de-la-serotonina-por-las-celulas-gliales-entericas-impulsa-la-inmunidad-antitumoral-en-el-cancer-colorrectal 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/3078/patrones-de-resultados-distintos-segun-el-estado-de-ras-y-braf-en-el-ccrm-con-msi-h-dmmr-tratado-con-inhibidores-de-puntos-de-control-inmunitario-una-revision-sistematica-y-un-metaanalisis 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2312/impacto-de-la-lidocaina-intravenosa-la-dexmedetomidina-y-la-morfina-intratecal-en-los-biomarcadores-relacionados-con-la-metastasis-y-los-perfiles-inmunitarios-celulares-en-la-cirugia-de-cancer 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2826/estrategias-de-administracion-de-virus-oncoliticos-en-los-canceres-gastrointestinales-avances-mecanismos-y-traslacion-clinica 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2828/efectos-antitumorales-de-las-celulas-car-nk92mi-dirigidas-contra-cd133-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2317/alteraciones-especificas-del-subtipo-en-el-transporte-de-cobre-asociadas-con-las-mutaciones-de-kras-en-lineas-celulares-isogenicas-de-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1819/eficacia-y-seguridad-comparativas-de-las-terapias-combinadas-basadas-en-nivolumab-con-ipilimumab-o-binimetinib-en-pacientes-con-cancer-colorrectal-metastasico-con-estabilidad-de-microsatelites-y-con 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2333/farmacoterapia-personalizada-del-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2850/aspirina-para-la-prevencion-del-cancer-en-individuos-con-sindrome-de-lynch-primeros-resultados-del-ensayo-multicentrico-aleatorizado-doble-ciego-de-no-inferioridad-capp3 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2353/nanoagonista-dirigido-a-base-de-zinc-con-respuesta-dual-a-tme-nir-para-la-amplificacion-multimodal-de-la-inmunoterapia-contra-el-cancer-mediada-por-sting 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2879/desarrollo-de-inmunoterapia-con-criterios-farmacodinamicos-pd-y-adaptada-a-las-caracteristicas-del-tumor-en-el-cancer-colorrectal-mss-pmmr 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2881/las-metastasis-peritoneales-en-el-cancer-de-colon-en-estadio-ii-iii-representan-un-punto-ciego-para-la-vigilancia-del-adn-tumoral-circulante 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2882/el-metabolismo-mitocondrial-y-las-firmas-genicas-relacionadas-con-la-succinilacion-como-predictores-del-pronostico-y-la-resistencia-a-los-farmacos-en-el-adenocarcinoma-de-colon 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2627/aine-para-el-cancer-de-cabeza-y-cuello-con-alteraciones-en-pi3k-una-oportunidad-terapeutica-basada-en-biomarcadores 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2883/creacion-de-modelos-tridimensionales-de-cancer-colorrectal-mediante-bioimpresion-y-evaluacion-de-su-eficacia-y-sensibilidad-a-los-farmacos 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2890/terapia-con-un-inhibidor-de-puntos-de-control-inmunitario-en-combinacion-o-como-agente-unico-en-cancer-colorrectal-metastasico-con-alta-inestabilidad-de-microsatelites-un-analisis-basado-en-datos-de 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2636/la-mutacion-oncogenica-del-gen-pik3ca-potencia-la-inmunogenicidad-tumoral-a-traves-del-eje-irf1-nlrc5-mhc-i-en-el-carcinoma-urotelial 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2384/bloqueo-dual-de-ctla-4-pd-1-frente-a-anti-pd-1-en-cancer-colorrectal-metastasico-msi-h-beneficio-temprano-en-la-supervivencia-y-predictores-clinicos-exploratorios 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2130/evaluaciones-endoscopicas-y-radiologicas-de-la-inmunoterapia-neoadyuvante-en-pacientes-con-cancer-colorrectal-localmente-avanzado-con-dmmr-msi-h-o-mutacion-en-los-genes-pole-pold1 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2156/caracterizacion-preclinica-y-resultados-de-la-fase-1-de-tqb2102-un-conjugado-anticuerpo-farmaco-biparatopico-her2-de-primera-generacion-en-pacientes-con-tumores-solidos-avanzados 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2415/adcs-para-el-carcinoma-colorrectal-analisis-de-la-evidencia-clinica-para-la-innovacion-en-el-diseno-molecular 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1650/eficacia-del-tratamiento-de-primera-linea-y-modelo-pronostico-en-cancer-colorrectal-metastasico-mutante-de-ras-un-estudio-del-mundo-real 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2675/la-furina-mantiene-las-senales-promotoras-de-tumores-en-el-cancer-colorrectal-con-mutaciones-en-los-genes-kras-y-braf-al-interactuar-con-el-eje-tgf-1-cox-2-en-una-red-de-regulacion-reciproca 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2429/redes-regulatorias-multidimensionales-de-la-resistencia-a-los-farmacos-en-el-cancer-colorrectal-desde-los-mecanismos-moleculares-hasta-nuevas-estrategias-terapeuticas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2686/analisis-del-microambiente-inmunosupresor-en-el-cancer-colorrectal-resistente-a-la-quimioterapia-mediante-el-analisis-transcriptomico-de-celulas-individuales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2687/dirigirse-a-lig1-para-superar-la-resistencia-al-oxaliplatino-mediante-la-induccion-de-la-panoptosis-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2969/ifebemtinib-mas-garsorasib-en-el-cancer-colorrectal-metastasico-con-mutacion-kras-g12c-previamente-tratado-un-ensayo-multicentrico-aleatorizado-de-fase-1b-2 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2205/comparacion-indirecta-ajustada-por-emparejamiento-de-sotorasib-mas-panitumumab-frente-a-trifluridina-tipiracilo-mas-bevacizumab-en-cancer-colorrectal-metastasico-quimiorrefractario 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2975/un-estudio-multicentrico-sobre-el-cribado-de-braf-para-la-implementacion-de-la-genomica-perioperatoria-en-el-tratamiento-de-las-metastasis-oligo-metastasicas-resecables-del-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1188/la-inmunoterapia-en-cancer-colorrectal-avanzado-panorama-actual-mecanismos-desafios-y-direcciones-futuras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2475/los-genes-relacionados-con-la-ferroptosis-asociados-con-las-metastasis-hepaticas-del-cancer-colorrectal-modulan-la-peroxidacion-lipidica-en-las-celulas-del-cancer-colorrectal 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2476/mecanismos-y-desafios-clinicos-de-la-remodelacion-del-microambiente-tumoral-mediada-por-la-inmunoterapia-con-inhibidores-de-puntos-de-control-en-el-carcinoma-nasofaringeo 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2479/mecanismos-y-avances-en-la-resistencia-a-los-farmacos-en-el-cancer-colorrectal-una-revision-sistematica-de-las-redes-reguladoras-multicapa 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2483/identificacion-sistematica-de-biomarcadores-genomicos-de-falta-de-respuesta-a-los-tratamientos-contra-el-cancer 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2739/tratamiento-del-cancer-de-recto-localizado-en-los-paises-nordicos-comparacion-de-las-guias-nordicas-con-las-guias-holandesas-de-la-esmo-y-de-la-nccn 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2237/la-arn-polimerasa-i-endotelial-que-esta-regulada-por-spen-es-un-objetivo-para-mejorar-la-inmunoterapia-anti-pd-1-en-el-tratamiento-del-cancer 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2750/el-contexto-tisular-determina-diferentes-resultados-premalignos-en-un-modelo-transgenico-de-raton-pik3ca-mutante-hpv16-e6-e7 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2496/prediccion-de-las-nauseas-inducidas-por-la-quimioterapia-durante-el-tratamiento-con-irinotecan-basandose-en-los-sintomas-previos-inducidos-por-el-oxaliplatino-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3013/biomarcadores-predictivos-para-la-terapia-de-reintroduccion-con-cetuximab-en-el-cancer-colorrectal-metastasico-un-analisis-conjunto-de-los-estudios-cave-y-cave-2-goim 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2504/quien-rechaza-el-asesoramiento-genetico-evaluacion-del-rechazo-al-asesoramiento-genetico-entre-los-participantes-en-un-programa-de-cribado-genomico-a-nivel-poblacional 2026-08-03 monthly 0.5 https://crcwarriors.org/articulo/2783/dependencia-de-la-enzima-tipo-furina-en-el-cancer-colorrectal-con-mutacion-en-kras-como-diana-para-estrategias-de-tratamiento-personalizadas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2274/dirigirse-a-la-proteina-bmx-en-el-cancer-mecanismos-moleculares-y-estrategias-terapeuticas-emergentes 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/3045/el-gen-del-cromosoma-y-kdm5d-restringe-la-inmunidad-antitumoral-de-las-celulas-t-cd8-a-traves-de-programas-de-agotamiento-del-tcr-y-del-colesterol 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/3046/deteccion-precisa-de-asociaciones-metagenomicas-a-nivel-de-cepa-mediante-el-uso-de-la-identidad-promedio-de-nucleotidos-con-strainspy 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/3047/la-evolucion-tumoral-influye-en-la-capacidad-metastasica-del-cancer-colorrectal 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/3048/un-analisis-clinico-genomico-integrado-revela-la-evolucion-y-los-patrones-de-metastasis-del-cancer-colorrectal-avanzado 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/3049/prevalencia-del-cancer-colorrectal-con-msi-h-dmmr-en-japon-datos-del-grupo-de-estudios-clinicos-del-registro-colorrectal-de-la-universidad-de-osaka 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3050/valor-pronostico-de-las-metastasis-hepaticas-y-las-mutaciones-del-gen-kras-en-pacientes-con-cancer-colorrectal-metastasico-un-analisis-combinado-de-ensayos-de-tercera-linea-controlados-con-placebo 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2802/factores-pronosticos-en-el-borde-de-invasion-y-en-el-area-peritumoral-del-cancer-colorrectal-perspectivas-actuales-y-consideraciones-futuras 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/3058/el-analisis-de-perfil-genetico-a-nivel-de-celula-unica-revela-caracteristicas-inmunitarias-distintas-en-tumores-primarios-de-cancer-colorrectal-y-metastasis-hepaticas-no-tratados 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1782/la-fase-logaritmica-como-una-estrategia-terapeutica-evaluacion-de-estrategias-farmacologicas-contra-la-progresion-del-cancer 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/1783/virus-oncoliticos-recubiertos-basados-en-una-estrategia-de-doble-ataque-que-desencadena-la-terapia-car-t-dirigida-a-cd19-en-tumores-gastrointestinales 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2810/arid1a-regula-la-metastasis-del-cancer-colorrectal-a-traves-de-la-via-akt-mtor-p70s6k 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2299/la-produccion-a-escala-clinica-de-celulas-tcr-t-durante-10-dias-utilizando-il-2-7-15-y-tgf-promueve-tempranamente-fenotipos-de-memoria-y-similares-a-celulas-residentes-en-los-tejidos-y-una-robusta 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2303/sintesis-y-evaluacion-preclinica-de-89-zr-dfo-atezolizumab-para-la-imagen-pet-inmunitaria-en-el-cancer-colorrectal 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2970/impacto-de-la-inmunoterapia-en-el-tratamiento-del-cancer-de-pulmon-no-microcitico-en-estadio-temprano-el-melanoma-y-el-cancer-colorrectal 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2979/valor-pronostico-de-fubp1-en-el-cancer-colorrectal-y-asociacion-con-las-caracteristicas-del-microambiente-inmunitario 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2985/ferroptosis-en-las-enfermedades-intestinales-mecanismos-moleculares-potencial-terapeutico-y-perspectivas-futuras 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2988/la-via-de-senalizacion-nf-b-lipocalina-2-atenua-la-resistencia-a-la-quimioterapia-del-cancer-colorrectal-con-mutacion-brafv600e-frente-al-cisplatino-al-promover-la-ferroptosis 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2766/panorama-genomico-y-molecular-del-cancer-colorrectal-de-inicio-temprano-nuevos-conocimientos-e-implicaciones-clinicas-una-revision-sistematica 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/3028/el-papel-de-la-disfuncion-metabolica-relacionada-con-el-estres-en-el-desarrollo-del-cancer-de-ovario-un-estudio-combinado-de-casos-y-controles 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/3029/revision-implicita-de-videos-quirurgicos-con-tecnologia-de-modelos-de-lenguaje-de-gran-tamano 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/3030/auditoria-de-la-evidencia-asistida-por-un-modelo-de-lenguaje-extenso-llm-sobre-la-incidencia-de-cancer-en-etapas-avanzadas-como-punto-final-de-un-ensayo-de-cribado 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/3038/un-polimorfismo-germinal-de-kdm3c-altera-la-reparacion-del-adn-y-aumenta-la-sensibilidad-a-la-quimiorradioterapia 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/1766/organoides-derivados-de-tumores-colorrectales-de-pacientes-con-braf-v600e-identifican-marcadores-biosanguineos-de-respuesta-a-la-inhibicion-de-egfr-y-braf-y-reproducen-datos-clinicos 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/3064/mechanomast-una-plataforma-multimodal-para-el-registro-espacial-de-datos-mecanicos-y-transcriptomicos-de-tejidos 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/2471/perfil-genomico-y-clinico-integrador-de-las-metastasis-hepaticas-del-cancer-colorrectal-para-orientar-la-cirugia-personalizada-y-el-trasplante-de-higado 2026-08-30 monthly 0.5 https://crcwarriors.org/articulo/3021/un-atlas-exhaustivo-de-las-tasas-de-mutacion-somatica-y-las-firmas-mutacionales-en-celulas-humanas-normales 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2275/descubrimiento-de-andamios-tetraciclicos-de-azaindol-indol-fusionados-con-pirimidina-como-nuevos-inhibidores-potentes-de-cdk7 2026-08-29 monthly 0.5 https://crcwarriors.org/articulo/2820/quimioterapia-neoadyuvante-y-bevacizumab-para-metastasis-peritoneales-de-cancer-colorrectal-resultados-clinicos-y-traslacionales-del-ensayo-de-fase-ii-bev-ip 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2062/respuesta-completa-duradera-a-pembrolizumab-tras-la-inhibicion-de-braf-mek-en-un-caso-de-cancer-colorrectal-recurrente-con-msi-h-dmmr-y-mutacion-braf-v600e-informe-de-un-caso 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2849/dirigirse-a-la-enfermedad-residual-molecular-y-a-la-evasion-inmune-en-la-recurrencia-del-cancer-colorrectal-inmunoterapia-y-terapias-celulares-guiadas-por-biomarcadores 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2857/predictores-genomicos-transcriptomicos-y-moleculares-de-la-respuesta-a-la-terapia-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado-una-revision-narrativa 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2862/informe-breve-beneficio-terapeutico-de-isa-2011b-en-el-cancer-colorrectal 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2867/radioterapia-de-corta-duracion-combinada-con-capeox-e-inhibidor-de-pd-1-tras-la-escision-local-en-el-cancer-colorrectal-temprano-de-alto-riesgo-protocolo-de-estudio-para-un-ensayo-prospectivo-de-fase 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2104/teranostica-de-precision-en-oncologia-integracion-de-conjugados-anticuerpo-farmaco-radioinmunoterapia-e-inmuno-pet-para-una-atencion-oncologica-adaptativa 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2365/la-decoccion-sanwu-huangqin-induce-la-ferroptosis-en-las-celulas-de-cancer-colorrectal-al-activar-la-ferritinafagia-mediada-por-ncoa4-fth1 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2621/un-estudio-retrospectivo-de-los-factores-pronosticos-diferenciales-en-el-cancer-colorrectal-de-inicio-temprano-frente-al-de-inicio-tardio-un-analisis-clinico-exhaustivo-y-basado-en-el-aprendizaje 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2640/ingenieria-de-car-t-de-ultima-generacion-para-el-cancer-colorrectal-integracion-de-dianas-barreras-del-microambiente-tumoral-y-estrategias-emergentes 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2900/el-panorama-genetico-del-cancer-colorrectal-desde-las-alteraciones-moleculares-hasta-las-vias-de-decision-terapeutica 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2910/el-tratamiento-pasado-presente-y-futuro-del-cancer-colorrectal-metastasico-con-mutacion-braf-v600-una-revision-exhaustiva 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2911/modelado-de-la-modulacion-del-microbioma-sobre-las-redes-metabolicas-tumorales-para-predecir-terapias-sinergicas 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2948/cps1-favorece-la-progresion-del-cancer-colorrectal-al-inducir-la-transicion-epitelio-mesenquimal-emt-y-activar-la-via-de-senalizacion-tgf-smad 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2949/radioterapia-profilactica-modificacion-del-microambiente-inmunitario-efectos-mecanismos-y-aplicaciones-clinicas-para-prevenir-la-metastasis-tumoral 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2957/estudio-internacional-de-fase-iv-realizado-en-el-ambito-clinico-para-validar-el-cuestionario-de-la-organizacion-europea-para-la-investigacion-y-el-tratamiento-del-cancer-destinado-a-evaluar-la 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2192/los-subtipos-de-mutacion-de-kras-permiten-una-mejor-estratificacion-pronostica-en-el-cancer-colorrectal-un-estudio-retrospectivo-de-cohortes 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2459/resultados-clinicos-del-regimen-folfiri-de-segunda-linea-mas-ramucirumab-segun-la-exposicion-previa-a-terapias-biologicas-en-el-cancer-colorrectal-metastasico-una-comparacion-retrospectiva-de-los 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2462/protocolo-del-estudio-administracion-dirigida-de-interleucina-12-en-combinacion-con-terapia-de-infusion-mediante-bomba-en-la-arteria-hepatica-para-pacientes-con-metastasis-hepaticas-de-carcinoma 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2992/la-transcriptomica-de-celulas-individuales-y-los-analisis-funcionales-identificaron-spin-doc-como-un-regulador-de-la-senalizacion-de-wnt-y-de-la-capacidad-de-formacion-de-celulas-madre-en-el-cancer 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2993/radioterapia-con-linac-y-ultrahipofraccionamiento-para-el-cancer-de-prostata-primario-resultados-preliminares-de-un-estudio-de-registro-a-nivel-nacional-austriaco 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2994/socs5-suprime-la-inmunidad-antitumoral-en-el-cancer-colorrectal-al-promover-la-ubiquitinacion-de-ifnar1-y-la-respuesta-del-interferon-de-tipo-i 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2995/relacion-estructura-actividad-de-los-complejos-l-ir-iii-cl-cp-que-interfieren-con-las-vias-cdk4-ciclina-d1-y-akt-mtor-para-suprimir-la-tumorigenesis-del-cancer-colorrectal-e-inducir-la-muerte-celular 2026-08-30 monthly 0.5 https://crcwarriors.org/articulo/2996/agentes-antiparasitarios-en-oncologia-mecanismos-innovadores-evidencia-emergente-y-potencial-clinico-en-el-tratamiento-del-cancer 2026-08-30 monthly 0.5 https://crcwarriors.org/articulo/2997/nanoplataforma-multifuncional-modificada-con-acido-hialuronico-y-hueca-de-mno-2-que-coadministra-l-arginina-y-regorafenib-para-una-terapia-sinergica-contra-el-cancer-colorrectal 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2998/xiao-chai-hu-tang-alivia-la-diarrea-inducida-por-irinotecan-al-promover-la-reabsorcion-de-acidos-biliares-y-disminuir-la-senalizacion-de-la-quinasa-de-adhesion-focal-segun-se-ha-revelado-mediante 2026-08-30 monthly 0.5 https://crcwarriors.org/articulo/2999/desarrollo-de-la-tecnologia-de-inmunoensayo-digital-integrado-crispr-cas12a-para-la-deteccion-de-cd44 2026-08-30 monthly 0.5 https://crcwarriors.org/articulo/2488/la-decoccion-xianlian-jiedu-induce-la-apoptosis-en-el-cancer-colorrectal-mediante-la-modulacion-de-la-senalizacion-jnk-p38-mapk-dependiente-de-la-esfingosina-1-fosfato 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/3000/la-luteolina-revierte-la-resistencia-a-la-quimioterapia-en-celulas-de-cancer-colorrectal-mediante-la-represion-epigenetica-dependiente-de-tet1-tdg-de-catenina 2026-08-30 monthly 0.5 https://crcwarriors.org/articulo/441/man1a1-promueve-la-metastasis-hepatica-del-cancer-colorrectal-al-mantener-la-estabilidad-del-proteina-tgfbr2 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/3001/resultados-tras-la-hemicolectomia-derecha-para-el-cancer-de-colon-ascendente-una-comparacion-entre-hospitales-universitarios-y-hospitales-comunitarios 2026-08-30 monthly 0.5 https://crcwarriors.org/articulo/2490/la-decoccion-de-sini-inhibe-la-metastasis-hepatica-del-cancer-colorrectal-al-suprimir-la-senalizacion-de-integrinas-exosomicas-dependiente-de-hif-1 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/3003/tecnologias-avanzadas-de-edicion-genetica-para-la-oncologia-mecanismos-aplicaciones-e-implementacion-clinica 2026-08-29 monthly 0.5 https://crcwarriors.org/articulo/3004/conjugados-de-benzotiazol-y-trifenilfosfonio-sintesis-analisis-in-silico-y-efectos-exploratorios-in-vitro-sobre-la-viabilidad-de-las-celulas-de-cancer-colorrectal-ht-29 2026-08-29 monthly 0.5 https://crcwarriors.org/articulo/1469/estudio-fitoquimico-de-homalanthus-giganteus-aislamiento-actividad-antiproliferativa-y-analisis-computacional-del-mecanismo-de-accion-de-diterpenos-tiglianos-contra-el-cancer-colorrectal 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/3005/nueva-generacion-de-celulas-car-t-dirigidas-contra-la-mesotelina-que-secretan-scfv-anti-pd-l1-para-una-inmunoterapia-potente-contra-organoides-de-cancer-colorrectal-derivados-de-pacientes-y 2026-08-29 monthly 0.5 https://crcwarriors.org/articulo/705/avances-en-la-deteccion-de-her2-en-subtipos-de-cancer-un-enfoque-pan-tumoral 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/3020/descifrando-nuevas-conexiones-transcripcionales-en-el-cancer-colorrectal-un-estudio-bioinformatico-y-experimental-integrativo 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/3023/los-degradadores-de-proteinas-programables-permiten-la-eliminacion-selectiva-de-subpoblaciones-patogenas-de-catenina-in-vitro-e-in-vivo 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/3024/lactobacillus-salivarius-potencia-la-inmunoterapia-del-cancer-gastrointestinal-a-traves-de-su-metabolito-el-acido-quenodeoxicolico 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/3025/las-sondas-hot-con-activacion-automatica-permiten-la-obtencion-de-imagenes-de-cromatina-en-tiempo-real-y-con-superresolucion-en-celulas-y-tejidos-vivos 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2278/analisis-integrativo-de-biomarcadores-circulantes-del-cancer-colorrectal-mediante-la-combinacion-de-espectroscopia-de-infrarrojo-medio-y-metabolomica-dirigida 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2792/analisis-de-la-incidencia-y-los-resultados-perioperatorios-de-las-reacciones-adversas-relacionadas-con-el-sistema-inmunitario-en-la-inmunoterapia-preoperatoria-para-el-cancer-colorrectal-basado-en 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/1010/estrategias-de-conservacion-del-organo-en-pacientes-con-tumores-msi-dmmr-incluyendo-sindrome-de-lynch-estado-actual-y-perspectivas-futuras-para-la-toma-de-decisiones-clinicas 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/3063/los-relojes-epigeneticos-revelan-la-aceleracion-de-la-edad-y-la-remodelacion-de-la-metilacion-compartida-en-diversos-tipos-de-cancer 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/3006/perfil-del-grupo-de-estudio-karoliver-un-grupo-de-pacientes-basado-en-la-poblacion-que-recibe-tratamiento-curativo-dirigido-al-higado-para-metastasis-hepaticas-de-cancer-colorrectal-en-un-centro 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/3019/un-analisis-multi-omico-espacial-revela-que-el-nicho-formado-por-macrofagos-y-celulas-endoteliales-con-altos-niveles-de-vimentina-determina-la-heterogeneidad-de-las-celulas-adyacentes-a-la-fibrosis 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/3044/la-disociacion-farmacologica-entre-la-activacion-de-los-irbc-y-el-colapso-anabolico-redefine-la-inhibicion-de-la-biogenesis-ribosomica-como-una-estrategia-selectiva-de-supresion-tumoral 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2930/monoterapia-antitumoral-anti-pd-1-neoadyuvante-seguida-de-una-estrategia-de-observacion-en-pacientes-con-cancer-colorrectal-dmmr-msi-h-un-estudio-multicentrico-en-el-mundo-real 2026-08-26 monthly 0.5 https://crcwarriors.org/articulo/2958/deficiencia-en-la-reparacion-de-errores-de-emparejamiento-o-inestabilidad-de-microsatelites-en-pacientes-con-cancer-colorrectal-localmente-avanzado-tratados-con-terapia-neoadyuvante-total 2026-08-26 monthly 0.5 https://crcwarriors.org/articulo/3008/una-funcion-de-menin-independiente-de-mll-promueve-la-resistencia-a-la-terapia-dirigida-a-la-via-mapk 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/3009/moldeando-el-futuro-de-la-prevencion-del-cancer-colorrectal-de-inicio-temprano 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/3010/la-deficiencia-de-ltbp4-induce-a-macrofagos-mrc1-cd44-para-promover-la-progresion-del-cancer-en-modelos-preclinicos-de-cancer-colorrectal 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2903/inmunoterapia-neoadyuvante-basada-en-pd-1-en-el-cancer-colorrectal-localizado-con-dmmr-msi-h-una-revision-sistematica-y-un-metaanalisis-basado-en-grupos 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/2419/evaluacion-de-la-carga-de-los-canceres-asociados-al-vph-en-brasil-tendencias-de-hospitalizacion-y-mortalidad-de-2011-a-2019 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/3007/un-marco-estadistico-para-la-clasificacion-de-enfermedades-mediante-datos-de-secuenciacion-de-arn-de-celulas-individuales-scrna-seq 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2428/estratificacion-diagnostica-de-globo-h-e-identificacion-de-dusp14-como-un-posible-blanco-terapeutico-en-el-cancer-colorrectal 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2770/terapia-neoadyuvante-total-basada-en-radioterapia-de-corta-duracion-mas-tislelizumab-para-el-cancer-colorrectal-localmente-avanzado-neo-star-resultados-preliminares-de-un-ensayo-aleatorizado-de-fase 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2357/sonda-fluorescente-de-infrarrojo-cercano-nir-ii-dirigida-a-vegfr2-para-la-obtencion-de-imagenes-precisas-y-la-guia-quirurgica-del-cancer-de-ovario 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/2685/el-papel-de-la-terapia-dirigida-en-el-manejo-de-las-metastasis-hepaticas-del-cancer-colorrectal-una-revision-sistematica-y-metaanalisis 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/2963/delta-marches-sintesis-de-imagenes-basada-en-inteligencia-artificial-generativa-para-descifrar-las-transformaciones-morfologicas-que-impulsan-la-enfermedad 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2708/alteraciones-del-genoma-mitocondrial-en-el-cancer-desde-mutaciones-y-epigenetica-hasta-terapias-dirigidas 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/2714/el-adn-tumoral-circulante-para-predecir-el-riesgo-de-tromboembolia-venosa-en-el-cancer-de-recto-localmente-avanzado 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/2952/incidencia-de-cancer-segun-la-localizacion-del-tumor-en-los-distintos-subtipos-clinicos-de-pacientes-con-diagnostico-reciente-de-diabetes-tipo-2-en-los-estados-unidos 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/2962/una-red-neuronal-de-grafos-heterogeneos-informada-biologicamente-para-la-prediccion-multitarea-de-las-interacciones-entre-ncrna-metastasis-y-cancer 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2966/la-obtencion-de-imagenes-metabolicas-con-deuterio-de-alta-resolucion-espacio-temporal-permite-la-fenotipificacion-in-vivo-de-la-heterogeneidad-intratumoral-e-intertumoral 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2941/indice-compuesto-tyg-inflammation-como-biomarcador-preoperatorio-de-vulnerabilidad-metabolico-inflamatoria-en-la-cirugia-de-cancer-colorrectal-asociaciones-con-complicaciones-postoperatorias-y 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/2942/grasas-dieteticas-inflamacion-celulas-tumorales-circulantes-y-adn-tumoral-circulante-en-supervivientes-de-cancer-colorrectal-un-estudio-transversal-exploratorio 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/2951/dosis-de-radiacion-ajustada-genomicamente-y-resultados-en-el-tratamiento-con-radioterapia-del-cancer-colorrectal-localmente-avanzado-un-analisis-combinado-multicohorte-que-incluye-los-ensayos 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/2953/un-organoide-intestinal-humano-peristaltico-de-tamano-centimetrico-con-sistemas-neuroinmuno-vasculares-integrados-reproduce-la-enteritis-y-el-cancer-colorrectal-ortotopico 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/2960/sistema-robotico-modular-noses-ii-para-el-cancer-de-recto-medio-un-estudio-preliminar-de-factibilidad-de-un-procedimiento-quirurgico-estructurado 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2964/la-plasticidad-fenotipica-inducida-por-mutaciones-impulsa-la-formacion-de-un-nicho-intrinseco-al-tumor-que-favorece-la-metastasis 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2779/impacto-en-la-supervivencia-de-los-eventos-adversos-graves-relacionados-con-la-inmunoterapia-en-los-canceres-digestivos-con-deficiencia-en-la-reparacion-del-desajuste-y-alta-inestabilidad-de 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/265/codebreak-o-codigo-azul-evaluando-las-constantes-vitales-de-sotorasib-en-cancer-colorrectal-metastasico 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2851/un-ensayo-de-fase-ii-de-un-solo-brazo-para-evaluar-la-reintroduccion-de-irinotecan-a-dosis-altas-guiada-por-el-genotipo-ugt1a1-en-pacientes-con-cancer-colorrectal-metastasico-refractario 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/1857/la-seleccion-de-alto-rendimiento-identifica-nt-1-que-actua-sinergicamente-con-mrtx1133-contra-el-cancer-colorrectal-con-kras-g12d-resistente-adquirido 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2914/expresion-de-la-glicoproteina-mucina-13-como-un-objetivo-terapeutico-en-el-cancer-colorrectal 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2915/funciones-moleculares-correlatos-clinicos-y-perspectivas-terapeuticas-de-la-expresion-de-b7-h3-en-el-cancer-colorrectal-una-revision-sistematica 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2920/nanoparticulas-de-acido-hialuronico-activadas-por-enzimas-y-especies-reactivas-de-oxigeno-permiten-la-administracion-de-celastrol-para-una-terapia-dirigida-a-sitios-especificos-en-las-enfermedades 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2698/los-carcinomas-colorectales-enteroblasticos-y-hepatoides-son-canceres-agresivos-con-un-inmunofenotipo-distintivo-mientras-que-el-carcinoma-de-celulas-claras-parece-representar-una-transformacion-de 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2699/trasplante-de-higado-de-donante-fallecido-y-supervivencia-postoperatoria-en-pacientes-con-metastasis-hepaticas-irresecables-de-cancer-colorrectal-un-estudio-multicentrico-retrospectivo 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2961/necesidad-del-factor-inducible-por-hipoxia-1-alfa-para-la-glucolisis-inducida-por-la-interleucina-1-beta-en-celulas-de-cancer-colorrectal 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2965/la-expresion-de-aldh7a1-inducida-por-la-hipoxia-protege-a-las-celulas-de-cancer-colorrectal-del-estres-oxidativo-y-el-dano-del-adn-a-traves-de-un-mecanismo-independiente-de-hif-1 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2973/hif-1-integra-los-programas-metabolicos-e-inmunorreguladores-en-las-celulas-t-reguladoras-rort-durante-la-inflamacion-intestinal 2026-08-26 monthly 0.5 https://crcwarriors.org/articulo/2762/sirexatamab-en-combinacion-con-bevacizumab-y-quimioterapia-como-terapia-de-segunda-linea-para-el-adenocarcinoma-colorrectal-avanzado-el-ensayo-de-fase-ii-defiance 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2866/trifluridina-tipiracil-con-o-sin-bevacizumab-en-el-cancer-colorrectal-metastasico-con-inestabilidad-de-microsatelites-alta-deficiencia-en-la-reparacion-de-errores-de-emparejamiento-un-estudio 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/850/inhibicion-de-kras-g12c-en-tumores-solidos-avances-biologicos-evidencia-clinica-y-desafios-abiertos 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2656/analisis-espacial-multi-omico-del-paisaje-de-las-metastasis-macroscopicas-y-microscopicas-del-cancer-colorrectal 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2935/la-expresion-de-arid1a-mediante-inmunohistoquimica-se-asocia-con-el-riesgo-de-polipos-colorrectales-metacronicos-evidencia-obtenida-a-partir-de-analisis-genomicos-y-transcriptomicos-integrados 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/2954/el-envejecimiento-biologico-y-la-arquitectura-oculta-del-riesgo-de-cancer-de-inicio-temprano 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/2955/la-modulacion-de-la-interaccion-triptica-entre-neuronas-celulas-cancerosas-y-celulas-inmunitarias-potencia-la-respuesta-a-la-quimioterapia-y-a-la-inmunoterapia 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/2744/eficacia-y-seguridad-a-corto-plazo-de-la-inmunoterapia-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado-con-deficiencia-en-la-reparacion-del-desajuste 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2753/vactosertib-mas-pembrolizumab-en-pacientes-con-cancer-colorrectal-o-gastrico-metastasico-con-inestabilidad-microsatelital-no-alta-un-estudio-multicentrico-de-fase-ib-iia 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/1736/evaluacion-economica-de-22-estrategias-de-vacunacion-contra-el-vph-para-minimizar-el-riesgo-de-cancer-peniano-anal-y-orofaringeo-en-varones-chinos-un-analisis-mediante-modelo-de-markov 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2944/evaluacion-comparativa-de-los-datos-de-nanostring-ncounter-en-diferentes-cohortes-para-la-prediccion-de-recurrencia-en-el-cancer-colorrectal 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/1944/respuesta-completa-a-pembrolizumab-en-un-paciente-pediatrico-con-cancer-colorrectal-asociado-al-sindrome-de-lynch-informe-de-un-caso-y-revision-de-la-obstruccion-intestinal-relacionada-con-la 2026-08-17 monthly 0.5 https://crcwarriors.org/articulo/2736/inmunoterapia-de-primera-linea-frente-a-quimioterapia-en-el-cancer-colorrectal-metastasico-con-msi-h-dmmr-una-revision-sistematica-y-un-metaanalisis-de-estudios-de-fase-iii 2026-08-17 monthly 0.5 https://crcwarriors.org/articulo/2840/linfoma-de-hodgkin-clasico-una-revision 2026-08-15 monthly 0.5 https://crcwarriors.org/articulo/2403/resistencia-a-la-inmunoterapia-en-el-cancer-colorrectal-estrategias-terapeuticas-y-enfoques-guiados-por-biomarcadores 2026-08-15 monthly 0.5 https://crcwarriors.org/articulo/2907/dirigirse-a-la-senalizacion-adrenergica-en-el-cancer-colorrectal-mecanismos-moleculares-y-potencial-terapeutico-de-los-betabloqueantes 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/2936/la-prevalencia-de-los-perfiles-moleculares-del-cancer-colorrectal-no-se-refleja-en-un-unico-umbral-de-edad 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/2722/estudio-de-fase-i-de-escalada-de-dosis-que-combina-la-quimioembolizacion-con-microesferas-de-irinotecan-y-la-radioembolizacion-con-microesferas-de-vidrio-de-itrio-90-en-metastasis-hepaticas-de-cancer 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/1636/eficacia-costo-efectiva-de-la-primera-linea-de-encorafenib-mas-cetuximab-con-mfolfox6-en-cancer-colorrectal-metastasico-mutante-braf-v600e 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2663/asociaciones-histopatologicas-moleculares-y-clinicas-de-los-carcinomas-gastrointestinales-con-fusion-positiva 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2923/las-celulas-b-de-memoria-residentes-en-los-tejidos-potencian-la-inmunidad-antitumoral-local-a-traves-de-la-iga 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2924/scdiva-integracion-semi-supervisada-y-anotacion-detallada-de-atlas-de-celulas-tumorales-e-inmunitarias-a-nivel-unicelular 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2413/mir-31-como-biomarcador-predictivo-de-la-eficacia-del-cetuximab-en-pacientes-con-cancer-colorrectal-metastasico-revision-sistematica 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2934/la-metformina-los-antibioticos-los-analgesicos-y-los-inhibidores-de-la-bomba-de-protones-modifican-el-microbioma-intestinal-incluidos-los-perfiles-microbianos-asociados-con-la-neoplasia-colorrectal 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/2692/variabilidad-genomica-de-la-linea-celular-hct116-identificada-mediante-secuenciacion-con-oxford-nanopore 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2439/reutilizacion-in-silico-de-farmacos-aprobados-para-uso-clinico-como-posibles-inhibidores-de-braf-un-cribado-virtual-basado-en-farmacoforos-e-investigacion-experimental 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2472/un-estudio-de-fase-ii-sobre-alpelisib-y-capecitabina-en-pacientes-con-cancer-colorrectal-metastasico-previamente-tratado-kcsg-co21-04 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2771/inmunoterapia-en-el-cancer-colorrectal-asociado-a-la-deficiencia-constitucional-del-sistema-de-reparacion-de-errores-de-emparejamiento-cmmrd-en-pacientes-pediatricos-informe-de-un-caso-de-una 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2796/oncofertilidad-femenina-en-el-cancer-colorrectal-incertidumbres-reproductivas-y-posibles-beneficios-de-la-inmunoterapia 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2806/las-mutaciones-del-gen-kras-reprograman-las-modificaciones-m6a-del-arn-para-impulsar-la-evasion-inmunitaria-dependiente-de-cd73-en-el-cancer-colorrectal 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2899/relacion-entre-el-nivel-de-competencia-de-los-cuidadores-en-el-manejo-de-la-ostomia-y-el-riesgo-de-complicaciones-de-la-ostomia-en-pacientes-con-cancer-colorrectal-en-el-plazo-de-un-mes-un-estudio-de 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2917/la-base-molecular-del-complejo-hacd-tecr-que-media-la-elongacion-de-acidos-grasos-de-cadena-muy-larga-revela-un-posible-objetivo-terapeutico-en-el-cancer-colorrectal 2026-08-15 monthly 0.5 https://crcwarriors.org/articulo/2710/quimiocirugia-neoadyuvante-con-dosis-escaladas-frente-a-la-quimiocirugia-neoadyuvante-estandar-para-el-cancer-colorrectal-localmente-avanzado-resultados-a-9-anos-de-un-ensayo-aleatorizado-de-fase-2 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2481/un-adenovirus-oncolitico-modificado-con-un-inhibidor-de-cdk4-6-revierte-el-agotamiento-de-las-celulas-t-a-traves-de-la-via-rb-p65-ccl5-y-potencia-la-actividad-antitumoral-de-la-terapia-anti-pd-1-o 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2817/dependencias-distintas-de-erk-y-pi3k-median-una-respuesta-heterogenea-a-la-inhibicion-de-ras-on-en-el-cancer-colorrectal-con-mutacion-en-kras 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2845/descubrimiento-de-derivados-de-hidrazona-como-nuevos-antagonistas-de-stat3-para-el-tratamiento-del-cancer-de-pancreas-y-de-colon 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2896/tendencias-en-la-utilizacion-de-las-pruebas-de-deteccion-de-cancer-de-mama-cervix-y-colon-entre-2010-y-2019-en-una-poblacion-con-seguro-medico-comercial-utilizando-la-base-de-datos-de-reclamaciones 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2897/la-prediccion-genetica-del-riesgo-de-cancer-colorrectal-en-seis-grupos-ancestrales-principales-ofrece-informacion-util-para-optimizar-las-pautas-de-deteccion 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2898/la-evolucion-epigenetica-del-cancer-colorrectal-y-su-microambiente-revela-nuevas-vulnerabilidades 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/1886/inhibidores-emergentes-de-kras-g12d-en-el-tratamiento-de-tumores-del-sistema-digestivo-oportunidades-y-desafios 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2922/el-aumento-de-mps1-transforma-la-corona-fibrosa-en-una-fuente-de-inestabilidad-cromosomica-en-el-cancer-de-colon 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/1191/efecto-de-la-transplante-de-heces-ileales-en-la-prevencion-de-la-colitis-por-derivacion-y-sus-complicaciones-debido-a-una-ileostomia-protectora-de-bucle-en-casos-de-cancer-rectal 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/1220/supervivencia-y-morbilidad-en-pacientes-ancianos-tratados-con-cirugia-citorreductora-e-hipertermia-intraperitoneal-hipec-para-metastasis-peritoneales-de-cancer-colorrectal-un-estudio-basado-en-la 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2797/la-actividad-citolitica-inmune-se-correlaciona-con-las-alteraciones-del-microambiente-tumoral-en-el-cancer-colorrectal 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2808/el-papel-multifacetico-de-socs3-en-el-cancer-colorrectal-mecanismos-moleculares-e-implicaciones-clinicas 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2825/organizacion-europea-para-la-prevencion-del-cancer-sobre-la-deteccion-precoz-del-cancer-un-documento-de-posicion-elaborado-por-un-panel-de-expertos 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/2833/nanoformulaciones-de-resveratrol-para-el-tratamiento-del-cancer-una-revision-exhaustiva-de-las-estrategias-especificas-para-cada-enfermedad-y-las-barreras-clinicas-y-traslacionales 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/2875/un-analisis-retrospectivo-de-12-anos-de-la-epidemiologia-del-cancer-en-un-importante-centro-de-oncologia-en-erbil-irak 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2877/el-analisis-multiomico-y-espacial-del-tejido-del-cancer-colorrectal-revela-la-persistencia-viral-y-la-desregulacion-inmune-en-el-covid-persistente 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2888/la-pleiotropia-antagonica-en-el-locus-hcar1-revela-una-base-genetica-para-la-resistencia-de-los-tumores-solidos-en-la-esquizofrenia 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2912/prevalencia-y-cronologia-de-los-procesos-mutacionales-asociados-a-la-colibactina-y-sus-espectros-de-microbioma-en-el-cancer-colorrectal-japones 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/2234/respuesta-patologica-completa-tras-la-inmunoterapia-neoadyuvante-en-el-cancer-colorrectal-con-deficiencia-en-el-sistema-de-reparacion-de-errores-mismatch-repair-e-invasion-de-organos-adyacentes 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/1764/respuesta-molecular-completa-al-protocolo-rin-regorafenib-ipilimumab-y-nivolumab-en-un-paciente-con-cancer-rectal-avanzado-recurrente-metastasico-de-reparacion-de-error-de-coincidencia-competente 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/2799/los-analisis-transcriptomicos-a-nivel-de-celula-unica-y-espacial-revelan-que-pigt-es-un-regulador-clave-del-remodelado-inmunometabolico-en-las-metastasis-hepaticas-del-cancer-colorrectal 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/2809/diferencias-en-la-transcriptomica-espacial-de-los-patrones-de-crecimiento-histopatologico-en-metastasis-hepaticas-del-cancer-colorrectal 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/2793/plasticidad-molecular-de-lama3-a-lo-largo-del-espectro-de-la-enfermedad-mecanismos-patogenicos-y-traslacion-clinica 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/2397/la-edicion-del-arn-a-nivel-de-celula-unica-identifica-a-adar1-en-las-celulas-t-como-un-regulador-clave-del-agotamiento-inmunitario-y-la-resistencia-anti-pd-1-en-el-cancer-colorrectal 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2865/la-omica-espacial-y-la-transcriptomica-unicelular-revelan-programas-celulares-asociados-a-la-senescencia-durante-la-progresion-del-adenoma-de-colon-a-cancer 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/2874/evaluacion-de-las-diferencias-etnicas-en-la-supervivencia-neta-estandarizada-por-edad-en-ocho-tipos-comunes-de-cancer-un-estudio-poblacional-realizado-en-inglaterra 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2411/una-revision-sistematica-exhaustiva-de-la-patogenia-molecular-de-los-canceres-del-sistema-digestivo-2013-2025 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/2446/una-nueva-firma-genetica-relacionada-con-la-lactilacion-permite-comprender-el-microambiente-inmunosupresor-y-estratificar-la-terapia-de-precision-en-el-cancer-colorrectal 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/2760/caracteristicas-de-la-microbiota-intestinal-en-el-cancer-colorrectal-con-diferentes-estados-de-inestabilidad-de-microsatelites 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/2864/un-metodo-sencillo-para-analizar-el-crecimiento-competitivo-de-multiples-tipos-de-celulas-en-tumores-de-xenoinjerto 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/2869/los-datos-de-referencia-obtenidos-mediante-la-simulacion-in-silico-de-la-adicion-de-secuencias-especificas-revelan-las-limitaciones-en-la-recuperacion-de-biomarcadores-del-microbioma-en-el-cancer 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/2876/aprendizaje-con-la-ia-geometrica-de-recurrencia-en-la-transcriptomica-espacial 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2449/toxicidad-y-finalizacion-del-tratamiento-con-folfoxiri-neoadyuvante-y-quimiorradioterapia-en-pacientes-con-cancer-colorrectal-localmente-avanzado-de-alto-riesgo-un-analisis-secundario-de-los 2026-08-06 monthly 0.5 https://crcwarriors.org/articulo/2738/patrones-de-progresion-y-supervivencia-en-pacientes-con-cancer-colorrectal-metastasico-dmmr-msi-h-tratados-con-inmunoterapia 2026-08-06 monthly 0.5 https://crcwarriors.org/articulo/2028/estudio-de-fase-i-de-telisotuzumab-adizutecan-temab-a-abbv-400-un-nuevo-conjugado-anticuerpo-farmaco-dirigido-a-c-met-en-pacientes-con-cancer-colorrectal-en-lineas-de-tratamiento-avanzadas-y-tumores 2026-08-06 monthly 0.5 https://crcwarriors.org/articulo/2853/lag3-como-biomarcador-independiente-del-microambiente-tumoral-en-el-cancer-colorrectal-chino-validacion-de-una-firma-de-subtipificacion-derivada-del-cancer-de-pulmon 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2854/asociacion-de-comorbilidades-cardiovasculares-con-neoplasias-malignas-y-benignas-del-colon-y-el-recto 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2856/las-vesiculas-y-particulas-extracelulares-tumorales-reprograman-los-macrofagos-intersticiales-en-el-pulmon-para-promover-la-permeabilidad-vascular-y-la-metastasis 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2371/los-factores-clinicos-estan-mas-fuertemente-asociados-con-el-pronostico-que-las-alteraciones-geneticas-en-el-cancer-colorrectal-de-inicio-temprano-un-estudio-retrospectivo-de-cohortes 2026-08-05 monthly 0.5 https://crcwarriors.org/articulo/2889/cartografiando-el-proteoma-fantasma-humano-clasificacion-y-sesgos-experimentales-en-la-identificacion-de-microproteinas-alternativas 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2742/relevancia-pronostica-de-los-margenes-quirurgicos-segun-el-estado-de-kras-y-braf-en-las-metastasis-hepaticas-del-cancer-colorrectal-grupo-colaborativo-braf-kras-livermet 2026-08-05 monthly 0.5 https://crcwarriors.org/articulo/2843/modelado-de-efectos-mixtos-de-la-sinergia-entre-los-inhibidores-de-los-puntos-de-control-inmunitario-y-los-inhibidores-de-la-trombina-en-un-modelo-preclinico-murino-de-cancer-de-colon 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2844/rendimiento-del-gen-premm5-criterios-clinicos-e-inmunohistoquimica-de-las-proteinas-mmr-en-la-evaluacion-del-riesgo-genetico-de-pacientes-mexicanos-con-cancer-colorrectal 2026-08-05 monthly 0.5 https://crcwarriors.org/articulo/2848/la-modulacion-del-receptor-5-ht2ar-periferico-mejora-la-inmunidad-antitumoral-en-el-cancer-colorrectal 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2868/el-medio-de-cultivo-de-celulas-madre-hematopoyeticas-induce-una-excesiva-fision-mitocondrial-a-traves-de-drp-1-para-atacar-el-cancer-colorrectal 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/2795/el-estado-de-p53-y-p21-influye-en-la-respuesta-celular-a-la-metformina-en-las-celulas-de-cancer-colorrectal-hct116-con-mutacion-en-el-gen-kras 2026-08-04 monthly 0.5 https://crcwarriors.org/articulo/2827/ceus-con-microburbujas-dirigidas-al-vegfr2-para-el-seguimiento-de-los-efectos-tempranos-de-la-inmunoterapia-en-un-modelo-de-cancer-colorrectal 2026-08-03 monthly 0.5 https://crcwarriors.org/articulo/2842/un-catalogo-de-firmas-mutacionales-en-diversos-tipos-de-cancer-basado-en-datos-del-mundo-real-que-incluye-111-711-tumores 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2855/las-mutaciones-de-mll4-kmt2d-aumentan-la-actividad-inmunitaria-y-predicen-la-eficacia-terapeutica-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2800/terapia-de-reintroduccion-nuevas-perspectivas-en-el-tratamiento-del-cancer 2026-08-02 monthly 0.5 https://crcwarriors.org/articulo/2816/pyra-metho-carnil-suprime-la-infiltracion-de-macrofagos-asociada-a-cd73-en-el-cancer-colorrectal-con-mutacion-en-kras 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/1290/entendimiento-actual-y-manejo-de-la-metastasis-cerebral-del-cancer-colorrectal-una-revision 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2841/las-alteraciones-en-el-microbioma-intestinal-humano-durante-la-quimioterapia-contra-el-cancer-dependen-de-la-dieta 2026-08-05 monthly 0.5 https://crcwarriors.org/articulo/2337/impacto-de-la-certificacion-del-oncologo-medico-en-los-resultados-de-supervivencia-en-el-cancer-colorrectal-metastasico-evidencia-del-estudio-observacional-scrum-japan-monstar-screen 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2860/asociaciones-entre-la-edad-y-las-caracteristicas-genomicas-tumorales-en-canceres-recurrentes-refractarios-analizados-mediante-el-ensayo-del-panel-de-genes-diana-del-estudio-nci-match 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2095/el-aprendizaje-profundo-consciente-de-firmas-revela-distintos-programas-de-genes-conductores-y-procesos-mutacionales-en-glioblastoma-y-adenocarcinoma-de-colon 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2096/descifrando-la-heterogeneidad-de-las-celulas-del-cancer-colorrectal-identificacion-de-biomarcadores-y-subpoblaciones-celulares-impulsoras-de-la-enfermedad-mediante-scissor-y-cibersortx-en-el-analisis 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/2352/timel-la-integracion-de-aprendizaje-profundo-y-metodos-estadisticos-revela-patrones-espaciales-del-estroma-y-del-sistema-inmunitario-en-el-cancer-colorrectal-agresivo 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2886/comparacion-de-la-trombocitopenia-y-la-esplenomegalia-en-pacientes-con-cancer-colorrectal-localmente-avanzado-que-reciben-terapia-neoadyuvante-total-con-y-sin-inmunoterapia 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2631/evaluacion-mediante-resonancia-magnetica-con-difusion-y-secuencias-en-fase-cest-mri-del-cancer-colorrectal-localmente-avanzado-con-pmmr-para-predecir-el-estado-de-activacion-inmune-tras-la 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2380/terapia-dirigida-a-braf-en-tumores-no-melanoma-con-mutacion-braf-una-revision-sistematica-de-la-eficacia-que-es-amplia-pero-modulada-segun-el-tipo-histologico 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2894/la-densidad-de-celulas-tumorales-cuantificada-mediante-inteligencia-artificial-se-asocia-con-un-beneficio-diferencial-del-tratamiento-quimiorradiante-basado-en-irinotecan-en-el-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2639/larotrectinib-en-el-tratamiento-adyuvante-y-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-metastasico-con-fusion-de-ntrk 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2389/inmunoterapia-y-toma-de-decisiones-quirurgicas-en-el-cancer-colorrectal-asociado-al-sindrome-de-lynch-implicaciones-para-el-manejo-personalizado-y-la-revision-de-las-guias-clinicas 2026-08-26 monthly 0.5 https://crcwarriors.org/articulo/2901/la-inhibicion-de-cdk9-sensibiliza-a-las-celulas-de-cancer-colorrectal-con-mutacion-braf-v600e-que-son-intrinsecamente-resistentes-a-los-inhibidores-de-braf 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2647/implante-de-doble-capa-impreso-en-3d-optimizado-mediante-inteligencia-artificial-solucion-al-dilema-de-la-administracion-secuencial-de-quimioterapia-e-inmunoterapia-en-la-metastasis-peritoneal-del 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/2393/diferencias-raciales-y-etnicas-en-los-resultados-del-cribado-del-cancer-de-prostata-en-los-estados-unidos-un-analisis-secundario-del-ensayo-sobre-el-cancer-de-prostata-pulmon-colon-y-ovario 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2398/evaluacion-de-la-mesotelina-como-un-blanco-inmunoterapeutico-para-las-celulas-t-endogenas 2026-08-01 monthly 0.5 https://crcwarriors.org/articulo/2655/dos-lineas-celulares-dos-historias-caracterizacion-de-la-eficacia-diferencial-de-los-farmacos-de-molecula-pequena-cediranib-y-nu-7441-en-el-cancer-colorrectal-primario-frente-al-metastasico 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/2400/erlotinib-mas-bevacizumab-en-tumores-solidos-metastasicos-con-amplificacion-de-egfr-resultados-del-estudio-kosmos-i-ii-que-evalua-la-terapia-guiada-por-el-perfilado-molecular-en-canceres-avanzados 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2658/6ppdq-favorece-la-progresion-maligna-del-cancer-colorrectal-al-potenciar-la-senalizacion-de-egf-egfr 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2405/eficacia-y-seguridad-comparativas-de-los-tratamientos-de-primera-linea-para-el-cancer-colorrectal-metastasico-con-ras-tipo-salvaje-una-revision-sistematica-y-un-metaanalisis-de-red 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2155/eficacia-de-la-dieta-mediterranea-para-la-prevencion-primaria-de-enfermedades-oncologicas-una-revision-sistematica-y-metaanalisis-que-se-incluye-en-las-guias-nacionales-italianas-la-dieta-mediterranea 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2420/la-cefarantina-induce-la-muerte-celular-inmunogenica-en-tumores-solidos-al-suprimir-la-expresion-de-la-poli-adp-ribosa-polimerasa-1-mediada-por-la-proteina-quinasa-c-zeta-y-presenta-una-accion 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2940/cancer-colorrectal-de-aparicion-precoz-con-metastasis-exclusivas-en-el-higado-un-estudio-de-cohorte-retrospectivo-que-integra-datos-clinicos-y-moleculares-del-mundo-real-recopilados-de-forma 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2705/oncologia-de-precision-de-ultima-generacion-en-el-cancer-colorrectal-con-estabilidad-en-los-microsatelites-enfoque-integrado-que-va-mas-alla-de-ras-y-raf 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2709/aplicaciones-del-aprendizaje-profundo-en-el-tratamiento-del-cancer-prediccion-base-de-investigacion-exhaustiva-para-una-revision-sistematica-y-un-metaanalisis 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2715/valor-pronostico-y-perfil-transcriptomico-espacial-de-los-patrones-de-crecimiento-histopatologicos-en-metastasis-hepaticas-sincronicas-de-cancer-colorrectal 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/2720/terapia-neoadyuvante-total-frente-a-quimiorradioterapia-neoadyuvante-estandar-para-el-cancer-colorrectal-localmente-avanzado-una-revision-sistematica-y-metaanalisis-de-los-resultados-a-largo-plazo 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2212/metastasis-hepaticas-de-cancer-colorrectal-estrategias-de-imagen-para-el-diagnostico-la-planificacion-del-tratamiento-local-y-la-evaluacion-de-la-respuesta-al-tratamiento-sistemico 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2727/biomarcadores-multiomicos-de-la-respuesta-al-tratamiento-neoadyuvante-en-el-cancer-de-recto-una-revision-narrativa 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2745/aspirina-como-terapia-adyuvante-para-el-cancer-colorrectal-con-tumores-con-mutacion-en-pik3ca-y-sobreexpresion-de-cox-2-el-estudio-de-investigacion-traslacional-ascolt-y-metaanalisis 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2495/descifrando-los-mecanismos-funcionales-de-eif3f-en-los-tumores-y-explorando-terapias-dirigidas 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2497/el-anticuerpo-anti-tigit-30-278-igg1-rmd-con-una-fraccion-cristalizable-fc-mejorada-amplifica-la-inmunidad-antitumoral-mediante-la-activacion-de-las-celulas-efectoras-y-presenta-una-accion-sinergica 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2243/sotorasib-en-combinacion-con-3-metiladenina-para-el-tratamiento-del-cancer-de-pancreas-con-mutacion-kras-g12c-y-sus-mecanismos-subyacentes 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/3016/la-metformina-mejora-la-respuesta-patologica-en-pacientes-no-diabeticos-con-cancer-de-recto-que-se-someten-a-quimiorradioterapia-neoadyuvante-un-ensayo-clinico-aleatorizado-y-controlado 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2250/caracterizacion-espectroscopica-raman-de-los-cambios-proteicos-inducidos-por-el-5-fluorouracilo-en-celulas-de-cancer-de-colon 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2764/nanoplataforma-probiotica-modificada-geneticamente-para-la-terapia-del-cancer-colorrectal-mediante-ultrasonido-que-permite-la-administracion-dirigida-la-modulacion-inmune-y-la-inhibicion-de-la 2026-07-26 monthly 0.5 https://crcwarriors.org/articulo/3022/un-meroterpenoide-de-origen-marino-inhibe-el-cancer-colorrectal-mediante-la-modulacion-de-la-via-pi3k-en-ratones 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2769/transportador-de-glucosa-1-en-la-salud-y-la-enfermedad 2026-07-26 monthly 0.5 https://crcwarriors.org/articulo/1498/una-plataforma-nano-basada-en-manganeso-que-aprovecha-los-efectos-quimiodynammaticos-y-adjutivos-para-la-vacunacion-in-situ-contra-el-cancer-colorrectal 2026-08-05 monthly 0.5 https://crcwarriors.org/articulo/2780/la-apigenina-7-glucosido-reprograma-el-metabolismo-tumoral-y-mejora-la-eficacia-de-la-inmunoterapia-en-el-cancer-colorrectal-a-traves-de-dlx5 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/2286/secuenciacion-rapida-de-proxima-generacion-in-situ-an-alternative-to-single-gene-and-send-out-testing-in-non-small-cell-lung-cancer-and-colorectal-cancer-in-a-community-pathology-laboratory-setting 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2805/expresion-de-ubc9-y-pi3k-en-el-cancer-colorrectal-posible-papel-pronostico 2026-08-30 monthly 0.5 https://crcwarriors.org/articulo/2811/resultados-de-supervivencia-en-pod1um-303-interaact-2-un-estudio-de-fase-iii-de-retifanlimab-mas-carboplatino-paclitaxel-en-primera-linea-de-tratamiento-para-el-cancer-anal-escamoso-avanzado 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2300/un-estudio-aleatorizado-que-compara-encorafenib-cetuximab-y-folfiri-frente-a-folfiri-con-o-sin-bevacizumab-en-cancer-colorrectal-con-mutacion-braf-v600e-cohorte-3-del-estudio-breakwater 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2831/resultados-de-una-decada-de-pruebas-geneticas-de-cancer-hereditario-en-la-poblacion-india-asiatica-estudio-retrospectivo 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2832/exploracion-de-las-interacciones-geneticas-bidireccionales-asociadas-con-caracteristicas-tumorales-especificas-en-el-cancer-colorrectal-aplicacion-de-boost-a-datos-geneticos-a-nivel-del-genoma 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2837/identificacion-de-los-focos-micrometastasicos-que-originan-la-recurrencia 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2434/estudio-de-la-proteina-ribosomica-s6-fosforilada-ps6-en-los-resultados-clinicos-de-pacientes-sometidos-a-hepatectomia-por-cancer-colorrectal-metastasico 2026-07-31 monthly 0.5 https://crcwarriors.org/articulo/2214/relacionar-la-distribucion-intestinal-con-el-mecanismo-farmacologico-la-berberina-previene-y-trata-el-cancer-colorrectal-al-dirigirse-a-sigmar1 2026-07-31 monthly 0.5 https://crcwarriors.org/articulo/1767/celulas-poliploides-y-con-aumento-del-numero-de-copias-cromosomicas-en-el-cancer-colorrectal-metastasico-correlaciones-genotipo-fenotipo-exploratorias 2026-07-31 monthly 0.5 https://crcwarriors.org/articulo/2821/la-transcriptomica-espacial-basada-en-sondas-personalizadas-permite-la-deteccion-del-microbioma-en-tejido-de-cancer-colorrectal-fijado-en-formalina-e-incluido-en-parafina-ffpe 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/1903/descubrimiento-y-evaluacion-de-la-actividad-in-vitro-e-in-vivo-de-nuevos-derivados-de-baicaleina-fosfonio-que-se-dirigen-a-la-mthfd2-mitocondrial-como-agentes-antitumores-para-el-tratamiento-del 2026-07-30 monthly 0.5 https://crcwarriors.org/articulo/2700/el-kras-mutado-suprime-la-deteccion-del-adn-al-remodelar-la-tension-de-la-membrana-para-eliminar-el-adn-tumoral-extracelular 2026-07-30 monthly 0.5 https://crcwarriors.org/articulo/2732/caracteristicas-tumorales-y-factores-predictivos-de-supervivencia-en-pacientes-con-cancer-colorrectal-experiencia-en-un-unico-centro-en-el-libano 2026-07-30 monthly 0.5 https://crcwarriors.org/articulo/2503/resultados-de-los-inhibidores-del-receptor-del-factor-de-crecimiento-epidermico-en-el-carcinoma-de-celulas-escamosas-anal-localmente-avanzado-y-metastasico-una-revision-sistematica-y-metaanalisis 2026-07-30 monthly 0.5 https://crcwarriors.org/articulo/2822/nota-de-retractacion-la-activacion-dirigida-de-la-ferroptosis-en-el-cancer-colorrectal-mediante-la-inhibicion-de-lgr4-supera-la-resistencia-adquirida-a-los-farmacos 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2830/evaluacion-del-ajuste-fino-de-cpgpt-un-modelo-preentrenado-con-arreglos-de-tejidos-basado-en-dmr-para-la-clasificacion-del-cancer-gastrointestinal-mediante-la-metilacion-dirigida-del-adn-libre-en 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2704/inhibidores-de-los-puntos-de-control-inmunitario-en-el-cancer-colorrectal-dmmr-msi-h-justificacion-avances-y-perspectivas 2026-07-29 monthly 0.5 https://crcwarriors.org/articulo/2752/desde-el-laboratorio-hasta-la-practica-clinica-avanzando-en-nuestra-comprension-de-la-radioresistencia-en-el-cancer-de-recto 2026-07-29 monthly 0.5 https://crcwarriors.org/articulo/2763/familia-de-transportadores-de-solutos-6-miembro-14-slc6a14-expresion-funcion-regulacion-e-impacto-en-la-progresion-tumoral 2026-07-29 monthly 0.5 https://crcwarriors.org/articulo/2772/bifidobacterium-probiotico-modificado-geneticamente-para-la-terapia-dirigida-al-tumor-en-el-cancer-de-pancreas 2026-07-29 monthly 0.5 https://crcwarriors.org/articulo/2781/los-efectos-inmunogenicos-de-la-hipertermia-en-un-modelo-experimental-de-metastasis-peritoneales-del-cancer-colorrectal-aumentan-la-susceptibilidad-tumoral-a-la-inmunoterapia 2026-07-29 monthly 0.5 https://crcwarriors.org/articulo/2281/la-senalizacion-de-cxcr3-favorece-el-reclutamiento-de-celulas-t-delta-one-y-la-eficacia-antitumoral-en-el-cancer-colorrectal 2026-07-29 monthly 0.5 https://crcwarriors.org/articulo/2801/el-analisis-de-perfilado-a-nivel-de-celula-unica-identifica-una-poblacion-de-neutrofilos-ccr2-asociada-con-la-metastasis-hepatica-del-cancer-colorrectal-en-un-modelo-murino 2026-07-30 monthly 0.5 https://crcwarriors.org/articulo/2814/patron-de-prescripcion-de-opioides-en-pacientes-con-cancer-de-mama-pulmon-y-colon-diagnosticados-con-dolor-cronico-preexistente-no-relacionado-con-el-cancer 2026-07-30 monthly 0.5 https://crcwarriors.org/articulo/2306/discriminacion-precisa-de-polimorfismos-de-un-solo-nucleotido-mediante-el-ensamblaje-de-sondas-de-bloqueo-mediadas-por-pna-y-la-amplificacion-por-circulo-rodante-utilizando-pna-modificado-quimicamente 2026-07-28 monthly 0.5 https://crcwarriors.org/articulo/2836/desarrollo-de-la-fase-i-de-una-herramienta-de-medicion-de-resultados-notificados-por-el-paciente-para-el-sindrome-de-reseccion-anterior-baja 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2652/la-activacion-del-ppar-sensibiliza-a-las-celulas-cancerosas-gastrointestinales-del-mss-al-bloqueo-del-pd1 2026-07-28 monthly 0.5 https://crcwarriors.org/articulo/2733/el-posible-papel-del-oligo-fucoidano-como-un-adyuvante-bioactivo-en-oncologia-una-perspectiva-personal-sobre-los-conocimientos-mecanicistas-y-la-continuidad-terapeutica 2026-07-28 monthly 0.5 https://crcwarriors.org/articulo/2746/eficacia-y-seguridad-de-la-reintroduccion-de-cetuximab-irinotecan-frente-a-regorafenib-en-cancer-colorrectal-metastasico-con-mutacion-ras-de-tipo-salvaje-un-ensayo-aleatorizado-exploratorio-de-un 2026-07-28 monthly 0.5 https://crcwarriors.org/articulo/2813/useq-cuantificacion-universal-de-la-tasa-de-mutacion-mediante-secuenciacion-profunda-de-una-unica-expansion-clonal 2026-08-29 monthly 0.5 https://crcwarriors.org/articulo/1558/resultados-en-la-practica-clinica-de-encorafenib-cetuximab-binimetinib-en-el-cancer-colorrectal-metastasico-con-mutacion-braf-el-estudio-beets-jaccro-cc-18 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/2093/toward-targeting-the-untargetable-un-conjugado-egfr-peptido-farmaco-no-canonico-logra-una-potente-actividad-antitumoral-en-el-ccr-con-mutacion-de-kras 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/2664/perfil-clinico-patologico-y-molecular-de-los-canceres-colorrectales-sincronicos-multiples-primarios-esporadicos-enfoque-en-el-estado-de-inestabilidad-de-microsatelites 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/1946/predictores-de-la-respuesta-al-bloqueo-de-los-puntos-de-control-inmunitario-en-el-cancer-colorrectal-con-dmmr-utilizando-una-plataforma-multiomica-integrada-y-mejorada-para-el-analisis-inmunitario 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/2716/linajes-moleculares-del-cancer-colorrectal-esporadico-con-deficiencia-en-la-reparacion-de-desajustes 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/2486/nt5e-favorece-la-progresion-del-cancer-colorrectal-y-se-correlaciona-con-la-expresion-de-pd-l1-evidencia-obtenida-a-partir-de-analisis-multiomicos-muestras-clinicas-y-ensayos-funcionales-celulares 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/2748/apatinib-potencia-la-inmunoterapia-dirigida-a-traves-de-la-via-il-6-gp130-pi3k-en-el-cancer-gastrico-her2-positivo 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/2812/las-celulas-tumorales-colorrectales-circulantes-remodelan-su-superficie-para-aumentar-su-viabilidad-y-su-potencial-metastasico-en-el-torrente-sanguineo 2026-08-29 monthly 0.5 https://crcwarriors.org/articulo/2815/la-deplecion-de-gaba-mediada-por-la-microbiota-en-la-obesidad-favorece-la-reprogramacion-metabolica-y-la-progresion-del-cancer-colorrectal 2026-07-30 monthly 0.5 https://crcwarriors.org/articulo/1889/dinamicas-del-adn-tumoral-circulante-en-pacientes-con-cancer-colorrectal-metastasico-limitado-al-higado-resecado-despues-del-tratamiento-sistemico-de-primera-linea 2026-07-26 monthly 0.5 https://crcwarriors.org/articulo/2619/mayor-frecuencia-de-mutaciones-subclonales-de-resistencia-a-egfr-en-las-muestras-obtenidas-tras-el-tratamiento-de-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-despues-de-recibir 2026-07-25 monthly 0.5 https://crcwarriors.org/articulo/2711/resultados-del-tratamiento-con-fruquintinib-en-combinacion-con-inhibidores-de-pd-1-en-cancer-colorrectal-avanzado-un-metaanalisis-reconstruido-a-nivel-de-paciente-a-partir-de-estudios-retrospectivos 2026-07-25 monthly 0.5 https://crcwarriors.org/articulo/2322/investigacion-de-la-eficacia-del-propranolol-en-el-tratamiento-del-estres-cronico-combinado-con-cancer-colorrectal-en-ratones-y-su-potencial-antitumoral 2026-07-24 monthly 0.5 https://crcwarriors.org/articulo/2453/inhibicion-sinergica-del-crecimiento-del-cancer-colorrectal-mediante-el-bloqueo-combinado-de-pi3k-y-cox-2-en-lineas-celulares-y-organoides-derivados-de-pacientes 2026-07-24 monthly 0.5 https://crcwarriors.org/articulo/2200/los-anticuerpos-bispecificos-dirigidos-al-tumor-inhiben-eficazmente-las-vias-oncogenicas-al-tiempo-que-minimizan-la-toxicidad 2026-07-24 monthly 0.5 https://crcwarriors.org/articulo/2264/superando-las-barreras-inmunologicas-mediadas-por-pequenas-vesiculas-extracelulares-en-el-microambiente-tumoral-mediante-peptidos-pegilados-que-se-pueden-activar-estrategicamente 2026-07-24 monthly 0.5 https://crcwarriors.org/articulo/2776/una-firma-transcripcional-de-la-perdida-de-funcion-de-lkb1-define-una-amplia-poblacion-de-pacientes-con-cancer-humano-que-podria-beneficiarse-de-terapias-dirigidas 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/2265/un-estudio-exploratorio-in-vitro-de-la-citotoxicidad-y-el-perfil-de-citoquinas-de-las-celulas-asesinas-inducidas-por-citoquinas-cik-contra-las-celulas-de-cancer-colorrectal-crc-hct-15 2026-07-24 monthly 0.5 https://crcwarriors.org/articulo/2777/supresion-de-la-inflamacion-y-evasion-del-programa-de-utilizacion-del-selenio-en-el-intestino-humano-en-el-contexto-del-cancer 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/2778/metaclaw-un-agente-de-ia-auditable-para-el-analisis-metagenomico-y-multi-omico-integral-y-multidireccional 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/2782/un-circuito-de-autoamplificacion-que-involucra-nervios-y-fibroblastos-impulsa-la-progresion-del-cancer-colorrectal 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/2787/las-mutaciones-heterocigotas-en-linea-germinal-del-gen-msh3-y-probablemente-tambien-las-mutaciones-en-el-gen-mlh3-actuan-como-supresores-tumorales-clasicos-lo-que-conlleva-un-aumento-de-las 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2788/mayor-preferencia-por-la-deteccion-de-cancer-colorrectal-mediante-analisis-de-sangre-en-la-comunidad-afroamericana 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2648/cambios-temporales-en-la-inmunidad-y-el-metabolismo-impulsan-la-eficacia-antitumoral-de-las-nanoparticulas-cargadas-con-resiquimod-en-la-carcinomatosis-peritoneal 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2649/el-glucano-de-avena-potencia-la-eficacia-de-los-inhibidores-de-pd-1-a-traves-del-butirato-y-el-acido-indol-3-propionico-derivados-de-faecalibacterium-prausnitzii 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2444/avances-en-la-evaluacion-del-estado-de-respuesta-tumoral-tras-la-terapia-neoadyuvante-para-el-cancer-de-recto 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2445/avances-en-las-estrategias-de-conversion-basadas-en-la-terapia-sistemica-para-el-cancer-colorrectal-localmente-avanzado 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2701/un-analisis-comparativo-clinico-y-molecular-del-cancer-colorrectal-con-mutaciones-en-el-exon-2-de-kras-y-en-el-exon-no-2-de-kras 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/1745/el-estudio-aleatorio-de-fase-2-arc-9-de-la-terapia-basada-en-etrumadenant-vs-regorafeno-en-pacientes-con-cancer-colorrectal-metastasico-previamante-tratado 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2272/metabolomica-asistida-por-analisis-transcriptomico-para-revelar-caracteristicas-metabolicas-y-biomarcadores-potenciales-del-cancer-colorrectal-de-aparicion-temprana 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/1763/desbloqueando-kras-navegando-su-biologia-molecular-y-paisaje-terapeutico-en-malignidades-gastrointestinales 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2794/el-supresor-tumoral-tip60-inhibe-la-senalizacion-de-torc1-en-respuesta-al-acetato-microbiano-para-promover-la-autofagia-y-la-diferenciacion-de-las-celulas-epiteliales-del-intestino 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2426/evaluacion-de-pegenzileukin-sar444245-thor-707-en-combinacion-con-pembrolizumab-o-cetuximab-en-cancer-gastrointestinal-metastasico-avanzado-el-estudio-pegathor-de-fase-ii 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/2683/manejo-de-la-trombosis-asociada-al-cancer-en-pacientes-con-canceres-gastrointestinales-aspectos-positivos-y-negativos 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/2684/variabilidad-glucemica-y-progresion-de-la-enfermedad-en-pacientes-con-cancer-colorrectal-metastasico-un-estudio-piloto-en-una-cohorte 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/2454/el-efecto-de-los-farmacos-antiinflamatorios-en-la-incidencia-del-cancer-colorrectal 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/947/conjugados-anticuerpo-peptido-como-agentes-de-inmunooncologia-en-el-cancer-colorrectal-blancos-cargas-terapeuticas-y-sinergias-terapeuticas 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/1461/busqueda-de-atencion-medica-con-sintomas-de-cancer-colorrectal-resultados-de-dos-encuestas-basadas-en-la-poblacion-danesa-en-2012-y-2022 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/2251/el-impacto-de-la-mutacion-de-apc-en-la-eficacia-de-la-terapia-anti-egfr-en-el-cancer-colorrectal-metastasico-con-ras-tipo-salvaje-un-analisis-retrospectivo 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/2786/evaluacion-de-modelos-de-lenguaje-de-gran-tamano-para-la-asistencia-en-la-preparacion-para-la-colonoscopia-correccion-y-diversidad-en-dialogos-sinteticos 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2185/la-deteccion-frecuente-de-mutaciones-en-kras-g12c-y-pik3ca-q546k-en-tumores-map-pone-de-relieve-su-papel-en-la-reclasificacion-de-variantes-mutyh-de-significado-incierto 2026-07-21 monthly 0.5 https://crcwarriors.org/articulo/2221/analisis-de-la-toxicidad-a-lo-largo-del-tiempo-de-la-terapia-de-mantenimiento-basada-en-anti-egfr-frente-a-la-estrategia-de-tratamiento-intermitente-en-el-cancer-colorrectal-metastasico-del-lado 2026-07-21 monthly 0.5 https://crcwarriors.org/articulo/2775/un-estudio-computacional-multicentrico-y-auto-supervisado-en-el-ambito-de-la-patologia-identifica-fenotipos-histomorfologicos-pronosticos-en-el-cancer-colorrectal 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/2785/la-microbiota-que-coloniza-el-tumor-diferencia-el-cancer-colorrectal-de-inicio-temprano-y-el-de-inicio-tardio-en-una-cohorte-de-pacientes-hispanos-latinos 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2691/la-polarizacion-de-los-macrofagos-como-objetivo-para-la-optimizacion-del-tratamiento-del-cancer-colorrectal-una-revision-sistematica 2026-07-20 monthly 0.5 https://crcwarriors.org/articulo/2512/el-pai-1-derivado-de-las-celulas-asociadas-al-cancer-actua-como-ligando-de-egfr-y-promueve-el-crecimiento-del-cancer-de-pancreas-con-mutaciones-en-kras 2026-07-20 monthly 0.5 https://crcwarriors.org/articulo/2484/impacto-clinico-del-estado-de-mutacion-del-homologo-del-oncogen-viral-del-sarcoma-de-la-rata-de-kirsten-kras-en-los-patrones-de-recidiva-y-en-la-eficacia-del-tratamiento-local-tras-una-hepatectomia 2026-07-19 monthly 0.5 https://crcwarriors.org/articulo/2728/desigualdades-en-la-deteccion-del-cancer-colorrectal-combinacion-de-maihda-con-el-metodo-de-diferencias-en-diferencias-para-evaluar-los-efectos-de-los-programas-en-los-diferentes-subgrupos-de-la 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2331/de-la-dosis-a-la-exposicion-una-nueva-perspectiva-sobre-los-fluoropirimidinicos-como-posibles-moduladores-de-los-puntos-de-control-inmunitario-en-los-canceres-gastrointestinales 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2370/un-mecanismo-dual-de-evasion-inmune-moldea-el-panorama-genetico-e-inmunogenico-de-los-tumores-colorrectales-con-deficiencia-en-la-reparacion-de-errores 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2637/rbmx-favorece-la-metastasis-hepatica-del-cancer-colorrectal-al-estabilizar-el-arnm-de-mthfd2-y-regular-la-homeostasis-redox 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2144/terapia-con-celulas-v1t-car-alogenicas-dirigidas-contra-b7-h3-en-tumores-solidos-avanzados-un-estudio-de-fase-i 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2657/optimizacion-de-las-terapias-de-tercera-linea-y-posteriores-para-el-cancer-colorrectal-metastasico-en-taiwan-un-consenso-basado-en-la-evidencia 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2671/fusobacterium-nucleatum-y-respuesta-al-tratamiento-en-el-cancer-de-colon-y-recto-una-revision-sistematica 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/1943/bi-905711-un-anticuerpo-bispecifico-trailr2-cdh17-solo-o-en-combinacion-con-quimioterapia-para-pacientes-con-canceres-gastrointestinales-avanzados-hallazgos-del-estudio-fase-i 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2726/prevalencia-y-factores-asociados-con-el-retraso-en-el-tratamiento-en-pacientes-con-cancer-colorrectal-del-hospital-nacional-de-referencia-mulago-y-del-instituto-de-cancer-de-uganda-un-estudio 2026-07-18 monthly 0.5 https://crcwarriors.org/articulo/2729/la-remodelacion-epigenetica-impulsada-por-il-26-favorece-la-evasion-inmune-en-el-cancer-colorrectal 2026-07-19 monthly 0.5 https://crcwarriors.org/articulo/2730/asb2-inhibe-la-acumulacion-de-lipidos-para-promover-la-homeostasis-y-la-inmunidad-antitumoral-de-las-celulas-ilc1-en-el-higado-del-raton 2026-07-19 monthly 0.5 https://crcwarriors.org/articulo/2731/identificacion-de-los-dominios-de-uhrf1-que-contribuyen-al-mantenimiento-de-la-metilacion-del-adn-y-las-propiedades-oncogenicas-en-el-cancer-de-colon-humano 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2741/el-aprendizaje-automatico-que-combina-la-prueba-de-sangre-oculta-en-heces-fit-con-hasta-1-025-variables-clinicas-ofrece-una-reduccion-limitada-en-el-numero-de-derivaciones-pero-podria-permitir-un 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/2628/una-firma-bacteriana-virulenta-se-asocia-con-el-desarrollo-de-recurrencia-tras-la-cirugia-de-cancer-colorrectal 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/1424/radioinmunoterapia-predirigida-basada-en-203-212-pb-dota-en-ratones-desnudos-con-xenoinjertos-humanos-de-cancer-colorrectal-establecidos-en-estudios-preclinicos 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2207/estudio-mecanicista-de-la-regulacion-farmacodinamica-en-la-tumorigenesis-modificacion-epigenetica-de-enzimas-clave-mediante-componentes-activos-de-ginsenosidos 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2725/bacterias-sulfidogenicas-y-el-riesgo-de-cancer-colorrectal 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/935/degradacion-dirigida-de-acido-hialuronico-mejoro-la-inhibicion-del-crecimiento-tumoral-en-modelos-de-cancer-gastrointestinal 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2641/la-inhibicion-de-klrg1-aumenta-la-eficacia-de-la-terapia-con-celulas-nk-car-contra-el-cancer-de-colon-a-traves-de-la-via-de-senalizacion-shp-2-zap-70-nf-b 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/866/una-conversion-de-estado-celular-plastica-de-emp1-a-lgr5-como-bypass-a-la-inhibicion-farmacologica-del-krasg12d-en-cancer-colorrectal-metastasico 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/2697/evaluacion-de-la-viabilidad-y-los-efectos-preliminares-del-entrenamiento-con-ejercicios-de-resistencia-y-la-suplementacion-con-creatina-en-pacientes-tratados-por-cancer-colorrectal 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2713/microrobots-multiestadio-con-liberacion-dependiente-del-ph-de-nanoparticulas-recubiertas-con-membrana-plaquetaria 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2468/arquetipos-inmunitarios-espaciales-en-el-cancer-gastrico-y-colorrectal-un-marco-conceptual-propuesto-para-la-resistencia-a-la-inmunoterapia-y-la-remodelacion-terapeutica 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/2724/el-destino-de-las-celulas-madre-epiteliales-determina-la-respuesta-a-la-quimiorradioterapia-en-el-cancer-de-recto 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2734/nanoparticulas-de-il-2-de-alta-densidad-con-tipo-salvaje-potencian-preferentemente-la-expansion-de-las-celulas-t-cd8-y-reprograman-el-microambiente-tumoral 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/2735/el-metabolito-de-folato-derivado-del-microbioma-intestinal-suprime-la-progresion-del-cancer-colorrectal 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/2740/utilizacion-de-datos-fragmentados-para-caracterizar-el-uso-de-los-servicios-de-atencion-medica-en-la-comunidad 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1274/evaluacion-preliminar-de-la-validez-externa-del-beneficio-de-trasplante-en-el-mundo-real-en-metastasis-hepaticas-irresecables-de-colon-recto-una-evaluacion-preliminar-de-la-validez-externa-del-ensayo 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/2688/deberian-las-pruebas-de-deteccion-temprana-de-multiples-tipos-de-cancer-sustituir-a-las-pruebas-de-deteccion-de-cancer-colorrectal-recomendadas-por-las-guias-clinicas-un-analisis-comparativo-mediante 2026-08-15 monthly 0.5 https://crcwarriors.org/articulo/2689/la-variacion-genetica-en-19q13-33-confiere-riesgo-de-cancer-colorrectal-a-traves-de-la-interaccion-entre-la-expresion-mucosa-de-fut2-y-los-niveles-de-vitamina-b12-en-plasma 2026-08-15 monthly 0.5 https://crcwarriors.org/articulo/2693/analisis-integrador-de-los-biomarcadores-proteoliticos-circulantes-y-el-panorama-genomico-en-el-cancer-colorrectal 2026-08-16 monthly 0.5 https://crcwarriors.org/articulo/2712/las-celulas-cancerosas-persistentes-activan-los-receptores-nmdar-para-sobrevivir-a-la-ferroptosis 2026-08-17 monthly 0.5 https://crcwarriors.org/articulo/2508/la-volumetria-tumoral-y-de-organos-basada-en-inteligencia-artificial-predice-la-progresion-temprana-tras-la-radioembolizacion-con-y-90-en-la-enfermedad-metastasica-con-predominio-hepatico 2026-07-14 monthly 0.5 https://crcwarriors.org/articulo/2677/la-concordancia-relacionada-con-el-huesped-de-tac-sarifa-en-los-carcinomas-dobles-y-triples-de-colon-sugiere-una-reprogramacion-metabolica-especifica-del-paciente 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/2696/la-invasion-microbiana-y-la-inmunosupresion-impulsan-la-progresion-de-los-adenomas-en-las-primeras-etapas-del-desarrollo-del-cancer-colorrectal 2026-08-16 monthly 0.5 https://crcwarriors.org/articulo/1697/herramientas-moleculares-para-el-cribado-el-pronostico-y-la-prediccion-en-el-cancer-colorrectal-avances-recientes-en-el-contexto-clasico 2026-07-12 monthly 0.5 https://crcwarriors.org/articulo/2277/accion-fotocitotoxica-de-un-colorante-cianinico-con-dos-cromoforos-formacion-del-radical-anion-superoxido 2026-07-12 monthly 0.5 https://crcwarriors.org/articulo/1046/descubrimiento-de-n8-un-nuevo-inhibidor-de-ikk-con-potente-actividad-antitumoral-a-traves-de-la-citotoxicidad-la-supresion-de-la-migracion-y-la-modulacion-de-la-autofagia 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/2673/el-cancer-colorrectal-aprovecha-un-programa-de-cicatrizacion-de-heridas-epidermicas-durante-la-metastasis-para-generar-celulas-tumorales-diseminadas 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/2226/preactivacion-con-citocinas-y-citotoxicidad-celular-dependiente-de-anticuerpos-adcc-una-estrategia-eficaz-para-potenciar-las-funciones-efectoras-de-las-celulas-nk-humanas-frente-a-modelos-tumorales 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/526/el-receptor-2-del-factor-de-crecimiento-epidermico-humano-como-diana-de-1-2-3-4-6-penta-o-galoil-d-glucosa-en-el-cancer-de-colon 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2630/infeccion-activa-por-helicobacter-pylori-y-resultados-en-la-supervivencia-en-pacientes-con-cancer-colorrectal-metastasico-de-novo-un-estudio-de-cohortes-retrospectivo 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/857/mutaciones-de-ras-en-cancer-colorrectal-avanzado-mecanismos-implicaciones-clinicas-y-nuevas-aproximaciones-terapeuticas 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2674/plasticidad-progresiva-de-las-celulas-tumorales-intestinales-activacion-de-myc-y-perdida-del-compromiso-de-la-linea-celular-troncal-tumoral-lgr5-tras-la-deplecion-de-wnt 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/2680/priorizacion-computacional-autonoma-de-las-vulnerabilidades-del-cancer-colorrectal-mediante-enjambres-de-inteligencia-artificial-multiescala 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/2183/las-mutaciones-de-kras-y-braf-modifican-los-resultados-de-la-quimioterapia-adyuvante-en-el-cancer-colorrectal-en-estadio-temprano 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2695/el-analisis-integrador-de-los-estados-transcriptomicos-del-tcga-y-las-dependencias-de-depmap-permite-establecer-un-orden-de-prioridad-de-las-vulnerabilidades-candidatas-en-el-cancer-colorrectal 2026-08-16 monthly 0.5 https://crcwarriors.org/articulo/2450/diferente-agresividad-molecular-y-clinica-en-el-cancer-colorrectal-metastasico-de-aparicion-muy-temprana-supervivencia-y-divergencia-genomica-entre-pacientes-de-30-a-39-anos-frente-a-pacientes-de-40 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2224/alteracion-del-ritmo-circadiano-en-el-cancer-colorrectal-la-cronoterapia-como-una-prometedora-estrategia-de-medicina-de-precision 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2493/las-celulas-t-nmb-cxcl13-cd4-producen-neuromedina-b-lo-que-promueve-la-senescencia-y-la-malignidad-de-las-celulas-malignas-positivas-para-el-receptor-1-de-la-neuropeptida-s 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2494/la-senalizacion-mediada-por-vesiculas-extracelulares-en-el-cancer-impulsada-por-la-obesidad-aspectos-mecanisticos-e-implicaciones-clinicas 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2262/sintilimab-mas-fruquintinib-con-o-sin-radioterapia-como-tratamiento-de-tercera-linea-para-el-cancer-colorrectal-con-metastasis-hepaticas-protocolo-de-estudio-para-un-ensayo-aleatorizado-multicentrico 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2126/evaluaciones-pragmaticas-de-tecnologias-sanitarias-de-biosimilares-un-estudio-piloto-sobre-el-uso-de-bevacizumab-en-el-cancer-colorrectal-para-nice 2026-07-09 monthly 0.5 https://crcwarriors.org/articulo/2651/pkn2-regula-las-uniones-celulares-para-limitar-la-colitis 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/2660/un-espacio-funcional-de-cinco-dimensiones-para-caracterizar-los-transcriptomas-de-enfermedades 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2661/las-mutaciones-mh2-de-smad4-alteran-el-reclutamiento-de-crebbp-ep300-y-la-transcripcion-inducida-por-tgf-en-el-cancer-colorrectal 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2662/el-empalme-aberrante-del-3-utr-impulsa-la-formacion-de-condensados-de-arnm-dependientes-de-fus-e-impide-que-la-catenina-se-desplace-desde-las-uniones-adherentes-lo-que-promueve-la-agresividad-del 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2694/la-caracterizacion-comparativa-de-oncopro-tm-y-los-medios-de-cultivo-basados-en-wnt-revela-distintos-estados-fenotipicos-y-farmacologicos-en-los-organoides-tumorales-derivados-de-pacientes 2026-08-16 monthly 0.5 https://crcwarriors.org/articulo/2443/analisis-de-los-factores-de-riesgo-para-complicaciones-anastomoticas-graves-a-largo-plazo-tras-la-cirugia-de-cancer-de-recto 2026-07-09 monthly 0.5 https://crcwarriors.org/articulo/917/la-terapia-neoadyuvante-triple-que-combina-el-bloqueo-de-los-puntos-de-control-inmunitarios-la-terapia-antiangiogenica-y-la-quimioterapia-mejora-la-respuesta-patologica-y-la-supervivencia-en-el 2026-07-09 monthly 0.5 https://crcwarriors.org/articulo/2076/correlacion-entre-el-reconocimiento-de-organoides-tumorales-autologos-por-los-linfocitos-infiltrantes-tumorales-procedentes-de-canceres-epiteliales-metastasicos-y-la-respuesta-clinica 2026-07-08 monthly 0.5 https://crcwarriors.org/articulo/1847/sobreexpresion-de-arnm-de-cxcr4-un-indicador-de-mal-pronostico-y-predictor-de-respuesta-a-inhibidores-de-puntos-de-control-inmunitarios-en-pacientes-con-cancer-colorrectal-metastasico 2026-07-08 monthly 0.5 https://crcwarriors.org/articulo/2117/diferencias-en-las-densidades-de-celulas-t-y-en-los-patrones-de-vecindad-en-adenomas-y-lesiones-serradas-sesiles-de-cancer-colorrectal-humano 2026-07-08 monthly 0.5 https://crcwarriors.org/articulo/2377/biomarcadores-emergentes-para-la-deteccion-precoz-del-cancer-colorrectal 2026-07-08 monthly 0.5 https://crcwarriors.org/articulo/2650/la-prostaglandina-estromal-es-un-regulador-espacial-dominante-de-la-plasticidad-del-destino-celular-en-el-cancer-colorrectal 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/2678/los-nanocristales-vs1-recubiertos-con-albumina-permiten-la-inhibicion-de-stard3-y-potencian-la-terapia-con-fluoropirimidinas-en-el-cancer-colorrectal 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/2679/el-envejecimiento-restringe-el-crecimiento-tumoral-del-cancer-colorrectal-mediante-la-represion-epigenetica-de-los-programas-genicos-del-desarrollo 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/1948/factores-predictivos-de-mortalidad-temprana-tras-el-inicio-del-tratamiento-con-regorafenib-o-trifluridina-tipiracil-en-el-cancer-colorrectal-metastasico 2026-07-08 monthly 0.5 https://crcwarriors.org/articulo/2634/diferentes-genotipos-de-cancer-colorrectal-influyen-en-los-ecosistemas-microbianos-y-revelan-las-dependencias-de-la-microbiota-especificas-de-cada-etapa 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2642/la-colangitis-esclerosante-primaria-presenta-una-topografia-de-la-mucosa-colica-distinta-pero-comparte-un-estado-de-las-celulas-mastocitarias-con-la-colitis-ulcerosa 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2162/mutaciones-oncogenicas-frecuentes-en-el-cancer-colorrectal-factores-clave-en-la-carcinogenesis-y-posibles-dianas-terapeuticas 2026-07-07 monthly 0.5 https://crcwarriors.org/articulo/2034/proteina-quinasa-2-que-interactua-con-el-receptor-ripk2-aspectos-estructurales-funciones-fisiopatologicas-y-avances-en-la-quimica-medicinal-para-el-diseno-de-inhibidores 2026-07-07 monthly 0.5 https://crcwarriors.org/articulo/1781/diferencias-entre-sexos-en-la-eficacia-y-la-toxicidad-del-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico-un-analisis-de-18-041-pacientes-en-la-base-de-datos-arcad-crc 2026-07-07 monthly 0.5 https://crcwarriors.org/articulo/1288/la-inmunizacion-oral-con-la-vacuna-de-listeria-monocytogenes-potencia-la-inmunoterapia-para-la-inmunidad-protectora-en-modelos-murinos-de-cancer-colorrectal 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/2626/investigacion-del-metabolismo-del-triptofano-en-el-cancer-colorrectal-mediante-la-secuenciacion-de-arn-de-celulas-individuales-utilizando-tecnicas-de-aprendizaje-automatico 2026-07-07 monthly 0.5 https://crcwarriors.org/articulo/2669/prediccion-de-mutaciones-geneticas-en-el-cancer-de-colon-mediante-el-aprendizaje-de-dependencias-temporales-a-largo-plazo-en-un-grafo-dirigido-de-asimetria-de-coocurrencia 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2437/evaluacion-temporal-de-la-mutacion-ras-mediante-biopsia-liquida-en-el-momento-de-la-progresion-tras-el-tratamiento-con-bevacizumab-en-pacientes-con-cancer-colorrectal-metastasico 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/2438/vacuna-peptidica-mutante-de-kras-con-bloqueo-dual-de-puntos-de-control-en-cancer-colorrectal-metastasico-un-ensayo-de-fase-i 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/403/la-cetuximab-aumenta-la-expresion-de-lgr5-y-potencia-la-eficacia-del-conjugado-anticuerpo-peptido-dirigido-a-lgr5-en-modelos-de-cancer-colorrectal-derivados-de-pacientes 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/2244/comprender-las-promesas-y-los-desafios-de-la-terapia-independiente-del-tipo-de-tumor-podria-una-unica-opcion-terapeutica-ser-realmente-adecuada-para-todos-los-pacientes 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/2112/el-ensayo-sherpa-un-estudio-de-fase-i-que-combina-el-inhibidor-de-shp2-rmc-4630-y-el-inhibidor-de-erk-ly3214996-en-pacientes-con-cancer-de-pancreas-cancer-de-pulmon-no-microcitico-y-cancer 2026-07-05 monthly 0.5 https://crcwarriors.org/articulo/2624/la-induccion-microbiana-de-la-expresion-de-mhc-ii-en-las-celulas-de-cancer-de-colon-supera-la-resistencia-a-la-inmunoterapia-y-limita-la-metastasis 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/2625/los-canceres-colorrectales-con-distinto-potencial-metastasico-desencadenan-respuestas-tempranas-divergentes-de-las-celulas-t 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/2632/un-metodo-solido-y-libre-de-celulas-para-el-analisis-del-arn-para-la-deteccion-temprana-del-cancer-colorrectal 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2633/los-fibroblastos-fap-positivos-presentes-en-polipos-hiperplasicos-de-colon-analizados-por-expertos-identifican-a-pacientes-con-un-mayor-riesgo-de-desarrollar-adenomas-metacronicos-un-estudio 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2383/mejora-de-la-respuesta-inmunoterapeutica-en-el-cancer-colorrectal-mediante-un-peptido-tumoral-que-penetra-en-el-tumor-y-se-dirige-a-la-neuropilina-1 2026-07-04 monthly 0.5 https://crcwarriors.org/articulo/2520/la-reprogramacion-del-inmunometabolismo-de-los-macrofagos-mediante-el-antagonismo-de-la-glutamina-potencia-la-terapia-del-cancer-colorrectal-en-ratones 2026-07-18 monthly 0.5 https://crcwarriors.org/articulo/2110/las-mutaciones-que-son-el-objetivo-de-la-inmunoterapia-nous-209-aparecen-en-las-primeras-etapas-de-las-lesiones-precancerosas-de-los-portadores-del-sindrome-de-lynch-que-presentan-inestabilidad-de 2026-07-03 monthly 0.5 https://crcwarriors.org/articulo/2173/un-ensayo-clinico-nacional-multicentrico-aleatorizado-controlado-de-grupos-paralelos-de-fase-iii-que-compara-el-tratamiento-neoadyuvante-con-folfoxiri-y-quimiorradioterapia-frente-al-tratamiento 2026-07-03 monthly 0.5 https://crcwarriors.org/articulo/2189/comentarios-sobre-el-articulo-titulado-el-potencial-diagnostico-de-los-compuestos-organicos-volatiles-en-la-orina-para-la-deteccion-de-neoplasias-colorrectales-en-el-sindrome-de-lynch-un-estudio 2026-07-03 monthly 0.5 https://crcwarriors.org/articulo/2507/bacterias-depredadoras-como-miembros-de-los-microbiomas-humanos-y-su-impacto-en-la-diversidad-y-la-homeostasis-intestinal 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2511/aprendizaje-de-representacion-grafica-multimodal-para-la-identificacion-de-celulas-malignas-a-partir-de-datos-de-secuenciacion-de-arn-de-celulas-individuales-scrna-seq-mediante-deepmalignant 2026-08-05 monthly 0.5 https://crcwarriors.org/articulo/2378/beclin-1-como-biomarcador-de-la-autofagia-en-el-cancer-colorrectal 2026-07-02 monthly 0.5 https://crcwarriors.org/articulo/1413/raros-pero-tratables-nuevas-perspectivas-sobre-los-carcinomas-ampulares 2026-07-02 monthly 0.5 https://crcwarriors.org/articulo/2489/adn-tumoral-circulante-en-pacientes-con-cancer-colorrectal-sometidos-a-cirugia-de-metastasis-hepaticas-con-intencion-curativa-en-francia-un-protocolo-de-estudio-de-cohortes-prospectivo-y 2026-07-03 monthly 0.5 https://crcwarriors.org/articulo/2501/patrones-espacio-temporales-y-prediccion-de-la-mortalidad-por-cancer-colorrectal-en-areas-chinas-de-registro-de-cancer-un-estudio-a-nivel-nacional-basado-en-multiples-modelos 2026-07-03 monthly 0.5 https://crcwarriors.org/articulo/2506/tendencias-del-cancer-en-inglaterra-en-adultos-jovenes-entre-2001-y-2023-comparacion-de-la-incidencia-la-mortalidad-y-el-estadio-al-momento-del-diagnostico 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/1780/aflibercept-y-5-fu-frente-a-folfox-como-tratamiento-de-primera-linea-para-pacientes-ancianos-o-fragiles-con-cancer-colorrectal-metastasico-el-ensayo-aleatorizado-de-fase-ii-aio-ikf-elderly-aio-krk 2026-07-02 monthly 0.5 https://crcwarriors.org/articulo/2559/el-analisis-mutacional-revela-que-el-complejo-de-destruccion-de-la-via-wnt-se-autorregula-mediante-un-mecanismo-asistido-por-sustrato 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2310/kras-g12r-en-el-cancer-de-pancreas-por-que-esta-mutacion-resiste-a-las-estrategias-inhibidoras-actuales 2026-07-01 monthly 0.5 https://crcwarriors.org/articulo/1289/caracteristicas-moleculares-y-clinicas-asi-como-resultados-del-tratamiento-en-163-casos-de-carcinomas-neuroendocrinos-metastasicos-de-colon-con-una-comparacion-con-los-adenocarcinomas-de-colon 2026-07-01 monthly 0.5 https://crcwarriors.org/articulo/2327/la-carga-mutacional-tumoral-evaluada-en-tejidos-y-sangre-predice-la-respuesta-al-tratamiento-con-inhibidores-de-pd-1-en-el-carcinoma-de-celulas-escamosas-de-cabeza-y-cuello-una-revision-sistematica-y 2026-07-07 monthly 0.5 https://crcwarriors.org/articulo/2341/vasculatura-funcional-en-organoides-tumorales-facilitando-la-medicina-de-precision-en-oncologia 2026-06-12 monthly 0.5 https://crcwarriors.org/articulo/2871/analisis-de-coste-efectividad-de-nivolumab-mas-ipilimumab-frente-a-nivolumab-en-monoterapia-en-pacientes-con-cancer-colorrectal-metastasico-previamente-tratados-y-con-deficiencia-en-la-reparacion-del 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2361/analisis-de-los-factores-de-riesgo-y-las-diferencias-sexuales-en-el-cancer-colorrectal-hallazgos-basados-en-la-evidencia-actual 2026-07-01 monthly 0.5 https://crcwarriors.org/articulo/2362/los-degradadores-moleculares-que-se-unen-a-hur-suprimen-el-cancer-colorrectal-con-mutacion-en-el-gen-braf 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2622/evaluacion-comparativa-de-los-niveles-sericos-de-peroxiredoxina-2-prdx2-peroxiredoxina-4-prdx4-y-de-la-metil-septina-9-plasmatica-msept9-frente-a-los-biomarcadores-convencionales-para-la-deteccion 2026-07-12 monthly 0.5 https://crcwarriors.org/articulo/1861/ensayos-clinicos-que-cambian-la-practica-en-canceres-gastrointestinales-en-asco-2025-una-revision-critica-y-contexto-clinico 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2373/el-papel-pronostico-de-la-inflamacion-postoperatoria-tras-la-reseccion-minimamente-invasiva-del-cancer-colorrectal 2026-07-07 monthly 0.5 https://crcwarriors.org/articulo/2374/los-subtipos-moleculares-consensuados-proporcionan-informacion-para-la-seleccion-del-agente-en-la-quimioterapia-hipertermia-intraperitoneal-hipec-en-las-metastasis-peritoneales-del-cancer-colorrectal 2026-07-02 monthly 0.5 https://crcwarriors.org/articulo/1607/aplicar-reguladores-nanomimeticos-para-fototerapia-in-situ-y-regulacion-de-lactato-con-el-fin-de-amplificar-la-terapia-inmunitaria-cuproptosis 2026-07-09 monthly 0.5 https://crcwarriors.org/articulo/2379/dirigirse-a-la-separacion-de-fases-liquido-liquido-de-aven-en-el-cancer-colorrectal-hallazgos-derivados-de-una-sonda-quimica-basada-en-raddeanina-a 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/1623/las-probioticos-ingenierizados-despojados-de-metionina-promueven-la-inmunoterapia-con-anticuerpos-anti-pd-l1-al-activar-el-camino-sting 2026-07-09 monthly 0.5 https://crcwarriors.org/articulo/2391/efecto-de-uno-o-dos-ciclos-de-inmunoterapia-combinada-con-nivolumab-e-ipilimumab-en-pacientes-con-cancer-colorrectal-con-deficiencia-en-la-reparacion-de-errores-reset-r-resultados-preliminares-de-un 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/876/eficacia-costo-efectiva-de-pembrolizumab-como-terapia-de-primera-linea-para-cancer-colorrectal-avanzado-con-alta-inestabilidad-microsatelital-o-deficiencia-en-reparacion-de-desparejas-en-japon 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2158/evaluacion-del-ct-adn-y-el-estado-mutacional-en-la-biopsia-liquida-de-pacientes-con-cancer-colorrectal-metastasico 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2414/seguridad-y-eficacia-de-una-estrategia-de-terapia-neoadyuvante-total-tipo-sandwich-para-el-cancer-colorrectal-distal-localmente-avanzado-de-bajo-riesgo-resultados-del-ensayo-tess-de-fase-ii 2026-07-26 monthly 0.5 https://crcwarriors.org/articulo/2164/analisis-de-las-similitudes-y-diferencias-en-las-guias-de-practica-clinica-globales-para-el-cancer-gastrico-una-revision-de-las-ultimas-guias-de-taiwan-en-comparacion-con-las-guias-de-asia-pacifico 2026-07-08 monthly 0.5 https://crcwarriors.org/articulo/1912/mutaciones-combinadas-de-ras-y-smad4-e-inestabilidad-de-microsatelites-predicen-los-resultados-en-metastasis-pulmonares-colorrectales-tratadas-con-ablacion-termica-guiada-por-imagen 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/2171/adn-tumoral-circulante-y-biomarcadores-de-precision-en-el-cancer-colorrectal-implicaciones-para-el-diagnostico-seguimiento-y-manejo-de-la-enfermedad-avanzada 2026-08-23 monthly 0.5 https://crcwarriors.org/articulo/2427/tener-en-cuenta-la-ubicacion-del-tumor-es-fundamental-para-una-interpretacion-precisa-de-los-resultados-de-la-biopsia-liquida-en-el-cancer-colorrectal-metastasico 2026-07-09 monthly 0.5 https://crcwarriors.org/articulo/2433/la-adaptacion-metabolica-inducida-por-la-compresion-impulsa-la-migracion-de-las-celulas-tumorales-en-un-espacio-confinado-y-la-metastasis-a-distancia-a-traves-del-refuerzo-de-los-microtubulos 2026-07-08 monthly 0.5 https://crcwarriors.org/articulo/1922/runx1-activa-directamente-a-wnt2-para-orquestar-la-reprogramacion-de-los-macrofagos-asociados-al-tumor-en-el-cancer-colorrectal 2026-07-07 monthly 0.5 https://crcwarriors.org/articulo/2179/biomarcadores-plasmaticos-asociados-con-los-resultados-clinicos-del-regimen-folfiri-mas-ramucirumab-en-el-cancer-colorrectal-metastasico-con-ras-tipo-salvaje-el-ensayo-jaccro-cc-16ar 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2441/cirugia-para-metastasis-hepaticas-bilaterales-de-cancer-colorrectal-desde-resecciones-escalonadas-hasta-trasplante-hepatico-una-revision-sistematica-de-los-resultados-de-las-diferentes-estrategias 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/2447/empire-nsabp-fc-13-un-ensayo-de-fase-ii-basado-en-biomarcadores-que-evalua-una-terapia-inmunologica-basada-en-cemiplimab-en-cancer-colorrectal-con-estabilidad-microsatelital-y-enfermedad-residual 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1698/displasia-en-lesiones-serradas-sesiles-frecuencia-variabilidad-interobservador-y-valor-anadido-de-la-inmunohistoquimica 2026-07-03 monthly 0.5 https://crcwarriors.org/articulo/1189/irs2-como-factor-impulsor-y-diana-terapeutica-en-las-metastasis-cerebrales-del-cancer-colorrectal-una-revision-sistematica-de-la-evidencia-mecanicista-y-traslacional 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1959/resumen-visual-de-aso-la-combinacion-de-mutaciones-en-ras-y-smad4-junto-con-la-inestabilidad-de-microsatelites-predice-los-resultados-en-metastasis-pulmonares-de-cancer-colorrectal-tratadas-con 2026-06-11 monthly 0.5 https://crcwarriors.org/articulo/1963/analisis-basado-en-secuenciacion-de-siguiente-generacion-del-espectro-de-mutaciones-geneticas-en-cancer-colorrectal-un-estudio-de-gran-escala-de-un-unico-centro-del-sureste-de-china-con-comparacion 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/1965/cibisatamab-y-fap-4-1bbl-en-el-cancer-colorrectal-con-estabilidad-microsatelital-un-ensayo-de-fase-1b 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2478/terapia-sistemica-perioperatoria-frente-a-cirugia-sola-para-metastasis-peritoneales-resecables-aisladas-de-cancer-colorrectal-cairo6-un-ensayo-aleatorizado-de-etiqueta-abierta-de-fase-3 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2232/la-plataforma-de-oncologia-de-precision-funcional-de-organoides-de-cancer-colorrectal-con-mutacion-braf-v600e-predice-la-respuesta-al-tratamiento-y-revela-la-inmunogenicidad-mediada-por-rnf43 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2747/ensayo-elecla-resultados-finales-de-la-quimioterapia-perioperatoria-con-fluoropirimidina-y-oxaliplatino-en-el-cancer-colorrectal-localmente-avanzado-con-reparacion-del-desajuste-de-emparejamiento 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/2498/bebidas-azucaradas-y-bebidas-endulzadas-artificialmente-zumos-de-frutas-y-verduras-y-riesgo-de-cancer-una-revision-sistematica-de-la-literatura-y-un-metaanalisis-del-programa-de-actualizacion-mundial 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2499/generacion-autonoma-de-pruebas-clinicas-de-calidad-para-la-toma-de-decisiones 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2500/mirccc-aprendizaje-de-grafos-con-conocimiento-de-la-represion-para-la-inferencia-de-la-comunicacion-celula-celula-mediada-por-microarn 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2502/reconsiderando-la-linfadenectomia-en-la-era-de-la-inmunoterapia-del-cancer-colorrectal-una-perspectiva-que-plantea-hipotesis 2026-07-28 monthly 0.5 https://crcwarriors.org/articulo/2505/analisis-farmacocinetico-poblacional-de-relacion-exposicion-respuesta-eficacia-y-seguridad-de-favezelimab-en-pacientes-con-tumores-solidos 2026-07-29 monthly 0.5 https://crcwarriors.org/articulo/1996/los-conjugados-peptido-farmaco-que-contienen-la-carga-antimitotica-ahx-da1-logran-una-potente-actividad-antitumoral-en-modelos-in-vivo-de-canceres-con-amplificacion-de-her2-positivos-para-egfr-y-con 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2509/mintcna-un-marco-unificado-para-el-analisis-integrativo-del-perfil-de-numero-de-copias-con-datos-multiomicos-de-celulas-individuales 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2510/la-reprogramacion-inmunitaria-y-de-las-celulas-tumorales-en-multiples-compartimentos-mediada-por-ifna2-supera-la-resistencia-a-la-inmunoterapia-en-el-cancer-de-colon 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2257/la-neferina-al-potenciar-la-formula-shenling-baizhu-tang-refuerza-la-terapia-anti-pd-1-en-las-metastasis-hepaticas-del-cancer-colorrectal-a-traves-de-la-reprogramacion-lipidica-mediada-por-cyp2e1-ppar 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/2261/quimiorradioterapia-adyuvante-frente-a-reseccion-total-del-meso-recto-complementaria-tras-reseccion-local-para-el-cancer-de-recto-en-estadio-temprano-tesar-un-ensayo-multicentrico-aleatorizado 2026-07-24 monthly 0.5 https://crcwarriors.org/articulo/984/identificacion-de-las-mutaciones-somaticas-especificas-del-sindrome-de-lynch-y-del-sindrome-similar-a-lynch-en-casos-de-cancer-colorrectal-con-alta-inestabilidad-de-microsatelites 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2270/estrategias-actuales-y-nuevos-enfoques-de-la-inmunoterapia-en-el-cancer-colorrectal-con-estabilidad-microsatelital-un-articulo-de-revision 2026-07-28 monthly 0.5 https://crcwarriors.org/articulo/2280/la-ferroptosis-en-el-cancer-colorrectal-mecanismos-moleculares-y-la-interaccion-reguladora-con-posibles-aplicaciones-terapeuticas-revision 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2030/la-respuesta-previa-a-los-agentes-anti-vegf-predice-la-eficacia-de-trifluridina-tipiracil-mas-bevacizumab-en-pacientes-con-cancer-colorrectal-metastasico 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2293/el-receptor-de-vitamina-d-en-los-tumores-una-revision-de-los-mecanismos-biologicos-los-posibles-usos-terapeuticos-y-los-valores-pronosticos 2026-06-15 monthly 0.5 https://crcwarriors.org/articulo/2038/sotorasib-mas-panitumumab-y-5-fluorouracilo-en-el-tratamiento-de-primera-linea-de-pacientes-con-cancer-colorrectal-irresecable-con-mutacion-kras-g12c-que-no-son-aptos-para-quimioterapia-combinada 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2294/superacion-de-la-resistencia-inmune-condicional-en-el-cancer-colorrectal-mss-y-pmmr-un-modelo-de-secuenciacion-escalonada-para-la-inmunoterapia 2026-07-14 monthly 0.5 https://crcwarriors.org/articulo/2301/un-nuevo-inhibidor-no-competitivo-de-p97-vcp-induce-apoptosis-y-autofagia-para-suprimir-el-crecimiento-del-cancer-colorrectal 2026-07-01 monthly 0.5 https://crcwarriors.org/articulo/2302/mas-alla-del-5-fluorouracilo-convencional-estrategias-recientes-de-quimica-medicinal-para-mejorar-su-eficacia-antitumoral 2026-07-01 monthly 0.5 https://crcwarriors.org/articulo/2316/la-delecion-de-egfr-en-celulas-mieloides-reprograma-el-paisaje-inmunosupresor-del-cancer-colorrectal 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/2122/informe-de-caso-adenocarcinomas-colorrectales-sincronicos-con-estado-de-reparacion-del-desajuste-discordante-un-caso-de-sindrome-similar-a-lynch-y-asociacion-con-la-via-serrada 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/2392/caracteristicas-moleculares-de-pacientes-chinos-con-cancer-colorrectal-y-inestabilidad-de-microsatelites 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/2435/la-secrecion-de-il-10-por-las-celulas-t-cd8-orquesta-el-reclutamiento-temprano-de-las-celulas-nk-y-la-inmunidad-antitumoral-tras-la-terapia-anti-vegfr-2-pd-1 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/1928/expresion-de-glut3-bajo-demanda-potencia-la-aptitud-metabolica-de-celulas-car-t-y-la-eficacia-antitumoral-en-modelos-preclinicos-de-glioblastoma 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/2448/manejo-del-peso-en-pacientes-con-cancer-y-obesidad-durante-el-tratamiento-activo-con-intencion-curativa-protocolo-del-estudio-de-factibilidad-canobese 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/1756/estudio-aleatorizado-de-fase-ii-que-compara-folfiri-mas-ramucirumab-con-folfoxiri-mas-ramucirumab-como-tratamiento-de-primera-linea-para-el-cancer-colorrectal-metastasico-wjog9216g-recast 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/2287/estudio-computacional-de-los-complejos-supramoleculares-de-actinonina-cucurbiturilo-8-para-la-terapia-del-cancer-colorrectal 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/2390/el-analisis-transcriptomico-de-celulas-individuales-revela-la-heterogeneidad-y-la-dinamica-del-agotamiento-de-las-celulas-t-citotoxicas-cd27-en-el-microambiente-tumoral-del-cancer-colorrectal 2026-06-29 monthly 0.5 https://crcwarriors.org/articulo/2436/analisis-clinicopatologico-de-tumores-con-deficiencia-de-smarca4-de-origen-en-el-sistema-digestivo 2026-06-29 monthly 0.5 https://crcwarriors.org/articulo/2455/retos-diagnosticos-en-la-evaluacion-del-estado-de-microsatelites-del-tejido-tumoral-y-en-la-sangre-en-el-cancer-colorrectal-metastasico-y-su-impacto-en-el-acceso-a-la-inmunoterapia-un-estudio 2026-06-29 monthly 0.5 https://crcwarriors.org/articulo/2470/la-raza-y-el-nivel-socioeconomico-influyen-en-la-supervivencia-en-casos-de-cancer-colorrectal-de-inicio-temprano-y-tardio 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2482/los-perfiles-de-mutaciones-somaticas-en-los-canceres-colorrectales-difieren-segun-la-poblacion 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2491/puede-una-firma-de-progresion-derivada-de-tejido-predecir-con-precision-las-transiciones-de-estadio-del-cancer-colorrectal-en-sangre 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2000/evaluacion-in-silico-de-triterpenos-seleccionados-como-inhibidores-potenciales-de-las-quinasas-braf-y-brafv600e-para-el-tratamiento-del-cancer 2026-06-29 monthly 0.5 https://crcwarriors.org/articulo/2466/integraterigor-optimizacion-de-la-integracion-sin-necesidad-de-anotaciones-para-la-recuperacion-de-la-identidad-celular-que-revela-nichos-de-interaccion-entre-el-cancer-y-el-sistema-inmunitario 2026-06-29 monthly 0.5 https://crcwarriors.org/articulo/1848/construccion-y-validacion-de-modelos-predictivos-multi-omicos-para-cancer-colorrectal-utilizando-enfoques-de-aprendizaje-automatico 2026-06-26 monthly 0.5 https://crcwarriors.org/articulo/1901/la-firma-molecular-de-las-metastasis-hepaticas-de-cancer-colorrectal-de-inicio-temprano-biologia-diferenciada-y-desafios-clinicos 2026-06-26 monthly 0.5 https://crcwarriors.org/articulo/1404/seguridad-y-eficacia-de-la-terapia-triplice-que-contiene-encorafenib-cetuximab-y-binimetinib-para-el-cancer-colorrectal-mutado-en-braf-v600e-una-revision-sistematica-y-analisis-meta 2026-06-26 monthly 0.5 https://crcwarriors.org/articulo/2458/identificacion-in-silico-de-genes-bacterianos-clave-asociados-directa-o-indirectamente-con-el-desarrollo-y-la-progresion-del-cancer-colorrectal-con-el-fin-de-explorar-agentes-antibacterianos 2026-06-27 monthly 0.5 https://crcwarriors.org/articulo/2465/la-elaboracion-de-perfiles-de-fragmentacion-del-adn-libre-en-celulas-en-los-sitios-de-inicio-de-la-transcripcion-mejora-la-seleccion-de-regiones-especificas-para-cada-tipo-de-cancer-con-el-fin-de 2026-08-29 monthly 0.5 https://crcwarriors.org/articulo/948/un-conjugado-anticuerpo-farmaco-humanoizado-dirigido-al-linfoma-anaplasico-de-quinasa-alk-con-una-carga-de-pirrolobencodiazepina-demuestra-eficacia-en-canceres-que-expresan-alk 2026-06-26 monthly 0.5 https://crcwarriors.org/articulo/1751/linea-de-tratamiento-inicial-con-nivolumab-mas-folfoxiri-bevacizumab-en-cancer-colorrectal-avanzado-mutado-en-ras-braf-eficacia-seguridad-y-descubrimiento-de-biomarcadores-del-ensayo-fase-ii-nivacor 2026-06-26 monthly 0.5 https://crcwarriors.org/articulo/2311/revision-exhaustiva-de-la-inmunoterapia-en-el-cancer-colorrectal-desde-los-mecanismos-hasta-las-intervenciones-de-enfermeria 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2592/el-estres-cronico-desencadena-un-circuito-intratumoral-que-involucra-fagos-fibroblastos-y-celulas-b-y-que-promueve-el-crecimiento-tumoral 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/563/inhibidores-duplex-de-krasg12d-y-hsp90-son-efectivos-contra-la-resistencia-a-los-inhibidores-de-krasg12d 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2363/dirigirse-a-la-ferroptosis-para-superar-la-radioresistencia-y-mejorar-la-inmunoterapia-en-el-cancer-colorrectal 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2404/renovacion-del-aire-en-el-dormitorio-como-terapia-adyuvante-antiinflamatoria-en-supervivientes-de-cancer-protocolo-para-la-serie-de-ensayos-aleatorizados-controlados-con-placebo-breaths-n-of-1 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2421/la-insuficiente-ferroptosis-en-las-celulas-tumorales-inducidas-por-la-radiacion-favorece-la-generacion-de-celulas-treg-lo-que-induce-resistencia-a-la-radioterapia 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2430/el-bloqueo-de-los-puntos-de-control-inmunitario-potencia-la-inmunidad-antitumoral-inducida-por-la-quimioterapia-depletor-de-linfocitos-al-expandir-los-clones-de-celulas-t-citotoxicas-cd8 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2271/parametros-de-la-fdg-pet-tc-para-diferenciar-entre-alta-y-baja-inestabilidad-de-microsatelites-en-el-cancer-colorrectal-una-revision-sistematica-y-metaanalisis 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/1775/estudio-de-fase-i-de-mosperafenib-un-nuevo-inhibidor-del-protooncogen-b-raf-serina-treonina-quinasa-braf-que-actua-como-paradox-breaker-en-pacientes-con-tumores-solidos-con-mutacion-braf-v600 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2573/los-monocitos-inflamatorios-limitan-la-proliferacion-celular-inducida-por-yap 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/2318/sorafenib-anclado-sobre-negro-de-carbon-como-un-electrocatalizador-redox-molecular-estable-para-la-oxidacion-de-tioles-y-la-deteccion-en-el-punto-de-atencion-en-celulas-cancerosas 2026-06-24 monthly 0.5 https://crcwarriors.org/articulo/2399/interaccion-entre-las-vias-de-muerte-celular-metabolica-en-el-cancer-colorrectal-implicaciones-para-la-terapia-de-precision 2026-06-24 monthly 0.5 https://crcwarriors.org/articulo/2464/semfa-un-marco-general-para-inferir-la-significacion-estadistica-de-la-similitud-de-mahalanobis-entre-muestras-con-perfiles-multiomicos-basado-en-el-analisis-factorial-multiple 2026-08-29 monthly 0.5 https://crcwarriors.org/articulo/2469/inhibicion-de-la-interleucina-6-mediante-analisis-genetico-y-riesgo-de-cancer-un-estudio-de-aleatorizacion-mendeliana-multietnica-del-objetivo-farmacologico-en-el-carcinoma-hepatocelular-y-el-cancer 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2544/fusobacterium-periodonticum-favorece-la-tumorigenesis-del-cancer-colorrectal-mediante-la-quimiotaxis-de-neutrofilos-inducida-por-el-acido-decanoico 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2099/alteracion-de-la-interaccion-entre-el-lipopolisacarido-bacteriano-y-las-celulas-inmunitarias-en-el-cancer-colorrectal-en-comparacion-con-el-tejido-intestinal-adyacente 2026-06-23 monthly 0.5 https://crcwarriors.org/articulo/1625/la-mutacion-de-tp53-esta-asociada-con-un-mejor-control-de-la-enfermedad-en-pacientes-con-adenocarcinoma-colorrectal-de-tipo-ras-wt-avanzado-tratados-con-cetuximab-y-pembrolizumab 2026-06-23 monthly 0.5 https://crcwarriors.org/articulo/2006/la-hipermetilacion-de-nos1-podria-participar-en-el-desarrollo-del-cancer-colorrectal-y-estar-asociada-con-su-pronostico 2026-06-23 monthly 0.5 https://crcwarriors.org/articulo/2335/resumen-ejecutivo-de-los-criterios-de-uso-adecuado-de-la-sociedad-americana-de-radio-para-el-tratamiento-del-cancer-de-recto-con-recurrencia-locorregional 2026-06-22 monthly 0.5 https://crcwarriors.org/articulo/2395/un-enfoque-probiotico-dirigido-a-la-hipersialilacion-revitaliza-la-inmunidad-de-las-celulas-t-cd8-y-mejora-la-eficacia-de-la-terapia-fotodinamica-en-tumores-solidos 2026-06-22 monthly 0.5 https://crcwarriors.org/articulo/2412/genes-clave-oncogenicos-anln-y-cthrc1-implicaciones-para-el-pronostico-del-cancer-y-las-terapias-basadas-en-vacunas 2026-06-22 monthly 0.5 https://crcwarriors.org/articulo/1667/prueba-de-actividad-afinidad-multimodal-de-los-vesiculas-extracelulares-de-adam-10-en-plasma-sin-tratamiento-revela-la-etapa-metastasica-del-cancer-colorrectal 2026-06-22 monthly 0.5 https://crcwarriors.org/articulo/1926/marco-basado-en-biomarcadores-estromales-para-identificar-canceres-colorrectales-pmmr-mss-y-dmmr-msi-con-mal-pronostico-y-beneficio-limitado-de-inmunoterapia 2026-06-22 monthly 0.5 https://crcwarriors.org/articulo/2463/cuantificacion-a-nivel-de-panel-de-la-metilacion-en-multiples-loci-en-adn-nativo-libre-de-celulas-mediante-un-procesamiento-enzimatico-secuencial-compatible-con-pcr 2026-08-29 monthly 0.5 https://crcwarriors.org/articulo/2225/estudio-multicentrico-de-fase-ii-que-evalua-el-regimen-folfoxiri-neoadyuvante-seguido-de-quimiorradioterapia-concurrente-en-pacientes-chinos-con-cancer-de-recto-de-alto-riesgo 2026-06-22 monthly 0.5 https://crcwarriors.org/articulo/2255/la-deficiencia-de-plscr3-desencadena-la-activacion-del-cgas-sting-impulsada-por-el-adn-mitocondrial-para-potenciar-la-inmunidad-antitumoral-en-el-cancer-colorrectal 2026-06-22 monthly 0.5 https://crcwarriors.org/articulo/2142/mfolfoxiri-neoadyuvante-con-o-sin-cadonilimab-frente-a-mfolfox6-en-cancer-colorrectal-localmente-avanzado-un-ensayo-aleatorizado-de-fase-2-optical-2 2026-06-21 monthly 0.5 https://crcwarriors.org/articulo/1891/nanomedicina-para-la-terapia-del-cancer-colorrectal-mediante-la-reversion-del-microambiente-inmunologico 2026-06-21 monthly 0.5 https://crcwarriors.org/articulo/2432/oraclescreen-lilrb4-descubrimiento-guiado-por-aprendizaje-automatico-de-moleculas-que-se-unen-a-puntos-de-control-inmunitarios-mieloides-validado-en-celulas-derivadas-de-pacientes 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2087/resistencia-adquirida-a-los-inhibidores-de-los-puntos-de-control-inmunitario-en-diversos-tipos-de-tumores-un-analisis-reconstruido-de-datos-individuales-de-pacientes 2026-06-19 monthly 0.5 https://crcwarriors.org/articulo/2376/asociacion-entre-el-grupo-sanguineo-abo-y-la-supervivencia-en-el-cancer-de-colon-en-estadio-temprano-un-analisis-retrospectivo-de-cohortes-realizado-en-un-unico-centro 2026-06-19 monthly 0.5 https://crcwarriors.org/articulo/2417/eficacia-de-los-criterios-de-deteccion-de-cancer-colorrectal-basados-en-el-historial-familiar-segun-la-raza-y-la-edad-al-diagnostico-en-el-estudio-disparidades-y-epidemiologia-del-cancer-dance 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/2186/diseno-sintesis-y-estudio-de-la-relacion-estructura-actividad-de-nuevos-compuestos-con-un-andamiaje-de-indolo-pirrol-dirigidos-a-nur77-en-celulas-tumorales-de-cancer-colorrectal 2026-06-24 monthly 0.5 https://crcwarriors.org/articulo/2541/la-capacidad-de-activacion-del-origen-de-replicacion-indica-la-sensibilidad-al-inhibidor-de-atr 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2245/evaluacion-de-un-ensayo-de-pcr-digital-de-gotas-para-la-deteccion-de-inestabilidad-de-microsatelites-en-cancer-colorrectal-cancer-gastrico-y-cancer-endometrial 2026-06-18 monthly 0.5 https://crcwarriors.org/articulo/2298/superacion-de-la-resistencia-adaptativa-al-bloqueo-de-krasg12d-en-el-cancer-de-pancreas-mediante-la-inhibicion-de-la-via-de-senalizacion 2026-06-18 monthly 0.5 https://crcwarriors.org/articulo/2048/quimioterapia-neoadyuvante-total-combinada-con-bloqueo-de-pd-1-e-il-2-en-cancer-colorrectal-localmente-avanzado-mss-pmmr-resultados-a-corto-plazo-de-un-estudio-prospectivo-de-un-solo-brazo-de-fase-ii 2026-06-17 monthly 0.5 https://crcwarriors.org/articulo/35/informe-de-caso-win-mtb-2023001-win-international-molecular-tumor-board-varon-de-62-anos-con-cancer-colorrectal-metastasico-con-5-lineas-de-tratamiento-previas 2026-06-17 monthly 0.5 https://crcwarriors.org/articulo/2339/significado-pronostico-de-la-expresion-de-b7-h3-en-pacientes-con-cancer-colorrectal-avanzado 2026-06-17 monthly 0.5 https://crcwarriors.org/articulo/1873/b7-h3-cd276-en-la-biogenesis-de-exosomas-y-el-microambiente-tumoral-un-nuevo-nexo-terapeutico 2026-06-17 monthly 0.5 https://crcwarriors.org/articulo/2178/efectos-pronosticos-y-relacionados-con-el-tratamiento-sobre-la-supervivencia-de-la-inestabilidad-de-microsatelites-en-los-diferentes-estadios-de-la-enfermedad-en-el-cancer-de-colon-un-analisis-de-la 2026-06-17 monthly 0.5 https://crcwarriors.org/articulo/942/desarrollo-de-un-adc-biespecifico-cdh17-gucy2c-que-lleva-el-inducir-de-ferropotesis-rsl3-para-el-tratamiento-del-cancer-colorrectal 2026-06-17 monthly 0.5 https://crcwarriors.org/articulo/2328/quien-se-beneficia-realmente-de-la-reexposicion-antiegfr-en-el-cancer-colorrectal-metastasico-del-enriquecimiento-clinico-a-la-hiperseleccion-molecular-guiada-por-ctadn 2026-06-16 monthly 0.5 https://crcwarriors.org/articulo/2329/mas-alla-de-la-lateralidad-la-metilacion-del-adn-como-biomarcador-para-refinar-la-seleccion-del-tratamiento-anti-egfr-en-el-cancer-colorrectal-metastasico-ras-braf-salvaje 2026-06-16 monthly 0.5 https://crcwarriors.org/articulo/2396/beneficio-en-la-supervivencia-de-la-monoterapia-sistemica-oral-en-pacientes-con-cancer-colorrectal-metastasico-previamente-tratados-un-metaanalisis 2026-06-18 monthly 0.5 https://crcwarriors.org/articulo/2416/retirado-el-aparato-de-golgi-como-arbitro-de-la-reprogramacion-oncofetal-una-revision-sistematica-y-un-metaanalisis-que-relacionan-el-origen-embrionario-de-la-capa-germinal-con-el-panorama-de-las 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/1800/estudio-de-seleccion-basecamp-1-un-modelo-para-la-inscripcion-eficiente-en-ensayos-clinicos-de-oncologia-de-precision 2026-06-15 monthly 0.5 https://crcwarriors.org/articulo/1805/perdida-de-antigenos-inducida-por-ifn-en-la-terapia-con-celulas-t-con-receptores-quimericos-de-antigenos 2026-06-15 monthly 0.5 https://crcwarriors.org/articulo/2319/el-analisis-de-datos-de-celulas-individuales-de-metastasis-cerebrales-de-cancer-de-pulmon-revela-que-sec61g-podria-ser-un-posible-indicador-de-riesgo 2026-06-15 monthly 0.5 https://crcwarriors.org/articulo/2402/inferencia-de-trayectorias-del-destino-celular-en-datos-de-etiquetado-metabolico-de-arn-resuelto-en-el-tiempo 2026-08-17 monthly 0.5 https://crcwarriors.org/articulo/1902/activacion-de-la-via-de-la-adenosina-define-subtipos-inmunosupresores-geneticamente-vinculados-en-metastasis-cerebrales-de-tumores-solidos 2026-06-15 monthly 0.5 https://crcwarriors.org/articulo/2546/la-senalizacion-del-interferon-de-tipo-i-impulsada-por-el-oncogen-kras-prepara-el-cancer-de-pancreas-para-la-necroptosis 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2075/terapia-combinada-predirigida-con-177-lu-225-ac-para-el-cancer-colorrectal 2026-06-13 monthly 0.5 https://crcwarriors.org/articulo/64/analisis-de-ctdna-en-cancer-colorrectal-amplificado-por-erbb2-analisis-de-biomarcadores-del-ensayo-mypathway 2026-06-13 monthly 0.5 https://crcwarriors.org/articulo/2127/seguridad-y-eficacia-de-folfiri-3-irinotecan-en-dosis-divididas-para-el-cancer-colorrectal-irresecable-un-analisis-estratificado-basado-en-los-polimorfismos-del-gen-ugt1a1 2026-06-13 monthly 0.5 https://crcwarriors.org/articulo/2246/evolucion-del-microambiente-inmunitario-a-lo-largo-de-la-via-de-la-neoplasia-serrada-y-su-relevancia-para-la-inmunoterapia 2026-06-13 monthly 0.5 https://crcwarriors.org/articulo/2519/evolucion-clonal-y-trayectorias-mutacionales-del-cancer-colorrectal-metastasico-influenciadas-por-las-terapias-antineoplasicas 2026-07-18 monthly 0.5 https://crcwarriors.org/articulo/2268/las-mutaciones-de-kras-g12v-a146t-se-asocian-con-resistencia-a-la-quimiorradioterapia-neoadyuvante-ncrt-a-traves-de-una-mayor-reparacion-de-las-roturas-de-doble-cadena-del-adn-y-respaldan-un-marco-de 2026-06-18 monthly 0.5 https://crcwarriors.org/articulo/2304/respuesta-inflamatoria-sistemica-tras-la-cirugia-abdominal-robotica-frente-a-la-laparoscopica-una-revision-sistematica-y-metaanalisis-con-analisis-de-subgrupos-de-cancer-colorrectal 2026-06-14 monthly 0.5 https://crcwarriors.org/articulo/2571/la-inhibicion-de-tmed4-mejora-la-funcion-de-los-linfocitos-t-cd8-y-la-eficacia-de-las-celulas-car-t-en-tumores-solidos-a-traves-del-eje-ire1-autofagia 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/2572/resmap-un-recurso-comunitario-para-el-mapeo-sistematico-de-las-dependencias-de-las-celulas-cancerosas-residuales-que-persisten-tras-la-terapia-en-diferentes-contextos 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/2320/significado-pronostico-de-las-mutaciones-kras-g12c-frente-a-las-mutaciones-ras-no-g12c-en-el-cancer-colorrectal-metastasico-una-revision-sistematica-y-metaanalisis 2026-06-12 monthly 0.5 https://crcwarriors.org/articulo/2321/la-paradoja-de-mir-107-en-oncologia-doble-papel-como-supresor-tumoral-y-oncomir 2026-06-12 monthly 0.5 https://crcwarriors.org/articulo/1568/estudio-de-fase-ii-de-trifluridina-tipiracil-tas-102-mas-bevacizumab-como-terapia-de-mantenimiento-tras-la-quimioterapia-de-induccion-en-el-cancer-colorrectal-metastasico 2026-06-12 monthly 0.5 https://crcwarriors.org/articulo/2094/puntuacion-revisada-de-la-carga-tumoral-para-la-estratificacion-pronostica-en-pacientes-con-cancer-colorrectal-metastasico-que-reciben-inmunoterapia-un-estudio-retrospectivo 2026-06-12 monthly 0.5 https://crcwarriors.org/articulo/2381/los-estudios-de-asociacion-a-gran-escala-de-la-metilacion-del-adn-y-el-transcriptoma-basados-en-la-deconvolucion-y-especificos-para-cada-tipo-celular-identifican-los-sitios-cpg-de-riesgo-y-los-genes 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/2382/la-estimulacion-electrica-pulsada-aumenta-la-permeabilidad-intestinal 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/2132/optimizacion-estructural-de-los-inhibidores-de-la-tirosil-adn-fosfodiesterasa-1-basados-en-benzofenantridinona-y-benzofenantridina-y-su-actividad-de-potenciacion-de-la-radioterapia 2026-06-12 monthly 0.5 https://crcwarriors.org/articulo/1768/un-glioma-pediatrico-de-alto-grado-deficiente-en-pms2-con-mutaciones-del-camino-pi3k-y-una-anomalia-venosa-de-desarrollo-adyacente-sugestiva-de-cmmrd 2026-06-12 monthly 0.5 https://crcwarriors.org/articulo/2540/diseno-de-nanoparticulas-basadas-en-peg10-humano-para-el-autoempaquetamiento-del-arn-su-administracion-y-la-terapia-contra-el-cancer 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2072/la-nanomedicina-autoamplificable-reprograma-el-metabolismo-redox-para-desencadenar-la-ferroptosis-inmunogenica-en-el-cancer-de-colon-el-analisis-multiomico-identifica-a-ampd3-como-un-nuevo-regulador 2026-06-11 monthly 0.5 https://crcwarriors.org/articulo/2587/el-mapa-de-los-mecanismos-de-resistencia-a-los-inhibidores-de-kras-en-el-cancer-colorrectal 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2588/estados-de-celulas-oncofetales-con-alta-plasticidad-en-las-fases-tempranas-del-cancer-colorrectal-premetastasico 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2593/descubrimiento-de-biomarcadores-espaciales-mediante-el-aprendizaje-semantico-interpretable-en-histopatologia 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2367/marcadores-metabolomicos-y-proteomicos-del-estado-fisico-cardiorrespiratorio-para-predecir-la-mortalidad-por-todas-las-causas-y-el-riesgo-de-enfermedades-no-transmisibles-un-estudio-prospectivo-en-el 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2388/la-modulacion-directa-de-lilrb4-ilt3-mediante-pequenas-moleculas-restaura-la-inmunidad-antitumoral-in-vivo-y-en-celulas-derivadas-de-pacientes 2026-08-16 monthly 0.5 https://crcwarriors.org/articulo/2175/descifrando-el-paradigma-multifuncional-y-traslacional-de-los-sistemas-nanoparticulados-contra-el-cancer-colorrectal 2026-06-21 monthly 0.5 https://crcwarriors.org/articulo/1954/avances-e-innovaciones-en-los-mecanismos-moleculares-y-el-tratamiento-del-cancer-colorrectal 2026-06-11 monthly 0.5 https://crcwarriors.org/articulo/1223/remision-del-cancer-duodenal-metastasico-despues-del-tratamiento-con-inhibidor-de-braf 2026-06-11 monthly 0.5 https://crcwarriors.org/articulo/2565/el-microambiente-inmunitario-y-los-arn-no-codificantes-influyen-en-las-primeras-etapas-de-la-carcinogenesis-del-cancer-colorrectal-en-pacientes-con-lesiones-premalignas 2026-08-15 monthly 0.5 https://crcwarriors.org/articulo/2387/descomposicion-funcional-multi-axial-del-microbioma-intestinal-humano-una-definicion-operativa-de-la-eubiosis-y-la-disbiosis-y-un-marco-de-referencia-claro-para-la-estratificacion-de-enfermedades 2026-08-15 monthly 0.5 https://crcwarriors.org/articulo/2133/troxerutina-como-flavonoide-bioactivo-perspectivas-sobre-sus-mecanismos-anticancerigenos-y-aplicaciones-terapeuticas 2026-06-10 monthly 0.5 https://crcwarriors.org/articulo/2307/identificacion-de-nuevos-variantes-geneticos-de-riesgo-asociados-con-el-accidente-cerebrovascular-isquemico-de-inicio-temprano-en-taiwan 2026-06-14 monthly 0.5 https://crcwarriors.org/articulo/2355/los-sitios-de-metilacion-del-adn-fluctuantes-codifican-el-historial-de-crecimiento-del-tumor-colorrectal 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2356/fomentar-la-toma-de-decisiones-compartida-en-el-cribado-del-cancer-colorrectal-en-atencion-primaria-un-ensayo-clinico-aleatorizado-de-grupos 2026-06-11 monthly 0.5 https://crcwarriors.org/articulo/2359/la-modulacion-del-punto-de-control-inmunitario-mieloide-ilt3-lilrb4-mediante-moleculas-pequenas-permite-la-reprogramacion-de-la-inmunidad-tumoral-supresora 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2360/interacciones-reguladoras-entre-potenciadores-y-genes-en-el-cancer-colorrectal-reveladas-mediante-perturbaciones-crispri-a-nivel-del-genoma 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/1645/autoensamblaje-rapido-y-amplificacion-de-la-senal-basados-en-el-fotoactivo-z907-para-la-deteccion-del-biomarcador-del-cancer-colorrectal-el-factor-de-crecimiento-endotelial-vascular 2026-06-09 monthly 0.5 https://crcwarriors.org/articulo/2354/la-diferenciacion-inducida-por-tgf-1-mejora-la-respuesta-a-la-quimioterapia-en-organoides-de-cancer-colorrectal-metastasico 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2386/utilizacion-de-la-evidencia-obtenida-a-partir-de-los-programas-de-deteccion-del-cancer-colorrectal-para-estratificar-el-riesgo-individual-en-personas-con-antecedentes-familiares-de-cancer-colorrectal 2026-08-15 monthly 0.5 https://crcwarriors.org/articulo/1890/perfiles-moleculares-multicapa-definen-un-subtipo-de-cancer-colorrectal-inmunologicamente-activo-con-relevancia-terapeutica 2026-06-08 monthly 0.5 https://crcwarriors.org/articulo/1865/automatizacion-del-flujo-e-ingenieria-de-contexto-clinico-impulsada-por-llm-local-registro-de-precision-de-recurrencia-del-cancer-colorrectal 2026-06-06 monthly 0.5 https://crcwarriors.org/articulo/1892/integracion-epigenetica-y-postranscripcional-de-los-lncarn-y-ezh2-en-la-tumorigenesis-del-tracto-gastrointestinal 2026-06-06 monthly 0.5 https://crcwarriors.org/articulo/2568/correccion-del-recurso-de-investigacion-titulado-analisis-sistematico-de-variantes-geneticas-y-epigeneticas-funcionales-en-el-cancer-colorrectal-de-e-chen-y-colaboradores 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/2343/alergias-a-medicamentos-y-complicaciones-tras-la-cirugia-un-estudio-de-cohortes-multicentrico-prospectivo 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2346/cuantificacion-de-los-criterios-de-elegibilidad-para-ensayos-clinicos-en-oncologia-mediante-el-uso-de-la-inteligencia-artificial 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/1868/irinotecan-con-trifluridina-tipiracil-y-bevacizumab-para-cancer-colorrectal-metastasico-en-segunda-linea-un-estudio-multicentrico-de-fase-ii 2026-06-05 monthly 0.5 https://crcwarriors.org/articulo/891/una-nueva-mutacion-germinal-en-el-gen-mutyh-p-w156-en-astrocitoma-de-alto-grado-con-mutacion-en-idh 2026-06-05 monthly 0.5 https://crcwarriors.org/articulo/2526/la-inhibicion-de-txndc5-una-proteina-presente-en-los-fibroblastos-resuelve-la-desmoplasia-tumoral-y-la-resistencia-a-pd-1-en-el-cancer-colorrectal-con-caracteristicas-mesenquimales 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/2039/es-necesaria-la-cirugia-en-pacientes-con-cancer-colorrectal-con-deficiencia-en-la-reparacion-del-desajuste-y-alta-inestabilidad-de-microsatelites-que-presentan-una-respuesta-clinica-completa-tras-la 2026-06-05 monthly 0.5 https://crcwarriors.org/articulo/2345/caracterizacion-a-nivel-de-celula-unica-de-los-paisajes-inmunitarios-tumorales-en-ratones-humanizados-con-cancer-colorrectal 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2605/los-nanomoduladores-que-interfieren-con-stat3-revierten-la-quimiorresistencia-asociada-al-metabolismo-lipidico-y-potencian-la-inmunoterapia-metalica-en-el-cancer-de-mama 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/2326/correccion-telerehabilitacion-asincrona-en-la-fase-de-prehabilitacion-y-en-la-recuperacion-postoperatoria-del-cancer-colorrectal-un-protocolo-para-un-ensayo-clinico-aleatorizado-y-controlado 2026-06-11 monthly 0.5 https://crcwarriors.org/articulo/2344/el-fucoidano-procedente-de-las-algas-pardas-laminaria-japonica-induce-la-apoptosis-en-las-celulas-de-cancer-de-colon 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2348/revelacion-de-los-efectos-de-la-acumulacion-y-el-orden-de-las-mutaciones-en-el-inicio-del-tumor-mediante-organoides-de-cancer-colorrectal-murino-modificados-geneticamente 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2153/caracteristicas-y-resultados-de-pacientes-con-neoplasias-previas-al-cancer-colorrectal-un-analisis-de-concordancia-por-puntuacion-de-propension 2026-06-03 monthly 0.5 https://crcwarriors.org/articulo/2170/la-via-de-senalizacion-mapk-erk-en-el-cancer-colorrectal-avances-recientes-y-nuevos-conocimientos 2026-06-21 monthly 0.5 https://crcwarriors.org/articulo/2522/la-manosiltransferasa-dpm1-regula-la-actividad-del-sensor-de-estres-del-reticulo-endoplasmico-ire1-en-el-cancer-colorrectal 2026-07-19 monthly 0.5 https://crcwarriors.org/articulo/2323/la-multimorbilidad-especifica-de-cada-sistema-obtenida-a-partir-de-datos-de-prescripcion-predice-los-resultados-del-cancer-colorrectal-un-estudio-de-enlace-de-datos-de-escocia 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2325/la-interleucina-11-favorece-la-regeneracion-de-organoides-epiteliales-del-colon-tras-una-alteracion-mecanica 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2336/modelado-de-errores-de-variantes-de-nucleotido-unico-snv-e-inserciones-deleciones-indel-en-datos-de-secuenciacion-profunda-y-dirigida-de-adn-libre-en-plasma-para-la-deteccion-sensible-de-adn-tumoral 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2342/analisis-de-coste-efectividad-y-coste-utilidad-de-la-endoscopia-con-capsula-en-un-programa-de-cribado-poblacional-para-el-cancer-colorrectal 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2524/la-remodelacion-de-la-via-del-mevalonato-impulsada-por-la-remodelacion-de-los-potenciadores-confiere-resistencia-a-los-inhibidores-de-kras-en-el-cancer-colorrectal 2026-07-19 monthly 0.5 https://crcwarriors.org/articulo/1796/una-eficaz-sonda-fluorescente-teranostica-derivada-de-un-producto-natural-para-la-bioimagen-de-la-carboxilesterasa-y-la-terapia-activable-de-tumores-de-colon 2026-06-01 monthly 0.5 https://crcwarriors.org/articulo/2309/la-epidemiologia-del-cancer-colorrectal-en-guangzhou-china-un-estudio-transversal-y-de-cohortes-por-edad-y-periodo 2026-06-14 monthly 0.5 https://crcwarriors.org/articulo/1030/utilidad-clinica-del-analisis-longitudinal-de-adn-tumoral-circulante-en-pacientes-con-cancer-colorrectal-metastasico-que-reciben-quimioterapia-paliativa 2026-07-24 monthly 0.5 https://crcwarriors.org/articulo/2315/umitic-un-marco-de-trabajo-no-supervisado-para-la-caracterizacion-conjunta-de-fenotipos-celulares-y-vecindarios-espaciales-en-datos-de-imagen-de-inmunofluorescencia-multiplex-e-hiperplex 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/2067/usp21-promueve-la-evasion-inmune-en-el-cancer-colorrectal-mediante-la-desubiquitinacion-y-la-estabilizacion-de-la-catenina 2026-07-01 monthly 0.5 https://crcwarriors.org/articulo/2324/analisis-de-colocalizacion-espacial-multigrupal-y-multimuestre-utilizando-panoramic 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2069/oncogenicidad-e-implicaciones-terapeuticas-de-los-biomarcadores-moleculares-en-el-carcinoma-colorrectal 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/1814/el-analisis-integrado-de-la-transcriptomica-unicelular-y-espacial-revela-el-microambiente-del-cancer-colorrectal 2026-06-04 monthly 0.5 https://crcwarriors.org/articulo/1560/lenvatinib-mas-pembrolizumab-para-pacientes-con-cancer-colorrectal-avanzado-previamente-tratado-resultados-del-estudio-fase-ii-leap-005 2026-07-09 monthly 0.5 https://crcwarriors.org/articulo/1817/multi-omics-driven-immune-classification-of-colorectal-cancer-implicaciones-para-la-prediccion-de-la-eficacia-de-la-inmunoterapia-y-mejora-con-la-inhibicion-de-la-senalizacion-wnt 2026-06-01 monthly 0.5 https://crcwarriors.org/articulo/2074/ingenieria-de-nanocapsulas-para-la-silenciamiento-eficiente-de-nsun2-y-una-terapia-inmunomoduladora-en-el-cancer-colorrectal-metastasico 2026-06-11 monthly 0.5 https://crcwarriors.org/articulo/2080/un-estado-celular-con-alta-activacion-de-la-via-mapk-y-baja-activacion-de-la-via-wnt-favorece-la-diseminacion-metastasica-en-el-cancer-colorrectal 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/2081/mutaciones-geneticas-que-rigen-la-sensibilidad-y-la-resistencia-a-la-ferroptosis-un-enfoque-de-precision-para-la-terapia-del-cancer 2026-06-01 monthly 0.5 https://crcwarriors.org/articulo/2347/un-modelo-basico-del-genoma-del-cancer 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2350/impacto-del-momento-del-dia-en-la-eficacia-de-la-inmunoterapia-combinada-con-quimioterapia-en-el-cancer-de-pulmon-no-microcitico 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/1845/lgr5-de-marcador-de-celulas-madre-a-diana-terapeutica 2026-07-28 monthly 0.5 https://crcwarriors.org/articulo/2102/la-transcripcion-y-el-empalme-no-canonicos-modelan-el-inmunopeptidoma-del-cancer-colorrectal-en-tumores-msi-y-mss 2026-07-02 monthly 0.5 https://crcwarriors.org/articulo/2358/papel-pronostico-del-adn-tumoral-circundante-postoperatorio-en-el-cancer-colorrectal-metastasico-tratado-con-intencion-curativa-una-revision-sistematica-y-metaanalisis 2026-06-12 monthly 0.5 https://crcwarriors.org/articulo/2103/creacion-de-una-plataforma-solida-para-estudios-iniciados-por-investigadores-la-experiencia-de-i-care 2026-05-21 monthly 0.5 https://crcwarriors.org/articulo/2617/la-oxigenacion-del-intestino-influye-en-el-desarrollo-del-cancer-colorrectal 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/1853/seguridad-y-eficacia-de-lapatinib-binimetinib-y-vinorelbina-en-cancer-colorrectal-metastasico-con-mutacion-ras-resultados-del-ensayo-rastric-fase-i-ii 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2366/vesiculas-extracelulares-de-car-t-cargadas-con-heparanasa-remodelan-el-microambiente-tumoral-del-cancer-colorrectal-y-potencian-la-inmunidad-antitumoral-de-las-celulas-t 2026-08-01 monthly 0.5 https://crcwarriors.org/articulo/1856/los-estudios-sobre-los-caf-hipoxicos-revelan-que-el-eje-pthrp-vitamina-d-ras-es-fundamental-en-los-caf 2026-06-24 monthly 0.5 https://crcwarriors.org/articulo/2368/la-transicion-dinamica-entre-estados-celulares-impulsados-por-mapk-y-estados-celulares-impulsados-por-wnt-impulsa-el-cancer-intestinal-y-determina-la-respuesta-al-tratamiento 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2369/inhibidores-de-los-puntos-de-control-inmunitario-en-el-cancer-colorrectal-metastasico-con-alta-inestabilidad-de-microsatelites-estrategias-de-tratamiento-particularidades-y-aspectos-clave-en-el 2026-08-06 monthly 0.5 https://crcwarriors.org/articulo/838/implicaciones-clinicas-y-pronosticas-de-las-mutaciones-de-ras-en-el-cancer-colorrectal-metastasico 2026-06-17 monthly 0.5 https://crcwarriors.org/articulo/2118/ensayo-fruquitas-diseno-del-estudio-de-un-ensayo-aleatorizado-de-fase-iii-del-grupo-de-colaboracion-engic-que-evalua-la-combinacion-de-trifluridina-tipiracil-con-o-sin-fruquintinib-en-pacientes-con 2026-07-31 monthly 0.5 https://crcwarriors.org/articulo/2125/quimioterapia-supramolecular-visualizada-basada-en-oxpt-ttvp-cb-8-activacion-del-dano-oxidativo-para-inducir-la-muerte-celular-programada-inmunogenica-y-potenciar-la-eliminacion-de-las-celulas 2026-06-01 monthly 0.5 https://crcwarriors.org/articulo/1876/prediccion-de-dmmr-a-partir-de-histopatologia-de-cancer-colorrectal-aprovechamiento-de-regiones-no-tumorales-y-de-bajo-aumento 2026-05-23 monthly 0.5 https://crcwarriors.org/articulo/1629/nanoparticulas-de-selenio-con-objetivo-bioortogonal-para-potenciar-la-terapia-celular-car-en-cancer-colorrectal 2026-06-01 monthly 0.5 https://crcwarriors.org/articulo/2653/respuesta-duradera-al-tratamiento-con-sotorasib-mas-panitumumab-en-el-cancer-rectal-con-mutacion-nras-g12c-e-inestabilidad-de-microsatelites-alta-msi-h-refractario-a-la-inmunoterapia 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2143/la-privacion-del-sueno-inhibe-la-funcion-de-los-linfocitos-t-cd8-al-aumentar-la-expresion-de-galectina-9-en-las-celulas-de-cancer-colorrectal 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/1888/camino-a-seguir-crioablacion-para-metastasis-hepaticas-de-cancer-colorrectal 2026-06-03 monthly 0.5 https://crcwarriors.org/articulo/2150/el-papel-del-adn-tumoral-circulante-en-la-terapia-adyuvante-de-precision-para-el-cancer-colorrectal-una-revision-exploratoria 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/1898/eficacia-de-pembrolizumab-perioperatorio-en-canceres-colorrectales-localizados-deficientes-en-reparacion-de-emparejamiento-de-bases-inestables-a-microsatelites-resultados-del-ensayo-de-fase-ii-imhotep 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1644/el-doble-papel-del-receptor-de-peptidos-formilados-1-fpr1-en-la-inflamacion-y-la-carcinogenesis-gastrointestinal-mecanismos-e-implicaciones-terapeuticas 2026-06-04 monthly 0.5 https://crcwarriors.org/articulo/2163/el-regorafenib-potencia-la-eficacia-terapeutica-anti-pdcd1-pd-1-en-el-cancer-colorrectal-al-promover-la-degradacion-de-cd274-pd-l1-mediada-por-sqstm1-p62 2026-08-23 monthly 0.5 https://crcwarriors.org/articulo/2174/estudio-sobre-el-efecto-de-los-antibioticos-en-la-eficacia-de-los-inhibidores-de-pd-1-y-su-mecanismo-regulador-a-traves-de-la-comunidad-bacteriana-intestinal 2026-06-21 monthly 0.5 https://crcwarriors.org/articulo/2431/identificacion-de-nuevos-inhibidores-de-moleculas-pequenas-dirigidos-a-kdm5b-y-evaluacion-de-sus-efectos-antitumorales 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/2187/significado-clinico-del-indice-pronostico-de-napoles-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal 2026-06-24 monthly 0.5 https://crcwarriors.org/articulo/1427/reinicio-exitoso-de-encorafenib-y-cetuximab-en-combinacion-con-nivolumab-en-cancer-colorrectal-metastasico-mutado-braf-v600e-y-con-reparo-de-desajuste-dn-competente-un-informe-de-caso-del-registro 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2197/deteccion-del-cancer-estratificada-segun-el-riesgo-un-modelo-conceptual-basado-en-el-consenso-de-eucanscreen 2026-06-24 monthly 0.5 https://crcwarriors.org/articulo/2199/sistema-de-administracion-oral-nano-vacunal-mucoadhesivo-con-capacidad-inmunomoduladora-para-una-terapia-sinergica-contra-el-cancer-colorrectal 2026-06-13 monthly 0.5 https://crcwarriors.org/articulo/1432/estudio-fase-iii-aleatorio-de-la-adicion-de-paclitaxel-a-la-quimiorradioterapia-con-capecitabina-y-mitomicina-c-en-carcinoma-escamoso-anal 2026-07-07 monthly 0.5 https://crcwarriors.org/articulo/1688/estudio-de-fase-ii-de-pembrolizumab-mas-capecitabina-y-bevacizumab-para-cancer-colorrectal-metastasico-estable-en-microsatelites-competente-en-reparacion-de-desajuste 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/1950/una-nanoparticula-hibrida-con-membrana-que-mimetiza-y-modula-la-respuesta-inmune-mediante-fototermia-inhibe-el-crecimiento-y-la-metastasis-del-cancer-colorrectal 2026-06-05 monthly 0.5 https://crcwarriors.org/articulo/416/nueva-plataforma-de-pcr-mediada-por-ligacion-y-sonda-de-interconexion-para-la-deteccion-ultrasensible-y-altamente-especifica-de-variaciones-de-un-solo-nucleotido-de-baja-frecuencia 2026-06-01 monthly 0.5 https://crcwarriors.org/articulo/2208/el-indice-pronostico-basado-en-biomarcadores-inflamatorios-ibpi-obtenido-a-partir-de-los-analisis-de-sangre-preoperatorios-estandar-predice-las-complicaciones-postoperatorias-en-pacientes-sometidos-a 2026-06-24 monthly 0.5 https://crcwarriors.org/articulo/1955/relevancia-pronostica-y-para-el-seguimiento-del-oxido-nitrico-sistemico-en-pacientes-con-cancer-de-colon 2026-06-03 monthly 0.5 https://crcwarriors.org/articulo/2213/desarrollo-y-validacion-de-un-modelo-de-aprendizaje-automatico-de-conjunto-para-predecir-la-supervivencia-en-el-cancer-colorrectal-localmente-avanzado-un-estudio-retrospectivo-multicentrico 2026-06-23 monthly 0.5 https://crcwarriors.org/articulo/2217/la-inhibicion-de-la-autofagia-mejora-la-eficacia-del-bloqueo-de-pd-1-en-el-cancer-colorrectal-con-reparacion-del-desajuste-funcional-conservada 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/1974/eficacia-y-seguridad-del-tratamiento-de-segunda-linea-con-fluorouracilo-leucovorina-e-irinotecan-mas-ramucirumab-segun-los-regimenes-previos-de-primera-linea-en-el-cancer-colorrectal-metastasico-un 2026-07-29 monthly 0.5 https://crcwarriors.org/articulo/1976/identificacion-preclinica-y-validacion-clinica-de-biomarcadores-dinamicos-para-trifluridina-tipiracil-con-o-sin-bevacizumab-en-el-cancer-colorrectal-metastasico 2026-06-04 monthly 0.5 https://crcwarriors.org/articulo/1977/la-validacion-integrada-a-traves-de-la-transcriptomica-y-la-proteomica-identifica-a-slc35d3-como-un-antigeno-de-superficie-selectivo-para-tumores-en-los-carcinomas-colorrectales-y-neuroendocrinos 2026-08-17 monthly 0.5 https://crcwarriors.org/articulo/1978/nuevos-y-consolidados-objetivos-terapeuticos-en-el-cancer-colorrectal-traslacion-de-la-biologia-a-la-terapia 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/1980/datos-sobre-las-firmas-transcriptomicas-de-microarn-los-genes-diana-predichos-y-el-analisis-de-vias-de-senalizacion-en-respuesta-a-cetuximab-o-panitumumab-en-celulas-de-cancer-colorrectal 2026-06-04 monthly 0.5 https://crcwarriors.org/articulo/2236/presentamos-la-base-de-datos-j-connect-un-recurso-de-oncologia-del-mundo-real-para-japon 2026-06-04 monthly 0.5 https://crcwarriors.org/articulo/2247/diseno-sintesis-y-actividad-antitumoral-en-cancer-colorrectal-de-quinoxalinas-con-propiedades-farmacologicas-mejoradas 2026-06-01 monthly 0.5 https://crcwarriors.org/articulo/2248/un-nuevo-degradador-dirigido-a-fak-diseno-sintesis-y-potencial-terapeutico-contra-el-cancer-colorrectal 2026-06-01 monthly 0.5 https://crcwarriors.org/articulo/1738/tnmplot-una-plataforma-mejorada-para-la-identificacion-de-dianas-farmacologicas-mediante-el-analisis-de-la-expresion-genica-en-diferentes-estadios-y-en-diversos-tipos-de-cancer 2026-06-03 monthly 0.5 https://crcwarriors.org/articulo/2252/sacituzumab-govitecan-en-el-cancer-colorrectal-evidencia-clinica-y-perspectivas-futuras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1999/el-inhibidor-selectivo-de-kras-g12d-mrtx1133-suprime-la-proliferacion-y-modula-diferencialmente-la-quimiosensibilidad-en-el-carcinoma-mucinoso-de-ovario 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/2256/efecto-de-la-terapia-antitumoral-previa-dirigida-contra-el-egfr-y-de-la-caracterizacion-inicial-del-ctdna-en-la-eficacia-de-pertuzumab-mas-trastuzumab-en-el-cancer-colorrectal-metastasico-con 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/2258/el-nivel-de-metilacion-del-adn-tumoral-circulante-es-un-biomarcador-pronostico-mas-preciso-en-el-cancer-de-colon 2026-06-29 monthly 0.5 https://crcwarriors.org/articulo/2259/paisaje-de-mutaciones-en-la-linea-germinal-distinto-e-implicaciones-clinicas-en-el-cancer-colorrectal-chino-un-analisis-genomico-a-gran-escala-de-1094-pacientes 2026-06-29 monthly 0.5 https://crcwarriors.org/articulo/2260/fkbp9-aumenta-la-proliferacion-de-las-celulas-de-cancer-de-colon-al-inhibir-la-ferroptosis-mediada-por-gpx4 2026-06-29 monthly 0.5 https://crcwarriors.org/articulo/2020/nivolumab-mas-ipilimumab-y-cobimetinib-en-pacientes-con-cancer-colorrectal-metastasico-con-microsatelites-estables-reparacion-deficiente-del-emparejamiento-del-adn-previamente-tratados-el-ensayo-de 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2276/fusobacterium-nucleatum-en-el-cancer-interacciones-con-la-microbiota-colonizacion-tumoral-y-progresion-del-cancer 2026-06-18 monthly 0.5 https://crcwarriors.org/articulo/1511/cambios-en-la-6a-edicion-de-la-clasificacion-de-la-organizacion-mundial-de-la-salud-de-los-tumores-del-sistema-digestivo 2026-05-22 monthly 0.5 https://crcwarriors.org/articulo/2279/novedades-en-el-manejo-del-cancer-anal-ha-comenzado-una-nueva-era 2026-08-02 monthly 0.5 https://crcwarriors.org/articulo/1003/evaluacion-inmunohistoquimica-de-la-expresion-de-proteina-egfr-y-densidad-microvascular-revela-una-firma-angiogenica-en-pacientes-tunecinos-con-cancer-colorrectal-metastasico 2026-05-29 monthly 0.5 https://crcwarriors.org/articulo/2027/inmunoterapia-en-el-cancer-colorrectal-localizado-practica-actual-y-perspectivas-futuras 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/2288/propiedades-antitumorales-in-vitro-e-in-vivo-del-aceite-esencial-de-lemmaphyllum-drymoglossoides-contra-el-cancer-colorrectal-y-posibles-mecanismos-de-accion 2026-06-15 monthly 0.5 https://crcwarriors.org/articulo/2218/nanoparticulas-para-la-terapia-del-cancer-colorrectal-una-revision 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2249/una-nueva-sonda-fluorescente-de-infrarrojo-cercano-dirigida-al-at1r-permite-la-visualizacion-y-la-reseccion-intraoperatorias-en-el-carcinoma-hepatocelular 2026-06-29 monthly 0.5 https://crcwarriors.org/articulo/2297/induccion-diferencial-de-la-muerte-de-las-celulas-cancerosas-mediante-extractos-de-raiz-hoja-y-flor-derivados-de-kalanchoe-pinnata 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/1544/deteccion-de-variantes-kras-g12d-en-cancer-colorrectal-mediante-secuenciacion-basada-en-proxima-generacion-un-estudio-de-cohorte-retrospectivo 2026-05-29 monthly 0.5 https://crcwarriors.org/articulo/2206/el-papel-de-la-proteina-quinasa-ii-dependiente-de-ca-2-calmodulina-en-la-resistencia-al-oxaliplatino-del-cancer-colorrectal-estudios-in-vitro-e-in-vivo 2026-06-24 monthly 0.5 https://crcwarriors.org/articulo/2219/biosintesis-de-nanoparticulas-de-metales-preciosos-utilizando-extractos-de-algas-verdes-para-la-terapia-del-cancer 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2223/slc25a48-promueve-el-crecimiento-del-cancer-colorrectal-al-mejorar-la-respiracion-mitocondrial-y-conferir-resistencia-a-la-ferroptosis 2026-05-29 monthly 0.5 https://crcwarriors.org/articulo/2283/la-retencion-del-intron-13-amplia-el-repertorio-de-isoformas-de-adar1-para-modificar-la-senalizacion-de-pkr-y-promover-la-tumorigenesis 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2284/priorizacion-integrativa-de-los-arn-no-codificantes-largos-de-relevancia-clinica-y-biologica-en-los-canceres-gastrointestinales 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2285/el-silenciamiento-epigenetico-de-mafg-es-un-posible-biomarcador-pronostico-en-los-adenocarcinomas-de-pulmon 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2291/pcsk9-presenta-una-nueva-localizacion-nuclear-en-las-celulas-endoteliales-sinusoidales-hepaticas-lsec-y-su-modulacion-con-nanoparticulas-bioinspiradas-reduce-la-metastasis-hepatica-del-cancer 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2292/la-trombospondina-1-derivada-de-los-fibroblastos-modula-la-polarizacion-de-los-macrofagos-en-modelos-de-cocultivo-humano-avanzados 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2050/el-hidrogel-de-doble-farmaco-que-contiene-meloxicam-1-d-mt-actua-como-inmunomodulador-para-revertir-la-recurrencia-postoperatoria-del-tumor-y-la-metastasis 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/2308/precios-disponibilidad-y-asequibilidad-de-los-medicamentos-contra-el-cancer-en-el-condado-de-kisumu-kenia 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/1806/targeting-gpa33-con-car-macrofagos-un-enfoque-inmunoterapeutico-novedoso-para-el-cancer-colorrectal 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/2063/inmunoterapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado-susceptible-de-reseccion 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/2595/los-organoides-derivados-de-tumores-de-pacientes-con-cancer-colorrectal-metastasico-reflejan-la-heterogeneidad-tumoral-y-predicen-la-supervivencia-del-paciente-y-la-sensibilidad-a-los-farmacos 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2598/la-catenina-palmitoilada-un-objetivo-farmacologico-regula-la-evasion-inmune-mediante-la-resistencia-a-la-ferroptosis-inmunogenica-y-la-inmunosupresion-mediada-por-pd-l1 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/1858/inmunoterapia-combinada-para-el-cancer-colorrectal-aplicaciones-clinicas-fundamentos-desafios-y-perspectivas-futuras 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/1949/puede-administrarse-el-extracto-acuoso-de-patrinia-villosa-durante-el-tratamiento-con-folfox-en-pacientes-con-cancer-de-colon-evidencia-obtenida-a-partir-de-un-estudio-preclinico-de-prueba-de-concepto 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/2209/camk1-suprime-la-resistencia-a-la-anoikis-y-la-metastasis-hepatica-en-el-cancer-colorrectal 2026-06-24 monthly 0.5 https://crcwarriors.org/articulo/949/cancer-colorrectal-her2-positivo-mutante-de-ras-mss-un-informe-sobre-un-subtipo-raro-y-nuevas-perspectivas-en-la-inmunoterapia-y-combinaciones-con-adc 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/1752/la-hipoxia-y-el-acido-acetilsalicilico-aumentan-de-manera-aditiva-la-acumulacion-intracelular-de-glutamina-en-celulas-de-cancer-colorrectal-con-mutaciones-en-pik3ca 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/2282/priorizacion-basada-en-la-secuencia-de-variantes-regulatorias-del-promotor-en-el-cancer-colorrectal-mediante-un-modelo-fundamental-de-adn 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2029/ensayo-de-fase-ib-ii-con-analisis-correlativos-de-doxorrubicina-mas-la-combinacion-de-durvalumab-en-pacientes-con-sarcoma-de-tejidos-blandos-avanzado 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/2290/nanotransportadores-de-rucaparib-fdump-con-alta-carga-de-farmaco-para-la-terapia-combinada-del-cancer-colorrectal 2026-09-01 monthly 0.5 https://crcwarriors.org/articulo/2296/analisis-espacial-mediante-aprendizaje-profundo-del-perfil-de-las-celulas-t-cd103-cd8-y-su-relacion-con-la-supervivencia-en-el-cancer-de-recto-tras-la-quimiorradioterapia-neoadyuvante 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/2586/la-separacion-de-fases-inducida-por-la-farnesilacion-de-kras-favorece-el-crecimiento-tumoral-en-el-colon 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/2614/la-composicion-y-el-potencial-funcional-del-microbioma-intestinal-se-asocian-con-la-incidencia-de-diabetes-tipo-2-en-4-685-adultos-de-una-cohorte-sueca-prospectiva 2026-07-12 monthly 0.5 https://crcwarriors.org/articulo/2105/la-decoccion-de-dabupi-atenua-la-mucositis-intestinal-inducida-por-fluorouracilo-mediante-la-activacion-del-receptor-x-farnesoide-y-la-regulacion-al-alza-de-la-dihidropirimidina-deshidrogenasa 2026-05-27 monthly 0.5 https://crcwarriors.org/articulo/1641/la-estabilizacion-mediada-por-stau1-de-itgb5-aumenta-la-actividad-transcripcional-de-foxp3-para-formar-un-circuito-autoreforzante-de-metastasis-en-el-cancer-colorrectal 2026-05-27 monthly 0.5 https://crcwarriors.org/articulo/1897/estado-actual-y-perspectivas-futuras-del-tratamiento-de-precision-para-el-cancer-de-recto-localmente-avanzado 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/950/rc48-induce-senescencia-en-celulas-de-cancer-colorrectal-que-expresan-her2-activando-el-camino-cdkn1a-rb-e2f1 2026-05-27 monthly 0.5 https://crcwarriors.org/articulo/1637/cancer-colorrectal-metastasico-de-alto-methylacion-con-tipo-genotipico-ras-braf-wt-tiene-patrones-de-expresion-genica-relacionados-con-msi-h-y-mutante-braf-v600e-investigacion-traslacional 2026-05-26 monthly 0.5 https://crcwarriors.org/articulo/2181/el-aumento-del-antigeno-carcinoembrionario-durante-la-quimioterapia-basada-en-oxaliplatino-predice-el-beneficio-del-nivolumab-en-el-cancer-colorrectal-metastasico-con-microsatelites-estables-un 2026-05-26 monthly 0.5 https://crcwarriors.org/articulo/2210/efectos-del-pm2-5-ambiental-y-sus-componentes-en-el-pronostico-de-los-supervivientes-de-cancer-colorrectal-progresion-de-la-enfermedad-y-posibles-vias-de-mediacion 2026-05-26 monthly 0.5 https://crcwarriors.org/articulo/2216/msianalyzer-la-secuenciacion-dirigida-con-nanoporos-permite-el-analisis-a-nivel-de-un-solo-nucleotido-de-la-diversidad-de-la-inestabilidad-de-los-microsatelites 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/1712/perfiles-clinicos-y-genomicos-distintos-de-los-subtipos-de-mutacion-braf-en-el-cancer-colorrectal-chino-un-estudio-de-cohortes-retrospectivo-con-validacion-entre-diferentes-poblaciones 2026-05-26 monthly 0.5 https://crcwarriors.org/articulo/2240/mayor-sensibilidad-de-las-celulas-de-cancer-de-ovario-y-de-cancer-colorrectal-a-los-farmacos-a-base-de-platino-y-a-los-innovadores-inhibidores-de-la-timidilato-sintasa-mediante-electroporacion 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2241/evaluacion-comparativa-de-multiples-algoritmos-de-aprendizaje-automatico-para-la-clasificacion-de-diversos-tipos-de-cancer-a-partir-del-secuenciamiento-de-arn-de-plaquetas-modificadas-por-el-tumor 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2242/un-modelo-generativo-profundo-consistente-en-los-ciclos-unifica-los-estados-celulares-en-diferentes-modalidades-espaciales-y-de-celulas-individuales-no-emparejadas 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/1737/una-plataforma-nanometrica-basada-en-fullerenos-amilados-permite-una-terapia-sinergica-dirigida-a-vegfr2-contra-la-angiogenesis-y-la-inmunoterapia-del-tumor 2026-05-26 monthly 0.5 https://crcwarriors.org/articulo/1251/modelado-de-dinamicas-inmunitarias-en-cancer-colorrectal-localemente-avanzado-msi-h-dmmr-con-tratamiento-neoadjuvante-de-pembrolizumab-de-ecuaciones-diferenciales-a-un-marco-basado-en-agentes 2026-05-26 monthly 0.5 https://crcwarriors.org/articulo/2289/los-acidos-grasos-poliinsaturados-de-cadena-larga-mitigan-in-vitro-el-desgaste-del-musculo-esqueletico-inducido-por-celulas-de-carcinoma-colorrectal-a-traves-de-una-via-dependiente-de-la-15-lox 2026-07-03 monthly 0.5 https://crcwarriors.org/articulo/2295/factores-nutricionales-conductuales-y-antropometricos-asociados-con-el-cancer-colorrectal-en-nuakchot-mauritania-un-estudio-de-casos-y-controles 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/1313/vesiculas-extracelulares-en-el-cancer-colorrectal-inmunomodulacion-diagnostico-y-perspectivas-terapeuticas 2026-05-25 monthly 0.5 https://crcwarriors.org/articulo/2097/el-analisis-de-redes-farmacologicas-multiomicas-y-la-validacion-computacional-revelan-que-la-amodiaquina-y-la-desetiloamodiaquina-son-candidatos-multitarget-que-regulan-la-apoptosis-en-el 2026-05-25 monthly 0.5 https://crcwarriors.org/articulo/1622/factores-pronosticos-y-medidas-de-resultados-tras-la-terapia-dirigida-contra-braf-en-el-cancer-colorrectal-metastasico-irresecable-con-mutacion-braf-v600e-un-analisis-a-nivel-de-cohorte-de-estudio 2026-05-25 monthly 0.5 https://crcwarriors.org/articulo/2159/analisis-molecular-comparativo-del-cancer-colorrectal-en-arabia-saudi-alteraciones-geneticas-y-caracteristicas-clinicas-distintas 2026-05-25 monthly 0.5 https://crcwarriors.org/articulo/1414/efectos-antitumorales-de-lpm5140276-y-su-potencial-combinacion-con-la-inhibicion-de-shp2-en-cancer-mutante-kras-g12d 2026-05-25 monthly 0.5 https://crcwarriors.org/articulo/2227/efectos-causales-diferenciales-de-las-variantes-patogenas-en-linea-germinal-de-los-genes-mutyh-y-palb2-en-una-paciente-con-poliposis-colorrectal-y-cancer-de-mama 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2239/imagen-volumetrica-multimodal-sin-necesidad-de-marcadores-de-tejido-de-cancer-de-colon-mediante-el-registro-de-la-tomografia-computarizada-de-contraste-de-fase-basada-en-la-propagacion-la-microscopia 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2552/sofisher-disenos-de-experimentos-guiados-por-aprendizaje-por-refuerzo-para-la-omomica-espacial 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2098/firma-pronostica-y-caracterizacion-del-microambiente-inmunitario-en-el-cancer-colorrectal-basada-en-genes-relacionados-con-las-interleucinas 2026-05-24 monthly 0.5 https://crcwarriors.org/articulo/2106/un-estudio-clinico-exploratorio-preliminar-de-xiao-chai-hu-tang-administrado-en-combinacion-con-quimioterapia-basada-en-irinotecan-en-cancer-colorrectal-avanzado 2026-05-24 monthly 0.5 https://crcwarriors.org/articulo/2141/superacion-de-la-inmunosupresion-mediada-por-sting-mediante-un-agonista-bifuncional-de-sting-inhibidor-de-pd-l1-para-mejorar-la-inmunidad-antitumoral 2026-05-24 monthly 0.5 https://crcwarriors.org/articulo/2211/las-huellas-de-oncometabolitos-resultantes-de-la-interaccion-entre-el-tumor-y-el-estroma-podrian-ser-biomarcadores-no-invasivos 2026-05-25 monthly 0.5 https://crcwarriors.org/articulo/2267/genos-m-un-modelo-base-para-los-genomas-de-microorganismos-asociados-al-ser-humano 2026-08-29 monthly 0.5 https://crcwarriors.org/articulo/2188/los-macrofagos-apoe-inducen-caracteristicas-metastasicas-en-las-celulas-tumorales-a-traves-de-la-senalizacion-tnfsf12-tnfrsf12a-lo-que-se-correlaciona-con-un-mal-pronostico-en-los-pacientes 2026-05-23 monthly 0.5 https://crcwarriors.org/articulo/2195/el-microbioma-en-los-tumores-gastrointestinales-implicaciones-en-la-oncogenesis-y-la-respuesta-terapeutica-el-microbioma-en-los-tumores-gastrointestinales 2026-06-24 monthly 0.5 https://crcwarriors.org/articulo/2196/bioinformatica-combinada-con-experimentos-biologicos-para-explorar-la-promocion-de-la-metastasis-pulmonar-por-ccl18-en-el-microambiente-inmunitario-del-cancer-colorrectal 2026-05-23 monthly 0.5 https://crcwarriors.org/articulo/1979/el-extracto-de-sanghuangporus-vaninii-ejerce-efectos-antitumorales-duales-en-el-cancer-colorrectal-asociado-a-colitis-mediante-citotoxicidad-directa-y-reprogramacion-de-macrofagos-a-traves-del-eje 2026-05-23 monthly 0.5 https://crcwarriors.org/articulo/2570/el-analisis-multirregional-revela-que-el-eje-thbs1-spp1-en-monocitos-y-macrofagos-impulsa-la-inmunosupresion-y-afecta-el-pronostico-en-las-metastasis-hepaticas-del-cancer-colorrectal 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/2574/analisis-de-variantes-de-un-solo-nucleotido-en-biopsia-liquida-mediante-reco-cas 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/2601/la-inmunoterapia-basada-en-metabolitos-fungicos-supera-la-inmunosupresion-de-los-macrofagos-asociados-al-tumor 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/2128/inmunoterapia-y-microbiota-intestinal-una-revision-de-los-adyuvantes-terapeuticos-microbianos-para-la-inmunoterapia-en-tumores-solidos 2026-05-22 monthly 0.5 https://crcwarriors.org/articulo/2180/declaracion-de-consenso-sobre-el-manejo-del-cancer-colorrectal-metastasico-mas-alla-de-la-terapia-de-segunda-linea-en-arabia-saudita 2026-05-23 monthly 0.5 https://crcwarriors.org/articulo/658/vemurafenib-cetuximab-y-camrelizumab-en-cancer-colorrectal-metastasico-mutado-en-braf-v600e-mss 2026-05-22 monthly 0.5 https://crcwarriors.org/articulo/2203/asociacion-entre-la-infeccion-por-clostridioides-difficile-y-la-incidencia-y-la-mortalidad-por-cancer-colorrectal-en-una-cohorte-nacional-de-la-administracion-de-asuntos-de-veteranos 2026-08-23 monthly 0.5 https://crcwarriors.org/articulo/1443/un-analisis-exhaustivo-del-perfil-espacial-e-inmunitario-del-cancer-colorrectal-metastasico-con-deficiencia-en-la-reparacion-de-errores-revela-la-respuesta-a-la-inmunoterapia 2026-05-22 monthly 0.5 https://crcwarriors.org/articulo/2215/la-plasticidad-evolutiva-de-los-fibroblastos-asociados-al-cancer-contribuye-a-la-progresion-maligna-de-los-canceres-gastricos 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2238/priorizacion-estratificada-por-cohortes-de-sgrnas-crispr-cas9-para-la-correccion-mediada-por-hdr-de-codones-tp53-hotspot-en-cancer 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2266/implementacion-y-evaluacion-de-un-programa-de-hospitalizacion-virtual-postoperatoria-para-la-cirugia-colorrectal-electiva-un-analisis-de-concordancia-de-probabilidades 2026-08-30 monthly 0.5 https://crcwarriors.org/articulo/1272/la-terapia-allogenica-fap-car-il15-inkt-mink-215-remodela-la-estroma-tumoral-para-potenciar-la-inmunidad-antitumoral 2026-05-22 monthly 0.5 https://crcwarriors.org/articulo/1296/remision-completa-inducida-por-inmunoterapia-en-carcinomatosis-peritoneal-debido-a-cancer-colorrectal 2026-05-21 monthly 0.5 https://crcwarriors.org/articulo/2590/mecanismos-de-resistencia-geneticos-y-no-geneticos-concurrentes-a-la-inhibicion-de-kras-en-el-cancer-colorrectal 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2138/dinamica-del-adn-tumoral-circulante-y-resultados-clinicos-en-pacientes-con-cancer-colorrectal-avanzado-tratados-con-un-regimen-de-induccion-y-mantenimiento-basado-en-cetuximab 2026-05-21 monthly 0.5 https://crcwarriors.org/articulo/2202/la-medicina-de-precision-basada-en-inteligencia-artificial-identifica-alteraciones-pronosticas-en-la-via-de-senalizacion-wnt-en-pacientes-con-cancer-colorrectal-de-raza-negra-aa-tratados-con-folfox 2026-08-23 monthly 0.5 https://crcwarriors.org/articulo/2253/la-fagocitosis-celular-define-nichos-metabolicos-competitivos-espacialmente-distintos-asociados-con-los-resultados-clinicos-en-el-cancer-colorrectal 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2035/las-meloaxilinas-a-e-cinco-alcaloides-indolicos-monoterpenoides-ineditos-obtenidos-de-melodinus-axillaris-suprimen-el-cancer-colorrectal-al-dirigirse-a-la-via-del-metabolismo-del-hierro 2026-05-21 monthly 0.5 https://crcwarriors.org/articulo/2046/de-los-grupos-de-pacientes-a-la-practica-clinica-una-firma-de-8-genes-combinada-con-la-presencia-de-un-componente-mucinoso-permite-estratificar-el-beneficio-de-la-adicion-de-un-anti-ctla-4-al 2026-05-21 monthly 0.5 https://crcwarriors.org/articulo/2051/las-estatinas-lipofilicas-reducen-los-niveles-de-gpx4-para-promover-la-ferroptosis-y-sensibilizar-las-celulas-cancerosas-al-bloqueo-de-los-puntos-de-control-inmunitario 2026-05-20 monthly 0.5 https://crcwarriors.org/articulo/2602/fragmentomica-del-adn-mitocondrial-libre-circulante-para-la-deteccion-temprana-del-cancer-gastrico-y-las-lesiones-precancerosas 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/2115/arn-no-codificantes-largos-en-las-neoplasias-femeninas-revision-exhaustiva-de-los-mecanismos-moleculares-las-lagunas-clinicas-y-las-perspectivas-terapeuticas 2026-05-20 monthly 0.5 https://crcwarriors.org/articulo/2116/la-inflamacion-sistemica-y-la-fibrosis-hepatica-como-factores-predictivos-de-los-resultados-quirurgicos-en-metastasis-hepaticas-del-cancer-colorrectal-un-estudio-de-supervivencia-basado-en 2026-05-20 monthly 0.5 https://crcwarriors.org/articulo/2134/la-dinamica-temprana-del-ctdna-predice-la-respuesta-a-mosperafenib-en-el-cancer-colorrectal-metastasico-con-mutacion-braf-v600 2026-05-20 monthly 0.5 https://crcwarriors.org/articulo/2165/evaluacion-del-adn-tumoral-circulante-metilado-de-bcat1-e-ikzf1-como-biomarcador-pronostico-en-los-adenocarcinomas-esofagogastricos 2026-05-23 monthly 0.5 https://crcwarriors.org/articulo/2182/estenosis-de-la-vena-innominada-derecha-relacionada-con-el-uso-de-un-cateter-port-en-pacientes-con-cancer-colorrectal-un-analisis-retrospectivo-de-factores-de-riesgo 2026-05-23 monthly 0.5 https://crcwarriors.org/articulo/2190/la-perdida-de-leo1-favorece-la-migracion-adaptada-al-estres-del-re-y-la-dependencia-del-colesterol-en-el-cancer-colorrectal 2026-08-23 monthly 0.5 https://crcwarriors.org/articulo/2191/descifrando-la-sintaxis-de-la-interaccion-mediante-la-separacion-de-las-lineas-celulares-intrinsecas-y-la-presion-del-microambiente 2026-08-23 monthly 0.5 https://crcwarriors.org/articulo/2229/envejecimiento-inflamatorio-del-estroma-en-la-colitis-ulcerosa-y-el-cancer-asociado-a-la-colitis 2026-06-26 monthly 0.5 https://crcwarriors.org/articulo/2230/un-estado-oncofetal-anclado-a-igf2-y-un-modulo-transcripcional-asociado-a-la-recurrencia-definen-el-riesgo-de-progresion-sistemica-en-el-cancer-colorrectal-de-inicio-temprano 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2010/correccion-terapia-neoadyuvante-con-cadonilimab-en-una-paciente-con-cancer-colorrectal-msi-h-dmmr-un-caso-clinico 2026-05-20 monthly 0.5 https://crcwarriors.org/articulo/2556/celulas-mesenquimales-celulas-madre-en-la-iniciacion-progresion-y-terapia-del-tumor 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/1550/pruebas-clinicas-de-terapia-con-anticuerpos-bifuncionales-para-el-cancer-colorrectal-avances-y-proximos-pasos 2026-05-19 monthly 0.5 https://crcwarriors.org/articulo/1323/supervivencia-beneficiosa-de-la-inmunoterapia-en-pacientes-con-cancer-rectal-en-estadio-iv-con-microsatelites-estables-a-propensity-score-matched-analysis 2026-05-19 monthly 0.5 https://crcwarriors.org/articulo/300/ensayo-fase-1-2-de-encorafenib-cetuximab-y-nivolumab-en-cancer-colorrectal-metastasico-estable-en-microsatelites-con-braf-v600e 2026-05-19 monthly 0.5 https://crcwarriors.org/articulo/2204/nuevos-nanobodies-dirigidos-a-la-cox-2-para-la-obtencion-de-imagenes-endoscopicas-moleculares-de-adenomas-colorrectales 2026-08-23 monthly 0.5 https://crcwarriors.org/articulo/2228/strip2-estabiliza-lcn2-para-suprimir-la-ferroptosis-y-favorece-la-malignidad-del-cancer-colorrectal 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/2007/analisis-preliminar-de-mfolfoxiri-mas-bevacizumab-combinado-con-cirugia-citorreductora-para-metastasis-peritoneales-resecables-procedentes-de-cancer-colorrectal-un-ensayo-clinico-prospectivo 2026-05-19 monthly 0.5 https://crcwarriors.org/articulo/2011/informe-de-caso-caracteristicas-ecograficas-de-la-respuesta-patologica-completa-en-el-cancer-de-recto-medio-e-inferior-con-alta-inestabilidad-de-microsatelites-tras-la-inmunoterapia-neoadyuvante-una 2026-05-19 monthly 0.5 https://crcwarriors.org/articulo/2548/microscopia-de-dispersion-raman-estimulada-sin-barrido-que-utiliza-simultaneamente-dos-desplazamientos-raman-para-la-obtencion-de-imagenes-biomoleculares-sin-necesidad-de-marcadores 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2083/en-pacientes-con-tumores-gastrointestinales-la-presencia-de-celulas-tumorales-circulantes-pd-l1-positivas-se-asocia-con-una-mayor-malignidad-tumoral-y-una-alteracion-de-la-inmunidad-sistemica 2026-05-18 monthly 0.5 https://crcwarriors.org/articulo/2177/hestia-integracion-multimodal-escalable-de-histologia-y-transcriptomica-espacial-de-alta-resolucion-para-una-identificacion-robusta-de-dominios-espaciales 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/898/estudio-fase-ii-de-folfiri-con-dosis-baja-de-irinotecano-mas-ramucirumab-como-tratamiento-de-segunda-linea-en-pacientes-japoneses-con-cancer-colorrectal-metastasico-estudio-rindo 2026-05-18 monthly 0.5 https://crcwarriors.org/articulo/2521/dkc1-favorece-la-progresion-del-cancer-colorrectal-y-la-resistencia-a-la-terapia-al-alterar-la-regulacion-de-la-biosintesis-de-esfingolipidos 2026-07-19 monthly 0.5 https://crcwarriors.org/articulo/1769/marcadores-biosanguineos-en-el-cancer-colorrectal-caracteristicas-moleculares-diagnosticas-y-pronosticas-relevantes-clinicamente-y-el-futuro-de-la-medicina-personalizada 2026-05-18 monthly 0.5 https://crcwarriors.org/articulo/1265/la-inmunoterapia-del-cancer-de-pulmon-en-2025-donde-estamos-y-que-viene-a-continuacion 2026-05-18 monthly 0.5 https://crcwarriors.org/articulo/1546/analisis-genetico-de-los-principales-componentes-de-la-cascada-de-senalizacion-pi3k-en-el-carcinoma-colorrectal 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/2073/una-intervencion-nutricional-proactiva-y-estructurada-administrada-a-traves-de-una-plataforma-de-seguimiento-digital-se-asocia-con-mejores-resultados-postoperatorios-en-pacientes-con-cancer-gastrico 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1893/sistema-nanosistematico-de-doble-bloqueo-activado-para-cancer-colorrectal-ferroptosis-mejorada-por-ptt-nir-ii-impulsada-por-ingenieria-de-defectos-para-desencadenar-inmunidad-antitumoral 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/2151/hacia-una-oncologia-de-precision-aprendizaje-no-supervisado-de-variedades-para-el-perfilado-molecular-espacial-en-tejidos-cancerosos 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/951/superando-la-resistencia-a-multiples-medicamentos-en-canceres-gastrointestinales-con-un-adc-dirigido-a-cdh17-conjugado-a-un-inhibidor-de-topoisoenzimas-del-adn 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1002/efecto-de-las-mutaciones-especificas-del-codon-de-kras-en-la-supervivencia-en-crc-metastasico-con-trifluoridina-tipiracil-con-sin-bevacizumab 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/2040/nuevos-conocimientos-sobre-el-papel-ambivalente-y-las-implicaciones-clinicas-de-las-proteinas-de-la-familia-de-motivos-tripartitos-en-el-cancer-colorrectal 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1293/cambio-en-el-microambiente-tumoral-despues-del-tratamiento-con-avelumab-y-combinaciones-de-agentes-inmunestimulantes-en-pacientes-con-tumores-solidos-avanzados 2026-05-16 monthly 0.5 https://crcwarriors.org/articulo/2139/asociacion-entre-la-colonoscopia-y-la-incidencia-de-cancer-colorrectal-en-personas-de-40-a-49-anos-un-estudio-de-cohorte-poblacional-a-nivel-nacional-basado-en-datos-de-reclamaciones 2026-05-16 monthly 0.5 https://crcwarriors.org/articulo/2140/la-presencia-intratumoral-de-prevotella-copri-reprograma-los-macrofagos-asociados-al-tumor-marco-al-disminuir-la-concentracion-de-glicerofosfocolina-lo-que-favorece-la-progresion-del-cancer 2026-05-16 monthly 0.5 https://crcwarriors.org/articulo/692/definicion-de-la-importancia-pronostica-de-braf-v600e-en-el-cancer-colorrectal-en-estadio-temprano-una-revision-sistematica-y-metaanalisis 2026-05-16 monthly 0.5 https://crcwarriors.org/articulo/2600/comprension-y-superacion-de-la-resistencia-a-la-inhibicion-de-mapk-tanto-innata-como-adquirida-en-el-cancer-anaplasico-de-tiroides 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2123/revision-sistematica-de-los-perfiles-transcriptomicos-de-los-monocitos-como-biomarcadores-diagnosticos-y-pronosticos-en-el-cancer-colorrectal 2026-05-15 monthly 0.5 https://crcwarriors.org/articulo/2124/identificacion-de-mettl3-y-prmt5-como-un-par-oncogenico-para-el-pronostico-y-como-posibles-dianas-terapeuticas-en-un-subtipo-de-cancer-colorrectal 2026-05-15 monthly 0.5 https://crcwarriors.org/articulo/2135/uso-de-la-inteligencia-artificial-en-el-analisis-de-imagenes-endoscopicas-para-detectar-enfermedad-residual-o-recurrencia-en-pacientes-con-cancer-de-recto-que-presentan-una-respuesta-clinica-completa 2026-05-16 monthly 0.5 https://crcwarriors.org/articulo/1970/inhibidores-de-los-puntos-de-control-inmunitario-en-el-cancer-colorrectal-con-deficiencia-en-los-mecanismos-de-correccion-de-pruebas-de-pole-pold1-desde-la-base-molecular-hasta-la-practica-clinica-y 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/2528/arid3b-suprime-la-infiltracion-y-la-funcion-de-las-celulas-t-cd8-en-el-cancer-colorrectal-con-estabilidad-de-microsatelites-a-traves-de-runx3 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/2068/respuesta-prolongada-a-pembrolizumab-en-cancer-colorrectal-metastasico-brafv600e-con-estabilidad-de-microsatelites-tras-un-aumento-de-la-carga-mutacional-tumoral 2026-05-14 monthly 0.5 https://crcwarriors.org/articulo/2145/impresion-tridimensional-de-fantomas-pet-realistas 2026-08-17 monthly 0.5 https://crcwarriors.org/articulo/2146/stomapy-inteligencia-artificial-para-la-estratificacion-del-riesgo-de-complicaciones-que-requieren-terapia-enterostomal-tras-el-alta-hospitalaria-despues-de-una-cirugia-de-cancer-colorrectal 2026-08-17 monthly 0.5 https://crcwarriors.org/articulo/2147/tumorarchetyper-un-marco-modular-para-obtener-subtipos-tumorales-basados-en-firmas 2026-08-16 monthly 0.5 https://crcwarriors.org/articulo/2157/analisis-diferencial-de-la-organizacion-espacial-de-los-genes-mediante-funciones-y-tensores-de-minkowski 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/2169/la-inhibicion-del-andamiaje-de-la-tanquirasa-en-el-complejo-de-destruccion-de-la-catenina-mediante-protac-supera-las-limitaciones-de-los-inhibidores-cataliticos-en-el-cancer 2026-05-19 monthly 0.5 https://crcwarriors.org/articulo/2536/la-modificacion-m6a-suprime-la-inmunidad-antitumoral-innata-en-el-cancer-colorrectal-al-limitar-la-acumulacion-de-arn-de-doble-cadena-derivado-de-alu 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/1017/cambio-en-el-estado-de-mmr-como-mecanismo-de-resistencia-adquirida-a-la-inmunoterapia-en-un-cancer-colorrectal-dmmr 2026-05-14 monthly 0.5 https://crcwarriors.org/articulo/2057/la-nat10-lactilada-contribuye-a-la-cuproptosis-inducida-por-elesclomol-a-traves-del-circuito-de-retroalimentacion-positiva-nat10-ac4c-dlat-arnm-dlat-en-el-ccrc 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/2060/la-inhibicion-de-vtcn1-supera-la-inmunosupresion-en-el-cancer-colorrectal-para-activar-las-celulas-t-a-traves-de-la-galectina-3 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/2577/de-los-puntos-calientes-a-los-espacios-calientes-acoplamiento-fotonico-plasmonico-en-cascada-para-el-analisis-en-profundidad-basado-en-sers-de-vesiculas-extracelulares-pequenas-completas 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1317/oncologia-de-precision-en-bulgaria-un-estudio-prospectivo-de-pacientes-con-cancer-colorrectal-metastasico 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/2119/una-nanoenzima-que-se-dirige-a-rig-i-induce-la-panoptosis-para-la-inmunoterapia-del-cancer 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/1616/ablacion-termica-versus-hepatectomia-para-metastasis-hepaticas-solitarias-de-cancer-colorrectal-de-hasta-5-cm-un-estudio-de-emulacion-de-un-ensayo-clinico-multicentrico-sobre-seguridad-eficacia-y 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/2137/la-transcriptomica-espacial-unicelular-identifica-programas-celulares-coordinados-asociados-con-un-buen-pronostico-en-el-cancer-colorrectal-con-estabilidad-microsatelital 2026-08-16 monthly 0.5 https://crcwarriors.org/articulo/1672/carga-tumoral-en-cancer-colorrectal-metastasico-cuantificada-utilizando-modelos-de-aprendizaje-profundo-valor-pronostico-y-beneficio-del-tratamiento-de-mantenimiento-en-la-prueba-cairo3 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/1215/terapias-celulares-adoptivas-no-modificadas-geneticamente-para-tumores-solidos-panorama-actual-y-desafios-futuros 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/2109/case-report-metastasis-cerebral-tras-terapia-estandar-en-cancer-colorrectal-de-tipo-salvaje-braf-kras-una-presentacion-inusual-de-la-progresion-de-la-enfermedad 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/2121/identificacion-de-genes-relacionados-con-la-interaccion-celula-celula-especificos-del-contexto-sin-el-uso-de-bases-de-datos-de-ligandos-y-receptores-a-partir-de-la-transcriptomica-espacial 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2136/paris-asignacion-y-redistribucion-probabilistica-de-secuencias-de-isomir-un-metodo-basado-en-datos-para-eliminar-el-ruido-de-los-datos-de-recuento-de-lecturas-de-isomir 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/1100/la-activacion-de-p53-intrinseco-a-las-celulas-t-mediante-acetilacion-induce-una-inmunidad-antitumoral-que-potencia-la-inmunoterapia-contra-el-cancer 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/1896/desarrollo-y-validacion-de-un-nomograma-multicentrico-para-predecir-el-riesgo-de-metastasis-hepatica-despues-de-la-reseccion-curativa-del-cancer-colorrectal 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/2036/plasmachord-un-enfoque-de-aprendizaje-automatico-para-distinguir-las-variantes-derivadas-de-la-hematopoyesis-clonal-en-las-biopsias-liquidas-de-pacientes-con-tumores-solidos 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/2084/reactivacion-del-bloqueo-de-puntos-de-control-en-el-cancer-colorrectal-mss-una-guia-de-precision-sobre-el-microbioma-desde-los-mecanismos-hasta-la-clinica 2026-05-10 monthly 0.5 https://crcwarriors.org/articulo/2045/la-secuenciacion-de-celulas-individuales-revela-la-heterogeneidad-de-las-celulas-t-en-funcion-de-diferentes-estados-de-inestabilidad-de-microsatelites-lo-que-podria-ser-un-biomarcador-potencial-para 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/2070/hpcal1-favorece-la-progresion-del-cancer-colorrectal-mediante-la-regulacion-al-alza-de-los-ligandos-de-la-via-wnt-y-la-activacion-de-la-via-wnt-catenina-un-proceso-mediado-por-tcf7-p65 2026-05-09 monthly 0.5 https://crcwarriors.org/articulo/2085/un-programa-notum-inhibidor-de-la-via-wnt-intrinseco-al-tumor-impulsa-la-resistencia-inmunitaria-en-el-cancer-colorrectal-con-estabilidad-microsatelital 2026-05-09 monthly 0.5 https://crcwarriors.org/articulo/1862/respuesta-completa-patologica-tras-inmunoterapia-en-carcinoma-de-celulas-escamosas-primario-del-colon-ascendente-dmmr-msi-h-un-informe-de-caso 2026-05-09 monthly 0.5 https://crcwarriors.org/articulo/1904/inhibicion-sinergica-del-crecimiento-tumoral-mediante-la-inhibicion-dirigida-de-met-y-cox-2-en-canceres-gastrico-y-colorrectal 2026-05-09 monthly 0.5 https://crcwarriors.org/articulo/1905/diseno-sintesis-y-estudio-mecanistico-de-una-estructura-de-fenilpirazolopirimidinona-basada-en-moleculas-pequenas-bispecificas-como-terapia-dual-dirigida-a-vegfr-y-al-punto-de-control-inmunitario-pd 2026-05-09 monthly 0.5 https://crcwarriors.org/articulo/1441/papel-emergente-de-las-mutaciones-del-dominio-no-exonucleasa-de-la-polimerasa-alfa-del-adn-en-el-cancer-colorrectal-de-las-variantes-secuenciales-a-las-implicaciones-clinicas 2026-05-09 monthly 0.5 https://crcwarriors.org/articulo/1964/diseno-y-sintesis-racional-de-derivados-de-flavonolactama-como-potentes-inhibidores-de-la-topoisomerasa-i-con-actividad-antitumoral 2026-05-25 monthly 0.5 https://crcwarriors.org/articulo/1981/doble-beneficio-de-xiao-chai-hu-tang-y-sus-compuestos-activos-en-la-terapia-con-cpt-11-proteccion-intestinal-mediante-la-restauracion-de-la-barrera-y-efecto-antiinflamatorio-combinado-con-una-mayor 2026-05-09 monthly 0.5 https://crcwarriors.org/articulo/2037/sintesis-mediante-quimica-de-clic-de-quinazolinonas-injertadas-con-triazoles-como-nuevos-agentes-anticancerigenos-de-amplio-espectro-conocimientos-mecanisticos-sobre-la-apoptosis-y-la-detencion-del 2026-05-12 monthly 0.5 https://crcwarriors.org/articulo/1538/estudio-erbitag-estudio-no-intervencionista-sobre-la-eficacia-de-cetuximab-en-el-tratamiento-de-primera-linea-en-pacientes-con-cancer-colorrectal-metastasico-de-tipo-ras-wt 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/2058/znf473-favorece-la-progresion-del-cancer-colorrectal-y-la-resistencia-a-la-quimioterapia-al-desestabilizar-la-proteina-p53-lo-que-a-su-vez-aumenta-la-expresion-de-survivin 2026-05-09 monthly 0.5 https://crcwarriors.org/articulo/2580/la-expansion-de-antigenos-media-la-erradicacion-heterogenea-de-tumores-solidos-mediante-celulas-car-t-programadas-con-un-agente-desmetilante-del-adn 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/2071/la-reprogramacion-de-la-interaccion-entre-las-celulas-t-y-las-celulas-mieloides-supera-la-resistencia-inmunitaria-en-el-cancer-colorrectal 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/2599/bacterias-modificadas-mediante-un-sistema-dual-y-celulas-dendriticas-permiten-una-administracion-precisa-de-il-12-dentro-del-tumor-y-generan-una-potente-respuesta-inmunitaria-antitumoral 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/1576/nivolumab-ipilimumab-en-pacientes-con-carcinoma-neuroendocrino-avanzado-previamente-tratado-el-ensayo-aleatorizado-de-fase-ii-gco-001-nipinec 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/2089/un-marco-de-trabajo-para-la-busqueda-y-priorizacion-de-la-literatura-que-sirva-de-guia-para-futuras-revisiones-sistematicas-en-el-marco-del-programa-mundial-de-actualizacion-sobre-el-cancer-de-la 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/2616/microsferas-moduladoras-del-microambiente-tumoral-para-potenciar-la-terapia-con-linfocitos-infiltrantes-tumorales-contra-tumores-solidos 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/2107/por-que-los-estados-unidos-de-america-no-han-ratificado-la-convencion-de-las-naciones-unidas-sobre-los-derechos-del-nino-el-poder-de-veto-como-nuevo-marco-de-analisis-para-las-politicas-de-salud 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/2108/la-degradacion-de-ccdc6-mediada-por-kras-impulsa-el-aumento-de-xct-y-la-evasion-de-la-ferroptosis 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/1871/omega-3-el-acido-graso-dha-induce-ferroptosis-en-organoides-derivados-de-pacientes-con-cancer-colorrectal-y-celulas-tolerantes-a-farmacos 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/1918/senalizacion-alterada-de-pi3k-y-erk-mapk-en-cancer-pancreatico-impulsado-por-krasg12r-presenta-oportunidades-para-terapia-de-precision 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/1937/la-induccion-del-espliceosoma-es-una-dependencia-farmacologicamente-targeteable-de-la-senescencia-y-el-cancer-impulsados-por-ras 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/1170/terapia-neoadyuvante-con-cadonilimab-en-un-paciente-con-cancer-colorrectal-msi-h-dmmr-informe-de-caso 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/669/dirigirse-a-drp1-promueve-la-inmunidad-antitumoral-inducida-por-radioterapia-a-traves-de-la-senalizacion-cgas-sting-mediada-por-adn-mitocondrial-en-cancer-colorrectal-mutado-por-kras 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/1505/bacterias-engineering-como-detectores-vivos-de-adn-tumoral-una-nueva-frontera-diagnostica 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/2059/eno2-induce-la-polarizacion-de-macrofagos-m2-en-las-celulas-tumorales-lo-que-favorece-la-metastasis-hepatica-del-cancer-colorrectal 2026-05-09 monthly 0.5 https://crcwarriors.org/articulo/2064/secuenciacion-del-exoma-completo-para-identificar-neoantigenos-personales-con-alta-inmunogenicidad-en-pacientes-con-cancer-colorrectal-avanzado-con-estabilidad-de-microsatelites-mss 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/2078/mas-alla-de-los-limites-de-las-vias-de-senalizacion-una-prueba-de-agrupamiento-de-redes-que-considera-el-grado-de-conexion-para-conjuntos-de-genes 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2079/la-integracion-multiomica-centrada-en-cms4-mejora-la-identificacion-de-antigenos-diana-en-el-cancer-colorrectal 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/1921/los-tumores-neuroendocrinos-bien-diferenciados-de-grado-3-del-tracto-gastrointestinal-extrapancreatico-presentan-un-comportamiento-mas-agresivo-en-comparacion-con-los-tumores-de-menor-grado-a-pesar 2026-05-07 monthly 0.5 https://crcwarriors.org/articulo/1164/modelo-de-organoide-tumorales-tridimensionales-derivados-del-paciente-para-la-screening-in-vitro-de-celulas-t-modificadas-con-receptores-antigenos-ciclicos 2026-05-07 monthly 0.5 https://crcwarriors.org/articulo/1968/diseno-sintesis-y-evaluacion-de-inhibidores-de-mnk1-2-basados-en-furo-3-2-c-piridina-para-el-tratamiento-del-cancer-colorrectal 2026-05-25 monthly 0.5 https://crcwarriors.org/articulo/1727/el-analisis-multiomico-revela-caracteristicas-que-mejoran-los-resultados-y-la-resistencia-a-la-inmunoterapia-en-el-cancer-colorrectal-mss 2026-05-07 monthly 0.5 https://crcwarriors.org/articulo/2041/nanomedicamentos-activadores-de-sting-en-la-inmunoterapia-del-cancer-mecanismos-diseno-y-resultados-terapeuticos 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/2047/una-plataforma-modular-y-programable-cas13d-para-la-deteccion-de-variantes-de-un-solo-nucleotido-en-el-arn 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/2049/la-redistribucion-subcelular-del-gpr15-en-las-membranas-internas-promueve-la-reprogramacion-metabolica-mediada-por-nad-y-aumenta-la-quimiosensibilidad-al-5-fu-en-el-cancer-colorrectal 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/2583/analisis-comparativo-de-la-dinamica-temporal-de-las-senales-de-fluorescencia-y-fotoacustica-del-conjugado-de-cetuximab-irdye800-en-tumores-con-sobreexpresion-de-egfr 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/2603/ndi-101150-un-inhibidor-de-hpk1-como-monoterapia-y-en-combinacion-con-pembrolizumab-en-pacientes-con-tumores-solidos-avanzados-resultados-de-un-ensayo-de-fase-i-ii 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/2092/las-neuronas-entericas-modulan-el-ciclo-celular-de-las-celulas-del-cancer-colorrectal-a-traves-de-un-eje-pcsk1-metionina-encefalina 2026-06-11 monthly 0.5 https://crcwarriors.org/articulo/2100/el-impacto-de-las-pruebas-de-deteccion-temprana-de-multiples-tipos-de-cancer-en-la-mortalidad-por-cancer-un-modelo-de-microsimulacion-a-10-anos 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/2101/regulacion-epigenetica-de-la-transformacion-de-las-celulas-madre-intestinales 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/1696/decodificacion-de-la-respuesta-a-la-inmunoterapia-en-cancer-colorrectal-perspectivas-traslacionales-mas-alla-del-msi 2026-05-06 monthly 0.5 https://crcwarriors.org/articulo/956/evaluacion-preclinica-de-la-inmunoterapia-con-celulas-car-t-que-utilizan-un-scfv-humano-completo-especifico-para-epcam-contra-el-cancer-pancreatico 2026-05-06 monthly 0.5 https://crcwarriors.org/articulo/1012/puede-tp53-tmb-y-tme-expandir-el-beneficio-de-la-inmunoterapia-en-cancer-colorrectal-metastasico 2026-05-06 monthly 0.5 https://crcwarriors.org/articulo/2077/la-omica-espacial-unicelular-identifica-los-caf-postn-que-median-la-resistencia-a-la-quimiorradioterapia-en-el-cancer-de-recto 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/2091/stat-un-marco-de-trabajo-con-multiples-agentes-para-el-analisis-espacial-transcriptomico-integrado-e-interactivo 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/1332/validacion-analitica-y-clinica-de-cancermaster-un-panel-de-secuenciacion-de-nueva-generacion-ngs-automatizado-y-dirigido-para-la-oncologia-de-precision-basada-unicamente-en-el-analisis-del-tumor 2026-05-05 monthly 0.5 https://crcwarriors.org/articulo/1863/acciones-dependientes-del-contexto-de-la-via-sting-en-colitis-y-cancer-de-colon-asociado 2026-05-05 monthly 0.5 https://crcwarriors.org/articulo/1877/analisis-proteomico-de-tejido-ffpe-pareado-y-vesiculas-extracelulares-revela-proteinas-asociadas-con-recurrencia-en-cancer-colorrectal-estadio-ii 2026-05-05 monthly 0.5 https://crcwarriors.org/articulo/2042/viabilidad-traslacional-de-una-biopsia-liquida-basada-en-un-microarreglo-plasmonico-para-la-deteccion-de-mutaciones-en-el-codon-kras-en-tejidos-plasma-y-orina-en-el-cancer-colorrectal-en-estadio 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/2052/los-cambios-en-el-transcriptoma-y-las-dependencias-de-letalidad-sintetica-que-se-producen-tras-la-expresion-de-kras-mutante-revelan-una-profunda-especificidad-tisular 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2053/el-modelado-de-sistemas-identifica-las-vias-de-senalizacion-que-determinan-el-fenotipo-y-que-estan-controladas-por-la-fosfatasa-ptprj-en-diversos-contextos-de-activacion-de-receptores-tirosina-quinasa 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2066/molidustat-se-dirige-a-una-vulnerabilidad-sinteticamente-letal-en-el-cancer-colorrectal-con-mutaciones-en-apc-mediante-la-co-inhibicion-de-gstp1-y-phd2 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2090/spatialytica-sistema-multimodal-e-interactivo-basado-en-agentes-para-el-analisis-espacial-de-datos-omicos-con-interfaz-visual 2026-06-11 monthly 0.5 https://crcwarriors.org/articulo/1624/fruquintinib-en-combinacion-con-inhibidores-de-la-via-de-muerte-celular-programada-frente-a-trifluridina-tipiracil-en-combinacion-con-bevacizumab-en-pacientes-con-mcrc-en-lineas-de-tratamiento 2026-05-04 monthly 0.5 https://crcwarriors.org/articulo/1741/un-analisis-retrospectivo-de-la-quimioterapia-basada-en-taxanas-en-adenocarcinoma-de-intestino-delgado 2026-05-04 monthly 0.5 https://crcwarriors.org/articulo/2008/avances-en-la-terapia-local-para-tumores-metastasicos-del-peritoneo-de-origen-gastrointestinal 2026-05-14 monthly 0.5 https://crcwarriors.org/articulo/1887/plataforma-nanobionica-activada-por-ultrasonido-permite-terapia-quimio-sonodinamica-de-accion-prolongada-del-cancer-de-prostata-y-metastasis-linfatica 2026-05-03 monthly 0.5 https://crcwarriors.org/articulo/1702/objetivo-de-pck1-para-superar-la-resistencia-a-los-inhibidores-de-cdk4-6-en-el-tratamiento-del-cancer-de-mama 2026-05-03 monthly 0.5 https://crcwarriors.org/articulo/1728/hongos-como-potentes-moduladores-de-autofagia-en-la-terapia-del-cancer-evidencia-actual-y-perspectivas-terapeuticas 2026-05-03 monthly 0.5 https://crcwarriors.org/articulo/1991/dirigirse-al-oncogen-kras-en-pacientes-con-cancer-colorrectal-metastasico 2026-05-03 monthly 0.5 https://crcwarriors.org/articulo/1514/adn-tumoral-circulante-como-marcador-pronostico-en-cancer-colorrectal-metastasico-analisis-post-hoc-de-la-respuesta-al-tratamiento-y-los-resultados-de-supervivencia-en-el-estudio-alter-c-002 2026-05-03 monthly 0.5 https://crcwarriors.org/articulo/67/avances-y-desafios-en-terapias-dirigidas-para-cancer-colorrectal-amplificado-por-her2 2026-05-02 monthly 0.5 https://crcwarriors.org/articulo/1608/la-desagregacion-del-tumor-sensibiliza-la-radioterapia-para-tumores-rectales-inferiores 2026-05-02 monthly 0.5 https://crcwarriors.org/articulo/1802/trastorno-subclinico-de-la-biologia-de-los-telomeros-en-pacientes-con-cancer-heterocigotos-para-la-variante-fundadora-rtel1-r1264h 2026-04-22 monthly 0.5 https://crcwarriors.org/articulo/2065/los-organoides-tumorales-inactivados-fisicamente-permiten-la-rapida-y-personalizada-expansion-de-celulas-t-citotoxicas-para-la-inmunoterapia-de-tumores-solidos 2026-07-08 monthly 0.5 https://crcwarriors.org/articulo/2082/el-basroparib-inhibe-los-canceres-impulsados-por-yap-mediante-la-estabilizacion-de-la-angiomotina 2026-05-18 monthly 0.5 https://crcwarriors.org/articulo/1320/la-prueba-de-ras-en-la-practica-clinica-del-cancer-colorrectal-metastasico-resultados-de-un-estudio-realizado-en-laboratorios-italianos 2026-05-18 monthly 0.5 https://crcwarriors.org/articulo/2088/evolucion-de-los-anticuerpos-bispecificos-y-multiespecificos-en-la-terapia-del-cancer 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/1581/trastuzumab-derzuximab-en-cancer-avanzado-de-estomago-o-adenocarcinoma-de-la-union-gastroesofagica-y-cancer-colorrectal-que-expresa-el-receptor-humano-epitelial-del-factor-de-crecimiento-eprogeno-2 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1582/comparacion-de-cetuximab-y-panitumumab-en-primera-linea-combinados-con-quimioterapias-dobles-para-el-cancer-colorrectal-izquierdo-un-estudio-observacional-multicentrico-en-el-mundo-real-realizado-por 2026-06-26 monthly 0.5 https://crcwarriors.org/articulo/1589/una-revision-sistematica-de-la-eficacia-de-los-inhibidores-de-kras-p-g12c-en-el-cancer-colorrectal-metastasico-el-estado-actual-de-la-ciencia 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1849/apariencias-citologicas-de-celulas-de-adenocarcinoma-colorrectal-en-orina 2026-04-28 monthly 0.5 https://crcwarriors.org/articulo/1854/terapia-perioperatoria-con-inhibidores-de-puntos-de-control-inmunologico-en-tumores-perspectivas-y-lecciones-compartidas-de-un-campo-en-rapida-evolucion 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/1869/nanorrobots-de-janus-biomimetica-derivados-de-salmonella-revitalizan-la-radio-inmunoterapia-del-cancer-colorrectal-mediante-la-inhibicion-de-la-glucolisis-y-la-activacion-de-cgas-sting 2026-05-15 monthly 0.5 https://crcwarriors.org/articulo/2129/optimizacion-de-la-terapia-en-el-cancer-colorrectal-metastasico-guiada-por-la-discrepancia-en-el-estado-de-mutacion-de-kras-entre-las-lesiones-primarias-y-las-lesiones-recurrentes-metacronicas-un 2026-05-21 monthly 0.5 https://crcwarriors.org/articulo/2131/mas-alla-de-la-imagen-lograr-una-respuesta-patologica-completa-en-el-cancer-colorrectal-metastasico-msi-alto-a-pesar-de-la-persistencia-de-la-actividad-en-la-pet 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1630/reorganizacion-dinamica-de-la-flora-bacteriana-intra-tumoral-durante-la-progresion-del-cancer-colorrectal 2026-05-04 monthly 0.5 https://crcwarriors.org/articulo/1126/quimioterapia-triple-combinada-con-tratamiento-anti-receptor-del-factor-de-crecimiento-epidermico-en-cancer-colorrectal-ras-wild-type-un-metaanalisis-de-red 2026-05-01 monthly 0.5 https://crcwarriors.org/articulo/1894/patrones-de-tratamiento-basados-en-inmunoterapia-y-resultados-clinicos-en-diferentes-lineas-de-terapia-en-cancer-colorrectal-metastasico-con-microsatelites-estables-un-estudio-del-mundo-real 2026-05-15 monthly 0.5 https://crcwarriors.org/articulo/1642/marcadores-epigeneticos-del-envejecimiento-y-el-riesgo-de-cancer 2026-04-25 monthly 0.5 https://crcwarriors.org/articulo/2166/exonerate-trace-una-biopsia-liquida-para-monitorizar-la-respuesta-al-tratamiento-basado-en-el-receptor-del-factor-de-crecimiento-epidermico-en-el-cancer-colorrectal-metastasico 2026-06-28 monthly 0.5 https://crcwarriors.org/articulo/1923/estudio-de-fase-ii-diseno-de-ensayo-clinico-descentralizado-wjog15221m-allbreak-para-evaluar-brigatinib-en-tumores-solidos-alk-positivos 2026-06-06 monthly 0.5 https://crcwarriors.org/articulo/1156/reinicio-de-cetuximab-en-cancer-colorrectal-metastasico-seleccionado-molecularmente-el-ensayo-clinico-aleatorio-cave-2-goim 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/1158/sistema-de-nano-distribucion-de-regorafenib-dirigido-a-lrp-1-cd44-que-aprovecha-la-antiangiogenesis-y-la-citotoxicidad-sinergica-contra-la-metastasis-peritoneal-del-cancer-colorrectal 2026-06-19 monthly 0.5 https://crcwarriors.org/articulo/1938/antecedentes-la-fibrosis-hepatica-como-factor-de-riesgo-microambiental-para-la-recurrencia-intrahepatica-en-las-metastasis-hepaticas-de-cancer-colorrectal 2026-05-02 monthly 0.5 https://crcwarriors.org/articulo/1939/biomarcadores-de-vesiculas-extracelulares-circulantes-como-biomarcadores-de-diagnostico-y-pronostico-de-metastasis-hepatica-en-cancer-colorrectal-una-revision-sistematica 2026-04-30 monthly 0.5 https://crcwarriors.org/articulo/1684/4-el-acetilantrocamol-lt3-suprime-el-crecimiento-y-la-metastasis-del-cancer-colorrectal-mediante-la-modulacion-de-las-vias-pi3k-akt-y-mapk 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1940/marcadores-tumorales-sericos-elevados-predicen-citorreduccion-incompleta-supervivencia-libre-de-enfermedad-y-supervivencia-global-en-pacientes-con-metastasis-peritoneales-de-cancer-colorrectal 2026-04-30 monthly 0.5 https://crcwarriors.org/articulo/918/la-intensidad-de-la-dosis-relativa-del-regimen-folfoxiri-y-folfox-folfiri-en-primera-linea-ambos-en-combinacion-con-bevacizumab-influye-en-el-pronostico-de-los-pacientes-con-cancer-colorrectal 2026-05-01 monthly 0.5 https://crcwarriors.org/articulo/2201/la-radioterapia-hipofraccionada-induce-la-aparicion-de-neutrofilos-isg15-mhc-i-para-potenciar-la-inmunidad-antitumoral-y-preparar-la-respuesta-a-la-inhibicion-de-los-puntos-de-control-inmunitario-en 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/1180/el-papel-del-camino-de-senalizacion-hedgehog-en-la-regulacion-de-la-muerte-celular-de-cancer-gastrointestinal 2026-05-07 monthly 0.5 https://crcwarriors.org/articulo/1957/la-combinacion-de-bloqueo-de-pd-1-y-quimiorradioterapia-neoadyuvante-beneficia-a-los-pacientes-pmmr-mss-con-cancer-de-recto-localmente-avanzado-un-ensayo-clinico-de-fase-2 2026-06-02 monthly 0.5 https://crcwarriors.org/articulo/1448/toxicidad-tardia-despues-de-quimiorradioterapia-potenciada-con-peposertib-en-pacientes-con-cancer-de-recto-manejados-con-preservacion-del-organo 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/1967/la-transcriptomica-espacio-temporal-caracteriza-el-microambiente-inmunitario-durante-el-envejecimiento-del-higado-en-ratones 2026-05-25 monthly 0.5 https://crcwarriors.org/articulo/1972/twist1-media-la-activacion-transcripcional-de-spon2-lo-que-favorece-la-metastasis-peritoneal-del-cancer-colorrectal-a-traves-de-una-red-de-senalizacion-de-las-celulas-del-estroma 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/1717/un-cambio-de-paradigma-en-la-predisposicion-genetica-al-cancer-colorrectal-el-impacto-del-cribado-germinativo-con-paneles-multigenicos-en-el-diagnostico-y-la-gestion 2026-05-04 monthly 0.5 https://crcwarriors.org/articulo/1732/ginsenosidos-como-adyuvantes-emergentes-para-la-inmunoterapia-en-canceres-gastrointestinales 2026-05-14 monthly 0.5 https://crcwarriors.org/articulo/1477/landscape-de-mutaciones-en-kras-nras-y-braf-en-pacientes-serbios-con-cancer-colorrectal-de-inicio-temprano 2026-05-01 monthly 0.5 https://crcwarriors.org/articulo/1735/etv4-promueve-la-progresion-del-cancer-colorrectal-al-reprogramar-la-metabolizacion-de-la-asparagina-para-remodelar-el-micromedio-estromal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/712/diferencias-moleculares-y-pronosticas-basadas-en-el-sexo-en-pancrencancer-un-analisis-a-lo-largo-de-cohortes-globales 2026-07-08 monthly 0.5 https://crcwarriors.org/articulo/1484/puntuaciones-de-riesgo-basadas-en-aprendizaje-profundo-a-partir-de-h-e-en-cancer-colorrectal-asociaciones-con-la-morfologia-del-tumor-la-biologia-y-la-respuesta-predictiva-a-los-farmacos 2026-05-02 monthly 0.5 https://crcwarriors.org/articulo/2254/avances-en-la-terapia-con-inhibidores-de-puntos-de-control-inmunitario-para-el-cancer-colorrectal-con-inestabilidad-de-microsatelites-alta-msi-h-y-deficiencia-en-la-reparacion-de-errores-de 2026-06-29 monthly 0.5 https://crcwarriors.org/articulo/1487/papeles-evolutivos-de-la-biopsia-liquida-en-medicina-personalizada-para-el-cancer-colorrectal-desde-el-analisis-de-un-solo-gen-hasta-el-perfiles-genomicos-amplios 2026-05-08 monthly 0.5 https://crcwarriors.org/articulo/1743/la-liquiritigenina-se-dirige-al-receptor-de-transferrina-para-potenciar-la-sensibilidad-a-la-ferropotesis-en-celulas-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2001/eficacia-de-la-quimioterapia-por-infusion-en-la-arteria-hepatica-combinada-con-regorafenib-y-sintilimab-frente-a-regorafenib-en-monoterapia-en-metastasis-hepaticas-de-cancer-colorrectal-mss-pmmr-tras 2026-06-27 monthly 0.5 https://crcwarriors.org/articulo/2513/la-activacion-tumoral-localizada-de-cd40-con-mp0317-un-darpin-fap-x-cd40-reprograma-el-microambiente-tumoral-en-pacientes-con-tumores-solidos-avanzados-un-estudio-de-fase-1-abierto-no-aleatorizado-y 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2516/seguridad-y-actividad-de-ro7300490-un-agonista-bispecifico-de-cd40-dirigido-a-la-proteina-de-activacion-de-fibroblastos-en-pacientes-con-tumores-solidos-avanzados-un-ensayo-de-fase-1-de-un-solo-brazo 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2012/significado-pronostico-de-la-proporcion-de-ganglios-linfaticos-en-el-cancer-colorrectal-obstructivo-un-estudio-retrospectivo-multicentrico 2026-05-14 monthly 0.5 https://crcwarriors.org/articulo/2018/el-analisis-del-lipidoma-de-las-celulas-cancerosas-y-sus-vesiculas-extracelulares-revela-firmas-lipidicas-especificas-del-tipo-de-cancer-y-permite-el-diseno-de-liposomas-mimeticos-de-las-vesiculas 2026-05-15 monthly 0.5 https://crcwarriors.org/articulo/2019/el-analisis-de-marcadores-apoptoticos-en-el-fluido-de-la-quimioterapia-intraperitoneal-hiperermica-se-asocia-con-el-pronostico-en-pacientes-con-metastasis-peritoneales 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/2021/fruquintinib-mas-tas-102-con-o-sin-sbrt-como-terapia-de-tercera-linea-o-posterior-para-el-cancer-colorrectal-metastasico-resultados-preliminares-de-un-ensayo-prospectivo-de-fase-ii 2026-06-11 monthly 0.5 https://crcwarriors.org/articulo/1258/tti1-indica-un-pronostico-pobre-y-esta-asociado-con-metastasis-e-inmunosupresion-del-cancer-colorrectal 2026-04-30 monthly 0.5 https://crcwarriors.org/articulo/1772/excision-total-mesorreteal-transanal-versus-excision-total-mesorreteal-laparoscopica-para-cancer-rectal-medio-y-bajo-color-iii-resultados-a-corto-plazo-de-un-ensayo-internacional-multicentrico-fase-3 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/1519/la-radiossensibilizacion-mediada-por-nanoparticulas-en-la-terapia-radioterapica-del-cancer-colorrectal-una-revision-narrativa-sobre-mecanismos-traduccion-clinica-y-perspectivas-futuras 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/1531/descubrimiento-de-inhibidores-covalentes-basados-en-indolino-del-ulk1-que-suprimieron-la-autofagia-e-indujeron-apoptosis-contra-el-carcinoma-colorrectal 2026-05-01 monthly 0.5 https://crcwarriors.org/articulo/2043/eje-oncogen-mecanica-kras-g12c-confiere-agilidad-lo-que-permite-respuestas-mecanotransducidas-malignas-a-la-peristalsis-en-el-cancer-colorrectal 2026-06-07 monthly 0.5 https://crcwarriors.org/articulo/2558/la-aparicion-de-metastasis-en-el-cancer-colorrectal 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1799/neoadyuvante-mfolfox6-mas-camrelizumab-y-apatinib-en-cancer-de-colon-e-investigacion-de-biomarcadores-mediante-perfilado-espaciotemporal-omico 2026-04-30 monthly 0.5 https://crcwarriors.org/articulo/2061/un-diccionario-del-programa-genetico-de-las-celulas-humanas 2026-09-05 monthly 0.5 https://crcwarriors.org/articulo/2584/un-patogeno-anaerobico-altera-el-metabolismo-del-huesped-para-impulsar-el-crecimiento-oxidativo-en-el-intestino-inflamado 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/690/caso-raro-de-pancreatitis-severa-inducida-por-encorafenib-y-cetuximab-en-cancer-colorrectal-positivo-para-braf-v600e 2026-04-30 monthly 0.5 https://crcwarriors.org/articulo/2023/enzcast-prediccion-de-la-cinetica-enzimatica-especifica-del-paciente-mediante-aprendizaje-profundo-multimodal-e-inferencia-bayesiana-resuelta-a-nivel-de-isoformas-basada-en-la-transcriptomica-de 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/2024/dcafa-analisis-diferencial-de-la-abundancia-comunitaria-y-las-caracteristicas-en-imagenes-histologicas 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/2025/telerehabilitacion-asincrona-en-la-fase-de-prehabilitacion-y-en-la-recuperacion-postoperatoria-del-cancer-colorrectal-un-protocolo-para-un-ensayo-clinico-aleatorizado-y-controlado 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/2033/actividad-biologica-dependiente-del-enantiomero-de-nanoparticulas-de-ceria-recubiertas-con-cisteina-en-celulas-de-cancer-colorrectal 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/2579/irs4-es-una-proteina-que-activa-la-via-pi3k-y-representa-una-dependencia-tumoral-cuya-expresion-se-incrementa-mediante-reordenamientos-del-adn-o-mecanismos-epigeneticos-en-multiples-tumores-solidos 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1638/un-modelo-de-aprendizaje-automatico-basado-en-metabolitos-sericos-predice-la-respuesta-a-la-inmunoterapia-neoadiuvante-en-cancer-colorrectal-deficiente-en-reparacion-de-desajustes 2026-04-29 monthly 0.5 https://crcwarriors.org/articulo/2014/desarrollo-de-mir-15a-modificado-con-gemcitabina-como-nueva-estrategia-de-tratamiento-multimodal-para-superar-la-resistencia-al-5-fu-y-al-oxaliplatino-en-el-cancer-colorrectal 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/2015/clasificacion-mediante-un-algoritmo-de-paseo-cuantico-estabilizado-por-teletransporte-en-entornos-de-neoantigenos-con-resultados-muy-similares 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/2016/la-resistencia-adquirida-a-los-inhibidores-de-los-puntos-de-control-inmunitario-se-asocia-con-la-hipoxia-y-la-remodelacion-de-la-matriz-extracelular-en-el-cancer-colorrectal 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/1516/semaforina-6d-impulsa-las-respuestas-de-tipo-i-de-interferon-antitumoral-para-reprogramar-el-microambiente-tumoral-en-cancer-colorrectal 2026-04-29 monthly 0.5 https://crcwarriors.org/articulo/2032/la-caracterizacion-de-la-via-de-senalizacion-estres-supervivencia-revela-que-mcm10-es-un-posible-biomarcador-de-las-disparidades-en-el-cancer-colorrectal-en-la-poblacion-hispana 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/2547/deteccion-con-informacion-espacial-de-alteraciones-en-el-numero-de-copias-a-partir-de-la-transcriptomica-espacial-mediante-spacna 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/1947/radioterapia-adyuvante-de-corta-duracion-combinada-con-quimioterapia-y-un-inhibidor-de-pd-1-para-el-melanoma-mucoso-resecado-protocolo-de-estudio-para-un-ensayo-de-fase-ii-prospectivo-de-un-solo-brazo 2026-04-28 monthly 0.5 https://crcwarriors.org/articulo/1982/el-panorama-terapeutico-y-los-mecanismos-subyacentes-de-la-taurina-en-el-cancer-colorrectal 2026-04-28 monthly 0.5 https://crcwarriors.org/articulo/2009/un-marco-de-segmentacion-basado-en-la-transcriptomica-y-simulacion-celular-para-la-transcriptomica-espacial-de-alta-resolucion-y-la-comunicacion-celula-celula 2026-05-31 monthly 0.5 https://crcwarriors.org/articulo/1127/el-ensayo-de-fase-ii-bevatomox-raltitrexed-oxaliplatino-bevacizumab-frente-a-mfolfox6-bevacizumab-en-el-cancer-colorrectal-metastasico-en-segunda-linea 2026-04-27 monthly 0.5 https://crcwarriors.org/articulo/1913/andamiajes-de-arn-polimerico-de-ingenieria-como-agonistas-innatos-combinatorios-programables-del-sistema-inmunologico 2026-04-27 monthly 0.5 https://crcwarriors.org/articulo/1709/insights-mecanicos-sobre-la-eficacia-mejorada-del-bloqueo-de-ctla-4-mediante-inmunomodulacion-mediada-por-eubacterium-rectale-en-la-presencia-de-cordicepina-en-cancer-colorrectal 2026-04-27 monthly 0.5 https://crcwarriors.org/articulo/2005/el-pdgf-bb-y-el-gdf-15-derivados-de-macrofagos-promueven-la-resistencia-a-los-farmacos-en-el-cancer-colorrectal-con-mutacion-de-kras 2026-05-29 monthly 0.5 https://crcwarriors.org/articulo/953/shr-a1811-es-un-nuevo-conjugado-anticuerpo-farmaco-anti-her2-con-una-relacion-optima-entre-farmaco-y-anticuerpo-una-eficacia-optima-para-la-destruccion-de-tumores-y-un-perfil-de-seguridad-favorable 2026-04-26 monthly 0.5 https://crcwarriors.org/articulo/1989/consumo-de-alcohol-y-subtipos-moleculares-del-cancer-colorrectal-analisis-combinados-observacionales-y-de-aleatorizacion-mendeliana 2026-04-26 monthly 0.5 https://crcwarriors.org/articulo/1604/descubrimiento-de-bbo-11818-un-inhibidor-no-covalente-potente-y-selectivo-de-on-y-off-kras-con-actividad-contra-multiples-mutantes-oncogenicos 2026-04-25 monthly 0.5 https://crcwarriors.org/articulo/1927/la-cetuximab-aumenta-la-expresion-de-lgr5-y-potencia-la-eficacia-del-conjugado-anticuerpo-farmaco-dirigido-a-lgr5-en-modelos-de-cancer-colorrectal-derivados-de-pacientes 2026-04-25 monthly 0.5 https://crcwarriors.org/articulo/2002/factores-de-riesgo-para-la-resistencia-a-los-antimicrobianos-en-pacientes-con-cancer-y-supervivientes-de-cancer-un-estudio-basado-en-registros-electronicos-de-salud 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2525/predictores-espaciales-de-la-respuesta-a-la-quimioinmunoterapia-en-el-cancer-colorrectal-metastasico-con-estabilidad-microsatelital 2026-07-21 monthly 0.5 https://crcwarriors.org/articulo/2031/un-metodo-escalable-para-la-extraccion-de-datos-validados-de-los-registros-electronicos-de-salud-mediante-modelos-de-lenguaje-de-gran-tamano 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/1116/la-mutacion-de-braf-impulsa-la-recurrencia-intrahepatica-multifocal-temprana-tras-la-reseccion-curativa-de-metastasis-de-cancer-colorrectal-limitadas-al-higado 2026-04-24 monthly 0.5 https://crcwarriors.org/articulo/1958/la-administracion-de-c-di-amp-mediante-salmonella-modificada-geneticamente-activa-la-via-sting-y-remodela-el-microambiente-tumoral 2026-04-24 monthly 0.5 https://crcwarriors.org/articulo/1973/formacion-del-nicho-premetastasico-impulsada-por-la-microbiota-intestinal-en-la-metastasis-hepatica-del-cancer-colorrectal-mecanismos-e-importancia-traslacional 2026-04-24 monthly 0.5 https://crcwarriors.org/articulo/1988/variabilidad-genomica-de-la-linea-celular-hct116-identificada-mediante-la-secuenciacion-de-oxford-nanopore 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2004/los-modelos-de-cancer-colorrectal-c26-y-ct26-presentan-fenotipos-de-caquexia-divergentes-inflamacion-intramuscular-y-senalizacion-de-la-renovacion-de-proteinas 2026-05-29 monthly 0.5 https://crcwarriors.org/articulo/1998/redes-de-similitud-derivadas-de-tensores-para-caracterizar-los-patrones-espaciales-en-el-cancer-colorrectal 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/989/un-activador-bispecifico-de-celulas-t-dirigido-a-kras-g12v-promueve-la-inmunidad-contra-tumores-solidos-de-cancer-colorrectal 2026-04-23 monthly 0.5 https://crcwarriors.org/articulo/2566/el-analisis-del-perfil-transcripcional-de-la-sangre-periferica-permite-predecir-el-subtipo-tumoral-y-los-resultados-de-la-quimioterapia-y-la-inmunoterapia-neoadyuvante-en-el-cancer-de-mama-humano 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1975/inmunidad-antitumoral-inducida-por-la-ablacion-con-etanol-en-gel-para-el-tratamiento-de-metastasis-hepaticas-irresecables-de-cancer-colorrectal 2026-04-23 monthly 0.5 https://crcwarriors.org/articulo/1986/heterogeneidad-intratumoral-una-perspectiva-basada-en-las-redes-reguladoras-de-genes 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/1987/el-microbioma-intestinal-como-biomarcador-diagnostico-para-la-deteccion-temprana-del-cancer-una-revision-sistematica-y-metaanalisis-de-18-estudios-en-cinco-tipos-de-cancer 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/1476/avances-en-la-inmunoterapia-para-el-cancer-colorrectal-superando-la-resistencia-en-tumores-con-reparacion-del-desajuste-de-bases-mismatch-repair-funcional 2026-04-22 monthly 0.5 https://crcwarriors.org/articulo/1993/impacto-de-la-colonoscopia-de-vigilancia-en-la-incidencia-y-la-mortalidad-por-cancer-colorrectal-en-el-sindrome-de-lynch-un-estudio-observacional-nacional-de-cohortes-de-pacientes-del-servicio 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/1994/medicina-herbal-china-como-terapia-complementaria-para-el-tratamiento-del-cancer-colorrectal-protocolo-de-estudio-para-una-encuesta-de-consenso-de-expertos-mediante-el-metodo-delphi 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/1995/estimacion-de-los-casos-de-cancer-en-personas-transgenero-y-con-diversidad-de-genero-en-inglaterra 2026-08-27 monthly 0.5 https://crcwarriors.org/articulo/1744/trasplante-de-microbiota-fecal-combinado-con-terapia-anti-pd-1-en-cancer-gastrico-refractario-con-estabilidad-de-microsatelites-un-estudio-de-fase-i-para-evaluar-la-viabilidad-y-la-seguridad 2026-04-22 monthly 0.5 https://crcwarriors.org/articulo/1795/diseno-sintesis-y-evaluacion-biologica-in-vitro-in-vivo-de-derivados-de-artesunato-ebselen-induccion-de-la-ferroptosis-dirigida-a-gpx4-y-activacion-sinergica-de-la-respuesta-inmune-antitumoral-en-el 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/1941/la-emergencia-de-plasticidad-oncofetal-es-ubicua-en-los-canceres-colorrectales-tempranos 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/932/desarrollo-y-ensayo-clinico-de-m701-un-anticuerpo-bifuncional-anti-epcam-x-anti-cd3-una-terapia-intraperitoneal-dirigida-para-ascitis-maligna-que-proviene-de-tumores-solidos-avanzados 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/1956/usp13-estabiliza-socs1-para-revertir-la-resistencia-a-pd-1-en-el-cancer-colorrectal-msi-h 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/1704/cuet-inhibe-la-progresion-del-sarcoma-de-ewing-oseo-a-traves-de-la-modulacion-del-eje-de-senalizacion-esm1-mapk-erk 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/1960/analisis-de-la-prevalencia-y-las-desigualdades-del-sindrome-de-ovario-poliquistico-en-mujeres-jovenes-en-953-ubicaciones-entre-1990-y-2040-mediante-predicciones-con-aprendizaje-profundo 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/1207/landscapea-completodelos-marcadores-diagnosticos-pronosticos-y-predictivos-en-cancer-colorrectal-desde-la-genomica-hasta-la-integracion-de-multi-omics-en-medicina-personalizada 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/1984/analisis-integrado-a-nivel-de-celula-unica-y-mediante-tecnicas-de-localizacion-espacial-de-la-expresion-genica-de-mmp-en-el-cancer-colorrectal 2026-06-27 monthly 0.5 https://crcwarriors.org/articulo/1985/reposicionamiento-computacional-de-farmacos-dirigido-a-la-senalizacion-intercelular-mediada-por-luxs-en-fusobacterium-nucleatum-un-enfoque-de-cribado-virtual-y-dinamica-molecular 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/2514/tmem87a-suprime-la-ferroptosis-e-incrementa-la-resistencia-a-la-inmunoterapia-contra-el-cancer-al-mantener-la-homeostasis-del-ph-del-aparato-de-golgi 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2003/pthrp-impulsa-caracteristicas-agresivas-en-las-celulas-de-cancer-colorrectal-implicaciones-de-la-interaccion-entre-las-celulas-tumorales-y-el-estroma 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/1268/sindrome-atenuado-de-li-fraumeni-con-tp53-p-r181h-en-un-paciente-japones-con-adenocarcinoma-rectal-metastasico-informe-de-caso 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/1014/sintesis-de-un-nanobody-bispecifico-anti-pd-l1-asistida-por-aminoacidos-no-canonicos-para-la-inmunoterapia-del-cancer-de-colon 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/2608/el-microbioma-intratumoral-cuya-composicion-varia-segun-el-sexo-influye-en-el-perfil-molecular-e-inmunitario-del-tumor-y-en-la-evolucion-de-la-enfermedad 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/2610/la-proteomica-de-las-vesiculas-extracelulares-plasmaticas-identifica-posibles-biomarcadores-para-predecir-la-respuesta-al-tratamiento-con-177lu-psma-617-en-pacientes-con-cancer-de-prostata-metastasico 2026-07-12 monthly 0.5 https://crcwarriors.org/articulo/2612/el-analisis-espacial-a-nivel-de-celula-unica-permite-estratificar-el-adenocarcinoma-de-pulmon-con-mutaciones-raras-que-pueden-ser-objeto-de-tratamiento-y-revela-interacciones-celulares 2026-07-12 monthly 0.5 https://crcwarriors.org/articulo/1077/tapistry-un-estudio-de-fase-ii-de-atezolizumab-en-pacientes-con-tumores-con-una-alta-carga-mutacional-tumoral 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/853/enfoques-sinteticos-y-aplicacion-clinica-de-inhibidores-de-kras-para-el-tratamiento-del-cancer 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1906/alfa-1-antitripsina-derivada-de-tumores-promueve-metastasis-hepatica-del-cancer-colorrectal-a-traves-de-la-via-de-trampas-extracelulares-de-neutrofilos-ccdc25 2026-04-23 monthly 0.5 https://crcwarriors.org/articulo/1907/un-conjunto-de-metodos-de-fusion-de-datos-multimodales-basados-en-aprendizaje-automatico-para-analisis-de-riesgo-pronostico-en-cancer-colorrectal-metastasico-tratado-con-bevacizumab 2026-04-23 monthly 0.5 https://crcwarriors.org/articulo/1942/el-tamano-importa-definicion-de-un-estandar-de-referencia-para-la-medicion-de-polipos-colorectales 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1961/mas-alla-de-los-marcadores-individuales-valor-pronostico-del-indice-combinado-cea-pni-en-el-cancer-colorrectal-metastasico-como-predictor-de-supervivencia 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/1997/estudio-in-silico-de-la-implicacion-clinica-de-los-marcadores-asociados-con-los-mecanismos-reguladores-de-pthrp-y-relacionados-con-la-angiogenesis-y-el-programa-de-transicion-epitelio-mesenquimal-del 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/1804/caracteristicas-basales-del-tumor-y-dinamicas-inmunologicas-sistemicas-subyacentes-a-la-eficacia-en-cancer-colorrectal-metastasico-mss-tratado-con-regorafenib-ipilimumab-y-nivolumab 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1130/olaparib-para-pacientes-con-tumores-que-presentan-alteraciones-en-los-genes-implicados-en-la-reparacion-por-recombinacion-homologa-resultados-del-protocolo-de-redescubrimiento-del-farmaco 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1468/papel-predictivo-del-adn-tumoral-circulante-en-el-cancer-de-colon-en-estadio-iii-tratado-con-celecoxib-un-analisis-post-hoc-del-ensayo-clinico-aleatorizado-de-fase-3-calgb-alliance-swog-80702 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1747/metastasis-cerebrales-de-cancer-colorrectal-un-estudio-retrospectivo-de-dos-centros 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1512/egfr-como-marcador-biologico-en-cancer-colorrectal-un-enfoque-de-biosensores-electroquimicos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1785/construccion-de-un-inmunosensor-de-electroquimioluminiscencia-basado-en-un-mecanismo-mejorado-de-preconcentracion-para-la-deteccion-ultrasensible-de-cea 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1910/ventajas-de-la-compresion-magnetica-en-anastomosis-colonica-de-ratas-un-estudio-comparativo-con-perspectiva-transcriptomica 2026-04-23 monthly 0.5 https://crcwarriors.org/articulo/957/cd300e-es-un-impulsor-del-entorno-microambiental-inmunosupresivo-y-la-progresion-del-cancer-colorrectal-a-traves-de-la-reprogramacion-de-los-macrofagos 2026-04-18 monthly 0.5 https://crcwarriors.org/articulo/1983/la-mutagenesis-asociada-a-la-terapia-en-los-sitios-de-union-de-ctcf-esta-influenciada-por-el-contexto-de-la-cromatina-y-la-capacidad-de-reparacion-del-adn 2026-05-26 monthly 0.5 https://crcwarriors.org/articulo/1953/los-datos-son-importantes-el-impacto-de-la-curacion-de-datos-en-la-clasificacion-de-conjuntos-de-datos-histopatologicos 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/1459/eficacia-y-seguridad-de-tislelizumab-como-tratamiento-neoadyuvante-en-pacientes-con-cancer-colorrectal-de-etapa-ii-iii-microsatelite-inestable-alto-deficit-de-reparacion-de-errores-de-pareo-un 2026-04-17 monthly 0.5 https://crcwarriors.org/articulo/694/inhibicion-de-los-puntos-de-control-inmunitario-como-terapia-neoadyuvante-en-el-cancer-colorrectal-msi-h-dmmr-una-revision-sistematica-de-ensayos-prospectivos-que-evaluan-la-eficacia-la-respuesta 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1864/valor-pronostico-de-la-proporcion-ca19-9-albumina-previa-al-tratamiento-en-cancer-colorrectal-metastasico-de-novo-un-estudio-de-cohorte-retrospectivo 2026-04-27 monthly 0.5 https://crcwarriors.org/articulo/1875/canales-piezo-en-tumores 2026-04-25 monthly 0.5 https://crcwarriors.org/articulo/1908/una-estrategia-de-cuidado-perioperatorio-para-la-prevencion-del-delirio-postoperatorio-en-pacientes-ancianos-con-tumores-gastrointestinales-un-estudio-observacional-clinico 2026-04-23 monthly 0.5 https://crcwarriors.org/articulo/1909/mayor-riesgo-de-metastasis-en-ganglios-linfaticos-mesocolicos-centrales-en-cancer-de-colon-estadio-i-iii-con-mutacion-braf 2026-04-23 monthly 0.5 https://crcwarriors.org/articulo/1911/primer-caso-de-un-paciente-con-una-mutacion-germinal-heterocigota-en-el-gen-mutyh-que-presenta-de-forma-sincronica-carcinomas-papilar-medular-y-timico 2026-04-22 monthly 0.5 https://crcwarriors.org/articulo/933/las-celulas-madre-de-cancer-colorrectal-interactuan-en-el-microentorno-inmune-tumoral-y-estrategias-terapeuticas-dirigidas 2026-04-16 monthly 0.5 https://crcwarriors.org/articulo/2539/los-sesgos-clonales-determinan-la-disponibilidad-de-mutaciones-clave-en-el-cancer-colorrectal-para-la-transformacion-tumoral 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/2557/microbiota-y-eventos-adversos-relacionados-con-el-sistema-inmunitario-en-la-inmunoterapia-del-cancer 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/768/cancer-gastrointestinal-patogenesis-molecular-y-terapia-dirigida 2026-04-15 monthly 0.5 https://crcwarriors.org/articulo/1797/nuevos-derivados-fenilamino-pirimidinicos-como-inhibidores-potentes-y-selectivos-de-la-tirosina-quinasa-abl1-para-la-terapia-dirigida-contra-el-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2585/las-fuerzas-oncogenicas-y-supresoras-de-tumores-convergen-en-un-nicho-de-celulas-progenitoras-durante-la-transicion-de-un-estado-benigno-a-uno-maligno 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/1590/la-gestion-guiada-por-ctdna-de-malignidades-gi-mutantes-de-pole-promueve-respuestas-excepcionales-y-una-supervivencia-prolongada-a-la-inmunoterapia 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/831/la-quimioterapia-linfodepletora-potencia-la-terapia-celular-dirigida-a-neoantigenos-al-mejorar-la-presentacion-de-antigenos 2026-04-15 monthly 0.5 https://crcwarriors.org/articulo/1934/la-fusion-celular-reprograma-celulas-tumorales-y-promueve-la-invasion-y-diseminacion-mediada-por-runx1-en-cancer-colorrectal 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/1935/la-progastrina-activa-los-fibroblastos-del-colon-e-induce-un-programa-paracrino-pro-migratorio-en-las-celulas-del-cancer-colorrectal 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/1936/mas-alla-de-marcadores-individuales-sinergias-bacterianas-identificadas-por-seleccion-de-caracteristicas-multidimensional-revelan-firmas-conservadas-de-enfermedad-del-microbioma 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/1951/las-mutaciones-asociadas-a-la-colibactina-en-el-colon-humano-parecen-reflejar-la-anatomia-y-la-exposicion-temprana-y-no-la-oncogenesis 2026-05-19 monthly 0.5 https://crcwarriors.org/articulo/1952/un-modelo-clinicorradiologico-para-la-prediccion-preoperatoria-de-la-metastasis-en-los-ganglios-linfaticos-laterales-en-el-cancer-de-recto 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/934/un-anticuerpo-bifuncional-que-se-dirige-a-pd-l1-tnfr2-aumenta-la-orientacion-hacia-el-tumor-y-potencia-la-eficacia-antitumoral-en-cancer-colorrectal 2026-04-15 monthly 0.5 https://crcwarriors.org/articulo/2551/una-biopsia-digital-basada-en-el-aprendizaje-profundo-para-predecir-la-recurrencia-temprana-en-el-cancer-gastrico 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/2555/ondas-transcripcionales-secuenciales-y-la-remodelacion-de-la-cromatina-impulsada-por-nf-b-dirigen-la-desdiferenciacion-inducida-por-farmacos-en-el-cancer 2026-07-18 monthly 0.5 https://crcwarriors.org/articulo/1545/eficacia-seguridad-y-resultados-de-supervivencia-de-los-inhibidores-de-puntos-de-control-inmune-en-pacientes-con-cancer-colorrectal-deficiente-en-reparacion-de-mismatch-un-estudio-retrospectivo 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1808/hmgb3-un-orquestador-fundamental-de-la-resistencia-terapeutica-y-la-stemness-del-cancer-en-malignidades-humanas-revision 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1809/deteccion-de-senales-de-eventos-adversos-asociados-con-fruquintinib-tras-la-comercializacion-utilizando-la-base-de-datos-faers 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1840/induccion-sinergica-de-muerte-celular-inmunogenica-y-remodelacion-del-microambiente-tumoral-mediante-nanoparticulas-de-polisacaridos-marinos-biotinilados-para-una-terapia-mejorada-del-cancer 2026-05-15 monthly 0.5 https://crcwarriors.org/articulo/819/la-secrecion-de-wnt-por-el-epitelio-favorece-la-diseminacion-de-las-celulas-cancerosas-gastricas-en-desarrollo-permitiendoles-escapar-del-microambiente-tumoral 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1850/emid2-circulante-como-marcador-pronostico-de-resultados-desfavorables-en-pacientes-con-cancer-colorrectal-metastasico 2026-04-28 monthly 0.5 https://crcwarriors.org/articulo/1851/la-interaccion-de-tils-cd8-y-densidad-microvascular-un-nuevo-indicador-pronostico-en-adenocarcinoma-colorrectal 2026-04-28 monthly 0.5 https://crcwarriors.org/articulo/1639/desempeno-in-vivo-de-la-5-fluorouracilo-encapsulado-en-nanocelulosa-bacteriana-en-un-cancer-colorrectal-inducido-por-azoximetano-y-sulfato-de-dextrana-perfiles-de-liberacion-del-farmaco-analisis 2026-04-14 monthly 0.5 https://crcwarriors.org/articulo/1646/descubrimiento-de-8-sulfonamidoquinolinas-como-agentes-antiproliferativos-contra-el-cancer-colorrectal-diseno-sintesis-y-evaluacion-biologica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1652/efecto-de-las-diferencias-sexuales-en-la-aparicion-de-mutaciones-de-ras-en-ctdna-en-cancer-colorrectal-de-tipo-ras-wt 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1653/landscape-emergente-de-inhibidores-de-kras-en-el-tratamiento-del-cancer 2026-04-14 monthly 0.5 https://crcwarriors.org/articulo/1932/aumento-de-la-expresion-de-un-subconjunto-de-genes-dentro-de-regiones-de-numero-de-copias-reducido-en-multiples-tipos-de-cancer 2026-05-18 monthly 0.5 https://crcwarriors.org/articulo/1933/trayectorias-evolutivas-de-un-solo-cripton-de-precanceres-colorrectales-esporadicos-y-hereditarios-en-humanos 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/695/el-analisis-de-costo-efectividad-de-los-inhibidores-del-punto-de-control-inmune-para-cancer-colorrectal-avanzado-con-inestabilidad-de-microsatelites-alta-deficit-de-reparacion-de-parejas-de-bases 2026-04-14 monthly 0.5 https://crcwarriors.org/articulo/1208/asociacion-de-tigit-y-cd155-con-mutaciones-geneticas-en-kras-nras-braf-pik3ca-y-akt-estado-msi-y-perfiles-de-citocinas-en-cancer-colorrectal 2026-04-14 monthly 0.5 https://crcwarriors.org/articulo/722/patrones-de-terapia-anti-her2-en-cancer-de-mama-metastasico-datos-del-mundo-real-sugieren-subtratamiento 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1770/combinando-la-farmacologia-de-redes-y-la-transcriptomica-para-validar-y-explorar-el-uso-de-la-formula-shenqiyichang-en-el-tratamiento-del-cancer-colorrectal-mediante-la-inhibicion-de-nqo1-la 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1822/el-analisis-multiomico-de-organoides-derivados-de-pacientes-revela-que-la-e3-ligasa-cop1-promueve-la-metastasis-hepatica-y-la-resistencia-al-oxaliplatino-en-el-cancer-colorrectal-a-traves-de-la 2026-04-13 monthly 0.5 https://crcwarriors.org/articulo/1842/reconocimiento-automatico-y-prediccion-pronostica-de-metastasis-hepaticas-colorrectales-utilizando-un-marco-de-aprendizaje-profundo-multiescala-estudio-de-desarrollo-y-validacion-de-modelos 2026-05-16 monthly 0.5 https://crcwarriors.org/articulo/1588/el-estado-de-mutacion-de-kras-como-marcador-pronostico-y-predictor-de-la-respuesta-al-tratamiento-en-el-cancer-colorrectal-un-analisis-de-la-ncdb 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1852/nomogramas-de-aprendizaje-automatico-para-cancer-gastrico-abordando-limitaciones-de-datos-en-modelos-basados-en-seer 2026-04-28 monthly 0.5 https://crcwarriors.org/articulo/1859/deteccion-de-polipos-utilizando-yolov9-en-imagenes-de-colonoscopia-reales-y-sinteticas 2026-04-27 monthly 0.5 https://crcwarriors.org/articulo/1866/omicas-de-celula-unica-microbiana-in-situ 2026-04-27 monthly 0.5 https://crcwarriors.org/articulo/1867/perfilacion-metabolomica-de-refrigerios-de-batata-enriquecidos-con-fructanos-de-agave-efectos-de-la-impregnacion-al-vacio-en-metabolitos-asociados-al-intestino-in-vitro 2026-04-26 monthly 0.5 https://crcwarriors.org/articulo/1647/efectos-de-las-enzimas-del-citocromo-p450-y-las-interacciones-farmacologicas-en-el-metabolismo-del-donafenib-estudios-in-vivo-in-vitro-e-in-silico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1915/perfilado-longitudinal-clinico-fisiologico-y-molecular-de-pacientes-con-cancer-metastasico-protocolo-y-viabilidad-de-un-estudio-de-oncologia-de-alta-definicion-multicentrico-en-mujeres 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/1916/firmas-metabolicas-distintas-distinguen-el-cancer-de-pulmon-colorrectal-y-de-ovario 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/1929/imas-permite-la-integracion-consciente-del-objetivo-del-multiomico-tumoral-para-resolver-mecanismos-reguladores-guiados-por-la-comunicacion 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/1930/firmas-de-metilacion-del-adn-en-cancer-colorrectal-deficiente-en-reparacion-de-errores-de-apareamiento 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/1931/una-firma-genetica-de-estres-nucleolar-para-puntuacion-cuantitativa-en-contextos-multiomicos 2026-08-18 monthly 0.5 https://crcwarriors.org/articulo/1183/un-nomograma-clinico-molecular-para-predecir-la-recurrencia-temprana-tras-la-reseccion-de-metastasis-hepaticas-de-cancer-colorrectal-inicialmente-irresecables 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1784/nanoemulsion-multifuncional-blindada-de-elemene-que-combina-la-induccion-de-la-ferroptosis-y-la-restauracion-de-la-homeostasis-intestinal-en-la-terapia-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1815/factores-pronosticos-para-pacientes-jovenes-con-cancer-colorrectal-y-metastasis-hepaticas-segun-la-base-de-datos-seer 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1816/vigilancia-postpolipectomia-de-precision-guiada-por-hemoglobina-fecal-en-el-marco-actual-un-estudio-de-cribado-basado-en-fit-con-cuatro-millones-de-participantes 2026-05-16 monthly 0.5 https://crcwarriors.org/articulo/1803/fbxo39-promueve-la-glucolisis-aerobica-mediada-por-ldha-y-la-progresion-del-cancer-colorrectal-mediante-la-degradacion-de-p53 2026-04-11 monthly 0.5 https://crcwarriors.org/articulo/614/izalontamab-si-b001-un-anticuerpo-bispecifico-novedoso-anti-egfr-her3-en-pacientes-con-tumor-epitelial-localmente-avanzado-o-metastasico-resultados-del-primer-estudio-en-humanos-de-fase-i-ib 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1914/un-cuento-de-dos-paises-comparacion-de-las-caracteristicas-del-cancer-rectal-entre-estadounidenses-pakistanies-y-pakistanies-nativos 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/892/un-estudio-de-fase-ia-b-del-inhibidor-de-mek1-2-binimetinib-en-combinacion-con-el-inhibidor-de-met-crizotinib-en-pacientes-con-cancer-colorrectal-avanzado-con-mutacion-en-ras-mercuric 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1917/alcance-integracion-de-la-seleccion-de-organoides-y-variables-clinicas-a-traves-del-aprendizaje-automatico-para-la-prediccion-de-resultados-en-ensayos-de-cancer 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/1024/distribucion-de-los-efectos-secundarios-de-los-tratamientos-anti-egfr-en-pacientes-con-cancer-colorrectal-metastasico-y-evaluacion-de-su-relacion-con-la-supervivencia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1798/celulas-tumorales-circulantes-como-incursion-de-la-biopsia-liquida-en-el-cribado-no-invasivo-del-cancer-colorrectal 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1060/diseno-de-novo-impulsado-por-ia-de-inhibidores-de-braf-con-afinidad-de-enlace-mejorada-y-optimizada-similitud-con-farmacos 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/611/toxicidades-oftalmicas-en-la-terapia-triple-beacon-para-el-cancer-colorrectal-con-mutacion-braf-v600e-una-serie-de-casos 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1683/mecanismo-terapeutico-de-la-decocta-changyong-en-la-supresion-del-progreso-del-cancer-colorrectal-y-la-induccion-de-ferropotesis-a-traves-del-eje-de-senalizacion-piezo1-pi3k-akt 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/672/caracteristicas-tumorales-afectan-la-pronostico-en-cancer-colorrectal-localizado-deficiente-de-reparo-de-disparidad-inestabilidad-microsatelital-alta-una-revision-sistematica-y-metanalisis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1466/dificultad-en-la-reparacion-de-desajustes-microssatelites-inestables-altos-del-cancer-colorrectal-paradigmas-actuales-de-tratamiento-limitaciones-y-perspectivas-futuras 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1884/la-dieta-occidental-suprime-las-celulas-madre-intestinales-canonicas-y-reprograma-las-celulas-madre-de-reserva-c-kit-a-traves-de-una-disbiosis-proinflamatoria 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/1442/desentranando-vias-de-senalizacion-en-la-interaccion-del-microambiente-inmune-para-superar-la-resistencia-a-la-inmunoterapia-en-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1757/la-targeting-de-los-tams-spp1-asociados-con-metastasis-hepaticas-invierte-la-inmunosupresion-y-sinergiza-con-la-inmunoterapia-en-cancer-colorrectal 2026-04-09 monthly 0.5 https://crcwarriors.org/articulo/2575/la-inhibicion-de-dj-1-remodela-el-microambiente-tumoral-y-potencia-los-inhibidores-de-los-puntos-de-control-inmunitario 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1810/comprension-de-los-mecanismos-del-microambiente-tumoral-que-impulsan-la-resistencia-a-la-inmunoterapia-en-las-metastasis-hepaticas-del-cancer-colorrectal 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1881/el-novedoso-polimero-fluoropirimidinico-cf10-demuestra-un-indice-terapeutico-superior-y-una-ventaja-en-la-supervivencia-en-modelos-derivados-de-pacientes-con-cancer-colorrectal-refractario-al-5 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/1882/sustituto-de-antitripsina-alphataxina-aumenta-las-celulas-t-cd4-tumorales-y-suprime-el-cancer-de-colon-murino 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/1883/analisis-de-ligando-receptor-consciente-de-la-geometria-que-distingue-la-asociacion-de-interfase-de-la-localizacion-espacial-y-revela-un-continuo-de-comunicacion-tumoral 2026-08-19 monthly 0.5 https://crcwarriors.org/articulo/2534/analisis-de-la-huella-de-la-microbiota-intestinal-humana-mediante-un-conjunto-de-sensores-basados-en-acido-boronico-y-su-aplicacion-en-la-clasificacion-del-cancer-colorrectal 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/1846/el-analisis-combinado-de-la-accesibilidad-de-la-cromatina-las-interacciones-entre-promotores-y-la-secuenciacion-del-genoma-completo-resolvio-la-heredabilidad-ausente-en-el-cancer-gastrico 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/1609/el-analisis-integrado-y-la-validacion-funcional-revelan-que-las-pildoras-de-dahuang-zhechong-actuan-como-supresores-tumorales-en-kcnq1-mediante-la-modulacion-de-la-cuprotopsis-en-el-cancer-colorrectal 2026-04-07 monthly 0.5 https://crcwarriors.org/articulo/1880/nfatc2-en-fibroblastos-asociados-al-cancer-pancreatico-predice-respuesta-al-tratamiento-y-facilita-terapias-dirigidas-a-erbb 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/1415/excision-mesocolica-completa-robotica-post-neoadyuvante-inmunoterapeutica-para-cancer-de-colon-ascendente-dmmr-msi-h-t4b 2026-04-07 monthly 0.5 https://crcwarriors.org/articulo/463/estudio-de-fase-i-ii-el-primero-en-humanos-de-incagn01876-un-agonista-del-receptor-del-factor-de-necrosis-tumoral-inducido-por-glucocorticoides-en-pacientes-con-tumores-solidos-avanzados-o 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1787/terapia-nanodinamica-en-cancer-colorrectal-ingenieria-de-la-inmunoterapia-de-precision-y-sinergia-multimodal 2026-04-07 monthly 0.5 https://crcwarriors.org/articulo/1839/mygenerisk-colon-una-herramienta-web-para-la-prediccion-personalizada-del-riesgo-de-cancer-colorrectal-basada-en-la-genetica-y-el-estilo-de-vida 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/1878/acidos-grasos-en-el-microambiente-tumoral-reprograman-neutrofilos-para-inducir-inmunosupresion-a-traves-de-adenosina 2026-05-19 monthly 0.5 https://crcwarriors.org/articulo/1879/analisis-sistematico-del-sistema-de-secrecion-tipo-vii-en-streptococcus-gallolyticus-subsp-gallolyticus-revela-diversidad-genomica-y-asociaciones-funcionales 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/1129/frecuencia-del-alelo-variante-ras-como-marcador-pronostico-potencial-de-supervivencia-global-en-pacientes-con-cancer-colorrectal-metastasico 2026-04-06 monthly 0.5 https://crcwarriors.org/articulo/1821/ritmo-circadiano-derivado-del-acelerometro-y-riesgo-de-cancer-colorrectal-en-el-biobanco-del-reino-unido-un-estudio-prospectivo-de-cohortes 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1837/la-integracion-transcriptomica-revela-una-paradoja-inflamatoria-proliferativa-conservada-en-la-resistencia-adquirida-al-bloqueo-de-los-puntos-de-control-inmunitarios 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/1838/modelos-graficos-espacialmente-variables-para-redes-de-interaccion-celula-celula-en-imagenes-tisulares-multiplexadas 2026-05-19 monthly 0.5 https://crcwarriors.org/articulo/1452/gestion-no-quirurgica-del-cancer-colorrectal-deficiente-en-reparacion-de-disparidades-dmmr-alta-inestabilidad-en-microsatelites-msi-h-tratado-con-inmunoterapia-revision-sistematica-y-metaanalisis 2026-04-05 monthly 0.5 https://crcwarriors.org/articulo/978/la-inmunoterapia-neoadyuvante-para-pacientes-con-cancer-rectal-avanzado-localmente-dmmr-msi-h-desentranando-el-paradigma-de-respuesta-clinica-completa-del-100 2026-04-05 monthly 0.5 https://crcwarriors.org/articulo/1753/el-virus-vaccinia-modificado-para-expresar-il-21-puede-curar-metastasis-hepaticas-de-cancer-colorrectal-en-modelos-murinos-mediante-la-administracion-intravenosa 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1811/cx3cr1-identifica-un-potente-subconjunto-de-celulas-t-cd8-efectoras-asociado-a-la-eficacia-terapeutica-anti-pd-1-en-cancer-colorrectal 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1818/rm-de-difusion-avanzada-de-alta-resolucion-de-muestras-quirurgicas-de-cancer-rectal-correlacion-de-las-caracteristicas-microestructurales-con-la-histologia 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1754/marcador-especifico-de-metastasis-spp1-y-su-caracterizacion-en-cancer-colorrectal-con-infeccion-por-hiv 2026-04-04 monthly 0.5 https://crcwarriors.org/articulo/2529/la-inhibicion-de-la-senalizacion-regulada-por-el-acido-glicocolico-circulante-potencia-la-terapia-de-inhibicion-de-puntos-de-control-inmunitario-en-el-cancer-colorrectal 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/1038/acupuntura-electroestimulada-combinada-con-fruquintinib-y-sintilimab-en-cancer-colorrectal-metastasico-estable-en-satelites-microsatelitales-un-estudio-fase-ii 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1835/reconstitucion-de-co-cultivos-organotipicos-de-microtejidos-2d-mediante-estarcido-secuencial 2026-08-20 monthly 0.5 https://crcwarriors.org/articulo/1836/la-perdida-de-arid2-desestabiliza-pbaf-e-impulsa-el-cancer-colorrectal 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/70/alteraciones-y-coalteraciones-activadoras-diversas-de-erbb2-erbb3-tienen-implicaciones-para-las-terapias-dirigidas-a-her2-3-en-tumores-solidos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1661/deteccion-de-mutaciones-del-adn-mitocondrial-en-celulas-t-despues-de-la-exposicion-a-5-fu-o-cisplatino 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1701/hidrogel-organico-nanocomposito-basado-en-polisacaridos-dinamicos-que-media-con-precision-la-terapia-oral-dirigida-para-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1203/el-acido-neogambogico-promueve-la-diferenciacion-de-los-mdsc-m-en-macrofagos-m1-para-inhibir-la-metastasis-peritoneal-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1755/un-modelo-predictivo-para-la-eficacia-del-tratamiento-en-el-cancer-colorrectal-avanzado-con-ras-tipo-salvaje-desarrollo-y-validacion-externa-para-un-inhibidor-de-egfr-mas-terapia-antiangiogenica 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1771/la-spermidina-y-el-eugenol-modulan-marcadores-de-juncciones-intercelulas-y-estaminalidad-en-esferoides-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2543/el-analisis-genomico-de-los-receptores-de-las-celulas-t-revela-firmas-inmunitarias-especificas-del-sindrome-de-lynch 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/771/remision-completa-de-un-cancer-rectal-avanzado-msi-h-en-un-paciente-joven-tratado-con-nivolumab-informe-de-caso-y-valoracion-critica-de-la-literatura 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1834/el-metodo-u-aprovechamiento-de-la-probabilidad-de-expresion-para-la-deteccion-robusta-de-marcadores-biologicos 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1677/una-nanovacuna-cargada-con-acido-gambogico-dirigida-a-un-tumor-reprograma-el-microentorno-tumoral-para-mejorar-la-inmunoterapia-contra-el-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/936/el-exopolisacarido-derivado-de-bifidobacteria-promueve-la-inmunidad-antitumoral 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/687/mosperafenib-es-un-nuevo-inhibidor-de-braf-denominado-paradox-breaker-que-ha-demostrado-una-potente-actividad-preclinica-en-el-cancer-colorrectal-con-mutaciones-en-el-gen-braf 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1467/mejora-de-la-actividad-de-las-celulas-nk-en-el-cancer-colorrectal-mediante-un-anticuerpo-optimizado-para-la-region-fc-que-se-dirige-contra-cd276-b7-h3 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/958/papeles-inmuno-reguladores-de-las-modificaciones-pos-traducionales-en-el-cancer-colorrectal-mecanismos-y-implicaciones-terapeuticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/976/terapia-secuencial-pseudoallogenica-con-celulas-t-car20-22-19-en-un-paciente-con-linfoma-de-celulas-b-grandes-difuso-en-recidiva-despues-de-allo-hsct-informe-de-caso 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1788/rompiendo-la-barrera-de-cancer-inmunologicamente-frio-en-cancer-colorrectal-metastasico-pmmr-mss-estrategias-emergentes-mas-alla-del-cuidado-estandar 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1539/las-celulas-dendriticas-dirigidas-al-antigeno-tumoral-cea-a-traves-de-dec205-en-combinacion-con-el-virus-oncolitico-reovirus-estimulan-una-respuesta-inmune-fuerte-en-un-modelo-de-cancer-colorrectal 2026-04-15 monthly 0.5 https://crcwarriors.org/articulo/1801/diana-terapeutica-de-pd-1-pd-l1-y-ctla-4-en-el-cancer-colorrectal-senalizacion-intrinseca-al-tumor-y-de-puntos-de-control-inmunitarios 2026-07-09 monthly 0.5 https://crcwarriors.org/articulo/1807/fulzerasib-mas-cetuximab-en-cancer-de-pulmon-no-microcitico-con-mutacion-de-kras-g12c-de-primera-linea-krocus-ensayo-multicentrico-de-un-solo-brazo-fase-1b-2 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1298/efectos-de-los-inhibidores-de-la-tirosinasa-difieren-en-la-genomizacion-por-uracilo-y-potencial-mutagenico-following-up-on-the-strict-rules-provided-here-s-the-corrected-version-without-any-notes-or 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1813/supervivencia-en-pacientes-con-baja-expresion-de-genes-de-recombinacion-homologa-de-tipo-silvestre-refining-the-homologous-recombination-paradigm-in-colorectal-cancer 2026-05-17 monthly 0.5 https://crcwarriors.org/articulo/1048/ubr4-aumenta-la-eficacia-del-anticuerpo-anti-egfr-facilitando-la-endocitosis-dependiente-de-clatrina-del-egfr-en-el-cancer-colorrectal 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1307/papel-de-los-fibroblastos-thbs2-en-la-transformacion-maligna-de-un-polipo-colrectal-en-cancer 2026-04-04 monthly 0.5 https://crcwarriors.org/articulo/1308/por-que-continua-fallando-la-terapia-dirigida-contra-el-egfr-en-cancer-de-mama-del-descifrado-mecanico-a-nuevas-estrategias-de-intervencion 2026-04-06 monthly 0.5 https://crcwarriors.org/articulo/542/el-adn-tumoral-circulante-como-biomarcador-predictivo-de-recurrencia-postquirurgica-del-cancer-colorrectal-una-revision-sistematica-y-metaanalisis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1312/reinicio-del-anti-egfr-en-comparacion-con-el-tratamiento-estandar-para-pacientes-con-cancer-colorrectal-metastasico-quimioterapia-refractario-y-ctdna-ras-braf-de-tipo-salvaje-una-revision-sistematica 2026-04-29 monthly 0.5 https://crcwarriors.org/articulo/802/inhbb-promueve-la-metastasis-hepatica-del-cancer-colorrectal-mediante-la-regulacion-de-la-senalizacion-tgf-smad-la-transicion-epitelio-mesenquimal-y-la-resistencia-a-la-anoikis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1318/los-subtipos-de-cms-se-correlacionan-con-la-respuesta-completa-en-un-ensayo-de-galunisertib-neoadyuvante-mas-quimiorradiacion-en-el-cancer-de-recto 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1575/procesos-diabetogenos-para-la-hiperinsulinemia-asociada-a-resistencia-a-la-insulina-estan-relacionados-con-el-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1831/analisis-computacional-guiado-por-la-estructura-de-los-efectos-de-enlace-en-un-scfv-dirigido-a-la-guanilil-ciclasa-c 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/40/caracteristicas-endoscopicas-de-la-reparacion-defectuosa-del-desparejo-de-bases-inestabilidad-microsatelite-alta-y-cancer-colorrectal-mutado-en-braf 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/1832/sptbn2-promueve-un-microambiente-tumoral-inmunosupresor-y-la-resistencia-cruzada-a-las-terapias-contra-el-cancer 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1833/la-combinacion-de-la-deteccion-de-mutaciones-con-las-caracteristicas-de-la-fragmentomica-conduce-a-una-mejor-deteccion-del-ctadn-informada-por-el-tumor 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1841/analisis-multi-omico-de-variaciones-microecologicas-del-intestino-en-cancer-colorrectal 2026-05-15 monthly 0.5 https://crcwarriors.org/articulo/1843/una-estrategia-neoadyuvante-multimodal-que-incorpora-pdt-rfa-e-icis-resulta-en-una-respuesta-patologica-notable-y-preservacion-del-esfinter-en-cancer-rectal-bajo-microsatellite-estable-un-informe-de 2026-05-15 monthly 0.5 https://crcwarriors.org/articulo/1844/efecto-sinergico-de-la-terapia-fotodinamica-con-terapia-multimodal-logra-preservacion-del-ano-en-cancer-rectal-ultra-bajo-mss-reporte-de-caso-y-revision-de-literatura 2026-05-15 monthly 0.5 https://crcwarriors.org/articulo/1333/el-papel-fundamental-de-la-transicion-epitelio-mesenquimal-tem-en-la-progresion-del-cancer-colorrectal-y-los-resultados-terapeuticos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1591/la-adaptacion-experimental-del-rotavirus-a-de-paloma-prva-en-celulas-de-cancer-colorrectal-humano-revela-respuestas-del-huesped-impulsadas-por-interferon-y-modulacion-de-los-puntos-de-control 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/2615/los-eventos-adversos-del-sistema-nervioso-central-snc-relacionados-con-el-bloqueo-de-puntos-de-control-se-caracterizan-por-celulas-t-colaboradoras-neurotoxicas-con-reactividad-antigenica-neuronal 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/1592/prueba-de-reparacion-de-desajuste-mmr-en-la-adopcion-y-uso-en-pacientes-con-cancer-colorrectal-temprano-que-tienen-tumores-deficientes-en-mmr-y-competentes-en-mmr 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2618/el-factor-de-transcripcion-hif-2-media-la-resistencia-a-la-ferroptosis-en-el-cancer-de-pancreas 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/1346/ablacion-de-la-senalizacion-de-prostaglandina-e-2-mediante-delecion-dual-de-receptores-en-celulas-car-t-mejora-la-eficacia-terapeutica-en-tumores-solidos 2026-06-26 monthly 0.5 https://crcwarriors.org/articulo/1860/pvt1-104aa-derivado-del-desierto-genico-8q24-promueve-la-tumorogenesis-del-cancer-colorrectal 2026-04-27 monthly 0.5 https://crcwarriors.org/articulo/326/el-arn-no-codificante-largo-c20orf56-como-predictor-de-la-respuesta-a-la-quimiorradioterapia-neoadyuvante-y-de-las-tasas-de-supervivencia-en-canceres-rectales 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1094/enfoques-inmunoterapeuticos-emergentes-en-cancer-colorrectal-de-los-inhibidores-de-puntos-de-control-a-las-celulas-t-car-y-vacunas-con-vectores-virales 2026-06-22 monthly 0.5 https://crcwarriors.org/articulo/1872/valor-pronostico-de-los-niveles-perioperatorios-de-adn-tumoral-circulante-estimados-por-metilacion-del-adn-libre-de-celulas-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-resecables 2026-04-26 monthly 0.5 https://crcwarriors.org/articulo/91/evidencia-histopatologica-y-molecular-de-potencial-maligno-en-los-morulos-asociados-a-la-neoplasia-gastrointestinal 2026-06-19 monthly 0.5 https://crcwarriors.org/articulo/1885/revision-anual-del-tratamiento-medico-sistemico-del-cancer-colorrectal-en-2025 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1122/estructura-inmunitaria-tumoral-y-evasion-inmunologica-en-canceres-colorrectales-con-instabilidad-de-microsatelites-asociados-a-carcinomas-esporadicos-y-del-sindrome-de-lynch 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2161/respuesta-excepcional-a-la-inmunoterapia-con-pembrolizumab-en-un-paciente-joven-con-cancer-colorrectal-metastasico-asociado-al-sindrome-de-lynch 2026-08-28 monthly 0.5 https://crcwarriors.org/articulo/1651/administracion-subcutanea-de-amivantamab-en-pacientes-con-tumores-solidos-avanzados-el-estudio-paloma-de-fase-ib 2026-06-02 monthly 0.5 https://crcwarriors.org/articulo/2167/desarrollo-de-sdp0505-un-anticuerpo-farmaco-conjugado-adc-bispecifico-her3-x-c-met-el-primero-de-su-clase-que-demuestra-una-potente-actividad-antitumoral-en-el-cancer-de-pulmon-no-microcitico-cpnm 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/2168/ivonescimab-y-otros-anticuerpos-bispecificos-anti-programada-muerte-celular-1-ligando-1-pd-l-1-factor-de-crecimiento-endotelial-vascular-vegf-avances-y-perspectivas-en-la-terapia-del-cancer 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/1412/la-terapia-fotodinamica-combinada-con-ablacion-por-radiofrecuencia-y-terapia-sistemica-para-cancer-avanzado-de-recto-bajo-mutante-kras-un-informe-de-caso 2026-04-24 monthly 0.5 https://crcwarriors.org/articulo/1668/la-proteina-prostein-p501s-se-expresa-en-el-carcinoma-de-paget-extramamario-primario 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1924/el-ensayo-controlado-aleatorizado-keynote-177-de-bloqueo-de-pd-1-de-primera-linea-para-cancer-colorrectal-avanzado-con-microsatelites-altos-o-deficiencia-de-reparacion-de-desajuste-consecuencias 2026-05-27 monthly 0.5 https://crcwarriors.org/articulo/1669/carcinomas-serosos-inicialmente-diagnosticados-en-biopsias-de-colon-una-serie-de-casos-resaltando-el-papel-del-p53-para-guiar-la-gestion 2026-04-08 monthly 0.5 https://crcwarriors.org/articulo/1925/agonistas-del-receptor-glp-1-y-terapia-con-inhibidores-de-puntos-de-control-inmunitario-una-revision-narrativa-sobre-la-evidencia-clinica-y-mecanicista 2026-08-23 monthly 0.5 https://crcwarriors.org/articulo/1673/aplicacion-de-inteligencia-artificial-en-patologia-rutinaria-rendimiento-de-chatgpt-4-0-y-gemini-2-5-pro-en-la-deteccion-de-deficiencia-de-mmr-en-cancer-colorrectal 2026-04-08 monthly 0.5 https://crcwarriors.org/articulo/1674/del-banco-de-laboratorio-a-la-sala-de-cirugia-perfilacion-molecular-y-tecnologias-de-celula-unica-en-la-cirugia-precisa-para-pacientes-con-cancer-colorrectal 2026-04-07 monthly 0.5 https://crcwarriors.org/articulo/1429/dirigido-a-la-transicion-epitelio-mesenquimal-y-a-la-apoptosis-nuevos-inhibidores-de-la-histona-metiltransferasa-para-la-supresion-del-cancer-de-colon 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1705/cancer-colorrectal-familiar-factores-de-riesgo-estrategias-de-tamizaje-y-medicina-personalizada 2026-04-09 monthly 0.5 https://crcwarriors.org/articulo/1706/regulacion-espaciotemporal-dinamica-del-eje-cx3cl1-cx3cr1-un-doble-filo-en-el-microentorno-inmune-tumoral-y-nuevas-estrategias-para-la-terapia-precisa 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1707/la-miosteatosis-y-la-miopenia-podrian-predecir-los-resultados-oncologicos-en-pacientes-con-cancer-de-recto-que-reciben-quimiorradioterapia-preoperatoria 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1196/la-terapia-fotodinamica-combinada-con-tratamiento-sistemico-logra-una-remision-significativa-en-el-cancer-colorrectal-localmente-avanzado-con-alta-inestabilidad-de-microsatelites-informe-de-un-caso-y 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/1708/recomendaciones-dieteticas-solas-o-combinadas-con-suplementos-nutricionales-orales-tras-el-alta-hospitalaria-en-pacientes-sometidos-a-cirugia-por-cancer-colorrectal-seguimiento-a-cinco-anos-de-un 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1453/nci9673-parte-b-estudio-etctn-aleatorizado-de-fase-ii-que-evalua-el-uso-de-nivolumab-con-o-sin-ipilimumab-en-pacientes-con-carcinoma-de-celulas-escamosas-metastasico-y-refractario-del-canal-anal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1710/recientes-avances-en-investigacion-y-estado-clinico-de-la-inmunoterapia-para-el-cancer-colorrectal 2026-06-17 monthly 0.5 https://crcwarriors.org/articulo/2222/caso-de-cancer-de-colon-irresecable-tratado-con-pembrolizumab-en-el-que-se-realizo-una-cirugia-de-conversion 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/1202/enfoques-innovadores-de-inmunoterapia-aprovechando-la-sinergia-del-bloqueo-dual-de-puntos-de-control-en-oncologia 2026-06-22 monthly 0.5 https://crcwarriors.org/articulo/1971/temsirolimus-en-pacientes-con-tumores-solidos-con-mutaciones-en-pik3ca-resultados-del-estudio-tapur-registro-de-utilizacion-y-perfilado-de-agentes-dirigidos 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/1204/conversion-precisa-de-metastasis-pulmonares-de-cancer-colorrectal-una-regimena-personalizada-cuadruple-que-integra-la-terapia-fotodinamica-con-terapias-dirigidas-inmunoterapeuticas-y 2026-04-13 monthly 0.5 https://crcwarriors.org/articulo/1463/prelid1-y-vdac3-coordinan-un-estado-similar-al-envejecimiento-en-celulas-b-del-centro-germinal-para-promover-la-inmunidad-antitumoral-impulsada-por-il-7-en-cancer-colorrectal 2026-06-27 monthly 0.5 https://crcwarriors.org/articulo/2233/item 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1210/reprogramacion-del-microambiente-tumoral-la-calebina-a-como-un-nuevo-enfoque-polifenolico-para-controlar-la-inflamacion-la-capacidad-de-autorrenovacion-y-la-resistencia-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1470/reutilizacion-de-dronedarone-para-el-tratamiento-del-cancer-colorrectal-mediante-supresion-de-los-caminos-de-senalizacion-akt-erk 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1471/la-disponibilidad-de-valina-controla-la-progresion-del-ciclo-celular-oncogenico-a-traves-de-la-traduccion-de-las-ciclinas-de-tipo-d 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1473/la-estrategia-estoma-descompresor-quimioterapia-neoadyuvante-folfox-colectomia-para-cancer-de-colon-obstructivo-no-metastasico-una-serie-de-casos-retrospectiva-multiinstitucional-francesa 2026-04-14 monthly 0.5 https://crcwarriors.org/articulo/1729/evaluacion-de-los-beneficios-en-la-supervivencia-global-en-canceres-avanzados-el-papel-de-los-estudios-con-cohortes-comparativas-externas-y-datos-del-mundo-real 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1478/una-nanoestructura-multimodal-basada-en-un-mof-magnetico-biomimetico-para-la-re-sensibilizacion-termica-mediada-por-h-2-s-y-la-reprogramacion-inmunitaria-en-la-terapia-multimodal-de-hipertermia 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1225/trastuzumab-deruxtecan-en-tumores-solidos-no-mamarios-ampliacion-de-las-indicaciones-eficacia-y-perspectivas-futuras 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1226/nfya-activa-transcripionalmente-gpx4-inhibiendo-la-ferropotesis-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/715/el-transporte-eficiente-deiones-de-cobre-desencadena-fototerapia-in-situ-y-cuprotopsis-para-potenciar-la-inmunoterapia-del-cancer-colorrectal 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1489/valor-pronostico-a-largo-plazo-de-celulas-positivas-para-el-arn-del-citoceratino-20-en-la-sangre-y-medula-osea-de-pacientes-con-cancer-colorrectal-localizado 2026-04-25 monthly 0.5 https://crcwarriors.org/articulo/1746/epidrogas-en-cancer-mecanismos-aplicaciones-y-direccion-futura 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1247/implicaciones-de-la-deficiencia-en-reordenamiento-homologo-para-la-quimioterapia-neoadiuvante-basada-en-plataforma-metalica-en-cancer-panceatico-una-revision-narrativa 2026-04-11 monthly 0.5 https://crcwarriors.org/articulo/1762/resultados-clinicos-de-la-combinacion-de-trifluridina-tipiracil-mas-bevacizumab-frente-a-trifluridina-tipiracil-o-regorafenib-en-el-cancer-colorrectal-metastasico-un-estudio-de-cohortes-multicentrico 2026-04-26 monthly 0.5 https://crcwarriors.org/articulo/1507/marcadores-exploratorios-para-la-respuesta-al-nivolumab-inducida-por-oxaliplatino-en-cancer-colorrectal-metastasico-de-satelites-microestables 2026-06-06 monthly 0.5 https://crcwarriors.org/articulo/1252/aspirina-y-inhibidores-de-la-ciclooxigenasa-2-como-terapia-adyuvante-en-el-cancer-colorrectal-con-mutacion-en-el-gen-pik3ca-tras-la-reseccion-quirurgica-una-revision-sistematica-y-metaanalisis-de 2026-06-25 monthly 0.5 https://crcwarriors.org/articulo/2022/nivolumab-mas-ipilimumab-en-pacientes-con-tumores-solidos-con-alta-carga-de-mutacion-tumoral-resultados-del-estudio-del-registro-de-utilizacion-y-perfilado-de-agentes-dirigidos 2026-05-13 monthly 0.5 https://crcwarriors.org/articulo/234/determine-el-impacto-en-la-supervivencia-y-la-eficiencia-economica-del-secuenciamento-de-paneles-multipalabras-geneticas-en-cancer-colorrectal-metastasico-con-aproaches-de-super-learning-following-up 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1774/posibles-consecuencias-metabolicas-de-alcance-amplio-de-la-colecistectomia 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1269/comorbilidades-uso-de-medicamentos-y-supervivencia-global-en-ocho-tipos-de-cancer-un-estudio-de-cohorte-multinacional-de-1-7-millones-de-pacientes-en-europa 2026-04-04 monthly 0.5 https://crcwarriors.org/articulo/1786/un-estudio-cualitativo-de-las-necesidades-de-atencion-especificas-de-la-edad-en-pacientes-con-cancer-colorrectal-avanzado-de-aparicion-temprana 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1792/distintos-patrones-y-tendencias-mundiales-en-el-riesgo-de-cancer-rectal-a-lo-largo-de-la-vida-dentro-del-cancer-colorrectal-un-analisis-poblacional-de-globocan-2022 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/1793/senales-de-envejecimiento-en-las-radiografias-de-torax-asociacion-de-la-aceleracion-de-la-edad-derivada-de-la-radiografia-de-torax-con-la-incidencia-futura-de-cancer-de-pulmon 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/1828/explorador-metagear-busquedas-interactivas-rapidas-y-analisis-de-cohortes-cruzadas-de-asociaciones-de-genes-del-microbioma-en-enfermedades 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1829/la-administracion-sistemica-de-sirna-egfr-mediada-por-liposomas-cationicos-mejora-la-eficacia-terapeutica-en-un-modelo-de-cancer-colorrectal-humano 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1830/klebsiella-pneumoniae-t6ss-exacerba-la-inflamacion-intestinal-promoviendo-la-tumorigenesis 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/2609/un-virus-oncolitico-modificado-geneticamente-que-incorpora-un-anticuerpo-simple-scfv-anti-pcsk9-potencia-la-inmunidad-a-largo-plazo-de-las-celulas-t-cd8-mediante-la-modulacion-de-la-presentacion-del 2026-07-12 monthly 0.5 https://crcwarriors.org/articulo/1614/diseno-racional-de-un-sensor-fluorogenico-de-gran-desplazamiento-de-stokes-para-la-deteccion-de-notum-en-sistemas-vivos-y-la-evaluacion-de-inhibidores 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/952/un-conjugado-de-anticuerpo-medicamento-de-alta-afinidad-actuximab-mmae-para-un-potente-y-selectivo-objetivo-de-tumores-positivos-para-ceacam5 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1812/perfiles-reproducibles-de-la-microbiota-intestinal-utilizando-muestras-clinicas-sobrantes-de-la-prueba-inmunoquimica-fecal-fit 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/1824/clumpycells-resuelve-la-agregacion-espacial-en-tejidos-complejos-superando-los-sesgos-de-tamano 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1825/el-analisis-transcriptomico-unicelular-y-masivo-integrado-aprovecha-los-genes-relacionados-con-la-metastasis-hepatica-para-desarrollar-un-modelo-pronostico-para-pacientes-con-cancer-colorrectal 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1826/bioactividades-especificas-de-disolventes-de-extractos-de-conos-hojas-y-tallos-de-un-lupulo-silvestre-autoctono-finlandes 2026-08-21 monthly 0.5 https://crcwarriors.org/articulo/1827/exploracion-funcional-de-pacientes-africanos-con-cancer-colorrectal-mediante-avatares-de-drosophila-personalizados 2026-05-20 monthly 0.5 https://crcwarriors.org/articulo/2607/la-apoptosis-mitocondrial-mediada-por-nanoparticulas-lipidicas-de-arnm-potencia-la-inmunoterapia-adoptiva-con-celulas-t 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/1079/la-entrega-de-nanoparticulas-dirigida-de-irinotecano-potencia-la-respuesta-tumoral-al-bloqueo-del-pd-l1-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1615/eficacia-antitumoral-combinada-de-un-nuevo-analogo-de-tanshinona-iia-e-irinotecano-con-alivio-del-efecto-secundario-gastrointestinal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1685/reposicionamiento-computacional-de-farmacos-basado-en-el-aprendizaje-automatico-para-identificar-nuevos-inhibidores-de-la-tubulina-contra-el-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1433/la-quimioterapia-desencadena-la-evasion-inmune-al-fomentar-la-diferenciacion-de-celulas-de-kupffer-lepr-en-metastasis-hepaticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1773/hungatella-hathewayi-una-bacteria-derivada-de-tumores-presente-en-mayor-proporcion-en-los-tejidos-de-cancer-colorrectal-y-un-posible-biomarcador-diagnostico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1790/impacto-pronostico-especifico-del-tipo-de-cancer-de-las-alteraciones-concurrentes-de-tp53-y-kras-un-analisis-genomico-de-cohortes-multiples 2026-08-22 monthly 0.5 https://crcwarriors.org/articulo/1381/fpsir-predice-las-respuestas-clinicas-terapeuticas-y-los-resultados-de-supervivencia-en-pacientes-con-cancer-colorrectal-metastasico-que-reciben-quimioterapia-de-primera-linea-que-contiene-bevacizumab 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/937/conjugados-antibiotico-droga-dirigidos-a-celulas-madre-tumoral-para-inmunoterapia-del-cancer-since-instructions-strictly-prohibit-adding-notes-or-explanations-here-is-the-corrected-version-without 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2523/evolucion-de-los-neoantigenos-y-respuesta-a-la-inmunoterapia-con-inhibidores-de-puntos-de-control-en-el-cancer-colorrectal 2026-07-19 monthly 0.5 https://crcwarriors.org/articulo/2532/el-aumento-del-lactato-mediado-por-la-quinasa-nek8-perjudica-la-inmunidad-antitumoral-y-disminuye-la-sensibilidad-a-la-radioterapia-en-el-cancer-colorrectal 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/1779/perfiles-genomicos-transcriptomicos-y-de-microbioma-del-cancer-colorrectal-por-linaje-proporcionan-insights-sobre-distinciones-moleculares 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2533/las-celulas-linfoides-innatas-inmaduras-que-se-infiltran-en-el-tumor-en-el-cancer-colorrectal-muestran-una-tendencia-hacia-la-diferenciacion-en-ilc1-celulas-nk-residentes-en-los-tejidos 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/1777/resecabilidad-del-tumor-y-respuesta-patologica-despues-de-la-quimiorradioterapia-preoperatoria-de-largo-curso-en-cancer-rectal-localmente-avanzado-en-un-entorno-con-recursos-limitados 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/1778/healthformer-transformadores-de-nivel-dual-conscientes-del-tiempo-para-eventos-irregulares-de-registros-electronicos-de-salud 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2589/una-alianza-inter-reino-que-impulsa-el-cancer-colorrectal 2026-08-12 monthly 0.5 https://crcwarriors.org/articulo/1583/la-terapia-viral-oncolitica-potencia-la-quimio-pd-1-inmunoterapia-al-comprometer-celulas-t-cd8-test-bystander-resistentes-a-la-quimioterapia-removing-the-note-the-correct-translation-should-be-la 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/311/dysfuncion-cardiaca-sintomatica-severa-en-un-paciente-con-cancer-colorrectal-metastasico-mutado-braf-v600e-tratado-con-encorafenib-binimetinib-y-cetuximab-informe-de-caso 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/862/la-sobreexpresion-de-ube2d3-inducida-por-ifn-altera-las-vias-de-presentacion-de-antigenos-y-la-inmunidad-antitumoral-en-el-cancer-de-pancreas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1655/la-hipermetilacion-de-sfmbt2-promueve-el-progreso-del-cancer-colorrectal-y-es-un-potencial-marcador-no-invasivo-para-el-crc-avanzado 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1660/una-plataforma-celuloimprimada-mejorada-en-afinidad-con-boron-y-pegilada-para-la-captura-eficiente-de-celulas-cancerosas-circulantes-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/919/polimorfismos-geneticos-en-las-clases-i-y-ii-del-sistema-de-histocompatibilidad-predictivos-de-los-resultados-en-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1703/micall2-promueve-la-angiogenesis-del-cancer-colorrectal-mediante-la-regulacion-del-eje-egfr-pi3k-akt-klf5-vegfa 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1716/analisis-longitudinal-del-estado-inmunitario-en-sangre-periferica-y-prediccion-dinamica-del-pronostico-en-pacientes-con-cancer-colorrectal-avanzado-tratados-con-quimioterapia-de-primera-linea 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/954/terapia-combinada-con-anticuerpo-conjugado-de-droga-dirigido-a-dr5-y-inhibidores-de-cdk-como-estrategia-para-el-cancer-colorrectal-avanzado 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1106/mas-alla-de-la-carga-elevando-la-inmunoterapia-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/595/carga-mutacional-tumoral-adquirida-alta-y-actividad-de-la-inmunoterapia-despues-del-tratamiento-dirigido-en-cancer-colorrectal-estable-en-microsatelites 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1192/estudio-fase-1b-2-de-bms-813160-un-antagonista-dual-de-ccr2-5-en-combinacion-con-quimioterapia-o-nivolumab-en-pacientes-con-cancer-pancreatico-o-colorrectal-avanzado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1711/examinando-la-red-genica-y-los-marcadores-pronosticos-en-el-inicio-del-cancer-colorrectal-en-muestras-de-heces-utilizando-aprendizaje-automatico 2026-03-29 monthly 0.5 https://crcwarriors.org/articulo/1221/aplicacion-preliminar-de-toripalimab-en-combinacion-con-el-regimen-gemox-como-opcion-de-tratamiento-de-primera-linea-para-tumores-avanzados-de-la-via-biliar 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1733/quimiorradioterapia-neoadyuvante-con-o-sin-inhibidores-de-pd-1-en-cancer-rectal-no-metastasico-mmr-proficiente-una-metanalisis-de-ensayos-controlados-aleatorios 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1748/evaluacion-de-la-fuga-anastomotica-durante-la-implementacion-de-cirugia-laparoscopica-para-cancer-rectal-en-marruecos-estudio-retrospectivo-de-21-anos 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/1749/hmgb1-reduce-el-dano-del-adn-al-unirse-a-ku70-para-activar-la-via-de-reparacion-por-union-hueca-en-celulas-de-cancer-colorrectal-despues-de-la-radiacion 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1750/analisis-temporal-y-geografico-del-cribado-del-cancer-colorrectal-durante-y-despues-de-la-pandemia-de-covid-19-en-un-centro-de-salud-calificado-federalmente 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1759/flashdeconv-permite-la-desconvolucion-espacial-a-escala-de-atlas-y-en-multiples-resoluciones-mediante-esquematizacion-que-preserva-la-estructura 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/1067/tratamiento-inicial-con-folfoxiri-modificado-mas-panitumumab-en-pacientes-con-cancer-colorrectal-metastasico-con-mutaciones-ras-braf-de-tipo-salvaje-resultados-finales-del-estudio-triplete-de-fase-iii 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1142/combinacao-multifactorial-supera-al-immunoterapia-sola-contra-el-cancer-colorrectal-following-your-strict-rules-multiagente-combo-supera-a-la-immunoterapia-sola-contra-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/675/src-en-el-cruce-de-la-resistencia-a-los-inhibidores-de-kras-mecanismos-y-oportunidades-terapeuticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1731/surufatinib-mas-tislelizumab-como-terapia-de-linea-posterior-para-cancer-colorrectal-metastasico-un-ensayo-fase-ii-de-un-brazo 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1739/prediccion-de-respuestas-terapeuticas-en-cancer-colorrectal-metastasico-a-traves-del-perfil-funcional-personalizado-de-esferoides-derivados-de-pacientes 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/920/respuesta-a-la-terapia-anti-egfr-en-cancer-colorrectal-metastasico-refractario-a-la-quimioterapia-del-lado-derecho-con-ras-wt-un-informe-de-caso-y-revision-de-la-literatura 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1297/enzima-nano-ros-amplificadora-hkust-1-para-terapia-mejorada-del-cancer-de-colon 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2578/la-deficiencia-de-caspasa-3-7-se-asocia-con-un-aumento-de-la-inflamacion-intestinal-y-una-reduccion-de-la-tumorigenesis 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1670/distribucion-y-valor-pronostico-de-los-macrofagos-en-el-cancer-colorrectal-y-la-mucosa-adyacente-en-pacientes-con-estadios-i-iii-frente-a-iv 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1431/morbilidad-afectiva-despues-del-diagnostico-de-cancer-incidencia-a-nivel-nacional-y-patrones-de-farmacoterapia-en-cinco-tipos-principales-de-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1724/nivel-de-adn-circulante-tras-la-cirugia-en-pacientes-con-cancer-de-colon-en-estadio-iii-impacto-en-la-fiabilidad-de-la-deteccion-de-enfermedad-residual-minima 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1730/hervominer-un-enfoque-basado-en-similitud-de-secuencia-para-reconocer-el-origen-de-los-retrovirus-endogenos-del-peptidoma 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2563/el-nitrato-de-origen-del-huesped-alimenta-la-produccion-de-indol-por-escherichia-coli-lo-que-favorece-la-progresion-de-la-enfermedad-renal-cronica 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/22/integracion-del-perfil-genomico-exhaustivo-obtenido-a-partir-de-biopsias-de-tejido-y-de-liquidos-para-predecir-la-eficacia-de-las-terapias-anti-egfr-en-el-cancer-colorrectal-metastasico-resultados 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2613/he4-induce-la-expresion-de-pd-l1-en-las-celulas-mieloides-a-traves-de-la-senalizacion-ifn-r-jak-stat3-lo-que-favorece-la-evasion-inmunitaria-tumoral 2026-07-12 monthly 0.5 https://crcwarriors.org/articulo/1335/el-mecanismo-de-la-acetil-l-carntina-en-el-cancer-colorrectal-y-su-estudio-metabolomico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1338/la-farmacologia-de-red-integrada-con-la-multiomica-demuestra-que-wumei-wan-modula-la-progresion-del-cancer-colorrectal-regulando-el-eje-de-senalizacion-de-adhesion-focal-yap 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1595/nanoparticulas-de-silicio-mesoporoso-ionizado-mediadas-para-la-entrega-de-siaurkb-en-el-tratamiento-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/841/caracterizacion-genomica-de-tumores-colorrectales-informacion-sobre-genes-vias-y-resultados-de-supervivencia-con-mutaciones-significativas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1723/el-silenciamiento-de-nuak1-potencia-la-ferropotesis-inducida-por-radioterapia-en-el-cancer-rectal-avanzado-localmente-al-impedir-la-transcripcion-dirigida-por-nrf2-del-gpx4 2026-03-29 monthly 0.5 https://crcwarriors.org/articulo/1734/sintetizando-perfiles-clinicos-multidimensionales-a-partir-de-imagenes-de-kaplan-meier-publicadas 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/1740/la-integrina-beta-4-promueve-la-progresion-del-cancer-colorrectal-al-aumentar-la-expresion-de-ezrin-y-activar-la-via-de-senalizacion-wnt-catenina 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/1486/anlotinib-en-combinacion-con-trifluridina-tipiracil-en-pacientes-con-cancer-colorrectal-metastasico-refractario-un-estudio-de-fase-ii-de-un-solo-brazo 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1758/no-fenotipos-en-ratones-knockout-de-ttc22 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/1760/decifrar-el-programa-epigenetico-dependiente-del-contexto-mediante-la-prediccion-basada-en-redes-de-elementos-regulatorios-abiertos-agrupados-a-partir-de-la-accesibilidad-cromatinica-a-nivel-de 2026-09-02 monthly 0.5 https://crcwarriors.org/articulo/1761/traducir-las-incrustaciones-de-modelo-de-fundacion-en-historiopatologia-en-caracteristicas-celulares-y-moleculares-para-estudios-clinicos 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/1524/discrepancia-entre-la-respuesta-radiologica-y-patologica-al-tratamiento-neoadyuvante-con-inmunoterapia-en-cancer-colorrectal-deficiente-en-reparacion-de-desajustes-microsatelites-instables-un 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/772/una-nueva-esperanza-bloqueo-dual-del-receptor-de-factores-de-crecimiento-epidermico-humano-2-y-quimioterapia-en-cancer-colorrectal-amplificado-por-el-receptor-de-factores-de-crecimiento-epidermico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/76/de-la-especificidad-tisular-al-diagnostico-tisular-la-sobreexpresion-de-her2-y-el-auge-de-los-conjugados-anticuerpo-farmaco 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1416/el-sindrome-de-lynch-como-un-espectro-de-cuatro-trastornos-geneticos-distintos-hacia-una-gestion-de-precision-guiada-por-el-genotipo-en-la-era-de-la-secuenciacion-de-nueva-generacion 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1687/fumar-promueve-el-cancer-colorrectal-a-traves-del-eje-ckap2l-areg 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1718/una-estrategia-de-enriquecimiento-selectivo-y-especifica-con-un-probeta-terminal-mediada-para-la-deteccion-altamente-sensible-de-microarns 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1719/la-desestabilizacion-de-saps3-mediada-por-aurka-impulsa-la-evasion-de-ferropotesis-a-traves-de-la-biosintesis-de-7-desidrocolesterol-en-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1725/identificacion-de-proteinas-plasmaticas-asociadas-con-el-riesgo-de-canceres-solidos-un-analisis-prospectivo-de-25-anos-de-4-712-proteinas-circulantes-en-el-estudio-aric 2026-04-30 monthly 0.5 https://crcwarriors.org/articulo/2549/la-perdida-de-polaridad-causada-por-la-deplecion-de-cdc42-y-la-activacion-oncogenica-de-kras-en-el-epitelio-intestinal-del-raton-conduce-a-una-enfermedad-similar-a-la-enterocolitis-necrosante-enc 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/1275/diseno-y-sintesis-de-inhibidores-de-kras-g12c-para-evaluacion-antitumoral-que-incorporan-terapia-combinada-con-inhibidores-de-nrf2-parp-7-y-pan-usp-para-aliviar-la-resistencia-a-los-farmacos-de-forma 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1656/una-firma-radiomica-de-tc-permite-la-estratificacion-de-riesgo-y-prediccion-de-supervivencia-en-metastasis-hepaticas-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1695/monitoreo-multietapas-de-ctdna-de-enfermedad-residual-minima-en-metastasis-hepaticas-de-cancer-colorrectal-de-ngt-tejido-a-plataformas-digitales-de-pcr-altamente-sensibles 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1713/la-deficiencia-de-reparacion-de-desajustes-impulsa-la-progresion-maligna-y-altera-el-microentorno-inmune-tumoral-en-modelos-de-glioblastoma 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1714/la-succinilacion-de-insig1-2-mediada-por-la-funcion-pleiotropica-de-adsl-promueve-la-lipogenesis-y-la-tumorigenesis-hepatica 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1721/srrm1-coordina-un-programa-de-splice-alternativo-que-promueve-la-expresion-de-isoformas-proteicas-oncogenicas 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/1071/marco-para-el-perfilado-y-interceptacion-de-la-evolucion-del-cancer-en-cancer-colorrectal-programa-ascend-crc 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1334/preparacion-rapida-de-muestras-mediante-microfluidica-para-analisis-por-espectrometria-de-masas-de-la-proteina-braf-de-tipo-silvestre-y-mutante 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1657/la-huella-de-alteracion-numerica-copiar-predice-la-respuesta-clinica-de-la-quimioterapia-basada-en-oxaliplatino-en-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1699/la-folato-promueve-la-progresion-del-cancer-colorrectal-mediante-el-deterioro-de-la-funcion-y-la-reclutamiento-de-las-celulas-t-cd8-a-traves-del-eje-slc19a1-p-akt-notch1-y-la-downregulacion-de-ccl5 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1720/mca-unet-una-u-net-de-multiples-escalas-con-contenido-y-atencion-para-la-segmentacion-de-polidos-colo-rectales 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/1579/butirato-hidroxilado-un-metabolono-principal-de-las-dietas-cetogenicas-y-su-doble-papel-en-la-modulacion-del-cancer-colorrectal-desde-mecanismos-moleculares-hasta-insights-terapeuticos 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1339/un-ensayo-clinico-controlado-con-placebo-y-un-estudio-experimental-preliminar-que-exploran-la-eficacia-de-la-decocto-modificado-banxia-xiexin-en-el-tratamiento-del-cancer-colorrectal-avanzado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1340/la-decoccion-fuzheng-shengbai-potencia-la-inmunidad-antitumoral-a-traves-de-la-estabilizacion-dependiente-de-ythdc2-del-arnm-de-clca2-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1092/el-ensayo-quicc-ensayo-de-inmunoterapia-cuadruple-para-el-cancer-colorrectal-para-el-cancer-colorrectal-metastasico-con-reparacion-del-desajuste-funcional 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/864/un-enfoque-de-biologia-sistematica-para-identificar-objetivos-clave-en-cancer-colorrectal-mutado-en-kras-braf 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1633/precision-de-la-medicion-del-tamano-de-tumores-colorrectales-grandes-2-cm-de-crecimiento-lateral-un-estudio-prospectivo-basado-en-video 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1640/medicinas-microbianas-desbloqueando-el-potencial-terapeutico-del-microbioma-en-el-tratamiento-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1643/metodo-basado-en-la-metilacion-del-adn-tumoral-circulante-para-la-deteccion-no-invasiva-y-la-estratificacion-del-estadio-del-tumor-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1654/perfiles-de-expresion-genica-y-de-citocinas-en-pacientes-con-cancer-colorrectal-metastasico-despues-de-la-administracion-de-reovirus 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1659/integrando-ani-y-filogenias-para-la-reevaluacion-de-la-taxonomia-y-las-asociaciones-con-enfermedades-de-fusobacterium 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1676/easdnet-potenciando-la-medicina-basada-en-evidencias-centrada-en-el-ser-humano-a-traves-de-una-red-basada-en-evidencias-y-atencion-para-la-desigualdad-espacial-discriminativa-en-la-screening 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1686/lisisoquinasa-de-atp-citratos-carcinogenesis-y-avances-terapeuticos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/961/la-terapia-de-celulas-t-con-receptor-quimerico-especifico-para-slc7a11-car-t-potencia-la-targeting-de-cancer-colorrectal-y-pancreatico-following-the-instructions-strictly-here-s-the-revised-version 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1235/diseno-desarrollo-y-evaluacion-funcional-de-un-anticuerpo-basado-en-nanobodies-dirigido-contra-cd73-para-inducir-la-muerte-celular-inmunogenica-en-una-linea-celular-de-cancer-colorrectal-resistente-a 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1253/el-sishen-wan-inhibe-el-cancer-colorrectal-a-traves-de-la-inhibicion-dual-de-los-caminos-pi3k-akt-mtor-y-stat3-mitofoagia-farmacologia-de-red-y-validacion-experimental 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/486/eficacia-y-seguridad-de-pyrotinib-en-pacientes-con-tumores-solidos-no-mamarios-previamente-tratados-positivos-para-her2-un-ensayo-clinico-fase-2-abierto-canasto 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1515/intervalos-de-confianza-y-estimaciones-puntuales-para-los-efectos-del-tratamiento-en-disenos-de-enriquecimiento-adaptativo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2576/interfase-electroquimica-microrrobotica-rica-en-cobre-para-la-administracion-dirigida-de-terapias-y-el-diagnostico-del-cancer-en-el-intestino 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1563/la-suplementacion-simbiotica-preoperatoria-modula-la-microbiota-intestinal-de-pacientes-con-cancer-colorrectal-evidencia-de-un-ensayo-clinico-aleatorizado 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1573/implicaciones-clinicas-e-inmunologicas-de-la-expresion-del-gen-de-activacion-de-linfocitos-3-en-el-cancer-colorrectal-metastasico 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1574/cicrnas-tumor-supresores-en-esferoides-de-cancer-colorrectal-y-pacientes 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1098/la-inflamacion-derivada-del-cancer-se-asocia-con-la-resistencia-al-bevacizumab-y-con-resultados-clinicos-inferiores-en-pacientes-con-cancer-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1662/melanoma-primario-de-la-tracto-gastrointestinal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1666/una-estrategia-de-intensificacion-del-tratamiento-guiada-por-la-calprotectina-fecal-mejora-la-remision-de-la-enfermedad-en-la-colitis-ulcerosa 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1690/prediccion-conjunta-de-la-respuesta-al-tratamiento-adyuvante-y-del-tiempo-hasta-la-respuesta-en-pacientes-con-cancer-mediante-el-metodo-personalized-drugrank 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1691/desacoplamiento-del-estres-nucleolario-de-la-dano-en-el-adn-en-celulas-de-cancer-colorrectal-hct116-mediante-la-targeting-de-la-interaccion-entre-los-factores-de-ensamblaje-ribosomico-bop1-wdr12 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1692/la-expresion-aberrante-de-la-quinasa-del-testiculo-tssk6-activa-la-senalizacion-fak-stat3-para-promover-el-crecimiento-tumoral 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/1693/metaresnet-mejorando-la-clasificacion-de-enfermedades-basada-en-el-microbioma-mediante-la-optimizacion-de-colormap-y-el-manejo-del-desequilibrio 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/1694/una-ensamblaje-de-siete-proteinas-promueve-la-estabilidad-neutralizacion-y-secrecion-del-efector-tele-del-sistema-secretorio-tipo-vii-t7ssb-lxg 2026-09-03 monthly 0.5 https://crcwarriors.org/articulo/1537/respuestas-ultrasonicas-de-serotoninilacion-y-firmas-genicas-de-los-caminos-distintivos-revelan-vulnerabilidades-del-microambiente-tumoral-y-subtipos-pronosticos-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1565/eficacia-de-una-dieta-basada-en-plantas-sobre-la-toxicidad-gastrointestinal-inducida-por-la-quimioterapia-folfox-en-pacientes-con-cancer-colorrectal-protocolo-de-estudio-para-un-ensayo-clinico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2594/el-panorama-de-la-variacion-estructural-en-el-cancer-pediatrico 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/810/inteligencia-artificial-avanzada-combinada-con-plataformas-sers-para-el-diagnostico-y-los-efectos-terapeuticos-del-cancer-en-aplicaciones-clinicas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1336/alta-eficacia-y-biocompatibilidad-aplicacion-y-evaluacion-biologica-del-liposomas-la67-en-la-terapia-del-cancer-de-colon 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1611/integracion-de-la-secuenciacion-de-rna-de-lecturas-cortas-y-largas-permite-el-descubrimiento-de-circrnas 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1626/marcador-de-sarcopenia-derivado-del-aprendizaje-profundo-predice-el-beneficio-del-tratamiento-anti-egfr-en-pacientes-con-cancer-colorrectal-metastasico-ras-wt 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1627/deteccion-de-ctdna-con-secuenciacion-whole-genoma-bisulfita-a-baja-pasada-en-cancer-colorrectal-metastasico-wild-type-ras-un-objetivo-exploratorio-del-ensayo-valentino 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1678/integracion-de-bioinformatica-y-aprendizaje-automatico-para-caracterizar-la-patogenicidad-de-fusobacterium-nucleatum 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1680/la-persistencia-del-spike-de-sars-cov-2-esta-asociada-con-una-desregulacion-localizada-del-sistema-inmunitario-en-las-biopsias-de-intestino-en-pacientes-con-long-covid 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1681/conciencia-publica-sobre-los-sintomas-y-factores-de-riesgo-de-cancer-colorrectal-y-explorando-las-barreras-para-la-deteccion-temprana-en-nueve-paises-un-estudio-transversal-multi-nacional 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1456/como-lo-hago-resectoscopia-laparoscopica-de-baja-anterior-con-preservacion-del-nervio-identificacion-y-conservacion-paso-a-paso-del-nervio 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2553/marco-de-trabajo-multimodal-para-el-analisis-conjunto-de-datos-de-secuenciacion-de-arn-de-celulas-individuales-y-de-secuenciacion-del-receptor-de-celulas-t-que-predice-la-respuesta-de-las-celulas-t-a 2026-07-18 monthly 0.5 https://crcwarriors.org/articulo/1541/nuevos-metabolicos-esteroideos-homo-aza-lactam-activos-para-el-tratamiento-del-cancer-pancreatico-y-colorrectal-humano 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1542/la-vitamina-c-en-el-tratamiento-del-cancer-colorrectal-entre-la-esperanza-y-el-desamparo 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1551/remodelacion-antigenica-en-cancer-colorrectal-como-la-radioterapia-y-la-quimioterapia-aumentan-la-respuesta-a-la-inmunoterapia 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1594/un-enfoque-practico-para-el-diagnostico-de-metastasis-hepaticas-del-cancer-de-origen-desconocido-aplicacion-de-la-inmunohistoquimica-y-actualizacion 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1612/optimizacion-farmacocinetica-del-predirigido-terapeutico-basado-en-radiocobre 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1665/evaluacion-del-grado-de-cumplimiento-y-la-disposicion-a-participar-en-los-programas-de-deteccion-del-cancer-colorrectal-entre-las-personas-que-viven-en-centros-penitenciarios 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1527/el-tratamiento-con-coctel-de-anticuerpos-especificos-del-tumor-inhibe-el-crecimiento-de-tumores-colorrectales-en-ratones 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1617/citocinas-y-quimiocinas-como-biomarcadores-emergentes-y-objetivos-terapeuticos-en-el-cancer-colorrectal-revision-narrativa 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1663/mas-alla-del-mrd-binario-interpretacion-cuantitativa-de-ctdna-despues-de-la-cirugia-con-intencion-curativa-para-el-cancer-colorrectal 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1664/sct4cms-prediccion-de-subtipado-molecular-consensuado-basado-en-tomografia-computarizada-preoperatoria-en-cancer-colorrectal-utilizando-aprendizaje-profundo-interpretable 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/649/klf7-como-biomarcador-del-estado-premetastasico-promueve-la-metastasis-hepatica-del-cancer-colorrectal-a-traves-de-la-senalizacion-autocrina-de-tgf 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/938/bloqueo-dual-de-tnfr2-y-cd47-remodela-el-microentorno-inmune-tumoral-e-improved-los-efectos-antitumorales-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1610/dlat-suprime-el-progreso-tumoral-y-modula-la-respuesta-al-tratamiento-en-el-cancer-colorrectal-perspectivas-de-un-modelo-pronostico-metabolico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/873/el-nuevo-inhibidor-de-cdk2-cdk9-fadraciclib-actua-sobre-las-vias-de-supervivencia-celular-y-de-dano-del-adn-y-presenta-un-efecto-sinergico-con-encorafenib-en-celulas-humanas-de-cancer-colorrectal-con 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1649/la-farmacologia-de-red-integrativa-y-el-aprendizaje-automatico-identifican-potentes-objetivos-del-acido-indol-3-lactico-en-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1162/un-metodo-de-proteomica-para-pocos-numeros-de-celulas-para-elucidar-los-mecanismos-de-desarrollo-de-celulas-madre-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1426/asociacion-de-variantes-en-la-linea-germinal-con-el-estado-de-mutacion-de-kras-en-el-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/939/avances-en-terapias-dirigidas-para-el-cancer-colorrectal-superando-desafios-y-explorando-direcciones-futuras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/962/la-administracion-sistemica-de-photobacterium-angustum-promueve-la-inmunidad-antitumoral-y-la-licopenesis-tumoral-directa-en-modelos-murinos-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1224/objetivo-de-braf-en-canceres-desde-la-diagnostica-molecular-hasta-la-terapia-personalizada 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1532/inhibir-hspb1-inhibe-el-crecimiento-tumoral-y-abroga-la-inmunosupresion-tumoral-mediada-por-treg 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1022/la-administracion-de-nano-purpurina-cu-mediante-macropinocitosis-inducida-por-tpgs-permite-la-sinergia-entre-la-cuproptosis-y-el-metabolismo-lo-que-contribuye-a-eliminar-las-caracteristicas-de-las 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1023/nanotransportadores-basados-en-polipeptidos-a-partir-de-ropisa-acuoso-rendimiento-dependiente-de-la-forma-en-modelos-de-cancer-colorrectal-y-de-mama 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1679/patrones-espaciotemporales-de-deformacion-activa-revelan-la-degradacion-de-la-adhesion-celula-celula-en-criptorganoides-derivados-de-pacientes-con-mutacion-en-braf-de-cancer-colorrectal 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1299/la-desregulacion-de-pcsk9-a-traves-de-programas-epitranscripticos-dependientes-de-m-6-a-fomenta-la-progresion-del-cancer-hepatocelular 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1566/landscape-proteomico-del-metastasis-hepatica-de-cancer-colorrectal-firmas-moleculares-y-nuevos-objetivos-terapeuticos 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1348/infusion-intravenosa-de-megacariocitos-ingenierizados-para-producir-plaquetas-oncolitas-in-vivo-para-una-terapia-inmunooncologica-mejorada 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1632/fixative-exchange-fx-seq-analisis-escalable-de-secuenciacion-de-arn-de-un-solo-nucleo-de-tejido-fijado-con-formaldehido-o-incluido-en-parafina-ffpe 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1169/evaluacion-de-biomarcadores-inmuno-oncologicos-y-de-la-expresion-de-catenina-en-la-respuesta-de-los-carcinomas-hepatocelulares-a-la-inmunoterapia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1517/microambiente-inmune-desregulado-en-cancer-colorrectal-metastasico 2026-03-29 monthly 0.5 https://crcwarriors.org/articulo/1525/tendencias-de-investigacion-de-macrofagos-asociados-a-tumores-en-cancer-colorrectal-un-analisis-bibliometrico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1533/el-adn-tumoral-circulante-informado-por-el-tumor-estratifica-el-riesgo-de-recurrencia-y-la-supervivencia-en-carcinoma-escamoso-anal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1534/subconjuntos-de-celulas-inmunitarias-del-sangre-periferica-como-marcadores-bioquimicos-no-invasivos-del-estado-de-la-enfermedad-colo-rectal-lateralidad-metastasis-y-supervivencia 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/324/efecto-del-receptor-de-factor-de-crecimiento-epidermico-humano-2-en-pacientes-con-cancer-colorrectal-metastasico-tratados-con-quimioterapia-mas-bevacizumab-o-anti-egfrs-analisis-exploratorio-de-ocho 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1102/supresion-translacional-de-kras-y-nras-a-traves-de-moleculas-pequenas-objetivo-de-g-cuadripalares-de-arn-para-el-tratamiento-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1618/la-recuperacion-acelerada-despues-de-la-cirugia-eras-incrementa-la-tasa-de-supervivencia-a-largo-plazo-despues-de-la-cirugia-en-pacientes-con-cancer-colorrectal-una-revision-sistematica-y-analisis 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1619/efectividad-de-la-mediacion-sanitaria-para-promover-la-realizacion-de-cribados-organizados-de-cancer-entre-poblaciones-desatendidas-y-subcreenadas-en-marsella-francia-hallazgos-de-una-encuesta 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1620/deteccion-de-variantes-genomiquicas-en-datos-de-secuenciacion-de-lecturas-largas-a-partir-de-muestras-de-pacientes-con-entrada-ultrabajada 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1621/cuidados-centrados-en-la-persona-toma-de-decisiones-compartida-y-modularidad-del-servicio-en-el-tratamiento-del-cancer-colorrectal-un-estudio-mixto-de-perspectivas-de-pacientes-y-profesionales 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1449/la-respuesta-al-bloqueo-de-puntos-de-control-inmunitario-se-potencia-en-presencia-de-inactivacion-hematopoyetica-de-tet2 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1543/carcinoma-pulmonar-de-celulas-claras-con-kras-q61h-caracteristicas-clinico-patologicas-diagnostico-y-el-panorama-evolutivo-del-tratamiento 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1303/reevaluar-el-omega-3-epa-dha-en-la-prevencion-y-manejo-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1562/explorando-el-tiempo-optimo-de-seguimiento-para-pacientes-con-cancer-colorrectal-resecable-un-estudio-de-cohorte-longitudinal-multicentrico-de-cinco-anos 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1596/bega-unet-boundary-explicit-guided-attention-u-net-con-agrupacion-de-caracteristicas-a-multiples-escalas-para-la-segmentacion-de-polipos-coloscopicos 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1597/una-plataforma-de-cultivo-microfluidica-de-alta-capacidad-para-el-perfilamiento-fenotipico-y-omico-de-multiples-parametros-de-organoides-derivados-de-pacientes 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1601/el-objetivo-senolitico-de-las-celulas-cancerosas-del-colon-inducidas-por-caf-que-expresan-krt17-inhibe-la-invasion-metastasica 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1602/la-reprogramacion-metabolica-controlada-por-la-alternativa-de-splicing-de-nf-ya-crea-oportunidades-terapeuticas-en-cancer-colorrectal 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1603/mapeo-guiado-por-perturbacion-de-los-estados-celulares-del-cancer-colorrectal-hacia-mecanismos-causales 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1104/efecto-de-la-infeccion-por-helicobacter-pylori-en-el-microbioma-intestinal-y-intratumoral-y-su-asociacion-con-la-respuesta-a-la-inmunoterapia-en-cancer-gastrointestinal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1479/analisis-sistematico-de-variantes-geneticas-y-epigeneticas-funcionales-en-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1508/el-analisis-metabomico-revela-nuevos-metabolitos-etilados-del-hidroxitirosol-en-celulas-de-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1584/analisis-de-las-diferencias-clinico-patograficas-histo-morfologicas-y-moleculares-en-carcinoma-colic-de-lado-derecho-y-lado-izquierdo 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1585/el-impacto-de-la-etnia-del-paciente-en-la-incidencia-de-cancer-tras-pruebas-de-recuento-de-plaquetas-y-proteina-c-reactiva-en-atencion-primaria-inglesa-un-estudio-de-cohortes-de-5-millones-de 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1586/los-deoxipsicolina-lipidicos-activan-cgas-sting1-y-potencian-la-inmunidad-antitumoral 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1599/proteomica-aumentada-ia-patologia-digital-en-carcinoma-colorrectal-mucoideo-metastasico-un-informe-de-caso 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1600/variantes-asociadas-con-cancer-en-el-mutyh-dentro-del-conectador-interdominio-diferencialmente-afectan-la-actividad-glicosilasa-y-la-reparacion-de-adn-celular 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1577/evaluacion-basada-en-modelos-de-la-eficacia-de-la-prueba-de-cancer-colorrectal-tres-rondas-de-pruebas-de-adn-del-ciego-multitarget-versus-una-colonoscopia 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1578/el-papel-de-la-prehabilitacion-en-mejorar-la-salud-cerebral-y-la-cognicion-despues-de-la-quimioterapia-en-pacientes-con-cancer-colorrectal-protocolo-del-estudio-del-proyecto-prehab-chemo-brain 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1587/un-modelo-de-red-neuronal-entrega-una-firma-proteica-altamente-pronostica-en-celulas-madre-tumorales-que-identifica-el-retorno-del-cancer-en-pacientes-con-cancer-colorrectal-de-etapa-iii 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1598/la-migracion-de-los-linfocitos-intraepiteliales-intestinales-y-la-homeostasis-tisular-estan-reguladas-por-g-13 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/858/moleculas-pequenas-para-canceres-mutantes-del-oncogen-homologo-del-virus-de-sarcoma-virico-de-rata-de-kirsten-pasado-presente-y-futuro 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1631/la-produccion-de-ai-2-en-fusobacterium-nucleatum-es-especifica-del-subsistema-y-desacoplada-del-sensing-cuorum 2026-09-04 monthly 0.5 https://crcwarriors.org/articulo/1480/ecog-6293-estudio-de-fase-ii-de-raltitrexed-en-cancer-colorrectal-avanzado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1481/firmas-metabomicas-de-plasma-de-todos-los-canceres-y-de-causa-especifica-un-estudio-basado-en-la-poblacion-con-multiples-plataformas 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1549/carga-global-regional-y-nacional-de-cancer-colorrectal-atribuible-a-factores-dieteticos-1990-a-2021-un-estudio-global-de-carga-de-enfermedad-de-2021 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1569/los-condensados-de-homer-orquestan-el-entrecruzamiento-de-senalizacion-yap-wnt-aguas-abajo-del-complejo-de-polaridad-crumbs 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1570/celulas-neuro-inmunes-asociadas-a-los-crypts-y-reprogramacion-mediante-rest-activacion-stromal-determinada-por-patogenos-induccion-de-hervs-y-senalamiento-antiviral-abortivo-en-carcinoma-colorrectal 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1572/un-punto-de-control-de-reparacion-del-adn-operativo-en-criptas-para-desacoplar-la-regeneracion-y-la-tumorigenesis 2026-09-06 monthly 0.5 https://crcwarriors.org/articulo/1406/los-agonistas-de-tlr8-remodelan-el-microambiente-inmunitario-tumoral-mediante-el-reclutamiento-de-celulas-t-dependiente-de-pf4-y-mecanismos-accesorios 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1178/quimiorradioterapia-neoadyuvante-mas-sintilimab-en-cancer-colorrectal-localmente-avanzado-con-reparacion-adecuada-del-desajuste-y-un-inmunoperfil-intermedio-alto-silar-un-ensayo-de-fase-ii-de-un-solo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1214/la-relacion-neutrofilo-linfocito-basal-y-dinamica-como-biomarcador-pronostico-en-pacientes-con-cancer-colorrectal-metastasico-tratados-con-panitumumab 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1482/caracterizacion-funcional-de-casp-una-isoforma-de-cux1-que-revela-su-papel-promotor-de-tumores-en-cancer-colorrectal-a-traves-de-senalizacion-mediada-por-trim21 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1283/bevacizumab-para-cancer-colorrectal-metastasico-con-inestabilidad-cromosomica-analisis-de-costo-efectividad-para-una-nueva-aproximacion-terapeutica-personalizada-en-alemania-irlanda-y-espana 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1548/resultado-de-la-cirugia-citorreductiva-y-quimioterapia-intraperitoneal-hipertermica-para-metastasis-peritoneales-de-colorectal-y-mesotelioma-un-estudio-de-12-anos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1294/la-inhibicion-de-la-sintesis-de-acidos-grasos-potencia-la-eficacia-terapeutica-y-retrasa-la-adquisicion-de-resistencia-adquirida-a-la-terapia-dirigida-al-braf-en-el-cancer-colorrectal 2026-06-30 monthly 0.5 https://crcwarriors.org/articulo/787/inhibicion-selectiva-del-cancer-colorrectal-mediante-liposomas-de-nano-dihidroartemisinina-insights-into-the-disruption-of-abcg2-and-bcl2-leading-to-induction-of-oxidative-stress-and-metabolic 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/788/la-pectina-como-nanovehiculo-dirigido-contra-el-cancer-y-agente-terapeutico-perspectivas-fisico-quimicas-y-biologicas-una-revision 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1302/las-interacciones-entre-el-microambiente-tumoral-y-el-estroma-mediadas-por-los-macrofagos-se-correlacionan-con-el-microambiente-tumoral-en-el-cancer-colorrectal-mucinoso-con-estabilidad-microsatelite 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1559/diagnostico-y-tratamiento-del-cancer-colorrectal-metastasico-positivo-para-el-receptores-de-factor-de-crecimiento-epidermico-humano-2-una-revision-sistematica-de-la-literatura 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1567/el-microbioma-tumoral-e-la-inmunoterapia-contra-el-cancer-una-revision-sistematica-de-una-nueva-frontera-mas-alla-del-intestino 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1823/il-12-dirigida-al-tumor-pds01adc-con-terapia-de-bomba-de-infusion-en-la-arteria-hepatica-para-metastasis-hepaticas-colorrectales-analisis-provisional-de-un-ensayo-de-fase-ii-no-aleatorizado 2026-05-16 monthly 0.5 https://crcwarriors.org/articulo/1571/celulas-car-t-dirigidas-a-muc4-restringen-el-cancer-colorrectal-resistente-a-la-quimioterapia 2026-06-07 monthly 0.5 https://crcwarriors.org/articulo/1321/arn-no-codificante-trojan-nanovehiculares-en-el-crc-encrucijadas-mecanicas-y-desafios-terapeuticos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/299/el-analisis-genomico-integrativo-identifica-marcadores-pronosticos-clinicamente-relevantes-para-pacientes-con-cancer-colorrectal-y-metastasis-hepaticas 2026-05-20 monthly 0.5 https://crcwarriors.org/articulo/1580/beamion-pantumor-1-justificacion-y-diseno-de-un-ensayo-de-fase-ii-con-zongertinib-en-tumores-solidos-con-sobreexpresion-amplificacion-de-her2-o-con-mutacion-en-her2 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/823/desentranar-el-papel-de-la-respuesta-mitocondrial-a-las-proteinas-desplegadas-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1593/mejorando-el-diagnostico-del-cancer-colorrectal-con-el-marcador-de-ferropotesis-gpx4-y-los-biomarcadores-sericos-un-analisis-retrospectivo-y-una-aproximacion-de-aprendizaje-automatico 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1342/xiao-yao-san-suprime-la-metastasis-del-cancer-colorrectal-relacionada-con-la-angustia-psicologica-y-mejora-las-respuestas-inmunitarias-antitumorales-mediante-la-regulacion-del-eje-microbiota 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1343/la-berberina-promueve-la-ubiquitinacion-de-catenina-e-inhibe-su-translocacion-nuclear-al-dirigirse-a-usp22-en-los-canceres-colorrectales 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1089/preniltetrefillin-un-regulador-de-p53-inhibe-la-progresion-del-cancer-colorrectal-a-traves-del-camino-de-estres-oxidativo-y-metabolismo-energetico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1345/variabilidad-interobservador-en-la-evaluacion-histopatologica-del-carcinoma-colorrectal-pt1 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1613/exploracion-de-variantes-geneticas-de-slc1a5-asct2-slc7a5-y-slc3a2-lat1-en-el-cancer-colorrectal-implicaciones-para-el-pronostico-y-el-tratamiento-personalizado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1111/estudio-aleatorio-de-grupo-paralelo-fase-ii-neoteric-de-atezolizumab-con-o-sin-tiragolumab-despues-de-la-quimiorradioterapia-neoadyuvante-en-cancer-rectal-avanzado-localmente 2026-04-08 monthly 0.5 https://crcwarriors.org/articulo/1628/evaluacion-multiparametrica-del-grado-de-regresion-patologica-tumoral-de-metastasis-peritoneales-de-cancer-colorrectal-no-mucinoso-durante-la-quimioterapia-neoadjuvante-utilizando-tc-de-doble-energia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1634/los-extractos-fenolicos-pigmentados-del-sorgo-regulan-la-expresion-de-los-genes-de-las-vias-de-desarrollo-del-cancer-en-las-celulas-ht-29-y-ccd-841-con-inducidas-por-hipoxia 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1635/el-adn-tumoral-circulante-con-mutacion-en-kras-previo-al-tratamiento-predice-la-incidencia-y-los-patrones-de-recurrencia-en-pacientes-sometidos-a-ablacion-por-radiofrecuencia-para-metastasis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/617/sino-c-un-nuevo-derivado-de-la-sinomenina-induce-la-muerte-celular-al-alterar-la-homeostasis-del-colesterol-en-las-celulas-de-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1131/zg16b-un-regulador-clave-de-la-progresion-tumoral-y-la-modulacion-del-microambiente-inmunitario-en-el-cancer-revision 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1132/nanoliposomas-multifuncionales-fotoinmunomoduladores-dirigidos-a-las-celulas-supresoras-derivadas-de-la-medula-osea-potencian-la-inmunidad-antitumoral-en-el-cancer-de-colon 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1658/revision-sistematica-y-metaanalisis-de-estudios-que-evaluan-la-cinetica-del-adn-tumoral-circulante-en-el-cancer-colorrectal-metastasico 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/2172/item 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/1149/seguridad-y-eficacia-de-nivolumab-mas-ipilimumab-en-cancer-colorrectal-de-instabilidad-microsatelital-alta-deficit-de-reparacion-por-desparejamiento-una-revision-sistematica 2026-06-13 monthly 0.5 https://crcwarriors.org/articulo/1150/revelando-los-fitoquimicos-de-tamarix-articulata-como-nuevos-inhibidores-naturales-del-cancer-colorrectal-un-enfoque-holistico-de-diseno-de-farmacos-y-toxicologico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1407/dirigirse-a-la-resistencia-a-los-farmacos-en-el-cancer-colorrectal-mediante-el-uso-de-andamios-basados-en-peptidos-nuevas-perspectivas-en-la-terapia-del-cancer-colorrectal 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/1411/aspectos-asociados-al-sexo-en-la-referencia-resectabilidad-y-supervivencia-en-pacientes-con-metastasis-hepaticas-de-colorectal-crlm-un-estudio-basado-en-poblacion-de-un-centro-unico-involucrando-1207 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/2184/item 2026-06-15 monthly 0.5 https://crcwarriors.org/articulo/393/resultados-siguientes-a-la-ablacion-por-microondas-de-669-neoplasias-primarias-y-metastasicas-del-pulmon 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1163/ultrasonido-focalizado-de-alta-intensidad-en-el-tratamiento-multimodal-de-metastasis-hepaticas-de-cancer-colorrectal-un-informe-de-caso 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1419/inferencia-causal-y-modelado-pronostico-en-cancer-colorrectal-a-traves-de-la-integracion-de-patologia-computacional-y-aleatorizacion-mendeliana 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1425/caracteristicas-clinico-patologicas-firmas-genomicas-y-resultados-de-los-pacientes-que-se-sometieron-a-reseccion-para-metastasis-hepaticas-colo-rectales-de-inicio-temprano-versus-tardio 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1172/regulacion-de-la-ferropotesis-en-cancer-colorrectal-mediante-modulacion-terapeutica-y-objetivo-de-micrarn 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1430/analisis-exploratorio-de-las-alteraciones-geneticas-y-la-respuesta-a-la-quimioterapia-resultados-obtenidos-de-una-base-de-datos-del-mundo-real-en-japon 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1177/segmentador-de-cancer-hepatico-clasificacion-de-confianza-guiada-por-metadatos-para-la-segmentacion-confiable-de-metastasis-colorrectales-en-el-higado-en-tc 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1689/supervivencia-global-con-bevacizumab-en-el-cancer-colorrectal-metastasico-un-analisis-actualizado-del-estudio-travastin 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/1945/alteraciones-del-gen-her-2-como-biomarcador-en-pacientes-con-cancer-colorrectal-metastasico-tratados-con-folfiri-cetuximab-resultados-del-estudio-capri-2-goim 2026-07-28 monthly 0.5 https://crcwarriors.org/articulo/1195/la-remodelacion-enzimatica-del-microambiente-tumoral-mejora-la-eficacia-de-las-celulas-car-t-anti-ceacam5-contra-el-cancer-colorrectal 2026-05-28 monthly 0.5 https://crcwarriors.org/articulo/1715/como-podemos-mejorar-la-subclasificacion-de-adenocarcinoma-colorectal-para-la-oncologia-precisa-el-agrupamiento-por-consenso-multi-omico-revela-grupos-moleculares-distintos-desde-el-punto-de-vista 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1205/marcadores-biosanguineos-para-la-deteccion-temprana-y-el-monitoreo-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1722/vision-general-comprehensiva-de-las-estrategias-terapeuticas-en-cancer-colorrectal-quimioterapia-terapias-dirigidas-e-inmunoterapia 2026-07-27 monthly 0.5 https://crcwarriors.org/articulo/1726/un-ensayo-aleatorizado-que-compara-encorafenib-y-cetuximab-con-irinotecan-cetuximab-o-folfiri-cetuximab-en-pacientes-chinos-con-cancer-colorrectal-metastasico-con-mutacion-braf-v600e-el-estudio 2026-07-09 monthly 0.5 https://crcwarriors.org/articulo/1472/el-papel-de-neto2-en-los-trastornos-neurologicos-y-el-cancer-desde-la-funcion-molecular-hasta-su-relevancia-clinica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1475/igsf9-promueve-la-resistencia-a-la-inmunoterapia-en-el-cancer-colorrectal-al-orquestar-un-microambiente-tumoral-inmunesupresor-y-permite-estrategias-de-objetivo-combinado 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1227/mir-27a-3p-se-dirige-a-cacna2d3-para-promover-la-progresion-del-cancer-colorrectal-a-traves-de-la-via-ca-2-ros-apoptotica-mitocondrial 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1483/segmentacion-por-regiones-de-metastasis-linfaticas-en-imagenes-de-seccion-completa-de-cancer-colorrectal-un-estudio-clinico-piloto 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1742/respuesta-patologica-completa-con-pembrolizumab-en-adenocarcinoma-sigmoide-recurrente 2026-06-26 monthly 0.5 https://crcwarriors.org/articulo/985/la-ferroptosis-el-amanecer-de-la-reversion-de-la-resistencia-a-los-medicamentos-en-canceres-digestivos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1497/quimioterapia-de-induccion-seguida-de-quimo-radioterapia-en-pacientes-con-canceres-anales-localmente-avanzados-el-ensayo-prodige-85-ffcd-1804-kanalrad 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/986/actualizaciones-sobre-el-papel-de-mir-193b-en-la-patogenia-de-los-canceres-y-otras-enfermedades-en-humanos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1506/peroxidasa-glutation-4-gpx4-como-factor-oncogenico-en-tumores-humanos-un-analisis-paneumologico 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/2026/diferencias-en-los-perfiles-anatomoclinicos-entre-los-canceres-colorrectales-con-mutacion-en-los-genes-ras-y-aquellos-con-tipo-salvaje-en-una-cohorte-del-este-de-argelia 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1004/decodificacion-de-la-heterogeneidad-impulsada-por-senescencia-en-cancer-colorrectal-de-pronta-aparicion-para-la-estratificacion-pronostica-y-terapeutica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1276/avances-moleculares-en-patologia-gastrointestinal 2026-07-14 monthly 0.5 https://crcwarriors.org/articulo/1277/la-inhibicion-farmacologica-de-la-laquilacion-de-histonas-mejora-la-eficacia-de-la-inmunoterapia-en-canceres-gastrointestinales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1279/ingenieria-de-nanoparticulas-basadas-en-rutenio-ii-para-terapia-sonodinamica-sinergica-con-catalisis-redox-multiobjetivo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1535/caracteristicas-clinicas-y-moleculares-de-las-mutaciones-clase-ii-y-iii-del-braf-en-el-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1561/deteccion-de-clostridioides-difficile-en-una-cohorte-humana-de-ccr 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1536/el-gen-anfitrion-del-arn-pequeno-nucleolar-3-snhg3-y-el-arn-no-codificante-asociado-a-la-leucemia-y-activador-de-igf1r-1-lunar1-se-correlacionaron-con-las-caracteristicas-clinicas-de-los-pacientes 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1552/enfermedad-vascular-cerebral-oculta-y-riesgo-de-enfermedades-neurologicas-reportadas-clinicamente-una-cohorte-de-toda-la-poblacion-de-367-988-personas-utilizando-el-procesamiento-del-lenguaje-natural 2026-07-05 monthly 0.5 https://crcwarriors.org/articulo/1553/nuevos-fenotipos-inmunitarios-de-adenomas-se-asocian-con-el-riesgo-de-polipos-metacronicos-y-cancer-colorrectal-en-una-cohorte-de-deteccion-de-enfermedades-del-intestino 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1554/la-barrera-cromatinica-adaptativa-dependiente-de-ezh1-h3k27me1-limita-la-respuesta-a-los-inhibidores-de-dnmt-en-el-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1324/imagenes-de-tc-espectral-en-cancer-colorrectal-aplicaciones-actuales-limitaciones-y-perspectivas-futuras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1108/tucatinib-mas-trastuzumab-para-el-cancer-colorrectal-metastasico-her2-positivo-y-ras-de-tipo-salvaje-resistente-a-la-quimioterapia-mountaineer-analisis-final 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/387/caracteristicas-clinico-patologicas-y-alteraciones-de-biomarcadores-en-cancer-colorrectal-de-inicio-temprano-versus-tardio-una-revision-sistematica-y-metanalisis 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1159/nanoprodrugo-que-se-dirige-a-bacterias-intra-celulares-asociadas-con-tumores-mejora-la-inmunoterapia-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2554/la-adaptacion-metabolica-tumoral-inducida-por-la-l-asparaginasa-revela-una-vulnerabilidad-a-los-inhibidores-de-parp1-2-en-los-linfomas-de-celulas-b 2026-07-18 monthly 0.5 https://crcwarriors.org/articulo/1025/practica-clinica-y-analisis-de-supervivencia-del-tratamiento-de-tercera-linea-en-pacientes-con-cancer-colorrectal-metastasico-un-estudio-retrospectivo-de-un-solo-centro 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2562/el-desequilibrio-en-las-interacciones-de-la-microbiota-intestinal-como-marcador-de-salud-y-enfermedad 2026-08-15 monthly 0.5 https://crcwarriors.org/articulo/1540/expresion-de-preocupacion-un-enfoque-practico-para-el-diagnostico-de-cancer-colorrectal-basado-en-aprendizaje-automatico 2026-03-30 monthly 0.5 https://crcwarriors.org/articulo/1556/la-evaluacion-de-la-reactividad-tumoral-utilizando-la-expresion-clonal-trace-revela-la-heterogeneidad-de-las-celulas-t-citotoxicas-cd8-en-tumores-solidos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1557/modelado-de-la-modulacion-del-microbioma-en-las-redes-metabolicas-tumorales-para-predecir-terapias-sinergicas 2026-06-07 monthly 0.5 https://crcwarriors.org/articulo/1309/respuesta-a-la-inmunoterapia-en-carcinoma-de-tiroides-mal-diferenciado-estable-en-microsatelites-con-deficit-en-reparacion-de-errores-de-replicacion-y-alta-carga-mutacional-tumoral 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2591/candida-albicans-actua-en-sinergia-con-fusobacterium-nucleatum-en-la-progresion-del-cancer-colorrectal-a-traves-de-la-interaccion-flo9-radd 2026-08-13 monthly 0.5 https://crcwarriors.org/articulo/1454/evaluando-el-costo-de-la-prueba-genomica-para-terapias-guiadas-por-biomarcadores-en-oncologia 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1206/la-carga-de-mutaciones-tumorales-predice-los-perfiles-de-neoantigenos-y-la-respuesta-a-la-inmunoterapia-en-tumores-estables-de-microsatelites-acros-diferentes-tipos-de-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/714/probetas-de-fluorescencia-nir-ii-para-la-etiquetado-rapido-del-hibrido-de-vesiculas-de-membrana-externa-probiotica-y-vesiculas-celulares-que-sobrexpresan-anti-pd-l1-scfv-con-fototerapia-termal-inmune 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1488/cartografia-de-la-fibrosis-en-las-metastasis-hepaticas-de-cancer-colorrectal-crlm-mediante-resonancia-magnetica-con-gadobenato-dimeglumina-implicaciones-pronosticas-y-biomarcadores-de-imagen 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1496/terapia-combinada-para-el-cancer-colorrectal-con-anti-pd-l1-y-vacuna-contra-el-cancer-un-modelo-matematico-multiescala-de-las-interacciones-tumor-inmune 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1509/valor-pronostico-del-indice-nutricional-pronostico-en-cancer-colorrectal-una-revision-sistematica-y-metanalisis 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1254/un-nanoenzima-multifuncional-que-integra-la-induccion-de-panoftosis-y-la-reprogramacion-metabolica-de-celulas-t-para-aumentar-la-eficacia-de-los-inhibidores-de-pd-1 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1262/los-peroxidos-de-zinc-enriquecidos-con-cobre-indujeron-una-cuproptosis-a-traves-de-la-desregulacion-metabolica-y-oxidativa-concurrente-para-potenciar-la-inmunoterapia-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1555/acb1801-aumenta-la-inmunogenicitad-del-tumor-mediante-el-objetivo-de-la-vulnerabilidad-de-la-glicolisis-ferroptosis-y-activando-la-senalizacion-de-stat1-para-superar-la-resistencia-a-anti-pd-1-en 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/847/slc38a5-drive-la-resistencia-a-la-ferropotesis-del-cancer-colorrectal-a-traves-del-eje-hipocampo-yap-nrf2 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1462/descifrando-el-microambiente-tumoral-en-la-resistencia-terapeutica-del-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1510/excision-mesorrectal-total-y-personalizada-para-el-cancer-de-recto-origenes-evolucion-y-mitos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1518/interaccion-microbioma-hospedador-en-cancer-colorrectal-tecnologia-computacional-emergente-integracion-de-multiples-omicas-y-mecanismos 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/2542/vrac-coordina-el-equilibrio-entre-la-absorcion-de-nutrientes-y-la-defensa-antimicrobiana-en-los-enterocitos-frente-a-la-inflamacion 2026-07-16 monthly 0.5 https://crcwarriors.org/articulo/1528/origene-un-biologo-de-enfermedades-virtuales-autoevolutivo-que-automatiza-la-descubierta-de-objetivos-terapeuticos 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1529/retractamiento-los-3-pufa-ejercen-actividad-antiinflamatoria-en-adipocitos-viscerales-de-pacientes-con-cancer-colorrectal 2026-03-30 monthly 0.5 https://crcwarriors.org/articulo/1045/estrategias-nano-inmunoterapeuticas-emergentes-logran-la-terapia-precisa-del-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1445/firmas-microbioma-metabolo-en-cancer-colorrectal-metastasico-promesa-trampas-y-el-camino-hacia-adelante 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/2527/el-perfil-de-la-microbiota-residente-en-los-tejidos-en-muestras-de-tejido-normal-polipos-y-cancer-colorrectal 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/1263/los-proantocianidinas-potencian-la-inmunidad-antitumoral-al-promover-la-degradacion-ubiquitina-proteosomica-de-pd-l1-mediante-la-estabilizacion-de-lkb1-y-syvn1 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1520/asociacion-entre-positividad-en-la-prueba-de-clostridioides-difficile-y-el-desarrollo-incidente-de-cancer-colorrectal-en-un-analisis-retrospectivo-basado-en-cohortes-hospitalarios-multisitio 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1522/identificacion-sistematica-de-marcadores-epigeneticos-de-metilacion-del-adn-para-la-deteccion-especifica-por-tipo-de-tumor 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1523/mapeo-de-todo-el-huerto-de-secciones-de-tejido-tumoral-mediante-la-arquitectura-de-fibra-a-traves-de-la-imagen-computacional-de-luz-difusa 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1327/fam65a-como-un-predictor-potencial-del-pronostico-promueve-la-progresion-del-cancer-colorrectal-a-traves-de-la-activacion-de-la-via-de-senalizacion-ras-erk-rsk 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1417/patrones-de-inestabilidad-cromosomica-y-alteraciones-epigeneticas-en-la-progresion-del-cancer-colorrectal-desde-displasia-de-alto-grado-hasta-metastasis-hepaticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1513/validacion-de-la-correccion-del-caso-y-el-acuerdo-en-los-intervalos-de-tiempo-en-el-registro-sueco-de-reanimacion-cardiopulmonar-utilizando-datos-de-despacho-medico-de-emergencia-2015-2024 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1521/infereccion-de-mutaciones-drivadoras-de-cancer-a-partir-de-la-composicion-del-microentorno-tumoral-un-estudio-pan-cancer-con-validacion-externa-cruzada-plataforma 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1428/las-deficiencias-en-la-reparacion-del-adn-germinal-estan-asociadas-con-canceres-gastrointestinales-de-inicio-temprano-y-orientan-estrategias-de-prevencion-precisa 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1438/los-compuestos-novedosos-de-hidrazona-derivada-de-pirazol-benzofurano-inhiben-el-crecimiento-de-celulas-cancerosas-al-dirigirse-a-mmps-caspasas-y-la-via-de-senalizacion-pi3k-akt-mtor 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1490/la-ayuna-de-16-horas-optimiza-la-inmunoterapia-contra-el-cancer-en-ratones-y-humanos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1499/caracterizacion-genomica-de-la-poliposis-asociada-al-tratamiento-revela-una-huella-mutacional-alquilante-del-tratamiento-previo 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/1500/tincion-dual-satb2-lamina-elastica-en-cancer-colorrectal-impacto-clinico-patologico-y-valor-pronostico 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/1502/un-perfil-finamente-ajustado-de-fosfatidilinositola-contribuye-a-la-diferenciacion-y-maligienizacion-de-las-celulas-colonicas-evidencia-desde-omica-integradas 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1503/atornille-el-lamp-una-plataforma-fotoelectroquimica-para-la-deteccion-de-mutaciones-en-kras-mediante-bloqueo-del-tipo-wt 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1264/las-macrofagas-asociadas-a-tumores-producen-pge2-para-promover-el-agotamiento-de-celulas-t-cd8-y-conducir-la-resistencia-al-bloqueo-de-pd-l1-en-cancer-colorrectal-estable-en-microsatelites 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1325/evaluacion-del-gellan-gum-reticulado-con-trilisina-para-la-administracion-intratumoral-de-un-anti-pd-1-en-un-modelo-murino-de-tumor-de-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1328/la-citometria-de-masa-a-nivel-de-celula-individual-revela-firmas-inmunitarias-distintas-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1485/smco-un-modelo-de-aprendizaje-profundo-que-integra-el-ecosistema-del-entorno-microambiental-celular-a-nivel-de-resolucion-unicelular-y-la-omicologia-multiple-para-la-prediccion-de-supervivencia-en 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1033/asociacion-entre-los-niveles-de-acido-urico-serico-y-los-resultados-clinicos-de-la-inmunoterapia-en-pacientes-con-cancer-colorrectal-avanzado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1291/significado-pronostico-de-las-mutaciones-en-los-genes-kras-nras-y-braf-en-el-cancer-colorrectal-una-revision-sistematica-y-metaanalisis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1300/itih2-en-la-metastasis-de-cancer-colorrectal-validacion-funcional-guiada-por-el-analisis-de-redes-de-coexpresion-genica-ponderada 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2581/las-celulas-t-con-receptores-quimericos-de-antigenos-dirigidos-contra-krasg12v-hla-a-02-01-muestran-una-potente-actividad-preclinica-contra-tumores-solidos 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1310/mejorando-la-precision-y-la-explicabilidad-en-la-clasificacion-de-lesiones-colorrectales-con-transformadores-de-vision-supervisados-por-atencion 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/648/respuesta-temprana-en-18f-fdg-pet-tc-despues-de-una-dosis-unica-de-terapia-anti-egfr-como-biomarcador-predictivo-del-beneficio-del-tratamiento-en-pacientes-con-cancer-colorrectal-avanzado 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/422/el-paisaje-molecular-y-funcional-de-la-resistencia-a-la-quimioterapia-folfiri-en-el-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1455/excision-robotica-por-via-unica-de-la-evisceracion-mesocolica-completa-para-neoplasias-colon-derechos-factibilidad-tecnica-y-oncologica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/435/el-bloqueo-de-vegfr2-supera-la-resistencia-adquirida-al-inhibidor-de-kras-g12d-la-cual-esta-impulsada-por-la-activacion-de-pi3k 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1460/nuevos-nanoc-c3-a9ligas-orales-respuesta-ph-con-doble-objetivo-para-la-terapia-precisa-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1501/papeles-distintos-y-cooperativos-de-la-osteopontina-del-huesped-y-del-tumor-en-la-metastasis-hepatica-del-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/2531/las-interacciones-metabolicas-interdominio-vinculan-a-methanobrevibacter-smithii-con-los-ecosistemas-microbianos-del-cancer-colorrectal 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/1280/equipo-humano-ia-para-mejorar-la-precision-y-eficiencia-del-preseleccion-de-criterios-de-elegibilidad-para-ensayos-oncologicos-un-ensayo-clinico-aleatorizado-utilizando-registros-electronicos-de 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1341/descubrimiento-de-inhibidores-de-stat3-de-molecula-pequena-derivados-del-benzoimidazo-2-amino-1-3-4-tiadiazol-carboxilato-para-la-terapia-del-carcinoma-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1418/impacto-pronostico-de-la-carga-mutacional-tumoral-en-sangre-en-el-cancer-colorrectal-metastasico-pmmr-mss-evaluado-mediante-foundationone-r-liquid-cdx 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1447/terapia-del-cancer-colorrectal-mediante-fotodisulfidrosis-mediada-por-complejo-ru-enlazado-por-disulfuro 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1457/aplicar-la-inteligencia-artificial-en-endoscopia-gastrointestinal-para-la-deteccion-temprana-de-lesiones-displasicas-en-enfermedad-inflamatoria-intestinal 2026-04-18 monthly 0.5 https://crcwarriors.org/articulo/1474/la-edicion-genica-espacialmente-confinada-permite-la-terapia-inmune-combinada-localizada 2026-05-05 monthly 0.5 https://crcwarriors.org/articulo/1255/descubrimiento-de-un-inhibidor-oral-y-biodisponible-basado-en-piridona-de-brd4-con-eficacia-antitumoral-potente-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2564/bdnf-val66met-protege-contra-la-neuropatia-periferica-inducida-por-oxaliplatino-en-pacientes-con-cancer-colorrectal 2026-08-15 monthly 0.5 https://crcwarriors.org/articulo/1035/un-analisis-multi-omico-identifica-una-firma-pronostica-relacionada-con-una-glicosiltransferasa-y-vinculada-al-entorno-inmunitario-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2582/la-aneuploidia-del-cromosoma-8-favorece-la-diferenciacion-hacia-el-linaje-mesenquimal-durante-las-transiciones-del-destino-celular 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1437/la-igfbp7-derivada-de-las-celulas-endoteliales-suprime-la-angiogenesis-y-la-progresion-tumoral-en-el-cancer-colorrectal-a-traves-de-la-via-vapa-tgf-1 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1464/las-asociaciones-de-los-factores-de-estilo-de-vida-con-la-fatiga-y-la-capacidad-para-trabajar-en-el-primer-ano-despues-de-la-cirugia-y-la-rehabilitacion-del-cancer-colorrectal 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/963/correccion-estrategias-emergentes-en-la-inmunoterapia-del-cancer-colorrectal-aumentando-la-eficacia-y-la-supervivencia 2026-03-29 monthly 0.5 https://crcwarriors.org/articulo/1493/medicion-de-impedancia-extracelular-subsegundaria-de-monolayers-de-celulas-epiteliales-utilizando-excitaciones-en-escalones-y-analisis-en-el-dominio-del-tiempo 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/1494/sting-garantiza-la-integridad-del-genoma-epitelial-y-protege-contra-la-carcinogenesis-a-traves-del-control-del-punto-de-control-mitotico 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/2518/la-composicion-temporal-y-espacial-del-microambiente-tumoral-predice-la-respuesta-a-la-inhibicion-de-los-puntos-de-control-inmunitario-en-el-cancer-de-mama-triple-negativo-metastasico 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/1495/identificacion-de-compuestos-naturales-bioactivos-potencialmente-protectores-contra-el-cancer-colorrectal-en-el-microbioma-intestinal-humano 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/1326/la-relacion-entre-la-expresion-de-sall4-y-fascin-y-la-progresion-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1420/perfiles-de-atp-mitoconico-unico-dirigen-el-descubrimiento-de-una-dependencia-en-la-oxphos-tratable-en-canceres 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1458/identificacion-de-los-principales-objetivos-y-mecanismos-del-cancer-colorrectal-inducido-por-el-ftalato-de-dietilo-mediante-la-toxicologia-de-redes-y-el-acoplamiento-molecular 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1465/los-probetas-quimioluminiscentes-permiten-la-identificacion-rapida-de-bacterias-productoras-de-colibactina 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1230/biosensores-fluorescentes-de-galactosidasa-para-el-cancer-de-colon 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1491/una-mezcla-de-polifenoles-vegetales-sorprendentemente-empeora-la-metastasis-hepatica-del-cancer-colorrectal-en-ratones 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/1492/coronin1a-regula-el-microambiente-tumoral-en-cancer-colorrectal-asociado-a-colitis-de-manera-dependiente-de-la-sumoizacion 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/1344/asociacion-entre-los-niveles-de-vitamina-b12-y-la-supervivencia-del-cancer-colorrectal-un-estudio-de-red-global 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1347/puma-dual-en-el-crc-un-supresor-de-autofagia-citoplasmica-y-un-promotor-de-mitofagia-mitocondrial 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/845/eventos-mutacionales-tempranos-y-dinamica-clonal-en-criptas-normales-implicaciones-para-la-carcinogenesis-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/895/eficacia-y-seguridad-de-shr-1701-en-combinacion-con-quimiorradioterapia-como-tratamiento-neoadyuvante-para-el-cancer-de-recto-localmente-avanzado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1421/la-modulacion-del-complejo-c-ebp-prame-ezh2-como-estrategia-terapeutica-afecta-al-eje-netrina-4-akt-para-inhibir-la-tumorigenesis-y-la-metastasis-del-cancer-renal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1450/modelos-de-particionamiento-aleatorio-espacialmente-alineados-en-datos-de-transcriptomica-resuelta-espacialmente 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/1451/la-eudiploidia-modula-el-tamano-del-nocelo-a-traves-de-la-dosificacion-de-las-regiones-organizadoras-del-nocelo 2026-08-07 monthly 0.5 https://crcwarriors.org/articulo/698/protocolo-del-estudio-combicor-vax-diseno-de-un-ensayo-clinico-fase-ii-monorramo-multicentrico-que-evalua-la-administracion-secuencial-de-pembrolizumab-mas-vacuna-celular-dendritica-seguida-por 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1243/un-estudio-del-mundo-real-de-trifluridina-tipiracil-tas-102-combinado-con-bevacizumab-como-tratamiento-de-linea-tardia-del-cancer-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1256/los-derivados-de-tanshinona-iia-inhiben-el-crecimiento-del-cancer-colorrectal-mediante-la-accion-sobre-la-kinasa-de-piruvato-m2 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1311/el-conjugado-de-oxaliplatino-artesunato-intensifica-la-supresion-del-cancer-colorrectal-al-potenciar-la-inmunidad-antitumoral 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1422/la-secuenciacion-por-nanoporos-revela-el-paisaje-oculto-de-las-transducciones-cortas-de-l1-en-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1439/incidencia-de-demencia-despues-de-un-reciente-diagnostico-de-cancer-entre-personas-con-vih 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1440/evaluacion-del-riesgo-de-demencia-temprana-dentro-de-los-5-anos-despues-del-diagnostico-de-cancer 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/773/analisis-de-correlacion-entre-las-mutaciones-del-gen-ras-y-las-caracteristicas-morfologicas-patologicas-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/32/encorafenib-cetuximab-y-mfolfox6-en-cancer-colorrectal-mutado-en-braf 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1330/tomografia-por-emision-de-positrones-del-eje-cd47-sirp-y-diseno-terapeutico-basado-en-imagenes 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/1099/prediccion-de-la-eficacia-de-bevacizumab-el-papel-emergente-de-actl6b-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1161/dirigirse-a-las-vias-metabolicas-y-reguladoras-del-ph-en-el-cancer-mediante-la-inhibicion-dual-de-la-nicotinamida-fosforribosiltransferasa-y-las-anhidrasas-carbonicas-ix-y-xii 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1434/diferencias-en-la-utilizacion-complicaciones-y-mortalidad-despues-de-la-cirugia-oncologica-por-estado-de-vih-entre-beneficiarios-del-medicaid-de-2001-a-2021 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1435/la-plasticidad-epitelial-y-un-microambiente-inmunosupresor-subyacen-a-la-brodificacion-tumoral-en-el-cancer-colorrectal 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/1233/la-grasa-de-la-leche-de-vaca-y-el-riesgo-de-cancer-una-espada-de-doble-filo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2530/mejora-de-los-fibroblastos-asociados-al-cancer-colorrectal-en-el-microambiente-inmunosupresor-mediante-una-nanoterapia-basada-en-la-ferroptosis 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/2569/elovl6-inhibe-la-progresion-del-cancer-colorrectal-a-traves-de-la-fusion-mitocondrial-y-la-reprogramacion-metabolica-mediadas-por-el-acido-estearico 2026-07-13 monthly 0.5 https://crcwarriors.org/articulo/1304/usp30-siente-los-niveles-de-serina-treonina-para-reglar-la-biosintesis-de-serina-y-la-tumorigenesis-colorectal-al-des-ubiquitinizar-fto-usp30-siente-los-niveles-de-serina-glicina-para-reglar-la 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1405/micromascaras-hidrogel-integradas-con-celulas-cancerosas-gastricas-humanas-primarias-para-la-prueba-personalizada-de-farmacos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1436/reconocimiento-y-resolucion-de-los-g-cuadriplexes-del-arn-utr-5-de-kras-por-hnrnpa1 2026-08-08 monthly 0.5 https://crcwarriors.org/articulo/940/b7-h3-un-marcador-consistente-en-el-cancer-colorrectal-metastasico-con-potencial-para-el-tratamiento-dirigido 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2545/nanovesiculas-exosomicas-disenadas-para-la-administracion-de-anticuerpos-en-el-tratamiento-de-la-enfermedad-inflamatoria-intestinal 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/761/la-enzima-des-ubiquitinadora-josd2-modula-el-cgas-para-facilitar-la-evasion-inmune-en-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/780/el-aprendizaje-integrativo-de-maquinas-identifica-una-firma-genica-relacionada-con-la-lactilacion-pronostica-para-la-eficacia-quimioterapeutica-en-carcinoma-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1305/eje-microbioma-intestinal-acuanalisis-en-la-modulacion-inmunitaria-y-la-enfermedad-de-mecanismos-a-traduccion-clinica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1329/tratamiento-neoadyuvante-con-folfoxiri-mas-bevacizumab-sin-radioterapia-para-cancer-rectal-de-alto-riesgo-ensayo-fase-ii-multicentrico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/849/alegrias-en-cancer-colorrectal-avanzado-mutante-kras-g12c-desde-mecanismos-hasta-la-practica-clinica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1408/el-cancer-colorrectal-se-basa-en-una-topografia-celular-inmunosupresora-y-adaptaciones-genomicas-para-establecer-metastasis-cerebrales 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/1409/decifrar-la-heterogeneidad-espacial-de-organoides-derivados-de-pacientes-de-tumores-colorrectales-para-el-descubrimiento-de-farmacos 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/1410/la-truncacion-de-apc-fuerza-la-senalizacion-optima-del-wnt-durante-la-tumorigenesis-intestinal-temprana 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/1201/dma-circulante-de-tumores-y-microbioma-intestinal-en-cancer-colorrectal-implicaciones-diagnosticas-pronosticas-y-terapeuticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2561/inferencia-y-validacion-en-diversos-tipos-de-cancer-de-mutaciones-hipermorficas-hipomorficas-y-neomorficas 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/1306/los-factores-de-riesgo-geneticos-modulan-la-asociacion-entre-la-actividad-fisica-y-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1354/el-humo-de-cigarrillo-induce-el-cancer-colorrectal-regulando-la-microbiota-intestinal-y-los-metabolitos-relacionados 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/618/la-senalizacion-sinergica-dbndd1-gdf15-activa-la-via-nf-b-para-promover-la-progresion-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1234/los-acidos-eicosapentaenoico-y-docosahexaenoico-presentes-en-la-dieta-reducen-los-oxilipinos-que-actuan-como-mediadores-tempranos-de-la-inflamacion-colonica-inducida-por-la-quimioterapia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/747/entrega-conjunta-de-gases-co-h-2-para-radiosensibilizacion-sinergica-y-proteccion-intestinal-en-el-tratamiento-de-metastasis-peritoneales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1278/imagen-del-tronco-tumoral-en-malignidades-conceptos-actuales-y-el-papel-cada-vez-mas-amplio-de-la-pet-tomografia-computarizada 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1353/cambios-dependientes-del-sexo-en-la-conectividad-del-cortex-insular-en-un-modelo-de-rata-de-dolor-comorbido 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/1355/reducir-ogt-y-o-glcnacilacion-potencian-los-efectos-antineoplasicos-de-la-oxaliplatino-en-celulas-de-cancer-colorrectal-metastasico-sw620 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1110/un-marco-hibrido-que-integra-marcadores-bioquimicos-sericos-y-la-espectroscopia-ftir-con-aprendizaje-automatico-para-la-deteccion-temprana-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1137/perfiles-ultrasensibles-de-celulas-tumorales-circulantes-mediante-nano-probas-activadas-por-mirna-ph-asociadas-con-la-encapsulacion-en-gotas-microfluidicas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1174/factibilidad-de-la-terapia-neoadyuvante-de-precision-guiada-por-ctdna-en-el-cancer-colorrectal-localmente-avanzado-hallazgos-del-ensayo-cints-r-en-curso 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/730/terapia-inmunologica-preoperatoria-en-oncologia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1011/analisis-multigenico-relacionado-con-la-edad-en-el-cancer-colorrectal-mediante-secuenciacion-de-nueva-generacion 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2597/el-ejercicio-preoperatorio-induce-celulas-de-kupffer-con-actividad-antitumoral-para-prevenir-la-metastasis-hepatica-del-cancer-colorrectal-la-cual-se-ve-favorecida-por-el-estres-quirurgico 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/1350/signaturas-distintas-del-microbioma-gastrointestinal-en-poblaciones-etnicamente-diversas-dentro-de-una-geografia-urbana-asiatica-compartida 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/1351/dinamica-espaciotemporal-de-la-abundancia-de-mcl-1-y-su-influencia-en-la-susceptibilidad-a-la-apoptosis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1352/correccion-del-efecto-de-lote-en-un-estudio-clinico-de-correlacion-funcional-con-organoides-de-cancer-colorrectal 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/2538/correccion-del-autor-los-macrofagos-que-expresan-id1-favorecen-la-capacidad-de-auto-renovacion-de-las-celulas-cancerosas-y-limitan-la-infiltracion-de-linfocitos-t-cd8-en-el-cancer-colorrectal 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/1384/optsurvcutr-seleccion-de-un-punto-de-corte-validado-para-el-analisis-de-supervivencia 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/1387/aplicar-los-monocitos-inflamatorios-para-superar-la-resistencia-a-la-inmunoterapia-anti-pd-1 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1382/identificacion-de-nuevos-biomarcadores-de-arnm-con-un-mejor-rendimiento-para-la-deteccion-del-cancer-colorrectal-a-partir-de-un-estudio-de-expresion-genica-a-gran-escala-y-multicentrico 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/2535/los-hepatocitos-reprogramados-funcionalmente-por-celulas-de-cancer-colorrectal-con-alta-expresion-de-kiaa1199-favorecen-la-acumulacion-de-neutrofilos-egr1-con-potencial-metastasico 2026-07-22 monthly 0.5 https://crcwarriors.org/articulo/1386/estados-transcripcionales-discretos-definen-una-respuesta-inmune-bifasica-y-transiciones-dinamicas-de-cms-en-cancer-colorrectal 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/1281/objetivo-de-la-via-mir-4653-3p-slc25a51-sirt3-para-inducir-letalidad-sintetica-en-cancer-colorrectal-arid1a-deficiente-a-traves-del-bloqueo-de-la-reparacion-del-adn 2026-03-29 monthly 0.5 https://crcwarriors.org/articulo/1282/lrp8-favorece-la-progresion-del-cancer-colorrectal-al-suprimir-la-ferroptosis-a-traves-del-eje-de-senalizacion-slc3a2-gpx4 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1284/escherichia-coli-promueve-la-metastasis-del-cancer-colorrectal-al-mantener-los-bucles-de-potenciador-ensamblador-a-traves-de-la-liberacion-de-trampas-extracelulares-neutrofilicas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1285/intercambio-neural-tumoral-y-objetivo-molecular-mecanismos-e-implicaciones-terapeuticas-en-neurociencia-oncologica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2611/los-vesiculos-de-car-nk-derivados-de-ipsc-programables-remodelan-el-microambiente-inmunitario-y-erradican-los-tumores 2026-07-12 monthly 0.5 https://crcwarriors.org/articulo/1383/enfoque-en-hif-2-en-cancer-colorrectal-revela-una-vulnerabilidad-ferropotica-dependiente-de-la-sintesis-de-colesterol 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1385/mecanismos-celulares-de-resistencia-adquirida-a-regorafenib-en-celulas-de-cancer-colorrectal 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/879/eficacia-de-pembrolizumab-ipilimumab-y-nivolumab-en-monoterapia-y-en-combinacion-para-el-cancer-colorrectal-una-revision-sistematica-y-metaanalisis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/689/caso-clinico-de-un-adenocarcinoma-hepatoides-poco-frecuente-con-msi-h-del-colon-y-mutacion-braf-v600e-que-logra-una-supervivencia-prolongada-sin-enfermedad-tras-el-tratamiento-adyuvante-con 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1222/deteccion-de-mutaciones-en-kras-nras-y-braf-en-biopsias-liquidas-de-pacientes-con-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2567/los-canceres-de-pulmon-con-mutaciones-en-kras-g12c-y-g12d-difieren-en-su-potencia-oncogenica-inmunogenicidad-y-tasa-de-recurrencia-tras-la-inhibicion-de-kras-en-modelos-murinos 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/264/analisis-exhaustivo-de-las-alteraciones-de-kras-en-diversos-tipos-de-cancer-con-especial-atencion-a-sus-implicaciones-pronosticas-y-terapeuticas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1270/indicaciones-expandidas-en-la-reseccion-endoscopica-avanzada-de-lesiones-gastrointestinales-malignas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1271/la-evidencia-in-vitro-y-el-analisis-bioinformatico-integrativo-identifican-el-eje-sglt2-ppar-como-un-posible-blanco-terapeutico-contra-la-reprogramacion-metabolica-inducida-por-microplasticos-de 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1315/akr1b10-reprograma-los-neutrofilos-mediante-la-lactilacion-de-histonas-para-fomentar-la-evasion-inmunitaria-en-la-metastasis-hepatica-del-cancer-colorrectal-con-mutacion-krasg12c 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/1356/factores-multinivel-que-influyen-en-la-adherencia-al-cribado-del-cancer-colorrectal-una-revision-sistematica-de-la-literatura 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1259/la-inhibicion-de-eno1-reprograma-la-polarizacion-de-los-macrofagos-para-activar-la-inmunidad-antitumoral-y-mejora-el-efecto-terapeutico-de-la-radioterapia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1260/la-modificacion-de-trna-mediada-por-mettl1-de-m-7-g-promueve-el-progreso-del-cancer-colorrectal-y-la-metastasis-hepatica-a-traves-de-la-regulacion-traslacional 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1261/descubrimiento-de-nuevas-moleculas-multifuncionales-para-una-teranostica-sinergica-basada-en-dianas-de-normalizacion-vascular 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1357/proteina-nucleolar-6-como-un-posible-factor-oncogenico-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1358/correccion-rendimiento-diagnostico-de-la-tecnologia-enose-en-la-deteccion-del-recidiva-de-cancer-colorrectal-una-evaluacion-prospectiva 2026-04-01 monthly 0.5 https://crcwarriors.org/articulo/1128/explorando-la-inmunoterapia-con-conjugados-anticuerpo-medicamento-en-oncologia-de-tumores-solidos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1244/bcl-xl-como-objetivo-terapeutico-en-cancer-colorrectal-refractario-a-la-cetuximab 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1245/adn-libre-de-celulas-en-modelos-de-cancer-de-pulmon-y-cancer-colorrectal-inducidos-por-carcinogenos-quimicos-sus-implicaciones-en-el-diagnostico-y-la-terapeutica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1248/el-perfil-de-expresion-de-circphlpp2-y-lncrna-ilf3-en-pacientes-con-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1249/la-restriccion-de-folato-mediada-por-la-deficiencia-de-slc46a1-suprime-la-progresion-del-cancer-colorrectal-a-traves-de-la-reprogramacion-epigenetico-transcripcional 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/770/resultados-de-supervivencia-en-pacientes-con-cancer-colorrectal-metastasico-con-amplificacion-de-erbb2-tratados-con-quimioterapia-de-primera-linea 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/1031/desarrollo-y-evaluacion-cinetica-in-vitro-de-micelas-biohibridas-peg-quitosano-cargadas-con-cbd-con-acido-biliar-catquina-como-modificadores-de-superficie-para-el-tratamiento-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/785/prediccion-de-factores-de-riesgo-patologicos-en-cancer-rectal-utilizando-la-fraccion-volumetrica-extracelular-combinada-del-mapeo-t1-y-el-coeficiente-de-difusion-aparente 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1043/valor-pronostico-del-adn-tumoral-circulante-para-la-recurrencia-y-la-supervivencia-en-pacientes-sometidos-a-tratamiento-local-para-metastasis-hepaticas-de-cancer-colorrectal-con-mutaciones-ras-raf 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1044/peor-supervivencia-en-pacientes-con-alteraciones-coexistentes-de-ras-tp53-con-metastasis-hepaticas-resecadas-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1301/comparaciones-indirectas-de-tucatinib-en-combinacion-con-trastuzumab-para-pacientes-con-cancer-colorrectal-metastasico-her2-positivo-previamente-tratado 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1047/linfocitos-infiltrantes-tumorales-positivos-para-cd103-predicen-un-pronostico-favorable-en-cancer-colorrectal-con-metastasis-hepaticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/794/npr3-promueve-la-proliferacion-migracion-invasion-y-resistencia-a-la-quimioterapia-de-celulas-de-cancer-colorrectal 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1564/resultados-exploratorios-de-marcadores-biologicos-del-uso-de-regorafenib-en-combinacion-con-toripalimab-en-pacientes-con-cancer-colorrectal-metastasico-refractario-estudio-regotori 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/798/analisis-mediante-gc-ms-y-evaluacion-computacional-de-los-componentes-del-aceite-esencial-de-c-cinerea-para-el-cancer-colorrectal-acoplamiento-molecular-dinamica-e-informacion-obtenida-mediante 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1054/intensificacion-del-tratamiento-con-quimioterapia-por-infusion-arterial-hepatica-en-pacientes-con-metastasis-colorectales-unicamente-en-higado-que-siguen-siendo-inquirrimables-despues-de-la 2026-04-15 monthly 0.5 https://crcwarriors.org/articulo/800/dirigiendo-el-tratamiento-a-las-metastasis-hepaticas-del-cancer-colorrectal-mediante-la-reutilizacion-de-inhibidores-metabolicos-e-inmunitarios-un-estudio-teorico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/801/la-dormancia-en-el-cancer-colorrectal-el-nucleo-funcional-de-la-resistencia-metastasis-y-recurrencia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/803/la-triada-microbioma-transcriptoma-histologia-mejora-la-estratificacion-del-riesgo-de-supervivencia-en-multiples-tipos-de-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1059/caracteristicas-histomorfologicas-y-moleculares-del-carcinoma-neuroendocrino-de-celulas-grandes-del-colon-en-un-paciente-con-poliposis-adenomatosa-familiar-informe-de-un-caso-y-revision-de-la 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1061/la-relacion-her2-cep17-se-asocia-con-la-pcr-despues-del-tratamiento-neoadiuvante-dirigido-a-her2-en-el-ensayo-clinico-fase-iii-neoaltto 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1062/carcinoma-adenocarcinomico-mucinoso-asociado-a-fistula-perianal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/553/rock1-impulsa-la-metastasis-hepatica-de-cancer-colorrectal-a-traves-de-la-reprogramacion-bioenergetica-mediada-por-prkch 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/809/una-dieta-cetogenica-altera-la-funcion-citotoxica-de-las-celulas-nk-en-las-metastasis-hepaticas-del-cancer-colorrectal-al-inducir-la-ferroptosis-mediante-la-supresion-de-la-via-p62-keap1-nrf2 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/811/hmmr-es-un-nuevo-marcador-pronostico-y-un-posible-objetivo-terapeutico-para-el-cancer-de-colon 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/812/modulacion-de-la-ferroptosis-por-mettl14-en-canceres-de-las-perspectivas-moleculares-a-las-estrategias-terapeuticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/813/el-analisis-de-secuenciacion-a-nivel-de-celula-individual-revela-a-churc1-como-un-oncogen-no-canonico-que-regula-la-carcinogenesis-colo-rectal-impulsada-por-celulas-goblet 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1070/inestabilidad-de-microsatelites-e-inmunoterapia-redefine-el-papel-de-la-cirugia-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2606/el-anticuerpo-terapeutico-dirigido-contra-la-sindecana-1-inhibe-la-macropinocitosis-y-provoca-una-respuesta-inmunitaria-antitumoral-en-el-cancer-de-pancreas 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/574/validacion-de-la-prueba-idylla-de-mutaciones-del-kras-en-lavados-de-aguja-de-puncion-fina-con-solucion-salina-y-cytolyt-sin-extraccion-de-adn-una-comparacion-con-muestras-tumorales-ffpe-emparejadas 2026-06-03 monthly 0.5 https://crcwarriors.org/articulo/1091/la-estabilizacion-de-nek8-mediante-la-desubiquitinacion-mediada-por-usp51-favorece-la-progresion-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1606/avances-y-desafios-actuales-en-el-cancer-colorrectal 2026-06-06 monthly 0.5 https://crcwarriors.org/articulo/1097/la-perdida-de-pde10a-se-asocia-con-la-metastasis-del-adenocarcinoma-colrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1120/explorando-la-resistencia-a-los-inhibidores-de-puntos-de-control-inmune-en-cancer-colorrectal-con-deficit-en-reparacion-de-desajustes-o-instable-microsatelites 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/877/caso-de-una-respuesta-notable-a-la-monoterapia-con-pembrolizumab-en-un-cancer-colorrectal-irresecable-con-dmmr-diagnosticado-tras-una-hemorragia-abdominal-debida-a-una-mediolisis-arterial-segmentaria 2026-05-25 monthly 0.5 https://crcwarriors.org/articulo/1133/el-paradoja-de-hyal1-en-el-cancer-de-la-compleja-biologia-tumoral-a-nuevas-estrategias-terapeuticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1134/los-conjugados-de-celulas-dendriticas-y-liposomas-revierten-el-microambiente-tumoral-inmunosupresor-para-inhibir-el-cancer-colorrectal-asociado-a-colitis 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1648/la-inmunoterapia-para-el-cancer-colorrectal-de-satelites-microestables-superando-la-resistencia-y-explorando-estrategias-terapeuticas-novedosas 2026-05-18 monthly 0.5 https://crcwarriors.org/articulo/2423/la-inhibicion-de-la-metilacion-de-la-proteina-de-union-y-motilidad-celular-1-reduce-la-infiltracion-de-macrofagos-m2-y-potencia-la-eficacia-del-anti-pd-1-en-el-cancer-colorrectal 2026-07-20 monthly 0.5 https://crcwarriors.org/articulo/1146/las-celulas-madre-mesenquimales-de-medula-osea-modificadas-con-mir-31-facilitan-la-muerte-celular-autofagica-del-cancer-colorrectal-mediante-la-union-a-ccr7-para-modular-las-senales-pi3k-akt-mtor 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1671/expresion-de-tumor-jagged1-como-marcador-pronostico-de-respuesta-a-bevacizumab-y-modulacion-de-la-eficacia-de-5-fluorouracilo-a-traves-de-inhibicion-de-secreasa-en-cancer-colorrectal 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1423/identificacion-de-mdm4-como-un-biomarcador-pronostico-y-un-objeto-de-terapeutica-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1175/profilaxis-antimetica-personalizada-con-nepa-para-pacientes-en-alto-riesgo-de-nausea-y-vomito-inducidos-por-quimioterapia-recibiendo-quimioterapia-emetogenica-moderada-resultados-del-ensayo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/666/analisis-longitudinal-de-biomarcadores-circulantes-clasificados-manual-y-automaticamente-y-su-prediccion-de-supervivencia-en-cancer-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1179/hidrogel-radiactivo-con-capacidad-de-degradacion-de-las-redes-extracelulares-para-el-radioinmunoterapia-mejorada-del-tumor 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1182/identificando-y-capitalizando-las-alteraciones-moleculares-unicas-del-carcinoma-ovarico-mucinoso-para-el-desarrollo-de-estrategias-terapeuticas-novedosas 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/673/la-localizacion-del-tumor-primario-esta-asociada-con-la-supervivencia-libre-de-progresion-y-la-supervivencia-global-despues-de-la-terapia-radiologica-interna-selectiva-en-metastasis-hepaticas-en 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1187/efecto-de-la-mutacion-del-gen-braf-en-el-cancer-colorrectal-no-metastasico-en-el-curso-de-la-enfermedad-y-los-resultados-de-supervivencia 2026-05-06 monthly 0.5 https://crcwarriors.org/articulo/676/glecirasib-con-o-sin-cetuximab-en-pacientes-previamente-tratados-con-cancer-colorrectal-de-avanzada-local-o-metastasico-con-mutacion-kras-g12c-jab-21822-1002-y-jab-21822-1007-dos-ensayos-abiertos-no 2026-04-17 monthly 0.5 https://crcwarriors.org/articulo/1446/foliculos-secundarios-similares-a-los-de-la-enfermedad-linfomatica-cutanea-como-un-factor-protector-en-cancer-rectal-pmmr-perspectivas-sobre-su-distribucion-regional-y-valor-pronostico 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1199/numero-calidad-de-muestras-de-biopsia-endoscopica-en-canceres-gastrointestinales-para-pruebas-de-biomarcadores-todo-lo-que-brilla-no-es-oro 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1200/la-terapia-con-fagos-en-el-tratamiento-del-cancer-mecanismos-innovaciones-emergentes-y-progreso-traslacional 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/718/metastasis-oseas-y-sinoviales-atipicas-de-adenocarcinoma-de-colon-recto-un-informe-de-caso 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/719/receptor-x-hepatico-un-posible-objetivo-terapeutico-para-la-enfermedad-inflamatoria-intestinal-y-el-cancer-colorrectal-revision 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1231/el-marcador-del-urotelio-upk2-identifica-canceres-colorrectales-agresivos-con-caracteristicas-moleculares-e-histologicas-distintas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1232/el-eje-il-17-en-la-carcinogenesis-gastrica-desde-la-inflamacion-hasta-la-transformacion-oncogenica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1236/tislelizumab-mas-bevacizumab-y-xelox-como-tratamiento-de-primera-linea-del-cancer-colorrectal-metastasico-mss-pmmr-ras-mutante-tactic-crc-02-un-estudio-fase-ii 2026-04-17 monthly 0.5 https://crcwarriors.org/articulo/1237/quimioterapia-de-primera-linea-basada-en-folfoxiri-para-el-cancer-colorrectal-metastasico-irresecable-resultados-reales-seguridad-y-cirugia-de-conversion 2026-04-22 monthly 0.5 https://crcwarriors.org/articulo/987/la-sobreexpresion-de-cullin1-se-asocia-con-la-progresion-del-cancer-colorrectal-y-un-mal-pronostico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/988/tasas-altas-de-cierre-de-defectos-despues-de-la-reseccion-de-lesiones-colorectales-grandes-no-pedunculadas-usando-un-clipo-a-traves-del-endoscopio-con-cardenales-anclaje 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1246/colostem-una-firma-oncotal-fetal-clave-que-identifica-tumores-colorrectales-de-mal-pronostico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1504/cancer-agresivo-del-colon-derecho-en-un-joven-adulto-mutaciones-triada-pole-kras-brca1-2-destacan-asociaciones-geneticas-emergentes 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/993/lactalizacion-en-cancer-colorrectal-del-mecanismo-a-la-aplicacion-clinica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/994/el-formononetina-inhibe-el-cancer-colorrectal-a-traves-del-eje-mir-490-3p-abcc2-y-potencia-la-accion-de-la-5-fluorouracilo-insights-mecanicos-e-implicaciones-terapeuticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/741/aprendizaje-de-pocos-ejemplos-e-ia-explicativa-para-la-histopatologia-del-cancer-colorrectal-una-red-prototipica-con-interpretabilidad-multitecnica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/742/medicina-de-precision-basada-en-el-microbioma-mediante-la-integracion-de-multiples-omicas-y-el-aprendizaje-automatico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/743/convergencia-la-combinacion-de-la-multiomica-y-la-inteligencia-artificial-esta-transformando-el-panorama-de-la-investigacion-biomedica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1257/tiempo-para-definir-el-papel-de-la-quimioterapia-hipertermica-intraperitoneal-hipec-en-el-cancer-de-colon-t4 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1015/efecto-de-la-metilacion-del-mgmt-en-la-supervivencia-global-en-tumores-solidos-una-revision-sistematica-y-un-meta-analisis 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1228/el-colageno-i-es-el-objetivo-terapeutico-efectivo-para-tratar-los-tumores-desmoidicos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1229/evaluacion-del-papel-de-la-calproteina-fecal-en-adultos-mayores-un-estudio-observacional-retrospectivo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1217/perdida-de-microrna-29b-promueve-la-regulacion-negativa-de-sting-mediada-por-dnmt3b-para-atenuar-la-inmunidad-antitumoral-inducida-por-radioterapia-en-cancer-colorrectal-con-mutacion-kras 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1219/una-firma-transcriptomica-basada-en-aprendizaje-automatico-para-predecir-el-recidiva-tumoral-despues-de-una-reseccion-curativa-en-cancer-colorrectal-t1-un-estudio-de-cohorte-retrospectivo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1155/adherencia-a-las-recomendaciones-de-la-wcrf-aicr-de-2018-y-el-riesgo-de-cancer-colorrectal-un-estudio-caso-control-y-de-aleatorizacion-mendeliana 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1211/diversidad-y-especializacion-clonotipica-del-receptor-de-celulas-t-en-los-canceres-del-sistema-digestivo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1212/la-carga-de-mutaciones-tumorales-como-determinante-de-los-patrones-de-diseminacion-metastasica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1213/intensidad-de-las-revisiones-posteriores-a-la-cirugia-de-cancer-colorrectal-en-pacientes-de-50-50-70-y-70-anos-un-analisis-dentro-del-ensayo-clinico-aleatorizado-colofol 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2517/bloqueo-neoadyuvante-del-pd-1-en-melanoma-desmoplasico-quirurgicamente-resecable-cohorte-a-del-ensayo-de-fase-2-swog-s1512 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/1216/reencuadrar-computacional-de-farmacos-aprobados-que-se-dirigen-a-kras-g12d-y-egfr-para-el-tratamiento-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2537/aprovechamiento-de-la-inmunidad-innata-inducida-por-el-glucano-para-la-reprogramacion-epigenetica-y-metabolica-de-los-macrofagos-con-el-fin-de-mejorar-la-respuesta-de-la-vacuna-contra-el-cancer 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/2596/las-metastasis-hepaticas-disminuyen-la-actividad-de-las-celulas-t-y-la-respuesta-a-la-inmunoterapia-mediada-por-il18-en-el-cancer-colorrectal 2026-07-10 monthly 0.5 https://crcwarriors.org/articulo/1359/retraccion-el-arctigenino-inhibe-la-progresion-del-cancer-colorrectal-a-traves-de-la-transicion-epitelial-mesenquimal-mediante-el-camino-de-senalizacion-pi3k-akt-mtor 2026-04-01 monthly 0.5 https://crcwarriors.org/articulo/1197/modificacion-quimica-de-stl427944-hacia-triazinas-basadas-en-morfolina-como-agentes-anticancerigenos-que-targetean-foxm1-sintesis-verde-evaluacion-biologica-y-perfilamiento-adme-tox-en-un-modelo-de 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1198/eficacia-de-regorafenib-en-combinacion-con-un-inhibidor-de-pd-1-pd-l1-en-el-cancer-colorrectal-avanzado-o-metastasico-un-metaanalisis-de-un-solo-brazo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1186/el-papel-fundamental-de-la-marilacion-de-grp78-bip-en-el-estres-del-reticulo-endoplasmico-del-cancer-colorrectal-con-mutaciones-en-kras 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1190/el-sistema-node-rads-en-la-resonancia-magnetica-preoperatoria-predice-la-supervivencia-relacionada-con-los-ganglios-linfaticos-en-pacientes-con-cancer-de-recto-no-tratados-previamente-un-nomograma 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1193/la-quimioinmunoterapia-adyuvante-muestra-una-eficacia-comparable-entre-el-cancer-de-colon-de-etapa-iii-con-deficit-en-la-reparacion-del-error-y-sin-deficit-en-la-reparacion-del-error-un-analisis 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1194/virus-vacinico-ortoclonico-que-codifica-para-la-epac-activa-constitutivamente-remodela-el-microentorno-tumoral-para-mejorar-la-eficacia-terapeutica-con-quimioterapia-y-cirugia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1360/un-estudio-sobre-el-efecto-de-una-intervencion-psicologica-basada-en-cbsm-en-la-capacidad-de-autogestion-y-la-calidad-de-vida-de-pacientes-con-cancer-colorrectal-desde-la-perspectiva-de-la-busqueda 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1141/combinar-los-picos-de-osmolaridad-de-nanoparticles-de-cloruro-sodico-con-quimioterapia-con-irinotecano-para-amplificar-el-estres-oxidativo-en-el-tratamiento-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1167/informe-de-caso-adenocarcinoma-pulmonar-de-origen-enterico-que-presenta-mutaciones-en-los-genes-kras-tp53-apc-y-metastasis-pulmonar-contralateral-desafios-diagnosticos-y-perspectivas-moleculares 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1184/avances-en-la-terapia-dirigida-a-los-mitocondrias-del-cancer-colorrectal-insights-mecanicos-y-traduccion-clinica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1185/resistencia-a-los-farmacos-mediada-por-las-celulas-madre-cancerosas-en-el-carcinoma-colorrectal-aspectos-moleculares-y-potenciales-terapeuticos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/967/estrategias-emergentes-en-la-inmunoterapia-del-cancer-colorrectal-mejorando-la-eficacia-y-la-supervivencia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2560/evolucion-genomica-del-cancer-de-pancreas-a-nivel-de-celula-individual 2026-07-15 monthly 0.5 https://crcwarriors.org/articulo/2604/de-una-idea-utopica-a-una-realidad-tangible-el-desarrollo-de-las-vacunas-contra-el-cancer-y-los-desafios-futuros 2026-07-11 monthly 0.5 https://crcwarriors.org/articulo/1173/la-glicosilacion-inmadura-de-cd276-impulsa-la-agresividad-del-cancer-colorrectal-y-la-evasion-inmune-mediada-por-las-celulas-t 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1176/diagnostico-y-tratamiento-del-cancer-colorrectal-en-la-era-de-la-inteligencia-artificial-revision-y-perspectiva 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/992/comparacion-de-las-estrategias-terapeuticas-neoadiuvantes-actuales-para-el-cancer-de-recto-un-estudio-retrospectivo-en-tres-brazos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1160/impacto-de-las-mutaciones-ras-brafv600e-en-el-microentorno-inmunitario-tumoral-en-canceres-colorrectales-deficientes-en-reparacion-de-desajustes-microsatelites-instables 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1314/evolucion-o-revolucion-en-el-tratamiento-del-cancer-colorrectal-presente-y-futuro-de-nuevas-opciones-terapeuticas-una-revision-narrativa 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1151/el-exosoma-de-celulas-tumorales-circ-0023919-promueve-la-emt-a-traves-del-eje-mir-197-5p-icam5-y-aumenta-la-resistencia-al-farmaco-del-cancer-colorrectal-a-5-fu 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1152/la-inhibicion-de-slc7a11-sensibiliza-a-las-celulas-de-cancer-colorrectal-a-la-cuproptosis-inducida-por-elesclomol-cu-a-traves-del-eje-gsh-gpx4 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1153/el-panorama-de-los-ensayos-clinicos-del-cancer-colorrectal-con-metastasis-hepaticas-analisis-de-perfiles-y-prediccion-de-dianas-terapeuticas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/2550/el-acido-palmitico-induce-la-palmitoilacion-de-b7h3-lo-que-favorece-la-evasion-inmune 2026-07-17 monthly 0.5 https://crcwarriors.org/articulo/619/la-induccion-de-la-sobreexpresion-espontanea-de-propiedades-estamineas-y-la-formacion-de-esferoides-3d-a-partir-de-celulas-cancerosas-individuales-provocada-por-un-recubrimiento-multilaminar 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1147/haus1-promueve-la-progresion-del-cancer-colorrectal-activando-la-transcripcion-de-cdca8-a-traves-del-eje-haus1-ezh2-e2f1 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/598/informe-de-caso-respuesta-unica-a-la-inmunoterapia-en-un-paciente-con-cancer-colorrectal-metacronico-no-asociado-con-el-sindrome-de-lynch 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1135/los-analisis-de-asociacion-a-nivel-transcriptomico-y-mediante-modelos-mixtos-identifican-factores-de-transcripcion-y-genes-asociados-con-la-susceptibilidad-al-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1136/s4-multi-mejora-de-la-prediccion-mediante-el-uso-de-puntuaciones-poligenicas-en-poblaciones-con-diversa-ascendencia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1138/una-plataforma-nanomolecular-de-adn-programada-espacialmente-para-el-perfilado-multiplexado-y-ortogonal-de-micrarn-permite-un-diagnostico-robusto-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1139/sexo-y-riesgo-especifico-del-organo-y-tendencias-temporales-de-cancer-anogenito-asociado-al-virus-del-papiloma-humano-entre-receptores-de-trasplante-de-organos-solidos-en-los-estados-unidos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1361/analisis-radiomico-combinado-con-factores-de-riesgo-clinicos-para-la-prediccion-preoperatoria-de-metastasis-linfaticas-en-el-cancer-colorrectal-un-estudio-multicentrico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1121/el-perfilamiento-protomico-del-plasma-identifico-indicadores-pronosticos-con-potencial-terapeutico-para-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1123/analisis-exploratorio-de-la-disfuncion-urinaria-y-sexual-en-pacientes-con-sindrome-de-reseccion-anterior-baja-que-se-someten-a-neuromodulacion-sacra-hallazgos-del-ensayo-sanlars 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/975/la-nanomedicina-desencadenadora-de-cuproptosis-potencia-la-inmunoterapia-antitumoral 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1101/desarrollo-de-un-ensayo-de-secuenciacion-duplex-basado-en-apc-y-tp53-para-predecir-de-forma-positiva-la-respuesta-del-cancer-colorrectal-a-la-terapia-anti-egfr 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1103/la-transicion-similar-a-paneth-conduce-a-la-resistencia-al-objetivo-dual-de-kras-y-egfr-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1105/analisis-exploratorio-de-biomarcadores-de-mutaciones-somaticas-de-ras-braf-y-firmas-de-expresion-genica-para-predecir-los-efectos-del-tratamiento-con-aflibercept-en-la-prueba-velour 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1107/el-eje-notch-mir-188-5p-timp2-3-orquesta-la-formacion-del-nicho-premetastasis-dirigido-por-exosomas-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1109/desde-las-caracteristicas-glicoliticas-hasta-los-pacientes-una-hoja-de-ruta-traslacional-para-el-despliegue-reproducible-y-equitativo-de-la-multiomica-y-la-ia-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1113/un-anticuerpo-anti-b7-h4-totalmente-humano-induce-la-ferroptosis-dependiente-de-lisosomas-para-revertir-la-resistencia-primaria-al-bloqueo-de-pd-1 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1362/histopatologia-con-aprendizaje-profundo-y-analisis-de-multiples-imagenes-para-la-estratificacion-pronostica-y-terapeutica-en-el-cancer-colorrectal-en-estadio-ii-un-estudio-multicentrico-retrospectivo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1363/incidencia-de-cancer-colorrectal-analisis-de-supervivencia-y-predicciones-monastir-tunez-2002-2030 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1364/impacto-del-covid-19-en-el-cribado-del-cancer-colorrectal-en-un-centro-de-salud-calificado-federalmente-perspectivas-del-proveedor-y-personal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1389/valor-pronostico-de-los-depositos-tumorales-y-su-diferente-respuesta-a-la-terapia-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1088/estellar-303-rompiendo-la-barrera-de-la-inmunoterapia-en-cancer-colorrectal-mss 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1090/aptasensores-en-cancer-colorrectal-herramientas-emergentes-para-diagnosticos-precisos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/905/pirrotinib-mas-trastuzumab-como-una-estrategia-terapeutica-eficaz-en-lineas-de-tratamiento-posteriores-para-el-cancer-colorrectal-metastasico-her2-positivo-resultados-de-un-estudio-de-fase-ii 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1084/analisis-retrospectivo-de-la-eficacia-del-regorafenib-en-el-tratamiento-del-cancer-colorrectal-metastasico-experiencia-de-dos-centros-oncologicos-polacos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1085/fibrilarina-un-puente-entre-la-biogenesis-de-los-ribosomas-y-la-apoptosis-en-condiciones-de-estres-celular-y-en-enfermedades 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1086/la-deplecion-de-mlkl-potencia-la-apoptosis-inducida-por-la-quimioterapia-en-el-cancer-colorrectal-mediante-la-prolongacion-de-la-retencion-de-tnfr-i-en-los-endosomas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1087/el-analisis-del-proteoma-basado-en-la-estabilidad-y-la-degradacion-revela-que-el-cannabidiol-es-un-prometedor-inhibidor-de-cdc123-eif2-para-la-terapia-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1069/la-mutacion-de-kras-y-su-asociacion-con-las-caracteristicas-clinicopatologicas-de-pacientes-con-cancer-colorrectal-en-africa-una-revision-sistematica-y-metaanalisis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1072/adenocarcinomas-colorrectales-de-alto-grado-con-deficiencia-de-smad4 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1073/identificacion-de-marcadores-circrna-especificos-de-crc-mediante-un-marco-de-biologia-sistematica-con-validacion-por-rt-qpcr 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1074/el-paisaje-evolutivo-del-cancer-colorrectal-la-carga-de-envejecimiento-y-factores-de-riesgo-metabolico-en-china-1990-2021 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1075/niveles-y-significado-clinico-de-c1qc-y-vcam-1-en-suero-en-pacientes-con-cancer-colorrectal-o-polipos-adenomas-colorrectales 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1076/drimartol-b-suprime-la-glicolisis-mediada-por-akt1-para-desencadenar-apoptosis-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1078/la-identificacion-del-subtipo-de-cancer-colorrectal-y-la-construccion-del-modelo-de-riesgo-basado-en-genes-relacionados-con-la-sintesis-de-colesterol-para-predecir-el-pronostico-y-guiar-la 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1080/reavivar-las-celulas-t-cd8-a-traves-del-bloqueo-de-adrb1-utilizando-nanoparticulas-de-cobre-propanolol-para-una-terapia-mejorada-de-inhibicion-de-puntos-de-control-inmune 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1114/regulacion-de-la-autofagia-de-la-pirotopsis-y-la-ferrotopsis-una-nueva-estrategia-para-el-tratamiento-del-cancer-colorrectal 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/1066/utilizacion-de-la-dinamica-temprana-de-la-mrd-y-la-vaf-en-el-periodo-posoperatorio-para-un-pronostico-preciso-en-metastasis-hepaticas-colorrectales-resecadas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1064/eficacia-amplia-del-conjugado-de-antibiotiquesito-acondicionado-con-ceacam6-y-degradador-de-proteinas-bet-en-modelos-murinos-de-cancer-colorrectal-pulmonar-y-de-mama 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1082/factores-sociales-en-el-retraso-del-inicio-del-tratamiento-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1083/comparacion-de-las-mutaciones-vias-que-presentan-un-enriquecimiento-diferencial-entre-el-estadio-ii-y-el-estadio-iv-del-cancer-colorrectal-con-dmmr-msi-h 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/870/caso-raro-de-metastasis-duodenal-desde-cancer-colorectal-revision-de-la-literatura-y-perspectivas-sobre-terapias-noveles 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2515/la-inhibicion-de-la-degradacion-de-catenina-con-inhibidores-de-gsk3-induce-la-muerte-celular-en-la-leucemia-linfoblastica-aguda 2026-07-23 monthly 0.5 https://crcwarriors.org/articulo/1051/moduladores-microbianos-del-epigenoma-regulacion-de-los-microarn-y-los-arn-largos-no-codificantes-por-los-probioticos-en-la-salud-y-la-enfermedad-y-en-la-medicina-preventiva 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1053/el-metabolito-y-los-enantiomeros-del-propranolol-influyen-en-el-desarrollo-del-cancer-colorrectal-al-inhibir-la-via-mapk-y-reducir-la-expresion-de-pd-1 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1365/desempeno-diagnostico-de-la-tecnologia-enose-en-la-deteccion-del-recidiva-de-cancer-colorrectal-una-evaluacion-prospectiva 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/693/efecto-inmuno-modulador-de-la-betulina-y-sus-derivados-en-la-expresion-de-il-6-en-lineas-celulares-de-cancer-colorrectal-e-insights-de-acoplamiento-molecular 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1041/diferencias-socioeconomicas-entre-pacientes-con-cancer-de-colon-en-etapas-i-iii-deteccion-tratamiento-y-supervivencia-relativa 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1021/desbloqueando-el-paisaje-epi-genico-del-cancer-colorrectal-un-paso-hacia-la-epi-genetica-para-la-precision 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1034/bacterias-modificadas-geneticamente-que-liberan-vesiculas-cargadas-con-lactato-reprograman-el-microambiente-tumoral-y-aumentan-la-radiosensibilidad-del-tumor 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1036/un-analisis-a-gran-escala-de-celulas-individuales-en-diversos-tipos-de-cancer-revela-la-heterogeneidad-y-la-diversidad-funcional-de-las-celulas-t-dobles-negativas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1039/pseudomonas-aeruginosa-induce-la-piroptosis-tumoral-y-activacion-inmune-para-potenciar-el-bloqueo-de-puntos-de-control-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1040/membrana-camuflada-funcionalizada-con-peptidos-para-la-inmunoterapia-fototermal-inducida-por-h-2-s-endogeno-en-cancer-colorrectal-ortotopico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1056/los-perfiles-de-indol-definen-la-virulencia-especifica-de-la-enfermedad-en-los-aislados-clinicos-de-fusobacterium-nucleatum 2026-08-09 monthly 0.5 https://crcwarriors.org/articulo/1027/bloqueo-dual-de-puntos-de-control-pd-1-y-tim-3-mediante-vesiculas-nanohibridas-ingenierizadas-para-mejorar-la-inmunoterapia-contra-el-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/822/microbios-intestinales-que-favorecen-el-crecimiento-tumoral-en-el-cancer-colorrectal-mecanismos-y-perspectivas-traslacionales 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/913/oxaliplatino-versus-irinotecano-como-terapia-de-primera-linea-en-cancer-colorrectal-metastasico-con-tratamiento-adyuvante-previo-un-estudio-retrospectivo-sobre-eficacia-terapia-secuencial-y-el 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1018/firma-molecular-predominantemente-serrada-en-el-cancer-colorrectal-tras-la-colonoscopia-una-revision-sistematica-y-metaanalisis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1019/una-pantalla-genomica-mundial-identifico-a-arhgap35-como-un-regulador-de-la-resistencia-al-regorafenib-en-el-cancer-hepatico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1020/la-dexmedetomidina-mejora-la-recuperacion-despues-de-la-cirugia-de-cancer-gastrointestinal-protegiendo-el-glicocalix-endotelial-un-estudio-aleatorizado-doble-ciego-controlado-con-placebo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1028/inferploidy-una-herramienta-rapida-de-inferencia-de-pleoidad-clasifica-con-precision-celulas-con-cnv-anormales-en-grandes-conjuntos-de-datos-de-rnaseq-de-una-celula 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/1029/uev1a-contrarresta-los-estimulos-oncogenicos-de-ras-tanto-en-celulas-poliploides-como-en-celulas-diploides 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/1016/el-perfilamiento-de-transcriptoma-a-nivel-de-celula-individual-y-espacial-identifica-el-nicho-espacial-inmunosupresor-en-cancer-colorrectal-mutante-de-kras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1026/interaccion-de-sistemas-de-entrega-de-nanomedicina-a-traves-de-fibroblastos-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1032/evaluacion-de-la-elevacion-de-enzimas-pancreaticas-inducida-por-regorafenib-en-el-tratamiento-del-cancer-colorrectal-metastasico 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/1037/dirigirse-a-ptpn13-con-peptidos-de-11-aminoacidos-del-extremo-c-terminal-de-apc-previene-la-evasion-inmune-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1049/cristales-de-colesterol-y-trampas-extracelulares-de-neutrofilos-conductores-de-tromboinflamacion-en-la-ateroesclerosis-y-canceres-gastrointestinales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1052/desigualdades-en-la-mortalidad-por-cancer-entre-personas-con-y-sin-discapacidad-un-estudio-de-vinculacion-nacional-de-datos-de-10-millones-de-adultos-en-australia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/541/ia-explicable-para-la-prediccion-de-mortalidad-y-factores-de-riesgo-en-cancer-colorrectal-en-corea-un-estudio-de-cohorte-nacional-de-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1316/la-significacion-pronostica-de-las-mutaciones-en-kras-nras-y-braf-en-el-cancer-colorrectal-una-revision-sistematica-y-analisis-meta-estadistico 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/1063/deteccion-no-invasiva-temprana-del-cancer-colorrectal-mediante-biomarcadores-derivados-de-la-microbioma-intestinal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/814/anticuerpo-anti-egfr-mas-quimioterapia-versus-quimioterapia-sola-en-metastasis-hepaticas-de-cancer-colorrectal-con-ras-tipo-salvaje-una-meta-analisis-de-los-resultados-de-supervivencia-en-entornos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1081/reprogramacion-de-los-macrofagos-asociados-al-tumor-mediante-la-inhibicion-dirigida-de-nat10-para-mejorar-la-inmunoterapia-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/580/avanzando-en-la-investigacion-del-cancer-insights-pioneros-de-modelos-murinos-derivados-de-trasplantes-de-tumores-de-pacientes-con-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/839/nucleophosmin-respalda-la-hiperproliferacion-y-la-iniciacion-tumoral-impulsadas-por-wnt 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1095/un-estudio-de-fase-iii-con-dostarlimab-en-el-periodo-perioperatorio-en-pacientes-con-cancer-colorrectal-resecable-con-dmmr-msi-h-diseno-del-estudio-azur-2 2026-05-18 monthly 0.5 https://crcwarriors.org/articulo/1096/caracterizacion-del-cancer-colorrectal-coreano-revela-un-nuevo-gen-ductor-y-mutaciones-clinicamente-relevantes 2026-04-12 monthly 0.5 https://crcwarriors.org/articulo/842/cambio-de-cetuximab-a-panitumumab-durante-el-tratamiento-basado-en-encorafenib-en-cancer-colorrectal-metastasico-mutado-braf-v600e-un-analisis-internacional-multicentrico-del-grupo-ageo 2026-06-05 monthly 0.5 https://crcwarriors.org/articulo/594/una-clasificacion-solida-basada-en-inmunohistoquimica-para-el-cancer-colorrectal-con-mutacion-braf-v600e-y-sus-implicaciones-clinicas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1117/mosaicos-moleculares-revelando-la-heterogeneidad-en-canceres-colorrectales-simultaneos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/863/foxo1-vincula-los-alelos-kras-g12d-y-g12v-a-la-metabolizacion-de-glutamina-y-nitrogeno-en-cancer-colorrectal 2026-04-27 monthly 0.5 https://crcwarriors.org/articulo/1119/analisis-genomico-exhaustivo-del-adenocarcinoma-anal-avanzado-en-japon 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1124/olaparib-en-pacientes-con-tumores-solidos-con-alteraciones-de-atm-resultados-del-estudio-de-registro-de-uso-de-agentes-terapeuticos-y-perfiles-tapur 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1125/un-ensayo-aleatorizado-de-fase-iii-sobre-la-vigilancia-estructurada-de-la-respuesta-tumoral-y-la-toma-de-decisiones-compartida-para-la-preservacion-de-organos-en-el-cancer-de-recto-protocolo-del 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/878/peptido-neoadyuvante-pembrolizumab-con-una-estrategia-de-observacion-y-espera-para-cancer-colorrectal-localizado-msi-dmmr-protocolo-del-estudio-para-un-ensayo-aleatorio-gercor-109-prodige-84-fase-ii 2026-05-18 monthly 0.5 https://crcwarriors.org/articulo/1143/landscape-actual-y-perspectivas-terapeuticas-de-hidratos-de-indol-para-el-tratamiento-del-cancer-colorrectal 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/376/nanoparticulas-de-porfirina-simples-para-terapia-foto-inmune-combinada-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/377/evaluacion-del-efecto-antitumoral-de-nanoparticulas-de-membranas-de-macrofagos-cargadas-con-acido-gambogico-combinadas-con-radioterapia-y-anticuerpo-monoclonal-anti-pd-1-en-un-modelo-de-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/378/una-matriz-hidrogel-de-decelularizacion-del-tejido-extracelular-derivada-del-paciente-como-esqueleto-bioinspirado-para-la-modelizacion-avanzada-de-cancer-colorrectal-en-3d 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/893/analisis-metaanalitico-de-datos-de-pacientes-individuales-de-los-subtipos-moleculares-por-consenso-como-biomarcadores-del-tratamiento-de-primera-linea-en-cancer-colorrectal-metastasico-tipo-ras-wt 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1157/una-patologia-en-evolucion-cancer-colorrectal-con-metastasis-a-la-axila-el-enfoque-terapeutico-y-la-respuesta 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/910/impacto-del-sexo-en-la-eficacia-y-seguridad-del-tratamiento-de-primera-linea-con-folfiri-mas-cetuximab-o-bevacizumab-en-el-cancer-colorrectal-metastasico-con-ras-braf-tipo-salvaje-un-analisis-de 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/399/desde-mutaciones-en-pik3ca-hasta-una-inhibicion-racional-de-pi3k-para-el-tratamiento-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1168/el-perfil-molecular-de-los-tumores-con-alteraciones-concomitantes-en-tp53-rb1-revela-nuevas-vulnerabilidades-terapeuticas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/915/la-combinacion-de-fragmentomas-de-adn-libre-de-celulas-y-el-volumen-total-del-tumor-mejora-la-pronostica-y-la-evaluacion-de-respuesta-tumoral-en-pacientes-con-metastasis-hepaticas-de-cancer 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/1171/evaluacion-de-los-criterios-de-respuesta-por-rm-en-cancer-rectal-de-instabilidad-de-microsatelites-alto-tratado-con-inhibidores-de-puntos-de-control-inmune 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/155/terapia-inmunogenica-eficiente-del-cancer-mediante-formulacion-de-arn-mensajero-modificado-con-lisado-de-celulas-tumorales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/925/la-perdida-de-ciclina-c-induce-resistencia-a-la-terapia-antitigit-mediante-el-aumento-de-la-evasion-inmune-mediada-por-cd155 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/671/potencial-terapeutico-de-la-melatonina-en-los-canceres-gastrointestinales-mecanismos-moleculares-evidencia-preclinica-e-implicaciones-clinicas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/944/anticuerpos-biespecificos-basados-en-nanocuerpos-que-se-dirigen-a-ctla-4-o-pd-l1-para-la-inmunoterapia-del-cancer 2026-04-24 monthly 0.5 https://crcwarriors.org/articulo/691/eficacia-del-tratamiento-de-primera-linea-de-anticuerpos-anti-egfr-versus-anti-vegf-en-cancer-colorrectal-metastasico-mutado-braf-v600e-segun-la-localizacion-lateral-del-tumor-primario-un-analisis 2026-06-01 monthly 0.5 https://crcwarriors.org/articulo/697/inhibidores-de-pequena-molecula-dirigidos-a-pd-1-pd-l1-en-cancer-colorrectal-mecanismos-desafios-y-perspectivas-clinicas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/700/terapia-inmune-para-la-desescalada-de-cancer-colorrectal-localmente-avanzado-con-defecto-en-el-sistema-de-reparacion-de-mutaciones-una-serie-de-casos-institucional-prospectiva 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/706/trastuzumab-deruxtecan-redefiniendo-la-oncologia-de-precision-en-los-canceres-impulsados-por-her2 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/707/enfoque-en-la-diana-her2-en-el-cancer-colorrectal-metastasico-terapias-actuales-refinamiento-de-biomarcadores-y-estrategias-emergentes 2026-05-07 monthly 0.5 https://crcwarriors.org/articulo/709/caracteristicas-clinico-patologicas-y-paisaje-mutacional-de-los-subgrupos-de-cancer-colorrectal-definidos-por-el-estado-msi-y-emast 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/971/retratamiento-con-panitumumab-seguido-de-regorafenib-frente-a-la-secuencia-inversa-en-pacientes-con-cancer-colorrectal-metastasico-resistente-a-la-quimioterapia-y-con-adn-tumoral-circundante-ras-y 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/979/significado-clinico-patologico-de-las-mutaciones-comunes-del-exon-pik3ca-en-el-cancer-colorrectal-no-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/995/la-metilacion-dirigida-de-cg24067911-suprime-la-metastasis-del-cancer-colorrectal-a-traves-del-eje-bcl6-atxn1-cdh1 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/745/la-expresion-tumoral-de-nectin-4-como-factor-pronostico-y-posible-diana-terapeutica-en-el-cancer-de-recto-en-estadio-ii-iii 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1009/implementar-immunoscore-en-el-cancer-colorrectal-lecciones-de-estudios-de-cohorte-limitaciones-y-barreras-para-su-adopcion 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/764/desentranando-la-resistencia-integrando-metabolismo-epigenetica-inmunologia-y-proteostasis-en-estrategias-contra-el-cancer-colorrectal-mutante-del-oncogen-homologo-al-virus-sarcomatoso-de-rata-kirsten 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/765/la-hipertranscripcion-y-la-diseminacion-metastasica-en-el-cancer-colorrectal-impulsadas-por-kras-podrian-superarse-mediante-el-objetivo-del-eje-de-senalizacion-nmhc-iia-plk1-con-un-nuevo-derivado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1013/tagln-un-marcador-pronostico-basado-en-rigidez-para-el-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1008/innovaciones-en-diagnostico-oncologico-investigacion-genetica-y-biopsia-liquida-como-herramientas-de-medicina-personalizada 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/998/el-perfil-de-los-exosomas-en-la-metastasis-pulmonar-firmas-moleculares-condicionamiento-microambiental-e-implicaciones-traslacionales-en-el-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/999/entendiendo-el-papel-de-la-vitamina-d-en-el-osteosarcoma-una-revision-narrativa 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1000/relacion-de-microbioma-entre-cancer-de-mama-cancer-colorrectal-y-cancer-de-pulmon 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/996/evasion-inmunitaria-en-cancer-colorrectal-mecanismos-y-desafios-de-la-resistencia-a-los-inhibidores-de-puntos-de-control-inmunologico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1001/los-peptibodies-basados-en-rspo2-conjugados-con-un-dimero-de-pirrolobenzodiazepina-o-un-analogo-de-camptotecina-demuestran-una-actividad-antitumoral-potente-al-dirigirse-a-los-tres-receptores-lgr4-5 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/820/el-acido-lactico-inhibe-la-ferropotesis-y-promueve-la-polarizacion-de-los-macrofagos-m2-en-el-cancer-colorrectal-a-traves-de-la-regulacion-de-gpx4 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/982/la-heterogeneidad-de-la-interaccion-entre-el-metabolismo-y-la-actividad-mitoconal-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/748/prediccion-basada-en-aprendizaje-automatico-de-la-recurrencia-a-corto-plazo-de-poliposis-adenomatosas-del-colon-y-recto-despues-de-emr-estudio-de-desarrollo-y-validacion-del-modelo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/799/estrategia-integrada-de-metabolomica-serica-farmacologia-de-redes-y-validacion-experimental-para-revelar-los-metabolitos-bioactivos-y-el-mecanismo-de-lycium-ruthenicum-murr-contra-el-carcinoma 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/821/sumo1-promueve-la-malignidad-y-la-quimiorresistencia-en-el-cancer-colorrectal-evidencia-clinica-y-funcional 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/980/una-proporcion-significativa-de-canceres-de-recto-en-estadio-ii-y-iii-seleccionados-mediante-resonancia-magnetica-de-precision-puede-tratarse-de-forma-segura-mediante-una-cirugia-de-reseccion 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/923/tratamiento-sistemico-de-segunda-linea-para-cancer-colorrectal-metastasico-una-revision-sistematica-y-un-analisis-bayesiano-de-redes-basado-en-ensayos-clinicos-controlados-aleatorios 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/973/respuesta-a-los-agentes-que-danan-el-adn-y-a-los-inhibidores-de-parp-en-el-cancer-colorrectal-metastasico-con-mutaciones-en-el-gen-atm-serie-de-casos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1115/avances-y-desafios-en-la-deteccion-de-mutaciones-de-kras-y-sus-implicaciones-clinicas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/867/la-ablacion-sistemica-de-kras-perturba-la-homeostasis-de-las-celulas-mieloideas-en-ratones-adultos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/868/amplificacion-en-cascada-de-cargas-terapeuticas-para-la-inmunoterapia-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/869/mutaciones-de-kras-en-el-adenocarcinoma-colorrectal-incidencia-y-asociacion-con-caracteristicas-histologicas-con-especial-referencia-a-gly12asp-en-un-estudio-multicentrico-gipad-de-la-practica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/871/el-analisis-multiomico-descubre-marcadores-predictivos-para-la-eficacia-y-los-resultados-del-quimoimmunoterapia-en-canceres-avanzados-de-vias-biliares-inquirrectibles 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/872/la-pantalla-de-alto-rendimiento-identifica-moleculas-pequenas-que-se-synergizan-con-mrtx1133-contra-la-resistencia-adquirida-mutada-kras-g12d-en-crc 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/882/seccion-transversal-espontanea-del-colon-despues-de-respuesta-completa-patologica-a-pembrolizumab-en-cancer-colorrectal-de-alta-inestabilidad-microsatelital-informe-de-caso-y-revision-de-la-literatura 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/884/respuesta-completa-inducida-por-inmunoterapia-en-cancer-rectal-dmmr-un-dilema-quirurgico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/885/analisis-bibliometrico-de-la-disregulacion-inmunitaria-e-inmunoterapia-en-cancer-colorrectal-deficit-de-reparo-de-parejas-de-bases 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/886/deficiencia-de-reparacion-por-mismatch-y-el-papel-de-las-funciones-no-canonicas-en-el-cancer-diagnostico-e-implicaciones-terapeuticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/887/tratamiento-con-inhibidores-de-puntos-de-control-para-cancer-intestinal-no-resecable-y-no-metastasico-deficiente-en-reparo-de-disparidad-de-coincidencia-una-serie-de-casos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/894/sbf-1-suprime-el-crecimiento-de-celulas-de-cancer-colorrectal-mediante-la-modulacion-de-la-reprogramacion-metabolica-del-colesterol 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/896/podemos-preservar-el-recto-mediante-una-estrategia-de-observacion-vigilante-o-cirugia-microanal-transanal-tras-una-radioterapia-de-corta-duracion-y-un-tratamiento-local-o-sistemico-adicional-para-el 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/897/eficacia-y-seguridad-de-la-bloqueada-de-pd-l1-con-envafolimab-como-tratamiento-neoadiuvante-en-cancer-colorrectal-localmente-avanzado-con-deficit-en-el-reparo-de-desmatches-un-estudio-abierto-de-un 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/901/quimioterapia-neoadyuvante-versus-quimiorradioterapia-para-cancer-rectal-de-avanzada-localizacion-un-estudio-multicentrico-ajustado-por-puntuaciones-de-propensidad 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/903/conservacion-del-organo-a-traves-de-la-terapia-neoadyuvante-total-basada-en-inmunoterapia-en-cancer-rectal-bajo-temprano-torch-e-un-estudio-fase-ii-multicentrico-abierto-y-de-un-solo-brazo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/906/fruquintinib-mas-sintilimab-en-pacientes-con-cancer-colorrectal-metastasico-refractario-previamente-tratado-con-bevacizumab-pmmr-mss-un-ensayo-clinico-fase-2 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/907/tratamiento-neoadyuvante-de-corta-duracion-con-o-sin-inhibidor-de-pd-1-para-cancer-rectal-avanzado-localmente-restringido-pmmr-resultados-de-fase-2-de-un-ensayo-aleatorizado-stellar-ii 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/908/toripalimab-combinado-con-quimioterapia-flot-como-terapia-de-conversion-en-cancer-gastrico-con-metastasis-peritoneal-un-ensayo-de-fase-ii-de-un-solo-brazo-y-etiqueta-abierta 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/911/reablation-y-ablacion-en-una-sola-sesion-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-despues-del-fracaso-de-la-quimioterapia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/912/terapia-dirigida-en-el-cancer-colorrectal-avanzado-con-mutacion-en-el-gen-braf-revision-sistematica-y-metaanalisis-de-red 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/914/tinzaparina-para-la-prevencion-de-eventos-tromboembioticos-en-pacientes-ambulatorios-con-cancer-colorrectal-metastasico-recibiendo-tratamiento-de-primera-linea-un-diseno-de-ensayo-clinico-aleatorizado 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/922/combinacion-de-la-inyeccion-de-compound-kushen-con-el-tratamiento-de-primera-linea-frente-al-tratamiento-de-primera-linea-en-monoterapia-para-el-cancer-colorrectal-avanzado-un-protocolo-de-estudio 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/924/gel-de-inyeccion-peritumoral-de-melitina-clonidina-para-tumores-frios-exposicion-de-antigenos-tumorales-y-reduccion-de-la-presion-inmunosupresora-sobre-las-celulas-inmunitarias 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/926/el-eje-mlkl-retromero-controla-el-reciclaje-de-pd-l1-para-comprometer-la-inmunidad-antitumoral-durante-la-necrotosis-inducida-por-la-inhibicion-de-vcp 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/927/el-butirato-de-sodio-inhibe-el-desarrollo-del-cancer-colorrectal-al-reducir-la-polarizacion-de-los-macrofagos-m2-y-la-expresion-de-pd-l1 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/928/la-inhibicion-de-ctgf-supera-la-resistencia-a-los-inhibidores-de-csf1r-evitando-la-activacion-de-las-celulas-fibroblastoides-tumorales-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/929/objetivo-la-evasion-inmune-inducida-por-sting-con-farmacologia-binaria-nanocarburada-para-mejorar-el-control-tumoral-en-ratones 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/930/integracion-multiomica-descifra-la-heterogeneidad-inmuno-metabolica-en-el-crc-un-modelo-pronostico-y-estrategias-terapeuticas-dirigidas-a-angptl4-fabp4-rbp7 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/931/mejora-de-la-inmunidad-antitumoral-por-oligonucleotidos-antisentido-de-ctla-4-con-motivo-cpg-en-ratones 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/941/una-anticuerpo-bifuncional-anti-pd-l1-cd3-potencia-los-efectos-antitumorales-del-regorafenib-contra-el-cancer-de-colon 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/943/la-orientacion-bispecifica-hacia-4-1bb-y-ccr8-potencia-la-inmunidad-antitumoral-mediante-la-deplecion-de-ti-treg-y-la-activacion-de-cd8 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/965/aplicar-las-celulas-modificadas-con-receptores-de-antigenos-quimericos-en-la-inmunoterapia-del-cancer-gastrointestinal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/966/la-timoptenina-potencia-la-inmunidad-antitumoral-a-traves-de-la-rejuvenescencia-timica-y-la-reprogramacion-funcional-de-las-celulas-t 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/968/reprogramacion-de-la-glicosilacion-branquial-n-de-celulas-t-cd8-limita-el-agotamiento-mejorando-la-citotoxicidad-y-la-eliminacion-del-tumor 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/837/un-sistema-de-administracion-de-carga-que-amplifica-la-inmunogenicidad-in-situ-para-la-inmunoterapia-del-cancer-con-mutaciones-en-el-gen-homologo-del-oncogen-viral-del-sarcoma-de-rata-de-kirsten 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/840/microambiente-tumoral-inmunosupresor-en-metastasis-pulmonares-de-cancer-colorrectal-implicaciones-para-la-recurrencia-despues-de-metastectomia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/843/el-espectro-de-desubitilizacion-relacionado-con-el-sistema-inmune-del-cancer-colorrectal-de-estabilidad-de-microsatelites-revela-a-usp7-como-un-posible-objetivo-terapeutico-inmunologico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/846/la-codexpresion-de-cd44-y-erk1-2-fosforilado-predice-metastasis-distantes-en-cancer-colorrectal-basada-en-un-estudio-de-1137-pacientes-saudies 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1057/eventos-geneticos-tempranos-en-la-via-carcinogenica-del-cancer-colorrectal-en-la-poliposis-adenomatosa-familiar-y-en-los-polipos-esporadicos-alteraciones-germinales-y-somaticas-en-la-carcinogenesis 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/832/patrones-espaciales-y-relevancia-pronostica-de-las-celulas-dendriticas-inmaduras-cd1a-y-las-celulas-dendriticas-maduras-cd208-en-el-cancer-colorrectal-desde-la-mucosa-adyacente-al-tumor-hasta-las 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/833/resultados-finales-de-anicca-class-ii-un-ensayo-de-fase-ii-de-un-solo-brazo-abierto-y-sin-enmascaramiento-que-evalua-el-uso-de-nivolumab-en-cancer-colorrectal-metastasico-con-microsatelites-estables 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/834/terapia-neoadyuvante-total-con-seis-ciclos-frente-a-cuatro-ciclos-de-capox-en-cancer-colorrectal-localmente-avanzado-un-estudio-en-la-practica-clinica-real 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/835/una-comparacion-por-estado-de-reparacion-de-desmatches-de-las-caracteristicas-y-resultados-del-mundo-real-en-pacientes-con-cancer-rectal-en-etapas-ii-iii-en-los-paises-bajos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/824/relojes-basados-en-metilacion-de-dna-tabaquismo-y-riesgo-de-cancer-de-pulmon 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/825/obtencion-rapida-de-imagenes-de-metastasis-pulmonares-procedentes-del-cancer-colorrectal-mediante-una-sonda-de-fluorescencia-roja-que-se-dirige-a-la-aminopeptidasa-y-la-dipeptidil-peptidasa-iv 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/826/el-apoyo-psicologico-integral-y-la-nutricion-enteral-temprana-guiada-por-la-pni-mejoran-el-sueno-la-recuperacion-nutricional-y-la-calidad-de-vida-tras-la-cirugia-curativa-del-cancer-colorrectal-un 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1366/el-analisis-transcriptomico-integrado-revela-un-eje-cebpb-dusp1-que-impulsa-la-progresion-tumoral-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/749/encontrados-clinico-patologicos-en-una-serie-de-especimenes-de-diseccion-submucosa-endoscopica-gastrointestinal-un-estudio-retrospectivo-de-5-anos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/828/consenso-sobre-las-interacciones-farmacologicas-para-la-identificacion-de-inhibidores-de-plk2-en-el-tratamiento-del-cancer-colorrectal 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/836/carga-metastasica-y-mutacion-de-tp53-sobresalen-el-valor-pronostico-independiente-de-kras-en-cancer-colorrectal 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/750/mejorando-la-precision-de-prediccion-del-dowstaging-patologico-en-cancer-rectal-avanzado-localmente-utilizando-modelos-de-aprendizaje-profundo-con-mri-preoperatoria-y-datos-clinico-patologicos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/776/glutaminasa-i-y-las-vias-de-la-glutamina-transaminasa-amidasa-en-el-cancer-colorrectal-reprogramacion-metabolica-y-nuevas-estrategias-terapeuticas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/816/el-microbioma-intratumoral-un-factor-regulador-crucial-en-el-desarrollo-y-la-progresion-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/817/subconjuntos-de-celulas-nk-anticancerigenos-especificos-del-tejido-identificados-en-metastasis-hepaticas-de-cancer-colorrectal-expresan-objetivos-terapeuticos-candidatos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/827/desconvolucion-ultra-precisa-de-transcriptomica-espacial-descodifica-la-heterogeneidad-inmune-y-programas-definidores-de-destino-en-tejidos 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/327/microrrobotico-terapeutico-intestinal-con-capacidad-de-enfocamiento-magnetico-y-degradacion-desencadenada-por-ph 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/328/nanoparticulas-de-ferritina-bionicas-responsive-a-enzimas-para-terapia-selectiva-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/751/plataforma-basada-en-organoides-tumorales-para-la-evaluacion-preclinica-temprana-de-la-eficacia-y-seguridad-antitumorales-de-hojas-nanometricas-hidrofilicas-de-mos-2-bidimensionales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/752/ia-para-cancer-de-colon-un-enfoque-en-la-clasificacion-deteccion-y-modelizacion-predictiva 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/796/analisis-de-costo-efectividad-de-larotrectinib-versus-estandar-de-cuidado-para-el-tratamiento-del-cancer-colorrectal-metastasico-con-fusion-ntrk 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/804/caracterizacion-de-la-microbiota-intestinal-en-pacientes-con-cancer-colorrectal-de-etapa-iii-un-estudio-caso-control 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/786/los-genes-responsivos-a-la-restriccion-dietetica-definen-subtipos-pronosticos-y-predice-metastasis-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/789/los-nanotubos-de-glucano-mejoran-la-administracion-oral-de-doxorrubicina-en-el-tratamiento-del-cancer-colorrectal-mediante-la-focalizacion-del-colon-mediada-por-la-microbiota-y-la-reduccion-de-la 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/790/la-proteina-ribosomica-rpl7a-modula-la-progresion-del-adenocarcinoma-de-pulmon-a-traves-de-la-degradacion-de-sirt6-mediada-por-circranbp17-upf1 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/818/ritmo-circadiano-una-nueva-estrategia-para-el-tratamiento-del-cancer-colorrectal 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/769/aplicando-aprendizaje-automatico-para-la-busqueda-virtual-de-compuestos-naturales-como-inhibidores-tanto-de-egfr-como-de-her2-en-el-cancer-colorrectal-una-nueva-propuesta-terapeutica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/774/canceres-colorrectales-mutantes-de-la-polimerasa-epsilon-dna-perspectivas-sobre-variantes-de-mutacion-en-el-dominio-no-exonucleasa-estado-de-inestabilidad-microsatelital-y-perfiles-de-co-mutaciones 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/775/reaprovechamiento-de-farmacos-mediante-dinamica-de-perturbacion-de-vias-un-enfoque-de-biologia-sistematica-para-la-oncologia-precisa 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/777/la-via-hoxc8-trim22-nf-b-al-activarse-favorece-la-capacidad-de-auto-renovacion-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/778/angptl3-promueve-la-progresion-y-la-metastasis-del-carcinoma-colorrectal-mediante-la-regulacion-de-la-transcripcion-de-col1a2-a-traves-de-la-interaccion-con-la-integrina-v-3 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/779/efectos-de-las-dietas-basadas-en-carne-las-dietas-basadas-en-carne-con-tocoferol-y-las-dietas-pesco-vegetarianas-sobre-los-biomarcadores-asociados-con-el-riesgo-de-cancer-colorrectal-un-ensayo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/784/papel-de-la-reprogramacion-metabolica-en-el-cancer-colorrectal-e-intervencion-farmacologica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/793/relevancia-traslacional-del-paisaje-genomico-de-canceres-colorrectales-y-pancreaticos-mutantes-de-krasg12d 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/791/modelos-de-difusion-contrafacticos-para-explicaciones-interpretables-de-modelos-de-inteligencia-artificial-en-patologia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/702/dirigirse-a-pin1-para-superar-el-microambiente-tumoral-inmunosupresor-en-el-cancer-colorrectal-mss 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/703/landscape-inmune-del-cancer-colorrectal-microambiente-tumoral-jugadores-celulares-y-oportunidades-terapeuticas-inmunologicas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/762/mejora-del-tratamiento-del-cancer-colorrectal-mediante-un-enfoque-de-terapia-triple-que-incluye-5-fluorouracilo-timoquinona-y-polygonum-minus 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/805/sintesis-ecologica-de-nanoparticulas-de-plata-recubiertas-con-quitosano-a-partir-de-la-planta-tephrosia-apollinea-un-enfoque-sostenible-prometedor-para-el-tratamiento-del-cancer-colorrectal 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/670/sintesis-de-conjugados-de-acido-boswelico-con-aminoacidos-para-dirigirse-al-cancer-de-colon-con-la-mutacion-kras-g13d 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/696/avances-en-la-investigacion-sobre-estrategias-de-reutilizacion-de-farmacos-para-lograr-una-sensibilizacion-sinergica-en-la-inmunoterapia-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/699/eficacia-de-los-anti-vegf-y-anti-egfr-en-cancer-colorrectal-metastasico-inestable-por-microsatelites-msi-h-en-un-estudio-de-cohorte-del-grupo-oncologico-turco-tog 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/701/microbiota-intestinal-y-ferroptosis-en-el-cancer-colorrectal-una-revision-exhaustiva-de-los-mecanismos-y-las-estrategias-terapeuticas-para-superar-la-resistencia-a-los-inhibidores-de-los-puntos-de 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/711/analisis-de-la-variacion-en-la-prevalencia-de-mutaciones-de-pik3ca-entre-poblaciones-con-cancer-colorrectal-una-revision-exhaustiva 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/713/determinantes-moleculares-guiados-por-inteligencia-artificial-de-las-alteraciones-del-camino-pi3k-en-el-cancer-colorrectal-de-inicio-temprano-entre-grupos-de-alto-riesgo-que-reciben-folfox 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/716/terapias-multitarget-con-geraniina-procedente-de-geranium-wilfordii-maxim-y-especies-relacionadas-mecanismos-y-aplicaciones 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/717/la-decoccion-jiedu-sangen-inhibe-la-transicion-epitelial-mesenquimal-del-adenocarcinoma-de-colon-a-traves-del-camino-pou4f2-hedgehog 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/720/probeo-fluorescente-nir-i-ii-dirigido-a-epha2-para-la-imagen-especifica-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/721/plataforma-de-chips-decm-multiplexados-que-imitan-el-tumor-para-el-cancer-colorrectal-evaluacion-de-la-sinergia-farmacologica-y-la-dinamica-de-la-immunosurveglancia-de-las-celulas-nk 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/723/fagonia-cretica-inhibe-la-proliferacion-de-celulas-de-cancer-colorrectal-y-de-prostata-mediante-la-disminucion-de-la-expresion-de-dnmt1-la-induccion-del-estres-oxidativo-y-la-activacion-del-receptor 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/724/ailantona-un-quasinoido-de-amplio-espectro-con-multiples-dianas-derivado-de-ailanthus-altissima-para-la-terapia-contra-diversos-tipos-de-cancer-una-revision-exhaustiva-de-los-mecanismos-la 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/725/la-medicina-tradicional-mongola-batri-7-presenta-actividad-quimioprevencion-en-el-cancer-colorrectal-asociado-a-colitis-mediante-la-modulacion-de-la-microbiota-y-la-inhibicion-del-inflamasoma-nlrp3 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/726/enfoque-en-yap-taz-tead-y-sus-interacciones-proteina-proteina-para-la-terapia-precisa-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/727/comparacion-de-los-efectos-de-la-rapamicina-y-el-azd8055-en-celulas-de-cancer-colorrectal-a-traves-de-metabolomica-basada-en-uplc-ms-ms 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/728/desarrollo-de-conjugados-ligando-pi3k-mtor-hsp90-para-una-terapia-mejorada-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/729/zif-8-post-funcionalizado-para-la-alta-rendimiento-isolacion-sinergica-de-vesiculas-extracelulares-mediante-coprecipitacion-following-the-instruction-strictly-zif-8-post-funcionalizado-para-la-alta 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/731/perfiles-de-transcriptoma-a-nivel-de-celula-individual-de-cancer-colorrectal-pos-tratamiento-y-naive-al-tratamiento-perspectivas-sobre-los-mecanismos-supuestos-de-quimiorresistencia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/732/consenso-internacional-de-expertos-sobre-la-integracion-clinica-de-las-celulas-tumorales-circulantes-en-tumores-solidos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/733/metabolitos-microbianos-del-tracto-gastrointestinal-en-la-inmunomodulacion-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/734/la-down-regulacion-de-rbm47-debido-a-una-disminucion-en-la-activacion-por-parte-del-forkhead-box-a1-foxa1-y-al-silenciamiento-mediante-metilacion-de-cpg-esta-asociada-con-la-transicion-epitelio 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/735/funciones-reguladoras-de-los-arn-no-codificantes-y-exosomicos-en-el-cancer-colorrectal-enfoque-en-la-angiogenesis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/744/la-espectrometria-de-masas-dirigida-ms-permitio-identificar-perfiles-lipidicos-con-implicaciones-diagnosticas-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/746/nanoformulacion-de-sensibilizacion-dual-que-combina-la-inhibicion-del-metabolismo-de-la-glutamina-y-la-activacion-de-fas-fasl-para-mejorar-la-inmunoterapia-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/753/el-valor-pronostico-de-la-dinamica-del-adn-libre-en-suero-durante-la-quimiorradioterapia-en-los-carcinomas-de-celulas-escamosas-del-ano 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/754/terapia-neoadyuvante-total-en-el-cancer-de-recto-el-protocolo-forest-un-enfoque-centrado-en-el-paciente-que-agrupa-a-dos-cohortes-con-resultados-diferentes 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/755/validacion-prospectiva-del-indice-modificado-para-el-cancer-colorrectal-metastasico-mccs-en-mas-de-600-pacientes-con-cancer-colorrectal-metastasico-ras-wild-type-tratados-con-panitumumab-en-primera 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/756/asociacion-entre-el-uso-de-aspirina-e-ibuprofeno-y-el-riesgo-de-cancer-de-endometrio-en-el-conjunto-de-datos-plco 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/792/prevalencia-y-caracteristicas-clinicas-asociadas-con-mutaciones-en-el-gen-kras-en-cancer-colorrectal-en-pacientes-ecuatorianos-un-estudio-transversal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1/el-impacto-pronostico-del-estado-del-receptores-de-factor-de-crecimiento-epidermico-humano-2-en-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/2/impacto-de-las-mutaciones-de-ras-y-braf-y-del-estado-de-microsatelites-en-las-metastasis-peritoneales-del-cancer-colorrectal-tratadas-con-citoreduccion-hipec-revision-sistematica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/3/modelos-de-raton-humanizados-de-cancer-colorrectal-y-de-pancreas-con-mutaciones-en-el-gen-kras-y-con-compatibilidad-de-hla-de-clase-i-para-la-evaluacion-preclinica-de-inmunoterapias-contra-el-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/521/prevalecimiento-y-pronostico-de-pacientes-con-cancer-de-mama-elegibles-para-la-terapia-adyuvante-con-abemaciclib-o-ribociclib-un-estudio-basado-en-la-poblacion-a-nivel-nacional 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/266/distribucion-diferencial-de-puntos-de-control-inmune-entre-los-subtipos-moleculares-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/781/prevencion-personalizada-de-enfermedades-neurodegenerativas-revision-panoramica-y-mapa-de-brechas-en-la-evidencia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/782/domino-estricto-conteniendo-7-un-marcador-epigenetico-basado-en-tejido-para-la-deteccion-temprana-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/783/cerrando-el-ciclo-en-la-terapia-de-egfr-decodificando-la-respuesta-a-cetuximab-a-traves-de-circ-egfr 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/273/sistema-de-entrega-nanometrica-dirigido-al-cruce-de-senales-entre-crcs-cafs-que-reprograma-el-microambiente-tumoral-para-revertir-la-resistencia-a-oxaliplatino-e-inhibir-la-metastasis-hepatica-en 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/21/respuesta-duradera-a-la-terapia-combinada-de-tercera-linea-en-un-paciente-con-cancer-colorrectal-metastasico-y-mutacion-braf-v600e-informe-de-un-caso 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/795/evaluacion-del-riesgo-beneficio-y-resultados-del-paciente-en-el-desarrollo-de-medicamentos-una-decada-de-ensayos-clinicos-con-vemurafenib 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/806/e7386-en-pacientes-con-tumores-solidos-avanzados-resultados-de-la-fase-de-escalada-de-dosis-y-de-una-fase-de-expansion-de-un-estudio-de-fase-i 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/807/perfiles-inmunes-impulsados-por-ia-a-partir-de-diapositivas-de-histopatologia-para-la-prediccion-del-resultado-de-quimiorradioterapia-en-cancer-rectal-un-estudio-utilizando-cohortes-de-ensayos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/808/identificando-mutaciones-geneticas-accionables-e-inestabilidad-de-microssatelites-en-biopsia-liquida-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1065/una-vision-general-de-las-terapias-dirigidas-al-kras-para-el-cancer-colorrectal-en-desarrollo-fase-i-y-fase-ii 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/301/la-caracterizacion-multiomica-del-subtipo-molecular-de-consenso-1-cms1-del-cancer-colorrectal-que-presenta-una-respuesta-inmunitaria-atenuada-mejora-la-medicina-de-precision 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/306/mbsparse-un-metodo-de-imputacion-basado-en-un-autocoder-para-abordar-la-escasez-en-datos-de-microbioma 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/314/se-construye-una-firma-pronostica-basada-en-el-aprendizaje-automatico-relacionada-con-la-glucolisis-y-el-metabolismo-de-los-acidos-grasos-y-se-identifica-acsl5-como-un-nuevo-marcador-que-inhibe-la 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/571/una-revision-de-paraguas-de-revisiones-sistematicas-sobre-la-utilidad-diagnostica-y-pronostica-del-adn-tumoral-circulante-y-microarn-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/578/motor-nanoimpulsado-por-rayos-x-con-penetracion-y-retencion-mejoradas-para-la-radioinmunoterapia-amplificada-con-monoxido-de-carbono-del-cancer-colorrectal-avanzado 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/337/el-patron-de-actividad-fisica-de-guerrero-del-fin-de-semana-y-el-riesgo-de-cancer-incidente 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/596/el-curcumino-revierte-la-resistencia-adquirida-a-la-irinotecan-en-celulas-de-cancer-colorrectal-dld1-perspectivas-a-partir-de-datos-transcriptomicos-integrales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/597/deficiencia-de-reparacion-de-desajustes-inestabilidad-microsatelital-dmmr-msi-h-en-pacientes-con-cancer-rectal-tratados-con-terapia-neoadyuvante-estandar-una-revision-sistematica-y-metaanalisis 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/346/la-senescencia-tumoral-inducida-por-kdm4a-mejora-la-eficacia-de-la-inmunoterapia-al-inhibir-la-mitofagia-mediada-por-el-eje-agt-phb1-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/347/en-la-dinamica-fototermocimica-en-situ-del-efecto-sinergico-de-mejora-del-efecto-antitumoral-basado-en-un-nanosistema-multifuncional-de-ficocianina 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/605/redefinir-la-precision-una-revision-sistematica-y-analisis-metaestadistico-de-ensayos-clinicos-aleatorios-comparando-cirugia-asistida-por-robot-versus-laparoscopia-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/608/efecto-de-la-digestion-in-vitro-en-la-citotoxicidad-y-viabilidad-microbiana-de-sopas-veganas-ricas-en-inhibidores-de-colinesterasa-en-modelos-celulares-intestinales-humanos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/104/diseno-basado-en-la-estructura-de-nuevos-inhibidores-potentes-y-altamente-selectivos-de-parp-1-para-el-tratamiento-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/616/primer-caso-de-poliposis-asociada-a-bap1 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/105/mejora-de-la-administracion-dirigida-y-la-eficacia-de-la-doxorrubicina-liposomica-pegilada-mediante-la-administracion-de-minoxidil-liposomico-estudios-exhaustivos-in-silico-in-vitro-e-in-vivo-en 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/106/caracterizacion-del-paisaje-de-celulas-madre-y-identificacion-del-gen-eny2-relacionado-con-la-stemness-en-cancer-colorrectal-mediante-analisis-transcriptomico-integrado 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/107/un-analisis-bibliometrico-de-dos-decadas-sobre-macrofagos-asociados-a-tumores-en-la-investigacion-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/875/avances-actuales-en-el-tratamiento-del-cancer-colorrectal-una-revision-de-ensayos-clinicos-recientes 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/108/lenvatinib-promueve-la-piroptosis-del-carcinoma-hepatocelular-regulando-la-palmitylacion-de-gsdme 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/109/identificacion-de-gbp6-como-un-potencial-marcador-pronostico-en-el-carcinoma-esofagico-mediante-analisis-bioinformatico-integrado-y-validacion-experimental 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/110/implicaciones-de-las-modificaciones-epigeneticas-mediadas-por-la-microbiota-intestinal-en-enfermedades-intestinales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/622/arroz-integral-naturaldream-cultivado-con-fertilizante-mineral-de-aguas-profundas-integracion-de-la-agricultura-sostenible-y-la-ciencia-de-los-alimentos-funcionales-para-la-prevencion-del-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/111/el-acido-indol-3-lactico-suprime-el-cancer-colorrectal-a-traves-de-la-reprogramacion-metabolica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/112/un-modelo-porcino-de-reseccion-laparoscopica-intersfinteriana-para-cancer-rectal-ultra-bajo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/113/una-revision-general-del-potencial-de-los-compuestos-naturales-para-regular-las-modificaciones-epigeneticas-en-el-cancer-colorrectal-una-actualizacion-reciente 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/114/desarrollo-preclinico-de-ozuriftamab-vedotin-ba3021-un-nuevo-conjugado-anticuerpo-farmaco-biologico-de-accion-condicional-especifico-para-ror2 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/626/asociaciones-longitudinales-del-comportamiento-sedentario-y-la-actividad-fisica-con-los-ritmos-de-reposo-actividad-diurnos-en-sobrevivientes-de-cancer-colorrectal-hasta-5-anos-post-tratamiento 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/115/el-impacto-de-los-acidos-grasos-cortocadena-microbianos-del-intestino-en-el-desarrollo-y-prevencion-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/371/terapia-antinflamatoria-adyuvante-en-cancer-colorrectal-posoperatorio-una-revision-sistematica-y-metanalisis-de-ensayos-clinicos-aleatorios 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/116/desentranando-el-nexo-anoikis-cancer-un-analisis-bibliometrico-de-las-tendencias-y-mecanismos-de-investigacion 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/372/la-construccion-de-un-modelo-de-nomograma-pronostico-para-cancer-colorrectal-y-la-prediccion-de-caracteristicas-inmunes-y-respuestas-al-tratamiento-inmunologico-basada-en-el-analisis-bioinformatico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/117/modelado-de-la-rentabilidad-y-el-acceso-ampliado-de-la-transicion-al-bevacizumab-biosimilar-en-el-cancer-colorrectal-metastasico-y-el-cancer-de-pulmon-no-microcitico-no-escamoso-en-medicare 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/118/descubrimiento-de-un-inhibidor-selectivo-de-pi3k-mediante-cribado-virtual-basado-en-la-estructura-para-la-terapia-dirigida-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/119/eficacia-de-la-ablacion-por-radiofrecuencia-en-primera-linea-combinada-con-quimioterapia-sistemica-mas-terapia-dirigida-para-metastasis-hepaticas-de-cancer-colorrectal-inicialmente-irresecables 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/120/un-conjugado-anticuerpo-farmaco-bispecifico-dirigido-a-pcad-y-cdh17-presenta-actividad-antitumoral-y-una-mayor-especificidad-tumoral 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1144/un-caso-de-msi-h-y-carcinoma-de-colon-con-celulas-de-anillo-signet 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/1145/dos-informes-de-casos-de-respuesta-completa-a-pembrolizumab-en-cancer-colorrectal-msi-h 2026-04-08 monthly 0.5 https://crcwarriors.org/articulo/122/las-metastasis-hepaticas-del-cancer-colorrectal-contienen-diferentes-subconjuntos-de-celulas-t-cd8-con-memoria-residente-en-el-tejido-que-se-correlacionan-con-un-riesgo-distinto-de-recurrencia-tras 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/635/el-modelo-de-riesgo-de-los-genes-relacionados-con-la-separacion-por-fase-liquido-liquido-revela-el-pronostico-y-las-caracteristicas-del-microambiente-tumoral-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/380/b7-h3-potencia-el-fenotipo-maligno-del-cancer-colorrectal-al-activar-la-via-wnt-catenina-proceso-mediado-por-cyp1b1 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1148/un-caso-de-supervivencia-a-largo-plazo-lograda-con-quimioterapia-para-metastasis-multiples-que-aparecieron-22-anos-despues-de-la-cirugia-por-cancer-rectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/643/implicaciones-clinicas-de-la-secuenciacion-del-genoma-completo-en-el-cancer-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/899/eficacia-y-seguridad-de-atezolizumab-mas-bevacizumab-en-cancer-colorrectal-metastasico-msi-igual-un-ensayo-clinico-fase-ii-abierto-de-un-solo-brazo-multicentrico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/900/terapia-inmunologica-neoadyuvante-con-prolgolimab-en-pacientes-con-cancer-colorrectal-de-alto-grado-de-insuficiencia-del-sistema-de-reparacion-de-pareo-de-bases-microsatelites-deficit-de-correccion 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/645/desbloqueando-el-potencial-terapeutico-de-nanovehiculos-basados-en-peptidos-ciclicicos-para-un-tratamiento-mejorado-del-cancer-colorectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/902/metabolitos-bioactivos-anticolorectales-de-hongos-endofitos-de-pyrola-spp-que-se-dirigen-a-la-via-p-atm-p53-mediante-experimentos-in-vitro-y-farmacologia-de-red 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/647/circ-egfr-es-un-predictor-de-respuesta-al-cetuximab-y-un-posible-objetivo-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/904/camrelizumab-combinado-con-lenvatinib-y-quimioterapia-por-infusion-arterial-hepatica-ralox-para-carcinoma-hepatocelular-inoperable-cal-era-un-ensayo-prospectivo-de-un-solo-brazo-fase-ii 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/139/evaluacion-personalizada-del-riesgo-de-cancer-colorrectal-a-traves-de-la-inteligencia-artificial-explicativa-y-el-perfilamiento-del-microbioma-gastrointestinal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/140/la-disfuncion-de-la-iga-secretora-subyace-detras-de-un-pronostico-pobre-en-cancer-colorrectal-infectado-por-fusobacterium 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/141/actualizaciones-sobre-combinaciones-de-radioterapia-e-inmunoterapia-actas-del-8o-congreso-anual-immunorad 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/909/eficacia-terapeutica-de-la-baicaleina-y-el-6-metilsulfinil-hexil-isotiocianato-solos-o-en-combinacion-con-5-fluorouracilo-en-el-tratamiento-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/654/hidrogelos-que-se-forman-in-situ-para-el-tratamiento-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/661/pdzk1-un-objetivo-directo-de-gli2-promueve-el-trafico-de-fgfr3-y-la-proliferacion-celular-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/412/efecto-de-la-inmunoterapia-neoadyuvante-en-el-cancer-rectal-localizado-una-revision-sistematica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/157/atovaquone-proguanil-y-reduccion-del-riesgo-de-cancer-digestivo-una-conexion-con-toxoplasma-gondii 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/158/las-celulas-inmunes-de-origen-sanguineo-transportan-restos-de-adn-de-baja-biomasa-de-microbios-en-pacientes-con-cancer-colorrectal-o-enfermedad-inflamatoria-intestinal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/159/tsr-0072-inhibe-la-progresion-del-cancer-colorrectal-mediante-la-modulacion-de-la-reprogramacion-metabolica-de-los-lipidos-y-la-vitamina-d-3-y-la-inactivacion-de-la-via-de-senalizacion-wnt-catenina 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/160/analisis-de-costo-efectividad-de-la-capecitabina-en-comparacion-con-el-monitoreo-activo-en-cancer-metastasico-de-colon-o-recto-estable-o-respondiente-despues-de-16-semanas-de-terapia-de-primera-linea 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/161/caracteristicas-clinicopatologicas-y-microambiente-inmunitario-tumoral-del-adenocarcinoma-pulmonar-de-tipo-enterico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/417/terapia-combinada-dirigida-con-encorafenib-y-cetuximab-para-el-cancer-colorrectal-metastasico-con-mutacion-braf-v600e-una-revision-sistematica-y-metaanalisis 2026-05-26 monthly 0.5 https://crcwarriors.org/articulo/162/la-inhibicion-dual-de-la-fosforilacion-oxidativa-y-la-glicolisis-utilizando-un-inhibidor-de-nox-en-particulas-nanocarriers-de-acido-hialuronico-mejoro-la-respuesta-a-la-radioterapia-en-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/163/sello-hidrogelico-adaptativo-inspirado-en-el-peritoneo-que-coordina-la-lubrificacion-a-largo-plazo-y-las-propiedades-antibacterianas-para-la-intubacion-de-tubos-de-drenaje 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/419/ot17-una-nueva-linea-celular-y-modelo-de-organoide-de-cancer-colorrectal-estable-en-microsatelites-para-investigar-la-oncogenesis-del-mutante-braf-v600e-y-terapeuticas-dirigidas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/164/asociacion-entre-el-logaritmo-de-las-probabilidades-de-presentar-metastasis-en-los-ganglios-linfaticos-y-la-supervivencia-global-en-pacientes-con-melanoma-anorrectal-maligno-primario-un-estudio 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/165/la-linfadenectomia-no-mejora-la-supervivencia-especifica-del-cancer-en-pacientes-con-cancer-colorrectal-que-se-sometieron-a-terapia-endoscopica-un-estudio-retrospectivo-basado-en-la-poblacion 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/421/recientes-avances-en-sistemas-de-entrega-de-farmacos-basados-en-nanoparticles-de-albumina-para-el-tratamiento-de-enfermedades-intestinales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/677/la-senalizacion-de-wnt-promueve-la-activacion-de-nf-b-y-la-resistencia-a-los-farmacos-en-el-cancer-colorrectal-con-mutacion-en-kras 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/166/resultados-de-la-ablacion-percutanea-guiada-por-ecografia-de-mas-de-5-frente-a-5-o-menos-metastasis-hepaticas-de-cancer-colorrectal-un-estudio-de-concordancia-por-puntuacion-de-propension 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/678/analisis-de-costo-efectividad-de-adagrasib-con-o-sin-cetuximab-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-y-mutacion-en-kras-g12c 2026-06-16 monthly 0.5 https://crcwarriors.org/articulo/167/analisis-de-los-factores-que-influyen-en-los-costos-de-hospitalizacion-para-cinco-tipos-comunes-de-cancer-en-china-utilizando-modelos-de-redes-neuronales 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/679/analisis-de-costo-efectividad-de-sotorasib-mas-panitumumab-en-el-tratamiento-del-cancer-colorrectal-refractario-con-mutacion-kras-g12c-en-los-ee-uu 2026-06-16 monthly 0.5 https://crcwarriors.org/articulo/168/marcadores-sustitutos-de-la-disfuncion-intestinal-asociados-con-la-supervivencia-en-canceres-avanzados 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/169/xl888-y-pembrolizumab-modulan-el-entorno-inmunitario-de-los-tumores-colorrectales-en-un-ensayo-clinico-de-fase-ib-ii 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/431/analisis-multiomico-integrado-de-cancer-colorrectal-con-inestabilidad-microssatelital-alta-identifica-una-subtipo-con-mal-pronostico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/688/estudio-breakwater-fase-iii-resultados-para-encorafenib-y-cetuximab-mas-mfolfox6-en-primera-linea-en-cancer-colorrectal-metastasico-mutante-braf-v600e 2026-05-26 monthly 0.5 https://crcwarriors.org/articulo/433/rompiendo-barreras-en-la-inmunoterapia-del-crc-avances-pioneros-en-el-desarrollo-de-vacunas-peptido-personalizadas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/434/validacion-analitica-de-una-prueba-de-adn-libre-de-raspado-para-la-deteccion-multicontrol-de-cancer-colorrectal-en-heces 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/438/la-curcumina-ejerce-efectos-terapeuticos-sobre-el-cancer-colorrectal-al-inducir-la-piroptosis-mediante-la-activacion-de-la-caspasa-1 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/439/el-inhibidor-dirigido-a-rev1-jh-re-06-induce-la-ferroptosis-a-traves-de-la-ferritinafagia-mediada-por-ncoa4-en-celulas-de-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/446/tolerancia-a-la-suplementacion-con-altas-dosis-de-fibra-en-los-participantes-de-un-ensayo-aleatorizado-para-reducir-el-riesgo-de-cancer-en-la-poblacion-nativa-de-alaska-alaska-first 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/959/caracteristicas-celulares-del-entorno-microambiental-inmune-del-cancer-colorrectal-y-progreso-en-la-investigacion-de-inmunoterapia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/960/estrategias-de-entrega-de-citocinas-basadas-en-nanotecnologia-en-canceres-gastrointestinales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/456/perfil-proteomico-de-las-metastasis-hepaticas-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/458/carga-y-pronostico-del-cancer-colorrectal-en-los-paises-asiaticos-orientales-seleccionados-1990-2036-un-analisis-sistematico-basado-en-el-estudio-global-de-carga-de-enfermedad-2021 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/972/objetivo-kras-g12d-avances-en-el-diseno-de-inhibidores 2026-04-09 monthly 0.5 https://crcwarriors.org/articulo/981/desarrollo-terapeutico-reciente-dirigido-a-mutaciones-de-kras-en-cancer-colorrectal 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/470/el-penfluridol-potencia-la-inmunidad-antitumoral-en-el-cancer-colorrectal-mediante-la-induccion-de-la-degradacion-mediada-por-proteasomas-de-pd-l1-a-traves-de-la-activacion-de-ampk 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/736/predicciones-preoperatorias-de-la-completitud-de-la-citorreduccion-para-metastasis-peritoneales-de-cancer-colorrectal-una-revision-sistematica-de-predictores-radiologicos-clinico-patologicos-y 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/737/cuantificacion-de-resonancia-molecular-y-caracterizacion-del-interactoma-sin-etiquetas-de-la-proteomia-total-de-biopsias-tumorales-decifra-predicciones-de-respuesta-y-exito-en-pacientes-con-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/738/expresion-de-los-mrna-de-esr1-pgr-erbb2-y-mki67-en-biopsias-de-tejidos-obtenidas-en-el-momento-del-diagnostico-de-pacientes-con-cancer-de-mama-que-participaron-en-el-ensayo-abcsg-34 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/739/b7-h3-en-adenocarcinoma-de-colon-recto-nos-estamos-enfocando-en-el-objetivo-correcto 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/484/eficacia-y-seguridad-de-fruquintinib-en-combinacion-con-inmunoterapia-en-el-tratamiento-en-lineas-posteriores-del-cancer-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/740/un-modelo-de-riesgo-basado-en-abcc1-es-efectivo-en-el-diagnostico-de-metastasis-peritoneales-sincronicas-en-cancer-colorrectal-avanzado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/492/valor-clinico-del-tnf-serico-y-la-il-2r-como-biomarcadores-predictivos-y-pronosticos-del-tratamiento-en-el-cancer-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1006/una-respuesta-patologica-completa-despues-del-tratamiento-con-pembrolizumab-para-un-cancer-colorrectal-deficiente-en-reparacion-de-disparejas-genomicas-instabilidad-microssatelital-alta-que-permite 2026-05-11 monthly 0.5 https://crcwarriors.org/articulo/243/nefrotoxicidad-leve-y-reversible-tras-la-administracion-repetida-de-damnacantal-en-ratones-desnudos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/244/observacion-clinica-y-efecto-inmunitario-del-tratamiento-con-ultrasonido-focalizado-de-alta-intensidad-hifu-en-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/509/radiocirugia-estereotactica-para-metastasis-cerebrales-evolucion-de-las-practicas-clinicas-segun-los-datos-de-la-base-de-datos-nacional-del-cancer-2004-2020 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/680/nanoparticulas-de-silicio-meso-poroso-funcionalizadas-con-sulfonato-antimetastasico-que-aumentan-la-estabilidad-y-la-entrega-de-irinotecano-para-el-tratamiento-del-cancer-colorrectal 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/1058/expresion-aberrante-de-ttf-1-en-adenocarcinoma-colorrectal-metastasico-que-simula-cancer-de-pulmon-primario-informe-de-un-caso-y-revision-de-los-errores-diagnosticos-mas-comunes 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/682/terapias-dirigidas-a-kras-en-cancer-colorrectal-un-analisis-sistematico-de-mutaciones-inhibidores-y-ensayos-clinicos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/681/nanoparticulas-de-albumina-autoensamblables-para-un-efecto-anticanceroso-mejorado-y-una-ferropotesis-reforzada-en-el-tratamiento-del-cancer-colorrectal-metastasico 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/991/perfiles-moleculares-de-kras-nras-y-braf-en-cancer-colorrectal-aportes-de-una-cohorte-libia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/684/un-algoritmo-de-conjunto-cubierta-identifica-objetivos-minimos-de-secuenciacion-de-adn-tumoral-circulante-para-la-deteccion-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/683/un-estudio-comparativo-de-las-caracteristicas-clinicas-y-moleculares-del-cancer-colorrectal-estable-en-microsatelites-con-y-sin-metastasis-hepaticas 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/550/aif1l-como-marcador-biologico-asociado-a-la-ferropotesis-en-cancer-colorrectal-impulsado-por-estados-microsatelite-insights-funcionales-y-diagnosticos-a-partir-del-analisis-multiomico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/568/informe-de-caso-falta-de-respuesta-al-tratamiento-con-inmunoterapia-anti-pd-1-en-un-paciente-con-cancer-colorrectal-y-alta-inestabilidad-microsatelital 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/577/inmunoterapia-versus-quimioterapia-como-terapia-adyuvante-para-cancer-colorrectal-msi-h-dmmr-resecado-evidencia-del-mundo-real-que-informa-estrategias-precisas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/663/radioterapia-intervencionista-bracuiterapia-combinada-con-tratamiento-sistemico-efecto-de-las-mutaciones-del-gen-ras-y-la-terapia-combinada-en-los-resultados-y-toxicidad-de-las-metastasis-hepaticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/664/avances-en-el-cancer-colorrectal-hereditario-como-la-medicina-de-precision-esta-transformando-el-panorama 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/665/nanoparticulas-basadas-en-plga-en-la-inmunoterapia-del-cancer-colorrectal-conceptos-actuales-y-perspectivas-futuras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/667/dapk1-identificado-como-un-nuevo-biomarcador-para-la-metastasis-hepatica-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1390/gestion-de-temperatura-en-bucle-cerrado-con-el-soporte-de-la-tecnologia-internet-de-las-cosas-en-la-cirugia-laparoscopica-rectal-para-pacientes-mayores-un-ensayo-controlado-aleatorio 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/659/la-caracterizacion-del-breathomica-facilita-el-cribado-personalizado-del-cancer-colorrectal 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/660/inhibir-slamf8-modula-los-macrofagos-asociados-a-tumores-y-restaure-la-inmunidad-antitumoral-mediada-por-celulas-t-cd8-en-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/655/la-ckb-plaquetaria-como-un-posible-factor-que-contribuye-a-las-alteraciones-de-la-creatina-quinasa-serica-y-a-la-metastasis-en-pacientes-con-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/657/una-nanoprobadora-de-absorcion-nir-ii-mejorada-con-sulfuro-de-estano-para-imagenologia-fotoacustica-y-terapia-quimiodinamica-aumentada-con-fototermia-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/646/inhibidores-de-la-quinolina-5-8-diona-cdc25-potentes-agentes-anticancerigenos-en-la-leucemia-y-en-los-organoides-de-cancer-colorrectal-derivados-de-pacientes 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/650/la-senalizacion-de-las-incretinas-en-la-interseccion-del-metabolismo-la-inflamacion-y-la-tumorigenesis-implicaciones-para-pacientes-con-obesidad 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/651/senales-de-seguridad-postmarketing-de-cetuximab-y-panitumumab-en-la-base-de-datos-faers-insights-del-mundo-real-enfocados-en-la-heterogeneidad-poblacional 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/830/conceptos-actuales-y-emergentes-para-el-tratamiento-sistemico-del-cancer-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/652/recientes-avances-clinicos-en-anticuerpos-no-conjugados-y-anticuerpos-drug-conjugados-para-el-tratamiento-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/564/klf5-promueve-la-proliferacion-tumoral-y-la-resistencia-al-oxaliplatino-a-traves-de-la-remodelacion-de-la-cromatina-en-el-cancer-colorrectal-con-mutaciones-en-kras 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/639/los-factores-mutacionales-que-influyen-en-la-respuesta-terapeutica-y-el-pronostico-de-pacientes-con-crc-de-etapa-iv-sometidos-a-reseccion-simultanea-del-lesion-primaria-y-metastasis-hepaticas-seguida 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/644/comp-promueve-la-progresion-del-cancer-colorrectal-al-reglar-la-transicion-epitelial-mesenquimal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/632/un-metanalisis-de-neoepitopios-validados-experimentalmente-patrones-sesgos-y-oportunidades 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/633/biologia-y-evolucion-del-tratamiento-de-los-canceres-resecables-con-dmmr-msi-h-estado-actual-y-perspectivas-futuras 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/634/analisis-del-papel-dependiente-del-contexto-de-mir-744-como-biomarcador-pronostico-diagnostico-y-terapeutico-en-diferentes-tipos-de-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/636/caracterizacion-proteogenomica-revela-vulnerabilidades-metabolicas-y-fosforilacion-anormal-en-metastasis-de-colon-recto-al-higado 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/637/biosensor-electroquimico-marcado-con-idarubicina-para-la-deteccion-de-celulas-tumorales-circulantes-en-pacientes-con-cancer-de-colon 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/638/carcinogenos-infecciosos-derivados-de-la-microflora-intestinal-mecanismos-de-transicion-microbiana-desde-eubiontes-hasta-patobiontes 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/640/los-factores-inducibles-por-hipoxia-promueven-la-downregulacion-mirna-medida-de-l2hgdh-y-hif1a-en-cancer-renal-de-celulas-claras-independiente-de-la-deletion-del-cromosoma-14q 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/685/kras-g12a-identifica-un-subconjunto-de-alto-riesgo-en-cancer-colorrectal-resecado-de-etapas-ii-iii 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/624/efecto-de-la-quimioterapia-en-las-mutaciones-pasajeras-en-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/627/epimutaciones-constitucionales-en-ltbp4-un-componente-de-la-senalizacion-de-tgf-y-en-brca1-como-posibles-factores-causantes-del-cancer-colorrectal-de-inicio-temprano 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/628/la-carga-mutacional-tumoral-modula-el-efecto-pronostico-de-las-mutaciones-de-ras-en-el-cancer-colorrectal-metastasico-aspectos-mecanisticos-y-correlaciones-genotipo-fenotipo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/629/asociacion-entre-los-biomarcadores-de-resistencia-a-la-insulina-y-el-pronostico-metastasico-en-pacientes-con-cancer-colorrectal-no-tratados-previamente-un-estudio-piloto 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/630/un-desglose-bioinformatico-multidimensional-de-los-mecanismos-moleculares-en-cancer-colorrectal-asociado-con-un-alto-imc-identificacion-y-validacion-de-egln1-como-un-objetivo-clave 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/631/diferencias-geneticas-entre-el-cancer-colorrectal-primario-y-sus-metastasis-sincronicas-y-metacronicas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/620/investigacion-de-la-galangina-contra-el-cancer-colorrectal-a-traves-de-la-modulacion-del-camino-de-senalizacion-mapk 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/621/las-proteinas-de-la-superfamilia-de-las-quinesinas-en-el-cancer-revelando-su-funcion-en-la-quimioterapia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1391/se-puede-omitir-la-quimiorradioterapia-neoadjuvante-en-cancer-rectal-medio-de-ct2n-y-ct3-protocolo-para-un-estudio-prospectivo-observacional-de-cohortes-cano 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/609/efectos-diferenciales-de-los-mutantes-del-dominio-g-y-la-region-hipervariable-de-kras-en-los-fenotipos-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/613/desde-la-deteccion-temprana-hasta-los-tratamientos-avanzados-como-el-adn-tumoral-circulante-esta-transformando-el-cuidado-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/615/analisis-integrativo-de-metilacion-y-transcriptomico-revela-genes-clave-que-relacionan-la-senescencia-celular-y-el-reprogramming-metabolico-en-metastasis-hepaticas-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/600/senales-de-imagen-subvisuales-como-biomarcadores-de-metastasis-pulmonares-imminentes-un-estudio-pan-cancer-multicentrico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/603/un-analisis-integrativo-de-datos-de-transcriptoma-metiloma-y-secuenciacion-de-arn-de-celulas-individuales-identifica-ube2h-como-marcador-de-resistencia-a-oxaliplatino-en-cancer-colorrectal 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/604/significado-clinico-patologico-de-la-expresion-de-akt-y-akt-fosforilado-en-el-carcinoma-hepatocelular-una-meta-analisis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/607/efecto-antitumoral-de-los-flavonoides-aislados-de-bidens-pilosa-l-mediante-la-regulacion-de-la-actividad-de-las-celulas-supresoras-derivadas-de-mieloides-dentro-del-microambiente-tumoral-en-ratones 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/517/distinguciones-genomicas-en-el-cancer-de-adolescentes-y-adultos-jovenes-una-revision-comprehensiva 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/518/avances-en-el-manejo-del-cancer-rectal-de-avanzada-local-un-cambio-hacia-un-enfoque-centrado-en-el-paciente-para-equilibrar-los-resultados-y-la-calidad-de-vida 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/10/vacuna-anfifila-dirigida-a-los-ganglios-linfaticos-y-especifica-para-mkras-en-cancer-de-pancreas-y-cancer-colorrectal-resultados-finales-del-ensayo-de-fase-1-amplify-201 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/534/la-microbiota-en-el-tratamiento-del-cancer-perspectivas-clinicas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/535/el-nuevo-papel-de-dusp4-en-la-supresion-de-la-ferropotesis-y-el-promovimiento-de-la-citotoxicidad-de-las-celulas-t-cd8-en-cancer-colorrectal-msi 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/797/deteccion-de-mutaciones-en-pik3ca-en-displasia-anal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/305/inhibidores-de-los-puntos-de-control-inmunitario-para-el-cancer-de-recto-localizado-con-dmmr-msi-una-revision-sistematica-de-las-estrategias-de-tratamiento 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/307/seleccion-y-caracterizacion-de-nuevos-aptameros-de-adn-dirigidos-a-celulas-de-cancer-colorrectal-con-potencial-maligno 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/312/prediccion-de-la-inestabilidad-de-microsatelites-en-cancer-colorrectal-basada-en-radiomica-un-enfoque-no-invasivo-para-la-estratificacion-del-tratamiento 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/569/el-papel-fundamental-de-sfrp2-en-la-promocion-de-la-glucolisis-y-la-progresion-en-el-grupo-de-alto-riesgo-segun-el-modelo-pronostico-de-metabolismo-de-los-glucanos-para-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/320/la-hipoxia-inducida-hif1a-compromete-la-sensibilidad-al-sorafenib-en-el-carcinoma-hepatocelular-a-traves-de-la-estabilizacion-mediada-por-nsun2-de-gdf15 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/579/evaluacion-de-los-efectos-de-fruquintinib-sobre-la-seguridad-cardiaca-en-pacientes-con-cancer-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/581/factores-predictivos-de-eficacia-de-ftd-tpi-mas-bevacizumab-en-pacientes-con-cancer-colorrectal-metastasico-refractario-un-subanalisis-del-grupo-espanol-del-ensayo-sunlight-de-fase-iii 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/582/contribucion-de-los-genotipos-del-grupo-de-complementacion-c-de-la-xeroderma-pigmentosa-al-cancer-colorrectal-en-taiwaneses 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/583/valor-predictivo-de-los-niveles-de-proteina-c-reactiva-pcr-posoperatorios-para-la-recurrencia-endoscopica-en-pacientes-con-enfermedad-de-crohn-sometidos-a-reseccion-ileocolica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/335/manejo-del-ccrc-tendencias-emergentes-en-la-deteccion-precoz-el-diagnostico-los-biomarcadores-el-tratamiento-y-la-prevencion 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/602/efecto-de-los-cambios-dinamicos-en-multiples-marcadores-sericos-tumorales-durante-el-tratamiento-neoadiuvante-en-el-resultado-clinico-del-cancer-gastrointestinal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/606/protocolo-del-estudio-astron-ogsg-2401-carboximaltosa-ferrica-para-la-anemia-por-deficiencia-de-hierro-en-pacientes-con-cancer-gastrointestinal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/865/progreso-en-la-investigacion-de-los-depredadores-proteicos-dirigidos-y-no-dirigidos-contra-kras-en-canceres-mutantes-de-kras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/610/impacto-de-las-mutaciones-en-los-genes-tp53-kras-y-apc-en-los-resultados-de-la-quimioterapia-neoadyuvante-en-el-cancer-colorrectal-localmente-avanzado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/623/puntuaciones-de-proliferacion-en-adenocarcinomas-de-sacos-anales-caninos-la-puntuacion-global-de-ki67-es-superior-a-los-indices-de-puntos-calientes-de-ki67-y-al-recuento-mitotico-para-el-pronostico 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/880/respuesta-patologica-completa-en-cancer-de-sigmoide-colonico-avanzado-localmente-difundido-msi-h-dmmr-tratado-con-pembrolizumab-y-reconstruccion-abdominal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/881/respuesta-notable-y-durable-a-la-pembrolizumab-en-cancer-rectal-de-estado-local-avanzado-dmmr-msi-h 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/391/identificacion-de-marcadores-del-microbioma-para-grupos-ordenados 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/142/una-nueva-estrategia-de-radioinmunoterapia-un-metabolito-de-la-microbiota-intestinal-combinado-con-un-hidrogel-radiactivo-para-el-tratamiento-del-cancer-de-recto-inferior 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/656/fusobacterium-nucleatum-en-salud-y-enfermedad 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/401/la-estabilizacion-de-ku70-80-mediada-por-usp10-inhibe-la-panoptosis-y-promueve-la-resistencia-quimica-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/662/inhibidores-pan-erbb-sinergizan-con-inhibidores-de-kras-en-cancer-rectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/686/avances-en-cancer-colorrectal-avanzado-mutante-de-kras-g12c-desde-mecanismos-hasta-la-practica-clinica 2026-08-24 monthly 0.5 https://crcwarriors.org/articulo/443/explorando-estrategias-novas-de-virus-oncoliticos-y-microbioma-intestinal-para-mejorar-la-terapia-de-celulas-t-car-para-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/964/macrofagos-car-con-regulacion-de-la-vida-util-derivados-de-progenitores-mieloides-para-mejorar-la-terapia-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/974/metastasis-peritoneales-del-cancer-colorrectal-tratadas-con-radioterapia-estereotactica-presentacion-de-un-caso-clinico-y-revision-de-la-literatura 2026-09-07 monthly 0.5 https://crcwarriors.org/articulo/983/eficacia-de-la-pembrolizumab-como-terapia-conversora-en-cancer-colorrectal-metastasico-hepatico-asociado-con-sindrome-de-lynch-y-deficit-de-reparacion-de-desajuste-microsatelites-inestables-altos-un 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/472/los-conjugados-de-anticuerpos-dna-nanoesestructuras-presentan-efectos-inhibidos-en-las-celulas-ct26-y-previenen-la-sobreexpresion-de-pd-1-en-el-microambiente-tumoral 2026-07-21 monthly 0.5 https://crcwarriors.org/articulo/997/sindrome-encefalopatico-reversible-posterior-serp-despues-de-la-administracion-de-fruquinib-en-un-paciente-hipertensivo-con-cancer-colorrectal-metastasico-un-reporte-de-caso-following-your-strict 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1005/prevencion-de-reacciones-recurrentes-por-infusion-de-cetuximab-dirigida-por-farmaceuticos 2026-05-26 monthly 0.5 https://crcwarriors.org/articulo/1007/una-mujer-mayor-con-metastasis-de-mamas-posoperatorias-del-cancer-de-colon-ascendente-tratadas-con-exito-con-pembrolizumab 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/501/un-estudio-de-fase-ii-multicentrico-de-eribulina-para-cancer-metastasico-de-colon-recto-con-mutacion-braf-v600e-el-estudio-bravery-epoc1701 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/505/la-lenta-adopcion-del-tratamiento-neoadiuvante-para-cancer-de-colon-clinico-t4b-un-analisis-de-la-base-de-datos-nacional-del-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/593/eficacia-de-la-inmunoterapia-en-tumores-gastrointestinales-gi-con-fenotipo-insolito-deficit-de-reparacion-de-desparejas-mmrd-un-estudio-del-mundo-real-de-ageo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/584/analisis-de-la-farmacocinetica-y-la-biodistribucion-preclinicas-de-oxalitex-un-profarmaco-de-oxaliplatino-basado-en-platino-iv-y-su-importancia-en-la-respuesta-antitumoral 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/585/perfiles-genomicos-de-alta-carga-mutacional-tumoral-en-cancer-colorrectal-estable-en-microsatelites-revelan-alteraciones-del-camino-de-senalizacion-mapk-despues-del-tratamiento-con-anti-egfr 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/587/actuabilidad-clinica-de-genes-en-tumores-gastrointestinales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/588/terapia-inmunomodular-neoadyuvante-para-el-cancer-colorrectal-predictores-clinicos-y-moleculares-de-respuesta-patologica-completa-y-evaluacion-de-seguridad 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/589/la-sobreexpresion-negativa-de-fusion-de-ntrk-tiene-relevancia-biologica-en-el-cancer-colorrectal-implicaciones-para-la-prediccion-de-respuestas-a-inhibidores-de-quinasas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/590/sintesis-evaluaciones-anticancerosas-in-vitro-e-in-silico-de-hibridos-novos-de-estileno-1-3-4-oxadiazol-sulfonamida-para-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/591/prueba-clinica-de-fase-1-del-inhibidor-de-la-ataxia-telangiectasia-y-rad3-relacionado-berzosertib-con-irinotecan-en-pacientes-con-tumores-solidos-avanzados-etctn-9938 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/592/descubrimiento-de-inhibidores-de-la-fosfatasa-promotora-de-cancer-prl-3-y-su-evaluacion-en-organoides-intestinales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/625/diseno-y-sintesis-basados-en-la-estructura-de-nuevos-inhibidores-altamente-potentes-y-selectivos-para-krasg12c 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/586/la-hipoalbuminemia-basal-aumenta-el-desarrollo-de-fatiga-severa-inducida-por-regorafenib-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-metastasico-en-la-practica-clinica 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/576/consenso-de-expertos-sobre-la-terapia-neoadyuvante-con-radioterapia-de-corta-duracion-seguida-de-quimioterapia-combinada-con-inmunoterapia-para-pacientes-con-cancer-colorrectal-localmente-avanzado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/575/importancia-pronostica-de-la-expresion-de-cd47-en-la-supervivencia-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/565/imagenes-de-tarjeta-completa-tinte-h-e-1020-con-supervivencia-y-marcadores-geneticos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/567/zanzalintinib-mas-atezolizumab-frente-a-regorafenib-en-el-cancer-colorrectal-refractario-stellar-303-un-ensayo-aleatorizado-de-etiqueta-abierta-de-fase-3 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/570/establecimiento-de-un-modelo-de-puntuacion-de-riesgo-clinico-para-pacientes-sometidos-a-reseccion-quirurgica-con-fines-curativos-de-metastasis-pulmonares-procedentes-de-cancer-colorrectal-basado-en 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/556/asociacion-de-la-capacidad-antioxidante-total-dietetica-con-la-mutacion-del-gen-kras-en-pacientes-con-cancer-colorrectal-metastasico-un-estudio-caso-control 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/557/mutaciones-de-kras-y-nras-en-cohortes-basados-en-la-poblacion-nordica-y-del-mundo-real-de-cancer-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/558/cgref1-promueve-la-migracion-de-celulas-cancerosas-y-predice-un-mal-pronostico-en-el-cancer-colorrectal 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/559/macrofagos-spp1-alto-inducen-estres-en-celulas-t-que-promueve-metastasis-hepatica-de-cancer-de-colon-a-traves-de-la-senalizacion-spp1-cd44-pi3k-akt 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/560/la-caracterizacion-de-tumores-colorrectales-tejido-saludable-adyacente-y-organoides-emparejados-mediante-multiomica-a-nivel-de-celula-individual-identifica-caracteristicas-unicas-del-crc 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/561/diseno-y-hallazgos-iniciales-de-un-estudio-de-historia-natural-del-hpv-anogenital-y-lesiones-asociadas-entre-mujeres-jovenes-en-costa-rica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/562/quimioterapia-que-contiene-ramucirumab-para-pacientes-con-carcinomas-neuroendocrinos-gastrointestinales-refractarios-intolerantes-a-la-quimioterapia-basada-en-platino-un-estudio-observacional 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/555/terapia-celular-inmunologica-de-nkg2d-car-nk-combinada-con-o-sin-bloqueo-de-pd-1-en-el-tratamiento-de-pacientes-con-cancer-colorrectal-metastasico-un-estudio-exploratorio 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/548/modelo-predictivo-basado-en-imagenologia-por-resonancia-magnetica-multiparametrica-para-la-respuesta-a-la-quimioterapia-en-pacientes-con-cancer-colorrectal-y-mutaciones-geneticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/551/crls1-influye-en-la-metastasis-hepatica-en-el-cancer-colorrectal-regulando-los-caminos-metabolicos-de-las-lipidos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/552/inmunoterapia-neoadyuvante-en-canceres-de-colon-con-reparacion-del-desajuste-funcional 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/554/cambio-en-la-microbiota-y-metabolitos-del-intestino-en-cancer-colorrectal-metastasico-mediante-16s-rrna-y-metabolomica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/546/mecanismos-duales-dependientes-de-keap1-de-la-pubescenosida-a-contra-la-colitis-ulcerosa-promueve-la-ubiquitinacion-y-degradacion-de-ddx5-y-la-translocacion-nuclear-de-nrf2-para-suprimir-la 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/547/bacterias-ingenierizadas-duales-respuesta-con-liberacion-espaciotemporal-de-citolisina-a-para-el-manejo-oral-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/549/examinando-los-patrones-de-tratamiento-y-resultados-en-pacientes-asiatico-americanos-nativo-hawaiano-y-del-pacifico-en-cancer-colorrectal-2007-2020 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/543/un-marco-de-metal-organico-inspirado-clinicamente-basado-en-olsalazina-permite-una-plataforma-universal-de-nanomedicamentos-para-enfermedades-diversas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/544/nutricion-ambiente-y-genetica-en-el-cancer-colorrectal-epigenetica-y-posible-perspectiva-futura 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/540/el-grado-de-diferenciacion-celular-presenta-una-alta-concordancia-entre-los-tumores-primarios-y-las-metastasis-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/450/la-plasticidad-metabolica-impulsa-mecanismos-especificos-de-resistencia-a-la-quimioterapia-y-a-la-terapia-dirigida-en-el-cancer-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/528/la-topografia-genomica-de-los-canceres-de-apendice-nuestro-conocimiento-actual-perspectivas-clinicas-y-futuras-direcciones 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/530/un-sistema-de-puntuacion-basado-en-el-aprendizaje-automatico-para-identificar-tumores-con-estabilidad-de-microsatelites-y-alta-inmunoactividad-mediante-la-cuantificacion-de-la-similitud-con-tumores 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/531/spp1-como-posible-marcador-especifico-de-la-etapa-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/533/huellas-geneticas-especificas-de-cepa-de-bacteroides-fragilis-enterotoxigenico-etbf-revelan-que-bft-2-es-un-candidato-biomarcador-para-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/536/dirigirse-al-metabolismo-y-la-senalizacion-lipidica-mediados-por-fads1-una-nueva-estrategia-terapeutica-para-la-oncologia-de-precision-en-los-canceres-colorrectal-y-esofagico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/537/consenso-delphi-de-2025-sobre-la-rectopexia-ventral-robotica-con-malla 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/539/correccion-canceres-colorrectales-con-componente-de-adenoma-residual-caracteristicas-clinico-patologicas-y-mutacion-en-kras 2026-04-02 monthly 0.5 https://crcwarriors.org/articulo/527/puntaje-de-trampas-extracelulares-de-neutrofilos-nets-un-nuevo-marcador-pronostico-para-pacientes-con-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/529/la-correccion-del-sesgo-gc-genomico-mejora-la-estimacion-de-la-abundancia-de-especies-a-partir-de-datos-metagenomicos 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/522/tratamiento-neoadyuvante-de-ibi310-mas-sintilimab-en-cancer-colorrectal-avanzado-localmente-msi-h-dmmr-un-estudio-fase-1b-aleatorizado 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/523/los-organoides-derivados-de-pacientes-pdos-como-una-plataforma-prometedora-para-el-tratamiento-personalizado-del-cancer-colorrectal-aplicaciones-actuales-y-desafios-futuros 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/524/analisis-del-panorama-mundial-de-la-investigacion-sobre-el-microambiente-tumoral-inflamatorio-en-la-patogenia-y-el-pronostico-del-cancer-colorrectal-desde-principios-de-este-siglo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/566/avances-en-el-uso-de-inhibidores-de-puntos-de-control-inmunitario-para-el-tratamiento-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/516/retos-diagnosticos-en-las-lesiones-serradas-sesiles-progresion-a-adenocarcinoma-en-un-paciente-de-alto-riesgo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/519/desarrollo-de-un-biosensor-basado-en-aptameros-y-crispr-cas12a-para-la-deteccion-de-fusobacterium-nucleatum-en-la-screening-no-invasiva-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/520/inhibicion-de-la-glicolisis-restaura-la-sensibilidad-inmune-en-cancer-colorrectal-deficientemente-en-gsnor 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/525/clasificacion-basada-en-aprendizaje-profundo-de-cancer-colorrectal-en-imagenes-de-histopatologia-para-la-deteccion-de-categorias 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/538/asociaciones-longitudinales-de-la-composicion-corporal-con-problemas-del-sueno-en-los-primeros-dos-anos-despues-del-tratamiento-del-cancer-colorrectal 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/513/utilizando-las-interacciones-gen-ambiente-para-explorar-las-vias-del-riesgo-de-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/512/circpfkp-orquesta-una-red-de-arn-exogenamente-competitiva-para-reglar-la-senalizacion-spry4-p38-mapk-y-modular-la-agresividad-del-carcinoma-papilar-de-tiroides 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/599/infeccion-infrecuente-por-vph-en-carcinoma-neuroendocrino-colorrectal-caracteristicas-moleculares-y-histologicas 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/507/diseno-sintesis-y-evaluacion-biologica-de-derivados-de-la-arctigenina-como-inhibidores-novos-del-gpx4-en-celulas-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/508/identificacion-de-derivados-de-pirazolo-piperidinona-que-se-dirigen-a-la-interfaz-3-de-yap-tead-como-agentes-anticancerigenos-mediante-el-uso-integrado-de-cribado-virtual-y-proteomica-por 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/510/la-carga-global-regional-y-nacional-del-cancer-1990-2023-con-pronosticos-hasta-2050-un-analisis-sistematico-para-el-estudio-global-de-carga-de-enfermedades-2023 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/511/desde-la-adiccion-lisosomica-hasta-los-tratamientos-dirigidos-explotando-nuevas-ventanas-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/85/analisis-de-fusiones-genicas-con-potencial-terapeutico-en-una-amplia-cohorte-de-pacientes-chinos-con-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/499/chispa-oculta-del-frio-al-caliente-en-cancer-colorrectal-braf 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/500/exploracion-de-los-mecanismos-de-weifuchun-en-el-cancer-colorrectal-identificacion-basada-en-farmacologia-de-redes-y-validacion-experimental-de-las-principales-vias-de-senalizacion 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/502/los-microplasticos-como-posibles-carcinogenos-emergentes-desde-contaminantes-ambientales-hasta-factores-oncogenicos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/504/efectividad-y-mecanismos-de-la-curcumina-para-el-cancer-colorrectal-en-modelos-preclinicos-una-revision-sistematica-y-meta-analisis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/292/definir-un-buen-pronostico-de-mutaciones-del-codon-659-de-rnf43-y-firmas-genomicas-concurrentes-en-crc-un-analisis-de-la-base-de-datos-de-cbioportal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/498/reduccion-de-las-fugas-anastomoticas-mediante-la-reseccion-laparoscopica-con-fluorescencia-en-el-cancer-rectal-ultra-bajo-un-analisis-de-concordancia-de-propensiones-con-estratificacion-del-imc 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/489/avances-en-biomarcadores-de-resistencia-a-inhibidores-dirigidos-a-la-mutacion-de-kras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/491/la-sobresaturacion-combinada-de-light-y-la-inhibicion-del-punto-de-control-altera-el-entorno-inmunitario-tumoral-afectando-las-metastasis-hepaticas-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/493/inmunometabologia-interaccion-con-la-metabolismo-tumoral-y-implicaciones-para-la-inmunoterapia-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/494/revisitar-desafios-en-el-mundo-real-con-video-colonscopia-utilizando-un-transformador-de-deteccion-de-polipos-dos-flujo-end-to-end-ts-pdtr 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/495/seguridad-de-la-diseccion-endoscopica-submucosa-de-lesiones-colonicas-sin-sedacion-un-estudio-retrospectivo-de-un-solo-centro 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/496/pronostico-en-el-cancer-colorrectal-en-estadio-ii-efecto-de-la-localizacion-del-tumor-primario-y-los-biomarcadores-un-estudio-de-cohortes-retrospectivo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/487/mejora-cronologica-de-la-supervivencia-con-el-tiempo-con-quimioterapia-basada-en-oxaliplatino-y-agentes-dirigidos-en-cancer-colorrectal-metastasico-un-estudio-de-la-base-de-datos-arcad 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/488/infeccion-por-helicobacter-pylori-firma-metabolomica-y-riesgo-de-cancer-extragastrico-un-analisis-de-mediacion-y-aleatorizacion-mendeliana 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/473/interaccion-entre-el-tejido-adiposo-y-el-tumor-en-el-cancer-colorrectal-identificacion-de-biomarcadores-epi-geneticos-para-la-progresion-tumoral-y-la-caquexia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/476/la-inflamacion-y-la-carga-mutacional-asociadas-diferencialmente-con-la-eficacia-de-la-combinacion-de-nivolumab-o-ipilimumab-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/477/spp1-impulsa-la-metastasis-hepatica-del-cancer-colorrectal-y-la-resistencia-a-la-inmunoterapia-al-estimular-la-produccion-de-cxcl12-en-los-fibroblastos-asociados-al-tumor 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/478/eficacia-de-la-terapia-prag-en-el-cancer-colorrectal-metastasico-con-estabilidad-en-los-microsatelites-un-analisis-comparativo-de-las-terapias-combinadas-basadas-en-inhibidores-de-pd-1-pd-l1 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/479/diversidad-genomica-y-estado-mutacional-de-bcl9l-en-celulas-tumorales-circulantes-predice-la-supervivencia-global-en-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/480/decifrar-la-reprogramacion-metabolica-de-celulas-inmunes-dentro-del-microentorno-tumoral 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/481/la-perdida-de-huwe1-favorece-la-capacidad-de-autorrenovacion-y-la-resistencia-a-los-farmacos-en-el-ccrc-con-un-complejo-de-destruccion-de-catenina-desregulado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/482/fbxo44-regula-la-degradacion-de-foxp1-a-traves-de-fosforilacion-dependiente-de-aurka-para-promover-el-progreso-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/483/deteccion-ultrasensible-de-mirna-21-mediante-ensamblaje-catalitico-de-cabello-mejorado-con-quimioluminiscencia-iniciada-por-luz-para-el-diagnostico-temprano-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/466/mnda-promueve-la-inmunosupresion-en-el-cancer-colorrectal-con-alta-inestabilidad-de-microsatelites-al-facilitar-la-infiltracion-de-pmn-mdsc-mediante-la-lactilacion-de-h3k18 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/467/celulas-tumorales-circulantes-mecanismos-y-significado-clinico-en-la-metastasis-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/468/precision-y-reproducibilidad-de-las-mediciones-realizadas-por-modelos-de-lenguaje-de-gran-tamano-en-metastasis-hepaticas-comparacion-con-las-mediciones-realizadas-por-radiologos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/469/despiece-completo-de-organoides-de-cancer-rectal-en-respuesta-a-quimiorradioterapia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/471/nanovesiculas-de-membrana-bacteriana-disenadas-para-establecer-una-simbiosis-con-el-tumor-permiten-una-inmunoterapia-y-quimioterapia-precisas-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/465/el-secuenciamiento-2brad-m-revela-diferencias-en-la-microbiota-del-suero-del-tumor-y-del-tejido-paraneoplasico-en-pacientes-con-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/464/eficacia-y-seguridad-de-glecirasib-en-tumores-solidos-con-mutacion-kras-g12c-un-analisis-conjunto-de-dos-ensayos-fase-i-ii 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/459/actividad-fisica-y-subtipos-moleculares-del-cancer-colorrectal-un-analisis-observacional-combinado-y-un-estudio-de-aleatorizacion-mendeliana 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/462/el-microambiente-tumoral-inmunitario-espacial-como-biomarcador-pronostico-y-predictivo-en-el-tratamiento-de-mantenimiento-basado-en-anti-egfr-para-el-cancer-colorrectal-metastasico-ras-wt-el-ensayo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/514/modelizacion-y-optimizacion-de-estrategias-terapeuticas-combinadas-para-cancer-pulmonar-mutante-de-kras-y-egfr 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/515/la-distribucion-subcelular-de-la-proteina-y-box-binding-1-fosforilada-en-s102-en-pacientes-con-cancer-colorrectal-estratificada-segun-el-estado-mutacional-de-kras-y-las-caracteristicas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/4/perfiles-de-mutaciones-de-kras-y-braf-en-tumores-primarios-y-celulas-tumorales-circulantes-en-pacientes-con-cancer-colorrectal-utilizando-el-interruptor-molecular-pna-lna 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/9/dirigirse-a-kras-mutado-mediante-un-car-y-un-activador-bispecifico-de-celulas-t-que-imitan-el-tcr-y-estan-restringidos-por-hla-a-02-01 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/49/efecto-del-microbioma-intestinal-en-la-eficacia-de-la-radioterapia-e-inmunoterapia-en-cancer-colorrectal-estable-en-microsatelites-papel-del-acido-propionico-y-b-fragilis 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/572/investigando-diferencias-genomicas-por-etnicidad-en-canceres-de-mama-colorrectal-y-prostata-analisis-secundario-de-los-datos-del-genomic-data-commons-gdc 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/318/desde-los-fundamentos-hasta-la-clinica-nuevas-oportunidades-para-la-metformina-en-la-intervencion-metabolica-y-el-tratamiento-del-tumor 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/63/incidencia-demografia-y-supervivencia-de-pacientes-con-metastasis-cerebrales-de-cancer-colorrectal-en-etapa-iv-un-estudio-basado-en-la-poblacion-de-2013-a-2023 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/329/son-secciones-mas-profundas-e-inmunohistoquimica-utiles-para-detectar-micrometastasis-y-celulas-tumorales-aisladas-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/82/expresion-de-la-proteina-ntrk-en-el-nsclc-y-su-correlacion-clinico-patologica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/612/bloqueo-neoadyuvante-de-pd-1-con-toripalimab-con-o-sin-celecoxib-en-pacientes-con-cancer-colorrectal-localmente-avanzado-deficiente-en-reparacion-de-desajustes-o-con-inestabilidad-de-microsatelites 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/359/el-papel-de-la-glicosilacion-proteica-en-el-cancer-colorrectal-de-los-caminos-moleculares-a-las-aplicaciones-clinicas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/360/diferencias-segun-el-sexo-en-la-supervivencia-tras-el-trasplante-hepatico-para-metastasis-hepaticas-de-cancer-colorrectal-un-analisis-multivariable 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/367/nuevas-estrategias-para-mejorar-la-eficacia-de-los-inhibidores-de-pd-1-pd-l1-en-el-tratamiento-del-cancer-colorrectal-estable-en-microsatelites 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/883/un-caso-de-respuesta-completa-patologica-posterior-al-tratamiento-con-pembrolizumab-para-metastasis-hepaticas-recurrentes-de-un-cancer-de-colon-ascendente 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/126/firma-genica-del-cromosoma-20q-asociada-con-la-progresion-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/128/crabp2-promueve-la-metastasis-peritoneal-en-el-ccrc-a-traves-de-la-senalizacion-de-la-emt-mediada-por-tgf-smad-y-la-formacion-de-invadopodios 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/384/identificacion-mediante-aprendizaje-profundo-de-la-combinacion-de-scube2-y-slc16a5-en-datos-de-secuenciacion-de-arn-como-un-nuevo-biomarcador-diagnostico-potencial-especifico-para-el-cancer-de 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/397/biopsia-liquida-de-celulas-tumorales-circulantes-desde-la-isolacion-enriquecimiento-y-secuenciacion-del-genoma-hasta-las-aplicaciones-clinicas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/143/factor-inhibidor-de-la-migracion-de-macrofagos-exploracion-de-sus-funciones-fisiologicas-y-comparacion-de-sus-beneficios-para-la-salud-frente-a-los-riesgos-oncogenicos-y-autoinmunes-revision 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/404/la-anoikis-y-la-netosis-en-la-metastasis-hepatica-de-cancer-colorrectal-la-relacion-y-perspectivas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/407/regulacion-multidimensional-del-eje-de-senalizacion-microbio-tlr4-en-el-cancer-colorrectal-desde-los-mecanismos-moleculares-hasta-las-terapias-dirigidas-a-los-microbios 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/410/un-modelo-basado-en-segmentacion-de-interaccion-jerarquica-de-caracteristicas-con-atencion-para-la-identificacion-del-estado-de-mutaciones-geneticas-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/414/evaluacion-de-la-utilidad-diagnostica-de-68ga-ga-pentixafor-en-tumores-solidos-una-revision-sistematica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/415/mejora-de-la-estratificacion-del-riesgo-en-el-cancer-colorrectal-en-estadio-ii-mediante-un-clasificador-de-tomografia-computarizada-basado-en-aprendizaje-profundo-y-marcadores-patologicos-para 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/418/firmas-mutacionales-en-adenocarcinomas-apendicectomia-potencial-para-la-personalizacion-futura-en-quimioterapia-hipertermica-intraperitoneal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/423/terapia-con-polimerosomas-dirigida-al-receptor-de-transferrina-1-para-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/424/el-impacto-de-la-mutacion-ras-braf-en-la-respuesta-patologica-completa-despues-del-tratamiento-neoadyuvante-total-en-cancer-rectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/428/predicciones-genomicas-y-clinicas-de-conversion-en-metastasis-hepaticas-de-cancer-colorrectal-inicialmente-irresecables 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/429/el-adn-tumoral-circulante-como-un-nuevo-biomarcador-pronostico-de-la-eficacia-terapeutica-en-pacientes-con-metastasis-hepaticas-irresecables-de-cancer-colorrectal-tratados-con-infusion-intraarterial 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/430/el-gen-reloj-arntl2-aumenta-la-resistencia-al-5-fluorouracilo-en-el-cancer-de-colon-al-regular-al-alza-slc7a11-y-suprimir-la-ferroptosis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/432/factores-profibrinoliticos-y-la-progresion-del-cancer-la-metastasis-y-la-supervivencia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/444/la-metioninasa-recombinante-elimina-selectivamente-las-celulas-cancerosas-co-cultivadas-con-fibroblastos-normales-indicando-la-alta-precision-de-la-eficacia-del-objetivo-adiccion-a-la-metionina-en-el 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/445/prevalecia-de-variantes-monoalelicas-de-mutyh-en-pacientes-con-cancer-hereditario-utilizando-pruebas-de-panel-multigenico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/451/el-patron-de-crecimiento-de-las-metastasis-hepaticas-de-cancer-colorrectal-no-depende-del-genotipo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/455/inestabilidad-de-microsatelites-y-su-impacto-en-los-perfiles-nutricionales-e-inflamatorios-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/457/genisteina-y-canceres-gastrointestinales-una-revision-comprehensiva-de-estudios-recientes-y-perspectivas-futuras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/969/los-marcados-efectos-citotoxicos-de-las-celulas-t-con-receptores-quimericos-de-antigenos-que-se-dirigen-a-b7-h3-en-organoides-y-xenoinjertos-hepaticos-derivados-de-pacientes-con-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/970/reprogramacion-del-microambiente-tumoral-mediante-la-inhibicion-de-la-citidina-desaminasa-en-tumores-de-adenocarcinoma-ductal-pancreatico-implicaciones-para-el-papel-de-los-receptores-p2y-6 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/461/la-nanoclusterizacion-y-senalamiento-de-kras-g12c-y-kras-g12d-responden-a-la-remodelacion-de-las-cadenas-acilicas-de-lipidos-de-manera-especifica-por-alelo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/485/las-micobiomas-de-enfermedades-inflamatorias-comparten-una-patogenicidad-funcional-predicha-por-la-proteina-c-reactiva 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/235/el-analisis-de-composicion-corporal-impulsado-por-inteligencia-artificial-mejora-la-prediccion-de-toxicidad-quimica-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/497/un-estudio-de-mundo-real-sobre-la-expresion-y-aplicacion-clinica-de-la-inmunohistoquimica-de-imp3-en-tumores-oseos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/503/el-polimorfismo-de-pnpla3-agrava-la-lesion-hepatica-asociada-a-la-quimioterapia-y-afecta-a-la-supervivencia-global-en-pacientes-con-cancer-colorrectal-con-metastasis-hepaticas-sometidos-a-reseccion 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/506/causas-de-muerte-en-individuos-con-sindrome-de-lynch-en-la-epoca-de-la-inmunoterapia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/253/el-triptonide-estabiliza-bim-para-potenciar-la-ferroptosis-y-la-apoptosis-inducidas-por-oxaliplatino-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/297/es-factible-la-inmunoterapia-neoadiuvante-para-pacientes-con-cancer-colorrectal-de-avanzada-localizada-dmmr-msi-h-un-estudio-retrospectivo 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/447/comparacion-metodologica-de-los-metodos-de-secuenciacion-de-lecturas-cortas-y-de-lecturas-largas-en-muestras-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/436/perfiles-clinicos-y-moleculares-del-cancer-colorrectal-un-estudio-de-cohorte-comprehensivo-de-casos-mutados-en-braf-de-un-centro-terciario 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/437/dissociacion-entre-la-respuesta-tumoral-y-la-progresion-de-la-tmpt-durante-el-tratamiento-con-entrectinib-en-cancer-colorectal-fusion-positivo-ntrk 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/440/exploracion-de-marcadores-biosanguineos-efectivos-y-celulas-inmunes-infiltrantes-en-cancer-colorrectal-metastasico-basado-en-el-analisis-bioinformatico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/442/un-anticuerpo-anti-pd-1-sct-i10a-mas-un-anticuerpo-anti-egfr-sct200-y-quimioterapia-para-cancer-colorrectal-metastasico-de-tipo-ras-braf-wt-un-estudio-fase-ib 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/448/la-microbiota-intestinal-como-un-modulador-oculto-de-la-quimioterapia-implicaciones-para-el-tratamiento-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/426/fitoestrogenos-y-sus-analogos-sinteticos-como-inhibidores-mimetizadores-del-sustrato-de-la-cyp1b1-una-actualizacion-2020-2025 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/427/conjugado-de-ibuprofeno-e-irinotecan-de-doble-accion-y-autoensamblado-para-la-terapia-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/420/resultados-de-supervivencia-de-pacientes-con-oligometastasis-resecables-extrahepaticas-de-cancer-colorrectal-mutante-braf-v600e-despues-de-metastectomia-paliativa 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/413/seleccion-e-identificacion-de-un-nuevo-aptamo-de-adn-para-reconocer-celulas-madre-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/405/la-aceptacion-de-la-automatizacion-refinando-la-enumeracion-de-celulas-tumorales-circulantes-para-un-mejor-pronostico-del-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/406/sunrise-crc-un-estudio-aleatorizado-de-fase-ii-que-compara-sunitinib-a-dosis-altas-administrado-de-forma-intermitente-con-trifluridina-tipiracil-en-el-carcinoma-colorrectal-metastasico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/408/la-fructosa-y-la-glucosa-presentes-en-las-bebidas-azucaradas-favorecen-la-metastasis-del-cancer-colorrectal-a-traves-de-la-via-sord 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/409/capacidades-de-procesamiento-de-modelos-de-lenguaje-extensos-de-chatgpt-4-0-para-generar-recomendaciones-de-la-junta-multidisciplinar-de-tumores-moleculares-una-evaluacion-critica-basada-en-datos-del 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/449/revision-de-comentarios-sobre-el-tratamiento-del-cancer-colorrectal 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/96/asociacion-entre-caracteristicas-genomicas-y-acumulacion-de-metales-teluro-toxicos-en-cancer-colorrectal-izquierdo-y-derecho 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/385/analisis-multi-cancerico-de-la-pantalla-de-msi-histoquimica-basada-en-imagenes-digitales-de-histologia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/400/un-estudio-retrospectivo-de-inhibidores-de-braf-y-egfr-combinados-con-inhibidores-de-puntos-de-control-inmune-en-pacientes-con-cancer-colorrectal-metastasico-estable-en-microsatelites-mutado-en-braf 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/396/aspirina-en-dosis-bajas-para-el-cancer-colorrectal-localizado-con-alteraciones-en-pi3k 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/398/terapia-de-car-dirigida-a-sialil-tn-abarca-carcinomas-solidos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/411/la-mutacion-kras-g12d-impulsa-el-tromboembolismo-venoso-tev-y-la-progresion-del-cancer-colorrectal-a-traves-de-la-senalizacion-mapk-erk 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/388/de-pronostico-pobre-a-promesa-de-precision-ensayos-clinicos-dirigidos-al-cancer-colorrectal-metastasico-mutante-de-braf 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/389/combinando-dinamica-molecular-y-aprendizaje-automatico-para-predecir-variantes-causantes-de-resistencia-a-los-farmacos-del-braf-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/392/terapias-inmunologicas-basadas-en-celulas-nk-para-el-cancer-colorrectal-estrategias-actuales-desafios-y-perspectivas-futuras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/27/impacto-clinico-de-las-estrategias-terapeuticas-de-primera-linea-en-cancer-colorrectal-metastasico-mutante-braf-v600e-evidencia-del-mundo-real-y-perspectiva-pronostica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/386/imprecision-y-sesgo-en-la-estimacion-endoscopica-del-tamano-de-polipos-colorrectales-grandes-datos-obtenidos-de-un-estudio-de-cohorte-prospectivo-de-1828-resecciones-en-bloque 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/379/el-tratamiento-con-magnesio-aumenta-la-sintesis-de-vitamina-d-por-la-microbiota-intestinal-e-inhibe-el-cancer-colorrectal-resultados-de-un-ensayo-aleatorizado-doble-ciego-controlado-con-placebo-y 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/374/un-estudio-molecular-y-clinico-comprehensivo-de-pacientes-con-cancer-colorrectal-de-onset-joven 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/375/potencial-de-seleccionados-quimiocinas-con-motivo-c-x-c-como-biomarcadores-en-el-diagnostico-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/381/personalizacion-del-tratamiento-del-cancer-colorrectal-prueba-de-farmacos-antineoplasicos-con-conglomerados-de-celulas-tumorales-derivadas-del-paciente 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/368/el-analisis-del-transcriptoma-a-nivel-de-celula-unica-revela-programas-reguladores-asociados-con-la-resistencia-tumoral-durante-la-inmunoterapia-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/370/la-administracion-espacial-y-temporal-de-hidrogeno-impulsada-por-un-nanobiocatalizador-induce-la-dormancia-y-potencia-la-terapia-tumoral-catalitica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/354/utilidad-clinica-de-la-prueba-de-perfilacion-genomica-comprehensiva-para-cancer-colorrectal-un-estudio-observacional-prospectivo-en-una-sola-institucion 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/355/loh-alelo-especifico-hla-en-tumores-solidos-patrones-distintos-segun-el-tipo-de-tumor-y-relevancia-pronostica-potencial 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/356/impacto-de-las-alteraciones-en-la-reparacion-del-dano-del-adn-en-la-respuesta-al-tratamiento-en-el-cancer-colorrectal-metastasico-en-la-practica-clinica 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/357/avances-en-la-comprension-de-los-mecanismos-y-las-innovaciones-nanomedicinales-de-las-proantocianidinas-oligomericas-en-la-oncologia-de-precision-ablacion-de-la-capacidad-de-autorrenovacion-de-las 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/358/carreadores-nano-del-siguiente-generacion-para-el-cancer-colorrectal-estrategias-pasivas-activas-y-en-respuesta-a-estimulos-para-la-terapia-de-precision 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/349/validad-clinica-de-foundationone-liquid-cdx-para-la-deteccion-de-brafv600e-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/350/montaje-de-nanestructuras-programables-de-un-derivado-de-paclitaxel-permite-una-terapia-anticancerosa-ajustable-a-traves-de-la-ingenieria-de-enlaces-de-hidrogeno 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/351/plataforma-de-biopsia-liquida-para-el-cancer-avanzado-para-la-deteccion-de-microarn-en-vesiculas-extracelulares-mediante-crispr-cas13a-y-nanoarrays-de-oro 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/352/alistipes-finegoldii-potencia-la-eficacia-de-la-inmunoterapia-contra-tumores-solidos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/394/valor-pan-inmunoinflamatorio-piv-y-indice-nutricional-pronostico-pni-estan-asociados-con-metastasis-distantes-en-cancer-colorrectal-con-mutacion-kras-pero-no-en-aquellos-con-tipo-wild-de-kras 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/339/la-imagen-optica-de-redox-con-deteccion-de-vanguardia-en-campo-amplio-permite-evaluar-la-respuesta-al-tratamiento-y-la-heterogeneidad-en-organoides-derivados-de-tumores-de-pacientes 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/343/catalisis-de-atomo-unico-p-dopado-en-cu-n-c-para-aumentar-la-electroluminiscencia-catodica-de-luminol-en-la-deteccion-de-microrna-320d 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/344/una-aproximacion-de-aprendizaje-profundo-para-el-seguimiento-de-vesiculas-exocromicas-derivadas-de-cancer-colorrectal-en-modelos-de-colon-y-pulmon 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/345/fabricacion-de-marcos-metrologicos-organicos-embutidos-con-streptavidina-para-la-deteccion-no-invasiva-del-gen-de-la-infeccion-por-helicobacter-pylori 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/340/el-aprendizaje-basado-en-cnn-de-transcriptomas-de-celulas-individuales-revela-una-firma-multisincrotica-detectable-en-sangre-del-metastasis-cerebral 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/341/activacion-del-mejorador-a-partir-de-elementos-transponibles-en-adn-extracromosomico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/333/enfermedad-renal-cronica-y-riesgo-de-cancer-incidente-un-metaanalisis-de-datos-individuales-de-participantes 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/334/riesgos-para-la-salud-del-consumo-de-carne-procesada-vias-y-soluciones-dieteticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/336/un-dispositivo-microfluidico-de-multiples-canales-impreso-en-3d-para-la-regulacion-precisa-del-oxigeno-disuelto-en-la-investigacion-sobre-hipoxia-en-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/330/diabetes-y-el-riesgo-y-la-supervivencia-del-cancer-colorrectal-de-acuerdo-con-el-estado-de-inmunidad-tumoral 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/331/insight-comparativo-registros-de-cancer-colorrectal-hereditario-en-iran-singapur-y-sudafrica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/332/tuberia-de-aprendizaje-automatico-con-busqueda-en-cuadricula-personalizada-para-datos-de-espectroscopia-raman-colo-rectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/342/resultados-de-una-campana-de-cribado-francesa-comparando-las-caracteristicas-clinicas-y-moleculares-de-los-canceres-colorrectales-de-intervalo-con-los-canceres-detectados-mediante-una-prueba-galica 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/322/la-combinacion-de-quimioterapia-por-infusion-arterial-hepatica-y-un-inhibidor-del-punto-de-control-inmune-pd1-mejora-la-supervivencia-en-pacientes-con-metastasis-hepaticas-irresecables-de-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/325/validacion-clinica-de-lb-recist-en-pacientes-con-cancer-colorrectal-metastasico-mcrc-hallazgos-del-estudio-platform-b 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/490/mutaciones-de-kras-y-nras-en-relacion-con-el-estado-microsatelite-en-cancer-colorrectal-un-estudio-de-un-solo-centro-de-rumania 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/321/variantes-geneticas-vinculadas-a-la-diabetes-tipo-2-en-cdkn1b-y-tcf7l2-influyen-en-los-resultados-de-supervivencia-en-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/310/correlatos-genomicos-de-metastasis-cerebral-y-progresion-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/315/cumplimiento-de-las-directrices-de-la-fundacion-mundial-para-la-investigacion-del-cancer-instituto-americano-para-la-investigacion-del-cancer-y-la-mortalidad-entre-los-participantes-con-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/316/el-papel-de-las-neoantigenos-y-la-carga-mutacional-tumoral-en-la-inmunoterapia-del-cancer-avances-mecanismos-y-perspectivas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/317/slc38a4-como-marcador-pronostico-y-correlacionado-con-la-infiltracion-inmune-en-metastasis-hepaticas-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/309/terapia-de-radiacion-interna-selectiva-con-itrio-90-para-tumores-malignos-hepaticos-derechos-un-estudio-de-resultados-clinicos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/258/avances-en-la-biopsia-liquida-para-el-cancer-de-mama-biomarcadores-moleculares-y-aplicaciones-clinicas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/5/tratamiento-dirigido-a-kras-en-el-cancer-colorrectal-revision 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/6/enfoque-en-el-objetivo-kras-en-la-inmunoterapia-del-cancer-colorrectal-razonamiento-desafios-y-direcciones-futuras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/7/la-combinacion-de-un-inhibidor-de-aurka-y-un-inhibidor-de-mek-potencia-significativamente-el-arresto-en-la-fase-g1-y-induce-un-efecto-antitumoral-sinergico-en-celulas-de-cancer-colorrectal-mutantes 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/270/celulas-tumorales-circulantes-y-adn-tumoral-circulante-en-pacientes-con-metastasis-hepaticas-resecables-de-cancer-colorrectal-miracle-un-estudio-prospectivo-observacional-de-biomarcadores 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1295/caracteristicas-y-resultados-en-el-mundo-real-de-pacientes-con-cancer-colorrectal-metastasico-mutante-braf-v600e-en-australia-el-proyecto-coala 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/276/el-ginsenosido-rh2-en-combinacion-con-ifn-potencio-el-efecto-antitumoral-al-mejorar-la-respuesta-de-la-senalizacion-del-interferon-en-las-celulas-de-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/278/alkbh5-suprime-la-modificacion-del-arnm-de-foxm1-mediada-por-m-6-a-para-promover-la-resistencia-al-cetuximab-en-el-cancer-colorrectal-con-mutaciones-en-kras 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/279/vitamina-c-a-dosis-altas-como-tratamiento-dirigido-para-canceres-impulsados-por-kras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/280/recientes-avances-en-la-terapeutica-dirigida-hacia-el-camino-kras-en-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/281/la-alteracion-de-la-autofagia-inducida-por-la-cefarantina-provoca-la-muerte-celular-inmunogenica-y-mejora-la-respuesta-anti-pd-1-en-el-cancer-colorrectal-de-tipo-mss 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/284/los-nanoparticulas-de-plata-conjugadas-con-sericina-quitosana-protegen-contra-el-cancer-colorrectal-inducido-por-1-2-dimetilhidrazino-en-ratones-al-regular-marcadores-biomedicos-metastasicos-prohibir 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/285/adn-tumoral-circulante-como-marcador-pronostico-en-pacientes-con-cancer-colorrectal-metastasico-sometidos-a-terapia-sistemica-una-revision-sistematica-y-metanalisis 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/286/volumen-sintetico-del-volumen-extracelular-tumoral-como-marcador-predictivo-para-pacientes-con-metastasis-hepaticas-de-cancer-colorrectal-antes-de-la-hepatectomia-curativa 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/288/cancerosas-hereditarias-microssatelite-inestables-asociadas-con-el-sindrome-de-lynch-marcadores-pronosticos-y-nuevas-aproximaciones-inmunoterapeuticas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/293/el-elemeno-promueve-la-ferropotesis-para-mejorar-la-sensibilidad-del-imatinib-en-los-tumores-gastrointestinales-del-tejido-de-soporte-mediante-el-objetivo-n6amt1 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/294/modelos-de-aprendizaje-automatico-para-predecir-reacciones-adversas-a-los-farmacos-inducidas-por-quimioterapia-en-pacientes-con-cancer-colorrectal 2026-07-07 monthly 0.5 https://crcwarriors.org/articulo/41/analisis-y-estudio-de-la-asociacion-entre-el-estado-de-los-marcadores-tumorales-sericos-y-las-caracteristicas-clinico-patologicas-asi-como-la-eficacia-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/42/deteccion-de-la-inestabilidad-de-microsatelites-en-el-carcinoma-endometrial-mediante-un-nuevo-ensayo-de-homopolimeros 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/298/un-subconjunto-conservado-de-macrofagos-fabp5-alto-promueve-la-fibrosis-y-la-carcinogenesis-en-enfermedad-hepatica-avanzada 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/302/analisis-pan-cancerigo-y-implicaciones-oncologicas-de-mgam-y-mgam2-hacia-la-oncologia-precisa-y-el-repositioning-de-farmacos-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/303/landscape-actual-del-uso-por-parte-de-la-administracion-de-alimentos-y-medicamentos-de-estados-unidos-de-aprobaciones-regulatorias-aceleradas-para-el-cuidado-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/308/desde-el-banco-de-pruebas-hasta-la-cama-del-paciente-el-viaje-de-desarrollo-de-fruquintinib-como-terapia-para-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/313/los-pacientes-con-cancer-colorrectal-de-inicio-temprano-presentan-una-huella-molecular-distinta-hallazgos-de-un-estudio-de-secuenciacion-de-nueva-generacion-a-gran-escala-realizado-en-1209-pacientes 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/60/tratamiento-radical-para-metastasis-de-adenocarcinoma-rectal-her2-positivo-en-el-higado-un-informe-de-caso-y-revision-de-la-literatura 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/319/la-importancia-de-la-normalizacion-de-los-niveles-de-cea-despues-del-tratamiento-neoadyuvante-en-pacientes-con-metastasis-hepaticas-resecables-inicialmente-de-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/323/terapia-personalizada-en-cancer-colorrectal-metastasico-uso-dirigido-por-biomarcadores-de-biologicos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/74/terapia-dirigida-a-her2-en-el-cancer-colorrectal-una-revision-exhaustiva 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/348/el-analisis-de-todo-el-transcriptoma-identifica-la-fusion-alb-eef1a1-como-un-nuevo-biomarcador-en-el-cancer-colorrectal-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/94/prevalencia-y-implicaciones-clinicas-de-aberraciones-de-pik3ca-en-diferentes-tipos-de-cancer-un-enfoque-de-secuenciacion-del-siguiente-generacion-en-el-mundo-real 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/129/las-contribuciones-multifaceticas-de-los-fibroblastos-asociados-con-el-cancer-a-la-resistencia-a-los-medicamentos-en-tumores-primarios-y-metastasicos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/131/carcinoma-adenoquistico-de-tipo-intestinono-del-seno-nasal-un-estudio-clinico-patologico-de-48-pacientes-con-revision-de-la-literatura 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/137/oportunidades-a-nivel-estatal-para-mejorar-las-pruebas-de-biomarcadores-en-pacientes-con-cancer-avanzado-y-en-planes-regulados-a-nivel-estatal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/145/el-papel-del-microbioma-intratumoral-en-la-ocurrencia-proliferacion-y-metastasis-del-cancer-colorrectal-y-sus-estrategias-terapeuticas-subyacentes 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/146/trim24-favorece-el-desarrollo-del-linfoma-de-celulas-t-y-la-resistencia-a-los-glucocorticoides-mediante-la-separacion-de-fases-del-receptor-de-glucocorticoides-mediada-por-fus 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/402/desentranando-el-papel-de-las-mutaciones-de-prex2-como-marcador-biosanguineo-para-la-respuesta-a-la-inmunoterapia-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/147/desarrollo-e-interpretacion-de-un-modelo-basado-en-la-patomica-para-la-prediccion-de-la-respuesta-a-la-inmunoterapia-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/452/fenotipos-tumorales-del-cancer-colorrectal-asociados-con-mutaciones-en-sitios-calientes-de-kras-nras-y-braf 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/460/un-varon-de-cuarenta-y-tres-anos-con-metastasis-penica-y-cavernosa-a-partir-de-un-cancer-rectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/236/calidad-de-vida-relacionada-con-la-salud-en-pacientes-con-cancer-metastasico-de-colon-y-recto-quimorrefractario-mutado-en-kras-g12c-tratados-con-sotorasib-mas-panitumumab-o-tratamiento-estandar 2026-08-14 monthly 0.5 https://crcwarriors.org/articulo/246/la-caracterizacion-integrativa-a-nivel-transcriptomico-y-mediante-el-analisis-de-proteinas-a-nivel-de-celula-unica-del-carcinoma-colorrectal-permite-identificar-distintos-microambientes-inmunitarios 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/249/impacto-clinico-de-las-alteraciones-subclonales-del-ras-braf-en-biopsias-liquidas-de-pacientes-con-crc-avanzado-o-metastasico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/251/relevancia-pronostica-de-la-mutacion-de-ras-en-ctdna-en-pacientes-con-cancer-colorrectal-metastasico-tratados-con-cetuximab 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/252/una-nueva-era-en-el-cancer-colorrectal-la-inteligencia-artificial-al-frente 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/254/alteracion-de-la-heterodimerizacion-de-c-myc-max-inducida-por-un-nuevo-agente-antitumoral-que-contiene-un-grupo-1-3-difenilurea-un-enfoque-combinado-in-silico-basado-en-la-quimioproteomica-y-in-vitro 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/255/la-tecnologia-de-omicas-espaciales-potencialmente-promueve-el-progreso-de-la-inmunoterapia-oncologica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/295/la-modulacion-inmunitaria-a-traves-de-las-interacciones-kir-hla-influye-en-la-eficacia-del-cetuximab-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/296/marcadores-biomarcadores-agnosticos-y-firmas-moleculares-en-cancer-colorrectal-dirigiendo-quimioterapia-y-prediciendo-respuesta 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/289/inhibicion-de-prmt5-como-una-estrategia-potencial-para-el-crc-mutante-de-kras-mediadores-downstream-del-crosstalk-prmt5-kras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/290/evaluacion-de-los-resultados-a-largo-plazo-tras-la-cirugia-citorreductora-para-la-metastasis-peritoneal-del-cancer-colorrectal-existen-realmente-pacientes-con-una-supervivencia-prolongada 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/291/folfoxiri-bevacizumab-versus-dobletes-bevacizumab-como-terapia-inicial-de-cancer-colorectal-metastasico-resecable-solo-en-el-higado-derecho-y-o-mutado-en-ras-o-braf-un-analisis-agrupado-basado-en 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/55/la-eficacia-y-seguridad-de-la-quimio-radioterapia-neoadyuvante-y-adyuvante-combinada-con-cirugia-en-pacientes-con-cancer-rectal-avanzado-localmente-que-presentan-un-sistema-defectuoso-de-reparacion 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/287/un-circuito-de-retroalimentacion-positiva-entre-stat1-y-yap1-estimula-la-biosintesis-de-lipidos-acelera-el-crecimiento-tumoral-y-favorece-la-resistencia-a-la-quimioterapia-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/304/la-mapeo-espacial-de-celulas-individuales-revela-la-alteracion-del-microentorno-tisular-durante-los-primeros-estadios-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/283/el-potencial-pronostico-del-arn-en-el-cancer-de-colon-en-estadio-ii-hallazgos-de-un-estudio-de-cohorte-multicentrico-y-basado-en-la-poblacion 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/282/sintesis-eficiente-optimizacion-guiada-por-la-estabilidad-y-evaluacion-de-la-actividad-anti-colitis-ulcerosa-del-peptido-melitina-presente-en-el-veneno-de-abeja 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/361/una-compilacion-de-13-pacientes-con-cancer-colorrectal-metastasico-y-mutaciones-concurrentes-en-braf-y-la-familia-ras 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/277/la-variante-de-rasal2-promueve-una-senalizacion-ras-aberrante-y-resistencia-a-la-terapia-anti-egfr-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/275/akr1b10-regula-la-estabilidad-de-c-myc-para-suprimir-la-metastasis-del-cancer-colorrectal-mediante-la-nitracion-de-pp2a 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/268/identificacion-de-subtipos-relacionados-con-la-metabolizacion-del-cobre-el-desarrollo-de-un-modelo-pronostico-y-caracterizacion-del-paisaje-inmune-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/269/la-oncologia-precisa-para-adenocarcinoma-de-etapa-avanzada-del-appendix-caracterizacion-molecular-integral-identifica-lesiones-accionables-y-potenciales-biomarcadores-predictivos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/271/la-proteina-ribonucleoproteica-ddx39b-promueve-el-progreso-del-adenocarcinoma-colorrectal-al-estabilizar-dclk1 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/272/el-valor-pronostico-de-la-indolamina-2-3-dioxigenasa-en-el-cancer-colorrectal-una-revision-sistematica-y-metaanalisis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/262/cancer-colorrectal-amplificado-por-fgfr1-un-subtipo-pronostico-distinto-identificado-mediante-perfiles-genomicos-integrados-y-inmunohistoquimicos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/263/la-inhibicion-terapeutica-del-eje-de-la-sindecana-1-supera-la-resistencia-adquirida-a-la-terapia-dirigida-a-kras-en-los-canceres-gastrointestinales 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/259/kras-la-llave-vulnerable-de-la-biologia-del-cancer-de-pancreas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/260/carcinoma-de-celulas-escamosas-del-colon-puerperal-con-una-mutacion-braf-v600e-informe-de-un-caso 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/261/puntuaciones-de-consumo-de-alcohol-basadas-en-metilacion-como-biomarcadores-pronosticos-en-cancer-colorrectal-perspectivas-de-una-cohorte-basada-en-la-poblacion 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/338/progreso-en-la-investigacion-para-predecir-mutaciones-del-gen-kras-en-cancer-colorrectal-mediante-el-uso-de-radiomica-y-imagen-medica-multimodal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/256/enfoque-en-los-antibodios-que-se-dirigen-a-pd-1-pd-l1-en-el-cancer-colorrectal-existen-opciones-mas-alla-de-dostarlimab-nivolumab-y-pembrolizumab-una-revision-comprehensiva 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/257/deteccion-de-inestabilidad-de-microsatelites-en-cancer-mediante-etiquetas-raman-mejoradas-por-brecha-ortogonal-multiplexadas 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/250/diseno-sintesis-y-evaluacion-biologica-de-derivados-de-e-4-2-1h-indol-5-il-metileno-hidrazinilo-5-6-7-8-tetrahidropirido-4-3-4-5-tieno-2-3-d-pirimidina-como-inhibidores-de-arf1-gefs-para-el 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/267/candida-albicans-impulsa-la-progresion-del-cancer-colorrectal-al-inducir-la-senalizacion-de-hipoxia 2026-08-10 monthly 0.5 https://crcwarriors.org/articulo/247/la-imagen-guiada-por-fluorescencia-de-verde-de-cianuro-de-indoxamina-mejora-la-eficiencia-y-precision-del-desbridamiento-linfatico-de-los-ganglios-linfaticos-del-arbol-linfatico-del-arterio 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/248/la-transformacion-de-la-representacion-del-paciente-utilizando-registros-electronicos-de-salud-permite-la-estratificacion-del-paciente-y-el-analisis-del-progreso 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/238/s100a14-como-un-potencial-biomarcador-de-la-via-neoplasica-serrata-del-colonrecto 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/239/factores-pronosticos-en-metastasis-hepaticas-de-colorectales-una-revision-exhaustiva-de-la-literatura-y-perspectivas-futuras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/240/navegando-el-paisaje-de-la-biopsia-liquida-en-cancer-colorrectal-perspectivas-actuales-y-direcciones-futuras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/241/analisis-de-los-resultados-discordantes-entre-la-pcr-de-fluorescencia-multiple-por-electroforesis-capilar-para-la-deteccion-de-la-inestabilidad-de-microsatelites-msi-y-la-inmunohistoquimica-ihq-para 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/242/un-polimero-que-imita-un-gasdermin-activado-para-inmunidad-antitumoral 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/230/cxcl13-como-biomarcador-pronostico-y-modulador-del-microambiente-tumoral-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/231/enfoques-optimizados-de-entrega-bacteriana-para-la-inmunoterapia-precisa-en-modelos-de-cancer-de-mama 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/233/la-formacion-de-granulos-estresores-dirigida-por-ubap2l-vincula-la-resistencia-a-la-oxaliplatina-con-el-cancer-gastrico 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/237/pipi-c-un-marco-de-optimizacion-combinatoria-para-identificar-cruces-de-modificaciones-pos-traducionales-en-datos-de-espectrometria-de-masas 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/170/una-hendidura-tubular-parecida-a-un-hidrospongelo-para-terapia-multifuncional-de-cancer-colorrectal-avanzado-following-the-instructions-strictly-a-hendidura-tubular-parecida-a-un-hidrospongelo-para 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/8/la-correlacion-de-los-datos-genomicos-obtenidos-mediante-biopsia-liquida-con-la-radiomica-en-pacientes-con-cancer-de-colon-pancreas-pulmon-y-prostata 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/11/nsabp-fc-11-un-estudio-de-fase-ii-de-neratinib-mas-trastuzumab-o-neratinib-mas-cetuximab-en-pacientes-con-cancer-colorrectal-metastasico-cuadruple-wild-type-kras-nras-braf-pik3ca-segun-el-estado-de 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/12/analisis-computacional-para-identificar-fitoquimicos-que-actuen-sobre-la-forma-mutada-de-kras-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/20/mutaciones-de-kras-en-el-cancer-de-las-perspectivas-moleculares-a-las-estrategias-terapeuticas 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/25/patrones-de-tratamiento-y-resultados-en-la-practica-clinica-segun-el-estado-de-ras-braf-en-el-cancer-colorrectal-metastasico-analisis-del-estudio-prospectivo-del-grupo-de-pacientes-con-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/26/eficacia-antitumoral-del-inhibidor-de-raf-mek-vs6766-en-celulas-de-cancer-colorrectal-con-mutacion-de-kras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/28/impacto-pronostico-de-la-mutacion-braf-v600e-en-pacientes-con-cancer-colorrectal-metastasico-msi-alto-tratados-con-inhibidores-de-puntos-de-control-inmunitario 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/29/fosforilacion-de-kiaa1429-promueve-resistencia-a-oxaliplatino-mediante-activacion-de-la-senalizacion-fzd7-wnt-en-cancer-colorrectal-mutado-en-braf-v600e 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/31/diseno-y-sintesis-de-nuevas-2-s-alquilquinazolinonas-como-inhibidores-duales-de-braf-v600e-y-egfr-en-el-melanoma-informacion-mecanicista-sobre-la-modulacion-de-la-apoptosis-y-el-ciclo-celular 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/33/reprogramacion-de-la-plasticidad-celular-a-traves-de-los-circuitos-reguladores-centrales-de-ets-y-myc-durante-la-respuesta-a-la-inhibicion-de-mapk-en-el-cancer-colorrectal-con-mutacion-en-braf 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/36/una-fuerte-expresion-de-hsp90-en-el-crc-primario-avanzado-se-asocia-con-una-menor-supervivencia-y-predice-la-respuesta-al-inhibidor-especifico-de-hsp90-pimitespib 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/43/papel-de-los-inhibidores-de-puntos-de-control-inmunitario-neoadyuvantes-en-el-cancer-rectal-localmente-avanzado-una-revision-sistematica-de-los-estudios-actualmente-disponibles 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/44/optimizacion-del-tratamiento-neoadyuvante-con-pembrolizumab-para-cancer-colorrectal-de-alto-grado-microsatelites-inestables-localmente-avanzado-utilizando-ecuaciones-integro-diferenciales-de-retraso 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/47/la-bacteria-probiotica-clostridium-butyricum-que-reside-en-el-tumor-mejora-la-eficacia-de-la-terapia-con-inhibidores-de-pd-1-en-modelos-de-cancer-colorrectal-al-inhibir-la-inmunosupresion-mediada-por 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/51/la-inhibicion-de-kat6a-aumenta-la-eficacia-de-la-inmunoterapia-en-el-cancer-colorrectal-al-activar-la-respuesta-a-interferon 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/53/inmunoterapia-en-canceres-gastrointestinales-lecciones-de-ensayos-clave-y-aplicaciones-clinicas-futuras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/54/caracteristicas-del-adenocarcinoma-hepatoide-gastrico-un-analisis-clinico-patologico-y-molecular 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/56/algunos-pacientes-con-cancer-colorrectal-pmmr-deben-someterse-a-una-prueba-adicional-de-pcr-msi-para-reducir-el-riesgo-de-mal-diagnostico-de-msi-h-y-sindrome-de-lynch 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/57/se-puede-usar-eficazmente-el-pembrolizumab-o-el-nivolumab-contra-los-canceres-colorrectales-con-defecto-en-la-reparacion-de-desajuste-y-alto-indice-de-inestabilidad-microsatelital 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/58/vacunas-terapeuticas-contra-el-cancer-colorrectal-modalidades-emergentes-y-oportunidades-de-traslacion 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/59/avances-en-la-inmunoterapia-neoadyuvante-para-el-cancer-colorrectal-localmente-avanzado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/62/baja-frecuencia-de-expresion-de-her2-en-cancer-colorrectal-un-estudio-de-un-centro-en-tunez 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/65/investigacion-de-la-incidencia-de-las-alteraciones-de-ras-raf-y-pik3ca-en-el-cancer-colorrectal-con-amplificacion-de-her2-un-analisis-exhaustivo 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/66/el-analisis-de-las-conexiones-mutacionales-germinales-y-somaticas-en-el-cancer-colorrectal-revela-patrones-tumorigenicos-diferenciales-y-un-nuevo-marcador-predictivo-para-los-portadores-de-mutaciones 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/68/caracterizacion-comprehensiva-de-mcl-1-en-pacientes-con-cancer-colorrectal-expresion-perfiles-moleculares-y-resultados 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/69/trastuzumab-mas-pertuzumab-versus-cetuximab-mas-irinotecan-en-pacientes-con-ras-braf-de-tipo-salvaje-her2-positivo-cancer-colorrectal-metastasico-s1613-un-ensayo-clinico-aleatorizado-fase-ii 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/73/eficacia-del-tratamiento-que-contiene-disitamab-vedotin-en-el-cancer-colorrectal-metastasico-un-informe-de-caso 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/75/que-viene-para-el-cancer-colorrectal-refractario-crc-mirando-mas-alla-de-sunlight-fresco2-recurse-y-correct 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/77/taletrectinib-promueve-la-piroptosis-en-el-carcinoma-colorrectal-a-traves-de-la-inhibicion-del-eje-src-akt-mtor 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/78/estado-actual-de-la-medicina-personalizada-en-cancer-colorrectal-en-japon 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/79/eficacia-y-seguridad-de-larotrectinib-en-pacientes-con-cancer-gastrointestinal-con-fusion-de-trk 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/83/fusion-genica-del-gen-ntrk-y-caracteristicas-patologicas-moleculares-del-cancer-colorrectal-deficit-de-reparacion-de-desajustes 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/86/bpi-28592-como-un-nuevo-inhibidor-de-segunda-generacion-para-tumores-con-fusion-de-ntrk 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/88/perfiles-cromosomicos-mutacionales-y-de-transcripcion-distintivos-en-canceres-de-colon-versus-recto 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/89/elegir-ando-a-los-pacientes-correctos-para-el-tratamiento-adyuvante-con-acido-acetilsalicilico-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/90/tratamiento-adyuvante-con-aspera-en-pacientes-con-cancer-colorrectal-mutado-en-pik3ca-el-ensayo-clinico-prospectivo-aleatorizado-controlado-con-placebo-y-doble-ciego-sakk-41-13 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/92/el-eje-inmunitario-tim-3-galectina-9-en-el-cancer-colorrectal-en-relacion-con-las-mutaciones-de-kras-nras-braf-pik3ca-akt1-el-estado-de-msi-y-el-entorno-de-citoquinas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/93/inhibicion-de-la-familia-bcl-2-potencia-la-inhibicion-de-mtorc1-2-en-cancer-colorrectal-mutante-de-pik3ca 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/95/las-mutaciones-especificas-del-codon-de-kras-modulan-de-forma-diferente-la-senalizacion-de-la-via-pi3k-y-alteran-la-sensibilidad-a-inavolisib-gdc-0077 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/97/analisis-completo-de-mutaciones-de-pik3ca-en-cancer-colorrectal-avanzado-utilizando-el-perfiles-de-adn-tumoral-circulante 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/98/comparacion-de-las-mutaciones-somaticas-y-las-caracteristicas-clinicopatologicas-de-los-carcinomas-colorrectales-micropapilares-y-no-micropapilares 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/99/utilidad-clinica-del-monitoreo-de-adn-tumoral-circulante-utilizando-un-panel-de-secuenciacion-de-proxima-generacion-dirigido-en-pacientes-con-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/100/la-aspirina-en-la-quimoprevencion-del-cancer-colorrectal-donde-estamos 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/103/iluminando-el-papel-de-las-mutaciones-en-kras-nras-y-braf-y-la-inestabilidad-microssatelital-en-el-cancer-colorrectal-a-traves-de-la-secuenciacion-por-next-generation 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/121/estabilidad-fotolica-mejorada-y-capacidad-de-targeting-de-nanovehiculos-huecos-mesoporosos-basados-en-manganeso-para-la-cirugia-guiada-por-imagen-fluorescente-en-el-rango-nir-ii-y-terapia-fototermal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/123/deteccion-altamente-sensible-y-portatil-de-exosomas-pd-l1-utilizando-un-sensor-cromatografico-asistido-por-telefono-inteligente 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/124/deteccion-y-caracterizacion-de-nucleosomas-circulantes-en-cancer-avanzado-mediante-biosensores-electroquimicos-asistidos-por-soportes-magneticos-y-tecnologias-proteomicas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/125/deteccion-rapida-de-metilacion-de-npy-en-cancer-colorrectal-utilizando-una-plataforma-fotoelectroquimica-raciometrica-basada-en-oxigeno-singulete 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/127/metastasis-hepaticas-o-peritoneales-la-secuenciacion-de-rna-de-una-celula-revela-que-la-organotropismo-en-el-cancer-colorrectal-es-impulsado-por-procesos-distintos-de-emt-parcial 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/130/prevencion-de-complicaciones-pulmonares-tras-la-cirugia-colorrectal-laparoscopica-un-protocolo-de-proteccion-pulmonar-frente-a-la-atencion-estandar-un-ensayo-clinico-aleatorizado-y-controlado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/132/utilidad-del-adn-tumoral-circulante-para-detectar-enfermedad-residual-minima-en-cancer-colorrectal-una-revision-sistematica-y-un-metanalisis-de-red 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/133/los-analisis-de-microarreglos-de-tejidos-y-las-tecnicas-de-biopsia-liquida-identifican-a-ephb3-cmet-y-mir-3168-como-biomarcadores-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/134/desarrollo-y-evaluacion-preclinica-de-la-imaginaria-inmunologica-pet-especifica-para-cdh17-en-canceres-colorrectales 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/135/eficacia-en-la-practica-clinica-de-la-quimioterapia-combinada-con-bevacizumab-e-inmunoterapia-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/136/una-evaluacion-preliminar-de-un-perfil-de-microarn-basado-en-heces-para-la-deteccion-temprana-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/138/p2x7-un-nuevo-objetivo-terapeutico-para-bloquear-la-metastasis-dependiente-de-vesiculas-en-carcinoma-colorrectal-papel-del-eje-a2a-cd39-cd73 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/144/perfiles-transcriptomicos-y-priorizacion-estadistica-dirigida-por-bioinformatica-de-marcadores-biosanguineos-en-crc-un-paso-hacia-la-oncologia-precisa 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/148/antigenos-autologos-expresados-en-mamiferos-6xhis-halotag-para-la-deteccion-de-respuesta-humoral-con-biosensores-electroquimicos-multiplexados-un-avance-en-el-diagnostico-personalizado-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/149/desarrollo-y-validacion-de-un-modelo-integrativo-de-identificacion-de-riesgo-basado-en-54-biomarcadores-para-multiples-tipos-de-cancer-en-42-666-individuos-un-estudio-prospectivo-basado-en-la 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/150/variaciones-geneticas-y-implicacion-del-haplotipo-de-la-long-intergenic-non-coding-rna-00511-linc00511-para-la-susceptibilidad-y-el-pronostico-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/151/aplicacion-de-la-foodomics-en-el-campo-de-la-prevencion-diagnostico-y-tratamiento-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/152/sistema-de-administracion-basado-en-ferritina-con-doble-direccionamiento-bloquea-la-comunicacion-entre-celulas-cancerosas-y-fibroblastos-asociados-al-cancer-para-potenciar-la-inmunoterapia-del-cancer 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/153/las-interacciones-microbianas-inducen-la-firma-mutacional-de-la-deficiencia-del-sistema-de-reparacion-de-errores-de-emparejamiento-en-el-cancer-colorrectal-y-se-asocian-con-mutaciones-en-eppk1 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/154/una-expresion-elevada-de-ms4a12-indica-resistencia-a-la-quimiorradioterapia-concomitante-y-una-menor-supervivencia-en-pacientes-con-cancer-de-recto 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/156/analisis-comparativo-de-la-mortalidad-por-neoplasias-malignas-en-moscu-y-la-region-de-moscu 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/189/vacuna-anfifila-dirigida-a-los-ganglios-linfaticos-y-especifica-para-mkras-en-cancer-de-pancreas-y-cancer-colorrectal-resultados-finales-del-ensayo-de-fase-1-amplify-201 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1392/efecto-de-la-peep-individualizada-en-la-puntuacion-de-la-ecografia-pulmonar-y-el-diametro-de-la-vaina-del-nervio-optico-en-pacientes-geriatricos-sometidos-a-cirugia-laparoscopica-para-el-cancer-de 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/224/condados-biomoleculares-de-topbp1-un-nuevo-objetivo-terapeutico-en-cancer-colorrectal-de-etapas-avanzadas 2026-08-11 monthly 0.5 https://crcwarriors.org/articulo/14/asociacion-entre-la-expresion-de-cd147-estado-mutacional-de-ras-y-recurrencia-local-en-cancer-rectal-avanzado-localmente-resecado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/15/caracteristicas-clinico-patologicas-del-cancer-colorrectal-mutante-de-kras-un-estudio-analitico-transversal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/16/adagrasib-en-el-tratamiento-del-cancer-colorrectal 2026-07-07 monthly 0.5 https://crcwarriors.org/articulo/17/inhibidores-de-pan-ras-y-polo-like-quinasa-1-objetivos-prometedores-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/18/caracteristicas-clinicas-y-pronosticas-del-cancer-colorrectal-metastasico-con-mutaciones-menores-de-ras 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/19/factores-predictivos-de-respuesta-a-la-quimioterapia-en-metastasis-hepaticas-de-colton-rectal-un-estudio-retrospectivo-que-utiliza-secuenciacion-por-nueva-generacion 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/23/la-co-prueba-de-src-supera-la-resistencia-a-los-inhibidores-de-braf-en-el-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/24/presentamos-el-caso-de-una-recurrencia-en-la-anastomosis-12-anos-despues-de-una-reseccion-interesfinter-para-un-melanoma-anorrectal-maligno 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/46/el-panorama-actual-de-la-terapia-neoadyuvante-para-el-cancer-de-colon-operable 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/61/validando-la-evaluacion-de-variacion-en-el-numero-de-copias-de-her2-mediante-ngs-un-analisis-comparativo-con-inmunohistoquimica-e-hibridacion-in-situ 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/851/comparaciones-indirectas-ajustadas-para-la-poblacion-de-terapias-contra-el-cancer-con-prestamo-de-informacion-pan-tumoral 2026-05-27 monthly 0.5 https://crcwarriors.org/articulo/852/d3s-001-en-tumores-solidos-avanzados-con-mutaciones-kras-g12c-un-ensayo-fase-1 2026-04-30 monthly 0.5 https://crcwarriors.org/articulo/383/colostomia-de-emergencia-por-obstruccion-en-cancer-colorrectal-de-inestabilidad-microssatelital-respuesta-completa-siguiendo-quimioterapia-neoadiuvante-inmunoquirurgica-following-the-strict-rules 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/395/efectos-diferenciales-del-gen-kras-en-la-recurrencia-de-metastasis-hepaticas-de-carcinoma-colorrectal-de-lado-derecho-vs-lado-izquierdo-sometidas-a-ablacion-por-radiofrecuencia 2026-07-06 monthly 0.5 https://crcwarriors.org/articulo/1393/electroacupuntura-frente-a-electroacupuntura-simulada-en-el-tratamiento-del-sindrome-de-reseccion-anterior-baja-tras-la-cirugia-de-cancer-de-recto-protocolo-de-estudio-para-un-ensayo-controlado 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/190/pretamab-artesan-un-conjugado-de-anticuerpo-farmaco-contra-ceacam5-en-cancer-colorrectal-metastasico-un-ensayo-fase-1 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/229/inhibidor-natural-basado-en-inteligencia-artificial-que-se-dirige-a-rps20-para-el-tratamiento-del-cancer-colorrectal-utilizando-enfoques-computacionales-integrados 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/225/no-tengo-una-bola-de-cristal-control-del-tiempo-durante-el-tratamiento-del-cancer-colorrectal 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/30/analisis-genomico-exhaustivo-mediante-biopsia-liquida-en-pacientes-con-cancer-colorrectal-metastasico-refractario-que-son-candidatos-para-una-nueva-terapia-anti-egfr-resultados-del-ensayo-cave-2-goim 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/48/aplicando-la-inmunoterapia-en-cancer-colorrectal-msi-h-dmmr-espontaneo-un-estudio-de-caso 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/50/marcadores-predictivos-en-la-inmunoterapia-oncologica-una-revision-narrativa-en-tumores-solidos-seleccionados 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/52/marcadores-predictivos-para-la-inhibicion-de-puntos-de-control-inmune-en-pacientes-con-cancer-colorrectal-una-revision-exhaustiva 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/854/inhibidores-de-kras-g12c-como-monoterapia-o-en-combinacion-para-el-cancer-colorrectal-metastasico-un-metaanalisis-comparativo-y-de-proporciones-de-la-eficacia-y-la-toxicidad-de-los-ensayos-de-fase-i 2026-04-25 monthly 0.5 https://crcwarriors.org/articulo/855/respuesta-y-resistencia-diferenciales-a-la-terapia-dirigida-a-kras 2026-04-21 monthly 0.5 https://crcwarriors.org/articulo/856/analisis-de-supervivencia-global-del-estudio-codebreak-300-de-fase-iii-de-sotorasib-en-combinacion-con-panitumumab-versus-eleccion-del-investigador-en-cancer-colorrectal-resistentes-a-la 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/101/el-adn-de-la-mutacion-de-pik3ca-derivado-de-los-exosomas-de-celulas-cancerosas-colorrectales-promueve-la-metastasis-tumoral-al-activar-a-los-fibroblastos-y-afectar-el-microentorno-metastasico-tumoral 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/227/tratamiento-del-cancer-colorrectal-impulsado-por-nanotecnologia-coincapsulizacion-de-irinotecano-y-ciclosporina-a-en-snedds-para-resultados-superiores 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/191/analisis-conjunto-de-3-741-metagenomas-de-heces-de-18-cohortes-para-marcadores-microbianos-reproducibles-a-nivel-de-etapa-y-cepa-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/34/tratamiento-exitoso-de-carcinoma-intrahepatico-de-conducto-bileaco-mutante-braf-v600e-con-encorafenib-binimetinib-y-cetuximab 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/37/cancer-colorrectal-de-apresentacion-temprana-de-la-descubierta-genetica-a-la-innovacion-clinica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/38/identificacion-in-silico-de-nuevos-epotentes-inhibidores-contra-la-forma-mutada-de-braf-v600e-simulaciones-de-dinamica-molecular-calculos-de-energia-libre-y-determinacion-experimental-de-la-afinidad 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/39/el-potencial-beneficio-de-encorafenib-mas-cetuximab-con-quimioterapia-en-comparacion-con-el-tratamiento-estandar-en-personas-con-cancer-colorrectal-metastasico-mutante-braf-v600e-en-el-estudio 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/859/landscape-genomico-de-las-alteraciones-de-resistencia-adquirida-clinicamente-en-pacientes-tratados-con-inhibidores-de-kras-g12c 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/874/un-resumen-en-lenguaje-sencillo-de-los-cambios-moleculares-que-se-observan-en-los-tumores-de-pacientes-con-cancer-colorrectal-con-la-mutacion-braf-v600e-segun-el-estudio-beacon 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/890/cancer-colorrectal-con-alta-carga-mutacional-tumoral-y-amplificacion-de-la-transicion-mesenquima-epitelio-met-con-enfermedad-hiperprogresiva-despues-del-tratamiento-con-pembrolizumab 2026-07-14 monthly 0.5 https://crcwarriors.org/articulo/860/el-papel-emergente-de-la-terapia-combinada-con-sotorasib-y-panitumumab-en-el-tratamiento-del-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/861/la-inhibicion-de-stat3-previene-la-resistencia-adaptativa-y-aumenta-la-citotoxicidad-de-las-celulas-nk-frente-a-los-inhibidores-de-kras-g12c-en-cancer-de-pulmon-no-pequeno 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/955/preparacion-y-evaluacion-de-la-capacidad-antitumoral-de-anticuerpos-anti-pd-l1-conjugados-con-curcumina-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/226/sistemas-de-entrega-nanomedica-dirigidos-e-inteligentes-para-el-tratamiento-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/228/avances-en-cargadores-lipidicos-nanoestructurados-para-el-tratamiento-del-cancer-colorrectal-una-revision-comprehensiva 2026-07-25 monthly 0.5 https://crcwarriors.org/articulo/71/un-analisis-genomico-exhaustivo-mediante-biopsia-liquida-permite-caracterizar-el-perfil-mutacional-del-cancer-colorrectal-metastasico-y-predecir-la-eficacia-antitumoral-del-regimen-folfiri-mas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/72/perfilacion-comprehensiva-de-erbb2-y-prognostico-en-cancer-colorrectal-de-etapa-iii-encontras-del-conjunto-de-datos-petacc8-y-idea-francia 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/80/caracteristicas-moleculares-y-aplicabilidad-clinica-de-las-fusiones-genicas-en-el-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/81/la-subtipificacion-molecular-y-la-elaboracion-de-perfiles-genomicos-amplian-la-medicina-de-precision-en-el-cancer-de-pancreas-con-kras-tipo-salvaje 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/245/como-tratar-el-adenocarcinoma-gastro-esofagico-con-dmmr-msi-en-2025-un-documento-de-posicion-del-grupo-de-trabajo-gastro-esofagico-eortc-gitcg 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/84/un-estudio-de-la-carga-mutacional-tumoral-realizado-en-la-base-de-datos-aacr-genie-revelo-que-el-carcinoma-colorrectal-crc-con-fusiones-ntrk-ntrk-y-ret-ret-representa-subconjuntos-distintos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/888/diseno-del-estudio-fase-iii-mountaineer-03-primera-linea-mfolfox6-tucatinib-trastuzumab-para-cancer-colorrectal-metastasico-her2 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/921/fosfatasa-alcalina-un-biomarcador-pronostico-en-pacientes-con-adenocarcinoma-colorectal-no-metastasico-un-estudio-de-un-solo-centro 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/274/entendiendo-la-quimiorresistencia-mediada-por-microarn-en-el-tratamiento-del-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/192/encorafenib-cetuximab-y-quimioterapia-en-cancer-colorrectal-con-mutacion-de-braf-un-ensayo-clinico-aleatorizado-fase-3 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/545/desvelando-el-potencial-tumoral-del-proteina-prion-celular-en-la-progresion-del-cancer 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/573/lrrc59-inhibe-la-apoptosis-inducida-por-el-camino-de-perk-y-promueve-la-proliferacion-migracion-e-invasion-de-celulas-cancerosas-colorrectales 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/642/corrigendum-el-compuesto-225-inhibe-la-proliferacion-de-celulas-de-cancer-colorrectal-humano-al-promover-la-detencion-del-ciclo-celular-e-inducir-apoptosis 2026-04-10 monthly 0.5 https://crcwarriors.org/articulo/668/sintesis-facil-de-silicalite-1-con-arquitecturas-porosas-ajustables-a-traves-de-desilicatizacion-recrecimiento-mejora-en-la-entrega-de-doxorubicina-y-inhibicion-del-crecimiento-contra-el-cancer 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1394/la-ultrasonografia-endorrectal-multimosical-basada-en-clip-mejora-la-prediccion-de-la-respuesta-al-quimiorradioterapia-neoadyuvante-en-cancer-rectal-avanzado-localmente 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/193/analisis-molecular-del-cancer-colorrectal-metastasico-con-mutacion-braf-v600e-en-el-ensayo-de-fase-3-beacon-crc 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/87/relevancia-clinica-y-potencial-terapeutico-de-las-fusiones-reciprocas-de-un-unico-gen-de-quinasa-un-estudio-a-gran-escala 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1395/correccion-protocolo-el-papel-del-estoma-desfrentador-antes-de-la-terapia-neoadiuvante-en-cancer-colorrectal-avanzado-localmente-revision-sistematica 2026-03-30 monthly 0.5 https://crcwarriors.org/articulo/1396/desentranando-el-papel-de-las-metricas-de-composicion-corporal-derivadas-de-la-tomografia-computarizada-en-las-tasas-de-fugas-anastomoticas-en-la-cirugia-del-cancer-rectal-un-protocolo-para-una 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1397/implementacion-de-la-rehabilitacion-del-piso-pelvico-despues-de-la-cirugia-de-cancer-rectal-un-estudio-cualitativo-guiado-por-el-marco-consolidado-para-la-implementacion-de-la-investigacion-cfir 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/364/enfoque-basado-en-una-puntuacion-pronostica-guiada-por-imagen-para-evaluar-los-beneficios-de-la-terapia-combinada-frente-a-la-monoterapia-con-inhibidores-de-puntos-de-control-inmunitario-en-pacientes 2026-08-25 monthly 0.5 https://crcwarriors.org/articulo/362/informe-de-caso-eficacia-de-la-inmunoterapia-como-terapia-conversora-en-cancer-colorrectal-dmmr-msi-h-una-serie-de-casos-y-revision-de-la-literatura 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1398/eficacia-a-largo-plazo-de-la-reseccion-local-transanal-frente-a-la-reseccion-total-del-meso-recto-tras-el-tratamiento-neoadyuvante-para-el-cancer-de-recto-un-metaanalisis 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1399/aplicar-una-neoescore-en-cancer-rectal-de-avanzada-local-es-beneficioso-para-predecir-las-recidivas-locales-despues-de-la-cirugia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/365/manejo-noquirurgico-de-cancer-colorrectal-dmmr-msi-h-despues-de-la-inmunoterapia-neoasociativa-una-revision-narrativa 2026-08-31 monthly 0.5 https://crcwarriors.org/articulo/363/desafios-y-oportunidades-terapeuticas-en-el-escenario-del-cancer-colorrectal-dmmr-msi-h 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/366/analisis-genomico-y-transcriptomico-de-pacientes-con-cancer-colorrectal-msi-h-con-alteraciones-targetables-identifica-implicaciones-clinicas-para-la-inmunoterapia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1400/tratamiento-neoauricular-total-versus-terapia-estandar-en-cancer-rectal-avanzado-localmente-una-revision-sistematica-y-metanalisis-de-15-ensayos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1401/protocolo-el-papel-del-estoma-desfuncional-antes-de-la-terapia-neoadiuvante-para-cancer-colorrectal-avanzado-localmente-revision-sistematica 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1402/utilidad-del-ctdna-en-la-prediccion-de-la-respuesta-a-la-quimiorradioterapia-neoadyuvante-y-en-la-evaluacion-del-pronostico-en-el-cancer-colorrectal-localmente-avanzado-un-estudio-de-cohortes 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1367/enmarcar-el-potencial-de-peptidos-marcoframaticos-publicos-como-objetivos-de-inmunoterapia-en-cancer-colorrectal 2026-04-03 monthly 0.5 https://crcwarriors.org/articulo/1403/identificacion-de-posibles-biomarcadores-metabolicos-del-cancer-de-recto-y-del-efecto-de-la-quimiorradioterapia-neoadyuvante 2026-04-20 monthly 0.5 https://crcwarriors.org/articulo/1368/estado-mutacional-y-valor-pronostico-de-las-mutaciones-de-kras-y-nras-en-pacientes-marroquies-con-cancer-colorrectal-un-primer-informe 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1369/grifolin-neogrifolin-y-confluentin-del-polipodo-terricola-albatrellus-flettii-suprimen-la-expresion-de-kras-en-celulas-cancerosas-colon-humanas 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1370/uso-de-quimioterapia-adyuvante-en-pacientes-con-cancer-de-colon-en-etapa-iii-en-puerto-rico-un-estudio-basado-en-la-poblacion 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1371/el-aceite-de-pescado-mitiga-la-miostenosis-y-mejora-la-eficacia-de-la-quimioterapia-en-un-modelo-preclinico-de-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1372/la-influencia-del-estado-de-mutacion-de-braf-y-kras-en-la-asociacion-entre-el-uso-de-aspirina-y-la-supervivencia-despues-del-diagnostico-de-cancer-colorrectal 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1373/cancer-de-colon-en-etapa-iii-la-estrategia-individualizada-de-quimioterapia-adyuvante-para-pacientes-mayores-y-menores-de-70-anos 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1374/enfoque-en-el-oncogen-kras-en-celulas-de-cancer-colorrectal-con-derivados-trialquiamina-de-indolo-3-2-b-quinolina-7-carboxilato 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1375/el-estado-de-metilacion-de-line-1-se-correlaciona-significativamente-con-la-recurrencia-posterapeutica-en-pacientes-con-cancer-de-colon-en-estadio-iii-que-reciben-quimioterapia-adyuvante-con-folfox-4 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1376/el-impacto-del-retraso-en-la-administracion-de-la-quimioterapia-en-su-finalizacion-y-en-los-resultados-de-supervivencia-en-pacientes-con-cancer-de-colon-en-estadio-ii 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1377/los-procianidinos-de-bajo-peso-molecular-presentes-en-las-semillas-de-uva-potencian-el-efecto-de-la-quimioterapia-con-5-fluorouracilo-sobre-las-celulas-caco-2-de-cancer-de-colon-humano 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1378/quimioinmunoterapia-con-oxaliplatino-e-interleucina-7-inhibe-la-metastasis-del-cancer-de-colon-en-ratones 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1379/evaluacion-de-la-supervivencia-libre-de-recurrencia-en-cancer-de-colon-t3n0-el-papel-de-la-quimioterapia-un-analisis-retrospectivo-multicentrico 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1380/el-acido-eicosapentaenoico-omega-3-disminuye-la-expresion-del-marcador-cd133-caracteristico-de-las-celulas-madre-del-cancer-de-colon-al-tiempo-que-aumenta-la-sensibilidad-a-la-quimioterapia 2026-04-19 monthly 0.5 https://crcwarriors.org/articulo/1388/la-quimioterapia-sensibiliza-a-las-celulas-iniciadoras-del-cancer-de-colon-a-la-citotoxicidad-mediada-por-las-celulas-t-v9v2 2026-04-19 monthly 0.5 https://crcwarriors.org/news-detail.php?id=nuevas-funcionalidades-en-el-buscador-de-ensayos-clinicos-mapa-interactivo-filtros-avanzados-y-mas 2026-09-07 monthly 0.5 https://crcwarriors.org/news-detail.php?id=nueva-experiencia-de-noticias-cientificas-ia-personalizada-traduccion-en-tiempo-real-y-mucho-mas 2026-08-31 monthly 0.5 https://crcwarriors.org/news-detail.php?id=lanzamos-la-beta-de-crc-warriors-buscamos-testers 2026-08-31 monthly 0.5 https://crcwarriors.org/news-detail.php?id=glosario-de-farmacos-2-0-mas-inteligente-mas-completo-mas-potente 2026-08-30 monthly 0.5 https://crcwarriors.org/combinaciones/63 2025-12-21 monthly 0.5 https://crcwarriors.org/combinaciones/62 2025-12-21 monthly 0.5 https://crcwarriors.org/combinaciones/33 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/34 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/36 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/52 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/11 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/45 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/42 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/1 2025-12-21 monthly 0.5 https://crcwarriors.org/combinaciones/12 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/48 2025-12-21 monthly 0.5 https://crcwarriors.org/combinaciones/13 2025-12-21 monthly 0.5 https://crcwarriors.org/combinaciones/30 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/53 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/3 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/5 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/50 2025-12-21 monthly 0.5 https://crcwarriors.org/combinaciones/15 2025-12-21 monthly 0.5 https://crcwarriors.org/combinaciones/39 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/59 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/2 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/49 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/56 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/64 2025-12-21 monthly 0.5 https://crcwarriors.org/combinaciones/38 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/4 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/16 2025-12-21 monthly 0.5 https://crcwarriors.org/combinaciones/19 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/54 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/51 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/40 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/55 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/18 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/61 2025-12-21 monthly 0.5 https://crcwarriors.org/combinaciones/41 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/20 2025-12-20 monthly 0.5 https://crcwarriors.org/combinaciones/21 2025-12-07 monthly 0.5 https://crcwarriors.org/combinaciones/22 2025-12-07 monthly 0.5 https://crcwarriors.org/help/getting-started.php 2026-09-01 monthly 0.4 https://crcwarriors.org/help/clinical-trials-guide.php 2026-09-01 monthly 0.4 https://crcwarriors.org/help/understanding-mutations.php 2026-09-01 monthly 0.4 https://crcwarriors.org/help/medication-database.php 2026-09-01 monthly 0.4 https://crcwarriors.org/help/privacy-security.php 2026-09-01 monthly 0.4 https://crcwarriors.org/help/faq.php 2026-09-01 monthly 0.4